data_1rxl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rxl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.607 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 56.6 m . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.11 0.481 . . . . 1.8300000000000001 111.206 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 31.8 mm-40 -85.49 110.97 19.57 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.914 -0.773 . . . . 2.29 108.914 174.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.644 HG21 HG12 ' A' ' 30' ' ' VAL . 7.6 p -109.92 127.72 66.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.495 0.664 . . . . 2.1000000000000001 111.167 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -87.61 107.27 18.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.183 -0.917 . . . . 4.25 109.977 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.469 HG13 ' HA3' ' A' ' 136' ' ' GLY . 44.6 t -110.97 121.27 63.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.642 -0.503 . . . . 1.8200000000000001 109.642 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.17 134.25 12.32 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.713 -0.756 . . . . 1.1899999999999999 112.725 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.33 117.85 14.5 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.31 -0.626 . . . . 2.1800000000000002 109.31 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.6 mt -117.25 98.54 6.49 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.873 -0.331 . . . . 2.0 111.708 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.0 t -102.04 113.25 26.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.122 -0.696 . . . . 1.5600000000000001 109.122 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.631 ' HB ' ' NZ ' ' A' ' 14' ' ' LYS . 76.8 t -152.41 148.67 14.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.093 -0.706 . . . . 2.04 109.093 -174.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -89.96 121.35 31.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.412 0.523 . . . . 1.23 112.412 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.631 ' NZ ' ' HB ' ' A' ' 12' ' ' VAL . 2.7 mptt -143.38 175.99 9.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.119 0.485 . . . . 3.9100000000000001 110.335 172.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.492 ' HA ' ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -111.08 150.0 30.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.503 -0.771 . . . . 1.21 109.994 171.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.492 ' NH1' ' HA ' ' A' ' 15' ' ' THR . 0.1 OUTLIER -86.5 -4.47 59.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.328 -0.619 . . . . 4.0800000000000001 109.328 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.47 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -88.24 -27.97 24.04 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.505 -1.038 . . . . 0.75 110.505 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -66.16 -34.08 77.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.734 -0.839 . . . . 2.6299999999999999 108.734 171.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.492 ' HB3' HG11 ' A' ' 100' ' ' VAL . 94.4 mt -65.99 96.34 0.31 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.876 -1.056 . . . . 1.6100000000000001 108.867 169.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 t -102.95 66.22 0.91 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.022 0.915 . . . . 2.2599999999999998 109.728 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.651 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 28.4 t70 65.48 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.515 -1.22 . . . . 1.8300000000000001 110.695 -174.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.42 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -95.11 76.05 3.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.17 0.51 . . . . 1.4299999999999999 110.686 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -142.69 99.32 5.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.992 -0.549 . . . . 1.3700000000000001 110.276 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.473 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 71.4 Cg_endo -75.98 100.27 1.36 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.748 2.299 . . . . 1.1200000000000001 112.484 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.558 ' CG2' ' HG2' ' A' ' 14' ' ' LYS . 5.4 mt -114.96 12.48 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.98 0.895 . . . . 3.0499999999999998 110.125 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.07 60.36 0.65 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.18 -0.918 . . . . 1.04 111.829 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 34.3 Cg_endo -65.0 104.19 0.56 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.423 2.082 . . . . 1.0 112.779 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.51 123.65 41.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.65 -0.705 . . . . 1.8300000000000001 109.874 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -78.98 89.41 4.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.271 0.558 . . . . 2.2000000000000002 110.663 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.644 HG12 HG21 ' A' ' 5' ' ' VAL . 23.7 t -91.4 118.36 36.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.701 . . . . 1.5600000000000001 111.345 -176.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 8.4 tt0 -112.82 123.85 51.26 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.464 -0.789 . . . . 2.48 109.155 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.51 116.75 28.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.404 -0.362 . . . . 1.25 111.013 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 8.9 mp -80.33 120.05 23.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 2.4700000000000002 110.504 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.79 -124.99 7.09 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.797 -0.716 . . . . 1.8100000000000001 112.303 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.4 m 63.85 24.06 13.6 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.693 0.397 . . . . 1.8799999999999999 111.217 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -49.76 -42.36 46.25 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.434 0.459 . . . . 2.71 111.84 -171.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.1 25.03 10.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.258 -0.428 . . . . 1.3600000000000001 110.687 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.525 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 1.4 tpm_? -121.63 145.35 48.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.042 0.449 . . . . 5.3499999999999996 111.688 -172.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -82.71 149.58 27.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.103 -0.702 . . . . 1.9099999999999999 109.103 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 93.1 t -109.37 129.86 63.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.851 -0.796 . . . . 1.1699999999999999 108.851 177.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.983 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -135.96 140.5 44.03 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 123.302 0.376 . . . . 1.0900000000000001 110.735 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 mt -103.19 150.55 23.57 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.127 -0.488 . . . . 1.4399999999999999 109.761 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.882 ' HE3' ' HB2' ' A' ' 129' ' ' PHE . 1.5 mptp? -134.84 151.66 51.1 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.297 -1.001 . . . . 2.5299999999999998 108.297 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.437 ' HB2' ' OD1' ' A' ' 48' ' ' ASN . . . -88.32 156.93 18.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.489 -0.559 . . . . 1.0700000000000001 109.489 174.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.61 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 5.8 t70 -89.5 172.57 8.89 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.899 -0.778 . . . . 0.70999999999999996 108.899 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.8 p -49.84 -25.26 2.98 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.816 1.043 . . . . 1.71 113.816 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -65.57 -38.68 90.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.786 0.327 . . . . 2.2200000000000002 111.217 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 26.5 p-10 -131.3 18.95 4.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 1.5800000000000001 111.282 -174.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 52.3 t80 -122.55 101.5 7.52 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.417 -0.586 . . . . 0.72999999999999998 109.417 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.67 ' HG2' ' HE1' ' A' ' 55' ' ' PHE . 5.5 pt-20 -106.83 98.75 8.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.295 -0.411 . . . . 2.4100000000000001 110.5 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 73.13 -49.33 0.69 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.197 -0.911 . . . . 4.1399999999999997 111.337 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 177.7 38.52 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.696 -0.562 . . . . 0.72999999999999998 111.696 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HD3' ' HB3' ' A' ' 81' ' ' ASN . 32.1 mmtp -136.48 135.17 38.37 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.491 -0.929 . . . . 2.6800000000000002 108.491 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.634 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -115.55 149.47 38.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.442 0.639 . . . . 0.65000000000000002 111.67 175.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.67 ' HE1' ' HG2' ' A' ' 50' ' ' GLU . 16.7 p90 -157.83 -179.96 8.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.039 -0.982 . . . . 0.73999999999999999 110.341 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.498 HD23 HD21 ' A' ' 114' ' ' LEU . 30.7 mt -94.08 112.12 23.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.662 -0.866 . . . . 2.0800000000000001 108.662 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.605 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 9.8 tp -107.75 140.4 26.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.544 -0.539 . . . . 1.21 109.544 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 37.1 t -78.96 156.02 28.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.247 -0.433 . . . . 1.9299999999999999 110.52 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -54.79 -27.59 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 2.3100000000000001 111.425 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -109.7 13.49 23.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.476 -0.329 . . . . 3.6600000000000001 111.184 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 52.1 33.54 12.36 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.556 0.576 . . . . 3.0600000000000001 112.556 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -79.34 -27.35 42.04 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.963 0.357 . . . . 5.1799999999999997 111.963 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.589 ' HB3' ' HH ' ' A' ' 112' ' ' TYR . 11.4 t70 -149.77 140.55 22.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.592 -0.522 . . . . 2.5099999999999998 109.592 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.529 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -128.89 132.5 47.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.763 -0.458 . . . . 2.6200000000000001 109.763 177.116 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 1.057 ' HB2' ' HG3' ' A' ' 104' ' ' GLN . 1.3 pt? -140.18 125.17 18.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.853 0.358 . . . . 2.48 110.927 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -69.71 143.08 53.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.869 -0.605 . . . . 1.1299999999999999 111.682 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 100' ' ' VAL . 14.2 m -133.14 171.43 18.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.428 -0.805 . . . . 1.29 110.015 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.465 ' HB2' ' HE2' ' A' ' 84' ' ' PHE . 5.4 p30 -130.89 129.13 41.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.289 -0.414 . . . . 2.1000000000000001 110.038 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.53 85.41 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.809 -0.811 . . . . 1.55 108.809 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.572 ' O ' ' HE1' ' A' ' 99' ' ' TYR . 6.7 ttp180 -108.78 139.99 21.41 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.48 -0.782 . . . . 4.3300000000000001 110.024 -170.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' HA ' HG22 ' A' ' 96' ' ' ILE . 50.3 Cg_exo -52.55 135.75 55.93 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.356 2.037 . . . . 0.90000000000000002 112.155 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.403 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 15.5 tmm? -59.16 -58.9 6.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 2.23 109.761 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -172.97 103.45 0.13 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.541 -0.754 . . . . 1.9199999999999999 109.457 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -177.65 -32.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 1.8899999999999999 111.811 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 p -164.4 179.02 7.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.797 0.332 . . . . 2.0699999999999998 111.128 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.28 130.54 56.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.818 -0.628 . . . . 1.5800000000000001 110.222 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.569 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 12.6 m0 -118.44 150.83 38.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.114 -0.494 . . . . 0.54000000000000004 110.216 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.4 m -79.7 114.09 18.35 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.929 -0.397 . . . . 1.22 109.929 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 t -87.48 114.43 24.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.998 0.904 . . . . 1.29 112.409 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -114.63 162.49 16.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 106.949 -1.501 . . . . 1.7 106.949 167.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.47 ' HB3' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -82.39 -16.47 48.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.724 -0.79 . . . . 1.3899999999999999 110.277 -177.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.59 -37.51 3.71 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.601 -0.809 . . . . 0.85999999999999999 112.341 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.527 HG23 ' CZ3' ' A' ' 121' ' ' TRP . 27.8 m -132.27 156.9 42.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.864 0.364 . . . . 1.73 110.519 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.716 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -135.84 105.3 6.06 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.202 -1.036 . . . . 0.41999999999999998 108.202 179.621 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.983 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 4.0 p90 -134.92 144.19 47.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.196 0.522 . . . . 1.1499999999999999 111.48 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.874 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 15.5 pttm -75.11 149.97 38.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.469 -0.787 . . . . 2.0299999999999998 110.392 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -76.11 -15.56 60.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.779 0.8 . . . . 2.6600000000000001 108.878 173.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.874 ' HB3' ' HD2' ' A' ' 86' ' ' LYS . 28.6 t70 -78.87 155.65 29.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.677 -1.147 . . . . 2.1000000000000001 110.431 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.0 m -121.84 131.02 74.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.005 0.431 . . . . 1.6599999999999999 109.861 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.79 172.83 16.49 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.845 -0.693 . . . . 0.63 111.714 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.1 p -65.64 124.35 22.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.591 -0.522 . . . . 1.5800000000000001 109.591 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.82 ' HB2' ' HZ2' ' A' ' 86' ' ' LYS . 32.0 t90 -91.29 -51.13 5.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.189 -0.46 . . . . 0.75 110.436 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 30.53 82.64 0.01 OUTLIER Glycine 0 N--CA 1.468 0.803 0 O-C-N 124.75 1.281 . . . . 1.25 115.26 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.35 -150.2 5.75 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.861 -0.685 . . . . 1.0 112.005 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.5 p -123.13 124.64 43.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.42 0.629 . . . . 1.3200000000000001 112.449 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -110.85 168.73 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.175 -1.046 . . . . 2.2400000000000002 108.175 169.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.61 161.0 27.43 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.11 -1.043 . . . . 0.53000000000000003 112.243 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.42 113.44 24.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.107 0.48 . . . . 1.53 110.139 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.651 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 5.9 m-85 -110.49 126.66 54.6 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.924 -1.139 . . . . 1.7 107.924 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.858 ' HA ' HG12 ' A' ' 67' ' ' VAL . 9.2 p -71.47 136.97 24.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.06 -0.719 . . . . 1.6799999999999999 109.06 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.23 98.91 1.08 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.864 0.364 . . . . 1.02 111.149 -175.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.87 20.73 79.74 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-O 119.17 -0.795 . . . . 1.53 114.207 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.418 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 18.4 tt0 51.98 99.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.49 0.645 . . . . 2.5699999999999998 110.742 -174.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 1.057 ' HG3' ' HB2' ' A' ' 65' ' ' LEU . 79.9 mm-40 -69.55 -63.99 0.97 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.18 -0.464 . . . . 3.1699999999999999 111.279 -172.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.5 m -178.86 -56.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.893 -0.594 . . . . 2.8599999999999999 110.858 -168.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.472 ' OD1' ' HD2' ' A' ' 16' ' ' ARG . 8.2 t30 72.21 79.24 0.15 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.156 -0.929 . . . . 1.5600000000000001 109.471 -167.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.13 125.96 66.62 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.508 -0.769 . . . . 2.0800000000000001 109.145 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -21.95 88.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 1 C-N-CA 125.425 4.084 . . . . 1.48 114.275 -172.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.741 ' HB3' ' HE1' ' A' ' 112' ' ' TYR . 1.1 Cg_endo -85.16 -157.76 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.092 3.195 . . . . 0.84999999999999998 114.087 -171.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.89 -81.04 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.742 -1.343 . . . . 0.76000000000000001 109.742 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -126.83 137.56 53.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.643 -0.502 . . . . 2.04 109.643 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.741 ' HE1' ' HB3' ' A' ' 109' ' ' PRO . 13.7 m-85 -125.55 141.76 51.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.395 -0.366 . . . . 1.1100000000000001 110.298 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.1 m -125.56 112.84 16.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.148 -0.478 . . . . 1.3400000000000001 110.778 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.498 HD21 HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -126.69 87.29 2.63 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.44 0.638 . . . . 1.1699999999999999 110.181 176.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 2.8 m -72.0 122.5 20.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.413 -0.812 . . . . 1.4099999999999999 110.099 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -111.17 120.2 41.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.083 0.468 . . . . 1.8 110.57 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.449 ' HA ' HG22 ' A' ' 135' ' ' THR . 19.3 m -92.18 121.22 33.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 1.3200000000000001 110.224 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -76.97 164.57 53.05 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.567 -0.825 . . . . 0.97999999999999998 111.866 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.18 179.62 36.92 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.87 -0.681 . . . . 0.64000000000000001 111.766 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.607 ' HB3' ' HB2' ' A' ' 3' ' ' CYS . 55.5 p90 -110.75 178.97 4.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.265 0.555 . . . . 1.2 110.298 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.678 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 8.5 t-105 -140.9 143.22 34.52 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.378 -0.828 . . . . 0.65000000000000002 109.087 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.605 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -140.96 60.73 1.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.139 0.792 . . . . 1.55 113.139 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 1.035 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER 169.88 -123.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.627 0.579 . . . . 3.8700000000000001 109.887 171.012 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -166.31 117.26 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 2.0800000000000001 111.455 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.678 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 23.3 t-20 61.43 -30.86 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.261 1.578 . . . . 3.0899999999999999 115.261 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -1.97 2.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 118.011 0.369 . . . . 2.3799999999999999 111.434 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.546 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 40.1 mt-30 72.79 45.85 0.29 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.657 -0.701 . . . . 2.1099999999999999 110.971 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.72 59.46 4.69 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.74 -0.944 . . . . 0.77000000000000002 110.74 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.882 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 50.3 p90 -105.19 146.56 29.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 110.071 -0.344 . . . . 1.49 110.071 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.4 m -131.12 113.47 15.99 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 110.148 -0.316 . . . . 1.8999999999999999 110.148 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -62.11 118.51 5.4 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.822 2.348 . . . . 1.1699999999999999 111.595 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.9 m -145.82 154.71 42.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.924 -0.58 . . . . 1.96 110.259 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.33 -123.36 6.19 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.671 -0.776 . . . . 1.1699999999999999 112.647 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.7 m -125.04 143.02 51.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.71 0.291 . . . . 2.9300000000000002 111.291 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 117' ' ' THR . 12.4 m -93.21 113.2 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.407 -0.59 . . . . 2.1800000000000002 109.407 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.469 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -96.99 126.14 8.73 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.771 -0.728 . . . . 0.72999999999999998 112.035 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.1 m -94.48 99.63 11.77 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.029 0.442 . . . . 1.23 110.31 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.425 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 24.9 m -79.78 119.08 22.19 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.178 -0.675 . . . . 1.1799999999999999 109.178 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -113.72 119.48 37.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.589 0.709 . . . . 2.6299999999999999 109.591 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 112' ' ' TYR . 4.7 tp -108.36 94.65 5.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.048 -0.978 . . . . 1.3100000000000001 110.847 -173.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.2 m -91.07 147.5 23.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.909 -1.041 . . . . 1.1799999999999999 109.18 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.469 ' HB ' HH12 ' A' ' 16' ' ' ARG . 9.1 p -102.28 124.11 55.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.914 -0.714 . . . . 2.3900000000000001 110.715 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.338 -0.839 . . . . 2.5899999999999999 109.497 178.759 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.859 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 19.2 t . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 121.208 0.528 . . . . 1.8300000000000001 110.595 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -86.18 140.18 30.4 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.61 -0.723 . . . . 2.29 110.359 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.779 HG23 HG13 ' A' ' 30' ' ' VAL . 3.2 p -111.69 124.22 68.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.696 -0.684 . . . . 2.1000000000000001 109.674 175.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.534 ' HA ' ' OG1' ' A' ' 134' ' ' THR . 99.3 mtt180 -96.29 104.01 15.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.333 0.587 . . . . 4.25 110.797 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.43 116.72 47.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.202 -0.908 . . . . 1.8200000000000001 109.456 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.78 150.35 34.29 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.63 -0.795 . . . . 1.1899999999999999 112.378 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -74.43 111.88 10.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.771 -0.455 . . . . 2.1800000000000002 109.771 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.654 HD12 HG21 ' A' ' 28' ' ' VAL . 92.8 mt -93.49 94.01 8.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.22 -0.446 . . . . 2.0 111.202 -177.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.1 m -94.9 112.69 24.39 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.052 -0.721 . . . . 1.5600000000000001 109.052 171.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.14 144.23 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.425 -0.352 . . . . 2.04 110.387 -174.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.517 ' HB3' ' OG1' ' A' ' 143' ' ' THR . . . -101.42 96.83 7.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.149 -0.478 . . . . 1.23 109.963 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.697 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 9.0 mmpt? -145.72 173.25 12.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 3.9100000000000001 110.453 -176.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.506 HG21 HG13 ' A' ' 142' ' ' VAL . 35.2 p -106.71 168.95 8.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.122 -0.49 . . . . 1.21 109.721 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.674 HH21 ' HD1' ' A' ' 112' ' ' TYR . 0.3 OUTLIER -87.01 -15.61 38.18 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.753 -0.832 . . . . 4.0800000000000001 108.753 178.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.8 -23.52 70.88 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.297 -0.865 . . . . 0.75 111.558 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -58.49 -31.15 67.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.4 0.619 . . . . 2.6299999999999999 109.707 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.589 HD22 HG23 ' A' ' 25' ' ' ILE . 9.9 mt -96.48 105.5 17.6 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.233 -0.894 . . . . 1.6100000000000001 109.711 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.583 ' H ' ' HB3' ' A' ' 23' ' ' ALA . 4.2 t -107.42 70.35 0.78 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.126 -0.694 . . . . 2.2599999999999998 109.126 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 17.8 t70 67.61 -80.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.7 -1.137 . . . . 1.8300000000000001 110.488 -174.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.34 63.69 0.99 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.613 0.72 . . . . 1.4299999999999999 110.646 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.583 ' HB3' ' H ' ' A' ' 20' ' ' THR . . . -143.35 117.87 6.22 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 114.897 -1.047 . . . . 1.3700000000000001 108.901 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -90.83 163.66 4.04 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.59 2.86 . . . . 1.1200000000000001 113.603 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.589 HG23 HD22 ' A' ' 19' ' ' LEU . 1.5 pt -118.7 -57.15 3.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.466 -0.788 . . . . 3.0499999999999998 110.899 174.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.516 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -116.15 99.17 0.86 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.85 -0.69 . . . . 1.04 112.553 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 60.4 Cg_endo -80.41 105.17 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.714 2.276 . . . . 1.0 112.051 173.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.654 HG21 HD12 ' A' ' 10' ' ' LEU . 18.1 t -74.96 125.96 35.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.701 -0.481 . . . . 1.8300000000000001 109.701 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.7 t -82.72 83.62 7.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.02 0.914 . . . . 2.2000000000000002 110.24 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.779 HG13 HG23 ' A' ' 5' ' ' VAL . 84.9 t -69.18 115.73 8.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.053 -0.976 . . . . 1.5600000000000001 110.833 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.48 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 4.4 pt20 -110.38 132.89 53.78 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.159 -0.682 . . . . 2.48 109.159 173.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.526 ' HB2' ' SG ' ' A' ' 3' ' ' CYS . . . -101.67 127.95 48.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.095 -0.502 . . . . 1.25 110.999 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.727 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 85.2 mt -107.59 111.78 24.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.511 -0.313 . . . . 2.4700000000000002 110.656 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.98 59.11 8.4 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.266 -0.492 . . . . 1.8100000000000001 113.211 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.859 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -87.08 -70.38 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.679 0.252 . . . . 1.8799999999999999 111.679 -177.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 69.25 -61.83 0.42 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.644 0.778 . . . . 2.71 111.632 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.8 71.41 1.35 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.338 0.59 . . . . 1.3600000000000001 109.889 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.695 ' HD2' ' SG ' ' A' ' 35' ' ' CYS . 1.4 tmt_? -143.42 131.81 22.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.544 -0.753 . . . . 5.3499999999999996 110.886 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.474 ' HG2' HG13 ' A' ' 89' ' ' VAL . 6.2 mt-30 -87.36 107.17 18.4 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.675 -0.861 . . . . 1.9099999999999999 108.675 174.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 41.7 t -62.66 109.21 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 1.1699999999999999 109.954 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.961 ' HB1' ' HB3' ' A' ' 85' ' ' TYR . . . -127.11 137.63 53.03 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 123.531 0.519 . . . . 1.0900000000000001 109.895 -176.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.748 HD11 HG21 ' A' ' 69' ' ' ILE . 65.6 mt -104.21 128.65 51.95 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.946 -0.39 . . . . 1.4399999999999999 109.946 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.701 ' HZ2' ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -110.33 151.77 27.02 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.618 -0.882 . . . . 2.5299999999999998 108.618 175.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.576 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -100.32 155.17 17.94 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.379 -0.529 . . . . 1.0700000000000001 110.024 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -73.67 149.0 42.25 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.978 -0.749 . . . . 0.70999999999999996 108.978 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -58.6 -18.08 27.26 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.286 0.476 . . . . 1.71 112.286 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.24 -27.18 68.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.151 0.5 . . . . 2.2200000000000002 110.33 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.6 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 4.1 p-10 -134.75 27.11 3.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.656 -0.702 . . . . 1.5800000000000001 109.916 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.609 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 75.1 t80 -140.75 102.41 4.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.436 -0.802 . . . . 0.72999999999999998 109.653 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.24 117.04 33.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.296 -0.411 . . . . 2.4100000000000001 110.583 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 68.46 -57.62 0.49 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.279 0.987 . . . . 4.1399999999999997 111.884 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.609 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -179.29 32.26 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.971 -0.633 . . . . 0.72999999999999998 111.93 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 81' ' ' ASN . 1.6 mptm? -129.9 134.28 47.39 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.396 -0.594 . . . . 2.6800000000000002 109.396 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.454 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -98.91 139.05 35.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.42 0.628 . . . . 0.65000000000000002 110.818 174.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.6 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 51.5 p90 -155.43 172.76 17.69 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.177 -0.919 . . . . 0.73999999999999999 110.338 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.982 ' HG ' HD21 ' A' ' 114' ' ' LEU . 5.9 mp -83.35 130.72 35.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.095 -0.705 . . . . 2.0800000000000001 109.095 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.583 HG21 ' O ' ' A' ' 113' ' ' THR . 10.4 tp -104.93 134.7 45.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.13 -0.628 . . . . 1.21 109.322 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.5 t -68.06 179.96 1.38 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.294 -0.866 . . . . 1.9299999999999999 111.298 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -56.0 -43.2 77.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.883 -0.599 . . . . 2.3100000000000001 111.456 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -115.07 -62.26 1.63 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.549 -0.296 . . . . 3.6600000000000001 110.594 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.1 p30 177.28 25.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.829 -0.623 . . . . 3.0600000000000001 109.595 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -73.03 -46.31 52.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.428 -0.805 . . . . 5.1799999999999997 111.406 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.99 156.16 47.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.837 -0.62 . . . . 2.5099999999999998 110.491 -172.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -142.59 139.73 31.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.883 -0.599 . . . . 2.6200000000000001 109.776 174.252 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.756 ' HG ' HD11 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -141.14 122.04 14.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.37 -0.377 . . . . 2.48 110.237 178.016 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.432 ' HA ' ' CB ' ' A' ' 55' ' ' PHE . 62.8 m-85 -72.18 153.15 41.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.347 -0.388 . . . . 1.1299999999999999 111.515 -173.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.48 ' HB ' HG21 ' A' ' 98' ' ' ILE . 29.2 m -117.24 161.78 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 1.29 111.404 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -126.65 121.67 32.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 2.1000000000000001 108.952 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.748 HG21 HD11 ' A' ' 42' ' ' LEU . 3.6 mm -95.37 86.23 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.745 -0.382 . . . . 1.55 110.04 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.515 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 8.1 mmm180 -93.55 128.27 42.85 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 120.491 -0.484 . . . . 4.3300000000000001 110.974 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.645 ' HA ' HG21 ' A' ' 96' ' ' ILE . 49.2 Cg_exo -51.53 133.41 43.53 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.526 2.151 . . . . 0.90000000000000002 112.229 172.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.6 ttt -78.8 81.45 5.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.572 -0.529 . . . . 2.23 109.572 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 66.35 20.16 10.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.823 -0.626 . . . . 1.9199999999999999 112.227 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -119.7 107.59 13.4 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.464 0.542 . . . . 1.8899999999999999 112.464 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.6 p 61.18 179.71 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.648 1.179 . . . . 2.0699999999999998 113.503 170.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.07 119.52 39.42 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.276 -0.874 . . . . 1.5800000000000001 110.485 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.6 m0 -110.18 149.08 30.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.93 -0.577 . . . . 0.54000000000000004 110.388 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.0 m -83.23 112.92 20.3 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.003 -0.74 . . . . 1.22 109.003 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 t -87.48 90.19 8.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.936 0.874 . . . . 1.29 112.433 -171.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.25 148.44 23.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.91 -1.145 . . . . 1.7 107.91 166.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -87.17 11.06 14.93 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.226 -0.59 . . . . 1.3899999999999999 110.526 -174.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.88 -27.46 1.25 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.597 -0.601 . . . . 0.85999999999999999 111.597 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.526 HG13 ' HG3' ' A' ' 43' ' ' LYS . 36.0 m -140.54 137.77 36.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.005 -0.739 . . . . 1.73 109.005 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.837 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -121.68 109.11 14.35 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.67 -0.812 . . . . 0.41999999999999998 108.946 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.961 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 2.0 p90 -137.35 139.26 40.7 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.512 0.508 . . . . 1.1499999999999999 111.394 -173.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.758 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 53.4 pttt -73.96 143.49 45.64 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.057 -0.72 . . . . 2.0299999999999998 109.057 171.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -64.72 -26.53 68.41 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.97 -0.559 . . . . 2.6600000000000001 110.103 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.758 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 12.6 m-20 -72.12 151.07 43.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.526 -0.761 . . . . 2.1000000000000001 110.573 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.474 HG13 ' HG2' ' A' ' 39' ' ' GLN . 30.9 m -114.04 123.26 69.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.026 0.441 . . . . 1.6599999999999999 110.276 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.8 -173.32 24.7 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.387 -0.911 . . . . 0.63 112.011 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.5 p -55.37 145.45 22.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.084 0.469 . . . . 1.5800000000000001 111.428 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.43 ' CH2' HG23 ' A' ' 96' ' ' ILE . 41.2 t90 -126.74 -53.86 1.43 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.912 -0.586 . . . . 0.75 109.82 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.556 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 35.23 87.54 0.01 OUTLIER Glycine 0 N--CA 1.465 0.577 0 O-C-N 124.835 1.334 . . . . 1.25 114.978 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.01 -131.77 1.29 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.9 -0.667 . . . . 1.0 112.126 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.64 132.92 23.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.951 0.405 . . . . 1.3200000000000001 111.459 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.645 HG21 ' HA ' ' A' ' 71' ' ' PRO . 1.7 pp -124.29 144.1 35.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.365 -0.605 . . . . 2.2400000000000002 109.365 172.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -117.97 151.8 17.81 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.118 -1.039 . . . . 0.53000000000000003 112.233 -174.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.48 HG21 ' HB ' ' A' ' 67' ' ' VAL . 77.1 mt -96.18 112.62 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.417 0.627 . . . . 1.53 110.639 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.515 ' CE1' ' HB2' ' A' ' 70' ' ' ARG . 1.2 m-85 -103.88 156.86 17.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.807 -1.088 . . . . 1.7 108.099 176.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.473 ' CG1' ' HA ' ' A' ' 103' ' ' GLN . 5.5 p -87.24 133.12 30.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.035 -0.666 . . . . 1.6799999999999999 109.393 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.92 101.83 0.3 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.381 -0.372 . . . . 1.02 111.756 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.11 23.4 77.21 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.804 -0.635 . . . . 1.53 114.026 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 62.9 tt0 57.93 97.98 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.237 0.541 . . . . 2.5699999999999998 110.905 -175.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.651 ' HG3' ' HB2' ' A' ' 65' ' ' LEU . 78.3 mm-40 -84.32 14.21 4.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 3.1699999999999999 111.312 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.1 m 74.01 -3.79 2.43 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.584 -0.735 . . . . 2.8599999999999999 112.239 170.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.514 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 7.3 t30 63.41 86.18 0.12 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.593 0.711 . . . . 1.5600000000000001 110.214 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.8 m -74.54 139.91 74.97 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.006 -0.997 . . . . 2.0800000000000001 109.355 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -30.5 89.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 125.162 3.908 . . . . 1.48 113.456 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.576 ' HB2' ' CG2' ' A' ' 142' ' ' VAL . 81.2 Cg_endo -93.23 -168.54 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.191 2.594 . . . . 0.84999999999999998 114.949 -167.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.13 -73.92 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.752 -1.339 . . . . 0.76000000000000001 109.752 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -135.13 126.93 29.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.546 -0.539 . . . . 2.04 109.546 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.674 ' HD1' HH21 ' A' ' 16' ' ' ARG . 69.6 m-85 -129.25 139.33 51.86 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.065 0.46 . . . . 1.1100000000000001 110.922 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.583 ' O ' HG21 ' A' ' 57' ' ' ILE . 70.8 m -111.68 129.15 56.2 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.318 -0.856 . . . . 1.3400000000000001 110.021 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.982 HD21 ' HG ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -142.84 86.91 1.95 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.733 0.777 . . . . 1.1699999999999999 109.602 174.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.7 m -88.06 135.83 33.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.003 -0.999 . . . . 1.4099999999999999 110.476 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 8.6 mp -119.01 116.49 26.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 1.8 110.682 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 38.5 m -89.08 114.02 25.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.81 -0.632 . . . . 1.3200000000000001 110.125 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.84 145.11 44.6 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.724 -0.751 . . . . 0.97999999999999998 112.365 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 132' ' ' SER . . . -175.59 177.34 47.43 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.892 -0.67 . . . . 0.64000000000000001 111.484 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.406 ' CE2' ' HB ' ' A' ' 130' ' ' THR . 28.9 p90 -101.26 -178.33 3.71 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.918 -0.713 . . . . 1.2 110.184 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.851 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 3.4 t-105 -151.69 144.45 24.35 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.253 -0.885 . . . . 0.65000000000000002 108.818 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.39 145.65 49.95 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.256 0.347 . . . . 1.55 110.466 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.896 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER 72.17 -136.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.745 0.818 . . . . 3.8700000000000001 110.741 178.121 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.588 ' HA ' ' HZ2' ' A' ' 121' ' ' TRP . 5.6 p-10 -162.96 133.87 4.77 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.132 0.173 . . . . 2.0800000000000001 110.631 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.484 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 52.4 t30 67.76 -38.76 0.37 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.901 1.075 . . . . 3.0899999999999999 113.901 174.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -5.04 5.18 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.341 0.591 . . . . 2.3799999999999999 111.19 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.851 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 6.1 tt0 65.21 72.56 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.723 -1.126 . . . . 2.1099999999999999 111.246 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -96.01 41.75 2.38 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.62 -0.8 . . . . 0.77000000000000002 111.213 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.701 ' HB2' ' HZ2' ' A' ' 43' ' ' LYS . 3.7 p90 -82.74 154.44 24.79 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.783 0.325 . . . . 1.49 110.894 -172.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.406 ' HB ' ' CE2' ' A' ' 120' ' ' TYR . 50.2 m -154.93 123.99 3.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.436 -0.347 . . . . 1.8999999999999999 110.082 173.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.2 128.81 31.18 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.975 2.45 . . . . 1.1699999999999999 112.254 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.417 ' N ' ' HA2' ' A' ' 119' ' ' GLY . 27.1 m -155.27 108.3 2.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.31 -0.404 . . . . 1.96 110.349 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.9 -127.85 7.52 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.45 -0.881 . . . . 1.1699999999999999 112.46 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.534 ' OG1' ' HA ' ' A' ' 6' ' ' ARG . 5.2 p -118.71 154.53 32.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.951 0.405 . . . . 2.9300000000000002 111.417 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 t -108.98 114.64 28.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.412 -0.588 . . . . 2.1800000000000002 109.412 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.96 126.87 9.0 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.716 -0.754 . . . . 0.72999999999999998 112.122 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.3 m -91.82 101.3 13.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.745 0.307 . . . . 1.23 110.725 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.494 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 28.3 m -80.63 108.65 14.45 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.14 -0.689 . . . . 1.1799999999999999 109.14 173.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -109.38 109.55 20.45 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.989 -0.745 . . . . 2.6299999999999999 108.989 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.596 ' HG ' ' NH2' ' A' ' 16' ' ' ARG . 16.1 tp -106.78 105.96 16.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.902 -1.045 . . . . 1.3100000000000001 110.913 -174.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 30.3 m -99.45 143.99 29.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.159 -0.928 . . . . 1.1799999999999999 109.36 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.576 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 92.9 t -74.32 129.56 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 112.793 0.664 . . . . 2.3900000000000001 112.793 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 95.0 m . . . . . 0 C--O 1.248 1.009 0 CA-C-N 115.06 -0.973 . . . . 2.5899999999999999 109.188 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.908 0.385 . . . . 1.8300000000000001 110.922 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -86.39 109.73 19.22 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.41 -0.589 . . . . 2.29 109.41 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.6 t -95.96 111.89 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.588 -0.523 . . . . 2.1000000000000001 109.588 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.805 ' HB2' ' HB2' ' A' ' 31' ' ' GLN . 31.2 mmt180 -84.39 99.55 10.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.628 -0.715 . . . . 4.25 110.451 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.95 115.59 48.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.382 -0.826 . . . . 1.8200000000000001 109.238 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.24 -169.88 27.04 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.465 -0.874 . . . . 1.1899999999999999 112.082 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -99.83 142.39 31.37 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.676 -0.491 . . . . 2.1800000000000002 109.676 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.72 126.84 12.91 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.02 -0.537 . . . . 2.0 109.911 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.9 m -108.93 115.69 30.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.987 -0.551 . . . . 1.5600000000000001 110.479 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.427 HG13 ' HG2' ' A' ' 14' ' ' LYS . 44.3 t -122.69 117.9 53.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.152 -0.476 . . . . 2.04 110.17 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -91.4 97.03 10.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.97 0.414 . . . . 1.23 110.893 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.427 ' HG2' HG13 ' A' ' 12' ' ' VAL . 73.9 mmtt -143.64 -174.44 4.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.561 -0.745 . . . . 3.9100000000000001 109.454 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.615 ' HB ' ' OD1' ' A' ' 106' ' ' ASN . 20.4 p -100.68 159.78 14.89 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.135 -0.32 . . . . 1.21 110.135 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.88 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -86.35 -26.22 24.96 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.629 -0.428 . . . . 4.0800000000000001 109.992 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.79 -28.63 73.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.919 -0.658 . . . . 0.75 111.613 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -51.14 -34.81 32.72 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.594 0.757 . . . . 2.6299999999999999 111.442 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.803 ' HB2' HG21 ' A' ' 100' ' ' VAL . 49.8 mt -70.51 -17.61 62.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.591 -0.731 . . . . 1.6100000000000001 112.816 -170.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.3 m 34.25 55.42 0.63 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.256 0.972 . . . . 2.2599999999999998 112.778 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.758 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 31.0 t70 70.27 -62.84 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.631 -0.713 . . . . 1.8300000000000001 111.809 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.48 ' HA ' ' CG ' ' A' ' 99' ' ' TYR . . . -139.46 69.59 1.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.311 0.577 . . . . 1.4299999999999999 112.068 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.65 98.42 16.41 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.38 -0.827 . . . . 1.3700000000000001 109.056 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.444 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 54.4 Cg_endo -70.02 119.81 6.67 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.817 2.345 . . . . 1.1200000000000001 113.411 -172.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.758 HG12 HD21 ' A' ' 19' ' ' LEU . 2.9 pt -80.67 -65.11 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 3.0499999999999998 111.524 173.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.636 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -117.83 101.55 0.92 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.879 -0.676 . . . . 1.04 111.935 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.575 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 37.7 Cg_endo -70.51 121.16 7.7 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.437 2.091 . . . . 1.0 112.083 177.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.34 122.16 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.86 -0.609 . . . . 1.8300000000000001 109.431 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.5 m -74.59 101.96 4.39 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.218 -0.446 . . . . 2.2000000000000002 110.298 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.453 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 48.9 t -95.81 114.49 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.157 -0.474 . . . . 1.5600000000000001 110.398 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.805 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 14.9 mm100 -103.07 133.91 47.38 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.343 -0.614 . . . . 2.48 109.343 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.4 108.29 13.94 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.172 -0.307 . . . . 1.25 110.172 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.16 134.24 55.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.129 -0.487 . . . . 2.4700000000000002 110.724 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.55 -7.83 68.59 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.819 -0.628 . . . . 1.8100000000000001 112.264 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.0 m -84.32 93.56 8.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.001 0.429 . . . . 1.8799999999999999 110.73 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -96.32 -18.92 19.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.962 0.411 . . . . 2.71 110.218 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -167.76 83.66 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.776 -0.647 . . . . 1.3600000000000001 110.048 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -165.11 150.09 9.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.898 -0.592 . . . . 5.3499999999999996 110.096 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -80.91 125.41 30.09 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.245 -0.65 . . . . 1.9099999999999999 109.245 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 61.0 t -92.99 124.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.46 -0.57 . . . . 1.1699999999999999 109.46 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -119.66 146.52 45.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.087 0.47 . . . . 1.0900000000000001 110.963 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 84' ' ' PHE . 14.6 mt -103.87 117.72 35.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.663 -0.698 . . . . 1.4399999999999999 109.329 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.617 ' NZ ' ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -118.73 152.02 36.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.552 -0.536 . . . . 2.5299999999999998 109.552 -177.316 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.513 ' HB2' ' ND2' ' A' ' 48' ' ' ASN . . . -104.23 157.19 17.3 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.369 -0.378 . . . . 1.0700000000000001 110.081 175.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 21.9 t70 -75.8 151.72 37.46 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.428 -0.582 . . . . 0.70999999999999996 109.428 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -56.75 -16.5 6.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.563 0.579 . . . . 1.71 112.563 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.58 -32.37 73.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.981 0.42 . . . . 2.2200000000000002 110.628 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 44' ' ' ALA . 6.0 p-10 -133.85 24.2 3.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 1.5800000000000001 110.247 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 82.0 t80 -132.33 101.33 5.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.492 -0.777 . . . . 0.72999999999999998 109.334 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 51' ' ' GLN . 56.5 mt-10 -95.07 100.26 12.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.422 -0.353 . . . . 2.4100000000000001 110.403 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 23.8 tt0 70.79 -58.56 0.56 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.875 0.734 . . . . 4.1399999999999997 111.184 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -172.32 38.12 0.16 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.6 -0.727 . . . . 0.72999999999999998 111.435 -177.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 2.1 mptm? -136.37 133.87 37.24 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.944 -0.762 . . . . 2.6800000000000002 108.944 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.403 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -106.08 141.67 37.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.245 0.545 . . . . 0.65000000000000002 110.96 174.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 16.9 p90 -147.27 167.04 25.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.674 -0.694 . . . . 0.73999999999999999 111.255 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 13.0 mt -85.33 113.66 21.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.457 -0.942 . . . . 2.0800000000000001 108.457 171.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.7 tp -106.26 125.08 61.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.595 0.712 . . . . 1.21 110.85 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 112' ' ' TYR . 40.3 t -84.39 153.34 23.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.982 -1.008 . . . . 1.9299999999999999 111.21 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.16 -35.39 73.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.471 -0.786 . . . . 2.3100000000000001 110.368 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -78.3 -13.23 59.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.662 -0.699 . . . . 3.6600000000000001 110.775 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 53.77 30.44 11.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.661 -0.699 . . . . 3.0600000000000001 111.122 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.633 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 8.3 mmp_? -83.79 -39.95 19.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.244 0.545 . . . . 5.1799999999999997 109.871 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.642 ' HB3' HD23 ' A' ' 65' ' ' LEU . 1.1 m-20 -123.09 124.77 43.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.377 -0.828 . . . . 2.5099999999999998 111.111 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -127.18 98.89 5.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.208 1.004 . . . . 2.6200000000000001 108.737 168.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.645 HD13 ' HB2' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -99.4 118.72 36.65 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.987 -1.006 . . . . 2.48 109.853 -168.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.433 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 73.0 m-85 -67.51 122.15 17.37 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.285 -0.635 . . . . 1.1299999999999999 109.285 -177.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.446 HG12 ' HG ' ' A' ' 56' ' ' LEU . 12.9 m -99.63 168.57 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.605 -0.725 . . . . 1.29 111.62 -174.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -126.12 110.2 13.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.839 -1.073 . . . . 2.1000000000000001 108.841 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.423 HG22 HG12 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -91.46 84.25 2.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.506 0.669 . . . . 1.55 109.196 173.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.793 ' HB3' ' OH ' ' A' ' 99' ' ' TYR . 32.6 ttm180 -101.82 131.78 22.42 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.979 -1.01 . . . . 4.3300000000000001 108.317 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.64 ' HA ' HG22 ' A' ' 96' ' ' ILE . 45.0 Cg_endo -63.25 148.02 93.35 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.431 2.087 . . . . 0.90000000000000002 112.208 -173.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.0 tpt -74.03 84.6 1.78 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.668 -0.696 . . . . 2.23 110.412 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 74.21 -46.84 0.63 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.134 0.974 . . . . 1.9199999999999999 113.211 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.401 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 56.8 m-80 -60.22 114.28 2.81 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.433 0.901 . . . . 1.8899999999999999 113.433 -171.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.7 t 74.4 159.48 0.22 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.722 -1.126 . . . . 2.0699999999999998 112.323 170.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.42 118.86 33.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.421 -0.809 . . . . 1.5800000000000001 110.113 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.841 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.4 m95 -112.39 142.49 44.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.16 -0.473 . . . . 0.54000000000000004 109.945 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.2 m -82.65 110.63 17.88 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.249 -0.648 . . . . 1.22 109.249 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -82.09 117.71 22.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.319 1.057 . . . . 1.29 112.521 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 22.3 t70 -121.59 154.87 36.16 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.898 -1.519 . . . . 1.7 106.898 167.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -83.94 2.6 37.92 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.009 -0.676 . . . . 1.3899999999999999 110.924 -174.059 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -122.67 -31.47 1.04 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.156 -0.545 . . . . 0.85999999999999999 112.134 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.459 ' O ' ' HB3' ' A' ' 80' ' ' ASP . 26.6 m -131.51 148.64 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.847 -0.427 . . . . 1.73 109.847 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -134.15 104.22 6.11 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.244 -1.021 . . . . 0.41999999999999998 108.244 -177.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.605 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 12.1 p90 -131.51 135.0 46.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.468 0.651 . . . . 1.1499999999999999 111.659 -174.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.841 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 18.9 pttp -74.42 139.68 44.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.829 -1.078 . . . . 2.0299999999999998 109.713 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -72.7 -17.86 61.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.176 -0.675 . . . . 2.6600000000000001 109.176 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.514 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 4.0 t70 -69.4 135.13 49.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.101 -0.954 . . . . 2.1000000000000001 109.684 172.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.0 m -99.57 122.79 51.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.232 0.539 . . . . 1.6599999999999999 110.651 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.3 -155.2 24.48 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.616 -0.802 . . . . 0.63 111.747 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.0 p -82.75 -173.56 4.73 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 122.501 0.321 . . . . 1.5800000000000001 110.276 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.401 ' CZ2' ' HB2' ' A' ' 74' ' ' ASN . 33.3 t90 -157.68 -57.13 0.08 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.799 -0.445 . . . . 0.75 109.799 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 42.15 92.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.42 1.075 . . . . 1.25 114.731 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.86 -141.83 3.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.663 -0.78 . . . . 1.0 112.286 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.575 ' HB ' ' HB2' ' A' ' 27' ' ' PRO . 11.1 p -133.12 140.43 47.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.139 0.495 . . . . 1.3200000000000001 112.218 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.64 HG22 ' HA ' ' A' ' 71' ' ' PRO . 18.7 pt -118.38 142.87 31.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.807 -0.633 . . . . 2.2400000000000002 109.501 174.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 24' ' ' PRO . . . -105.1 141.09 15.26 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.23 -0.986 . . . . 0.53000000000000003 112.386 -174.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 69' ' ' ILE . 59.7 mt -96.57 120.31 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.985 0.421 . . . . 1.53 111.088 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.793 ' OH ' ' HB3' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -139.26 164.96 28.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.335 -0.848 . . . . 1.7 110.153 173.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.803 HG21 ' HB2' ' A' ' 19' ' ' LEU . 3.6 t -90.13 125.94 43.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.98 -0.554 . . . . 1.6799999999999999 110.791 -174.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.5 97.04 0.4 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.934 -0.395 . . . . 1.02 109.934 177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.62 -15.82 44.98 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.892 -0.67 . . . . 1.53 113.759 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.416 ' HB2' ' N ' ' A' ' 21' ' ' ASP . 65.2 tt0 67.27 118.35 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.067 0.547 . . . . 2.5699999999999998 110.769 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.645 ' HB2' HD13 ' A' ' 65' ' ' LEU . 12.7 mm100 -104.47 -6.83 20.3 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.316 0.487 . . . . 3.1699999999999999 112.316 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 m 71.16 14.63 6.63 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.984 0.421 . . . . 2.8599999999999999 111.317 168.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.88 ' HB3' ' HB2' ' A' ' 16' ' ' ARG . 0.3 OUTLIER 41.86 91.51 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.68 1.363 . . . . 1.5600000000000001 114.68 177.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.806 HG22 ' HD2' ' A' ' 108' ' ' PRO . 1.2 m -82.07 143.74 49.81 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 107.914 -1.143 . . . . 2.0800000000000001 107.914 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.806 ' HD2' HG22 ' A' ' 107' ' ' THR . 75.0 Cg_exo -12.04 83.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.669 1 C-N-CA 125.737 4.292 . . . . 1.48 114.705 -168.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -74.13 -157.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.849 3.033 . . . . 0.84999999999999998 113.993 -172.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.58 -140.74 6.62 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 109.878 -1.289 . . . . 0.76000000000000001 109.878 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -82.22 120.7 25.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.953 0.406 . . . . 2.04 110.097 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 58' ' ' SER . 14.1 m-85 -108.74 119.83 40.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.167 0.508 . . . . 1.1100000000000001 109.972 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 77.0 m -106.74 98.54 8.19 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.414 -0.812 . . . . 1.3400000000000001 111.051 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.483 HD11 HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -120.57 107.97 13.49 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.268 0.556 . . . . 1.1699999999999999 110.526 178.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 20.2 m -96.18 140.21 31.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 1.4099999999999999 110.181 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 96.5 mt -117.5 125.79 51.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.893 0.378 . . . . 1.8 110.252 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.5 m -103.36 119.61 39.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.982 0.42 . . . . 1.3200000000000001 110.302 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -74.56 163.43 54.38 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.79 -0.719 . . . . 0.97999999999999998 112.632 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.49 166.57 14.38 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.494 -0.642 . . . . 0.64000000000000001 111.494 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -91.02 176.11 6.71 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.707 -0.397 . . . . 1.2 110.663 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.653 ' HA ' ' HA ' ' A' ' 129' ' ' PHE . 1.9 t-105 -133.09 152.8 51.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.265 -0.879 . . . . 0.65000000000000002 108.69 176.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.09 140.91 46.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.966 0.413 . . . . 1.55 111.615 175.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 74.55 -143.31 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.381 1.073 . . . . 3.8700000000000001 111.358 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 126' ' ' LYS . 6.1 p-10 -147.62 124.38 11.2 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.336 -0.546 . . . . 2.0800000000000001 112.135 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.464 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 8.6 t30 65.53 -22.81 0.09 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.862 1.06 . . . . 3.0899999999999999 113.862 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -71.43 -3.36 20.52 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.873 0.469 . . . . 2.3799999999999999 110.951 -178.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.845 ' HG3' ' CE2' ' A' ' 129' ' ' PHE . 51.4 tt0 70.37 79.24 0.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.433 -0.803 . . . . 2.1099999999999999 110.384 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -109.61 27.69 11.88 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 119.793 -1.194 . . . . 0.77000000000000002 112.655 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.845 ' CE2' ' HG3' ' A' ' 127' ' ' GLN . 38.9 p90 -87.72 126.39 34.96 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.041 -0.664 . . . . 1.49 111.239 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 85.8 m -114.25 132.02 22.97 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.936 -0.575 . . . . 1.8999999999999999 109.767 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.92 122.61 11.21 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.771 2.314 . . . . 1.1699999999999999 112.097 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.9 m -155.61 122.55 5.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.218 -0.446 . . . . 1.96 110.185 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 120.0 -117.62 3.63 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.267 -0.733 . . . . 1.1699999999999999 111.267 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 p -131.81 178.44 6.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.004 0.402 . . . . 2.9300000000000002 110.621 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.0 t -126.59 104.22 8.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.796 0.807 . . . . 2.1800000000000002 108.943 171.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.78 143.45 16.03 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.637 -0.711 . . . . 0.72999999999999998 112.414 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 73.8 m -101.0 117.41 34.98 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.958 0.409 . . . . 1.23 110.903 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.443 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 18.7 m -86.61 111.44 20.63 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.664 -0.865 . . . . 1.1799999999999999 108.664 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -99.34 109.29 21.92 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.809 0.814 . . . . 2.6299999999999999 110.065 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.474 HD23 ' HG3' ' A' ' 16' ' ' ARG . 22.6 tp -103.21 95.98 6.47 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.444 -1.253 . . . . 1.3100000000000001 109.765 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 12.0 m -100.07 144.02 29.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.546 -0.752 . . . . 1.1799999999999999 109.441 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.5 p -82.45 142.96 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.551 -0.537 . . . . 2.3900000000000001 109.551 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.758 -0.639 . . . . 2.5899999999999999 111.472 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.1 t . . . . . 0 N--CA 1.445 -0.675 0 CA-C-O 121.16 0.505 . . . . 1.8300000000000001 110.363 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.402 ' HG3' ' HA3' ' A' ' 133' ' ' GLY . 7.6 tt0 -98.64 128.03 44.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.722 -0.672 . . . . 2.29 109.274 176.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.55 HG11 HG12 ' A' ' 30' ' ' VAL . 51.2 t -104.99 135.4 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.506 -0.553 . . . . 2.1000000000000001 109.506 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.436 ' HA ' ' HE ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -92.57 101.21 13.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.084 0.468 . . . . 4.25 110.99 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.479 HG13 ' HA3' ' A' ' 136' ' ' GLY . 73.4 t -129.73 115.32 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.873 -0.788 . . . . 1.8200000000000001 108.873 173.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.83 -147.67 6.81 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.859 -0.686 . . . . 1.1899999999999999 112.412 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.29 142.16 27.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.209 0.528 . . . . 2.1800000000000002 111.413 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.75 124.38 7.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.276 -0.875 . . . . 2.0 109.658 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 139' ' ' LYS . 31.1 m -116.03 116.57 28.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.212 -0.449 . . . . 1.5600000000000001 110.709 -178.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.462 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 27.8 t -121.49 116.75 50.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.931 0.396 . . . . 2.04 110.182 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -83.64 109.06 17.13 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.924 -0.58 . . . . 1.23 111.436 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.507 ' HE3' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -168.63 175.9 5.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.703 -0.681 . . . . 3.9100000000000001 110.136 178.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.52 HG21 HG23 ' A' ' 142' ' ' VAL . 51.6 p -100.81 174.93 5.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.305 -0.407 . . . . 1.21 110.723 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.443 ' HA ' HD13 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -84.47 -6.56 59.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.774 -0.824 . . . . 4.0800000000000001 108.774 173.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.575 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -89.84 -22.0 37.69 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.128 -0.942 . . . . 0.75 111.569 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.47 -25.97 65.25 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.712 -0.848 . . . . 2.6299999999999999 108.712 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.602 HD12 ' HB ' ' A' ' 100' ' ' VAL . 18.5 mt -74.85 159.79 31.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.092 -0.958 . . . . 1.6100000000000001 109.087 172.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.403 ' HG1' ' C ' ' A' ' 19' ' ' LEU . 11.2 m -153.8 60.29 0.73 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.467 -0.938 . . . . 2.2599999999999998 108.467 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 22.6 t70 61.28 -84.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.033 -1.439 . . . . 1.8300000000000001 110.255 -171.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.462 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -88.72 74.94 8.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.137 0.494 . . . . 1.4299999999999999 110.641 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.76 99.99 3.51 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.838 -0.619 . . . . 1.3700000000000001 110.134 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 91.5 Cg_endo -82.52 109.5 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.762 2.308 . . . . 1.1200000000000001 112.616 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -116.24 28.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.94 0.876 . . . . 3.0499999999999998 109.868 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.88 60.1 0.42 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.105 -0.952 . . . . 1.04 112.265 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.63 97.89 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.328 2.019 . . . . 1.0 112.948 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.1 t -80.31 126.22 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.856 -0.611 . . . . 1.8300000000000001 109.758 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -84.37 94.16 8.42 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 121.03 0.443 . . . . 2.2000000000000002 110.657 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.684 ' CG2' HD13 ' A' ' 96' ' ' ILE . 14.5 t -94.49 115.21 32.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.308 0.575 . . . . 1.5600000000000001 111.065 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -102.71 124.92 49.13 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.29 -0.868 . . . . 2.48 109.687 174.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.74 93.97 6.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.019 -0.537 . . . . 1.25 110.695 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 tp -87.28 112.76 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.811 -0.632 . . . . 2.4700000000000002 110.83 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.22 56.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.553 -0.832 . . . . 1.8100000000000001 112.306 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -83.72 95.7 8.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.962 0.411 . . . . 1.8799999999999999 110.444 177.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -103.09 -35.03 8.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.884 -0.598 . . . . 2.71 110.155 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.413 ' C ' ' HB ' ' A' ' 89' ' ' VAL . . . -144.81 35.81 1.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.822 -0.626 . . . . 1.3600000000000001 110.417 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.543 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.7 tpp180 -120.34 148.01 44.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.044 0.45 . . . . 5.3499999999999996 111.649 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.496 ' HG3' HG13 ' A' ' 89' ' ' VAL . 18.2 mt-30 -92.48 128.23 38.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.173 -0.677 . . . . 1.9099999999999999 109.173 173.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 72.1 t -92.9 128.97 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.141 -0.689 . . . . 1.1699999999999999 109.141 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.877 ' HB1' ' HB3' ' A' ' 85' ' ' TYR . . . -129.9 144.29 51.24 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.335 0.588 . . . . 1.0900000000000001 110.887 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 31.1 mt -102.08 143.95 31.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.495 -0.775 . . . . 1.4399999999999999 109.821 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.743 ' HE3' ' CB ' ' A' ' 129' ' ' PHE . 1.2 mptp? -143.73 152.99 41.97 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.284 -0.636 . . . . 2.5299999999999998 109.284 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -102.88 160.54 14.51 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.008 -0.542 . . . . 1.0700000000000001 109.606 171.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -83.36 159.65 21.8 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.129 -1.063 . . . . 0.70999999999999996 108.129 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -58.76 -9.64 1.89 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.982 0.42 . . . . 1.71 111.744 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.44 -38.11 71.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.682 -0.69 . . . . 2.2200000000000002 111.449 171.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -141.66 23.18 2.12 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.971 0.415 . . . . 1.5800000000000001 110.406 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 62.8 t80 -126.14 108.15 11.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.72999999999999998 110.189 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -112.82 107.85 16.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.214 -0.291 . . . . 2.4100000000000001 110.214 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 71.11 -58.86 0.56 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.982 0.801 . . . . 4.1399999999999997 110.957 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -178.52 40.92 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.443 -0.799 . . . . 0.72999999999999998 111.148 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 3.4 mptp? -131.76 133.9 45.26 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.64 -0.874 . . . . 2.6800000000000002 108.64 173.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.403 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -109.91 135.96 49.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.148 0.499 . . . . 0.65000000000000002 110.507 172.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 21.7 p90 -142.52 167.5 21.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.553 0.692 . . . . 0.73999999999999999 111.85 -175.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 16.0 mt -80.02 104.64 10.73 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.939 -1.028 . . . . 2.0800000000000001 109.591 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.3 tp -108.2 138.51 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.751 -0.463 . . . . 1.21 109.751 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 p -83.55 166.16 18.47 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.935 -0.395 . . . . 1.9299999999999999 109.935 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.28 -28.14 68.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.939 -0.763 . . . . 2.3100000000000001 108.939 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -80.96 -20.38 42.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.031 -0.986 . . . . 3.6600000000000001 110.479 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.0 m120 67.25 27.78 8.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.647 -0.706 . . . . 3.0600000000000001 111.268 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 63' ' ' ASP . 19.7 ptt180 -88.09 -46.4 9.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.485 -0.325 . . . . 5.1799999999999997 111.287 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.461 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 7.5 m-20 -107.52 143.52 35.8 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.91 -0.404 . . . . 2.5099999999999998 109.91 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.75 153.87 47.28 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.297 0.373 . . . . 2.6200000000000001 110.277 174.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.658 ' HG ' ' HG3' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -154.09 118.61 4.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.442 -0.947 . . . . 2.48 108.442 177.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 1.5 m-85 -69.91 138.97 52.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.933 0.397 . . . . 1.1299999999999999 109.945 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.484 HG12 HD22 ' A' ' 56' ' ' LEU . 15.1 m -117.38 176.53 2.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.139 -0.482 . . . . 1.29 110.846 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.49 111.65 10.89 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.822 -0.626 . . . . 2.1000000000000001 109.673 175.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.412 HG22 HG13 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -86.85 85.46 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.719 0.771 . . . . 1.55 109.196 171.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.677 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 37.7 ttt-85 -102.23 136.46 19.43 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 114.756 -1.111 . . . . 4.3300000000000001 110.396 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.575 ' HA ' HG22 ' A' ' 96' ' ' ILE . 6.1 Cg_exo -46.05 110.63 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.178 2.585 . . . . 0.90000000000000002 112.267 176.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.08 97.34 8.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.72 -0.673 . . . . 2.23 110.033 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 71.61 17.7 5.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.094 -0.957 . . . . 1.9199999999999999 110.881 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -128.59 79.11 1.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.084 0.402 . . . . 1.8899999999999999 112.084 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.4 t 68.56 -172.2 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.837 -0.62 . . . . 2.0699999999999998 111.804 172.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.57 141.48 48.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.792 -0.64 . . . . 1.5800000000000001 110.433 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.43 ' CG ' ' HG3' ' A' ' 71' ' ' PRO . 19.9 m0 -123.45 162.92 21.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.3 -0.409 . . . . 0.54000000000000004 110.602 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 m -76.41 104.85 7.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.74 -0.837 . . . . 1.22 108.74 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 t -93.43 110.5 22.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.813 0.816 . . . . 1.29 112.515 -170.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -110.86 159.35 17.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.017 -1.105 . . . . 1.7 108.017 166.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.407 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -76.59 -5.1 46.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.469 -0.197 . . . . 1.3899999999999999 110.469 -176.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -126.74 -32.62 0.69 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.026 -0.607 . . . . 0.85999999999999999 112.822 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 15.8 m -121.51 148.22 25.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 122.325 -0.515 . . . . 1.73 110.594 175.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.766 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -140.27 100.35 3.88 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.56 -0.533 . . . . 0.41999999999999998 109.56 -177.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.877 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 3.6 p90 -131.06 146.05 52.23 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.318 -0.252 . . . . 1.1499999999999999 110.318 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HZ2' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -81.86 150.58 27.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.01 -0.676 . . . . 2.0299999999999998 109.804 176.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -76.45 -13.52 60.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.59 0.709 . . . . 2.6600000000000001 110.069 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 19.4 m-20 -86.01 145.72 26.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.511 -0.768 . . . . 2.1000000000000001 110.136 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.496 HG13 ' HG3' ' A' ' 39' ' ' GLN . 19.5 m -103.85 123.39 57.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.282 0.563 . . . . 1.6599999999999999 110.586 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.47 -147.17 18.85 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.701 -0.762 . . . . 0.63 112.347 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.3 p -75.0 178.68 5.45 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.421 0.629 . . . . 1.5800000000000001 111.618 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.432 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 83.6 t90 -170.92 -55.63 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.087 -0.96 . . . . 0.75 108.729 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 29.19 97.72 0.01 OUTLIER Glycine 0 N--CA 1.469 0.898 0 O-C-N 125.057 1.473 . . . . 1.25 115.894 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.55 -153.37 10.25 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.58 -0.819 . . . . 1.0 112.964 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 p -101.38 129.66 47.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.871 0.693 . . . . 1.3200000000000001 112.871 -173.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.684 HD13 ' CG2' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -119.34 130.66 73.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.496 -0.928 . . . . 2.2400000000000002 108.496 170.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 69' ' ' ILE . . . -106.17 153.23 17.06 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.137 -1.03 . . . . 0.53000000000000003 112.59 -171.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 mp -87.58 112.01 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.014 0.435 . . . . 1.53 110.334 175.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.677 ' CE1' ' HB3' ' A' ' 70' ' ' ARG . 7.4 m-85 -101.66 153.48 19.73 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.935 -1.135 . . . . 1.7 107.935 171.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.602 ' HB ' HD12 ' A' ' 19' ' ' LEU . 3.6 p -87.48 124.7 40.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.323 -0.621 . . . . 1.6799999999999999 109.323 172.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -83.37 95.35 8.19 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.958 -0.697 . . . . 1.02 109.559 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.58 78.49 0.71 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.55 -0.833 . . . . 1.53 111.535 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.428 ' HA ' HG22 ' A' ' 100' ' ' VAL . 5.7 pt20 -37.97 120.66 0.87 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.724 0.773 . . . . 2.5699999999999998 112.527 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.658 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 9.7 mm-40 -92.41 19.79 6.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.326 -0.852 . . . . 3.1699999999999999 110.683 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 m 65.45 5.34 3.15 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.512 -0.767 . . . . 2.8599999999999999 112.302 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.575 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 12.5 t30 63.78 86.04 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.507 0.67 . . . . 1.5600000000000001 111.211 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.0 t -80.94 140.53 50.22 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 107.84 -1.17 . . . . 2.0800000000000001 107.84 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -26.76 92.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.835 3.69 . . . . 1.48 113.943 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.409 ' CB ' ' HE2' ' A' ' 112' ' ' TYR . 39.9 Cg_endo -90.74 -161.05 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.192 2.594 . . . . 0.84999999999999998 112.682 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.73 -76.51 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.342 -1.103 . . . . 0.76000000000000001 110.342 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -140.58 122.27 15.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.678 -0.49 . . . . 2.04 109.678 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.409 ' HE2' ' CB ' ' A' ' 109' ' ' PRO . 75.7 m-85 -117.62 124.46 48.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.438 0.637 . . . . 1.1100000000000001 110.18 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 51.5 m -116.14 97.62 6.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.907 -1.042 . . . . 1.3400000000000001 109.509 -173.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.544 HD22 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -104.05 100.83 10.6 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.413 0.625 . . . . 1.1699999999999999 110.108 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.9 m -73.14 117.94 15.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.033 -0.985 . . . . 1.4099999999999999 110.002 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -111.44 136.23 50.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.133 0.492 . . . . 1.8 110.857 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 45.8 m -129.32 106.18 8.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.223 -0.658 . . . . 1.3200000000000001 109.223 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 131' ' ' PRO . . . -89.01 -156.76 32.01 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.736 -0.745 . . . . 0.97999999999999998 111.767 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.64 -162.85 28.28 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.469 -0.872 . . . . 0.64000000000000001 111.932 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.554 ' CZ ' ' HB ' ' A' ' 130' ' ' THR . 52.6 p90 -101.65 144.82 29.9 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.987 0.422 . . . . 1.2 110.269 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.653 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 15.1 t-105 -101.23 131.82 47.03 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.749 -0.834 . . . . 0.65000000000000002 108.749 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 123' ' ' LYS . . . -141.18 54.87 1.55 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.233 0.54 . . . . 1.55 112.22 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.687 ' CG ' ' HA3' ' A' ' 128' ' ' GLY . 29.0 mmtp -158.98 -142.28 0.09 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.566 -1.272 . . . . 3.8700000000000001 107.566 174.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 126' ' ' LYS . 4.0 p-10 -151.57 107.08 3.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.238 0.542 . . . . 2.0800000000000001 111.926 174.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.653 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 84.4 m-20 63.91 -36.74 0.17 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.474 -1.239 . . . . 3.0899999999999999 114.272 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -55.04 -51.48 66.18 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.478 0.547 . . . . 2.3799999999999999 112.478 -170.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.674 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 36.4 tt0 152.82 22.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.082 0.864 . . . . 2.1099999999999999 110.801 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.687 ' HA3' ' CG ' ' A' ' 123' ' ' LYS . . . -80.79 88.39 1.34 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 119.957 -1.116 . . . . 0.77000000000000002 112.222 -175.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.743 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 28.4 p90 -140.82 155.17 46.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.592 0.234 . . . . 1.49 110.395 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.554 ' HB ' ' CZ ' ' A' ' 120' ' ' TYR . 99.5 m -139.74 125.27 11.73 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.594 -0.275 . . . . 1.8999999999999999 110.695 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.61 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 47.8 Cg_exo -56.59 134.06 61.95 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.076 2.517 . . . . 1.1699999999999999 112.018 177.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.7 t -151.84 103.51 2.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.44 -0.345 . . . . 1.96 110.78 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' HA3' ' HG3' ' A' ' 4' ' ' GLN . . . 82.08 -4.89 73.94 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.938 -0.648 . . . . 1.1699999999999999 112.901 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.548 ' HB ' ' H ' ' A' ' 118' ' ' GLY . 25.2 p -109.93 113.93 27.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.98 0.733 . . . . 2.9300000000000002 112.98 -170.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.6 m -140.11 95.18 2.85 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.954 -1.128 . . . . 2.1800000000000002 107.954 162.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.479 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -118.1 160.94 13.62 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.063 -1.065 . . . . 0.72999999999999998 113.02 -171.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -143.02 103.98 4.24 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.77 -0.456 . . . . 1.23 109.77 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.511 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 39.5 m -79.97 108.45 13.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.937 -0.764 . . . . 1.1799999999999999 108.937 174.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.412 ' HB3' HG23 ' A' ' 11' ' ' THR . 2.7 tppp? -94.7 109.39 21.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.222 0.534 . . . . 2.6299999999999999 110.052 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.507 HD12 ' HE3' ' A' ' 14' ' ' LYS . 2.3 tp -98.99 104.27 16.29 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.176 -0.92 . . . . 1.3100000000000001 109.317 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 9.2 m -119.23 140.02 50.92 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.848 -0.614 . . . . 1.1799999999999999 109.771 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.52 HG23 HG21 ' A' ' 15' ' ' THR . 12.3 p -82.07 149.12 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.459 . . . . 2.3900000000000001 110.711 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.512 -0.756 . . . . 2.5899999999999999 109.449 175.639 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 41.8 t . . . . . 0 C--O 1.237 0.399 0 N-CA-C 109.61 -0.515 . . . . 1.8300000000000001 109.61 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -113.47 128.51 56.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.013 -0.539 . . . . 2.29 109.55 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.504 ' HB ' HG23 ' A' ' 134' ' ' THR . 35.1 t -106.56 111.79 36.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.407 -0.59 . . . . 2.1000000000000001 109.407 -175.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 49.5 mtp180 -84.99 92.51 8.35 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.014 0.435 . . . . 4.25 110.961 -176.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.636 HG23 HG21 ' A' ' 134' ' ' THR . 81.1 t -102.66 115.45 44.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.643 -0.873 . . . . 1.8200000000000001 108.643 171.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.2 169.22 23.74 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.601 -0.809 . . . . 1.1899999999999999 112.984 -174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -88.12 152.93 21.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.933 0.397 . . . . 2.1800000000000002 110.393 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.936 HD13 ' HB ' ' A' ' 28' ' ' VAL . 89.2 mt -134.74 144.67 47.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.844 -0.616 . . . . 2.0 110.214 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 m -134.41 115.77 14.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.793 -0.447 . . . . 1.5600000000000001 109.793 171.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.702 HG11 HG21 ' A' ' 25' ' ' ILE . 21.0 t -130.95 130.58 64.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.471 -0.332 . . . . 2.04 110.947 -176.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.707 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -99.89 99.67 10.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.377 -0.374 . . . . 1.23 110.517 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -165.86 167.69 16.58 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.426 -0.352 . . . . 3.9100000000000001 110.256 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.482 ' HA ' HG22 ' A' ' 142' ' ' VAL . 70.4 p -87.25 167.24 14.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 1.21 111.095 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -88.18 -12.16 44.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.83 -0.804 . . . . 4.0800000000000001 108.83 173.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.72 -29.88 74.18 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.541 -0.754 . . . . 0.75 111.423 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -62.91 -35.02 78.68 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.601 -0.518 . . . . 2.6299999999999999 109.601 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.552 HD12 ' HB ' ' A' ' 100' ' ' VAL . 48.9 mt -64.8 95.14 0.14 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.421 -0.809 . . . . 1.6100000000000001 110.118 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -98.16 72.57 2.16 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.973 -0.751 . . . . 2.2599999999999998 108.973 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 34.0 t70 56.18 -95.7 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.828 -1.078 . . . . 1.8300000000000001 109.814 -169.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -84.6 77.15 10.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.164 0.507 . . . . 1.4299999999999999 111.016 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -132.41 96.75 18.66 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.718 -0.674 . . . . 1.3700000000000001 109.734 175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.48 ' HD3' ' HE1' ' A' ' 99' ' ' TYR . 55.2 Cg_endo -71.9 96.89 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.54 2.16 . . . . 1.1200000000000001 112.457 -177.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.702 HG21 HG11 ' A' ' 12' ' ' VAL . 16.2 mt -86.64 -30.09 5.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.366 0.603 . . . . 3.0499999999999998 110.513 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.18 63.51 0.63 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.374 -0.917 . . . . 1.04 112.712 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 14.1 Cg_endo -58.67 106.32 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.342 2.028 . . . . 1.0 111.494 172.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.936 ' HB ' HD13 ' A' ' 10' ' ' LEU . 7.6 p -91.78 130.66 40.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.163 -0.471 . . . . 1.8300000000000001 110.24 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.9 m -85.7 98.04 10.47 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.9 -0.591 . . . . 2.2000000000000002 110.626 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.655 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 52.1 t -89.96 115.11 28.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.915 -0.584 . . . . 1.5600000000000001 110.213 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.461 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 0.2 OUTLIER -104.38 110.13 22.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.948 -0.569 . . . . 2.48 109.551 -176.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.31 105.51 17.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.245 -0.434 . . . . 1.25 110.793 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.61 121.03 23.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.6 -0.727 . . . . 2.4700000000000002 110.002 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.74 -120.3 8.8 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.741 -0.742 . . . . 1.8100000000000001 112.141 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 56.4 m 70.36 -58.03 0.56 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.25 0.62 . . . . 1.8799999999999999 110.722 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.458 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 93.4 m-20 70.1 -48.13 0.63 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.921 0.888 . . . . 2.71 113.272 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.1 77.91 1.22 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.239 -0.652 . . . . 1.3600000000000001 109.239 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.508 ' HG3' ' HB2' ' A' ' 120' ' ' TYR . 2.9 tpp85 -156.05 146.87 22.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.61 -0.723 . . . . 5.3499999999999996 110.493 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.704 ' HG3' HG13 ' A' ' 89' ' ' VAL . 55.3 mt-30 -83.2 116.43 22.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.365 -0.38 . . . . 1.9099999999999999 110.518 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 59.3 t -84.15 124.67 39.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.69 -0.485 . . . . 1.1699999999999999 109.69 176.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.643 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . . . -125.23 139.51 53.67 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.765 0.317 . . . . 1.0900000000000001 110.402 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 mt -102.85 129.28 49.48 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.79 -0.448 . . . . 1.4399999999999999 109.79 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.664 ' HZ2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -120.57 151.3 39.6 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.243 -0.651 . . . . 2.5299999999999998 109.243 176.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.576 ' HB2' ' ND2' ' A' ' 48' ' ' ASN . . . -100.54 152.91 19.84 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.081 0.467 . . . . 1.0700000000000001 110.632 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.405 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 17.7 t70 -75.18 148.46 39.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.359 -0.837 . . . . 0.70999999999999996 109.678 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.5 t -57.91 -17.07 14.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.026 0.75 . . . . 1.71 113.026 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.62 -32.17 70.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.975 0.417 . . . . 2.2200000000000002 110.202 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.593 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 4.8 p-10 -123.73 20.1 9.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.05 -0.523 . . . . 1.5800000000000001 110.237 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.589 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 61.6 t80 -139.97 106.22 5.26 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.619 -0.719 . . . . 0.72999999999999998 109.932 -177.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -107.36 108.21 19.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.641 -0.254 . . . . 2.4100000000000001 110.36 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 71.23 -53.87 0.67 Allowed 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.974 0.796 . . . . 4.1399999999999997 111.778 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.589 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -179.96 31.88 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.904 -0.665 . . . . 0.72999999999999998 112.578 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -134.63 134.91 41.72 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.757 -0.831 . . . . 2.6800000000000002 108.757 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -112.51 148.62 34.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.447 0.642 . . . . 0.65000000000000002 112.181 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.593 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 9.5 p90 -156.12 171.51 20.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.975 -1.012 . . . . 0.73999999999999999 110.304 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.658 HD21 HD21 ' A' ' 114' ' ' LEU . 10.2 mt -84.57 115.42 22.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.531 -0.914 . . . . 2.0800000000000001 108.531 172.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.443 HG23 ' HB3' ' A' ' 48' ' ' ASN . 7.7 tp -107.54 116.43 51.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.687 0.756 . . . . 1.21 110.96 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 23.8 p -62.43 151.36 37.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.33 -0.85 . . . . 1.9299999999999999 111.561 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.65 -24.11 64.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.168 0.509 . . . . 2.3100000000000001 110.355 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -93.5 17.56 11.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.815 -0.629 . . . . 3.6600000000000001 110.581 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 25.82 67.3 0.05 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.438 1.095 . . . . 3.0600000000000001 112.771 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.506 HH21 HG21 ' A' ' 107' ' ' THR . 7.1 ptm85 -120.41 -44.59 2.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.552 -0.749 . . . . 5.1799999999999997 111.895 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.656 ' HB3' ' HH ' ' A' ' 112' ' ' TYR . 26.4 t0 -138.5 139.66 38.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.754 -0.462 . . . . 2.5099999999999998 109.754 -175.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 2.2 pptp? -128.68 138.92 52.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.08 0.467 . . . . 2.6200000000000001 110.703 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.651 HD23 ' HB2' ' A' ' 104' ' ' GLN . 6.1 mp -129.16 120.53 26.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.189 -0.46 . . . . 2.48 110.666 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -70.7 131.79 44.42 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.0 -0.37 . . . . 1.1299999999999999 110.0 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 100' ' ' VAL . 15.7 m -128.6 124.47 61.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.248 -0.433 . . . . 1.29 110.759 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.53 120.12 32.68 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.266 0.555 . . . . 2.1000000000000001 110.16 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.43 HG22 ' HB ' ' A' ' 96' ' ' ILE . 2.9 mt -82.6 85.3 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 1.55 110.237 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 65.7 mtp180 -90.26 133.58 32.99 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.0 -0.741 . . . . 4.3300000000000001 109.0 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.62 ' HG3' ' CD1' ' A' ' 77' ' ' TRP . 40.3 Cg_endo -66.87 134.99 36.48 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.569 1.513 . . . . 0.90000000000000002 111.157 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.5 ttt -79.32 92.1 5.12 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.855 -0.612 . . . . 2.23 110.666 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 68.24 36.04 3.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.465 -0.789 . . . . 1.9199999999999999 112.064 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -139.11 115.23 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.055 0.761 . . . . 1.8899999999999999 113.055 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.8 m 63.21 -167.15 0.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.076 -0.965 . . . . 2.0699999999999998 113.0 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.41 114.31 19.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.655 -0.702 . . . . 1.5800000000000001 110.137 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.62 ' CD1' ' HG3' ' A' ' 71' ' ' PRO . 11.8 m95 -109.49 141.43 41.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.826 -0.625 . . . . 0.54000000000000004 110.705 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.1 m -80.44 111.35 16.76 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.53 -0.544 . . . . 1.22 109.53 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.6 t -86.04 113.47 22.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.798 0.809 . . . . 1.29 112.079 -173.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -129.29 156.07 44.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.154 -0.93 . . . . 1.7 108.509 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -82.87 -0.53 48.63 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.716 -0.394 . . . . 1.3899999999999999 111.61 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.57 -34.23 2.3 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.467 -0.873 . . . . 0.85999999999999999 111.868 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.577 HG13 ' HZ3' ' A' ' 121' ' ' TRP . 10.7 m -138.73 154.64 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.634 -0.506 . . . . 1.73 109.634 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.4 ' HD1' ' HE3' ' A' ' 77' ' ' TRP . 0.6 OUTLIER -140.48 106.86 5.27 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.105 -1.072 . . . . 0.41999999999999998 108.105 178.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 2.0 p90 -139.49 141.98 37.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.757 0.789 . . . . 1.1499999999999999 112.895 -170.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.589 ' HB2' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -70.64 128.22 35.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.987 -1.46 . . . . 2.0299999999999998 111.04 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.56 -35.34 79.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.59 . . . . 2.6600000000000001 109.69 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.589 ' OD1' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -68.5 125.75 27.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.364 -0.834 . . . . 2.1000000000000001 109.673 175.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.704 HG13 ' HG3' ' A' ' 39' ' ' GLN . 16.4 m -91.91 118.4 37.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.159 0.504 . . . . 1.6599999999999999 110.958 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.458 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 159.6 -169.14 35.6 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.393 -0.908 . . . . 0.63 112.348 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.3 p -70.4 151.27 45.37 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.127 -0.694 . . . . 1.5800000000000001 109.127 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.412 ' HD1' ' HZ2' ' A' ' 86' ' ' LYS . 37.0 t90 -135.71 -64.89 0.61 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.755 -0.378 . . . . 0.75 110.121 -175.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 35.86 85.28 0.01 OUTLIER Glycine 0 N--CA 1.468 0.776 0 O-C-N 124.307 1.004 . . . . 1.25 114.618 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.17 -153.91 6.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.922 -0.656 . . . . 1.0 112.236 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -106.11 132.9 51.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.198 0.523 . . . . 1.3200000000000001 112.363 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.638 HD12 ' CG2' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -125.22 141.04 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.857 -0.794 . . . . 2.2400000000000002 108.857 171.306 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -114.56 151.1 18.55 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.16 -1.019 . . . . 0.53000000000000003 112.647 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -92.7 114.34 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.514 -0.55 . . . . 1.53 109.514 174.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 10.1 m-85 -120.97 129.87 53.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.437 -0.802 . . . . 1.7 108.892 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.718 ' HA ' HG12 ' A' ' 67' ' ' VAL . 8.6 p -71.03 142.66 15.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.035 -0.357 . . . . 1.6799999999999999 110.035 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.57 95.45 0.33 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.385 -0.37 . . . . 1.02 110.867 176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 50.38 48.81 40.4 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.973 -0.558 . . . . 1.53 113.67 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.437 ' HA ' HG12 ' A' ' 100' ' ' VAL . 3.9 pt20 38.41 88.47 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.005 0.907 . . . . 2.5699999999999998 112.34 -174.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.651 ' HB2' HD23 ' A' ' 65' ' ' LEU . 38.5 mm-40 -56.98 -76.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.816 -1.083 . . . . 3.1699999999999999 113.129 -175.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -146.37 -64.66 0.3 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.388 -0.369 . . . . 2.8599999999999999 111.979 -169.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 15.7 t30 60.85 47.2 7.98 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 122.259 1.028 . . . . 1.5600000000000001 108.393 -170.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.506 HG21 HH21 ' A' ' 62' ' ' ARG . 16.2 m -72.45 123.31 89.35 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 114.84 -1.073 . . . . 2.0800000000000001 109.246 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -11.82 84.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.342 1 C-N-CA 125.966 4.444 . . . . 1.48 114.44 -164.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 2.8 Cg_endo -87.0 -169.09 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.634 2.889 . . . . 0.84999999999999998 114.035 -168.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.35 -111.82 0.25 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.224 -1.55 . . . . 0.76000000000000001 109.224 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -89.39 131.23 35.56 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.848 0.356 . . . . 2.04 110.311 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.656 ' HH ' ' HB3' ' A' ' 63' ' ' ASP . 6.3 m-85 -125.35 125.31 43.27 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.778 -0.452 . . . . 1.1100000000000001 109.778 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.9 m -96.63 129.36 44.04 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.698 -0.683 . . . . 1.3400000000000001 110.23 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.658 HD21 HD21 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -144.68 104.57 4.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.522 -0.918 . . . . 1.1699999999999999 108.522 171.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.405 ' HB ' ' CB ' ' A' ' 45' ' ' ASP . 32.5 m -108.19 123.97 49.57 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.527 -0.916 . . . . 1.4099999999999999 108.527 -174.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.416 ' N ' HD21 ' A' ' 116' ' ' LEU . 2.8 mm? -113.35 110.92 21.14 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.397 0.618 . . . . 1.8 110.755 -173.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 9.8 m -98.27 103.71 15.68 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.256 -0.884 . . . . 1.3200000000000001 108.733 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.744 ' H ' ' HB ' ' A' ' 134' ' ' THR . . . -92.29 -157.13 33.36 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 120.378 -0.915 . . . . 0.97999999999999998 112.023 -173.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 147.87 -167.9 28.77 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.707 -0.957 . . . . 0.64000000000000001 110.707 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.508 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 50.5 p90 -98.86 138.24 36.27 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.83 -0.748 . . . . 1.2 109.945 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.611 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 11.2 t-105 -91.72 141.7 28.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.473 -1.24 . . . . 0.65000000000000002 109.142 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.17 57.33 1.2 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.162 0.43 . . . . 1.55 112.162 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.506 ' C ' ' HE1' ' A' ' 121' ' ' TRP . 55.5 mmtt -158.96 -139.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.364 -0.976 . . . . 3.8700000000000001 108.364 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 126' ' ' LYS . 7.6 p-10 -154.84 100.47 2.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.32 0.581 . . . . 2.0800000000000001 112.087 173.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.611 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 27.1 t-20 60.65 -41.58 0.11 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.454 1.502 . . . . 3.0899999999999999 114.309 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 127' ' ' GLN . 19.4 ptpt -52.56 -51.18 60.95 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.753 0.649 . . . . 2.3799999999999999 112.753 -172.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.504 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 8.1 tt0 152.37 88.96 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.236 1.014 . . . . 2.1099999999999999 109.239 -176.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.446 ' HA3' ' CG ' ' A' ' 123' ' ' LYS . . . -142.31 90.65 0.17 Allowed Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.33 -0.938 . . . . 0.77000000000000002 111.129 172.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.664 ' HB3' ' HZ2' ' A' ' 43' ' ' LYS . 44.7 p90 -144.78 168.51 20.04 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.869 -0.419 . . . . 1.49 109.869 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 4.1 t -156.68 129.25 4.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.897 0.379 . . . . 1.8999999999999999 110.615 173.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 24.0 Cg_exo -64.2 110.71 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.939 2.426 . . . . 1.1699999999999999 111.776 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.1 t -131.57 91.93 3.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.395 -0.366 . . . . 1.96 110.314 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.25 -3.18 85.54 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.98 -0.629 . . . . 1.1699999999999999 112.702 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.744 ' HB ' ' H ' ' A' ' 118' ' ' GLY . 16.5 p -100.5 113.6 26.52 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 113.376 0.88 . . . . 2.9300000000000002 113.376 -168.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 54.4 m -141.3 94.88 2.75 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.624 -0.51 . . . . 2.1800000000000002 109.624 165.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.476 ' HA3' HG11 ' A' ' 7' ' ' VAL . . . -110.01 85.03 0.39 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.205 -0.998 . . . . 0.72999999999999998 112.729 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.8 m -81.15 95.01 6.75 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.618 -0.512 . . . . 1.23 109.618 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.602 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 27.5 m -89.15 108.5 19.64 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.106 -0.701 . . . . 1.1799999999999999 109.106 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 139' ' ' LYS . 29.1 ttmt -103.89 108.79 20.28 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.848 0.832 . . . . 2.6299999999999999 109.583 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.491 HD21 HD11 ' A' ' 56' ' ' LEU . 21.6 tp -105.35 104.05 13.7 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.281 -1.327 . . . . 1.3100000000000001 109.343 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.707 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.8 m -117.74 138.11 52.25 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.937 -0.574 . . . . 1.1799999999999999 110.883 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' A' ' 15' ' ' THR . 40.3 t -91.58 111.35 23.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.518 -0.919 . . . . 2.3900000000000001 108.518 170.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.407 -0.806 . . . . 2.5899999999999999 110.743 -176.555 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.764 0.316 . . . . 1.8300000000000001 111.786 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -86.64 111.26 20.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.216 -0.661 . . . . 2.29 109.216 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.969 HG21 ' HA3' ' A' ' 118' ' ' GLY . 33.1 m -80.93 137.68 20.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.176 0.513 . . . . 2.1000000000000001 110.417 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.544 ' HA ' ' NE ' ' A' ' 6' ' ' ARG . 5.2 mmp_? -96.46 95.07 7.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.146 -0.479 . . . . 4.25 110.078 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.77 140.15 40.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.503 -0.771 . . . . 1.8200000000000001 109.163 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.62 136.08 9.54 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.388 -0.911 . . . . 1.1899999999999999 111.895 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.81 106.52 2.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.803 -0.443 . . . . 2.1800000000000002 109.803 177.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.551 HD11 HG22 ' A' ' 138' ' ' THR . 4.1 pp -116.73 151.29 36.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.308 -0.405 . . . . 2.0 110.779 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -120.61 123.64 43.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.038 -0.528 . . . . 1.5600000000000001 110.194 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.437 HG11 ' HG2' ' A' ' 14' ' ' LYS . 39.2 t -130.12 135.46 60.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.268 -0.424 . . . . 2.04 110.493 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -103.67 96.15 6.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.879 0.371 . . . . 1.23 110.658 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HG2' HG11 ' A' ' 12' ' ' VAL . 33.8 mmtp -144.32 163.44 33.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 3.9100000000000001 110.288 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.787 ' HA ' HG11 ' A' ' 142' ' ' VAL . 31.3 p -91.8 149.89 21.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.339 -0.392 . . . . 1.21 110.433 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.767 ' NH1' ' HG3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -81.97 -0.03 42.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.198 0.523 . . . . 4.0800000000000001 110.062 177.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.687 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -84.33 -22.75 53.54 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.816 -0.914 . . . . 0.75 110.816 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -56.61 -31.08 63.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.774 0.797 . . . . 2.6299999999999999 109.361 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.813 HD22 HG21 ' A' ' 25' ' ' ILE . 7.1 mt -89.61 111.27 22.17 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.832 -1.076 . . . . 1.6100000000000001 109.765 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -107.97 75.35 0.99 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.491 -0.929 . . . . 2.2599999999999998 108.491 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.653 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 36.4 t70 62.6 -93.18 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.401 -1.272 . . . . 1.8300000000000001 110.336 -170.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.23 73.84 10.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.321 0.581 . . . . 1.4299999999999999 111.065 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -152.79 121.6 3.23 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.259 -0.882 . . . . 1.3700000000000001 108.88 174.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 48.2 Cg_endo -89.85 151.06 4.97 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.074 2.516 . . . . 1.1200000000000001 113.654 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.813 HG21 HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.68 -64.46 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.627 -0.715 . . . . 3.0499999999999998 110.781 175.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.95 77.52 0.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.679 -0.772 . . . . 1.04 112.898 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.527 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 5.2 Cg_endo -48.24 111.1 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.32 2.68 . . . . 1.0 112.327 168.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.55 HG21 HD23 ' A' ' 10' ' ' LEU . 26.0 t -87.13 134.37 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.533 -0.758 . . . . 1.8300000000000001 110.305 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 32.4 p -78.09 79.26 4.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 2.2000000000000002 110.392 175.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.498 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 40.3 t -82.94 114.62 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.271 0.557 . . . . 1.5600000000000001 110.46 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.639 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 8.9 tt0 -110.94 135.07 52.01 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.13 -0.941 . . . . 2.48 109.96 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.462 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -104.76 123.8 48.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.084 -0.507 . . . . 1.25 110.572 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.39 123.05 49.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.258 -0.428 . . . . 2.4700000000000002 110.882 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.71 28.7 8.19 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.861 -0.685 . . . . 1.8100000000000001 111.939 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 32' ' ' ALA . 19.6 m -120.74 94.65 4.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.893 0.378 . . . . 1.8799999999999999 111.019 -176.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -98.48 -19.37 17.7 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.372 -0.603 . . . . 2.71 109.372 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -167.78 72.35 0.11 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.78 -0.645 . . . . 1.3600000000000001 111.138 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -152.36 146.9 25.71 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 110.319 -0.252 . . . . 5.3499999999999996 110.319 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.89 131.52 36.44 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.408 -0.59 . . . . 1.9099999999999999 109.408 174.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 95.1 t -103.1 120.34 52.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.193 -0.669 . . . . 1.1699999999999999 109.193 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.683 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -114.12 143.2 45.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.105 0.479 . . . . 1.0900000000000001 111.453 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.3 mt -102.78 114.75 29.27 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.719 -0.673 . . . . 1.4399999999999999 109.767 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.589 ' HZ1' ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -111.78 152.55 27.72 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.441 -0.8 . . . . 2.5299999999999998 109.093 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 116' ' ' LEU . . . -92.38 154.42 18.55 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.305 -0.628 . . . . 1.0700000000000001 109.305 170.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.72 159.13 31.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.203 -1.036 . . . . 0.70999999999999996 108.203 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.66 -20.58 34.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.707 1.003 . . . . 1.71 113.707 -168.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.25 -32.89 73.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.016 0.436 . . . . 2.2200000000000002 110.903 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -115.36 13.23 16.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.634 0.73 . . . . 1.5800000000000001 109.924 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -130.52 101.75 5.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.848 -0.614 . . . . 0.72999999999999998 109.506 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.45 103.31 14.2 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.988 -0.375 . . . . 2.4100000000000001 109.988 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 71.48 -56.64 0.63 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 124.084 0.865 . . . . 4.1399999999999997 111.322 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.28 39.08 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.036 -0.826 . . . . 0.72999999999999998 111.036 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.431 ' HB3' ' OD1' ' A' ' 81' ' ' ASN . 43.6 mmtm -138.36 135.03 34.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.172 -1.048 . . . . 2.6800000000000002 108.172 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.4 148.5 37.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.607 0.717 . . . . 0.65000000000000002 111.211 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.728 ' CE2' ' HB ' ' A' ' 57' ' ' ILE . 0.8 OUTLIER -145.93 -169.11 3.16 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.994 -1.003 . . . . 0.73999999999999999 110.755 -170.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.763 ' HG ' HD21 ' A' ' 114' ' ' LEU . 1.1 mp -111.2 104.24 12.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.567 -1.271 . . . . 2.0800000000000001 107.567 167.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.728 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 9.4 tp -107.81 136.5 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.273 0.559 . . . . 1.21 111.669 -172.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.2 t -70.72 140.55 51.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.003 -0.74 . . . . 1.9299999999999999 109.003 171.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.21 -16.97 64.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.981 0.42 . . . . 2.3100000000000001 111.118 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -87.32 -14.43 40.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 3.6600000000000001 110.657 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.5 t30 59.89 94.46 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.798 -0.637 . . . . 3.0600000000000001 110.966 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -153.74 -46.5 0.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 5.1799999999999997 110.126 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -117.31 138.63 51.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.508 -0.769 . . . . 2.5099999999999998 109.555 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.94 153.27 46.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.227 1.013 . . . . 2.6200000000000001 111.499 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.727 ' HG ' HE21 ' A' ' 104' ' ' GLN . 6.4 mp -120.65 175.58 5.94 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 113.377 -1.738 . . . . 2.48 106.82 169.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -126.56 145.13 50.65 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.58 -0.896 . . . . 1.1299999999999999 108.58 151.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.545 HG12 HD13 ' A' ' 56' ' ' LEU . 29.4 m -134.22 160.07 41.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.861 0.362 . . . . 1.29 110.867 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 99' ' ' TYR . 14.4 p-10 -126.11 111.99 15.31 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.853 -0.612 . . . . 2.1000000000000001 109.865 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.423 HG21 HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -72.88 101.44 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.033 -0.729 . . . . 1.55 109.033 173.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -122.14 139.86 31.28 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.825 -0.625 . . . . 4.3300000000000001 110.215 -170.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.51 122.61 5.93 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.67 2.246 . . . . 0.90000000000000002 111.793 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 53.7 ttp -53.09 -54.01 41.89 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.702 0.626 . . . . 2.23 111.706 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -155.96 15.03 0.34 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.954 0.407 . . . . 1.9199999999999999 110.504 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -80.81 -81.83 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.032 -0.531 . . . . 1.8899999999999999 111.658 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.462 ' HB2' ' HE1' ' A' ' 92' ' ' TRP . 3.7 m -136.56 172.35 13.15 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.472 -0.196 . . . . 2.0699999999999998 110.472 -175.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.98 122.46 32.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.989 0.423 . . . . 1.5800000000000001 110.859 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.495 ' HE3' ' HD1' ' A' ' 84' ' ' PHE . 12.5 m0 -107.79 156.94 18.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.892 -0.595 . . . . 0.54000000000000004 110.319 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 m -72.44 121.03 18.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.958 -0.756 . . . . 1.22 108.958 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 t -103.42 101.24 11.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.928 0.87 . . . . 1.29 112.979 -168.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.33 161.29 15.78 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.721 -1.214 . . . . 1.7 107.721 168.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 53' ' ' LYS . 2.1 t-20 -86.82 -7.26 58.4 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.696 -0.801 . . . . 1.3899999999999999 110.154 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.53 -30.29 3.6 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.525 -0.845 . . . . 0.85999999999999999 112.556 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.1 m -135.68 149.39 28.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 110.047 -0.353 . . . . 1.73 110.047 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.683 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -139.44 110.8 7.01 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.224 -0.658 . . . . 0.41999999999999998 109.224 -179.622 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 8.2 p90 -142.87 149.3 38.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.13 -0.322 . . . . 1.1499999999999999 110.13 -174.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.461 ' HB3' ' NE1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -74.47 145.07 43.9 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.037 -0.665 . . . . 2.0299999999999998 110.524 -178.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.03 -27.45 65.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.215 -0.902 . . . . 2.6600000000000001 110.969 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -95.09 -166.19 1.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.623 -0.717 . . . . 2.1000000000000001 110.551 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.6 -169.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.838 -0.619 . . . . 1.6599999999999999 109.413 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.65 -154.0 27.84 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.623 -0.798 . . . . 0.63 111.9 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.7 m -87.35 -171.69 3.59 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.156 -0.683 . . . . 1.5800000000000001 109.156 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.462 ' HE1' ' HB2' ' A' ' 75' ' ' SER . 77.9 t90 -168.33 -50.0 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.573 -0.529 . . . . 0.75 109.573 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.639 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 18.44 92.71 0.01 OUTLIER Glycine 0 N--CA 1.474 1.186 0 O-C-N 125.208 1.567 . . . . 1.25 115.862 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 29' ' ' THR . . . -150.33 -125.37 1.29 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.797 -0.716 . . . . 1.0 112.311 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.47 126.58 35.39 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.195 0.443 . . . . 1.3200000000000001 112.195 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -119.8 129.26 75.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.053 -0.721 . . . . 2.2400000000000002 109.053 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -112.79 152.34 17.95 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.257 -0.973 . . . . 0.53000000000000003 112.071 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.6 mp -90.12 112.48 24.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.898 -0.408 . . . . 1.53 109.898 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.476 ' HD2' ' N ' ' A' ' 23' ' ' ALA . 2.9 m-85 -107.03 140.68 39.45 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.223 -1.029 . . . . 1.7 108.223 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 8.5 p -84.19 136.36 22.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.47 . . . . 1.6799999999999999 109.919 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.57 112.33 16.73 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.193 -0.317 . . . . 1.02 110.658 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.9 37.01 60.96 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 1.53 113.238 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 17.9 pt20 39.82 103.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.481 1.289 . . . . 2.5699999999999998 114.481 177.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.727 HE21 ' HG ' ' A' ' 65' ' ' LEU . 6.0 tp-100 -62.8 -27.09 69.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.873 -0.603 . . . . 3.1699999999999999 109.897 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.9 m 65.11 14.84 9.65 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.846 0.832 . . . . 2.8599999999999999 110.069 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.687 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 20.6 t30 59.83 92.04 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.416 -1.265 . . . . 1.5600000000000001 112.488 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.1 m -94.93 124.51 54.14 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.621 -0.881 . . . . 2.0800000000000001 108.621 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -26.28 93.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.414 4.076 . . . . 1.48 114.934 -171.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.767 ' HG3' ' NH1' ' A' ' 16' ' ' ARG . 55.6 Cg_endo -100.18 -153.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 124.633 3.556 . . . . 0.84999999999999998 113.682 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.89 -104.73 0.18 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.504 -1.038 . . . . 0.76000000000000001 110.504 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.41 113.2 26.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.868 0.366 . . . . 2.04 110.323 175.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -107.52 135.64 48.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.208 0.527 . . . . 1.1100000000000001 109.937 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 42.5 m -116.97 98.97 6.76 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.176 -0.92 . . . . 1.3400000000000001 110.447 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.763 HD21 ' HG ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -110.61 91.63 3.73 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.494 0.664 . . . . 1.1699999999999999 110.173 178.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 1.2 m -82.84 125.65 31.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.314 -0.857 . . . . 1.4099999999999999 110.195 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 91.0 mt -115.72 110.65 19.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.882 0.372 . . . . 1.8 111.158 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 135' ' ' THR . 28.7 m -90.19 108.52 19.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.112 -0.495 . . . . 1.3200000000000001 110.25 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.969 ' HA3' HG21 ' A' ' 5' ' ' VAL . . . -74.4 178.26 44.99 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.952 -0.642 . . . . 0.97999999999999998 113.289 -176.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 153.56 -170.24 32.33 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 121.073 -0.584 . . . . 0.64000000000000001 111.663 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -103.52 -176.23 3.02 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.452 -0.499 . . . . 1.2 110.273 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.673 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 6.3 t-105 -144.8 151.63 39.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.655 -0.702 . . . . 0.65000000000000002 109.634 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -129.51 141.58 50.96 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.722 0.296 . . . . 1.55 111.471 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 20.5 mmtp 71.66 -152.21 0.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.101 0.961 . . . . 3.8700000000000001 112.078 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 126' ' ' LYS . 19.9 m-20 -132.9 110.86 10.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.68 0.622 . . . . 2.0800000000000001 112.68 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.673 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 12.3 m120 59.43 -7.72 0.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.781 1.232 . . . . 3.0899999999999999 114.3 174.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -75.86 -3.68 36.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.841 0.353 . . . . 2.3799999999999999 110.767 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.912 HE21 ' HE2' ' A' ' 129' ' ' PHE . 59.7 tt0 74.61 85.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.978 -1.01 . . . . 2.1099999999999999 110.83 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -120.48 33.0 4.65 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.484 -0.865 . . . . 0.77000000000000002 111.466 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.912 ' HE2' HE21 ' A' ' 127' ' ' GLN . 11.4 p90 -78.89 152.3 31.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.11 0.481 . . . . 1.49 110.535 -172.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.438 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 34.5 m -134.99 133.28 20.82 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.792 -0.64 . . . . 1.8999999999999999 109.561 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.11 112.24 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.286 1.991 . . . . 1.1699999999999999 111.818 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.4 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 13.5 m -139.22 105.99 5.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.739 -0.664 . . . . 1.96 109.69 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 126.91 -128.12 6.15 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.561 -0.828 . . . . 1.1699999999999999 111.492 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.2 m -133.12 159.16 40.93 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.627 -0.508 . . . . 2.9300000000000002 109.627 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 12.6 t -97.18 110.37 22.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.616 0.722 . . . . 2.1800000000000002 109.342 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -90.16 118.39 5.28 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.754 -0.736 . . . . 0.72999999999999998 112.144 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 7.4 m -84.77 101.29 12.12 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.715 -0.476 . . . . 1.23 109.715 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.551 HG22 HD11 ' A' ' 10' ' ' LEU . 19.6 m -77.91 108.9 11.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.244 -1.021 . . . . 1.1799999999999999 108.244 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.441 ' HB2' ' HE3' ' A' ' 139' ' ' LYS . 32.5 ttmt -97.05 108.99 21.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.688 0.756 . . . . 2.6299999999999999 110.439 -172.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 tp -107.11 108.15 19.48 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.461 -1.245 . . . . 1.3100000000000001 110.253 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.672 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 10.6 m -108.43 117.32 33.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.37 -0.832 . . . . 1.1799999999999999 109.077 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 15' ' ' THR . 39.5 t -93.11 116.26 33.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.206 0.527 . . . . 2.3900000000000001 112.058 -172.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.5 m . . . . . 0 C--O 1.249 1.067 0 CA-C-N 115.262 -0.881 . . . . 2.5899999999999999 109.249 172.945 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 91.5 m . . . . . 0 CA--C 1.52 -0.205 0 N-CA-C 112.146 0.425 . . . . 1.8300000000000001 112.146 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -87.86 108.65 19.27 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.873 -1.158 . . . . 2.29 107.873 171.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -93.21 111.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.597 -0.52 . . . . 2.1000000000000001 109.597 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.547 HH21 ' NE2' ' A' ' 31' ' ' GLN . 71.4 mtm180 -94.45 97.42 10.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.951 -0.568 . . . . 4.25 110.77 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.0 t -103.5 115.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.114 -0.948 . . . . 1.8200000000000001 108.651 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.1 155.44 23.62 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.399 -0.905 . . . . 1.1899999999999999 112.249 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -73.34 142.95 47.06 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.973 -0.38 . . . . 2.1800000000000002 109.973 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -157.16 148.49 22.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.085 -0.507 . . . . 2.0 109.95 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.5 t -109.55 133.58 52.93 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.093 0.473 . . . . 1.5600000000000001 109.887 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.9 t -117.34 126.2 74.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.761 -0.654 . . . . 2.04 109.378 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -106.16 104.12 13.75 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.409 -0.219 . . . . 1.23 110.409 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -172.59 -178.67 1.99 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.155 -0.475 . . . . 3.9100000000000001 110.835 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.484 HG22 HG21 ' A' ' 142' ' ' VAL . 46.3 p -102.93 167.09 10.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.89 -0.595 . . . . 1.21 110.933 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.753 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -87.8 -10.34 51.2 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.863 -0.791 . . . . 4.0800000000000001 108.863 175.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.608 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -71.29 -20.32 78.08 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.293 -0.867 . . . . 0.75 111.578 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -58.57 -41.33 85.46 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.596 0.712 . . . . 2.6299999999999999 109.365 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.645 HD22 HG12 ' A' ' 25' ' ' ILE . 4.5 mt -80.19 100.07 8.11 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.615 -1.175 . . . . 1.6100000000000001 110.449 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.648 HG21 HE21 ' A' ' 103' ' ' GLN . 0.8 OUTLIER -103.66 70.76 1.04 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.784 -0.821 . . . . 2.2599999999999998 108.784 174.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 1.0 OUTLIER 67.16 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.647 -1.16 . . . . 1.8300000000000001 110.295 -171.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.63 66.01 5.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.308 0.575 . . . . 1.4299999999999999 111.194 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 19' ' ' LEU . . . -141.94 115.36 6.61 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.39 -0.823 . . . . 1.3700000000000001 109.858 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.5 Cg_endo -91.52 151.12 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.51 2.806 . . . . 1.1200000000000001 113.341 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.645 HG12 HD22 ' A' ' 19' ' ' LEU . 3.3 pt -116.97 -56.58 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 3.0499999999999998 112.174 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.487 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -114.04 88.97 0.5 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.475 -0.869 . . . . 1.04 112.914 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 38.2 Cg_exo -60.46 126.93 21.24 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.601 2.201 . . . . 1.0 112.067 172.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.5 t -98.66 127.7 50.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.984 -0.553 . . . . 1.8300000000000001 110.273 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 m -74.45 101.24 4.07 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 116.156 -0.475 . . . . 2.2000000000000002 110.489 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 99.3 t -104.04 115.6 46.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.101 -0.5 . . . . 1.5600000000000001 110.525 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.617 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 8.2 tt0 -113.61 107.02 15.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.999 0.428 . . . . 2.48 110.713 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.75 109.06 20.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.644 -0.707 . . . . 1.25 109.835 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.28 130.29 48.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.025 -0.534 . . . . 2.4700000000000002 110.287 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.68 29.51 10.73 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.798 -0.715 . . . . 1.8100000000000001 113.203 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.5 m -94.07 -74.07 0.55 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.926 0.343 . . . . 1.8799999999999999 111.926 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.535 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 9.1 t30 71.2 -44.69 0.6 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.85 0.46 . . . . 2.71 112.062 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.14 76.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.205 0.526 . . . . 1.3600000000000001 110.282 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.532 ' H ' ' N ' ' A' ' 90' ' ' GLY . 1.7 tpm_? -157.82 148.52 20.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.436 -0.802 . . . . 5.3499999999999996 110.455 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.436 HE21 ' HD1' ' A' ' 121' ' ' TRP . 19.8 mt-30 -86.2 134.67 33.76 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.098 -0.705 . . . . 1.9099999999999999 109.098 172.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 93.3 t -110.53 125.3 67.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.943 -0.391 . . . . 1.1699999999999999 109.943 -176.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB1' ' HE2' ' A' ' 43' ' ' LYS . . . -117.54 152.62 34.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 123.485 0.491 . . . . 1.0900000000000001 111.293 -173.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' A' ' 84' ' ' PHE . 28.2 mt -103.76 104.41 14.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.734 -0.666 . . . . 1.4399999999999999 109.868 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.682 ' HE2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -98.38 122.75 41.95 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.311 -0.626 . . . . 2.5299999999999998 109.311 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.497 ' HB2' ' CD1' ' A' ' 49' ' ' PHE . . . -83.48 158.21 22.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.332 -0.395 . . . . 1.0700000000000001 110.774 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.686 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 13.6 t70 -87.19 152.2 22.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.188 -0.46 . . . . 0.70999999999999996 109.782 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -54.74 -20.37 8.26 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.803 0.668 . . . . 1.71 112.803 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.9 -37.54 74.21 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.936 0.398 . . . . 2.2200000000000002 111.269 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 5.6 p-10 -129.27 16.14 6.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.895 -0.593 . . . . 1.5800000000000001 109.956 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 82.2 t80 -132.85 101.73 5.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.308 -0.86 . . . . 0.72999999999999998 109.148 -176.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -93.58 93.83 8.29 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.198 -0.456 . . . . 2.4100000000000001 110.571 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 69.46 -50.3 0.61 Allowed 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.154 0.909 . . . . 4.1399999999999997 112.103 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.51 35.73 0.16 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.772 -0.531 . . . . 0.72999999999999998 111.772 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 43.4 mmtm -137.49 133.28 34.42 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.404 -0.961 . . . . 2.6800000000000002 108.404 172.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -117.43 136.57 53.09 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.004 0.907 . . . . 0.65000000000000002 112.077 178.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 30.8 p90 -141.06 -176.7 4.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.049 -1.432 . . . . 0.73999999999999999 108.51 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.897 HD22 HD23 ' A' ' 114' ' ' LEU . 10.9 mt -102.7 127.58 49.77 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.549 -0.908 . . . . 2.0800000000000001 108.549 172.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.45 133.88 49.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.406 0.622 . . . . 1.21 110.636 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 112' ' ' TYR . 29.5 t -83.87 150.06 25.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.323 -0.853 . . . . 1.9299999999999999 110.654 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.18 -26.41 68.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.962 -0.563 . . . . 2.3100000000000001 110.239 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -75.32 -13.62 60.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.658 . . . . 3.6600000000000001 110.537 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.6 m120 61.09 20.04 10.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.568 -0.742 . . . . 3.0600000000000001 111.999 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.846 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -95.49 -70.42 0.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.875 0.369 . . . . 5.1799999999999997 110.989 -177.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.67 158.48 16.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.788 -0.642 . . . . 2.5099999999999998 111.845 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.46 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -143.66 175.08 10.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.24 -0.891 . . . . 2.6200000000000001 110.319 -178.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.471 HD13 HG21 ' A' ' 100' ' ' VAL . 1.5 pt? -157.17 125.57 5.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.28 -0.418 . . . . 2.48 110.29 173.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 94.2 m-85 -72.83 144.74 47.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.052 -0.722 . . . . 1.1299999999999999 109.052 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' ' HE1' ' A' ' 54' ' ' PHE . 15.7 m -123.66 157.18 30.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.308 0.575 . . . . 1.29 111.784 -175.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.464 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -118.94 111.54 18.48 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.438 -0.949 . . . . 2.1000000000000001 108.438 171.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.4 HG22 HD12 ' A' ' 96' ' ' ILE . 0.9 OUTLIER -92.52 86.17 2.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.33 -0.619 . . . . 1.55 109.33 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.5 ' HG3' ' HD2' ' A' ' 71' ' ' PRO . 57.7 ttp180 -112.41 142.15 26.47 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.41 -0.589 . . . . 4.3300000000000001 109.41 -174.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 84.9 Cg_exo -44.26 140.23 5.83 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.052 2.501 . . . . 0.90000000000000002 112.927 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 52.8 ttp -60.56 -52.96 62.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.693 -0.855 . . . . 2.23 108.693 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -153.34 107.63 3.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.138 -0.937 . . . . 1.9199999999999999 109.315 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -168.73 -163.15 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.737 0.303 . . . . 1.8899999999999999 111.191 -175.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 p -60.32 168.06 2.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.882 -0.599 . . . . 2.0699999999999998 112.02 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 120.16 23.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.73 -0.668 . . . . 1.5800000000000001 111.153 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.793 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.8 m95 -107.34 134.11 50.89 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.543 -0.753 . . . . 0.54000000000000004 109.967 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.9 m -76.35 116.73 17.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.524 -0.547 . . . . 1.22 109.524 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 t -88.57 115.51 26.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.492 0.663 . . . . 1.29 112.329 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -129.06 159.79 34.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.69 -1.226 . . . . 1.7 107.69 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -84.26 -6.71 59.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.42 -0.512 . . . . 1.3899999999999999 111.57 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.57 -35.39 3.83 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.126 -1.035 . . . . 0.85999999999999999 111.761 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 30.4 m -140.32 154.24 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.885 0.374 . . . . 1.73 110.134 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.1 t80 -138.18 106.82 5.88 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.019 -1.104 . . . . 0.41999999999999998 108.019 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 6.0 p90 -140.65 144.08 35.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.817 0.341 . . . . 1.1499999999999999 111.662 -171.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.793 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 25.7 pttm -72.58 142.24 48.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 2.0299999999999998 109.625 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.416 HD21 ' N ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -77.63 -5.54 50.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.293 0.568 . . . . 2.6600000000000001 110.35 178.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.416 ' N ' HD21 ' A' ' 87' ' ' ASN . 6.6 m-20 -86.08 142.93 28.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.392 -0.822 . . . . 2.1000000000000001 110.182 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 m -99.5 108.62 22.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.483 0.658 . . . . 1.6599999999999999 110.633 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.535 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 167.11 -164.12 37.63 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.648 -0.705 . . . . 0.63 111.707 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.3 m -79.97 -178.19 6.36 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.2 -0.667 . . . . 1.5800000000000001 109.2 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.462 ' CH2' HG21 ' A' ' 96' ' ' ILE . 29.0 t90 -154.9 -61.84 0.12 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.571 -0.451 . . . . 0.75 110.367 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 34.15 85.63 0.01 OUTLIER Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.436 1.085 . . . . 1.25 115.242 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.58 -151.35 6.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.771 -0.728 . . . . 1.0 112.5 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -118.34 124.17 47.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.461 0.648 . . . . 1.3200000000000001 112.514 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 13.7 pt -108.5 148.75 12.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.319 -0.855 . . . . 2.2400000000000002 109.159 174.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.35 151.25 17.55 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.303 -0.951 . . . . 0.53000000000000003 111.365 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 70.1 mt -95.11 112.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 120.295 -0.562 . . . . 1.53 110.339 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.464 ' HD1' ' O ' ' A' ' 68' ' ' ASN . 10.5 m-85 -104.7 151.95 23.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.972 -1.013 . . . . 1.7 108.514 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 104' ' ' GLN . 8.1 p -83.07 140.03 16.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.441 -0.504 . . . . 1.6799999999999999 109.693 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.81 82.27 2.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.937 -0.764 . . . . 1.02 108.937 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.55 114.69 0.58 Allowed Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.636 -0.711 . . . . 1.53 111.459 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.648 HE21 HG21 ' A' ' 20' ' ' THR . 7.2 tt0 -32.53 107.11 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.973 0.909 . . . . 2.5699999999999998 112.64 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.478 ' HB2' HG23 ' A' ' 100' ' ' VAL . 48.8 tp60 -78.01 -13.26 59.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.571 . . . . 3.1699999999999999 110.461 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.2 m 64.71 15.85 10.02 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.791 -0.64 . . . . 2.8599999999999999 111.036 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.753 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 10.4 t30 58.29 77.67 0.28 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.351 0.596 . . . . 1.5600000000000001 110.918 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.423 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 11.2 t -77.81 144.1 68.06 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.386 -0.968 . . . . 2.0800000000000001 108.386 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 45.1 Cg_exo -27.51 92.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.984 3.789 . . . . 1.48 114.388 -173.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -100.1 -157.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 123.398 2.732 . . . . 0.84999999999999998 113.791 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.17 -91.06 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.683 -1.367 . . . . 0.76000000000000001 109.683 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -125.75 119.35 27.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.305 -0.628 . . . . 2.04 109.305 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 58' ' ' SER . 24.6 m-85 -108.81 128.42 54.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.352 0.596 . . . . 1.1100000000000001 110.293 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.1 m -105.87 122.29 45.81 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.927 -1.033 . . . . 1.3400000000000001 110.369 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.897 HD23 HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -136.86 121.59 18.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.928 -0.578 . . . . 1.1699999999999999 109.688 176.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 6.5 m -112.08 128.42 56.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.797 -0.638 . . . . 1.4099999999999999 109.296 -174.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.414 ' N ' HD21 ' A' ' 116' ' ' LEU . 3.0 mm? -121.57 119.7 32.67 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.02 0.438 . . . . 1.8 110.527 -173.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.2 m -94.65 117.7 30.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.074 -0.512 . . . . 1.3200000000000001 110.605 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.15 146.72 49.4 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.838 -0.696 . . . . 0.97999999999999998 112.318 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.48 156.98 9.91 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 111.544 -0.623 . . . . 0.64000000000000001 111.544 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -89.48 -176.66 5.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.223 0.535 . . . . 1.2 110.762 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.7 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 1.3 t-105 -142.08 151.92 42.81 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.182 -0.917 . . . . 0.65000000000000002 110.02 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.56 144.33 51.08 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.0 -0.546 . . . . 1.55 111.23 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.67 ' HG2' ' H ' ' A' ' 124' ' ' ASP . 34.3 tttp 67.61 -147.79 0.15 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.455 1.102 . . . . 3.8700000000000001 111.906 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.67 ' H ' ' HG2' ' A' ' 123' ' ' LYS . 6.7 m-20 -139.67 118.65 12.57 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.573 0.583 . . . . 2.0800000000000001 112.573 -173.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.661 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.7 OUTLIER 45.49 14.02 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.427 1.639 . . . . 3.0899999999999999 115.427 175.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.552 ' HE2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -92.32 -2.18 56.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.56 0.695 . . . . 2.3799999999999999 109.832 175.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.7 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 20.5 mt-30 72.71 54.19 0.15 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 114.37 -1.286 . . . . 2.1099999999999999 111.923 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.522 ' N ' ' HD2' ' A' ' 126' ' ' LYS . . . -89.86 93.44 1.88 Allowed Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 108.826 -1.71 . . . . 0.77000000000000002 108.826 165.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.552 ' HB2' ' HZ2' ' A' ' 43' ' ' LYS . 50.8 p90 -134.84 134.91 41.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 117.91 0.855 . . . . 1.49 110.863 -173.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.8 m -115.78 134.88 22.64 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 116.091 -0.504 . . . . 1.8999999999999999 110.217 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.34 106.03 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.882 2.388 . . . . 1.1699999999999999 111.084 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.8 m -146.6 99.3 3.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.042 0.449 . . . . 1.96 110.342 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 141.61 -141.52 11.12 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.383 -0.913 . . . . 1.1699999999999999 112.603 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 6' ' ' ARG . 2.7 m -100.13 143.27 30.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.627 0.251 . . . . 2.9300000000000002 110.86 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 24.1 m -94.73 95.86 9.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.147 -0.686 . . . . 2.1800000000000002 109.147 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.45 155.65 21.83 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.777 -0.725 . . . . 0.72999999999999998 112.049 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -124.78 114.56 19.41 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.655 0.265 . . . . 1.23 110.647 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.768 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 3.5 m -89.69 119.88 30.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.221 -1.029 . . . . 1.1799999999999999 108.221 172.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -117.48 109.36 16.64 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.687 0.756 . . . . 2.6299999999999999 110.392 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.402 ' HG ' ' NH2' ' A' ' 16' ' ' ARG . 23.9 tp -101.93 106.1 16.99 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.425 -1.262 . . . . 1.3100000000000001 111.112 -172.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 6.2 m -105.02 143.77 32.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.49 -0.777 . . . . 1.1799999999999999 109.32 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.484 HG21 HG22 ' A' ' 15' ' ' THR . 7.3 p -89.22 128.77 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.162 0.506 . . . . 2.3900000000000001 111.065 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.624 -0.716 . . . . 2.5899999999999999 110.082 177.947 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.414 ' SG ' ' HG2' ' A' ' 38' ' ' ARG . 42.3 t . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 108.374 -0.973 . . . . 1.8300000000000001 108.374 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 1.11 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 5.4 tt0 -108.6 119.52 39.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.729 -0.669 . . . . 2.29 111.593 -172.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.423 HG23 HG12 ' A' ' 40' ' ' VAL . 22.5 t -91.61 111.54 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.046 -0.724 . . . . 2.1000000000000001 109.046 173.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 88.2 mtt180 -87.83 109.49 19.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.254 -0.43 . . . . 4.25 111.654 -177.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 116' ' ' LEU . 48.9 t -125.21 115.37 43.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.293 -0.867 . . . . 1.8200000000000001 109.152 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.37 -179.37 35.33 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.598 -0.81 . . . . 1.1899999999999999 111.965 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -99.02 147.25 25.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.922 0.391 . . . . 2.1800000000000002 109.978 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.48 147.36 20.48 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.364 -0.606 . . . . 2.0 109.364 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.7 m -116.94 117.68 30.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.907 0.384 . . . . 1.5600000000000001 111.09 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.15 109.48 28.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.884 -0.598 . . . . 2.04 109.431 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -83.61 96.65 8.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.229 -0.441 . . . . 1.23 111.188 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -149.9 179.41 8.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.16 0.505 . . . . 3.9100000000000001 110.94 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.407 ' HA ' HH11 ' A' ' 16' ' ' ARG . 52.9 p -101.77 167.43 10.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.738 -0.664 . . . . 1.21 109.875 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.566 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.3 OUTLIER -86.3 -11.62 51.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.792 -0.818 . . . . 4.0800000000000001 108.792 177.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.598 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -81.21 -24.98 56.25 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.959 -1.019 . . . . 0.75 111.038 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -61.7 -26.62 68.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.41 0.624 . . . . 2.6299999999999999 110.119 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.637 ' HG ' HG22 ' A' ' 100' ' ' VAL . 0.6 OUTLIER -67.27 -54.46 20.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.053 -0.976 . . . . 1.6100000000000001 109.917 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.8 m 56.81 49.02 14.97 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.825 -1.079 . . . . 2.2599999999999998 109.221 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' N ' ' HB3' ' A' ' 103' ' ' GLN . 20.9 t70 77.38 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.279 -1.328 . . . . 1.8300000000000001 110.428 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.416 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -109.69 87.35 2.48 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.272 0.471 . . . . 1.4299999999999999 112.272 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.87 113.65 3.15 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 1.3700000000000001 109.916 169.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' HD3' ' HE2' ' A' ' 99' ' ' TYR . 50.8 Cg_endo -68.46 94.05 0.43 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.689 2.259 . . . . 1.1200000000000001 111.814 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.611 HG13 HD21 ' A' ' 19' ' ' LEU . 51.3 mm -89.34 -42.94 14.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.988 -0.551 . . . . 3.0499999999999998 111.639 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.77 51.98 0.75 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 119.636 -1.269 . . . . 1.04 113.9 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.534 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 8.9 Cg_endo -50.21 123.46 11.09 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.312 2.675 . . . . 1.0 112.481 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.69 139.7 24.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.21 -0.45 . . . . 1.8300000000000001 110.047 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 t -82.75 102.88 11.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.92 0.867 . . . . 2.2000000000000002 110.751 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 67.0 t -94.17 114.52 30.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.963 -1.017 . . . . 1.5600000000000001 110.292 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 57.5 tt0 -99.21 126.47 45.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.784 -0.45 . . . . 2.48 109.784 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.7 94.95 8.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.294 -0.412 . . . . 1.25 109.996 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . 6.4 tt -80.01 114.1 18.67 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.006 -0.739 . . . . 2.4700000000000002 109.006 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.98 -129.91 10.57 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.603 -0.808 . . . . 1.8100000000000001 111.252 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.0 m 64.05 23.14 13.15 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.603 0.237 . . . . 1.8799999999999999 111.593 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.499 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 3.6 t-20 -59.81 -29.67 68.4 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.157 0.429 . . . . 2.71 112.157 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.6 25.31 10.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.214 0.53 . . . . 1.3600000000000001 110.269 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.414 ' HG2' ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -123.92 154.71 39.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.133 -0.485 . . . . 5.3499999999999996 111.253 -172.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.704 ' HG3' HG13 ' A' ' 89' ' ' VAL . 16.1 mt-30 -93.14 128.75 39.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.945 -0.57 . . . . 1.9099999999999999 109.533 173.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 87.2 t -101.7 117.13 46.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.492 -0.322 . . . . 1.1699999999999999 110.669 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.73 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -114.44 167.09 11.03 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 123.402 0.439 . . . . 1.0900000000000001 110.381 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.3 mt -120.11 109.66 15.72 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.061 -0.518 . . . . 1.4399999999999999 109.632 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.94 ' HE2' HG23 ' A' ' 83' ' ' VAL . 20.4 mmtp -105.86 119.77 40.02 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.552 0.691 . . . . 2.5299999999999998 110.131 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.632 ' HB2' ' ND2' ' A' ' 48' ' ' ASN . . . -71.48 155.3 40.75 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.553 -1.203 . . . . 1.0700000000000001 110.363 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 13.5 t70 -72.19 153.73 41.44 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.937 -0.764 . . . . 0.70999999999999996 108.937 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -58.56 -18.81 32.7 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.183 0.438 . . . . 1.71 112.183 -172.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -62.89 -37.57 87.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.821 0.343 . . . . 2.2200000000000002 110.985 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.632 ' ND2' ' HB2' ' A' ' 44' ' ' ALA . 8.0 p-10 -125.18 20.28 8.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.178 0.514 . . . . 1.5800000000000001 110.335 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.702 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 27.3 t80 -127.92 107.42 9.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.296 -0.866 . . . . 0.72999999999999998 108.708 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 7.2 pt-20 -106.96 107.01 17.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.501 -0.318 . . . . 2.4100000000000001 110.454 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 70.79 -56.26 0.62 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.03 0.532 . . . . 4.1399999999999997 111.294 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.702 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -176.03 34.05 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.78 -0.928 . . . . 0.72999999999999998 110.78 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 18.5 mmtp -132.34 135.0 45.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.639 -0.874 . . . . 2.6800000000000002 108.639 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.499 ' CD2' ' HA2' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -107.49 140.11 40.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.47 0.652 . . . . 0.65000000000000002 110.934 171.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.777 ' CD2' ' HB2' ' A' ' 64' ' ' LYS . 40.6 p90 -147.49 174.36 11.78 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.208 -0.905 . . . . 0.73999999999999999 110.353 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.498 HD21 HD21 ' A' ' 114' ' ' LEU . 16.9 mt -88.31 116.95 26.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.392 -0.966 . . . . 2.0800000000000001 108.392 171.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.574 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 8.0 tp -106.42 128.54 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.546 0.689 . . . . 1.21 110.927 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.6 p -66.56 129.23 39.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.254 -0.885 . . . . 1.9299999999999999 110.161 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.15 -30.33 70.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.325 0.583 . . . . 2.3100000000000001 109.67 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.91 -14.29 62.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.046 -0.979 . . . . 3.6600000000000001 110.487 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 59.66 81.91 0.16 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.244 -0.889 . . . . 3.0600000000000001 110.559 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.429 ' NH1' ' HB2' ' A' ' 108' ' ' PRO . 9.3 ptp180 -144.07 -41.44 0.27 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.68 -0.691 . . . . 5.1799999999999997 111.218 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -147.36 174.59 11.52 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.497 -0.481 . . . . 2.5099999999999998 111.483 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.777 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -160.29 142.77 13.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.706 -0.679 . . . . 2.6200000000000001 110.526 -177.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 65' ' ' LEU . 1.8 pt? -140.6 132.44 27.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.551 0.215 . . . . 2.48 110.96 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.432 ' CZ ' ' HE3' ' A' ' 64' ' ' LYS . 17.0 m-85 -72.22 141.67 48.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.381 . . . . 1.1299999999999999 110.749 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.67 HG11 ' HA ' ' A' ' 100' ' ' VAL . 13.3 m -135.31 128.85 49.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.056 -0.52 . . . . 1.29 110.547 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -94.51 113.36 25.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.555 0.693 . . . . 2.1000000000000001 110.336 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -76.93 85.5 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.424 -0.807 . . . . 1.55 109.907 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.668 ' HG2' ' HD2' ' A' ' 71' ' ' PRO . 13.8 ttp180 -98.32 140.59 21.95 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.36 -0.836 . . . . 4.3300000000000001 109.216 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.668 ' HD2' ' HG2' ' A' ' 70' ' ' ARG . 97.4 Cg_exo -43.42 136.56 5.97 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.816 2.344 . . . . 0.90000000000000002 112.807 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.2 tpt -63.41 -58.91 5.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.876 -0.602 . . . . 2.23 110.3 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -159.66 105.04 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.991 -0.55 . . . . 1.9199999999999999 111.142 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.459 HD22 ' HZ2' ' A' ' 92' ' ' TRP . 2.8 p30 -174.47 -88.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.416 0.448 . . . . 1.8899999999999999 111.594 172.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.4 m -127.13 -175.44 3.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.638 0.256 . . . . 2.0699999999999998 110.522 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.29 139.37 36.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.348 -0.387 . . . . 1.5800000000000001 111.264 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.484 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 11.2 m0 -114.0 151.18 32.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.669 -0.696 . . . . 0.54000000000000004 109.779 176.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.2 m -70.69 116.29 10.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.31 -0.626 . . . . 1.22 109.31 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t -96.49 117.45 30.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.469 0.652 . . . . 1.29 112.584 -171.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.18 161.99 26.42 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.287 -1.005 . . . . 1.7 108.287 170.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -21.02 63.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.818 0.303 . . . . 1.3899999999999999 111.818 -171.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.499 ' HA2' ' CD2' ' A' ' 54' ' ' PHE . . . -139.44 16.23 3.15 Favored Glycine 0 CA--C 1.509 -0.285 0 N-CA-C 111.519 -0.632 . . . . 0.85999999999999999 111.519 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.94 HG23 ' HE2' ' A' ' 43' ' ' LYS . 95.8 t -139.2 124.63 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.867 -0.79 . . . . 1.73 108.867 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.73 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -139.22 105.47 5.26 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.087 -0.708 . . . . 0.41999999999999998 109.087 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 1.3 p90 -145.86 141.75 28.15 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.56 0.538 . . . . 1.1499999999999999 110.529 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.484 ' HB3' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -75.93 138.93 41.33 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.56 -0.456 . . . . 2.0299999999999998 109.81 177.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.84 -29.14 68.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.369 -0.832 . . . . 2.6600000000000001 110.259 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 16.6 m-20 -75.13 137.6 41.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.225 -0.898 . . . . 2.1000000000000001 110.75 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.704 HG13 ' HG3' ' A' ' 39' ' ' GLN . 27.7 m -90.46 132.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.729 -0.471 . . . . 1.6599999999999999 109.729 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 36' ' ' ASN . . . 146.55 -170.4 27.59 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.645 -0.788 . . . . 0.63 111.179 -174.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.5 m -77.65 -175.1 3.72 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 109.573 -0.528 . . . . 1.5800000000000001 109.573 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.459 ' HZ2' HD22 ' A' ' 74' ' ' ASN . 76.2 t90 -163.3 -56.47 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.752 -0.462 . . . . 0.75 109.752 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 32.15 95.15 0.01 OUTLIER Glycine 0 N--CA 1.47 0.917 0 O-C-N 124.843 1.34 . . . . 1.25 115.674 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.64 -165.62 27.31 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.515 -0.634 . . . . 1.0 111.515 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 p -101.35 128.74 47.38 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.063 0.459 . . . . 1.3200000000000001 111.908 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.602 HG21 ' HA ' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -112.71 158.54 13.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.442 -0.948 . . . . 2.2400000000000002 108.442 167.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -116.97 153.69 17.21 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.244 -0.979 . . . . 0.53000000000000003 112.449 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.512 HG21 ' HB ' ' A' ' 67' ' ' VAL . 2.8 mp -91.07 114.34 28.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.766 -0.457 . . . . 1.53 109.766 175.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.545 ' HE2' ' HD3' ' A' ' 24' ' ' PRO . 2.3 m-85 -116.63 139.43 50.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.443 -0.947 . . . . 1.7 108.443 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.67 ' HA ' HG11 ' A' ' 67' ' ' VAL . 86.7 t -74.74 123.52 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.952 -0.388 . . . . 1.6799999999999999 109.952 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -78.58 86.42 4.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.693 -0.854 . . . . 1.02 108.693 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.72 83.44 1.4 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.684 -0.77 . . . . 1.53 111.742 -174.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.49 ' HB3' ' N ' ' A' ' 21' ' ' ASP . 2.6 pt20 -40.11 117.82 0.82 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.663 0.616 . . . . 2.5699999999999998 112.663 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.433 HE21 ' HB2' ' A' ' 104' ' ' GLN . 6.9 tt0 -90.56 5.14 49.04 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.53 -0.759 . . . . 3.1699999999999999 110.058 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.455 ' O ' HG21 ' A' ' 105' ' ' THR . 11.1 m 62.23 23.54 13.93 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.697 -0.683 . . . . 2.8599999999999999 111.287 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.598 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 8.2 t30 66.92 92.97 0.08 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.632 -0.713 . . . . 1.5600000000000001 111.86 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.591 HG21 ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -74.73 147.64 84.47 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-O 118.51 -0.757 . . . . 2.0800000000000001 109.427 172.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.591 ' HD2' HG21 ' A' ' 107' ' ' THR . 1.6 Cg_endo -43.11 93.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 124.106 3.204 . . . . 1.48 112.539 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -97.74 -165.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.265 2.643 . . . . 0.84999999999999998 114.615 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.88 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 108.789 -1.724 . . . . 0.76000000000000001 108.789 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -115.29 122.92 47.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.799 -0.815 . . . . 2.04 108.799 169.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.475 ' HB2' HH21 ' A' ' 16' ' ' ARG . 6.5 m-85 -109.24 113.91 27.15 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.63 0.728 . . . . 1.1100000000000001 109.913 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 57' ' ' ILE . 47.3 m -94.82 135.49 36.25 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.553 -1.203 . . . . 1.3400000000000001 110.791 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.498 HD21 HD21 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -147.84 91.01 1.89 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.497 0.665 . . . . 1.1699999999999999 109.687 173.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.714 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 44.7 m -82.5 135.63 35.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.651 -0.704 . . . . 1.4099999999999999 110.055 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.494 ' HB2' HG13 ' A' ' 7' ' ' VAL . 95.2 mt -118.34 120.04 36.43 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.118 -0.492 . . . . 1.8 109.705 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.3 m -92.69 110.83 22.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.306 -0.406 . . . . 1.3200000000000001 109.926 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.84 118.46 12.03 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.665 -0.779 . . . . 0.97999999999999998 111.555 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.512 ' HA2' ' H ' ' A' ' 132' ' ' SER . . . -165.8 145.0 9.67 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.851 -0.69 . . . . 0.64000000000000001 111.521 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.421 ' CZ ' ' HB ' ' A' ' 130' ' ' THR . 47.3 p90 -88.41 172.97 8.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.303 0.573 . . . . 1.2 110.621 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.702 ' HE3' ' HZ2' ' A' ' 43' ' ' LYS . 2.3 t-105 -123.2 148.47 45.77 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.471 -0.786 . . . . 0.65000000000000002 110.017 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.33 145.95 49.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.672 -0.694 . . . . 1.55 110.431 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.912 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER 70.27 -140.97 0.07 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.762 0.825 . . . . 3.8700000000000001 110.519 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 126' ' ' LYS . 7.9 p-10 -159.74 125.38 4.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.067 0.46 . . . . 2.0800000000000001 111.604 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.632 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 17.6 m120 63.13 -24.7 0.06 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.002 1.482 . . . . 3.0899999999999999 115.002 177.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.446 ' HG2' ' HG2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -70.55 -3.25 17.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.925 0.393 . . . . 2.3799999999999999 111.435 -178.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.557 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 22.7 tt0 74.45 61.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.365 -0.834 . . . . 2.1099999999999999 111.22 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -102.53 113.17 4.5 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.619 -0.992 . . . . 0.77000000000000002 110.619 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.532 ' HB3' ' HZ3' ' A' ' 43' ' ' LYS . 50.0 p90 -135.75 163.91 29.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.571 0.685 . . . . 1.49 110.296 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.421 ' HB ' ' CZ ' ' A' ' 120' ' ' TYR . 37.9 m -152.38 110.45 2.8 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.82 -0.437 . . . . 1.8999999999999999 109.82 173.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.467 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 16.5 Cg_exo -65.37 116.36 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.617 2.211 . . . . 1.1699999999999999 112.228 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.512 ' H ' ' HA2' ' A' ' 119' ' ' GLY . 12.1 t -155.05 108.19 2.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.455 -0.793 . . . . 1.96 108.87 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 1.11 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 151.37 -138.07 6.36 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.519 -0.848 . . . . 1.1699999999999999 111.808 -176.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.4 m -111.72 138.61 48.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.648 0.261 . . . . 2.9300000000000002 110.394 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.6 m -94.44 98.46 10.89 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.72 -0.474 . . . . 2.1800000000000002 109.72 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.33 130.29 9.51 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.449 -0.881 . . . . 0.72999999999999998 112.504 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.714 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 86.1 m -96.25 114.82 26.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.629 0.252 . . . . 1.23 110.426 178.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.472 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 13.9 m -78.32 116.86 19.04 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.222 -1.029 . . . . 1.1799999999999999 108.222 173.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -102.74 108.58 19.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.502 0.668 . . . . 2.6299999999999999 110.281 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.425 ' CD2' HD11 ' A' ' 56' ' ' LEU . 10.6 tp -106.28 94.67 5.28 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.938 -1.028 . . . . 1.3100000000000001 109.844 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 12.1 m -102.28 144.4 30.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.707 -0.679 . . . . 1.1799999999999999 109.431 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.0 p -83.63 133.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.397 -0.521 . . . . 2.3900000000000001 110.585 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 13' ' ' ALA . 43.9 m . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.607 -0.711 . . . . 2.5899999999999999 109.516 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 t . . . . . 0 CA--C 1.514 -0.408 0 N-CA-C 107.809 -1.182 . . . . 1.8300000000000001 107.809 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 10.1 mm100 -86.8 112.2 21.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.101 -0.954 . . . . 2.29 110.647 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.426 HG11 HG12 ' A' ' 7' ' ' VAL . 61.5 t -82.16 110.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.877 -0.786 . . . . 2.1000000000000001 108.877 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -80.77 91.25 5.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.65 0.738 . . . . 4.25 110.616 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.426 HG12 HG11 ' A' ' 5' ' ' VAL . 3.5 m -104.85 140.34 23.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.646 -1.161 . . . . 1.8200000000000001 109.734 175.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.6 167.29 24.84 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.157 -1.021 . . . . 1.1899999999999999 112.706 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.47 131.42 35.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.079 -0.341 . . . . 2.1800000000000002 110.079 175.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.18 137.75 24.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.125 -0.489 . . . . 2.0 109.929 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.6 m -103.29 122.42 44.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.043 -0.526 . . . . 1.5600000000000001 110.442 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.735 HG12 ' HB ' ' A' ' 25' ' ' ILE . 45.2 t -118.76 111.3 33.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.918 -0.583 . . . . 2.04 109.877 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -92.54 101.41 13.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.41 -0.359 . . . . 1.23 110.444 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 5.7 tppt? -163.39 165.47 23.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.981 0.419 . . . . 3.9100000000000001 110.566 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.579 ' HA ' HG13 ' A' ' 142' ' ' VAL . 82.4 p -89.79 159.01 17.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.017 -0.538 . . . . 1.21 110.558 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -0.03 27.31 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.393 -0.595 . . . . 4.0800000000000001 109.393 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.55 -20.81 76.22 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.586 -1.006 . . . . 0.75 110.586 171.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -66.39 -48.48 69.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.812 -0.81 . . . . 2.6299999999999999 108.812 168.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.602 HD22 HG12 ' A' ' 25' ' ' ILE . 11.0 mt -73.04 92.72 1.7 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.9 -1.046 . . . . 1.6100000000000001 110.276 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.671 ' H ' ' HB1' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -96.35 69.24 2.64 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.318 -0.623 . . . . 2.2599999999999998 109.318 177.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.5 t70 63.89 -90.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 114.639 -1.164 . . . . 1.8300000000000001 109.89 -172.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.68 63.66 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.345 0.593 . . . . 1.4299999999999999 110.726 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HB1' ' H ' ' A' ' 20' ' ' THR . . . -140.39 116.74 7.85 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.442 -0.799 . . . . 1.3700000000000001 109.805 175.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 93.0 Cg_endo -87.24 150.82 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.464 2.776 . . . . 1.1200000000000001 113.469 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.735 ' HB ' HG12 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -102.75 -62.76 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.3 -0.864 . . . . 3.0499999999999998 111.125 175.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.445 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -127.73 90.93 0.34 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.5 -0.857 . . . . 1.04 112.646 -177.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.78 117.28 3.82 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.82 2.347 . . . . 1.0 111.857 172.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -83.75 133.23 29.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 1.8300000000000001 109.825 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.9 p -75.91 83.77 2.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.3 0.571 . . . . 2.2000000000000002 110.36 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.6 t -94.07 115.18 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.709 -0.678 . . . . 1.5600000000000001 110.315 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.63 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 63.7 tt0 -112.71 135.54 53.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.881 -0.6 . . . . 2.48 109.993 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.44 103.03 13.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.512 -0.551 . . . . 1.25 109.512 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 4' ' ' GLN . 51.6 tp -82.25 112.29 19.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.367 -0.379 . . . . 2.4700000000000002 110.359 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 -117.73 5.1 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.779 -0.724 . . . . 1.8100000000000001 112.094 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 57.0 m 69.43 -71.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.66 0.784 . . . . 1.8799999999999999 111.112 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 66.22 -56.57 0.37 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.999 0.92 . . . . 2.71 112.75 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.32 40.65 3.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.152 0.501 . . . . 1.3600000000000001 110.354 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.418 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 13.2 tpp180 -126.16 148.27 49.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.159 -0.473 . . . . 5.3499999999999996 111.509 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -87.6 124.15 33.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 1.9099999999999999 109.879 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 57.8 t -91.08 121.05 41.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.733 -0.469 . . . . 1.1699999999999999 109.733 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -121.81 147.94 45.32 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 120.758 0.313 . . . . 1.0900000000000001 110.472 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -102.02 105.39 16.14 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.254 0.549 . . . . 1.4399999999999999 109.95 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.643 ' HE3' ' HB3' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -96.2 151.47 19.46 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.84 -0.8 . . . . 2.5299999999999998 108.84 176.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.419 ' HB3' ' HD1' ' A' ' 49' ' ' PHE . . . -111.62 156.67 21.45 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 110.014 -0.365 . . . . 1.0700000000000001 110.014 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -79.9 152.93 29.34 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.506 -0.924 . . . . 0.70999999999999996 108.506 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -57.08 -13.67 3.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.946 0.339 . . . . 1.71 111.851 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -56.54 -37.38 70.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 2.2200000000000002 111.077 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.59 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 26.0 p-10 -134.05 19.87 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.578 -0.283 . . . . 1.5800000000000001 110.509 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.732 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 63.1 t80 -124.62 102.55 7.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.78 -0.452 . . . . 0.72999999999999998 109.78 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.732 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 15.3 pt-20 -101.26 105.44 16.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.395 -0.366 . . . . 2.4100000000000001 110.585 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 71.61 -55.96 0.65 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.804 0.842 . . . . 4.1399999999999997 111.154 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.732 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -174.11 37.52 0.12 Allowed Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.932 -0.652 . . . . 0.72999999999999998 111.973 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 29.4 mmtm -146.15 139.07 25.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.009 -0.367 . . . . 2.6800000000000002 110.009 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -113.5 150.16 33.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.268 0.556 . . . . 0.65000000000000002 111.948 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.732 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 22.5 p90 -157.61 177.84 10.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.265 -0.88 . . . . 0.73999999999999999 111.159 -172.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.741 HD23 HD23 ' A' ' 114' ' ' LEU . 14.9 mt -81.12 115.51 20.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.328 -0.99 . . . . 2.0800000000000001 108.328 170.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.584 HG21 ' O ' ' A' ' 113' ' ' THR . 9.2 tp -105.13 120.12 55.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.806 -0.757 . . . . 1.21 109.828 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.567 ' HB2' ' CE1' ' A' ' 112' ' ' TYR . 42.6 t -75.12 147.56 40.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.341 -0.845 . . . . 1.9299999999999999 111.465 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.59 -29.53 70.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.526 -0.761 . . . . 2.3100000000000001 109.753 170.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -81.29 -24.05 37.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.297 -0.865 . . . . 3.6600000000000001 110.124 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.4 t30 65.67 21.09 11.62 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.418 -0.81 . . . . 3.0600000000000001 111.948 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 62' ' ' ARG . 63.6 mtt180 -98.21 -6.66 30.81 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.077 -0.389 . . . . 5.1799999999999997 110.815 176.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.5 143.72 30.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.108 -0.497 . . . . 2.5099999999999998 111.249 -175.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -150.22 130.5 13.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.729 -0.669 . . . . 2.6200000000000001 110.232 172.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.598 ' HB2' HD12 ' A' ' 56' ' ' LEU . 2.9 mm? -120.21 130.11 54.4 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.315 -0.402 . . . . 2.48 110.329 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 94.4 m-85 -68.57 146.53 52.99 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.77 -0.372 . . . . 1.1299999999999999 110.052 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.35 149.89 20.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.059 0.457 . . . . 1.29 110.904 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -114.41 110.4 19.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.779 -0.823 . . . . 2.1000000000000001 108.779 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.425 HG21 HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -91.88 107.1 18.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.906 -0.775 . . . . 1.55 108.906 177.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.482 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 64.5 mtp180 -122.77 143.05 39.25 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.346 -0.388 . . . . 4.3300000000000001 110.93 -168.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.615 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 32.3 Cg_exo -59.29 139.33 89.47 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.026 2.484 . . . . 0.90000000000000002 111.721 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.0 ttt -70.28 79.18 0.53 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.433 -0.349 . . . . 2.23 111.274 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.8 t70 55.05 45.98 25.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.553 -0.748 . . . . 1.9199999999999999 112.134 172.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -113.95 -89.45 0.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.048 -0.407 . . . . 1.8899999999999999 111.59 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -114.66 166.36 11.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.763 0.316 . . . . 2.0699999999999998 110.617 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.9 113.09 21.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.951 -0.568 . . . . 1.5800000000000001 110.583 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.566 ' CE2' ' HB3' ' A' ' 86' ' ' LYS . 11.2 m0 -104.56 137.43 42.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.652 -0.704 . . . . 0.54000000000000004 110.465 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.3 m -65.26 125.06 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.47 -0.567 . . . . 1.22 109.47 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -107.42 105.01 14.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.057 0.932 . . . . 1.29 112.797 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -122.3 145.0 48.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.16 -1.422 . . . . 1.7 107.16 163.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.504 ' HB2' ' CD ' ' A' ' 53' ' ' LYS . 7.9 m120 -71.83 5.07 2.78 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 120.388 -0.525 . . . . 1.3899999999999999 112.15 -176.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.03 -13.41 2.19 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.81 -0.709 . . . . 0.85999999999999999 111.578 170.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.596 ' HA ' ' HZ2' ' A' ' 43' ' ' LYS . 57.5 t -131.83 114.74 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.981 -0.377 . . . . 1.73 109.981 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.675 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.2 t80 -130.75 97.55 4.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.551 -0.907 . . . . 0.41999999999999998 108.551 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 12.2 p90 -137.35 150.1 47.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.975 0.417 . . . . 1.1499999999999999 111.124 -173.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 12.6 pttp -84.42 145.28 28.26 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.728 -0.669 . . . . 2.0299999999999998 110.951 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.16 -32.69 73.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.17 0.51 . . . . 2.6600000000000001 109.751 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.639 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -68.94 140.14 55.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.627 -0.715 . . . . 2.1000000000000001 110.412 174.106 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.2 m -101.38 131.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.214 0.531 . . . . 1.6599999999999999 110.612 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.77 -164.5 25.74 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.459 -0.656 . . . . 0.63 111.459 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.7 p -85.14 137.74 32.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.652 -0.499 . . . . 1.5800000000000001 109.652 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.615 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 89.7 t90 -102.47 -60.63 1.51 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.418 -0.956 . . . . 0.75 108.418 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 48.43 112.75 0.01 OUTLIER Glycine 0 N--CA 1.468 0.811 0 O-C-N 124.556 1.16 . . . . 1.25 115.663 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.52 -130.5 1.62 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.352 -0.699 . . . . 1.0 111.352 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 p -124.31 130.75 53.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.008 0.432 . . . . 1.3200000000000001 111.213 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.6 mm -111.5 126.21 68.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.31 -0.626 . . . . 2.2400000000000002 109.31 176.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.11 141.24 15.45 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.495 -0.86 . . . . 0.53000000000000003 111.869 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 mp -90.59 112.04 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.383 -0.599 . . . . 1.53 109.383 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CE1' ' HB2' ' A' ' 70' ' ' ARG . 28.6 m-85 -109.59 142.07 41.22 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.33 -0.989 . . . . 1.7 108.33 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' A' ' 103' ' ' GLN . 7.2 p -77.72 140.36 17.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.275 -0.57 . . . . 1.6799999999999999 109.63 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.16 88.97 3.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.277 -0.638 . . . . 1.02 109.277 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.78 107.23 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.823 -0.704 . . . . 1.53 111.45 -173.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 0.7 OUTLIER -46.74 127.82 10.1 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 121.226 0.536 . . . . 2.5699999999999998 112.031 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.497 ' HG2' HD22 ' A' ' 65' ' ' LEU . 57.3 tp60 -89.74 1.99 55.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.687 -0.688 . . . . 3.1699999999999999 110.095 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 m 60.91 22.91 13.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.717 -0.674 . . . . 2.8599999999999999 111.231 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 59.52 94.07 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.624 -0.716 . . . . 1.5600000000000001 111.207 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.473 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 11.3 t -102.98 146.11 31.82 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 107.435 -1.32 . . . . 2.0800000000000001 107.435 174.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.473 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 78.3 Cg_exo -24.19 90.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 1 C-N-CA 125.303 4.002 . . . . 1.48 114.313 -173.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.442 ' HG2' HG12 ' A' ' 142' ' ' VAL . 94.8 Cg_endo -104.37 -166.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 123.586 2.857 . . . . 0.84999999999999998 114.736 -171.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -175.35 -120.83 0.62 Allowed Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.202 -1.363 . . . . 0.76000000000000001 109.976 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -92.9 122.38 35.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.748 0.308 . . . . 2.04 110.315 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.567 ' HB3' ' HB3' ' A' ' 56' ' ' LEU . 91.6 m-85 -116.02 123.69 48.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.271 0.558 . . . . 1.1100000000000001 110.075 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.584 ' O ' HG21 ' A' ' 57' ' ' ILE . 16.2 m -100.58 140.34 34.99 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.434 -0.803 . . . . 1.3400000000000001 110.641 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.741 HD23 HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -143.36 92.43 2.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.447 0.642 . . . . 1.1699999999999999 109.634 173.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 32.3 m -86.72 116.84 25.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.562 -0.745 . . . . 1.4099999999999999 110.841 -176.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 93.8 mt -99.87 140.39 34.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.069 -0.514 . . . . 1.8 110.547 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.3 m -107.28 109.57 21.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.041 -0.527 . . . . 1.3200000000000001 109.82 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.1 129.11 29.03 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.785 -0.721 . . . . 0.97999999999999998 111.71 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.47 ' HA2' ' H ' ' A' ' 132' ' ' SER . . . -170.52 167.66 40.78 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.734 -0.746 . . . . 0.64000000000000001 111.824 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -102.64 161.43 13.74 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.009 0.433 . . . . 1.2 110.007 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.604 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 4.3 t-105 -119.03 152.31 36.65 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.483 -0.781 . . . . 0.65000000000000002 109.705 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -134.45 137.06 43.67 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.803 -0.635 . . . . 1.55 110.201 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.561 ' HG3' ' HE2' ' A' ' 126' ' ' LYS . 74.4 mmtt 82.21 -146.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.197 0.999 . . . . 3.8700000000000001 111.016 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 126' ' ' LYS . 8.2 p-10 -147.91 117.41 7.0 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.179 0.807 . . . . 2.0800000000000001 113.179 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.604 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 28.0 t-20 64.32 -19.85 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.892 1.277 . . . . 3.0899999999999999 114.126 171.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.561 ' HE2' ' HG3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -69.05 -2.99 11.4 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.493 0.317 . . . . 2.3799999999999999 111.491 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 72.04 69.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.21 -0.905 . . . . 2.1099999999999999 110.623 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -112.22 99.32 1.05 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 109.997 -1.241 . . . . 0.77000000000000002 109.997 168.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 40.5 p90 -144.57 145.86 32.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.103 0.952 . . . . 1.49 110.369 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 29.2 m -132.25 116.39 15.39 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.25 -0.432 . . . . 1.8999999999999999 109.988 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.442 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 29.3 Cg_exo -60.7 125.09 16.37 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.856 2.37 . . . . 1.1699999999999999 112.222 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.47 ' H ' ' HA2' ' A' ' 119' ' ' GLY . 5.8 t -152.05 96.3 2.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.985 -0.746 . . . . 1.96 108.985 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.09 -112.61 0.53 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.83 -0.908 . . . . 1.1699999999999999 110.83 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.93 171.61 14.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.095 0.448 . . . . 2.9300000000000002 111.029 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.3 96.06 7.8 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.274 -0.639 . . . . 2.1800000000000002 109.274 171.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -97.67 113.49 4.73 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.776 -0.726 . . . . 0.72999999999999998 112.18 -174.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 77.9 m -88.84 107.13 18.82 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.106 0.479 . . . . 1.23 110.546 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.582 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 10.2 m -78.83 120.55 23.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.958 -1.127 . . . . 1.1799999999999999 107.958 172.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -111.8 109.44 19.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.359 0.6 . . . . 2.6299999999999999 110.773 -173.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.676 HD22 HD21 ' A' ' 56' ' ' LEU . 7.7 tp -98.96 100.82 12.05 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.969 -1.014 . . . . 1.3100000000000001 109.742 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.672 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 31.8 m -107.38 118.37 36.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.742 -0.663 . . . . 1.1799999999999999 109.507 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.579 HG13 ' HA ' ' A' ' 15' ' ' THR . 58.2 t -79.28 108.95 13.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.012 0.434 . . . . 2.3900000000000001 111.327 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.701 -0.666 . . . . 2.5899999999999999 109.774 176.672 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.661 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 7.0 t . . . . . 0 N--CA 1.445 -0.711 0 CA-C-O 121.423 0.63 . . . . 1.8300000000000001 110.158 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.61 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 58.9 tt0 -86.82 110.43 19.94 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.989 -1.005 . . . . 2.29 109.606 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.436 HG12 HG11 ' A' ' 30' ' ' VAL . 97.6 t -103.43 112.62 37.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.846 -0.616 . . . . 2.1000000000000001 110.234 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -93.1 111.06 22.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.942 -0.572 . . . . 4.25 110.075 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 116' ' ' LEU . 59.9 t -88.46 114.84 27.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.052 -0.721 . . . . 1.8200000000000001 109.052 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.34 112.28 4.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.137 -0.554 . . . . 1.1899999999999999 112.75 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.9 106.37 4.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.244 -0.651 . . . . 2.1800000000000002 109.244 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.509 HD22 HG21 ' A' ' 28' ' ' VAL . 3.4 pp -137.61 154.43 49.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.054 -0.521 . . . . 2.0 111.02 -175.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.5 m -119.08 123.6 44.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.804 -0.634 . . . . 1.5600000000000001 110.187 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.487 HG23 ' HG2' ' A' ' 14' ' ' LYS . 14.6 p -121.23 141.72 40.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.801 -0.444 . . . . 2.04 109.801 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -108.91 99.66 8.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.652 0.263 . . . . 1.23 110.966 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.487 ' HG2' HG23 ' A' ' 12' ' ' VAL . 75.3 mmtt -142.5 172.88 12.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.3 0.571 . . . . 3.9100000000000001 110.573 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 1.0 OUTLIER -104.0 154.13 20.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.161 -0.927 . . . . 1.21 109.592 172.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.938 ' NH2' ' HH ' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -86.61 -1.43 57.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.105 0.478 . . . . 4.0800000000000001 110.671 -176.371 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.526 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -85.8 -26.83 33.67 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.017 -0.611 . . . . 0.75 112.16 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 15' ' ' THR . 10.0 pt20 -79.83 -2.08 41.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.963 0.411 . . . . 2.6299999999999999 110.719 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.667 ' HA ' ' HB1' ' A' ' 23' ' ' ALA . 71.8 mt -76.4 -26.94 56.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.642 . . . . 1.6100000000000001 111.256 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 7.5 t 32.59 57.16 0.41 Allowed 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.215 0.947 . . . . 2.2599999999999998 113.286 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' THR . 70.4 m-20 76.72 -46.69 0.52 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.461 0.704 . . . . 1.8300000000000001 111.924 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.78 88.66 1.84 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.252 0.464 . . . . 1.4299999999999999 112.252 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.667 ' HB1' ' HA ' ' A' ' 19' ' ' LEU . . . -139.82 108.19 7.04 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.007 -0.542 . . . . 1.3700000000000001 110.493 171.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.637 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 38.6 Cg_endo -67.5 99.9 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.176 2.584 . . . . 1.1200000000000001 112.114 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.542 HG12 HD21 ' A' ' 19' ' ' LEU . 2.6 pp -101.08 -23.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.876 -0.602 . . . . 3.0499999999999998 111.829 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.445 ' N ' HD12 ' A' ' 25' ' ' ILE . . . -128.64 50.99 0.87 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.101 -1.047 . . . . 1.04 113.396 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 10.0 Cg_endo -53.9 109.97 0.44 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.554 2.169 . . . . 1.0 112.534 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.509 HG21 HD22 ' A' ' 10' ' ' LEU . 61.5 t -91.97 138.42 19.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.465 -0.788 . . . . 1.8300000000000001 110.543 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 p -78.62 97.92 5.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.944 0.402 . . . . 2.2000000000000002 110.844 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.667 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 97.4 t -103.51 113.93 41.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.114 -0.494 . . . . 1.5600000000000001 110.271 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.636 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -109.05 108.32 18.97 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.75 -0.833 . . . . 2.48 108.75 177.185 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.66 91.22 4.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.094 0.473 . . . . 1.25 110.448 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.25 112.75 21.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.708 -0.678 . . . . 2.4700000000000002 110.098 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.91 -17.97 17.05 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.531 -0.842 . . . . 1.8100000000000001 112.694 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 1.7 m -74.0 104.77 4.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.876 0.369 . . . . 1.8799999999999999 110.543 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -106.22 -39.75 5.84 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.301 -0.629 . . . . 2.71 109.301 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.44 64.19 1.35 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.241 -0.89 . . . . 1.3600000000000001 109.217 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.605 ' HD3' ' H ' ' A' ' 39' ' ' GLN . 8.7 tpp180 -146.76 149.89 34.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.677 -0.692 . . . . 5.3499999999999996 110.756 -174.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.605 ' H ' ' HD3' ' A' ' 38' ' ' ARG . 36.6 mt-30 -84.81 125.96 33.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.912 -0.585 . . . . 1.9099999999999999 109.669 176.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 22.1 t -92.29 125.36 44.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.838 -0.43 . . . . 1.1699999999999999 109.838 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.576 ' HB1' ' HE2' ' A' ' 43' ' ' LYS . . . -121.36 142.37 50.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.046 0.45 . . . . 1.0900000000000001 111.053 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 96' ' ' ILE . 14.5 mt -103.0 112.42 25.24 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.149 -0.686 . . . . 1.4399999999999999 109.149 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.576 ' HE2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -109.32 151.32 26.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.179 -0.464 . . . . 2.5299999999999998 110.244 -178.545 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.61 167.44 10.34 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.978 -0.556 . . . . 1.0700000000000001 110.362 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 23.4 t70 -94.65 157.72 15.84 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.149 -0.686 . . . . 0.70999999999999996 109.149 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -53.22 -18.69 2.49 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.382 0.426 . . . . 1.71 111.848 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.6 -37.37 68.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.726 -0.67 . . . . 2.2200000000000002 111.683 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 6.4 p30 -135.58 16.94 3.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.926 0.393 . . . . 1.5800000000000001 110.66 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 60.3 t80 -118.85 102.53 8.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 0.72999999999999998 109.382 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 14.4 pt-20 -102.06 100.6 10.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.824 0.345 . . . . 2.4100000000000001 110.409 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 71.31 -53.29 0.68 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.615 -0.72 . . . . 4.1399999999999997 111.289 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.1 39.17 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.604 -0.999 . . . . 0.72999999999999998 110.604 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 22.0 mmmt -137.7 133.7 34.51 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.986 -0.746 . . . . 2.6800000000000002 108.986 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -115.1 151.35 34.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.18 0.514 . . . . 0.65000000000000002 110.995 173.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.499 ' CE1' ' HB ' ' A' ' 57' ' ' ILE . 13.8 p90 -156.24 176.94 12.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.534 -0.757 . . . . 0.73999999999999999 110.805 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.552 HD12 HD12 ' A' ' 65' ' ' LEU . 29.7 mt -80.34 111.22 16.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.176 -1.046 . . . . 2.0800000000000001 108.176 170.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 48' ' ' ASN . 8.7 tp -107.6 127.94 63.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.287 0.565 . . . . 1.21 110.32 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.524 ' HB2' ' OD2' ' A' ' 63' ' ' ASP . 47.4 t -70.86 152.4 43.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.793 -0.64 . . . . 1.9299999999999999 109.34 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.27 -32.87 72.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.087 0.47 . . . . 2.3100000000000001 110.269 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -80.34 -0.43 36.77 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.002 -0.544 . . . . 3.6600000000000001 110.699 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 p30 37.3 60.81 1.02 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.454 1.102 . . . . 3.0600000000000001 113.394 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -127.56 -11.71 5.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.941 -0.572 . . . . 5.1799999999999997 110.037 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.524 ' OD2' ' HB2' ' A' ' 58' ' ' SER . 1.9 p-10 -136.63 152.02 49.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.484 -0.78 . . . . 2.5099999999999998 110.481 -176.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.622 ' O ' HD21 ' A' ' 65' ' ' LEU . 9.5 ptpp? -156.89 152.98 27.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.544 -0.298 . . . . 2.6200000000000001 111.013 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.799 ' HB3' ' HG3' ' A' ' 104' ' ' GLN . 1.6 mt -141.29 124.98 16.86 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.149 -1.426 . . . . 2.48 107.149 170.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 99.2 m-85 -69.26 133.88 48.46 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.121 0.486 . . . . 1.1299999999999999 110.806 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.944 HG13 ' HA ' ' A' ' 100' ' ' VAL . 29.2 m -128.83 175.23 10.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.388 -0.824 . . . . 1.29 109.796 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.839 ' HB2' ' HE2' ' A' ' 84' ' ' PHE . 2.2 p30 -152.34 128.27 10.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.235 0.54 . . . . 2.1000000000000001 109.918 172.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.585 HG23 HD11 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -79.85 87.67 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 1.55 110.382 -174.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.409 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 79.3 mtt180 -86.4 137.6 34.45 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.637 -0.711 . . . . 4.3300000000000001 110.206 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.409 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 74.1 Cg_exo -51.15 124.65 14.43 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.453 2.102 . . . . 0.90000000000000002 112.047 174.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.2 ttt -75.4 82.47 2.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.828 0.347 . . . . 2.23 110.678 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 61.87 21.15 12.05 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.536 -0.756 . . . . 1.9199999999999999 112.063 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.96 -51.55 5.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.618 -0.265 . . . . 1.8899999999999999 111.432 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.7 t -167.72 179.15 4.93 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.738 -0.467 . . . . 2.0699999999999998 109.738 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.15 123.88 45.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 1.5800000000000001 110.576 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.456 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 12.0 m0 -116.32 160.99 19.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.89 -0.596 . . . . 0.54000000000000004 110.057 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.1 m -81.86 113.46 19.81 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.356 -0.609 . . . . 1.22 109.356 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 t -95.56 108.55 20.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.579 0.704 . . . . 1.29 112.484 -171.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -117.44 162.26 18.24 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.228 -1.027 . . . . 1.7 108.228 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 10.6 m120 -85.28 -8.52 58.47 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.377 -0.529 . . . . 1.3899999999999999 110.984 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.42 ' O ' ' HE1' ' A' ' 49' ' ' PHE . . . -100.93 -35.98 4.09 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.305 -0.95 . . . . 0.85999999999999999 111.725 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.545 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 27.5 m -140.08 156.27 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.626 -0.509 . . . . 1.73 109.626 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.839 ' HE2' ' HB2' ' A' ' 68' ' ' ASN . 1.0 OUTLIER -134.5 97.96 3.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.201 -1.037 . . . . 0.41999999999999998 108.201 178.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.643 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 2.4 p90 -132.56 144.99 50.78 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.488 -0.485 . . . . 1.1499999999999999 111.456 -172.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.909 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 40.9 pttt -78.56 148.92 33.16 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.656 -0.702 . . . . 2.0299999999999998 110.555 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.3 -23.36 61.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 2.6600000000000001 109.443 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.909 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 5.7 m-20 -72.38 162.3 29.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.247 -0.888 . . . . 2.1000000000000001 110.297 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.9 m -121.86 139.52 48.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.783 0.325 . . . . 1.6599999999999999 110.578 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.0 -159.03 17.68 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.674 -0.774 . . . . 0.63 111.926 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.7 m -69.21 166.79 17.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.971 0.415 . . . . 1.5800000000000001 110.473 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.409 ' HZ2' ' HB3' ' A' ' 71' ' ' PRO . 63.2 t90 -152.46 -52.05 0.11 Allowed 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.263 -0.643 . . . . 0.75 109.263 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.667 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 27.21 89.8 0.01 OUTLIER Glycine 0 N--CA 1.466 0.654 0 O-C-N 125.12 1.513 . . . . 1.25 115.448 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.18 -150.17 5.73 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.39 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 p -112.4 125.58 54.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.446 0.536 . . . . 1.3200000000000001 112.446 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 69' ' ' ILE . 1.2 pt -115.75 129.42 72.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.77 -0.65 . . . . 2.2400000000000002 109.685 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -108.4 160.32 13.82 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.211 -0.995 . . . . 0.53000000000000003 112.743 -173.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -91.34 113.65 27.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.905 0.384 . . . . 1.53 110.189 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.637 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -116.5 126.83 53.92 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.92 -1.141 . . . . 1.7 107.92 174.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.944 ' HA ' HG13 ' A' ' 67' ' ' VAL . 13.9 p -62.98 124.96 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.316 -0.994 . . . . 1.6799999999999999 108.316 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.07 88.04 2.4 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.225 -0.657 . . . . 1.02 109.225 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA2' ' OD1' ' A' ' 21' ' ' ASP . . . 90.51 112.32 1.56 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.567 -1.013 . . . . 1.53 110.567 -171.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -51.08 114.23 1.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.354 0.597 . . . . 2.5699999999999998 110.967 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.799 ' HG3' ' HB3' ' A' ' 65' ' ' LEU . 11.9 mm-40 -91.98 20.81 5.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.476 -0.784 . . . . 3.1699999999999999 111.094 -174.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.6 m 72.7 -21.72 0.24 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.589 -0.732 . . . . 2.8599999999999999 112.816 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.526 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 8.9 t30 70.57 84.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.704 0.764 . . . . 1.5600000000000001 110.238 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.549 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 12.2 t -103.93 149.22 36.97 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.974 -1.121 . . . . 2.0800000000000001 107.974 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.549 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 91.4 Cg_exo -18.11 89.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 1 C-N-CA 125.76 4.307 . . . . 1.48 115.001 -172.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.68 ' CB ' HG13 ' A' ' 142' ' ' VAL . 3.3 Cg_exo -81.01 -150.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.693 2.929 . . . . 0.84999999999999998 114.214 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.91 -163.69 37.11 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 109.071 -1.612 . . . . 0.76000000000000001 109.071 -173.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.444 ' C ' HD21 ' A' ' 111' ' ' ASN . 0.2 OUTLIER -80.2 101.69 8.99 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.299 -0.63 . . . . 2.04 109.299 178.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.938 ' HH ' ' NH2' ' A' ' 16' ' ' ARG . 47.8 m-85 -84.9 126.59 33.61 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.003 0.43 . . . . 1.1100000000000001 109.965 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.9 m -130.71 97.36 4.33 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.906 -0.588 . . . . 1.3400000000000001 109.594 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -104.27 105.6 15.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.483 0.659 . . . . 1.1699999999999999 110.51 -176.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 1.3 m -78.27 121.57 24.58 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.148 -0.933 . . . . 1.4099999999999999 110.527 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.544 ' HB2' HG11 ' A' ' 7' ' ' VAL . 96.0 mt -107.29 146.0 32.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.87 0.367 . . . . 1.8 110.635 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.0 m -119.19 109.16 15.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.373 -0.376 . . . . 1.3200000000000001 110.415 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.97 162.09 54.07 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.957 -0.64 . . . . 0.97999999999999998 112.952 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 151.16 166.35 13.7 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.032 -0.604 . . . . 0.64000000000000001 111.621 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.661 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 46.9 p90 -89.19 -173.53 4.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.16 0.505 . . . . 1.2 111.043 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.626 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 2.3 t-105 -137.76 149.97 46.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.631 -0.713 . . . . 0.65000000000000002 110.276 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.79 147.66 50.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.308 -0.406 . . . . 1.55 110.49 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.553 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 5.8 tmtt? 70.41 -142.36 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.66 0.6 . . . . 3.8700000000000001 110.432 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.517 ' HA ' ' HZ2' ' A' ' 121' ' ' TRP . 6.9 p-10 -160.08 132.66 6.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.622 0.248 . . . . 2.0800000000000001 111.405 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.555 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 8.9 t30 66.86 -30.06 0.15 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.939 1.089 . . . . 3.0899999999999999 113.939 174.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.626 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -68.81 -3.51 12.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 2.3799999999999999 110.951 178.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.626 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 20.4 tt0 68.57 59.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.208 -0.905 . . . . 2.1099999999999999 110.856 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.626 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -89.06 48.55 3.46 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.603 -0.808 . . . . 0.77000000000000002 111.358 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.579 ' HD1' ' HG2' ' A' ' 127' ' ' GLN . 16.4 p90 -78.81 140.85 38.13 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 110.026 -0.361 . . . . 1.49 110.026 -174.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.544 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 36.6 m -118.94 137.59 25.21 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.315 -0.254 . . . . 1.8999999999999999 110.315 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.08 111.09 2.39 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.977 2.451 . . . . 1.1699999999999999 111.274 172.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.1 m -153.08 108.68 3.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.851 0.357 . . . . 1.96 110.489 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.61 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 137.4 -127.51 3.99 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.534 -0.841 . . . . 1.1699999999999999 111.907 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 m -124.96 145.7 49.74 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.282 -0.266 . . . . 2.9300000000000002 110.282 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.2 m -92.31 95.75 9.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.103 -0.702 . . . . 2.1800000000000002 109.103 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -92.17 128.7 9.5 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.918 -0.658 . . . . 0.72999999999999998 111.975 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.88 105.44 17.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.888 0.375 . . . . 1.23 110.211 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.531 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 21.7 m -78.32 108.8 11.92 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.845 -0.798 . . . . 1.1799999999999999 108.845 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -103.45 109.06 20.56 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.551 0.691 . . . . 2.6299999999999999 110.535 -174.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.4 tp -100.82 97.12 7.77 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.617 -1.174 . . . . 1.3100000000000001 109.092 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.716 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 24.8 m -97.64 122.28 40.54 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.613 -0.721 . . . . 1.1799999999999999 109.802 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.68 HG13 ' CB ' ' A' ' 109' ' ' PRO . 33.2 m -75.24 114.66 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-O 121.55 0.69 . . . . 2.3900000000000001 111.29 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.7 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 38.4 m . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.301 -0.856 . . . . 2.5899999999999999 109.834 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 53.9 m . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.633 0.254 . . . . 1.8300000000000001 110.623 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -86.46 110.17 19.56 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.565 -0.454 . . . . 2.29 110.018 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.43 117.92 49.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.894 -0.594 . . . . 2.1000000000000001 109.73 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -82.7 109.59 17.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.946 -0.57 . . . . 4.25 111.618 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.35 117.13 52.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.509 -0.923 . . . . 1.8200000000000001 108.509 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.38 144.39 17.05 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.443 -0.884 . . . . 1.1899999999999999 113.23 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -62.05 146.84 49.13 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.492 0.317 . . . . 2.1800000000000002 110.227 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -156.14 126.66 6.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.937 0.399 . . . . 2.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.442 ' HA ' ' HB3' ' A' ' 139' ' ' LYS . 28.0 m -108.75 114.58 28.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.111 -0.495 . . . . 1.5600000000000001 109.827 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.508 ' HB ' ' NZ ' ' A' ' 14' ' ' LYS . 61.9 t -144.17 146.04 21.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.595 -0.73 . . . . 2.04 109.328 -176.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -92.99 124.85 37.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.524 0.565 . . . . 1.23 112.524 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.508 ' NZ ' ' HB ' ' A' ' 12' ' ' VAL . 1.1 mptt -147.6 168.44 22.0 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.889 0.376 . . . . 3.9100000000000001 110.043 172.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.529 ' O ' HD21 ' A' ' 19' ' ' LEU . 73.4 p -112.66 161.89 16.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.313 -0.995 . . . . 1.21 108.313 169.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.414 ' CZ ' ' HH ' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -76.1 0.29 19.35 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.555 -0.858 . . . . 4.0800000000000001 110.236 175.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.99 -26.91 25.14 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 110.251 -1.139 . . . . 0.75 110.251 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -62.57 -29.61 70.72 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.442 -0.947 . . . . 2.6299999999999999 108.442 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.866 HD23 HD12 ' A' ' 25' ' ' ILE . 2.3 mm? -75.33 129.16 36.93 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.394 -1.275 . . . . 1.6100000000000001 109.593 171.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.633 HG22 ' HB2' ' A' ' 23' ' ' ALA . 13.7 t -127.94 42.18 3.37 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.391 1.091 . . . . 2.2599999999999998 108.262 -176.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.486 ' HB2' ' NE2' ' A' ' 103' ' ' GLN . 29.4 t70 75.3 -69.72 0.17 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.54 -1.663 . . . . 1.8300000000000001 109.607 -171.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.438 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -99.15 85.02 3.14 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.799 -0.445 . . . . 1.4299999999999999 109.799 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HB2' HG22 ' A' ' 20' ' ' THR . . . -142.51 94.63 6.7 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.219 -0.446 . . . . 1.3700000000000001 110.923 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 32.9 Cg_endo -68.43 85.9 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 123.189 2.593 . . . . 1.1200000000000001 111.72 177.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.866 HD12 HD23 ' A' ' 19' ' ' LEU . 12.3 pt -83.31 -16.62 11.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.734 -1.121 . . . . 3.0499999999999998 111.392 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.35 69.74 0.4 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.542 -0.837 . . . . 1.04 112.802 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.16 108.16 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.631 2.221 . . . . 1.0 111.697 173.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.6 t -84.47 141.69 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.016 -0.538 . . . . 1.8300000000000001 110.299 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.5 p -71.05 97.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.391 . . . . 2.2000000000000002 110.371 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.747 HG22 ' HA ' ' A' ' 95' ' ' THR . 6.6 t -83.59 142.27 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.933 0.873 . . . . 1.5600000000000001 111.397 -174.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.17 114.18 5.44 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.18 -1.373 . . . . 2.48 107.658 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.82 104.63 11.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.785 0.326 . . . . 1.25 110.911 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 46.3 tp -81.7 120.16 24.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.868 -0.605 . . . . 2.4700000000000002 109.963 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.9 -144.44 17.26 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.604 -0.808 . . . . 1.8100000000000001 111.923 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 4.2 m 59.75 32.33 21.33 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 122.192 0.197 . . . . 1.8799999999999999 111.503 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -55.46 -30.36 60.42 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.102 0.477 . . . . 2.71 110.77 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.56 54.6 1.93 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.901 -0.59 . . . . 1.3600000000000001 110.083 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.407 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.9 tpp180 -140.28 150.49 44.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.263 -0.426 . . . . 5.3499999999999996 111.287 -176.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -93.22 92.53 7.78 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.312 -0.625 . . . . 1.9099999999999999 109.312 178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 58.1 t -56.61 134.08 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.678 -0.692 . . . . 1.1699999999999999 110.639 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.969 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -143.82 149.88 37.67 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.962 0.41 . . . . 1.0900000000000001 111.045 -176.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.454 HD13 ' HB ' ' A' ' 69' ' ' ILE . 11.7 mt -102.96 155.17 18.54 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.011 -0.54 . . . . 1.4399999999999999 109.549 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.579 ' HE3' ' HB2' ' A' ' 129' ' ' PHE . 1.7 mptp? -140.05 150.92 44.96 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.862 -0.792 . . . . 2.5299999999999998 108.862 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -86.25 155.45 20.68 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.307 -0.627 . . . . 1.0700000000000001 109.307 171.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.603 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 27.6 t70 -71.78 161.45 30.95 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.667 -0.494 . . . . 0.70999999999999996 109.667 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -55.96 -23.1 30.14 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.929 0.715 . . . . 1.71 112.929 -173.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.0 -16.61 54.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 2.2200000000000002 111.424 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.594 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 20.3 m120 -123.04 8.19 9.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.215 -0.448 . . . . 1.5800000000000001 110.292 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 83.2 t80 -131.71 109.47 10.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.776 -0.647 . . . . 0.72999999999999998 110.24 -174.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HG2' ' HE1' ' A' ' 55' ' ' PHE . 14.2 pt-20 -134.0 124.11 25.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.357 -0.383 . . . . 2.4100000000000001 110.193 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 54.68 39.04 31.04 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.98 -0.554 . . . . 4.1399999999999997 111.586 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.93 36.72 65.06 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.758 -0.655 . . . . 0.72999999999999998 112.854 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.506 ' HB3' ' HE2' ' A' ' 66' ' ' TYR . 47.2 mmtm -132.8 134.91 45.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.304 -0.628 . . . . 2.6800000000000002 109.304 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -116.98 141.18 48.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.418 0.628 . . . . 0.65000000000000002 111.639 176.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.531 ' HE1' ' HG2' ' A' ' 50' ' ' GLU . 41.8 p90 -155.04 160.87 41.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.453 -0.794 . . . . 0.73999999999999999 109.912 -175.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.749 ' HB3' HD23 ' A' ' 114' ' ' LEU . 1.7 pp -81.21 143.08 32.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.64 -0.504 . . . . 2.0800000000000001 109.64 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 113' ' ' THR . 11.1 tp -121.05 146.9 25.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.697 -0.401 . . . . 1.21 110.36 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.435 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 2.8 p -100.3 174.4 6.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.963 -0.562 . . . . 1.9299999999999999 111.666 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -53.86 -41.37 67.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.54 -0.755 . . . . 2.3100000000000001 110.54 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.68 -14.04 46.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.156 -0.929 . . . . 3.6600000000000001 111.138 -174.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.408 ' HA ' HD11 ' A' ' 57' ' ' ILE . 43.3 m-80 62.29 18.97 10.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.167 0.508 . . . . 3.0600000000000001 110.285 -171.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -90.62 -50.01 6.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.857 -0.61 . . . . 5.1799999999999997 110.883 -175.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -100.75 134.22 44.04 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.712 -0.477 . . . . 2.5099999999999998 109.712 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' HD2' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -144.39 154.67 43.22 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.846 -0.616 . . . . 2.6200000000000001 109.854 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.727 HD22 HG22 ' A' ' 100' ' ' VAL . 23.3 tp -150.95 134.74 16.52 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.11 -0.495 . . . . 2.48 109.88 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.506 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 65.3 m-85 -78.71 131.37 36.58 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.679 -0.691 . . . . 1.1299999999999999 110.033 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.579 HG21 HD12 ' A' ' 114' ' ' LEU . 11.0 m -125.34 130.9 72.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.975 -0.557 . . . . 1.29 110.702 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -99.77 121.78 41.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.102 -0.499 . . . . 2.1000000000000001 110.027 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.504 HD11 HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -83.17 87.64 2.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.165 -0.47 . . . . 1.55 109.969 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.479 ' HE ' ' HB2' ' A' ' 99' ' ' TYR . 33.1 mtt180 -99.71 144.44 28.33 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.185 -0.461 . . . . 4.3300000000000001 109.929 -173.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.601 ' HA ' HG21 ' A' ' 96' ' ' ILE . 77.7 Cg_exo -50.89 140.38 38.85 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.711 2.274 . . . . 0.90000000000000002 112.439 174.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tpt -77.5 74.63 4.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.25 -0.648 . . . . 2.23 109.25 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 43.02 84.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.01 -0.996 . . . . 1.9199999999999999 111.386 -174.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.748 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 2.2 t-20 -145.98 -67.08 0.29 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.241 -0.436 . . . . 1.8899999999999999 110.591 -173.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 m -142.88 164.52 29.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.71 -0.478 . . . . 2.0699999999999998 109.71 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.06 107.33 17.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.212 0.53 . . . . 1.5800000000000001 110.604 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.726 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.4 m0 -101.89 137.45 40.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.663 -0.699 . . . . 0.54000000000000004 110.067 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.7 m -69.75 114.51 8.02 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.568 -0.53 . . . . 1.22 109.568 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -93.14 105.2 17.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.906 0.86 . . . . 1.29 112.176 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -105.79 161.2 14.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.078 -1.082 . . . . 1.7 108.078 167.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -85.62 3.64 39.9 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.628 -0.429 . . . . 1.3899999999999999 111.1 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.65 -40.06 0.87 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.333 -0.937 . . . . 0.85999999999999999 111.826 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.572 HG22 ' CZ3' ' A' ' 121' ' ' TRP . 30.9 m -133.03 156.88 42.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.988 -0.375 . . . . 1.73 109.988 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.709 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -133.72 97.64 3.97 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.961 -1.126 . . . . 0.41999999999999998 107.961 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.969 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -125.71 142.21 51.63 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 120.754 0.312 . . . . 1.1499999999999999 110.717 -175.472 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.931 ' HZ3' ' HB2' ' A' ' 92' ' ' TRP . 18.5 pttm -72.45 144.12 48.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.353 -0.61 . . . . 2.0299999999999998 109.353 173.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.65 43.8 0.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.009 0.909 . . . . 2.6600000000000001 108.88 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.774 ' HB3' ' HD2' ' A' ' 86' ' ' LYS . 17.4 t70 -149.16 154.41 39.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.591 -1.186 . . . . 2.1000000000000001 109.411 -171.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -115.71 124.38 72.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.094 0.473 . . . . 1.6599999999999999 110.564 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.66 174.97 22.94 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.502 -0.856 . . . . 0.63 112.432 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 p -74.66 124.15 26.19 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.99 -0.374 . . . . 1.5800000000000001 109.99 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.931 ' HB2' ' HZ3' ' A' ' 86' ' ' LYS . 13.4 t90 -100.64 -43.84 6.03 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.844 -0.342 . . . . 0.75 111.677 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.577 ' O ' ' HB ' ' A' ' 30' ' ' VAL . . . 51.34 -122.1 14.07 Favored Glycine 0 C--O 1.213 -1.175 0 N-CA-C 110.968 -0.853 . . . . 1.25 110.968 -173.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 73.17 -144.68 35.04 Favored Glycine 0 C--N 1.321 -0.271 0 C-N-CA 120.908 -0.663 . . . . 1.0 113.9 166.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.747 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -152.09 134.06 14.94 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 122.647 0.379 . . . . 1.3200000000000001 110.746 -179.08 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.654 HG13 HG21 ' A' ' 30' ' ' VAL . 2.2 pp -124.92 151.58 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.601 -0.518 . . . . 2.2400000000000002 109.601 174.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.35 167.77 23.33 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.364 -0.922 . . . . 0.53000000000000003 112.56 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.572 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.9 mp -91.11 113.26 26.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.743 0.306 . . . . 1.53 110.252 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 1.6 m-85 -113.89 124.14 51.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.864 -0.791 . . . . 1.7 108.864 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.727 HG22 HD22 ' A' ' 65' ' ' LEU . 11.4 p -55.58 139.07 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.632 0.253 . . . . 1.6799999999999999 110.709 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -86.61 82.75 7.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.813 -0.81 . . . . 1.02 108.813 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.8 100.7 0.41 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.266 -0.734 . . . . 1.53 111.266 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.486 ' NE2' ' HB2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -43.01 120.25 1.74 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.543 0.687 . . . . 2.5699999999999998 111.87 -179.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.487 ' HG3' ' OG1' ' A' ' 107' ' ' THR . 21.1 tp60 -75.94 -3.13 33.8 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.813 -0.63 . . . . 3.1699999999999999 110.719 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.9 m 66.73 24.81 9.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.345 0.593 . . . . 2.8599999999999999 111.446 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 60.71 71.34 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.77 0.795 . . . . 1.5600000000000001 111.529 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.487 ' OG1' ' HG3' ' A' ' 104' ' ' GLN . 3.1 m -82.64 139.62 44.01 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.971 -1.013 . . . . 2.0800000000000001 108.501 168.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 107' ' ' THR . 66.6 Cg_exo -24.9 94.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.096 1 C-N-CA 125.481 4.12 . . . . 1.48 114.558 -176.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.472 ' CB ' ' HE2' ' A' ' 112' ' ' TYR . 57.1 Cg_endo -87.67 -174.89 1.33 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.14 2.56 . . . . 0.84999999999999998 113.532 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.45 -121.18 0.57 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.215 -1.154 . . . . 0.76000000000000001 110.215 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -99.45 109.81 22.34 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.129 -0.693 . . . . 2.04 109.129 171.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.53 ' CD1' HD13 ' A' ' 56' ' ' LEU . 53.4 m-85 -107.11 104.77 14.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.803 0.811 . . . . 1.1100000000000001 110.667 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.452 ' O ' HG21 ' A' ' 57' ' ' ILE . 86.6 m -98.04 118.21 34.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.889 -1.051 . . . . 1.3400000000000001 109.897 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.749 HD23 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -133.78 96.76 3.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.22 0.533 . . . . 1.1699999999999999 110.214 175.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 7.6 m -75.12 127.61 33.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.089 -0.505 . . . . 1.4099999999999999 110.157 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.504 HD11 HD11 ' A' ' 69' ' ' ILE . 90.2 mt -116.59 126.13 52.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.009 -0.367 . . . . 1.8 110.009 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 131' ' ' PRO . 17.3 m -106.75 126.51 52.39 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.849 0.357 . . . . 1.3200000000000001 110.63 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.69 157.54 45.81 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.809 -0.71 . . . . 0.97999999999999998 111.619 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 171.79 -169.56 42.62 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.629 -0.796 . . . . 0.64000000000000001 111.923 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -111.97 179.92 3.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.181 0.515 . . . . 1.2 110.325 177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.772 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 1.7 t-105 -145.48 148.31 33.12 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.495 -0.775 . . . . 0.65000000000000002 109.272 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.47 144.26 50.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.831 0.348 . . . . 1.55 111.155 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.694 ' HD3' ' H ' ' A' ' 124' ' ' ASP . 4.7 tmtm? 67.83 -136.69 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.918 0.887 . . . . 3.8700000000000001 110.212 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.694 ' H ' ' HD3' ' A' ' 123' ' ' LYS . 4.1 p30 -161.56 138.59 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.067 0.394 . . . . 2.0800000000000001 110.934 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.521 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 55.9 m-80 64.85 -40.8 0.28 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.702 1.201 . . . . 3.0899999999999999 113.891 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.467 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -62.9 -3.63 1.72 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.21 0.604 . . . . 2.3799999999999999 112.339 -174.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.772 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 44.1 mt-30 68.01 67.1 0.35 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.491 0.662 . . . . 2.1099999999999999 111.576 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.467 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -95.13 39.61 2.84 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.948 -0.861 . . . . 0.77000000000000002 110.948 173.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.579 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 41.8 p90 -81.81 151.39 27.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.692 0.282 . . . . 1.49 110.611 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 74.6 m -147.37 125.79 6.13 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.598 -0.273 . . . . 1.8999999999999999 110.707 174.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.478 ' HB3' HG23 ' A' ' 117' ' ' THR . 9.2 Cg_exo -72.17 114.18 3.91 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.933 2.422 . . . . 1.1699999999999999 111.51 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 p -151.04 126.98 10.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.045 0.45 . . . . 1.96 110.931 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.85 -113.55 2.69 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.633 -0.794 . . . . 1.1699999999999999 112.17 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.3 m -130.44 135.37 47.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.63 0.252 . . . . 2.9300000000000002 110.582 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.2 t -99.78 140.53 33.86 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.49 -0.559 . . . . 2.1800000000000002 109.49 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -130.41 119.84 2.87 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.45 -0.881 . . . . 0.72999999999999998 112.355 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 6.0 m -77.77 104.72 8.48 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.781 -0.452 . . . . 1.23 109.781 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.419 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 50.7 m -78.59 108.26 11.86 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.062 -0.718 . . . . 1.1799999999999999 109.062 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 12.4 tppt? -98.68 112.97 24.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.762 0.791 . . . . 2.6299999999999999 110.405 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.61 HD23 HD21 ' A' ' 56' ' ' LEU . 9.4 tp -102.06 94.42 5.76 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 114.676 -1.147 . . . . 1.3100000000000001 109.409 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.72 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 17.1 m -105.69 144.82 31.9 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.265 -0.642 . . . . 1.1799999999999999 109.265 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.4 p -95.41 135.97 27.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.157 0.503 . . . . 2.3900000000000001 110.21 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.4 m . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.714 -0.66 . . . . 2.5899999999999999 109.728 178.888 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 51.9 t . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.502 0.668 . . . . 1.8300000000000001 109.538 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -94.62 120.46 34.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.385 -0.825 . . . . 2.29 110.392 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.6 115.78 42.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.184 -0.462 . . . . 2.1000000000000001 110.669 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 31' ' ' GLN . 37.5 ttm180 -80.12 108.16 13.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.688 -0.687 . . . . 4.25 109.802 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -114.83 122.55 69.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.808 -0.633 . . . . 1.8200000000000001 109.829 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.51 169.38 27.4 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.815 -0.707 . . . . 1.1899999999999999 112.389 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.57 123.39 40.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.049 -0.352 . . . . 2.1800000000000002 110.049 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.444 ' HB2' HG21 ' A' ' 138' ' ' THR . 55.8 mt -107.45 121.49 44.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.927 0.394 . . . . 2.0 111.582 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.1 m -112.82 113.32 25.36 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.029 -0.73 . . . . 1.5600000000000001 109.029 170.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.419 HG12 ' HZ3' ' A' ' 14' ' ' LYS . 11.4 t -142.76 147.78 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.913 -0.403 . . . . 2.04 109.913 -176.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -112.28 135.43 52.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.625 -0.261 . . . . 1.23 110.99 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.474 ' HE2' ' HB ' ' A' ' 25' ' ' ILE . 10.9 ptpp? 178.5 163.82 0.75 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.982 -0.554 . . . . 3.9100000000000001 109.957 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.812 ' HA ' HG11 ' A' ' 142' ' ' VAL . 76.1 p -85.44 161.71 19.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.132 -0.485 . . . . 1.21 109.865 175.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.967 ' NH2' ' HH ' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -80.32 -0.4 36.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.3 -0.63 . . . . 4.0800000000000001 109.3 174.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.502 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -96.53 -18.41 30.62 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.197 -0.91 . . . . 0.75 110.962 176.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -71.12 -23.82 62.16 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.538 -0.912 . . . . 2.6299999999999999 108.538 172.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.403 ' CB ' HG11 ' A' ' 100' ' ' VAL . 46.9 mt -86.49 116.99 24.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.641 -1.163 . . . . 1.6100000000000001 108.989 173.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 p -111.42 77.13 1.02 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.77 0.319 . . . . 2.2599999999999998 110.682 -175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 29.5 t70 61.39 -83.56 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.155 -0.93 . . . . 1.8300000000000001 110.835 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.648 ' HA ' ' CD2' ' A' ' 99' ' ' TYR . . . -107.07 84.6 2.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.304 0.574 . . . . 1.4299999999999999 110.309 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.47 ' O ' HG13 ' A' ' 25' ' ' ILE . . . -146.68 87.72 6.28 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.191 -0.913 . . . . 1.3700000000000001 109.304 175.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.518 ' CB ' ' HA3' ' A' ' 97' ' ' GLY . 59.8 Cg_endo -69.57 94.86 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.657 2.238 . . . . 1.1200000000000001 112.683 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.474 ' HB ' ' HE2' ' A' ' 14' ' ' LYS . 4.9 mt -111.82 23.46 4.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 122.005 0.907 . . . . 3.0499999999999998 110.056 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.507 ' N ' ' HD3' ' A' ' 27' ' ' PRO . . . -140.66 53.17 0.67 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.89 -1.05 . . . . 1.04 111.578 168.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.766 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 48.4 Cg_exo -55.81 115.06 2.19 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.299 1.999 . . . . 1.0 113.433 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.2 t -88.58 129.89 38.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.361 -0.836 . . . . 1.8300000000000001 109.282 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 p -76.95 88.13 3.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.244 0.545 . . . . 2.2000000000000002 110.868 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.1 115.44 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.673 -0.694 . . . . 1.5600000000000001 110.755 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . 52.1 tt0 -114.35 113.01 23.98 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.251 -0.431 . . . . 2.48 109.988 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.598 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -95.98 101.27 12.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.843 -0.617 . . . . 1.25 110.306 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 tt -95.83 126.35 41.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.765 -0.652 . . . . 2.4700000000000002 110.592 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.2 69.9 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.087 -0.577 . . . . 1.8100000000000001 114.4 169.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.598 ' SG ' ' HB1' ' A' ' 32' ' ' ALA . 31.3 m -80.54 -66.96 0.82 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.343 0.572 . . . . 1.8799999999999999 110.112 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.581 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 3.2 m-20 67.81 -45.98 0.5 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.136 1.162 . . . . 2.71 114.136 172.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.52 29.08 2.69 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.062 -0.399 . . . . 1.3600000000000001 111.905 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -133.26 161.06 35.5 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.23 -0.285 . . . . 5.3499999999999996 110.23 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -91.73 141.14 29.01 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.904 -0.406 . . . . 1.9099999999999999 109.904 172.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 53.1 t -94.03 136.28 26.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.849 -0.796 . . . . 1.1699999999999999 108.849 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -127.53 135.39 50.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.851 0.358 . . . . 1.0900000000000001 110.803 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 mt -103.54 105.57 15.84 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.164 -0.68 . . . . 1.4399999999999999 109.164 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.805 ' HG3' HG12 ' A' ' 83' ' ' VAL . 1.4 mppt? -108.4 125.41 51.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.52 -0.919 . . . . 2.5299999999999998 108.52 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.616 ' HB2' HD22 ' A' ' 48' ' ' ASN . . . -72.94 156.95 38.33 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.686 -0.406 . . . . 1.0700000000000001 110.248 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.7 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 21.5 t70 -71.77 147.4 47.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.205 -0.452 . . . . 0.70999999999999996 109.839 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -61.66 -6.27 2.43 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.91 0.707 . . . . 1.71 112.91 -171.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.83 -29.24 44.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.992 0.425 . . . . 2.2200000000000002 110.378 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.616 HD22 ' HB2' ' A' ' 44' ' ' ALA . 5.5 p-10 -124.28 19.79 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 1.5800000000000001 109.553 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.456 ' CE1' ' HA2' ' A' ' 52' ' ' GLY . 84.7 t80 -137.45 107.4 6.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.281 -0.872 . . . . 0.72999999999999998 109.916 -175.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -103.07 96.91 7.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.411 -0.358 . . . . 2.4100000000000001 110.653 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 68.2 -52.32 0.54 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.983 0.802 . . . . 4.1399999999999997 112.047 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 49' ' ' PHE . . . -174.33 37.08 0.12 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 111.671 -0.572 . . . . 0.72999999999999998 111.671 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.766 ' HD2' ' HB3' ' A' ' 81' ' ' ASN . 8.7 mmmm -138.95 133.52 31.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.64 -1.244 . . . . 2.6800000000000002 107.64 172.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.15 147.03 43.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.667 0.746 . . . . 0.65000000000000002 112.055 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.488 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 9.2 p90 -150.19 -179.63 7.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.568 -1.196 . . . . 0.73999999999999999 109.603 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.951 HD11 HD21 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -89.37 121.55 31.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.979 -1.119 . . . . 2.0800000000000001 107.979 169.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.569 HG23 ' HB3' ' A' ' 48' ' ' ASN . 8.8 tp -106.79 116.86 51.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.571 0.701 . . . . 1.21 109.439 177.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 22.6 t -72.51 147.65 45.79 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.06 -0.518 . . . . 1.9299999999999999 110.214 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.84 -8.07 33.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.456 0.646 . . . . 2.3100000000000001 109.703 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -95.26 -3.12 48.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.385 -0.825 . . . . 3.6600000000000001 110.023 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.07 28.01 0.35 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.884 1.273 . . . . 3.0600000000000001 113.553 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -86.46 -53.83 4.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.087 -0.383 . . . . 5.1799999999999997 111.118 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.513 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 7.2 m-20 -125.66 159.64 31.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.414 -0.357 . . . . 2.5099999999999998 110.705 -175.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.488 ' HB2' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -145.63 133.11 20.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.78 -0.646 . . . . 2.6200000000000001 109.718 176.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.611 ' O ' HD23 ' A' ' 56' ' ' LEU . 2.0 mm? -128.37 133.35 48.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.336 -0.616 . . . . 2.48 109.336 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -75.25 138.34 41.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.147 0.498 . . . . 1.1299999999999999 110.376 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.47 HG12 HD12 ' A' ' 56' ' ' LEU . 2.4 m -117.48 167.19 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-N 115.734 -0.667 . . . . 1.29 110.476 177.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -121.78 110.34 15.79 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.775 -0.648 . . . . 2.1000000000000001 109.339 173.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.1 pt -88.77 84.93 2.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.021 -0.733 . . . . 1.55 109.021 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.571 ' HB3' ' OH ' ' A' ' 99' ' ' TYR . 44.9 ttt180 -116.69 136.2 23.13 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 115.445 -0.798 . . . . 4.3300000000000001 109.132 -173.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.574 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 91.9 Cg_exo -42.92 121.0 2.08 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.0 2.467 . . . . 0.90000000000000002 112.284 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.9 ttt -68.18 87.83 0.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 2.23 110.424 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t0 49.35 66.76 1.02 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.143 -0.935 . . . . 1.9199999999999999 111.019 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -140.17 -53.19 0.51 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 1.8899999999999999 111.559 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.0 m -149.57 161.42 42.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.576 0.227 . . . . 2.0699999999999998 110.624 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.6 86.45 3.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.94 0.4 . . . . 1.5800000000000001 110.081 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 17.2 m0 -77.25 158.27 30.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.706 -0.679 . . . . 0.54000000000000004 110.3 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.9 m -69.63 116.33 9.91 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.063 -0.717 . . . . 1.22 109.063 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 t -98.01 97.31 8.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.819 0.819 . . . . 1.29 112.094 -170.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.33 159.85 14.67 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.295 -1.002 . . . . 1.7 108.295 168.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.766 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -79.73 -7.31 58.54 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.335 -0.546 . . . . 1.3899999999999999 110.017 -178.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.452 ' CA ' ' HE1' ' A' ' 49' ' ' PHE . . . -118.64 -36.74 0.88 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.13 -1.033 . . . . 0.85999999999999999 112.887 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.805 HG12 ' HG3' ' A' ' 43' ' ' LYS . 33.4 m -124.52 151.76 30.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.275 -0.639 . . . . 1.73 109.275 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -135.03 102.48 5.23 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.297 -1.001 . . . . 0.41999999999999998 108.297 -178.422 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.668 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 15.6 p90 -135.9 140.87 44.4 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.137 0.494 . . . . 1.1499999999999999 110.903 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 17.1 pttp -82.44 140.98 33.1 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.562 -0.745 . . . . 2.0299999999999998 110.986 -178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -67.47 -34.4 77.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.291 -1.003 . . . . 2.6600000000000001 108.291 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.595 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 2.2 m-20 -58.44 124.48 19.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.636 -1.166 . . . . 2.1000000000000001 110.31 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.8 131.46 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.512 -0.475 . . . . 1.6599999999999999 109.818 174.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.581 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 146.07 -165.19 28.18 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.584 -0.817 . . . . 0.63 111.832 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.8 p -81.82 -172.78 4.08 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.619 -0.511 . . . . 1.5800000000000001 109.619 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.574 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 22.5 t90 -154.0 -59.99 0.13 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.953 -0.388 . . . . 0.75 109.953 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 39.69 88.44 0.01 OUTLIER Glycine 0 N--CA 1.467 0.724 0 O-C-N 124.275 0.985 . . . . 1.25 114.901 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.69 -139.6 2.68 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.022 -0.609 . . . . 1.0 111.669 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 p -131.77 124.62 30.07 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.43 0.634 . . . . 1.3200000000000001 112.167 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 37.5 pt -100.0 161.54 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.375 -0.972 . . . . 2.2400000000000002 108.375 172.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.518 ' HA3' ' CB ' ' A' ' 24' ' ' PRO . . . -128.02 147.9 17.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.53 -1.319 . . . . 0.53000000000000003 113.126 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 79.8 mt -101.75 120.73 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 120.731 0.3 . . . . 1.53 110.886 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.648 ' CD2' ' HA ' ' A' ' 22' ' ' ALA . 1.4 p90 -138.6 155.2 48.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.85 -0.614 . . . . 1.7 110.392 173.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.464 HG13 ' HA ' ' A' ' 103' ' ' GLN . 12.8 p -85.58 136.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.822 -0.626 . . . . 1.6799999999999999 110.761 -170.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.13 101.87 0.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.825 -0.625 . . . . 1.02 111.391 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.75 34.83 66.4 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-O 119.451 -0.638 . . . . 1.53 113.848 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.464 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.4 pt20 38.92 96.88 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.984 0.897 . . . . 2.5699999999999998 113.187 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.518 ' HG3' ' HB3' ' A' ' 65' ' ' LEU . 14.7 mm100 -80.39 17.45 1.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.49 -0.777 . . . . 3.1699999999999999 111.927 -172.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 8.8 m 76.32 -29.15 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.392 0.677 . . . . 2.8599999999999999 112.671 168.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.502 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 15.0 t30 77.8 84.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.851 0.834 . . . . 1.5600000000000001 111.08 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.445 ' N ' HH12 ' A' ' 16' ' ' ARG . 25.9 m -93.79 137.43 23.17 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.542 -1.208 . . . . 2.0800000000000001 109.535 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.414 ' HD2' ' CG2' ' A' ' 107' ' ' THR . 72.2 Cg_exo -19.58 92.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 1 C-N-CA 126.198 4.598 . . . . 1.48 115.461 -174.228 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.783 ' HG2' HG13 ' A' ' 142' ' ' VAL . 10.2 Cg_endo -96.96 -155.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.355 3.37 . . . . 0.84999999999999998 114.31 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -172.94 -105.25 0.18 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 114.118 -1.401 . . . . 0.76000000000000001 109.603 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -102.74 130.11 49.59 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.57 -0.53 . . . . 2.04 109.57 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.967 ' HH ' ' NH2' ' A' ' 16' ' ' ARG . 6.7 m-85 -118.58 120.66 38.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.036 0.446 . . . . 1.1100000000000001 110.587 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.2 m -97.48 135.36 39.45 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 1.3400000000000001 110.768 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.951 HD21 HD11 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -153.84 94.06 1.72 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.463 0.649 . . . . 1.1699999999999999 109.783 175.08 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.7 ' HB ' ' CB ' ' A' ' 45' ' ' ASP . 14.8 m -84.45 140.65 31.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.741 -0.663 . . . . 1.4099999999999999 109.95 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.5 mt -118.42 119.93 36.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.409 -0.359 . . . . 1.8 110.496 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 43.5 m -98.47 121.34 40.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.014 0.435 . . . . 1.3200000000000001 110.236 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.12 -159.4 19.05 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.842 -0.694 . . . . 0.97999999999999998 112.673 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.69 ' HA2' ' HB2' ' A' ' 132' ' ' SER . . . 109.64 165.88 20.0 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.518 -0.633 . . . . 0.64000000000000001 111.518 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -89.34 177.26 6.64 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.142 -0.623 . . . . 1.2 111.017 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.661 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 4.6 t-105 -129.25 151.95 49.35 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.804 -1.089 . . . . 0.65000000000000002 109.902 -174.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.45 149.85 52.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.105 -0.498 . . . . 1.55 110.175 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.441 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 6.4 mmtt 64.25 -146.52 0.28 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.21 0.604 . . . . 3.8700000000000001 111.053 -176.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 126' ' ' LYS . 4.2 p30 -151.02 136.14 17.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.516 0.198 . . . . 2.0800000000000001 110.945 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.6 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.7 OUTLIER 51.97 -7.9 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.306 1.842 . . . . 3.0899999999999999 115.883 176.569 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -80.5 -2.52 46.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.362 0.601 . . . . 2.3799999999999999 109.999 176.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.661 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 7.7 tt0 68.47 54.43 0.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.432 -1.258 . . . . 2.1099999999999999 110.839 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -89.47 110.68 3.75 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 109.823 -1.311 . . . . 0.77000000000000002 109.823 170.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 26.7 p90 -151.0 171.26 17.58 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.297 -0.631 . . . . 1.49 109.297 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.571 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 5.9 t -150.19 146.03 19.54 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 110.009 -0.367 . . . . 1.8999999999999999 110.009 173.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.12 106.76 1.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.7 2.267 . . . . 1.1699999999999999 111.47 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.69 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 10.6 m -131.95 122.07 24.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.913 -0.585 . . . . 1.96 109.78 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.75 -110.57 3.78 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.714 -0.755 . . . . 1.1699999999999999 111.483 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.6 p -144.01 176.2 9.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.052 0.453 . . . . 2.9300000000000002 110.957 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.1 t -126.86 129.71 48.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.31 -0.626 . . . . 2.1800000000000002 109.31 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.49 138.18 14.65 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.647 -0.787 . . . . 0.72999999999999998 112.155 -175.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 19.2 m -99.06 103.73 15.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.992 -0.373 . . . . 1.23 109.992 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.453 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 21.6 m -81.81 113.18 19.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.355 -0.609 . . . . 1.1799999999999999 109.355 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -100.22 109.08 21.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.471 0.653 . . . . 2.6299999999999999 109.506 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.5 HD23 ' HG ' ' A' ' 56' ' ' LEU . 13.7 tp -92.58 95.85 9.85 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.711 -1.132 . . . . 1.3100000000000001 109.415 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 24.7 m -93.64 126.8 39.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.76 -0.654 . . . . 1.1799999999999999 109.576 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.812 HG11 ' HA ' ' A' ' 15' ' ' THR . 30.7 t -107.23 106.18 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.675 -0.41 . . . . 2.3900000000000001 111.242 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.289 -0.863 . . . . 2.5899999999999999 109.498 173.737 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.958 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 4.8 t . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 108.656 -0.868 . . . . 1.8300000000000001 108.656 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -97.67 141.42 30.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.25 -0.432 . . . . 2.29 110.928 -175.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.536 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 74.9 t -117.37 117.2 54.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.749 -0.659 . . . . 2.1000000000000001 110.397 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -88.86 106.22 18.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.112 -0.495 . . . . 4.25 110.79 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.435 HG23 HG13 ' A' ' 5' ' ' VAL . 66.9 t -113.76 115.02 48.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.115 -0.493 . . . . 1.8200000000000001 109.937 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.77 -178.53 25.72 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.63 -0.795 . . . . 1.1899999999999999 112.029 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.27 146.47 24.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.959 -0.385 . . . . 2.1800000000000002 109.959 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.9 pt? -140.92 142.11 34.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.12 -0.491 . . . . 2.0 109.718 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -116.65 117.59 30.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.405 -0.362 . . . . 1.5600000000000001 110.697 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.35 140.37 47.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.938 0.399 . . . . 2.04 110.534 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.438 ' HB3' ' OG1' ' A' ' 143' ' ' THR . . . -116.67 112.5 21.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 1.23 110.222 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -163.81 179.7 6.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.049 0.452 . . . . 3.9100000000000001 110.417 -178.617 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.563 ' H ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -103.42 158.73 16.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 1.21 110.328 178.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.638 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -80.46 -9.2 59.76 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.961 -0.462 . . . . 4.0800000000000001 111.023 -175.81 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.57 -15.36 79.25 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.081 -0.807 . . . . 0.75 111.081 172.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HA ' HE21 ' A' ' 18' ' ' GLN . 0.0 OUTLIER -66.07 -31.79 72.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.124 -0.538 . . . . 2.6299999999999999 110.856 176.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.845 ' HB2' HG12 ' A' ' 100' ' ' VAL . 12.2 mt -91.25 19.8 5.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.889 -0.596 . . . . 1.6100000000000001 112.183 -168.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -36.25 93.59 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 N-CA-C 114.007 1.114 . . . . 2.2599999999999998 114.007 -172.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 69.9 -53.34 0.62 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.858 -1.064 . . . . 1.8300000000000001 111.923 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.807 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -158.13 78.41 0.82 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.189 0.518 . . . . 1.4299999999999999 111.26 176.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 19' ' ' LEU . . . -138.93 117.87 9.25 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.488 -0.778 . . . . 1.3700000000000001 109.096 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD3' ' HE1' ' A' ' 99' ' ' TYR . 96.0 Cg_endo -79.74 132.48 9.79 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.88 2.387 . . . . 1.1200000000000001 114.417 -170.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.731 HG21 HD22 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -77.49 -56.61 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.425 -0.807 . . . . 3.0499999999999998 110.162 169.104 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.44 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -138.91 98.24 0.25 Allowed Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.388 -0.824 . . . . 1.04 111.67 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.606 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 31.3 Cg_endo -67.66 126.58 14.95 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.271 1.98 . . . . 1.0 111.378 176.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.75 124.44 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 1.8300000000000001 109.653 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 t -77.7 74.98 4.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.472 0.654 . . . . 2.2000000000000002 110.508 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.484 HG11 ' CG1' ' A' ' 5' ' ' VAL . 70.0 t -72.42 113.2 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.728 -0.669 . . . . 1.5600000000000001 109.949 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -116.12 125.82 52.87 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.778 -0.646 . . . . 2.48 109.833 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.483 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -111.61 130.61 55.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.408 -0.815 . . . . 1.25 110.351 -177.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 35.2 tp -111.44 116.45 30.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.137 -0.483 . . . . 2.4700000000000002 111.324 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.09 71.63 0.84 Allowed Glycine 0 C--N 1.331 0.304 0 O-C-N 123.573 0.545 . . . . 1.8100000000000001 113.423 173.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.958 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 9.9 m -106.71 -68.83 0.86 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.883 -0.327 . . . . 1.8799999999999999 111.465 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 68.41 -48.22 0.55 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.466 0.706 . . . . 2.71 112.32 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.81 69.89 1.26 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.206 0.527 . . . . 1.3600000000000001 110.348 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.628 HH11 ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -149.95 131.8 15.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.994 -0.548 . . . . 5.3499999999999996 110.586 -177.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.686 ' HG3' HG11 ' A' ' 89' ' ' VAL . 98.6 mt-30 -85.48 124.19 31.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.109 0.48 . . . . 1.9099999999999999 110.078 178.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.628 ' HA ' HH11 ' A' ' 38' ' ' ARG . 71.0 t -95.14 110.55 24.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.088 -0.506 . . . . 1.1699999999999999 109.946 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.817 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . . . -117.72 144.44 45.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 123.624 0.578 . . . . 1.0900000000000001 111.039 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.82 HD11 HD12 ' A' ' 96' ' ' ILE . 64.5 mt -103.7 129.07 51.0 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.488 -0.56 . . . . 1.4399999999999999 109.488 172.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.817 ' HE2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -120.28 152.12 38.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.858 -0.793 . . . . 2.5299999999999998 108.858 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.47 ' HB1' ' OD1' ' A' ' 48' ' ' ASN . . . -92.67 159.2 15.56 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.719 -0.392 . . . . 1.0700000000000001 110.036 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 14.8 t70 -87.61 170.01 11.66 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.563 -0.903 . . . . 0.70999999999999996 108.563 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -65.54 -1.98 3.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.975 0.361 . . . . 1.71 111.975 -173.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -88.94 -26.34 21.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.72 -0.218 . . . . 2.2200000000000002 111.262 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 28.9 p-10 -131.73 12.16 4.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.732 0.301 . . . . 1.5800000000000001 111.699 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.447 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 55.2 t80 -114.44 101.37 9.07 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.537 -0.542 . . . . 0.72999999999999998 109.537 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.799 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 8.3 pt-20 -95.35 93.71 7.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.877 0.37 . . . . 2.4100000000000001 110.387 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 68.39 -50.95 0.56 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.428 -0.805 . . . . 4.1399999999999997 112.036 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.447 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -172.04 36.58 0.15 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.183 -0.767 . . . . 0.72999999999999998 111.183 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.606 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 10.3 mmmm -137.84 134.87 35.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.946 -0.761 . . . . 2.6800000000000002 108.946 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -117.9 148.69 41.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.493 0.663 . . . . 0.65000000000000002 112.307 177.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.799 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 7.6 p90 -156.58 176.94 12.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.019 -0.991 . . . . 0.73999999999999999 111.1 -174.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 20.1 mt -89.24 111.05 21.76 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.351 -0.981 . . . . 2.0800000000000001 108.351 168.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.526 ' HB ' ' HE1' ' A' ' 55' ' ' PHE . 8.3 tp -107.33 138.69 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.703 -0.48 . . . . 1.21 109.703 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 3.1 t -102.41 152.73 20.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.529 -0.305 . . . . 1.9299999999999999 110.372 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -49.11 -42.48 39.27 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.053 0.846 . . . . 2.3100000000000001 113.023 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.31 -21.8 66.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.711 0.263 . . . . 3.6600000000000001 111.711 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 63.34 84.43 0.15 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.365 0.602 . . . . 3.0600000000000001 109.95 -176.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -154.79 -40.7 0.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.615 . . . . 5.1799999999999997 111.034 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.87 153.52 50.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.915 -0.584 . . . . 2.5099999999999998 110.322 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.6 pptp? -152.25 128.04 10.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.804 -0.635 . . . . 2.6200000000000001 109.739 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.487 HD22 ' HG2' ' A' ' 104' ' ' GLN . 4.5 mt -114.27 119.12 35.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.261 -0.427 . . . . 2.48 110.026 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.439 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 93.4 m-85 -67.85 128.73 37.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 1.1299999999999999 110.156 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 100' ' ' VAL . 11.2 m -121.27 123.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.878 -0.601 . . . . 1.29 111.428 -175.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -97.21 111.67 23.81 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.961 -0.563 . . . . 2.1000000000000001 109.53 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.434 HG23 ' HB ' ' A' ' 96' ' ' ILE . 2.6 mt -76.32 86.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.562 -0.745 . . . . 1.55 110.454 -176.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -93.62 142.84 25.68 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.995 -0.548 . . . . 4.3300000000000001 109.866 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.564 ' HA ' HG22 ' A' ' 96' ' ' ILE . 77.1 Cg_exo -51.12 134.08 42.64 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.693 2.262 . . . . 0.90000000000000002 112.52 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tpt -75.14 72.75 2.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.984 -0.553 . . . . 2.23 109.948 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.4 t70 52.58 75.59 0.23 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.363 -0.835 . . . . 1.9199999999999999 110.785 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -146.56 -59.94 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.866 -0.606 . . . . 1.8899999999999999 111.248 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 m -151.02 178.83 8.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 2.0699999999999998 111.055 -175.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.26 121.75 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.751 -0.658 . . . . 1.5800000000000001 109.891 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.512 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 17.8 m0 -113.07 168.21 9.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.256 -0.429 . . . . 0.54000000000000004 111.001 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -87.97 131.37 34.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.018 -0.734 . . . . 1.22 109.018 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 t -107.93 113.59 26.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.605 0.717 . . . . 1.29 112.353 -171.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -127.24 161.33 28.82 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.782 -1.192 . . . . 1.7 107.782 170.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.481 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 15.8 m120 -85.91 -5.52 59.22 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.295 -0.562 . . . . 1.3899999999999999 110.812 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.82 -38.37 3.66 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.19 -1.005 . . . . 0.85999999999999999 111.81 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.687 HG13 ' HG3' ' A' ' 43' ' ' LYS . 27.0 m -140.49 156.72 23.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.971 0.415 . . . . 1.73 110.403 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.671 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -132.15 108.87 9.56 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.659 -0.867 . . . . 0.41999999999999998 108.659 177.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 12.7 p90 -145.75 149.24 34.03 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.22 0.325 . . . . 1.1499999999999999 110.675 -174.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.745 ' HZ2' ' HB2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -80.55 141.36 35.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.948 -0.701 . . . . 2.0299999999999998 109.205 174.306 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -57.97 -33.81 69.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.843 -0.617 . . . . 2.6600000000000001 110.412 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -61.99 122.14 14.74 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.741 -0.663 . . . . 2.1000000000000001 111.587 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.686 HG11 ' HG3' ' A' ' 39' ' ' GLN . 13.1 m -80.94 105.59 11.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.141 0.496 . . . . 1.6599999999999999 109.95 173.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.75 -162.77 35.83 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.134 -1.032 . . . . 0.63 112.603 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -84.0 163.81 19.71 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.013 0.435 . . . . 1.5800000000000001 110.447 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.745 ' HB2' ' HZ2' ' A' ' 86' ' ' LYS . 41.3 t90 -148.86 -62.41 0.24 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.344 -0.613 . . . . 0.75 109.344 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 38.54 91.72 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 O-C-N 124.341 1.026 . . . . 1.25 115.161 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.16 -127.45 0.91 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.701 -0.761 . . . . 1.0 112.377 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 p -135.85 133.02 37.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.054 0.454 . . . . 1.3200000000000001 111.805 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.82 HD12 HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -130.87 134.26 62.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 2.2400000000000002 109.692 176.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -106.61 156.26 16.22 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.34 -0.933 . . . . 0.53000000000000003 113.005 -170.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 mp -97.56 117.75 42.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.9 0.381 . . . . 1.53 110.089 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.807 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 1.1 m-85 -126.19 133.56 51.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.631 -0.713 . . . . 1.7 109.509 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.845 HG12 ' HB2' ' A' ' 19' ' ' LEU . 12.3 p -66.21 119.77 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.855 -0.794 . . . . 1.6799999999999999 108.855 173.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.92 83.54 1.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.579 0.704 . . . . 1.02 109.477 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.99 93.83 2.3 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 114.799 -1.091 . . . . 1.53 110.961 -171.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.535 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 16.5 pt20 -31.48 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.276 0.843 . . . . 2.5699999999999998 113.276 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.487 ' HG2' HD22 ' A' ' 65' ' ' LEU . 55.9 tp60 -82.59 -15.37 52.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 3.1699999999999999 110.692 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 m 62.6 26.31 15.61 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.361 0.6 . . . . 2.8599999999999999 111.134 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.638 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 7.2 t30 64.08 89.41 0.09 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.589 -0.732 . . . . 1.5600000000000001 112.204 172.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.3 m -89.6 133.87 33.55 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.819 -0.808 . . . . 2.0800000000000001 108.819 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -19.46 90.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.794 4.329 . . . . 1.48 115.1 -171.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.613 ' CB ' ' HE1' ' A' ' 112' ' ' TYR . 90.0 Cg_endo -99.99 -161.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.968 3.112 . . . . 0.84999999999999998 113.889 -174.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.55 -101.98 0.15 Allowed Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.926 -1.034 . . . . 0.76000000000000001 110.633 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -112.38 111.41 22.25 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.339 -0.615 . . . . 2.04 109.339 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.613 ' HE1' ' CB ' ' A' ' 109' ' ' PRO . 27.6 m-85 -95.35 128.09 41.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.233 0.54 . . . . 1.1100000000000001 110.303 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.7 m -116.06 98.46 6.64 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.071 -0.968 . . . . 1.3400000000000001 110.395 -175.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.461 ' HG ' ' HB ' ' A' ' 138' ' ' THR . 0.2 OUTLIER -119.34 100.55 7.38 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.042 -0.527 . . . . 1.1699999999999999 110.367 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 23.8 m -88.37 132.52 34.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.148 -0.478 . . . . 1.4099999999999999 110.527 -178.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -114.63 124.84 52.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.083 0.468 . . . . 1.8 110.556 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.434 ' HA ' HG23 ' A' ' 135' ' ' THR . 27.5 m -91.06 113.04 25.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.752 -0.658 . . . . 1.3200000000000001 110.478 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.1 122.65 6.25 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.737 -0.744 . . . . 0.97999999999999998 111.754 177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.57 -176.33 39.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.241 -0.98 . . . . 0.64000000000000001 112.426 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -102.96 177.84 4.73 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.278 0.561 . . . . 1.2 110.294 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.803 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.9 OUTLIER -147.29 149.32 32.62 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.323 -0.992 . . . . 0.65000000000000002 108.323 -177.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.61 144.14 51.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.421 0.153 . . . . 1.55 110.79 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HG3' ' HE2' ' A' ' 126' ' ' LYS . 32.9 mmtp 74.97 -144.34 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.62 0.768 . . . . 3.8700000000000001 111.368 175.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 126' ' ' LYS . 11.6 p-10 -150.68 123.21 8.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.322 0.582 . . . . 2.0800000000000001 112.275 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.565 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 27.6 t-20 68.44 -28.58 0.15 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.445 1.098 . . . . 3.0899999999999999 113.947 174.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HE2' ' HG3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -65.34 -3.19 3.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.219 0.533 . . . . 2.3799999999999999 111.164 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.803 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 46.1 tt0 66.79 66.45 0.44 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.12 -0.946 . . . . 2.1099999999999999 110.862 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 121' ' ' TRP . . . -90.89 46.96 2.93 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.329 -0.938 . . . . 0.77000000000000002 111.37 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.668 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 3.9 p90 -86.69 144.66 27.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.773 0.321 . . . . 1.49 110.856 -170.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 46.3 m -150.3 132.26 7.83 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 110.37 -0.233 . . . . 1.8999999999999999 110.37 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.71 132.74 47.14 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.708 2.272 . . . . 1.1699999999999999 112.345 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -156.28 95.17 1.57 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.234 -0.439 . . . . 1.96 110.4 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 5' ' ' VAL . . . 130.25 -102.71 0.54 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.776 -0.726 . . . . 1.1699999999999999 112.162 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.4 m -152.3 147.45 26.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.711 0.256 . . . . 2.9300000000000002 110.741 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 117' ' ' THR . 28.9 m -101.2 127.49 47.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.649 -0.5 . . . . 2.1800000000000002 109.649 174.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.96 141.11 12.41 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.467 -0.873 . . . . 0.72999999999999998 112.524 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 72.8 m -94.3 123.15 37.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.025 0.44 . . . . 1.23 110.913 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.461 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 24.9 m -85.88 115.26 23.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.514 -0.921 . . . . 1.1799999999999999 108.514 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -100.88 111.91 24.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.21 0.528 . . . . 2.6299999999999999 110.208 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 tp -108.64 100.45 9.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.048 -0.978 . . . . 1.3100000000000001 110.385 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 m -93.15 143.67 26.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.852 -0.613 . . . . 1.1799999999999999 109.809 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.587 ' HA ' HH12 ' A' ' 16' ' ' ARG . 7.3 p -71.02 132.79 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.467 0.651 . . . . 2.3900000000000001 112.349 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 85.5 m . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.133 -0.94 . . . . 2.5899999999999999 109.129 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.849 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 48.2 t . . . . . 0 N--CA 1.44 -0.938 0 N-CA-C 108.3 -1.0 . . . . 1.8300000000000001 108.3 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -85.68 123.71 31.38 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.285 -0.566 . . . . 2.29 110.393 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.51 HG23 HH22 ' A' ' 38' ' ' ARG . 61.3 t -95.56 112.06 27.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.718 -0.673 . . . . 2.1000000000000001 110.045 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.704 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 14.5 mmm180 -81.64 93.74 6.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.706 -0.679 . . . . 4.25 110.834 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.554 HG11 ' HA3' ' A' ' 136' ' ' GLY . 37.2 t -107.62 115.62 49.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.394 -0.965 . . . . 1.8200000000000001 108.394 171.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.76 -175.77 21.65 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.498 -0.858 . . . . 1.1899999999999999 112.261 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -100.59 146.15 27.49 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.926 -0.398 . . . . 2.1800000000000002 109.926 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -152.6 139.26 18.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.552 -0.536 . . . . 2.0 109.552 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.9 m -107.77 115.89 30.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.183 -0.462 . . . . 1.5600000000000001 110.305 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 140' ' ' LEU . 4.1 p -110.61 126.01 67.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.14 -0.482 . . . . 2.04 109.9 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -105.31 104.21 13.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.898 -0.592 . . . . 1.23 110.452 -176.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -172.9 -178.68 1.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 3.9100000000000001 110.478 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.5 p -107.43 162.77 13.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.127 -0.488 . . . . 1.21 111.065 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.956 ' NH2' ' HH ' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -80.27 -0.44 36.48 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.644 -0.502 . . . . 4.0800000000000001 109.644 176.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.596 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -79.39 -17.58 75.76 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.367 -0.693 . . . . 0.75 111.367 177.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -74.17 -22.62 59.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.847 -0.797 . . . . 2.6299999999999999 108.847 173.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.898 HD23 HG12 ' A' ' 25' ' ' ILE . 67.2 mt -87.16 95.9 10.12 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.699 -1.137 . . . . 1.6100000000000001 110.985 -175.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.0 m -101.3 68.05 1.2 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.045 -0.724 . . . . 2.2599999999999998 109.045 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.4 t70 69.56 -62.68 0.41 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.753 -1.112 . . . . 1.8300000000000001 111.036 -175.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.411 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -114.31 98.09 6.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.797 0.332 . . . . 1.4299999999999999 110.887 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 19' ' ' LEU . . . -154.54 92.08 2.98 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.439 . . . . 1.3700000000000001 111.071 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.493 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 28.7 Cg_endo -64.19 80.82 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.349 2.699 . . . . 1.1200000000000001 112.372 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.898 HG12 HD23 ' A' ' 19' ' ' LEU . 1.1 pp -70.7 -53.71 21.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.405 -0.816 . . . . 3.0499999999999998 112.336 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.24 63.88 0.57 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.203 -0.998 . . . . 1.04 113.249 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.654 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 5.5 Cg_endo -47.07 111.59 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.601 2.867 . . . . 1.0 113.004 172.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 p -84.63 134.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.896 -0.593 . . . . 1.8300000000000001 109.813 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -88.64 102.87 15.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.672 0.748 . . . . 2.2000000000000002 110.804 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.641 ' CG2' HD11 ' A' ' 96' ' ' ILE . 41.5 t -94.79 116.26 35.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.556 -0.747 . . . . 1.5600000000000001 110.204 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.704 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 34.7 tt0 -102.01 125.14 48.62 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.641 -0.709 . . . . 2.48 110.182 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . . . -112.89 113.98 26.29 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.956 -0.387 . . . . 1.25 109.956 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.1 mt -104.99 111.52 24.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.969 0.414 . . . . 2.4700000000000002 111.986 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.95 55.32 8.18 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.508 -0.769 . . . . 1.8100000000000001 113.283 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.849 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 84.1 m -87.14 -49.31 7.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.857 0.329 . . . . 1.8799999999999999 110.585 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.8 t30 71.14 -63.78 0.41 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.708 0.803 . . . . 2.71 112.69 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.91 71.0 1.25 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.676 0.75 . . . . 1.3600000000000001 109.19 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.617 ' NE ' ' HB3' ' A' ' 120' ' ' TYR . 41.0 ttt-85 -146.54 133.19 19.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.178 -0.919 . . . . 5.3499999999999996 111.012 -169.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -83.17 96.86 8.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.615 -0.513 . . . . 1.9099999999999999 109.615 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 46.7 t -73.6 117.22 17.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 1.1699999999999999 110.315 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -119.48 148.31 43.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.129 -0.487 . . . . 1.0900000000000001 110.977 -176.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 mt -102.77 113.79 27.5 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.115 -0.698 . . . . 1.4399999999999999 109.115 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.552 ' CE ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -104.75 125.8 51.19 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.632 -0.507 . . . . 2.5299999999999998 109.632 -178.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB3' ' ND2' ' A' ' 48' ' ' ASN . . . -76.81 143.26 39.9 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.517 -0.549 . . . . 1.0700000000000001 109.517 174.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.597 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 27.2 t70 -76.02 148.34 38.11 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.918 -0.771 . . . . 0.70999999999999996 108.918 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.687 ' HA ' ' HB3' ' A' ' 49' ' ' PHE . 10.1 t -56.56 -16.51 6.18 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.866 0.691 . . . . 1.71 112.866 -172.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.28 -31.45 72.04 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.239 0.543 . . . . 2.2200000000000002 110.289 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.603 ' ND2' ' HB3' ' A' ' 44' ' ' ALA . 5.1 p-10 -129.43 24.31 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.773 -0.648 . . . . 1.5800000000000001 109.479 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.687 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 10.1 t80 -134.03 108.5 8.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.257 -0.883 . . . . 0.72999999999999998 109.16 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.782 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 10.9 pt-20 -116.65 116.61 27.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.649 0.261 . . . . 2.4100000000000001 110.448 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 71.34 -51.45 0.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.793 0.837 . . . . 4.1399999999999997 111.805 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . 170.02 31.17 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.719 -0.952 . . . . 0.72999999999999998 110.719 -177.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.678 ' HA ' ' HB3' ' A' ' 81' ' ' ASN . 14.5 mptt -129.88 140.23 51.02 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.178 -0.675 . . . . 2.6800000000000002 109.178 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.41 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -120.69 147.68 44.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.585 0.707 . . . . 0.65000000000000002 111.636 176.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.782 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 16.9 p90 -157.46 174.93 14.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.886 -1.052 . . . . 0.73999999999999999 110.752 -170.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.544 HD13 HD23 ' A' ' 140' ' ' LEU . 8.6 mt -84.16 111.84 19.71 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.146 -1.057 . . . . 2.0800000000000001 108.146 170.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.583 ' HB ' ' HE1' ' A' ' 55' ' ' PHE . 8.4 tp -105.3 125.83 60.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.805 0.812 . . . . 1.21 110.021 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.571 ' HB2' ' CE1' ' A' ' 112' ' ' TYR . 33.5 t -76.84 135.74 38.89 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.073 -0.967 . . . . 1.9299999999999999 110.714 -177.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.52 -34.17 72.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.868 -0.79 . . . . 2.3100000000000001 108.868 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -69.28 -24.67 63.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.566 -1.197 . . . . 3.6600000000000001 110.611 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 t30 63.83 97.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.701 -0.681 . . . . 3.0600000000000001 111.27 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -166.27 -44.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.716 -0.674 . . . . 5.1799999999999997 110.584 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.39 139.78 53.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.902 -0.59 . . . . 2.5099999999999998 109.955 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.777 ' HE3' ' HH ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -135.35 106.51 6.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.989 0.899 . . . . 2.6200000000000001 109.429 170.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.759 HD23 HG23 ' A' ' 100' ' ' VAL . 7.9 tp -108.19 126.32 52.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.24 -0.891 . . . . 2.48 110.927 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.777 ' HH ' ' HE3' ' A' ' 64' ' ' LYS . 5.2 m-85 -72.95 141.4 47.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.956 -1.02 . . . . 1.1299999999999999 110.306 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.558 HG13 ' HA ' ' A' ' 100' ' ' VAL . 16.4 m -136.65 142.61 37.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.549 -0.296 . . . . 1.29 110.468 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -102.89 120.54 40.8 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.788 -0.449 . . . . 2.1000000000000001 109.788 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.455 HG22 ' HB ' ' A' ' 96' ' ' ILE . 0.9 OUTLIER -82.61 87.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.816 -0.629 . . . . 1.55 109.876 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.489 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 60.0 ttt180 -93.99 128.63 40.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.414 -0.357 . . . . 4.3300000000000001 110.812 -174.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.623 ' HA ' HG23 ' A' ' 96' ' ' ILE . 4.2 Cg_endo -50.36 139.77 36.01 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.319 2.679 . . . . 0.90000000000000002 112.216 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.6 ttt -72.66 64.11 0.63 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.661 -0.7 . . . . 2.23 111.304 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 t70 62.89 14.96 7.89 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.715 0.806 . . . . 1.9199999999999999 112.302 175.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -78.13 -35.0 49.61 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.829 -0.544 . . . . 1.8899999999999999 111.559 -175.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.2 p -170.78 172.74 5.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.378 -0.23 . . . . 2.0699999999999998 110.378 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.72 129.06 35.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.981 0.42 . . . . 1.5800000000000001 110.101 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.695 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 13.8 m0 -117.28 155.84 28.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.07 -0.513 . . . . 0.54000000000000004 110.535 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.8 m -89.6 113.22 24.62 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.265 -0.643 . . . . 1.22 109.265 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 t -88.58 124.25 33.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.796 0.807 . . . . 1.29 111.91 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -130.56 160.98 32.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.44 -1.318 . . . . 1.7 107.44 168.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.678 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 16.1 m120 -85.94 -3.55 58.95 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.368 -0.533 . . . . 1.3899999999999999 111.262 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.92 -36.92 2.65 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.303 -0.951 . . . . 0.85999999999999999 111.664 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.517 HG12 ' HG3' ' A' ' 43' ' ' LYS . 29.3 m -137.01 156.67 34.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.997 0.427 . . . . 1.73 110.306 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.612 ' HD1' ' HE3' ' A' ' 77' ' ' TRP . 0.7 OUTLIER -136.64 106.74 6.33 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.95 -1.13 . . . . 0.41999999999999998 107.95 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 8.7 p90 -138.19 146.5 42.76 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.913 -0.315 . . . . 1.1499999999999999 111.377 -174.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.721 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 49.3 pttt -78.22 157.57 29.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 2.0299999999999998 110.826 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -85.21 7.47 21.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.795 . . . . 2.6600000000000001 110.041 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.721 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 35.8 m-20 -106.48 128.04 53.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.538 -0.755 . . . . 2.1000000000000001 109.331 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -90.04 106.36 17.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.555 0.693 . . . . 1.6599999999999999 111.002 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.28 -162.71 36.5 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.051 -0.819 . . . . 0.63 111.051 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.4 m -84.14 147.25 27.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.976 0.417 . . . . 1.5800000000000001 109.941 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.487 ' CD2' ' HZ2' ' A' ' 77' ' ' TRP . 55.3 t90 -120.07 -59.05 1.83 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.65 -0.5 . . . . 0.75 109.65 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 34.53 90.42 0.01 OUTLIER Glycine 0 N--CA 1.464 0.548 0 O-C-N 124.637 1.21 . . . . 1.25 115.477 176.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.16 -125.09 0.75 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.004 -0.617 . . . . 1.0 111.955 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.456 ' O ' ' HH2' ' A' ' 92' ' ' TRP . 1.2 p -137.18 132.42 33.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 1.3200000000000001 111.571 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.641 HD11 ' CG2' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -118.46 134.8 60.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.169 -0.678 . . . . 2.2400000000000002 109.169 174.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -99.58 158.52 19.81 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.331 -0.937 . . . . 0.53000000000000003 112.555 -175.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.502 HG21 ' HB ' ' A' ' 67' ' ' VAL . 2.8 mp -95.03 112.81 28.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.649 -0.5 . . . . 1.53 109.649 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.493 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 1.6 m-85 -110.95 120.91 43.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.817 -0.808 . . . . 1.7 108.817 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.759 HG23 HD23 ' A' ' 65' ' ' LEU . 14.5 p -58.68 137.34 21.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.816 0.341 . . . . 1.6799999999999999 110.993 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.65 81.94 8.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.715 -0.846 . . . . 1.02 108.715 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.65 110.34 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.525 -0.762 . . . . 1.53 111.815 -172.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -40.09 125.11 1.95 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.493 0.663 . . . . 2.5699999999999998 112.582 177.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.559 ' HB2' HD12 ' A' ' 65' ' ' LEU . 7.7 tp-100 -92.69 21.27 5.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.559 . . . . 3.1699999999999999 110.461 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 6.1 m 69.25 -11.58 0.47 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.696 -0.684 . . . . 2.8599999999999999 112.714 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.596 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 1.9 t-20 68.18 88.21 0.11 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.73 0.776 . . . . 1.5600000000000001 110.629 -175.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.63 146.8 34.93 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 114.689 -1.141 . . . . 2.0800000000000001 109.007 173.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -38.26 93.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.999 3.132 . . . . 1.48 112.509 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.588 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 3.0 Cg_exo -76.84 -179.56 5.51 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.198 2.598 . . . . 0.84999999999999998 113.333 -169.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.06 -124.42 0.89 Allowed Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.151 -1.18 . . . . 0.76000000000000001 110.151 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 58' ' ' SER . 51.6 t-20 -97.5 107.4 19.9 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.129 -0.693 . . . . 2.04 109.129 172.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.956 ' HH ' ' NH2' ' A' ' 16' ' ' ARG . 68.4 m-85 -102.16 107.34 18.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.468 0.651 . . . . 1.1100000000000001 109.524 174.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -97.85 126.79 43.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.017 -0.992 . . . . 1.3400000000000001 110.534 -175.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 138' ' ' THR . 0.1 OUTLIER -135.01 107.14 7.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.548 0.689 . . . . 1.1699999999999999 109.927 176.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 11.9 m -94.02 139.76 30.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.456 -0.793 . . . . 1.4099999999999999 110.299 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 44' ' ' ALA . 95.4 mt -124.96 126.14 45.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.909 0.385 . . . . 1.8 110.569 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 m -101.18 117.0 34.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.216 -0.447 . . . . 1.3200000000000001 110.219 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.27 147.71 47.79 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.748 -0.739 . . . . 0.97999999999999998 112.576 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.04 179.73 39.71 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.783 -0.722 . . . . 0.64000000000000001 112.214 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.617 ' HB3' ' NE ' ' A' ' 38' ' ' ARG . 48.6 p90 -102.63 174.16 6.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.051 0.453 . . . . 1.2 110.325 177.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.725 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.8 OUTLIER -132.69 146.53 51.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.413 -0.812 . . . . 0.65000000000000002 109.101 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -118.85 141.28 48.78 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.069 0.461 . . . . 1.55 111.208 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 7.0 tptm 71.97 -145.07 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.676 -1.147 . . . . 3.8700000000000001 111.265 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 126' ' ' LYS . 4.9 t70 -146.98 124.42 11.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.615 -0.266 . . . . 2.0800000000000001 111.496 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.598 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.5 OUTLIER 53.64 -5.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.132 1.773 . . . . 3.0899999999999999 115.542 176.312 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.596 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -79.03 -3.38 44.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 2.3799999999999999 110.216 177.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.725 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 33.6 tt0 69.08 71.61 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.792 -1.095 . . . . 2.1099999999999999 110.644 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.596 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -106.97 43.01 1.78 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.698 -0.763 . . . . 0.77000000000000002 112.134 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.43 ' HB2' ' HZ3' ' A' ' 43' ' ' LYS . 21.5 p90 -78.19 130.08 35.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.15 0.5 . . . . 1.49 110.857 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.6 m -121.56 118.91 29.49 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.215 -0.448 . . . . 1.8999999999999999 110.559 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.93 123.37 11.83 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.964 2.443 . . . . 1.1699999999999999 112.27 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.01 94.15 1.5 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.967 -0.56 . . . . 1.96 110.193 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 145.58 -145.95 15.64 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.284 -0.726 . . . . 1.1699999999999999 111.284 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.531 HG22 ' NH1' ' A' ' 6' ' ' ARG . 38.3 p -110.12 158.08 18.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.989 0.423 . . . . 2.9300000000000002 111.398 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.0 m -99.93 100.32 11.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.824 -0.626 . . . . 2.1800000000000002 109.786 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.554 ' HA3' HG11 ' A' ' 7' ' ' VAL . . . -93.79 160.76 24.44 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.847 -0.692 . . . . 0.72999999999999998 111.775 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.1 m -126.82 109.51 12.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.026 0.413 . . . . 1.23 111.311 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.591 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 3.7 m -82.23 116.43 21.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.634 -0.876 . . . . 1.1799999999999999 108.634 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -112.1 108.83 18.24 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.27 0.557 . . . . 2.6299999999999999 110.544 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.544 HD23 HD13 ' A' ' 56' ' ' LEU . 15.2 tp -96.56 109.16 21.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.031 -0.986 . . . . 1.3100000000000001 109.072 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.0 m -121.52 144.47 48.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.529 -0.759 . . . . 1.1799999999999999 110.947 -173.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 109' ' ' PRO . 13.0 p -83.16 141.73 14.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.433 -0.581 . . . . 2.3900000000000001 109.433 172.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.243 0.749 0 CA-C-O 118.426 -0.797 . . . . 2.5899999999999999 109.723 178.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 120' ' ' TYR . 43.5 t . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.656 -0.498 . . . . 1.8300000000000001 109.656 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -103.61 111.84 24.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.192 -0.458 . . . . 2.29 110.766 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.679 HG23 HG13 ' A' ' 40' ' ' VAL . 38.5 t -107.49 125.32 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.118 -0.492 . . . . 2.1000000000000001 110.701 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.586 ' HG2' ' HB3' ' A' ' 31' ' ' GLN . 11.1 ptp180 -92.18 142.54 27.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.036 0.446 . . . . 4.25 110.684 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.7 t -120.53 115.43 47.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.781 -0.822 . . . . 1.8200000000000001 108.781 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.38 126.6 11.5 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.554 -0.831 . . . . 1.1899999999999999 112.38 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -68.34 104.04 1.77 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.574 -0.528 . . . . 2.1800000000000002 109.574 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.427 ' HB2' HG22 ' A' ' 138' ' ' THR . 72.8 mt -105.37 152.43 22.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.95 -0.568 . . . . 2.0 110.739 -176.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 m -133.09 114.42 13.89 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.035 -0.728 . . . . 1.5600000000000001 109.035 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.414 HG11 HG22 ' A' ' 25' ' ' ILE . 41.3 t -118.16 140.32 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.386 -0.37 . . . . 2.04 110.313 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.99 103.21 11.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.284 -0.416 . . . . 1.23 110.028 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -165.02 176.04 8.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.433 -0.58 . . . . 3.9100000000000001 109.433 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.485 HG23 HG22 ' A' ' 142' ' ' VAL . 31.9 p -96.43 163.34 13.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.613 -0.267 . . . . 1.21 110.911 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.43 ' HD2' ' H ' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -86.98 -3.42 59.09 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.91 -0.774 . . . . 4.0800000000000001 108.91 176.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -79.77 -28.22 51.59 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.79 -0.924 . . . . 0.75 110.79 173.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.89 -39.08 87.92 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.624 -0.88 . . . . 2.6299999999999999 108.624 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.464 ' HB3' ' CG1' ' A' ' 100' ' ' VAL . 62.8 mt -63.95 113.33 3.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.912 -1.04 . . . . 1.6100000000000001 109.746 171.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 m -130.4 85.28 2.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.562 0.22 . . . . 2.2599999999999998 110.536 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 7.9 m-20 63.48 -74.66 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.664 -0.698 . . . . 1.8300000000000001 111.854 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.13 81.71 1.87 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.191 0.52 . . . . 1.4299999999999999 110.671 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.18 100.27 4.2 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.544 -0.753 . . . . 1.3700000000000001 109.89 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 59.5 Cg_endo -72.1 105.51 1.85 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.816 2.344 . . . . 1.1200000000000001 112.847 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.414 HG22 HG11 ' A' ' 12' ' ' VAL . 49.4 mm -96.3 -26.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.181 -0.463 . . . . 3.0499999999999998 110.734 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.75 54.65 0.62 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.897 -1.144 . . . . 1.04 113.689 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 12.1 Cg_endo -57.03 114.1 1.77 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.281 1.987 . . . . 1.0 112.064 170.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.421 ' HA ' HD11 ' A' ' 10' ' ' LEU . 45.9 t -87.75 135.82 24.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.881 -0.6 . . . . 1.8300000000000001 110.433 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.95 102.24 4.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.603 0.716 . . . . 2.2000000000000002 110.133 174.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.864 HG21 HG12 ' A' ' 96' ' ' ILE . 6.7 t -94.08 141.96 14.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.862 -1.063 . . . . 1.5600000000000001 111.879 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.586 ' HB3' ' HG2' ' A' ' 6' ' ' ARG . 31.4 tt0 -146.87 117.41 7.5 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.651 -1.159 . . . . 2.48 109.079 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -110.46 105.73 14.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.287 -0.415 . . . . 1.25 110.144 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.4 tp -77.61 112.76 14.76 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.508 -0.553 . . . . 2.4700000000000002 109.508 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.64 -121.97 6.2 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.704 -0.76 . . . . 1.8100000000000001 111.773 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 32' ' ' ALA . 66.7 m 65.13 11.6 7.3 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 122.598 0.359 . . . . 1.8799999999999999 111.707 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.637 ' HA ' ' HA2' ' A' ' 90' ' ' GLY . 19.3 m120 -63.36 -11.44 22.51 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.631 0.604 . . . . 2.71 112.631 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.8 ' HA ' ' CG1' ' A' ' 89' ' ' VAL . . . -144.62 60.95 1.33 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.5 -0.556 . . . . 1.3600000000000001 109.5 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 38' ' ' ARG . 0.8 OUTLIER -170.07 159.96 7.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.361 -0.836 . . . . 5.3499999999999996 109.68 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.447 ' HA ' ' HZ1' ' A' ' 86' ' ' LYS . 1.6 mp0 -94.22 143.38 26.43 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.116 -0.698 . . . . 1.9099999999999999 109.116 173.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.679 HG13 HG23 ' A' ' 5' ' ' VAL . 71.8 t -97.99 122.05 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.424 -0.584 . . . . 1.1699999999999999 109.424 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -122.48 141.33 51.75 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 123.368 0.418 . . . . 1.0900000000000001 111.099 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.428 ' CD1' HG23 ' A' ' 96' ' ' ILE . 31.3 mt -102.72 126.21 49.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.194 -0.669 . . . . 1.4399999999999999 109.194 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.767 ' HE2' ' HB2' ' A' ' 129' ' ' PHE . 6.3 mptt -119.2 152.12 37.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.571 -0.529 . . . . 2.5299999999999998 109.571 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.415 ' CB ' ' HB3' ' A' ' 54' ' ' PHE . . . -96.22 153.62 17.7 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.803 -0.443 . . . . 1.0700000000000001 109.803 173.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.686 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 31.2 t70 -82.44 164.79 20.74 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.719 -0.845 . . . . 0.70999999999999996 108.719 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -56.17 -18.48 10.24 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.336 0.588 . . . . 1.71 110.677 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.77 -38.8 72.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.271 -0.877 . . . . 2.2200000000000002 111.526 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 27.0 p-10 -139.57 22.31 2.52 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.723 0.268 . . . . 1.5800000000000001 111.723 -176.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.527 ' HE1' ' HA2' ' A' ' 82' ' ' GLY . 60.0 t80 -123.48 102.39 7.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.435 -0.58 . . . . 0.72999999999999998 109.435 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -103.3 105.8 16.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 2.4100000000000001 110.385 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 67.19 -56.43 0.44 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.107 0.879 . . . . 4.1399999999999997 112.04 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.472 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -175.58 35.08 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.006 -0.838 . . . . 0.72999999999999998 111.006 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 81' ' ' ASN . 34.7 mmtp -135.07 135.57 41.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.001 -0.74 . . . . 2.6800000000000002 109.001 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -110.72 142.33 42.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.611 0.719 . . . . 0.65000000000000002 111.965 175.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.62 ' CD2' ' HB2' ' A' ' 64' ' ' LYS . 44.1 p90 -151.32 -177.0 5.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.974 -1.012 . . . . 0.73999999999999999 110.014 -176.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.888 HD23 HD22 ' A' ' 114' ' ' LEU . 13.8 mt -99.53 123.81 44.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.579 -0.897 . . . . 2.0800000000000001 108.579 172.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 113' ' ' THR . 9.0 tp -106.81 124.6 62.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.472 0.653 . . . . 1.21 111.035 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.5 t -68.88 125.08 25.49 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.275 -1.009 . . . . 1.9299999999999999 108.275 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -57.8 -26.2 61.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.119 0.415 . . . . 2.3100000000000001 112.119 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -84.26 -1.64 55.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.61 -0.268 . . . . 3.6600000000000001 111.368 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 57.99 89.21 0.05 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.167 0.587 . . . . 3.0600000000000001 111.244 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -155.79 -38.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 5.1799999999999997 111.055 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.408 ' OD1' ' HB ' ' A' ' 107' ' ' THR . 24.2 t70 -139.74 144.71 37.6 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.415 -0.357 . . . . 2.5099999999999998 110.35 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.62 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 2.4 pptp? -146.7 145.77 30.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.971 -0.559 . . . . 2.6200000000000001 110.134 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.503 HD11 HG22 ' A' ' 100' ' ' VAL . 1.3 pt? -138.03 132.13 31.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.139 -0.482 . . . . 2.48 110.415 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -75.64 128.61 35.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 1.1299999999999999 110.129 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.526 ' HB ' HG22 ' A' ' 98' ' ' ILE . 15.9 m -118.33 136.89 54.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.862 -0.608 . . . . 1.29 110.544 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.476 ' N ' HD21 ' A' ' 68' ' ' ASN . 0.8 OUTLIER -96.5 110.65 22.99 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.707 -0.679 . . . . 2.1000000000000001 109.356 178.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.411 HG22 HG12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -79.99 102.09 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.928 -0.767 . . . . 1.55 108.928 174.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.55 ' HG2' ' CZ ' ' A' ' 84' ' ' PHE . 89.3 mtt180 -122.99 140.47 33.5 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.244 -0.434 . . . . 4.3300000000000001 110.181 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.785 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 1.7 Cg_endo -48.3 132.93 24.58 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.942 2.428 . . . . 0.90000000000000002 111.927 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.4 ttt -63.22 -49.96 72.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.408 -0.36 . . . . 2.23 110.275 -177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -177.79 105.95 0.05 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.121 -0.49 . . . . 1.9199999999999999 110.566 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -161.81 -62.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 1.8899999999999999 111.198 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.8 t -154.69 163.68 39.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.915 -0.402 . . . . 2.0699999999999998 109.915 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.9 127.58 32.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.069 0.461 . . . . 1.5800000000000001 111.252 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.637 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.1 m0 -112.28 150.75 30.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.651 -0.704 . . . . 0.54000000000000004 110.27 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.6 m -83.21 125.1 31.2 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.142 -0.688 . . . . 1.22 109.142 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -100.47 122.36 43.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.798 0.808 . . . . 1.29 112.54 -171.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -135.42 159.71 40.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.725 -1.213 . . . . 1.7 107.725 167.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.461 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 11.4 m120 -82.93 -4.38 58.12 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.276 -0.57 . . . . 1.3899999999999999 110.833 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.527 ' HA2' ' HE1' ' A' ' 49' ' ' PHE . . . -100.48 -41.33 2.77 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.203 -0.998 . . . . 0.85999999999999999 111.885 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.68 155.4 30.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.963 -0.384 . . . . 1.73 109.963 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -137.99 109.85 7.17 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.291 -1.003 . . . . 0.41999999999999998 108.291 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.652 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 13.5 p90 -140.09 143.89 36.52 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.15 0.281 . . . . 1.1499999999999999 111.498 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -77.91 137.5 38.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 120.328 -0.549 . . . . 2.0299999999999998 109.542 177.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -63.68 -24.47 67.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.734 -0.667 . . . . 2.6600000000000001 110.204 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 4.6 m-20 -73.92 147.14 43.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.519 -0.764 . . . . 2.1000000000000001 110.671 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.8 ' CG1' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -94.84 143.0 12.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.666 -0.864 . . . . 1.6599999999999999 108.666 168.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 36' ' ' ASN . . . 131.77 -175.59 19.64 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.411 -0.9 . . . . 0.63 111.636 -177.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m -72.39 -178.73 2.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.976 -0.379 . . . . 1.5800000000000001 109.976 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.785 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 21.1 t90 -157.38 -42.54 0.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.733 -0.212 . . . . 0.75 110.575 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.707 ' O ' ' HB ' ' A' ' 30' ' ' VAL . . . 50.84 -120.35 8.92 Favored Glycine 0 C--O 1.21 -1.366 0 N-CA-C 111.292 -0.723 . . . . 1.25 111.292 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.45 -151.68 43.68 Favored Glycine 0 C--N 1.318 -0.434 0 C-N-CA 121.142 -0.552 . . . . 1.0 114.225 163.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.527 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -147.84 133.51 18.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.085 -0.557 . . . . 1.3200000000000001 110.427 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.864 HG12 HG21 ' A' ' 30' ' ' VAL . 6.8 mm -107.52 129.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.357 -0.609 . . . . 2.2400000000000002 109.357 177.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -100.82 149.2 18.45 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.712 -0.756 . . . . 0.53000000000000003 111.704 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.526 HG22 ' HB ' ' A' ' 67' ' ' VAL . 71.3 mt -99.58 114.45 37.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 120.897 0.38 . . . . 1.53 110.567 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.549 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 8.6 m-85 -115.22 131.97 56.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 1.7 108.818 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.508 ' CG1' ' HA ' ' A' ' 103' ' ' GLN . 13.8 p -71.34 134.48 29.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.799 0.333 . . . . 1.6799999999999999 110.558 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -74.89 91.47 2.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.059 0.457 . . . . 1.02 110.902 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.13 13.34 62.15 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.132 -0.556 . . . . 1.53 113.918 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.508 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 64.9 tt0 62.22 113.71 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.709 0.766 . . . . 2.5699999999999998 112.367 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -76.8 -27.29 55.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.479 -0.782 . . . . 3.1699999999999999 109.645 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.1 m 65.42 20.52 11.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.126 -0.943 . . . . 2.8599999999999999 110.195 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.53 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 7.6 t30 60.79 87.94 0.09 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.905 -1.043 . . . . 1.5600000000000001 112.358 173.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.656 HG23 ' HD2' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -92.09 143.55 27.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.295 -1.002 . . . . 2.0800000000000001 108.295 174.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.656 ' HD2' HG23 ' A' ' 107' ' ' THR . 94.2 Cg_exo -20.3 88.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.348 1 C-N-CA 125.617 4.212 . . . . 1.48 114.818 -175.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.454 ' HG2' HG21 ' A' ' 142' ' ' VAL . 9.9 Cg_endo -92.2 -154.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.687 2.925 . . . . 0.84999999999999998 114.354 -171.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.42 -131.08 1.85 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.364 -1.895 . . . . 0.76000000000000001 108.364 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -97.22 123.43 41.0 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.101 -0.703 . . . . 2.04 109.101 170.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -105.84 128.45 53.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.002 0.43 . . . . 1.1100000000000001 109.916 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 57' ' ' ILE . 91.4 m -106.38 134.22 49.86 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.334 -0.848 . . . . 1.3400000000000001 109.405 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.888 HD22 HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -138.91 89.55 2.37 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.487 0.66 . . . . 1.1699999999999999 109.358 175.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 7.4 m -78.39 116.05 18.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.124 -0.944 . . . . 1.4099999999999999 110.607 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 97.8 mt -105.11 136.41 44.66 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.04 0.448 . . . . 1.8 110.939 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.5 m -110.17 115.02 28.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.147 -0.478 . . . . 1.3200000000000001 110.441 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.16 167.88 47.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.702 -0.761 . . . . 0.97999999999999998 112.103 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.42 ' HA2' ' HB2' ' A' ' 132' ' ' SER . . . 145.35 -175.15 25.07 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.557 -0.83 . . . . 0.64000000000000001 112.096 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.49 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 52.8 p90 -97.7 -176.52 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.358 0.599 . . . . 1.2 111.403 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.641 ' HZ2' ' H ' ' A' ' 125' ' ' ASN . 0.5 OUTLIER -150.33 149.72 30.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.989 -1.005 . . . . 0.65000000000000002 108.687 178.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.42 144.48 49.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.893 0.378 . . . . 1.55 111.578 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.634 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 22.9 mtpp 65.3 -143.71 0.22 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.067 0.947 . . . . 3.8700000000000001 111.807 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 126' ' ' LYS . 6.0 p-10 -149.46 124.39 9.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.075 0.464 . . . . 2.0800000000000001 112.239 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.641 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 7.7 t30 63.52 -18.0 0.06 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.698 1.199 . . . . 3.0899999999999999 113.676 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.634 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -71.36 -4.07 24.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.796 0.331 . . . . 2.3799999999999999 110.82 178.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.616 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 8.9 tt0 70.08 77.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.39 -0.823 . . . . 2.1099999999999999 110.923 -177.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.427 ' CA ' ' HE3' ' A' ' 126' ' ' LYS . . . -107.88 32.22 7.27 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.442 -0.885 . . . . 0.77000000000000002 111.431 173.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.767 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 3.9 p90 -74.08 144.1 45.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.014 0.435 . . . . 1.49 110.661 -175.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 28.9 m -143.61 134.62 12.48 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.303 -0.408 . . . . 1.8999999999999999 110.169 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.92 126.29 11.16 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.785 2.323 . . . . 1.1699999999999999 111.782 175.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.42 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 17.2 m -152.84 113.46 4.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.319 -0.4 . . . . 1.96 110.122 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 125.1 -105.21 0.82 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.088 -0.577 . . . . 1.1699999999999999 111.74 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.9 t -150.34 153.45 36.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.836 0.351 . . . . 2.9300000000000002 110.314 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.9 m -93.55 97.06 10.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.026 -0.534 . . . . 2.1800000000000002 109.775 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -83.99 132.29 10.98 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.954 -0.641 . . . . 0.72999999999999998 112.285 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 m -102.72 108.77 20.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.683 0.278 . . . . 1.23 110.316 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.669 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 24.0 m -86.25 117.53 25.12 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.754 -0.832 . . . . 1.1799999999999999 108.754 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -104.08 127.31 51.65 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.879 -0.6 . . . . 2.6299999999999999 109.984 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.639 HD23 HD13 ' A' ' 56' ' ' LEU . 18.6 tp -125.58 102.25 7.28 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.542 -0.754 . . . . 1.3100000000000001 110.829 -176.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.5 m -99.06 142.75 30.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.792 -0.64 . . . . 1.1799999999999999 109.966 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.485 HG22 HG23 ' A' ' 15' ' ' THR . 7.3 p -93.27 104.82 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.689 0.757 . . . . 2.3900000000000001 111.323 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.06 -0.971 . . . . 2.5899999999999999 109.352 176.219 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 110.262 -0.273 . . . . 5.7300000000000004 110.262 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -101.05 104.69 15.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.448 -0.575 . . . . 3.0800000000000001 109.448 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.607 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 56.6 m -84.11 103.93 13.74 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.617 -0.719 . . . . 1.8300000000000001 111.206 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 31.8 mm-40 -85.49 110.97 19.57 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.914 -0.773 . . . . 2.29 108.914 174.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.644 HG21 HG12 ' A' ' 30' ' ' VAL . 7.6 p -109.92 127.72 66.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.495 0.664 . . . . 2.1000000000000001 111.167 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -87.61 107.27 18.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.183 -0.917 . . . . 4.25 109.977 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.469 HG13 ' HA3' ' A' ' 136' ' ' GLY . 44.6 t -110.97 121.27 63.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.642 -0.503 . . . . 1.8200000000000001 109.642 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.17 134.25 12.32 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.713 -0.756 . . . . 1.1899999999999999 112.725 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.33 117.85 14.5 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.31 -0.626 . . . . 2.1800000000000002 109.31 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.6 mt -117.25 98.54 6.49 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.873 -0.331 . . . . 2.0 111.708 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.0 t -102.04 113.25 26.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.122 -0.696 . . . . 1.5600000000000001 109.122 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.631 ' HB ' ' NZ ' ' A' ' 14' ' ' LYS . 76.8 t -152.41 148.67 14.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.093 -0.706 . . . . 2.04 109.093 -174.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -89.96 121.35 31.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.412 0.523 . . . . 1.23 112.412 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.631 ' NZ ' ' HB ' ' A' ' 12' ' ' VAL . 2.7 mptt -143.38 175.99 9.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.119 0.485 . . . . 3.9100000000000001 110.335 172.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.492 ' HA ' ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -111.08 150.0 30.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.503 -0.771 . . . . 1.21 109.994 171.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.492 ' NH1' ' HA ' ' A' ' 15' ' ' THR . 0.1 OUTLIER -86.5 -4.47 59.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.328 -0.619 . . . . 4.0800000000000001 109.328 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.47 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -88.24 -27.97 24.04 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.505 -1.038 . . . . 0.75 110.505 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -66.16 -34.08 77.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.734 -0.839 . . . . 2.6299999999999999 108.734 171.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.492 ' HB3' HG11 ' A' ' 100' ' ' VAL . 94.4 mt -65.99 96.34 0.31 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.876 -1.056 . . . . 1.6100000000000001 108.867 169.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 t -102.95 66.22 0.91 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.022 0.915 . . . . 2.2599999999999998 109.728 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.651 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 28.4 t70 65.48 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.515 -1.22 . . . . 1.8300000000000001 110.695 -174.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.42 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -95.11 76.05 3.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.17 0.51 . . . . 1.4299999999999999 110.686 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -142.69 99.32 5.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.992 -0.549 . . . . 1.3700000000000001 110.276 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.473 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 71.4 Cg_endo -75.98 100.27 1.36 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.748 2.299 . . . . 1.1200000000000001 112.484 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.558 ' CG2' ' HG2' ' A' ' 14' ' ' LYS . 5.4 mt -114.96 12.48 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.98 0.895 . . . . 3.0499999999999998 110.125 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.07 60.36 0.65 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.18 -0.918 . . . . 1.04 111.829 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 34.3 Cg_endo -65.0 104.19 0.56 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.423 2.082 . . . . 1.0 112.779 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.51 123.65 41.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.65 -0.705 . . . . 1.8300000000000001 109.874 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -78.98 89.41 4.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.271 0.558 . . . . 2.2000000000000002 110.663 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.644 HG12 HG21 ' A' ' 5' ' ' VAL . 23.7 t -91.4 118.36 36.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.701 . . . . 1.5600000000000001 111.345 -176.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 8.4 tt0 -112.82 123.85 51.26 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.464 -0.789 . . . . 2.48 109.155 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.51 116.75 28.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.404 -0.362 . . . . 1.25 111.013 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 8.9 mp -80.33 120.05 23.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 2.4700000000000002 110.504 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.79 -124.99 7.09 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.797 -0.716 . . . . 1.8100000000000001 112.303 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.4 m 63.85 24.06 13.6 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.693 0.397 . . . . 1.8799999999999999 111.217 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -49.76 -42.36 46.25 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.434 0.459 . . . . 2.71 111.84 -171.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.1 25.03 10.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.258 -0.428 . . . . 1.3600000000000001 110.687 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.525 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 1.4 tpm_? -121.63 145.35 48.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.042 0.449 . . . . 5.3499999999999996 111.688 -172.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -82.71 149.58 27.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.103 -0.702 . . . . 1.9099999999999999 109.103 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 93.1 t -109.37 129.86 63.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.851 -0.796 . . . . 1.1699999999999999 108.851 177.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.983 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -135.96 140.5 44.03 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 123.302 0.376 . . . . 1.0900000000000001 110.735 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 mt -103.19 150.55 23.57 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.127 -0.488 . . . . 1.4399999999999999 109.761 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.882 ' HE3' ' HB2' ' A' ' 129' ' ' PHE . 1.5 mptp? -134.84 151.66 51.1 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.297 -1.001 . . . . 2.5299999999999998 108.297 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.437 ' HB2' ' OD1' ' A' ' 48' ' ' ASN . . . -88.32 156.93 18.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.489 -0.559 . . . . 1.0700000000000001 109.489 174.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.61 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 5.8 t70 -89.5 172.57 8.89 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.899 -0.778 . . . . 0.70999999999999996 108.899 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.8 p -49.84 -25.26 2.98 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.816 1.043 . . . . 1.71 113.816 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -65.57 -38.68 90.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.786 0.327 . . . . 2.2200000000000002 111.217 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 26.5 p-10 -131.3 18.95 4.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 1.5800000000000001 111.282 -174.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 52.3 t80 -122.55 101.5 7.52 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.417 -0.586 . . . . 0.72999999999999998 109.417 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.67 ' HG2' ' HE1' ' A' ' 55' ' ' PHE . 5.5 pt-20 -106.83 98.75 8.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.295 -0.411 . . . . 2.4100000000000001 110.5 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 73.13 -49.33 0.69 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.197 -0.911 . . . . 4.1399999999999997 111.337 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 177.7 38.52 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.696 -0.562 . . . . 0.72999999999999998 111.696 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HD3' ' HB3' ' A' ' 81' ' ' ASN . 32.1 mmtp -136.48 135.17 38.37 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.491 -0.929 . . . . 2.6800000000000002 108.491 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.634 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -115.55 149.47 38.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.442 0.639 . . . . 0.65000000000000002 111.67 175.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.67 ' HE1' ' HG2' ' A' ' 50' ' ' GLU . 16.7 p90 -157.83 -179.96 8.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.039 -0.982 . . . . 0.73999999999999999 110.341 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.498 HD23 HD21 ' A' ' 114' ' ' LEU . 30.7 mt -94.08 112.12 23.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.662 -0.866 . . . . 2.0800000000000001 108.662 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.605 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 9.8 tp -107.75 140.4 26.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.544 -0.539 . . . . 1.21 109.544 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 37.1 t -78.96 156.02 28.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.247 -0.433 . . . . 1.9299999999999999 110.52 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -54.79 -27.59 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 2.3100000000000001 111.425 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -109.7 13.49 23.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.476 -0.329 . . . . 3.6600000000000001 111.184 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 52.1 33.54 12.36 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.556 0.576 . . . . 3.0600000000000001 112.556 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -79.34 -27.35 42.04 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.963 0.357 . . . . 5.1799999999999997 111.963 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.589 ' HB3' ' HH ' ' A' ' 112' ' ' TYR . 11.4 t70 -149.77 140.55 22.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.592 -0.522 . . . . 2.5099999999999998 109.592 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.529 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -128.89 132.5 47.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.763 -0.458 . . . . 2.6200000000000001 109.763 177.116 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 1.057 ' HB2' ' HG3' ' A' ' 104' ' ' GLN . 1.3 pt? -140.18 125.17 18.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.853 0.358 . . . . 2.48 110.927 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -69.71 143.08 53.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.869 -0.605 . . . . 1.1299999999999999 111.682 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 100' ' ' VAL . 14.2 m -133.14 171.43 18.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.428 -0.805 . . . . 1.29 110.015 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.465 ' HB2' ' HE2' ' A' ' 84' ' ' PHE . 5.4 p30 -130.89 129.13 41.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.289 -0.414 . . . . 2.1000000000000001 110.038 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.53 85.41 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.809 -0.811 . . . . 1.55 108.809 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.572 ' O ' ' HE1' ' A' ' 99' ' ' TYR . 6.7 ttp180 -108.78 139.99 21.41 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.48 -0.782 . . . . 4.3300000000000001 110.024 -170.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' HA ' HG22 ' A' ' 96' ' ' ILE . 50.3 Cg_exo -52.55 135.75 55.93 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.356 2.037 . . . . 0.90000000000000002 112.155 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.403 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 15.5 tmm? -59.16 -58.9 6.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 2.23 109.761 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -172.97 103.45 0.13 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.541 -0.754 . . . . 1.9199999999999999 109.457 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -177.65 -32.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 1.8899999999999999 111.811 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 p -164.4 179.02 7.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.797 0.332 . . . . 2.0699999999999998 111.128 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.28 130.54 56.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.818 -0.628 . . . . 1.5800000000000001 110.222 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.569 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 12.6 m0 -118.44 150.83 38.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.114 -0.494 . . . . 0.54000000000000004 110.216 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.4 m -79.7 114.09 18.35 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.929 -0.397 . . . . 1.22 109.929 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 t -87.48 114.43 24.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.998 0.904 . . . . 1.29 112.409 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -114.63 162.49 16.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 106.949 -1.501 . . . . 1.7 106.949 167.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.47 ' HB3' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -82.39 -16.47 48.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.724 -0.79 . . . . 1.3899999999999999 110.277 -177.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.59 -37.51 3.71 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.601 -0.809 . . . . 0.85999999999999999 112.341 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.527 HG23 ' CZ3' ' A' ' 121' ' ' TRP . 27.8 m -132.27 156.9 42.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.864 0.364 . . . . 1.73 110.519 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.716 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -135.84 105.3 6.06 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.202 -1.036 . . . . 0.41999999999999998 108.202 179.621 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.983 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 4.0 p90 -134.92 144.19 47.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.196 0.522 . . . . 1.1499999999999999 111.48 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.874 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 15.5 pttm -75.11 149.97 38.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.469 -0.787 . . . . 2.0299999999999998 110.392 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -76.11 -15.56 60.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.779 0.8 . . . . 2.6600000000000001 108.878 173.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.874 ' HB3' ' HD2' ' A' ' 86' ' ' LYS . 28.6 t70 -78.87 155.65 29.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.677 -1.147 . . . . 2.1000000000000001 110.431 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.0 m -121.84 131.02 74.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.005 0.431 . . . . 1.6599999999999999 109.861 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.79 172.83 16.49 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.845 -0.693 . . . . 0.63 111.714 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.1 p -65.64 124.35 22.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.591 -0.522 . . . . 1.5800000000000001 109.591 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.82 ' HB2' ' HZ2' ' A' ' 86' ' ' LYS . 32.0 t90 -91.29 -51.13 5.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.189 -0.46 . . . . 0.75 110.436 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 30.53 82.64 0.01 OUTLIER Glycine 0 N--CA 1.468 0.803 0 O-C-N 124.75 1.281 . . . . 1.25 115.26 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.35 -150.2 5.75 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.861 -0.685 . . . . 1.0 112.005 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.5 p -123.13 124.64 43.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.42 0.629 . . . . 1.3200000000000001 112.449 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -110.85 168.73 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.175 -1.046 . . . . 2.2400000000000002 108.175 169.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.61 161.0 27.43 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.11 -1.043 . . . . 0.53000000000000003 112.243 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.42 113.44 24.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.107 0.48 . . . . 1.53 110.139 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.651 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 5.9 m-85 -110.49 126.66 54.6 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.924 -1.139 . . . . 1.7 107.924 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.858 ' HA ' HG12 ' A' ' 67' ' ' VAL . 9.2 p -71.47 136.97 24.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.06 -0.719 . . . . 1.6799999999999999 109.06 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.23 98.91 1.08 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.864 0.364 . . . . 1.02 111.149 -175.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.87 20.73 79.74 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-O 119.17 -0.795 . . . . 1.53 114.207 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.418 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 18.4 tt0 51.98 99.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.49 0.645 . . . . 2.5699999999999998 110.742 -174.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 1.057 ' HG3' ' HB2' ' A' ' 65' ' ' LEU . 79.9 mm-40 -69.55 -63.99 0.97 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.18 -0.464 . . . . 3.1699999999999999 111.279 -172.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.5 m -178.86 -56.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.893 -0.594 . . . . 2.8599999999999999 110.858 -168.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.472 ' OD1' ' HD2' ' A' ' 16' ' ' ARG . 8.2 t30 72.21 79.24 0.15 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.156 -0.929 . . . . 1.5600000000000001 109.471 -167.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.13 125.96 66.62 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.508 -0.769 . . . . 2.0800000000000001 109.145 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -21.95 88.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 1 C-N-CA 125.425 4.084 . . . . 1.48 114.275 -172.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.741 ' HB3' ' HE1' ' A' ' 112' ' ' TYR . 1.1 Cg_endo -85.16 -157.76 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.092 3.195 . . . . 0.84999999999999998 114.087 -171.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.89 -81.04 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.742 -1.343 . . . . 0.76000000000000001 109.742 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -126.83 137.56 53.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.643 -0.502 . . . . 2.04 109.643 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.741 ' HE1' ' HB3' ' A' ' 109' ' ' PRO . 13.7 m-85 -125.55 141.76 51.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.395 -0.366 . . . . 1.1100000000000001 110.298 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.1 m -125.56 112.84 16.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.148 -0.478 . . . . 1.3400000000000001 110.778 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.498 HD21 HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -126.69 87.29 2.63 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.44 0.638 . . . . 1.1699999999999999 110.181 176.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 2.8 m -72.0 122.5 20.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.413 -0.812 . . . . 1.4099999999999999 110.099 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -111.17 120.2 41.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.083 0.468 . . . . 1.8 110.57 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.449 ' HA ' HG22 ' A' ' 135' ' ' THR . 19.3 m -92.18 121.22 33.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 1.3200000000000001 110.224 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -76.97 164.57 53.05 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.567 -0.825 . . . . 0.97999999999999998 111.866 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.18 179.62 36.92 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.87 -0.681 . . . . 0.64000000000000001 111.766 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.607 ' HB3' ' HB2' ' A' ' 3' ' ' CYS . 55.5 p90 -110.75 178.97 4.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.265 0.555 . . . . 1.2 110.298 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.678 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 8.5 t-105 -140.9 143.22 34.52 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.378 -0.828 . . . . 0.65000000000000002 109.087 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.605 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -140.96 60.73 1.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.139 0.792 . . . . 1.55 113.139 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 1.035 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER 169.88 -123.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.627 0.579 . . . . 3.8700000000000001 109.887 171.012 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -166.31 117.26 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 2.0800000000000001 111.455 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.678 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 23.3 t-20 61.43 -30.86 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.261 1.578 . . . . 3.0899999999999999 115.261 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -1.97 2.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 118.011 0.369 . . . . 2.3799999999999999 111.434 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.546 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 40.1 mt-30 72.79 45.85 0.29 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.657 -0.701 . . . . 2.1099999999999999 110.971 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.72 59.46 4.69 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.74 -0.944 . . . . 0.77000000000000002 110.74 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.882 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 50.3 p90 -105.19 146.56 29.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 110.071 -0.344 . . . . 1.49 110.071 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.4 m -131.12 113.47 15.99 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 110.148 -0.316 . . . . 1.8999999999999999 110.148 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -62.11 118.51 5.4 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.822 2.348 . . . . 1.1699999999999999 111.595 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.9 m -145.82 154.71 42.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.924 -0.58 . . . . 1.96 110.259 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.33 -123.36 6.19 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.671 -0.776 . . . . 1.1699999999999999 112.647 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.7 m -125.04 143.02 51.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.71 0.291 . . . . 2.9300000000000002 111.291 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 117' ' ' THR . 12.4 m -93.21 113.2 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.407 -0.59 . . . . 2.1800000000000002 109.407 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.469 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -96.99 126.14 8.73 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.771 -0.728 . . . . 0.72999999999999998 112.035 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.1 m -94.48 99.63 11.77 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.029 0.442 . . . . 1.23 110.31 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.425 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 24.9 m -79.78 119.08 22.19 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.178 -0.675 . . . . 1.1799999999999999 109.178 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -113.72 119.48 37.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.589 0.709 . . . . 2.6299999999999999 109.591 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 112' ' ' TYR . 4.7 tp -108.36 94.65 5.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.048 -0.978 . . . . 1.3100000000000001 110.847 -173.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.2 m -91.07 147.5 23.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.909 -1.041 . . . . 1.1799999999999999 109.18 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.469 ' HB ' HH12 ' A' ' 16' ' ' ARG . 9.1 p -102.28 124.11 55.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.914 -0.714 . . . . 2.3900000000000001 110.715 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.338 -0.839 . . . . 2.5899999999999999 109.497 178.759 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 121.131 0.491 . . . . 5.7300000000000004 110.373 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -151.86 97.38 2.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.891 -0.781 . . . . 3.0800000000000001 108.891 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.859 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 19.2 t -85.5 99.72 11.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.208 0.528 . . . . 1.8300000000000001 110.595 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -86.18 140.18 30.4 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.61 -0.723 . . . . 2.29 110.359 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.779 HG23 HG13 ' A' ' 30' ' ' VAL . 3.2 p -111.69 124.22 68.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.696 -0.684 . . . . 2.1000000000000001 109.674 175.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.534 ' HA ' ' OG1' ' A' ' 134' ' ' THR . 99.3 mtt180 -96.29 104.01 15.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.333 0.587 . . . . 4.25 110.797 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.43 116.72 47.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.202 -0.908 . . . . 1.8200000000000001 109.456 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.78 150.35 34.29 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.63 -0.795 . . . . 1.1899999999999999 112.378 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -74.43 111.88 10.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.771 -0.455 . . . . 2.1800000000000002 109.771 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.654 HD12 HG21 ' A' ' 28' ' ' VAL . 92.8 mt -93.49 94.01 8.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.22 -0.446 . . . . 2.0 111.202 -177.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.1 m -94.9 112.69 24.39 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.052 -0.721 . . . . 1.5600000000000001 109.052 171.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.14 144.23 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.425 -0.352 . . . . 2.04 110.387 -174.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.517 ' HB3' ' OG1' ' A' ' 143' ' ' THR . . . -101.42 96.83 7.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.149 -0.478 . . . . 1.23 109.963 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.697 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 9.0 mmpt? -145.72 173.25 12.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 3.9100000000000001 110.453 -176.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.506 HG21 HG13 ' A' ' 142' ' ' VAL . 35.2 p -106.71 168.95 8.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.122 -0.49 . . . . 1.21 109.721 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.674 HH21 ' HD1' ' A' ' 112' ' ' TYR . 0.3 OUTLIER -87.01 -15.61 38.18 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.753 -0.832 . . . . 4.0800000000000001 108.753 178.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.8 -23.52 70.88 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.297 -0.865 . . . . 0.75 111.558 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -58.49 -31.15 67.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.4 0.619 . . . . 2.6299999999999999 109.707 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.589 HD22 HG23 ' A' ' 25' ' ' ILE . 9.9 mt -96.48 105.5 17.6 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.233 -0.894 . . . . 1.6100000000000001 109.711 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.583 ' H ' ' HB3' ' A' ' 23' ' ' ALA . 4.2 t -107.42 70.35 0.78 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.126 -0.694 . . . . 2.2599999999999998 109.126 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 17.8 t70 67.61 -80.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.7 -1.137 . . . . 1.8300000000000001 110.488 -174.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.34 63.69 0.99 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.613 0.72 . . . . 1.4299999999999999 110.646 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.583 ' HB3' ' H ' ' A' ' 20' ' ' THR . . . -143.35 117.87 6.22 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 114.897 -1.047 . . . . 1.3700000000000001 108.901 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -90.83 163.66 4.04 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.59 2.86 . . . . 1.1200000000000001 113.603 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.589 HG23 HD22 ' A' ' 19' ' ' LEU . 1.5 pt -118.7 -57.15 3.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.466 -0.788 . . . . 3.0499999999999998 110.899 174.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.516 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -116.15 99.17 0.86 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.85 -0.69 . . . . 1.04 112.553 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 60.4 Cg_endo -80.41 105.17 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.714 2.276 . . . . 1.0 112.051 173.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.654 HG21 HD12 ' A' ' 10' ' ' LEU . 18.1 t -74.96 125.96 35.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.701 -0.481 . . . . 1.8300000000000001 109.701 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.7 t -82.72 83.62 7.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.02 0.914 . . . . 2.2000000000000002 110.24 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.779 HG13 HG23 ' A' ' 5' ' ' VAL . 84.9 t -69.18 115.73 8.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.053 -0.976 . . . . 1.5600000000000001 110.833 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.48 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 4.4 pt20 -110.38 132.89 53.78 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.159 -0.682 . . . . 2.48 109.159 173.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.526 ' HB2' ' SG ' ' A' ' 3' ' ' CYS . . . -101.67 127.95 48.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.095 -0.502 . . . . 1.25 110.999 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.727 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 85.2 mt -107.59 111.78 24.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.511 -0.313 . . . . 2.4700000000000002 110.656 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.98 59.11 8.4 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.266 -0.492 . . . . 1.8100000000000001 113.211 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.859 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -87.08 -70.38 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.679 0.252 . . . . 1.8799999999999999 111.679 -177.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 69.25 -61.83 0.42 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.644 0.778 . . . . 2.71 111.632 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.8 71.41 1.35 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.338 0.59 . . . . 1.3600000000000001 109.889 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.695 ' HD2' ' SG ' ' A' ' 35' ' ' CYS . 1.4 tmt_? -143.42 131.81 22.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.544 -0.753 . . . . 5.3499999999999996 110.886 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.474 ' HG2' HG13 ' A' ' 89' ' ' VAL . 6.2 mt-30 -87.36 107.17 18.4 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.675 -0.861 . . . . 1.9099999999999999 108.675 174.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 41.7 t -62.66 109.21 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 1.1699999999999999 109.954 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.961 ' HB1' ' HB3' ' A' ' 85' ' ' TYR . . . -127.11 137.63 53.03 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 123.531 0.519 . . . . 1.0900000000000001 109.895 -176.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.748 HD11 HG21 ' A' ' 69' ' ' ILE . 65.6 mt -104.21 128.65 51.95 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.946 -0.39 . . . . 1.4399999999999999 109.946 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.701 ' HZ2' ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -110.33 151.77 27.02 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.618 -0.882 . . . . 2.5299999999999998 108.618 175.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.576 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -100.32 155.17 17.94 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.379 -0.529 . . . . 1.0700000000000001 110.024 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -73.67 149.0 42.25 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.978 -0.749 . . . . 0.70999999999999996 108.978 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -58.6 -18.08 27.26 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.286 0.476 . . . . 1.71 112.286 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.24 -27.18 68.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.151 0.5 . . . . 2.2200000000000002 110.33 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.6 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 4.1 p-10 -134.75 27.11 3.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.656 -0.702 . . . . 1.5800000000000001 109.916 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.609 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 75.1 t80 -140.75 102.41 4.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.436 -0.802 . . . . 0.72999999999999998 109.653 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.24 117.04 33.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.296 -0.411 . . . . 2.4100000000000001 110.583 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 68.46 -57.62 0.49 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.279 0.987 . . . . 4.1399999999999997 111.884 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.609 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -179.29 32.26 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.971 -0.633 . . . . 0.72999999999999998 111.93 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 81' ' ' ASN . 1.6 mptm? -129.9 134.28 47.39 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.396 -0.594 . . . . 2.6800000000000002 109.396 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.454 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -98.91 139.05 35.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.42 0.628 . . . . 0.65000000000000002 110.818 174.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.6 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 51.5 p90 -155.43 172.76 17.69 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.177 -0.919 . . . . 0.73999999999999999 110.338 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.982 ' HG ' HD21 ' A' ' 114' ' ' LEU . 5.9 mp -83.35 130.72 35.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.095 -0.705 . . . . 2.0800000000000001 109.095 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.583 HG21 ' O ' ' A' ' 113' ' ' THR . 10.4 tp -104.93 134.7 45.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.13 -0.628 . . . . 1.21 109.322 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.5 t -68.06 179.96 1.38 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.294 -0.866 . . . . 1.9299999999999999 111.298 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -56.0 -43.2 77.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.883 -0.599 . . . . 2.3100000000000001 111.456 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -115.07 -62.26 1.63 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.549 -0.296 . . . . 3.6600000000000001 110.594 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.1 p30 177.28 25.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.829 -0.623 . . . . 3.0600000000000001 109.595 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -73.03 -46.31 52.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.428 -0.805 . . . . 5.1799999999999997 111.406 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.99 156.16 47.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.837 -0.62 . . . . 2.5099999999999998 110.491 -172.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -142.59 139.73 31.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.883 -0.599 . . . . 2.6200000000000001 109.776 174.252 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.756 ' HG ' HD11 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -141.14 122.04 14.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.37 -0.377 . . . . 2.48 110.237 178.016 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.432 ' HA ' ' CB ' ' A' ' 55' ' ' PHE . 62.8 m-85 -72.18 153.15 41.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.347 -0.388 . . . . 1.1299999999999999 111.515 -173.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.48 ' HB ' HG21 ' A' ' 98' ' ' ILE . 29.2 m -117.24 161.78 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 1.29 111.404 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -126.65 121.67 32.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 2.1000000000000001 108.952 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.748 HG21 HD11 ' A' ' 42' ' ' LEU . 3.6 mm -95.37 86.23 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.745 -0.382 . . . . 1.55 110.04 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.515 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 8.1 mmm180 -93.55 128.27 42.85 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 120.491 -0.484 . . . . 4.3300000000000001 110.974 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.645 ' HA ' HG21 ' A' ' 96' ' ' ILE . 49.2 Cg_exo -51.53 133.41 43.53 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.526 2.151 . . . . 0.90000000000000002 112.229 172.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.6 ttt -78.8 81.45 5.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.572 -0.529 . . . . 2.23 109.572 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 66.35 20.16 10.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.823 -0.626 . . . . 1.9199999999999999 112.227 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -119.7 107.59 13.4 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.464 0.542 . . . . 1.8899999999999999 112.464 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.6 p 61.18 179.71 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.648 1.179 . . . . 2.0699999999999998 113.503 170.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.07 119.52 39.42 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.276 -0.874 . . . . 1.5800000000000001 110.485 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.6 m0 -110.18 149.08 30.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.93 -0.577 . . . . 0.54000000000000004 110.388 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.0 m -83.23 112.92 20.3 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.003 -0.74 . . . . 1.22 109.003 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 t -87.48 90.19 8.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.936 0.874 . . . . 1.29 112.433 -171.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.25 148.44 23.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.91 -1.145 . . . . 1.7 107.91 166.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -87.17 11.06 14.93 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.226 -0.59 . . . . 1.3899999999999999 110.526 -174.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.88 -27.46 1.25 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.597 -0.601 . . . . 0.85999999999999999 111.597 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.526 HG13 ' HG3' ' A' ' 43' ' ' LYS . 36.0 m -140.54 137.77 36.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.005 -0.739 . . . . 1.73 109.005 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.837 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -121.68 109.11 14.35 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.67 -0.812 . . . . 0.41999999999999998 108.946 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.961 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 2.0 p90 -137.35 139.26 40.7 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.512 0.508 . . . . 1.1499999999999999 111.394 -173.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.758 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 53.4 pttt -73.96 143.49 45.64 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.057 -0.72 . . . . 2.0299999999999998 109.057 171.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -64.72 -26.53 68.41 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.97 -0.559 . . . . 2.6600000000000001 110.103 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.758 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 12.6 m-20 -72.12 151.07 43.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.526 -0.761 . . . . 2.1000000000000001 110.573 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.474 HG13 ' HG2' ' A' ' 39' ' ' GLN . 30.9 m -114.04 123.26 69.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.026 0.441 . . . . 1.6599999999999999 110.276 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.8 -173.32 24.7 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.387 -0.911 . . . . 0.63 112.011 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.5 p -55.37 145.45 22.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.084 0.469 . . . . 1.5800000000000001 111.428 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.43 ' CH2' HG23 ' A' ' 96' ' ' ILE . 41.2 t90 -126.74 -53.86 1.43 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.912 -0.586 . . . . 0.75 109.82 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.556 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 35.23 87.54 0.01 OUTLIER Glycine 0 N--CA 1.465 0.577 0 O-C-N 124.835 1.334 . . . . 1.25 114.978 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.01 -131.77 1.29 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.9 -0.667 . . . . 1.0 112.126 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.64 132.92 23.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.951 0.405 . . . . 1.3200000000000001 111.459 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.645 HG21 ' HA ' ' A' ' 71' ' ' PRO . 1.7 pp -124.29 144.1 35.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.365 -0.605 . . . . 2.2400000000000002 109.365 172.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -117.97 151.8 17.81 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.118 -1.039 . . . . 0.53000000000000003 112.233 -174.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.48 HG21 ' HB ' ' A' ' 67' ' ' VAL . 77.1 mt -96.18 112.62 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.417 0.627 . . . . 1.53 110.639 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.515 ' CE1' ' HB2' ' A' ' 70' ' ' ARG . 1.2 m-85 -103.88 156.86 17.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.807 -1.088 . . . . 1.7 108.099 176.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.473 ' CG1' ' HA ' ' A' ' 103' ' ' GLN . 5.5 p -87.24 133.12 30.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.035 -0.666 . . . . 1.6799999999999999 109.393 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.92 101.83 0.3 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.381 -0.372 . . . . 1.02 111.756 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.11 23.4 77.21 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.804 -0.635 . . . . 1.53 114.026 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 62.9 tt0 57.93 97.98 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.237 0.541 . . . . 2.5699999999999998 110.905 -175.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.651 ' HG3' ' HB2' ' A' ' 65' ' ' LEU . 78.3 mm-40 -84.32 14.21 4.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 3.1699999999999999 111.312 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.1 m 74.01 -3.79 2.43 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.584 -0.735 . . . . 2.8599999999999999 112.239 170.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.514 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 7.3 t30 63.41 86.18 0.12 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.593 0.711 . . . . 1.5600000000000001 110.214 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.8 m -74.54 139.91 74.97 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.006 -0.997 . . . . 2.0800000000000001 109.355 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -30.5 89.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 125.162 3.908 . . . . 1.48 113.456 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.576 ' HB2' ' CG2' ' A' ' 142' ' ' VAL . 81.2 Cg_endo -93.23 -168.54 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.191 2.594 . . . . 0.84999999999999998 114.949 -167.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.13 -73.92 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.752 -1.339 . . . . 0.76000000000000001 109.752 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -135.13 126.93 29.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.546 -0.539 . . . . 2.04 109.546 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.674 ' HD1' HH21 ' A' ' 16' ' ' ARG . 69.6 m-85 -129.25 139.33 51.86 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.065 0.46 . . . . 1.1100000000000001 110.922 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.583 ' O ' HG21 ' A' ' 57' ' ' ILE . 70.8 m -111.68 129.15 56.2 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.318 -0.856 . . . . 1.3400000000000001 110.021 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.982 HD21 ' HG ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -142.84 86.91 1.95 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.733 0.777 . . . . 1.1699999999999999 109.602 174.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.7 m -88.06 135.83 33.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.003 -0.999 . . . . 1.4099999999999999 110.476 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 8.6 mp -119.01 116.49 26.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 1.8 110.682 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 38.5 m -89.08 114.02 25.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.81 -0.632 . . . . 1.3200000000000001 110.125 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.84 145.11 44.6 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.724 -0.751 . . . . 0.97999999999999998 112.365 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 132' ' ' SER . . . -175.59 177.34 47.43 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.892 -0.67 . . . . 0.64000000000000001 111.484 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.406 ' CE2' ' HB ' ' A' ' 130' ' ' THR . 28.9 p90 -101.26 -178.33 3.71 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.918 -0.713 . . . . 1.2 110.184 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.851 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 3.4 t-105 -151.69 144.45 24.35 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.253 -0.885 . . . . 0.65000000000000002 108.818 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.39 145.65 49.95 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.256 0.347 . . . . 1.55 110.466 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.896 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER 72.17 -136.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.745 0.818 . . . . 3.8700000000000001 110.741 178.121 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.588 ' HA ' ' HZ2' ' A' ' 121' ' ' TRP . 5.6 p-10 -162.96 133.87 4.77 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.132 0.173 . . . . 2.0800000000000001 110.631 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.484 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 52.4 t30 67.76 -38.76 0.37 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.901 1.075 . . . . 3.0899999999999999 113.901 174.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -5.04 5.18 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.341 0.591 . . . . 2.3799999999999999 111.19 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.851 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 6.1 tt0 65.21 72.56 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.723 -1.126 . . . . 2.1099999999999999 111.246 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -96.01 41.75 2.38 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.62 -0.8 . . . . 0.77000000000000002 111.213 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.701 ' HB2' ' HZ2' ' A' ' 43' ' ' LYS . 3.7 p90 -82.74 154.44 24.79 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.783 0.325 . . . . 1.49 110.894 -172.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.406 ' HB ' ' CE2' ' A' ' 120' ' ' TYR . 50.2 m -154.93 123.99 3.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.436 -0.347 . . . . 1.8999999999999999 110.082 173.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.2 128.81 31.18 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.975 2.45 . . . . 1.1699999999999999 112.254 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.417 ' N ' ' HA2' ' A' ' 119' ' ' GLY . 27.1 m -155.27 108.3 2.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.31 -0.404 . . . . 1.96 110.349 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.9 -127.85 7.52 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.45 -0.881 . . . . 1.1699999999999999 112.46 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.534 ' OG1' ' HA ' ' A' ' 6' ' ' ARG . 5.2 p -118.71 154.53 32.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.951 0.405 . . . . 2.9300000000000002 111.417 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 t -108.98 114.64 28.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.412 -0.588 . . . . 2.1800000000000002 109.412 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.96 126.87 9.0 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.716 -0.754 . . . . 0.72999999999999998 112.122 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.3 m -91.82 101.3 13.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.745 0.307 . . . . 1.23 110.725 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.494 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 28.3 m -80.63 108.65 14.45 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.14 -0.689 . . . . 1.1799999999999999 109.14 173.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -109.38 109.55 20.45 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.989 -0.745 . . . . 2.6299999999999999 108.989 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.596 ' HG ' ' NH2' ' A' ' 16' ' ' ARG . 16.1 tp -106.78 105.96 16.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.902 -1.045 . . . . 1.3100000000000001 110.913 -174.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 30.3 m -99.45 143.99 29.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.159 -0.928 . . . . 1.1799999999999999 109.36 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.576 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 92.9 t -74.32 129.56 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 112.793 0.664 . . . . 2.3900000000000001 112.793 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 95.0 m . . . . . 0 C--O 1.248 1.009 0 CA-C-N 115.06 -0.973 . . . . 2.5899999999999999 109.188 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.046 0.45 . . . . 5.7300000000000004 110.905 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -92.73 121.43 34.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.629 -0.714 . . . . 3.0800000000000001 109.831 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.3 m -119.45 100.51 7.33 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.34 -0.391 . . . . 1.8300000000000001 110.922 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -86.39 109.73 19.22 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.41 -0.589 . . . . 2.29 109.41 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.6 t -95.96 111.89 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.588 -0.523 . . . . 2.1000000000000001 109.588 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.805 ' HB2' ' HB2' ' A' ' 31' ' ' GLN . 31.2 mmt180 -84.39 99.55 10.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.628 -0.715 . . . . 4.25 110.451 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.95 115.59 48.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.382 -0.826 . . . . 1.8200000000000001 109.238 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.24 -169.88 27.04 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.465 -0.874 . . . . 1.1899999999999999 112.082 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -99.83 142.39 31.37 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.676 -0.491 . . . . 2.1800000000000002 109.676 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.72 126.84 12.91 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.02 -0.537 . . . . 2.0 109.911 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.9 m -108.93 115.69 30.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.987 -0.551 . . . . 1.5600000000000001 110.479 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.427 HG13 ' HG2' ' A' ' 14' ' ' LYS . 44.3 t -122.69 117.9 53.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.152 -0.476 . . . . 2.04 110.17 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -91.4 97.03 10.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.97 0.414 . . . . 1.23 110.893 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.427 ' HG2' HG13 ' A' ' 12' ' ' VAL . 73.9 mmtt -143.64 -174.44 4.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.561 -0.745 . . . . 3.9100000000000001 109.454 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.615 ' HB ' ' OD1' ' A' ' 106' ' ' ASN . 20.4 p -100.68 159.78 14.89 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.135 -0.32 . . . . 1.21 110.135 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.88 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -86.35 -26.22 24.96 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.629 -0.428 . . . . 4.0800000000000001 109.992 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.79 -28.63 73.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.919 -0.658 . . . . 0.75 111.613 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -51.14 -34.81 32.72 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.594 0.757 . . . . 2.6299999999999999 111.442 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.803 ' HB2' HG21 ' A' ' 100' ' ' VAL . 49.8 mt -70.51 -17.61 62.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.591 -0.731 . . . . 1.6100000000000001 112.816 -170.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.3 m 34.25 55.42 0.63 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.256 0.972 . . . . 2.2599999999999998 112.778 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.758 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 31.0 t70 70.27 -62.84 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.631 -0.713 . . . . 1.8300000000000001 111.809 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.48 ' HA ' ' CG ' ' A' ' 99' ' ' TYR . . . -139.46 69.59 1.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.311 0.577 . . . . 1.4299999999999999 112.068 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.65 98.42 16.41 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.38 -0.827 . . . . 1.3700000000000001 109.056 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.444 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 54.4 Cg_endo -70.02 119.81 6.67 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.817 2.345 . . . . 1.1200000000000001 113.411 -172.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.758 HG12 HD21 ' A' ' 19' ' ' LEU . 2.9 pt -80.67 -65.11 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 3.0499999999999998 111.524 173.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.636 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -117.83 101.55 0.92 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.879 -0.676 . . . . 1.04 111.935 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.575 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 37.7 Cg_endo -70.51 121.16 7.7 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.437 2.091 . . . . 1.0 112.083 177.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.34 122.16 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.86 -0.609 . . . . 1.8300000000000001 109.431 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.5 m -74.59 101.96 4.39 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.218 -0.446 . . . . 2.2000000000000002 110.298 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.453 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 48.9 t -95.81 114.49 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.157 -0.474 . . . . 1.5600000000000001 110.398 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.805 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 14.9 mm100 -103.07 133.91 47.38 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.343 -0.614 . . . . 2.48 109.343 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.4 108.29 13.94 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.172 -0.307 . . . . 1.25 110.172 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.16 134.24 55.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.129 -0.487 . . . . 2.4700000000000002 110.724 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.55 -7.83 68.59 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.819 -0.628 . . . . 1.8100000000000001 112.264 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.0 m -84.32 93.56 8.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.001 0.429 . . . . 1.8799999999999999 110.73 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -96.32 -18.92 19.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.962 0.411 . . . . 2.71 110.218 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -167.76 83.66 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.776 -0.647 . . . . 1.3600000000000001 110.048 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -165.11 150.09 9.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.898 -0.592 . . . . 5.3499999999999996 110.096 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -80.91 125.41 30.09 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.245 -0.65 . . . . 1.9099999999999999 109.245 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 61.0 t -92.99 124.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.46 -0.57 . . . . 1.1699999999999999 109.46 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -119.66 146.52 45.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.087 0.47 . . . . 1.0900000000000001 110.963 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 84' ' ' PHE . 14.6 mt -103.87 117.72 35.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.663 -0.698 . . . . 1.4399999999999999 109.329 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.617 ' NZ ' ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -118.73 152.02 36.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.552 -0.536 . . . . 2.5299999999999998 109.552 -177.316 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.513 ' HB2' ' ND2' ' A' ' 48' ' ' ASN . . . -104.23 157.19 17.3 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.369 -0.378 . . . . 1.0700000000000001 110.081 175.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 21.9 t70 -75.8 151.72 37.46 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.428 -0.582 . . . . 0.70999999999999996 109.428 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -56.75 -16.5 6.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.563 0.579 . . . . 1.71 112.563 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.58 -32.37 73.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.981 0.42 . . . . 2.2200000000000002 110.628 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 44' ' ' ALA . 6.0 p-10 -133.85 24.2 3.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 1.5800000000000001 110.247 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 82.0 t80 -132.33 101.33 5.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.492 -0.777 . . . . 0.72999999999999998 109.334 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 51' ' ' GLN . 56.5 mt-10 -95.07 100.26 12.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.422 -0.353 . . . . 2.4100000000000001 110.403 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 23.8 tt0 70.79 -58.56 0.56 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.875 0.734 . . . . 4.1399999999999997 111.184 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -172.32 38.12 0.16 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.6 -0.727 . . . . 0.72999999999999998 111.435 -177.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 2.1 mptm? -136.37 133.87 37.24 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.944 -0.762 . . . . 2.6800000000000002 108.944 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.403 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -106.08 141.67 37.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.245 0.545 . . . . 0.65000000000000002 110.96 174.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 16.9 p90 -147.27 167.04 25.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.674 -0.694 . . . . 0.73999999999999999 111.255 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 13.0 mt -85.33 113.66 21.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.457 -0.942 . . . . 2.0800000000000001 108.457 171.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.7 tp -106.26 125.08 61.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.595 0.712 . . . . 1.21 110.85 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 112' ' ' TYR . 40.3 t -84.39 153.34 23.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.982 -1.008 . . . . 1.9299999999999999 111.21 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.16 -35.39 73.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.471 -0.786 . . . . 2.3100000000000001 110.368 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -78.3 -13.23 59.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.662 -0.699 . . . . 3.6600000000000001 110.775 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 53.77 30.44 11.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.661 -0.699 . . . . 3.0600000000000001 111.122 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.633 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 8.3 mmp_? -83.79 -39.95 19.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.244 0.545 . . . . 5.1799999999999997 109.871 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.642 ' HB3' HD23 ' A' ' 65' ' ' LEU . 1.1 m-20 -123.09 124.77 43.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.377 -0.828 . . . . 2.5099999999999998 111.111 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -127.18 98.89 5.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.208 1.004 . . . . 2.6200000000000001 108.737 168.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.645 HD13 ' HB2' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -99.4 118.72 36.65 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.987 -1.006 . . . . 2.48 109.853 -168.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.433 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 73.0 m-85 -67.51 122.15 17.37 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.285 -0.635 . . . . 1.1299999999999999 109.285 -177.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.446 HG12 ' HG ' ' A' ' 56' ' ' LEU . 12.9 m -99.63 168.57 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.605 -0.725 . . . . 1.29 111.62 -174.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -126.12 110.2 13.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.839 -1.073 . . . . 2.1000000000000001 108.841 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.423 HG22 HG12 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -91.46 84.25 2.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.506 0.669 . . . . 1.55 109.196 173.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.793 ' HB3' ' OH ' ' A' ' 99' ' ' TYR . 32.6 ttm180 -101.82 131.78 22.42 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.979 -1.01 . . . . 4.3300000000000001 108.317 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.64 ' HA ' HG22 ' A' ' 96' ' ' ILE . 45.0 Cg_endo -63.25 148.02 93.35 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.431 2.087 . . . . 0.90000000000000002 112.208 -173.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.0 tpt -74.03 84.6 1.78 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.668 -0.696 . . . . 2.23 110.412 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 74.21 -46.84 0.63 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.134 0.974 . . . . 1.9199999999999999 113.211 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.401 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 56.8 m-80 -60.22 114.28 2.81 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.433 0.901 . . . . 1.8899999999999999 113.433 -171.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.7 t 74.4 159.48 0.22 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.722 -1.126 . . . . 2.0699999999999998 112.323 170.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.42 118.86 33.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.421 -0.809 . . . . 1.5800000000000001 110.113 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.841 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.4 m95 -112.39 142.49 44.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.16 -0.473 . . . . 0.54000000000000004 109.945 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.2 m -82.65 110.63 17.88 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.249 -0.648 . . . . 1.22 109.249 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -82.09 117.71 22.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.319 1.057 . . . . 1.29 112.521 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 22.3 t70 -121.59 154.87 36.16 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.898 -1.519 . . . . 1.7 106.898 167.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -83.94 2.6 37.92 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.009 -0.676 . . . . 1.3899999999999999 110.924 -174.059 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -122.67 -31.47 1.04 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.156 -0.545 . . . . 0.85999999999999999 112.134 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.459 ' O ' ' HB3' ' A' ' 80' ' ' ASP . 26.6 m -131.51 148.64 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.847 -0.427 . . . . 1.73 109.847 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -134.15 104.22 6.11 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.244 -1.021 . . . . 0.41999999999999998 108.244 -177.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.605 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 12.1 p90 -131.51 135.0 46.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.468 0.651 . . . . 1.1499999999999999 111.659 -174.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.841 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 18.9 pttp -74.42 139.68 44.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.829 -1.078 . . . . 2.0299999999999998 109.713 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -72.7 -17.86 61.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.176 -0.675 . . . . 2.6600000000000001 109.176 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.514 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 4.0 t70 -69.4 135.13 49.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.101 -0.954 . . . . 2.1000000000000001 109.684 172.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.0 m -99.57 122.79 51.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.232 0.539 . . . . 1.6599999999999999 110.651 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.3 -155.2 24.48 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.616 -0.802 . . . . 0.63 111.747 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.0 p -82.75 -173.56 4.73 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 122.501 0.321 . . . . 1.5800000000000001 110.276 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.401 ' CZ2' ' HB2' ' A' ' 74' ' ' ASN . 33.3 t90 -157.68 -57.13 0.08 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.799 -0.445 . . . . 0.75 109.799 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 42.15 92.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.42 1.075 . . . . 1.25 114.731 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.86 -141.83 3.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.663 -0.78 . . . . 1.0 112.286 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.575 ' HB ' ' HB2' ' A' ' 27' ' ' PRO . 11.1 p -133.12 140.43 47.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.139 0.495 . . . . 1.3200000000000001 112.218 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.64 HG22 ' HA ' ' A' ' 71' ' ' PRO . 18.7 pt -118.38 142.87 31.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.807 -0.633 . . . . 2.2400000000000002 109.501 174.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 24' ' ' PRO . . . -105.1 141.09 15.26 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.23 -0.986 . . . . 0.53000000000000003 112.386 -174.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 69' ' ' ILE . 59.7 mt -96.57 120.31 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.985 0.421 . . . . 1.53 111.088 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.793 ' OH ' ' HB3' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -139.26 164.96 28.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.335 -0.848 . . . . 1.7 110.153 173.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.803 HG21 ' HB2' ' A' ' 19' ' ' LEU . 3.6 t -90.13 125.94 43.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.98 -0.554 . . . . 1.6799999999999999 110.791 -174.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.5 97.04 0.4 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.934 -0.395 . . . . 1.02 109.934 177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.62 -15.82 44.98 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.892 -0.67 . . . . 1.53 113.759 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.416 ' HB2' ' N ' ' A' ' 21' ' ' ASP . 65.2 tt0 67.27 118.35 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.067 0.547 . . . . 2.5699999999999998 110.769 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.645 ' HB2' HD13 ' A' ' 65' ' ' LEU . 12.7 mm100 -104.47 -6.83 20.3 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.316 0.487 . . . . 3.1699999999999999 112.316 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 m 71.16 14.63 6.63 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.984 0.421 . . . . 2.8599999999999999 111.317 168.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.88 ' HB3' ' HB2' ' A' ' 16' ' ' ARG . 0.3 OUTLIER 41.86 91.51 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.68 1.363 . . . . 1.5600000000000001 114.68 177.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.806 HG22 ' HD2' ' A' ' 108' ' ' PRO . 1.2 m -82.07 143.74 49.81 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 107.914 -1.143 . . . . 2.0800000000000001 107.914 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.806 ' HD2' HG22 ' A' ' 107' ' ' THR . 75.0 Cg_exo -12.04 83.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.669 1 C-N-CA 125.737 4.292 . . . . 1.48 114.705 -168.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -74.13 -157.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.849 3.033 . . . . 0.84999999999999998 113.993 -172.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.58 -140.74 6.62 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 109.878 -1.289 . . . . 0.76000000000000001 109.878 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -82.22 120.7 25.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.953 0.406 . . . . 2.04 110.097 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 58' ' ' SER . 14.1 m-85 -108.74 119.83 40.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.167 0.508 . . . . 1.1100000000000001 109.972 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 77.0 m -106.74 98.54 8.19 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.414 -0.812 . . . . 1.3400000000000001 111.051 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.483 HD11 HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -120.57 107.97 13.49 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.268 0.556 . . . . 1.1699999999999999 110.526 178.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 20.2 m -96.18 140.21 31.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 1.4099999999999999 110.181 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 96.5 mt -117.5 125.79 51.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.893 0.378 . . . . 1.8 110.252 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.5 m -103.36 119.61 39.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.982 0.42 . . . . 1.3200000000000001 110.302 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -74.56 163.43 54.38 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.79 -0.719 . . . . 0.97999999999999998 112.632 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.49 166.57 14.38 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.494 -0.642 . . . . 0.64000000000000001 111.494 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -91.02 176.11 6.71 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.707 -0.397 . . . . 1.2 110.663 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.653 ' HA ' ' HA ' ' A' ' 129' ' ' PHE . 1.9 t-105 -133.09 152.8 51.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.265 -0.879 . . . . 0.65000000000000002 108.69 176.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.09 140.91 46.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.966 0.413 . . . . 1.55 111.615 175.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 74.55 -143.31 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.381 1.073 . . . . 3.8700000000000001 111.358 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 126' ' ' LYS . 6.1 p-10 -147.62 124.38 11.2 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.336 -0.546 . . . . 2.0800000000000001 112.135 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.464 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 8.6 t30 65.53 -22.81 0.09 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.862 1.06 . . . . 3.0899999999999999 113.862 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -71.43 -3.36 20.52 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.873 0.469 . . . . 2.3799999999999999 110.951 -178.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.845 ' HG3' ' CE2' ' A' ' 129' ' ' PHE . 51.4 tt0 70.37 79.24 0.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.433 -0.803 . . . . 2.1099999999999999 110.384 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -109.61 27.69 11.88 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 119.793 -1.194 . . . . 0.77000000000000002 112.655 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.845 ' CE2' ' HG3' ' A' ' 127' ' ' GLN . 38.9 p90 -87.72 126.39 34.96 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.041 -0.664 . . . . 1.49 111.239 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 85.8 m -114.25 132.02 22.97 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.936 -0.575 . . . . 1.8999999999999999 109.767 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.92 122.61 11.21 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.771 2.314 . . . . 1.1699999999999999 112.097 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.9 m -155.61 122.55 5.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.218 -0.446 . . . . 1.96 110.185 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 120.0 -117.62 3.63 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.267 -0.733 . . . . 1.1699999999999999 111.267 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 p -131.81 178.44 6.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.004 0.402 . . . . 2.9300000000000002 110.621 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.0 t -126.59 104.22 8.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.796 0.807 . . . . 2.1800000000000002 108.943 171.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.78 143.45 16.03 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.637 -0.711 . . . . 0.72999999999999998 112.414 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 73.8 m -101.0 117.41 34.98 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.958 0.409 . . . . 1.23 110.903 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.443 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 18.7 m -86.61 111.44 20.63 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.664 -0.865 . . . . 1.1799999999999999 108.664 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -99.34 109.29 21.92 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.809 0.814 . . . . 2.6299999999999999 110.065 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.474 HD23 ' HG3' ' A' ' 16' ' ' ARG . 22.6 tp -103.21 95.98 6.47 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.444 -1.253 . . . . 1.3100000000000001 109.765 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 12.0 m -100.07 144.02 29.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.546 -0.752 . . . . 1.1799999999999999 109.441 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.5 p -82.45 142.96 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.551 -0.537 . . . . 2.3900000000000001 109.551 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.758 -0.639 . . . . 2.5899999999999999 111.472 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.885 -0.413 . . . . 5.7300000000000004 109.885 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -172.4 156.51 3.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.679 -0.86 . . . . 3.0800000000000001 108.679 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.1 t -90.49 110.29 21.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.16 0.505 . . . . 1.8300000000000001 110.363 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.402 ' HG3' ' HA3' ' A' ' 133' ' ' GLY . 7.6 tt0 -98.64 128.03 44.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.722 -0.672 . . . . 2.29 109.274 176.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.55 HG11 HG12 ' A' ' 30' ' ' VAL . 51.2 t -104.99 135.4 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.506 -0.553 . . . . 2.1000000000000001 109.506 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.436 ' HA ' ' HE ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -92.57 101.21 13.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.084 0.468 . . . . 4.25 110.99 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.479 HG13 ' HA3' ' A' ' 136' ' ' GLY . 73.4 t -129.73 115.32 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.873 -0.788 . . . . 1.8200000000000001 108.873 173.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.83 -147.67 6.81 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.859 -0.686 . . . . 1.1899999999999999 112.412 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.29 142.16 27.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.209 0.528 . . . . 2.1800000000000002 111.413 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.75 124.38 7.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.276 -0.875 . . . . 2.0 109.658 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 139' ' ' LYS . 31.1 m -116.03 116.57 28.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.212 -0.449 . . . . 1.5600000000000001 110.709 -178.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.462 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 27.8 t -121.49 116.75 50.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.931 0.396 . . . . 2.04 110.182 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -83.64 109.06 17.13 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.924 -0.58 . . . . 1.23 111.436 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.507 ' HE3' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -168.63 175.9 5.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.703 -0.681 . . . . 3.9100000000000001 110.136 178.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.52 HG21 HG23 ' A' ' 142' ' ' VAL . 51.6 p -100.81 174.93 5.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.305 -0.407 . . . . 1.21 110.723 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.443 ' HA ' HD13 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -84.47 -6.56 59.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.774 -0.824 . . . . 4.0800000000000001 108.774 173.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.575 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -89.84 -22.0 37.69 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.128 -0.942 . . . . 0.75 111.569 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.47 -25.97 65.25 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.712 -0.848 . . . . 2.6299999999999999 108.712 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.602 HD12 ' HB ' ' A' ' 100' ' ' VAL . 18.5 mt -74.85 159.79 31.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.092 -0.958 . . . . 1.6100000000000001 109.087 172.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.403 ' HG1' ' C ' ' A' ' 19' ' ' LEU . 11.2 m -153.8 60.29 0.73 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.467 -0.938 . . . . 2.2599999999999998 108.467 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 22.6 t70 61.28 -84.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.033 -1.439 . . . . 1.8300000000000001 110.255 -171.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.462 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -88.72 74.94 8.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.137 0.494 . . . . 1.4299999999999999 110.641 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.76 99.99 3.51 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.838 -0.619 . . . . 1.3700000000000001 110.134 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 91.5 Cg_endo -82.52 109.5 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.762 2.308 . . . . 1.1200000000000001 112.616 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -116.24 28.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.94 0.876 . . . . 3.0499999999999998 109.868 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.88 60.1 0.42 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.105 -0.952 . . . . 1.04 112.265 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.63 97.89 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.328 2.019 . . . . 1.0 112.948 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.1 t -80.31 126.22 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.856 -0.611 . . . . 1.8300000000000001 109.758 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -84.37 94.16 8.42 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 121.03 0.443 . . . . 2.2000000000000002 110.657 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.684 ' CG2' HD13 ' A' ' 96' ' ' ILE . 14.5 t -94.49 115.21 32.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.308 0.575 . . . . 1.5600000000000001 111.065 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -102.71 124.92 49.13 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.29 -0.868 . . . . 2.48 109.687 174.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.74 93.97 6.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.019 -0.537 . . . . 1.25 110.695 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 tp -87.28 112.76 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.811 -0.632 . . . . 2.4700000000000002 110.83 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.22 56.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.553 -0.832 . . . . 1.8100000000000001 112.306 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -83.72 95.7 8.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.962 0.411 . . . . 1.8799999999999999 110.444 177.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -103.09 -35.03 8.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.884 -0.598 . . . . 2.71 110.155 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.413 ' C ' ' HB ' ' A' ' 89' ' ' VAL . . . -144.81 35.81 1.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.822 -0.626 . . . . 1.3600000000000001 110.417 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.543 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.7 tpp180 -120.34 148.01 44.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.044 0.45 . . . . 5.3499999999999996 111.649 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.496 ' HG3' HG13 ' A' ' 89' ' ' VAL . 18.2 mt-30 -92.48 128.23 38.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.173 -0.677 . . . . 1.9099999999999999 109.173 173.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 72.1 t -92.9 128.97 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.141 -0.689 . . . . 1.1699999999999999 109.141 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.877 ' HB1' ' HB3' ' A' ' 85' ' ' TYR . . . -129.9 144.29 51.24 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.335 0.588 . . . . 1.0900000000000001 110.887 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 31.1 mt -102.08 143.95 31.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.495 -0.775 . . . . 1.4399999999999999 109.821 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.743 ' HE3' ' CB ' ' A' ' 129' ' ' PHE . 1.2 mptp? -143.73 152.99 41.97 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.284 -0.636 . . . . 2.5299999999999998 109.284 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -102.88 160.54 14.51 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.008 -0.542 . . . . 1.0700000000000001 109.606 171.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -83.36 159.65 21.8 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.129 -1.063 . . . . 0.70999999999999996 108.129 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -58.76 -9.64 1.89 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.982 0.42 . . . . 1.71 111.744 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.44 -38.11 71.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.682 -0.69 . . . . 2.2200000000000002 111.449 171.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -141.66 23.18 2.12 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.971 0.415 . . . . 1.5800000000000001 110.406 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 62.8 t80 -126.14 108.15 11.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.72999999999999998 110.189 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -112.82 107.85 16.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.214 -0.291 . . . . 2.4100000000000001 110.214 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 71.11 -58.86 0.56 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.982 0.801 . . . . 4.1399999999999997 110.957 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -178.52 40.92 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.443 -0.799 . . . . 0.72999999999999998 111.148 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 3.4 mptp? -131.76 133.9 45.26 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.64 -0.874 . . . . 2.6800000000000002 108.64 173.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.403 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -109.91 135.96 49.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.148 0.499 . . . . 0.65000000000000002 110.507 172.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 21.7 p90 -142.52 167.5 21.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.553 0.692 . . . . 0.73999999999999999 111.85 -175.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 16.0 mt -80.02 104.64 10.73 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.939 -1.028 . . . . 2.0800000000000001 109.591 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.3 tp -108.2 138.51 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.751 -0.463 . . . . 1.21 109.751 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 p -83.55 166.16 18.47 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.935 -0.395 . . . . 1.9299999999999999 109.935 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.28 -28.14 68.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.939 -0.763 . . . . 2.3100000000000001 108.939 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -80.96 -20.38 42.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.031 -0.986 . . . . 3.6600000000000001 110.479 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.0 m120 67.25 27.78 8.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.647 -0.706 . . . . 3.0600000000000001 111.268 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 63' ' ' ASP . 19.7 ptt180 -88.09 -46.4 9.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.485 -0.325 . . . . 5.1799999999999997 111.287 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.461 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 7.5 m-20 -107.52 143.52 35.8 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.91 -0.404 . . . . 2.5099999999999998 109.91 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.75 153.87 47.28 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.297 0.373 . . . . 2.6200000000000001 110.277 174.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.658 ' HG ' ' HG3' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -154.09 118.61 4.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.442 -0.947 . . . . 2.48 108.442 177.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 1.5 m-85 -69.91 138.97 52.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.933 0.397 . . . . 1.1299999999999999 109.945 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.484 HG12 HD22 ' A' ' 56' ' ' LEU . 15.1 m -117.38 176.53 2.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.139 -0.482 . . . . 1.29 110.846 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.49 111.65 10.89 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.822 -0.626 . . . . 2.1000000000000001 109.673 175.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.412 HG22 HG13 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -86.85 85.46 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.719 0.771 . . . . 1.55 109.196 171.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.677 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 37.7 ttt-85 -102.23 136.46 19.43 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 114.756 -1.111 . . . . 4.3300000000000001 110.396 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.575 ' HA ' HG22 ' A' ' 96' ' ' ILE . 6.1 Cg_exo -46.05 110.63 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.178 2.585 . . . . 0.90000000000000002 112.267 176.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.08 97.34 8.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.72 -0.673 . . . . 2.23 110.033 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 71.61 17.7 5.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.094 -0.957 . . . . 1.9199999999999999 110.881 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -128.59 79.11 1.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.084 0.402 . . . . 1.8899999999999999 112.084 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.4 t 68.56 -172.2 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.837 -0.62 . . . . 2.0699999999999998 111.804 172.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.57 141.48 48.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.792 -0.64 . . . . 1.5800000000000001 110.433 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.43 ' CG ' ' HG3' ' A' ' 71' ' ' PRO . 19.9 m0 -123.45 162.92 21.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.3 -0.409 . . . . 0.54000000000000004 110.602 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 m -76.41 104.85 7.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.74 -0.837 . . . . 1.22 108.74 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 t -93.43 110.5 22.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.813 0.816 . . . . 1.29 112.515 -170.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -110.86 159.35 17.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.017 -1.105 . . . . 1.7 108.017 166.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.407 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -76.59 -5.1 46.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.469 -0.197 . . . . 1.3899999999999999 110.469 -176.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -126.74 -32.62 0.69 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.026 -0.607 . . . . 0.85999999999999999 112.822 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 15.8 m -121.51 148.22 25.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 122.325 -0.515 . . . . 1.73 110.594 175.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.766 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -140.27 100.35 3.88 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.56 -0.533 . . . . 0.41999999999999998 109.56 -177.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.877 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 3.6 p90 -131.06 146.05 52.23 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.318 -0.252 . . . . 1.1499999999999999 110.318 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HZ2' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -81.86 150.58 27.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.01 -0.676 . . . . 2.0299999999999998 109.804 176.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -76.45 -13.52 60.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.59 0.709 . . . . 2.6600000000000001 110.069 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 19.4 m-20 -86.01 145.72 26.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.511 -0.768 . . . . 2.1000000000000001 110.136 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.496 HG13 ' HG3' ' A' ' 39' ' ' GLN . 19.5 m -103.85 123.39 57.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.282 0.563 . . . . 1.6599999999999999 110.586 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.47 -147.17 18.85 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.701 -0.762 . . . . 0.63 112.347 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.3 p -75.0 178.68 5.45 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.421 0.629 . . . . 1.5800000000000001 111.618 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.432 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 83.6 t90 -170.92 -55.63 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.087 -0.96 . . . . 0.75 108.729 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 29.19 97.72 0.01 OUTLIER Glycine 0 N--CA 1.469 0.898 0 O-C-N 125.057 1.473 . . . . 1.25 115.894 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.55 -153.37 10.25 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.58 -0.819 . . . . 1.0 112.964 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 p -101.38 129.66 47.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.871 0.693 . . . . 1.3200000000000001 112.871 -173.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.684 HD13 ' CG2' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -119.34 130.66 73.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.496 -0.928 . . . . 2.2400000000000002 108.496 170.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 69' ' ' ILE . . . -106.17 153.23 17.06 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.137 -1.03 . . . . 0.53000000000000003 112.59 -171.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 mp -87.58 112.01 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.014 0.435 . . . . 1.53 110.334 175.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.677 ' CE1' ' HB3' ' A' ' 70' ' ' ARG . 7.4 m-85 -101.66 153.48 19.73 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.935 -1.135 . . . . 1.7 107.935 171.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.602 ' HB ' HD12 ' A' ' 19' ' ' LEU . 3.6 p -87.48 124.7 40.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.323 -0.621 . . . . 1.6799999999999999 109.323 172.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -83.37 95.35 8.19 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.958 -0.697 . . . . 1.02 109.559 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.58 78.49 0.71 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.55 -0.833 . . . . 1.53 111.535 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.428 ' HA ' HG22 ' A' ' 100' ' ' VAL . 5.7 pt20 -37.97 120.66 0.87 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.724 0.773 . . . . 2.5699999999999998 112.527 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.658 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 9.7 mm-40 -92.41 19.79 6.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.326 -0.852 . . . . 3.1699999999999999 110.683 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 m 65.45 5.34 3.15 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.512 -0.767 . . . . 2.8599999999999999 112.302 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.575 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 12.5 t30 63.78 86.04 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.507 0.67 . . . . 1.5600000000000001 111.211 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.0 t -80.94 140.53 50.22 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 107.84 -1.17 . . . . 2.0800000000000001 107.84 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -26.76 92.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.835 3.69 . . . . 1.48 113.943 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.409 ' CB ' ' HE2' ' A' ' 112' ' ' TYR . 39.9 Cg_endo -90.74 -161.05 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.192 2.594 . . . . 0.84999999999999998 112.682 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.73 -76.51 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.342 -1.103 . . . . 0.76000000000000001 110.342 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -140.58 122.27 15.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.678 -0.49 . . . . 2.04 109.678 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.409 ' HE2' ' CB ' ' A' ' 109' ' ' PRO . 75.7 m-85 -117.62 124.46 48.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.438 0.637 . . . . 1.1100000000000001 110.18 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 51.5 m -116.14 97.62 6.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.907 -1.042 . . . . 1.3400000000000001 109.509 -173.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.544 HD22 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -104.05 100.83 10.6 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.413 0.625 . . . . 1.1699999999999999 110.108 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.9 m -73.14 117.94 15.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.033 -0.985 . . . . 1.4099999999999999 110.002 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -111.44 136.23 50.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.133 0.492 . . . . 1.8 110.857 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 45.8 m -129.32 106.18 8.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.223 -0.658 . . . . 1.3200000000000001 109.223 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 131' ' ' PRO . . . -89.01 -156.76 32.01 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.736 -0.745 . . . . 0.97999999999999998 111.767 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.64 -162.85 28.28 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.469 -0.872 . . . . 0.64000000000000001 111.932 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.554 ' CZ ' ' HB ' ' A' ' 130' ' ' THR . 52.6 p90 -101.65 144.82 29.9 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.987 0.422 . . . . 1.2 110.269 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.653 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 15.1 t-105 -101.23 131.82 47.03 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.749 -0.834 . . . . 0.65000000000000002 108.749 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 123' ' ' LYS . . . -141.18 54.87 1.55 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.233 0.54 . . . . 1.55 112.22 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.687 ' CG ' ' HA3' ' A' ' 128' ' ' GLY . 29.0 mmtp -158.98 -142.28 0.09 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.566 -1.272 . . . . 3.8700000000000001 107.566 174.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 126' ' ' LYS . 4.0 p-10 -151.57 107.08 3.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.238 0.542 . . . . 2.0800000000000001 111.926 174.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.653 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 84.4 m-20 63.91 -36.74 0.17 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.474 -1.239 . . . . 3.0899999999999999 114.272 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -55.04 -51.48 66.18 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.478 0.547 . . . . 2.3799999999999999 112.478 -170.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.674 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 36.4 tt0 152.82 22.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.082 0.864 . . . . 2.1099999999999999 110.801 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.687 ' HA3' ' CG ' ' A' ' 123' ' ' LYS . . . -80.79 88.39 1.34 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 119.957 -1.116 . . . . 0.77000000000000002 112.222 -175.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.743 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 28.4 p90 -140.82 155.17 46.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.592 0.234 . . . . 1.49 110.395 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.554 ' HB ' ' CZ ' ' A' ' 120' ' ' TYR . 99.5 m -139.74 125.27 11.73 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.594 -0.275 . . . . 1.8999999999999999 110.695 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.61 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 47.8 Cg_exo -56.59 134.06 61.95 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.076 2.517 . . . . 1.1699999999999999 112.018 177.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.7 t -151.84 103.51 2.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.44 -0.345 . . . . 1.96 110.78 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' HA3' ' HG3' ' A' ' 4' ' ' GLN . . . 82.08 -4.89 73.94 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.938 -0.648 . . . . 1.1699999999999999 112.901 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.548 ' HB ' ' H ' ' A' ' 118' ' ' GLY . 25.2 p -109.93 113.93 27.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.98 0.733 . . . . 2.9300000000000002 112.98 -170.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.6 m -140.11 95.18 2.85 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.954 -1.128 . . . . 2.1800000000000002 107.954 162.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.479 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -118.1 160.94 13.62 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.063 -1.065 . . . . 0.72999999999999998 113.02 -171.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -143.02 103.98 4.24 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.77 -0.456 . . . . 1.23 109.77 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.511 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 39.5 m -79.97 108.45 13.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.937 -0.764 . . . . 1.1799999999999999 108.937 174.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.412 ' HB3' HG23 ' A' ' 11' ' ' THR . 2.7 tppp? -94.7 109.39 21.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.222 0.534 . . . . 2.6299999999999999 110.052 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.507 HD12 ' HE3' ' A' ' 14' ' ' LYS . 2.3 tp -98.99 104.27 16.29 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.176 -0.92 . . . . 1.3100000000000001 109.317 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 9.2 m -119.23 140.02 50.92 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.848 -0.614 . . . . 1.1799999999999999 109.771 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.52 HG23 HG21 ' A' ' 15' ' ' THR . 12.3 p -82.07 149.12 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.459 . . . . 2.3900000000000001 110.711 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.512 -0.756 . . . . 2.5899999999999999 109.449 175.639 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.752 0.311 . . . . 5.7300000000000004 111.611 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -131.59 140.31 49.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.673 0.273 . . . . 3.0800000000000001 110.929 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 41.8 t -80.9 98.09 7.71 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.61 -0.515 . . . . 1.8300000000000001 109.61 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -113.47 128.51 56.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.013 -0.539 . . . . 2.29 109.55 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.504 ' HB ' HG23 ' A' ' 134' ' ' THR . 35.1 t -106.56 111.79 36.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.407 -0.59 . . . . 2.1000000000000001 109.407 -175.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 49.5 mtp180 -84.99 92.51 8.35 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.014 0.435 . . . . 4.25 110.961 -176.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.636 HG23 HG21 ' A' ' 134' ' ' THR . 81.1 t -102.66 115.45 44.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.643 -0.873 . . . . 1.8200000000000001 108.643 171.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.2 169.22 23.74 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.601 -0.809 . . . . 1.1899999999999999 112.984 -174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -88.12 152.93 21.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.933 0.397 . . . . 2.1800000000000002 110.393 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.936 HD13 ' HB ' ' A' ' 28' ' ' VAL . 89.2 mt -134.74 144.67 47.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.844 -0.616 . . . . 2.0 110.214 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 m -134.41 115.77 14.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.793 -0.447 . . . . 1.5600000000000001 109.793 171.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.702 HG11 HG21 ' A' ' 25' ' ' ILE . 21.0 t -130.95 130.58 64.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.471 -0.332 . . . . 2.04 110.947 -176.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.707 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -99.89 99.67 10.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.377 -0.374 . . . . 1.23 110.517 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -165.86 167.69 16.58 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.426 -0.352 . . . . 3.9100000000000001 110.256 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.482 ' HA ' HG22 ' A' ' 142' ' ' VAL . 70.4 p -87.25 167.24 14.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 1.21 111.095 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -88.18 -12.16 44.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.83 -0.804 . . . . 4.0800000000000001 108.83 173.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.72 -29.88 74.18 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.541 -0.754 . . . . 0.75 111.423 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -62.91 -35.02 78.68 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.601 -0.518 . . . . 2.6299999999999999 109.601 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.552 HD12 ' HB ' ' A' ' 100' ' ' VAL . 48.9 mt -64.8 95.14 0.14 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.421 -0.809 . . . . 1.6100000000000001 110.118 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -98.16 72.57 2.16 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.973 -0.751 . . . . 2.2599999999999998 108.973 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 34.0 t70 56.18 -95.7 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.828 -1.078 . . . . 1.8300000000000001 109.814 -169.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -84.6 77.15 10.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.164 0.507 . . . . 1.4299999999999999 111.016 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -132.41 96.75 18.66 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.718 -0.674 . . . . 1.3700000000000001 109.734 175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.48 ' HD3' ' HE1' ' A' ' 99' ' ' TYR . 55.2 Cg_endo -71.9 96.89 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.54 2.16 . . . . 1.1200000000000001 112.457 -177.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.702 HG21 HG11 ' A' ' 12' ' ' VAL . 16.2 mt -86.64 -30.09 5.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.366 0.603 . . . . 3.0499999999999998 110.513 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.18 63.51 0.63 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.374 -0.917 . . . . 1.04 112.712 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 14.1 Cg_endo -58.67 106.32 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.342 2.028 . . . . 1.0 111.494 172.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.936 ' HB ' HD13 ' A' ' 10' ' ' LEU . 7.6 p -91.78 130.66 40.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.163 -0.471 . . . . 1.8300000000000001 110.24 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.9 m -85.7 98.04 10.47 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.9 -0.591 . . . . 2.2000000000000002 110.626 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.655 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 52.1 t -89.96 115.11 28.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.915 -0.584 . . . . 1.5600000000000001 110.213 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.461 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 0.2 OUTLIER -104.38 110.13 22.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.948 -0.569 . . . . 2.48 109.551 -176.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.31 105.51 17.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.245 -0.434 . . . . 1.25 110.793 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.61 121.03 23.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.6 -0.727 . . . . 2.4700000000000002 110.002 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.74 -120.3 8.8 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.741 -0.742 . . . . 1.8100000000000001 112.141 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 56.4 m 70.36 -58.03 0.56 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.25 0.62 . . . . 1.8799999999999999 110.722 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.458 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 93.4 m-20 70.1 -48.13 0.63 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.921 0.888 . . . . 2.71 113.272 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.1 77.91 1.22 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.239 -0.652 . . . . 1.3600000000000001 109.239 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.508 ' HG3' ' HB2' ' A' ' 120' ' ' TYR . 2.9 tpp85 -156.05 146.87 22.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.61 -0.723 . . . . 5.3499999999999996 110.493 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.704 ' HG3' HG13 ' A' ' 89' ' ' VAL . 55.3 mt-30 -83.2 116.43 22.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.365 -0.38 . . . . 1.9099999999999999 110.518 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 59.3 t -84.15 124.67 39.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.69 -0.485 . . . . 1.1699999999999999 109.69 176.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.643 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . . . -125.23 139.51 53.67 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.765 0.317 . . . . 1.0900000000000001 110.402 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 mt -102.85 129.28 49.48 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.79 -0.448 . . . . 1.4399999999999999 109.79 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.664 ' HZ2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -120.57 151.3 39.6 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.243 -0.651 . . . . 2.5299999999999998 109.243 176.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.576 ' HB2' ' ND2' ' A' ' 48' ' ' ASN . . . -100.54 152.91 19.84 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.081 0.467 . . . . 1.0700000000000001 110.632 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.405 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 17.7 t70 -75.18 148.46 39.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.359 -0.837 . . . . 0.70999999999999996 109.678 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.5 t -57.91 -17.07 14.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.026 0.75 . . . . 1.71 113.026 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.62 -32.17 70.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.975 0.417 . . . . 2.2200000000000002 110.202 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.593 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 4.8 p-10 -123.73 20.1 9.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.05 -0.523 . . . . 1.5800000000000001 110.237 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.589 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 61.6 t80 -139.97 106.22 5.26 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.619 -0.719 . . . . 0.72999999999999998 109.932 -177.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -107.36 108.21 19.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.641 -0.254 . . . . 2.4100000000000001 110.36 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 71.23 -53.87 0.67 Allowed 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.974 0.796 . . . . 4.1399999999999997 111.778 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.589 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -179.96 31.88 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.904 -0.665 . . . . 0.72999999999999998 112.578 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -134.63 134.91 41.72 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.757 -0.831 . . . . 2.6800000000000002 108.757 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -112.51 148.62 34.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.447 0.642 . . . . 0.65000000000000002 112.181 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.593 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 9.5 p90 -156.12 171.51 20.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.975 -1.012 . . . . 0.73999999999999999 110.304 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.658 HD21 HD21 ' A' ' 114' ' ' LEU . 10.2 mt -84.57 115.42 22.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.531 -0.914 . . . . 2.0800000000000001 108.531 172.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.443 HG23 ' HB3' ' A' ' 48' ' ' ASN . 7.7 tp -107.54 116.43 51.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.687 0.756 . . . . 1.21 110.96 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 23.8 p -62.43 151.36 37.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.33 -0.85 . . . . 1.9299999999999999 111.561 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.65 -24.11 64.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.168 0.509 . . . . 2.3100000000000001 110.355 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -93.5 17.56 11.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.815 -0.629 . . . . 3.6600000000000001 110.581 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 25.82 67.3 0.05 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.438 1.095 . . . . 3.0600000000000001 112.771 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.506 HH21 HG21 ' A' ' 107' ' ' THR . 7.1 ptm85 -120.41 -44.59 2.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.552 -0.749 . . . . 5.1799999999999997 111.895 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.656 ' HB3' ' HH ' ' A' ' 112' ' ' TYR . 26.4 t0 -138.5 139.66 38.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.754 -0.462 . . . . 2.5099999999999998 109.754 -175.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 2.2 pptp? -128.68 138.92 52.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.08 0.467 . . . . 2.6200000000000001 110.703 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.651 HD23 ' HB2' ' A' ' 104' ' ' GLN . 6.1 mp -129.16 120.53 26.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.189 -0.46 . . . . 2.48 110.666 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -70.7 131.79 44.42 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.0 -0.37 . . . . 1.1299999999999999 110.0 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 100' ' ' VAL . 15.7 m -128.6 124.47 61.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.248 -0.433 . . . . 1.29 110.759 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.53 120.12 32.68 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.266 0.555 . . . . 2.1000000000000001 110.16 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.43 HG22 ' HB ' ' A' ' 96' ' ' ILE . 2.9 mt -82.6 85.3 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 1.55 110.237 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 65.7 mtp180 -90.26 133.58 32.99 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.0 -0.741 . . . . 4.3300000000000001 109.0 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.62 ' HG3' ' CD1' ' A' ' 77' ' ' TRP . 40.3 Cg_endo -66.87 134.99 36.48 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.569 1.513 . . . . 0.90000000000000002 111.157 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.5 ttt -79.32 92.1 5.12 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.855 -0.612 . . . . 2.23 110.666 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 68.24 36.04 3.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.465 -0.789 . . . . 1.9199999999999999 112.064 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -139.11 115.23 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.055 0.761 . . . . 1.8899999999999999 113.055 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.8 m 63.21 -167.15 0.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.076 -0.965 . . . . 2.0699999999999998 113.0 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.41 114.31 19.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.655 -0.702 . . . . 1.5800000000000001 110.137 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.62 ' CD1' ' HG3' ' A' ' 71' ' ' PRO . 11.8 m95 -109.49 141.43 41.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.826 -0.625 . . . . 0.54000000000000004 110.705 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.1 m -80.44 111.35 16.76 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.53 -0.544 . . . . 1.22 109.53 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.6 t -86.04 113.47 22.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.798 0.809 . . . . 1.29 112.079 -173.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -129.29 156.07 44.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.154 -0.93 . . . . 1.7 108.509 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -82.87 -0.53 48.63 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.716 -0.394 . . . . 1.3899999999999999 111.61 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.57 -34.23 2.3 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.467 -0.873 . . . . 0.85999999999999999 111.868 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.577 HG13 ' HZ3' ' A' ' 121' ' ' TRP . 10.7 m -138.73 154.64 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.634 -0.506 . . . . 1.73 109.634 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.4 ' HD1' ' HE3' ' A' ' 77' ' ' TRP . 0.6 OUTLIER -140.48 106.86 5.27 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.105 -1.072 . . . . 0.41999999999999998 108.105 178.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 2.0 p90 -139.49 141.98 37.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.757 0.789 . . . . 1.1499999999999999 112.895 -170.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.589 ' HB2' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -70.64 128.22 35.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.987 -1.46 . . . . 2.0299999999999998 111.04 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.56 -35.34 79.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.59 . . . . 2.6600000000000001 109.69 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.589 ' OD1' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -68.5 125.75 27.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.364 -0.834 . . . . 2.1000000000000001 109.673 175.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.704 HG13 ' HG3' ' A' ' 39' ' ' GLN . 16.4 m -91.91 118.4 37.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.159 0.504 . . . . 1.6599999999999999 110.958 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.458 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 159.6 -169.14 35.6 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.393 -0.908 . . . . 0.63 112.348 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.3 p -70.4 151.27 45.37 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.127 -0.694 . . . . 1.5800000000000001 109.127 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.412 ' HD1' ' HZ2' ' A' ' 86' ' ' LYS . 37.0 t90 -135.71 -64.89 0.61 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.755 -0.378 . . . . 0.75 110.121 -175.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 35.86 85.28 0.01 OUTLIER Glycine 0 N--CA 1.468 0.776 0 O-C-N 124.307 1.004 . . . . 1.25 114.618 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.17 -153.91 6.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.922 -0.656 . . . . 1.0 112.236 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -106.11 132.9 51.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.198 0.523 . . . . 1.3200000000000001 112.363 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.638 HD12 ' CG2' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -125.22 141.04 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.857 -0.794 . . . . 2.2400000000000002 108.857 171.306 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -114.56 151.1 18.55 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.16 -1.019 . . . . 0.53000000000000003 112.647 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -92.7 114.34 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.514 -0.55 . . . . 1.53 109.514 174.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 10.1 m-85 -120.97 129.87 53.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.437 -0.802 . . . . 1.7 108.892 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.718 ' HA ' HG12 ' A' ' 67' ' ' VAL . 8.6 p -71.03 142.66 15.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.035 -0.357 . . . . 1.6799999999999999 110.035 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.57 95.45 0.33 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.385 -0.37 . . . . 1.02 110.867 176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 50.38 48.81 40.4 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.973 -0.558 . . . . 1.53 113.67 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.437 ' HA ' HG12 ' A' ' 100' ' ' VAL . 3.9 pt20 38.41 88.47 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.005 0.907 . . . . 2.5699999999999998 112.34 -174.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.651 ' HB2' HD23 ' A' ' 65' ' ' LEU . 38.5 mm-40 -56.98 -76.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.816 -1.083 . . . . 3.1699999999999999 113.129 -175.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -146.37 -64.66 0.3 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.388 -0.369 . . . . 2.8599999999999999 111.979 -169.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 15.7 t30 60.85 47.2 7.98 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 122.259 1.028 . . . . 1.5600000000000001 108.393 -170.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.506 HG21 HH21 ' A' ' 62' ' ' ARG . 16.2 m -72.45 123.31 89.35 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 114.84 -1.073 . . . . 2.0800000000000001 109.246 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -11.82 84.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.342 1 C-N-CA 125.966 4.444 . . . . 1.48 114.44 -164.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 2.8 Cg_endo -87.0 -169.09 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.634 2.889 . . . . 0.84999999999999998 114.035 -168.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.35 -111.82 0.25 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.224 -1.55 . . . . 0.76000000000000001 109.224 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -89.39 131.23 35.56 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.848 0.356 . . . . 2.04 110.311 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.656 ' HH ' ' HB3' ' A' ' 63' ' ' ASP . 6.3 m-85 -125.35 125.31 43.27 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.778 -0.452 . . . . 1.1100000000000001 109.778 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.9 m -96.63 129.36 44.04 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.698 -0.683 . . . . 1.3400000000000001 110.23 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.658 HD21 HD21 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -144.68 104.57 4.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.522 -0.918 . . . . 1.1699999999999999 108.522 171.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.405 ' HB ' ' CB ' ' A' ' 45' ' ' ASP . 32.5 m -108.19 123.97 49.57 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.527 -0.916 . . . . 1.4099999999999999 108.527 -174.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.416 ' N ' HD21 ' A' ' 116' ' ' LEU . 2.8 mm? -113.35 110.92 21.14 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.397 0.618 . . . . 1.8 110.755 -173.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 9.8 m -98.27 103.71 15.68 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.256 -0.884 . . . . 1.3200000000000001 108.733 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.744 ' H ' ' HB ' ' A' ' 134' ' ' THR . . . -92.29 -157.13 33.36 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 120.378 -0.915 . . . . 0.97999999999999998 112.023 -173.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 147.87 -167.9 28.77 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.707 -0.957 . . . . 0.64000000000000001 110.707 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.508 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 50.5 p90 -98.86 138.24 36.27 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.83 -0.748 . . . . 1.2 109.945 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.611 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 11.2 t-105 -91.72 141.7 28.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.473 -1.24 . . . . 0.65000000000000002 109.142 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.17 57.33 1.2 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.162 0.43 . . . . 1.55 112.162 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.506 ' C ' ' HE1' ' A' ' 121' ' ' TRP . 55.5 mmtt -158.96 -139.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.364 -0.976 . . . . 3.8700000000000001 108.364 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 126' ' ' LYS . 7.6 p-10 -154.84 100.47 2.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.32 0.581 . . . . 2.0800000000000001 112.087 173.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.611 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 27.1 t-20 60.65 -41.58 0.11 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.454 1.502 . . . . 3.0899999999999999 114.309 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 127' ' ' GLN . 19.4 ptpt -52.56 -51.18 60.95 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.753 0.649 . . . . 2.3799999999999999 112.753 -172.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.504 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 8.1 tt0 152.37 88.96 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.236 1.014 . . . . 2.1099999999999999 109.239 -176.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.446 ' HA3' ' CG ' ' A' ' 123' ' ' LYS . . . -142.31 90.65 0.17 Allowed Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.33 -0.938 . . . . 0.77000000000000002 111.129 172.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.664 ' HB3' ' HZ2' ' A' ' 43' ' ' LYS . 44.7 p90 -144.78 168.51 20.04 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.869 -0.419 . . . . 1.49 109.869 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 4.1 t -156.68 129.25 4.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.897 0.379 . . . . 1.8999999999999999 110.615 173.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 24.0 Cg_exo -64.2 110.71 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.939 2.426 . . . . 1.1699999999999999 111.776 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.1 t -131.57 91.93 3.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.395 -0.366 . . . . 1.96 110.314 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.25 -3.18 85.54 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.98 -0.629 . . . . 1.1699999999999999 112.702 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.744 ' HB ' ' H ' ' A' ' 118' ' ' GLY . 16.5 p -100.5 113.6 26.52 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 113.376 0.88 . . . . 2.9300000000000002 113.376 -168.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 54.4 m -141.3 94.88 2.75 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.624 -0.51 . . . . 2.1800000000000002 109.624 165.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.476 ' HA3' HG11 ' A' ' 7' ' ' VAL . . . -110.01 85.03 0.39 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.205 -0.998 . . . . 0.72999999999999998 112.729 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.8 m -81.15 95.01 6.75 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.618 -0.512 . . . . 1.23 109.618 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.602 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 27.5 m -89.15 108.5 19.64 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.106 -0.701 . . . . 1.1799999999999999 109.106 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 139' ' ' LYS . 29.1 ttmt -103.89 108.79 20.28 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.848 0.832 . . . . 2.6299999999999999 109.583 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.491 HD21 HD11 ' A' ' 56' ' ' LEU . 21.6 tp -105.35 104.05 13.7 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.281 -1.327 . . . . 1.3100000000000001 109.343 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.707 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.8 m -117.74 138.11 52.25 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.937 -0.574 . . . . 1.1799999999999999 110.883 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' A' ' 15' ' ' THR . 40.3 t -91.58 111.35 23.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.518 -0.919 . . . . 2.3900000000000001 108.518 170.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.407 -0.806 . . . . 2.5899999999999999 110.743 -176.555 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 109.111 -0.7 . . . . 5.7300000000000004 109.111 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.12 115.64 28.17 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.437 -0.579 . . . . 3.0800000000000001 109.437 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.1 m -91.68 109.54 20.85 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.0 -0.546 . . . . 1.8300000000000001 111.786 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -86.64 111.26 20.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.216 -0.661 . . . . 2.29 109.216 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.969 HG21 ' HA3' ' A' ' 118' ' ' GLY . 33.1 m -80.93 137.68 20.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.176 0.513 . . . . 2.1000000000000001 110.417 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.544 ' HA ' ' NE ' ' A' ' 6' ' ' ARG . 5.2 mmp_? -96.46 95.07 7.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.146 -0.479 . . . . 4.25 110.078 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.77 140.15 40.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.503 -0.771 . . . . 1.8200000000000001 109.163 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.62 136.08 9.54 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.388 -0.911 . . . . 1.1899999999999999 111.895 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.81 106.52 2.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.803 -0.443 . . . . 2.1800000000000002 109.803 177.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.551 HD11 HG22 ' A' ' 138' ' ' THR . 4.1 pp -116.73 151.29 36.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.308 -0.405 . . . . 2.0 110.779 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -120.61 123.64 43.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.038 -0.528 . . . . 1.5600000000000001 110.194 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.437 HG11 ' HG2' ' A' ' 14' ' ' LYS . 39.2 t -130.12 135.46 60.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.268 -0.424 . . . . 2.04 110.493 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -103.67 96.15 6.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.879 0.371 . . . . 1.23 110.658 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HG2' HG11 ' A' ' 12' ' ' VAL . 33.8 mmtp -144.32 163.44 33.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 3.9100000000000001 110.288 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.787 ' HA ' HG11 ' A' ' 142' ' ' VAL . 31.3 p -91.8 149.89 21.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.339 -0.392 . . . . 1.21 110.433 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.767 ' NH1' ' HG3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -81.97 -0.03 42.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.198 0.523 . . . . 4.0800000000000001 110.062 177.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.687 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -84.33 -22.75 53.54 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.816 -0.914 . . . . 0.75 110.816 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -56.61 -31.08 63.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.774 0.797 . . . . 2.6299999999999999 109.361 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.813 HD22 HG21 ' A' ' 25' ' ' ILE . 7.1 mt -89.61 111.27 22.17 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.832 -1.076 . . . . 1.6100000000000001 109.765 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -107.97 75.35 0.99 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.491 -0.929 . . . . 2.2599999999999998 108.491 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.653 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 36.4 t70 62.6 -93.18 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.401 -1.272 . . . . 1.8300000000000001 110.336 -170.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.23 73.84 10.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.321 0.581 . . . . 1.4299999999999999 111.065 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -152.79 121.6 3.23 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.259 -0.882 . . . . 1.3700000000000001 108.88 174.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 48.2 Cg_endo -89.85 151.06 4.97 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.074 2.516 . . . . 1.1200000000000001 113.654 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.813 HG21 HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.68 -64.46 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.627 -0.715 . . . . 3.0499999999999998 110.781 175.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.95 77.52 0.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.679 -0.772 . . . . 1.04 112.898 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.527 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 5.2 Cg_endo -48.24 111.1 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.32 2.68 . . . . 1.0 112.327 168.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.55 HG21 HD23 ' A' ' 10' ' ' LEU . 26.0 t -87.13 134.37 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.533 -0.758 . . . . 1.8300000000000001 110.305 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 32.4 p -78.09 79.26 4.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 2.2000000000000002 110.392 175.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.498 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 40.3 t -82.94 114.62 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.271 0.557 . . . . 1.5600000000000001 110.46 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.639 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 8.9 tt0 -110.94 135.07 52.01 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.13 -0.941 . . . . 2.48 109.96 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.462 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -104.76 123.8 48.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.084 -0.507 . . . . 1.25 110.572 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.39 123.05 49.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.258 -0.428 . . . . 2.4700000000000002 110.882 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.71 28.7 8.19 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.861 -0.685 . . . . 1.8100000000000001 111.939 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 32' ' ' ALA . 19.6 m -120.74 94.65 4.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.893 0.378 . . . . 1.8799999999999999 111.019 -176.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -98.48 -19.37 17.7 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.372 -0.603 . . . . 2.71 109.372 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -167.78 72.35 0.11 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.78 -0.645 . . . . 1.3600000000000001 111.138 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -152.36 146.9 25.71 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 110.319 -0.252 . . . . 5.3499999999999996 110.319 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.89 131.52 36.44 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.408 -0.59 . . . . 1.9099999999999999 109.408 174.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 95.1 t -103.1 120.34 52.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.193 -0.669 . . . . 1.1699999999999999 109.193 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.683 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -114.12 143.2 45.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.105 0.479 . . . . 1.0900000000000001 111.453 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.3 mt -102.78 114.75 29.27 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.719 -0.673 . . . . 1.4399999999999999 109.767 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.589 ' HZ1' ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -111.78 152.55 27.72 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.441 -0.8 . . . . 2.5299999999999998 109.093 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 116' ' ' LEU . . . -92.38 154.42 18.55 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.305 -0.628 . . . . 1.0700000000000001 109.305 170.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.72 159.13 31.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.203 -1.036 . . . . 0.70999999999999996 108.203 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.66 -20.58 34.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.707 1.003 . . . . 1.71 113.707 -168.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.25 -32.89 73.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.016 0.436 . . . . 2.2200000000000002 110.903 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -115.36 13.23 16.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.634 0.73 . . . . 1.5800000000000001 109.924 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -130.52 101.75 5.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.848 -0.614 . . . . 0.72999999999999998 109.506 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.45 103.31 14.2 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.988 -0.375 . . . . 2.4100000000000001 109.988 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 71.48 -56.64 0.63 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 124.084 0.865 . . . . 4.1399999999999997 111.322 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.28 39.08 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.036 -0.826 . . . . 0.72999999999999998 111.036 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.431 ' HB3' ' OD1' ' A' ' 81' ' ' ASN . 43.6 mmtm -138.36 135.03 34.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.172 -1.048 . . . . 2.6800000000000002 108.172 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.4 148.5 37.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.607 0.717 . . . . 0.65000000000000002 111.211 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.728 ' CE2' ' HB ' ' A' ' 57' ' ' ILE . 0.8 OUTLIER -145.93 -169.11 3.16 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.994 -1.003 . . . . 0.73999999999999999 110.755 -170.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.763 ' HG ' HD21 ' A' ' 114' ' ' LEU . 1.1 mp -111.2 104.24 12.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.567 -1.271 . . . . 2.0800000000000001 107.567 167.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.728 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 9.4 tp -107.81 136.5 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.273 0.559 . . . . 1.21 111.669 -172.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.2 t -70.72 140.55 51.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.003 -0.74 . . . . 1.9299999999999999 109.003 171.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.21 -16.97 64.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.981 0.42 . . . . 2.3100000000000001 111.118 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -87.32 -14.43 40.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 3.6600000000000001 110.657 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.5 t30 59.89 94.46 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.798 -0.637 . . . . 3.0600000000000001 110.966 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -153.74 -46.5 0.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 5.1799999999999997 110.126 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -117.31 138.63 51.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.508 -0.769 . . . . 2.5099999999999998 109.555 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.94 153.27 46.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.227 1.013 . . . . 2.6200000000000001 111.499 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.727 ' HG ' HE21 ' A' ' 104' ' ' GLN . 6.4 mp -120.65 175.58 5.94 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 113.377 -1.738 . . . . 2.48 106.82 169.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -126.56 145.13 50.65 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.58 -0.896 . . . . 1.1299999999999999 108.58 151.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.545 HG12 HD13 ' A' ' 56' ' ' LEU . 29.4 m -134.22 160.07 41.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.861 0.362 . . . . 1.29 110.867 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 99' ' ' TYR . 14.4 p-10 -126.11 111.99 15.31 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.853 -0.612 . . . . 2.1000000000000001 109.865 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.423 HG21 HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -72.88 101.44 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.033 -0.729 . . . . 1.55 109.033 173.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -122.14 139.86 31.28 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.825 -0.625 . . . . 4.3300000000000001 110.215 -170.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.51 122.61 5.93 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.67 2.246 . . . . 0.90000000000000002 111.793 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 53.7 ttp -53.09 -54.01 41.89 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.702 0.626 . . . . 2.23 111.706 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -155.96 15.03 0.34 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.954 0.407 . . . . 1.9199999999999999 110.504 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -80.81 -81.83 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.032 -0.531 . . . . 1.8899999999999999 111.658 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.462 ' HB2' ' HE1' ' A' ' 92' ' ' TRP . 3.7 m -136.56 172.35 13.15 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.472 -0.196 . . . . 2.0699999999999998 110.472 -175.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.98 122.46 32.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.989 0.423 . . . . 1.5800000000000001 110.859 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.495 ' HE3' ' HD1' ' A' ' 84' ' ' PHE . 12.5 m0 -107.79 156.94 18.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.892 -0.595 . . . . 0.54000000000000004 110.319 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 m -72.44 121.03 18.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.958 -0.756 . . . . 1.22 108.958 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 t -103.42 101.24 11.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.928 0.87 . . . . 1.29 112.979 -168.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.33 161.29 15.78 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.721 -1.214 . . . . 1.7 107.721 168.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 53' ' ' LYS . 2.1 t-20 -86.82 -7.26 58.4 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.696 -0.801 . . . . 1.3899999999999999 110.154 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.53 -30.29 3.6 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.525 -0.845 . . . . 0.85999999999999999 112.556 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.1 m -135.68 149.39 28.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 110.047 -0.353 . . . . 1.73 110.047 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.683 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -139.44 110.8 7.01 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.224 -0.658 . . . . 0.41999999999999998 109.224 -179.622 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 8.2 p90 -142.87 149.3 38.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.13 -0.322 . . . . 1.1499999999999999 110.13 -174.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.461 ' HB3' ' NE1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -74.47 145.07 43.9 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.037 -0.665 . . . . 2.0299999999999998 110.524 -178.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.03 -27.45 65.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.215 -0.902 . . . . 2.6600000000000001 110.969 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -95.09 -166.19 1.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.623 -0.717 . . . . 2.1000000000000001 110.551 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.6 -169.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.838 -0.619 . . . . 1.6599999999999999 109.413 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.65 -154.0 27.84 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.623 -0.798 . . . . 0.63 111.9 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.7 m -87.35 -171.69 3.59 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.156 -0.683 . . . . 1.5800000000000001 109.156 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.462 ' HE1' ' HB2' ' A' ' 75' ' ' SER . 77.9 t90 -168.33 -50.0 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.573 -0.529 . . . . 0.75 109.573 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.639 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 18.44 92.71 0.01 OUTLIER Glycine 0 N--CA 1.474 1.186 0 O-C-N 125.208 1.567 . . . . 1.25 115.862 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 29' ' ' THR . . . -150.33 -125.37 1.29 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.797 -0.716 . . . . 1.0 112.311 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.47 126.58 35.39 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.195 0.443 . . . . 1.3200000000000001 112.195 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -119.8 129.26 75.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.053 -0.721 . . . . 2.2400000000000002 109.053 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -112.79 152.34 17.95 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.257 -0.973 . . . . 0.53000000000000003 112.071 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.6 mp -90.12 112.48 24.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.898 -0.408 . . . . 1.53 109.898 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.476 ' HD2' ' N ' ' A' ' 23' ' ' ALA . 2.9 m-85 -107.03 140.68 39.45 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.223 -1.029 . . . . 1.7 108.223 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 8.5 p -84.19 136.36 22.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.47 . . . . 1.6799999999999999 109.919 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.57 112.33 16.73 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.193 -0.317 . . . . 1.02 110.658 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.9 37.01 60.96 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 1.53 113.238 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 17.9 pt20 39.82 103.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.481 1.289 . . . . 2.5699999999999998 114.481 177.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.727 HE21 ' HG ' ' A' ' 65' ' ' LEU . 6.0 tp-100 -62.8 -27.09 69.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.873 -0.603 . . . . 3.1699999999999999 109.897 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.9 m 65.11 14.84 9.65 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.846 0.832 . . . . 2.8599999999999999 110.069 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.687 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 20.6 t30 59.83 92.04 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.416 -1.265 . . . . 1.5600000000000001 112.488 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.1 m -94.93 124.51 54.14 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.621 -0.881 . . . . 2.0800000000000001 108.621 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -26.28 93.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.414 4.076 . . . . 1.48 114.934 -171.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.767 ' HG3' ' NH1' ' A' ' 16' ' ' ARG . 55.6 Cg_endo -100.18 -153.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 124.633 3.556 . . . . 0.84999999999999998 113.682 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.89 -104.73 0.18 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.504 -1.038 . . . . 0.76000000000000001 110.504 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.41 113.2 26.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.868 0.366 . . . . 2.04 110.323 175.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -107.52 135.64 48.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.208 0.527 . . . . 1.1100000000000001 109.937 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 42.5 m -116.97 98.97 6.76 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.176 -0.92 . . . . 1.3400000000000001 110.447 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.763 HD21 ' HG ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -110.61 91.63 3.73 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.494 0.664 . . . . 1.1699999999999999 110.173 178.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 1.2 m -82.84 125.65 31.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.314 -0.857 . . . . 1.4099999999999999 110.195 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 91.0 mt -115.72 110.65 19.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.882 0.372 . . . . 1.8 111.158 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 135' ' ' THR . 28.7 m -90.19 108.52 19.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.112 -0.495 . . . . 1.3200000000000001 110.25 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.969 ' HA3' HG21 ' A' ' 5' ' ' VAL . . . -74.4 178.26 44.99 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.952 -0.642 . . . . 0.97999999999999998 113.289 -176.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 153.56 -170.24 32.33 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 121.073 -0.584 . . . . 0.64000000000000001 111.663 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -103.52 -176.23 3.02 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.452 -0.499 . . . . 1.2 110.273 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.673 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 6.3 t-105 -144.8 151.63 39.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.655 -0.702 . . . . 0.65000000000000002 109.634 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -129.51 141.58 50.96 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.722 0.296 . . . . 1.55 111.471 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 20.5 mmtp 71.66 -152.21 0.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.101 0.961 . . . . 3.8700000000000001 112.078 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 126' ' ' LYS . 19.9 m-20 -132.9 110.86 10.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.68 0.622 . . . . 2.0800000000000001 112.68 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.673 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 12.3 m120 59.43 -7.72 0.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.781 1.232 . . . . 3.0899999999999999 114.3 174.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -75.86 -3.68 36.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.841 0.353 . . . . 2.3799999999999999 110.767 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.912 HE21 ' HE2' ' A' ' 129' ' ' PHE . 59.7 tt0 74.61 85.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.978 -1.01 . . . . 2.1099999999999999 110.83 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -120.48 33.0 4.65 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.484 -0.865 . . . . 0.77000000000000002 111.466 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.912 ' HE2' HE21 ' A' ' 127' ' ' GLN . 11.4 p90 -78.89 152.3 31.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.11 0.481 . . . . 1.49 110.535 -172.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.438 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 34.5 m -134.99 133.28 20.82 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.792 -0.64 . . . . 1.8999999999999999 109.561 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.11 112.24 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.286 1.991 . . . . 1.1699999999999999 111.818 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.4 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 13.5 m -139.22 105.99 5.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.739 -0.664 . . . . 1.96 109.69 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 126.91 -128.12 6.15 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.561 -0.828 . . . . 1.1699999999999999 111.492 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.2 m -133.12 159.16 40.93 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.627 -0.508 . . . . 2.9300000000000002 109.627 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 12.6 t -97.18 110.37 22.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.616 0.722 . . . . 2.1800000000000002 109.342 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -90.16 118.39 5.28 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.754 -0.736 . . . . 0.72999999999999998 112.144 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 7.4 m -84.77 101.29 12.12 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.715 -0.476 . . . . 1.23 109.715 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.551 HG22 HD11 ' A' ' 10' ' ' LEU . 19.6 m -77.91 108.9 11.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.244 -1.021 . . . . 1.1799999999999999 108.244 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.441 ' HB2' ' HE3' ' A' ' 139' ' ' LYS . 32.5 ttmt -97.05 108.99 21.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.688 0.756 . . . . 2.6299999999999999 110.439 -172.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 tp -107.11 108.15 19.48 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.461 -1.245 . . . . 1.3100000000000001 110.253 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.672 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 10.6 m -108.43 117.32 33.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.37 -0.832 . . . . 1.1799999999999999 109.077 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 15' ' ' THR . 39.5 t -93.11 116.26 33.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.206 0.527 . . . . 2.3900000000000001 112.058 -172.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.5 m . . . . . 0 C--O 1.249 1.067 0 CA-C-N 115.262 -0.881 . . . . 2.5899999999999999 109.249 172.945 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.469 0.652 . . . . 5.7300000000000004 111.377 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -120.76 169.21 10.63 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.91 -0.774 . . . . 3.0800000000000001 108.91 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 91.5 m -62.36 88.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.527 0.517 . . . . 1.8300000000000001 112.146 -176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -87.86 108.65 19.27 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.873 -1.158 . . . . 2.29 107.873 171.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -93.21 111.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.597 -0.52 . . . . 2.1000000000000001 109.597 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.547 HH21 ' NE2' ' A' ' 31' ' ' GLN . 71.4 mtm180 -94.45 97.42 10.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.951 -0.568 . . . . 4.25 110.77 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.0 t -103.5 115.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.114 -0.948 . . . . 1.8200000000000001 108.651 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.1 155.44 23.62 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.399 -0.905 . . . . 1.1899999999999999 112.249 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -73.34 142.95 47.06 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.973 -0.38 . . . . 2.1800000000000002 109.973 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -157.16 148.49 22.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.085 -0.507 . . . . 2.0 109.95 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.5 t -109.55 133.58 52.93 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.093 0.473 . . . . 1.5600000000000001 109.887 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.9 t -117.34 126.2 74.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.761 -0.654 . . . . 2.04 109.378 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -106.16 104.12 13.75 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.409 -0.219 . . . . 1.23 110.409 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -172.59 -178.67 1.99 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.155 -0.475 . . . . 3.9100000000000001 110.835 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.484 HG22 HG21 ' A' ' 142' ' ' VAL . 46.3 p -102.93 167.09 10.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.89 -0.595 . . . . 1.21 110.933 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.753 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -87.8 -10.34 51.2 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.863 -0.791 . . . . 4.0800000000000001 108.863 175.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.608 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -71.29 -20.32 78.08 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.293 -0.867 . . . . 0.75 111.578 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -58.57 -41.33 85.46 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.596 0.712 . . . . 2.6299999999999999 109.365 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.645 HD22 HG12 ' A' ' 25' ' ' ILE . 4.5 mt -80.19 100.07 8.11 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.615 -1.175 . . . . 1.6100000000000001 110.449 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.648 HG21 HE21 ' A' ' 103' ' ' GLN . 0.8 OUTLIER -103.66 70.76 1.04 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.784 -0.821 . . . . 2.2599999999999998 108.784 174.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 1.0 OUTLIER 67.16 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.647 -1.16 . . . . 1.8300000000000001 110.295 -171.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.63 66.01 5.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.308 0.575 . . . . 1.4299999999999999 111.194 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 19' ' ' LEU . . . -141.94 115.36 6.61 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.39 -0.823 . . . . 1.3700000000000001 109.858 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.5 Cg_endo -91.52 151.12 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.51 2.806 . . . . 1.1200000000000001 113.341 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.645 HG12 HD22 ' A' ' 19' ' ' LEU . 3.3 pt -116.97 -56.58 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 3.0499999999999998 112.174 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.487 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -114.04 88.97 0.5 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.475 -0.869 . . . . 1.04 112.914 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 38.2 Cg_exo -60.46 126.93 21.24 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.601 2.201 . . . . 1.0 112.067 172.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.5 t -98.66 127.7 50.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.984 -0.553 . . . . 1.8300000000000001 110.273 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 m -74.45 101.24 4.07 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 116.156 -0.475 . . . . 2.2000000000000002 110.489 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 99.3 t -104.04 115.6 46.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.101 -0.5 . . . . 1.5600000000000001 110.525 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.617 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 8.2 tt0 -113.61 107.02 15.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.999 0.428 . . . . 2.48 110.713 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.75 109.06 20.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.644 -0.707 . . . . 1.25 109.835 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.28 130.29 48.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.025 -0.534 . . . . 2.4700000000000002 110.287 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.68 29.51 10.73 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.798 -0.715 . . . . 1.8100000000000001 113.203 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.5 m -94.07 -74.07 0.55 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.926 0.343 . . . . 1.8799999999999999 111.926 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.535 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 9.1 t30 71.2 -44.69 0.6 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.85 0.46 . . . . 2.71 112.062 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.14 76.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.205 0.526 . . . . 1.3600000000000001 110.282 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.532 ' H ' ' N ' ' A' ' 90' ' ' GLY . 1.7 tpm_? -157.82 148.52 20.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.436 -0.802 . . . . 5.3499999999999996 110.455 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.436 HE21 ' HD1' ' A' ' 121' ' ' TRP . 19.8 mt-30 -86.2 134.67 33.76 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.098 -0.705 . . . . 1.9099999999999999 109.098 172.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 93.3 t -110.53 125.3 67.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.943 -0.391 . . . . 1.1699999999999999 109.943 -176.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB1' ' HE2' ' A' ' 43' ' ' LYS . . . -117.54 152.62 34.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 123.485 0.491 . . . . 1.0900000000000001 111.293 -173.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' A' ' 84' ' ' PHE . 28.2 mt -103.76 104.41 14.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.734 -0.666 . . . . 1.4399999999999999 109.868 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.682 ' HE2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -98.38 122.75 41.95 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.311 -0.626 . . . . 2.5299999999999998 109.311 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.497 ' HB2' ' CD1' ' A' ' 49' ' ' PHE . . . -83.48 158.21 22.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.332 -0.395 . . . . 1.0700000000000001 110.774 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.686 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 13.6 t70 -87.19 152.2 22.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.188 -0.46 . . . . 0.70999999999999996 109.782 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -54.74 -20.37 8.26 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.803 0.668 . . . . 1.71 112.803 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.9 -37.54 74.21 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.936 0.398 . . . . 2.2200000000000002 111.269 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 5.6 p-10 -129.27 16.14 6.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.895 -0.593 . . . . 1.5800000000000001 109.956 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 82.2 t80 -132.85 101.73 5.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.308 -0.86 . . . . 0.72999999999999998 109.148 -176.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -93.58 93.83 8.29 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.198 -0.456 . . . . 2.4100000000000001 110.571 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 69.46 -50.3 0.61 Allowed 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.154 0.909 . . . . 4.1399999999999997 112.103 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.51 35.73 0.16 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.772 -0.531 . . . . 0.72999999999999998 111.772 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 43.4 mmtm -137.49 133.28 34.42 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.404 -0.961 . . . . 2.6800000000000002 108.404 172.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -117.43 136.57 53.09 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.004 0.907 . . . . 0.65000000000000002 112.077 178.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 30.8 p90 -141.06 -176.7 4.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.049 -1.432 . . . . 0.73999999999999999 108.51 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.897 HD22 HD23 ' A' ' 114' ' ' LEU . 10.9 mt -102.7 127.58 49.77 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.549 -0.908 . . . . 2.0800000000000001 108.549 172.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.45 133.88 49.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.406 0.622 . . . . 1.21 110.636 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 112' ' ' TYR . 29.5 t -83.87 150.06 25.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.323 -0.853 . . . . 1.9299999999999999 110.654 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.18 -26.41 68.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.962 -0.563 . . . . 2.3100000000000001 110.239 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -75.32 -13.62 60.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.658 . . . . 3.6600000000000001 110.537 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.6 m120 61.09 20.04 10.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.568 -0.742 . . . . 3.0600000000000001 111.999 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.846 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -95.49 -70.42 0.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.875 0.369 . . . . 5.1799999999999997 110.989 -177.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.67 158.48 16.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.788 -0.642 . . . . 2.5099999999999998 111.845 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.46 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -143.66 175.08 10.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.24 -0.891 . . . . 2.6200000000000001 110.319 -178.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.471 HD13 HG21 ' A' ' 100' ' ' VAL . 1.5 pt? -157.17 125.57 5.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.28 -0.418 . . . . 2.48 110.29 173.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 94.2 m-85 -72.83 144.74 47.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.052 -0.722 . . . . 1.1299999999999999 109.052 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' ' HE1' ' A' ' 54' ' ' PHE . 15.7 m -123.66 157.18 30.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.308 0.575 . . . . 1.29 111.784 -175.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.464 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -118.94 111.54 18.48 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.438 -0.949 . . . . 2.1000000000000001 108.438 171.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.4 HG22 HD12 ' A' ' 96' ' ' ILE . 0.9 OUTLIER -92.52 86.17 2.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.33 -0.619 . . . . 1.55 109.33 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.5 ' HG3' ' HD2' ' A' ' 71' ' ' PRO . 57.7 ttp180 -112.41 142.15 26.47 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.41 -0.589 . . . . 4.3300000000000001 109.41 -174.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 84.9 Cg_exo -44.26 140.23 5.83 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.052 2.501 . . . . 0.90000000000000002 112.927 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 52.8 ttp -60.56 -52.96 62.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.693 -0.855 . . . . 2.23 108.693 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -153.34 107.63 3.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.138 -0.937 . . . . 1.9199999999999999 109.315 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -168.73 -163.15 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.737 0.303 . . . . 1.8899999999999999 111.191 -175.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 p -60.32 168.06 2.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.882 -0.599 . . . . 2.0699999999999998 112.02 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 120.16 23.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.73 -0.668 . . . . 1.5800000000000001 111.153 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.793 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.8 m95 -107.34 134.11 50.89 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.543 -0.753 . . . . 0.54000000000000004 109.967 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.9 m -76.35 116.73 17.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.524 -0.547 . . . . 1.22 109.524 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 t -88.57 115.51 26.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.492 0.663 . . . . 1.29 112.329 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -129.06 159.79 34.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.69 -1.226 . . . . 1.7 107.69 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -84.26 -6.71 59.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.42 -0.512 . . . . 1.3899999999999999 111.57 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.57 -35.39 3.83 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.126 -1.035 . . . . 0.85999999999999999 111.761 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 30.4 m -140.32 154.24 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.885 0.374 . . . . 1.73 110.134 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.1 t80 -138.18 106.82 5.88 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.019 -1.104 . . . . 0.41999999999999998 108.019 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 6.0 p90 -140.65 144.08 35.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.817 0.341 . . . . 1.1499999999999999 111.662 -171.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.793 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 25.7 pttm -72.58 142.24 48.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 2.0299999999999998 109.625 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.416 HD21 ' N ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -77.63 -5.54 50.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.293 0.568 . . . . 2.6600000000000001 110.35 178.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.416 ' N ' HD21 ' A' ' 87' ' ' ASN . 6.6 m-20 -86.08 142.93 28.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.392 -0.822 . . . . 2.1000000000000001 110.182 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 m -99.5 108.62 22.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.483 0.658 . . . . 1.6599999999999999 110.633 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.535 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 167.11 -164.12 37.63 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.648 -0.705 . . . . 0.63 111.707 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.3 m -79.97 -178.19 6.36 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.2 -0.667 . . . . 1.5800000000000001 109.2 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.462 ' CH2' HG21 ' A' ' 96' ' ' ILE . 29.0 t90 -154.9 -61.84 0.12 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.571 -0.451 . . . . 0.75 110.367 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 34.15 85.63 0.01 OUTLIER Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.436 1.085 . . . . 1.25 115.242 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.58 -151.35 6.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.771 -0.728 . . . . 1.0 112.5 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -118.34 124.17 47.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.461 0.648 . . . . 1.3200000000000001 112.514 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 13.7 pt -108.5 148.75 12.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.319 -0.855 . . . . 2.2400000000000002 109.159 174.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.35 151.25 17.55 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.303 -0.951 . . . . 0.53000000000000003 111.365 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 70.1 mt -95.11 112.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 120.295 -0.562 . . . . 1.53 110.339 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.464 ' HD1' ' O ' ' A' ' 68' ' ' ASN . 10.5 m-85 -104.7 151.95 23.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.972 -1.013 . . . . 1.7 108.514 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 104' ' ' GLN . 8.1 p -83.07 140.03 16.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.441 -0.504 . . . . 1.6799999999999999 109.693 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.81 82.27 2.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.937 -0.764 . . . . 1.02 108.937 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.55 114.69 0.58 Allowed Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.636 -0.711 . . . . 1.53 111.459 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.648 HE21 HG21 ' A' ' 20' ' ' THR . 7.2 tt0 -32.53 107.11 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.973 0.909 . . . . 2.5699999999999998 112.64 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.478 ' HB2' HG23 ' A' ' 100' ' ' VAL . 48.8 tp60 -78.01 -13.26 59.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.571 . . . . 3.1699999999999999 110.461 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.2 m 64.71 15.85 10.02 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.791 -0.64 . . . . 2.8599999999999999 111.036 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.753 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 10.4 t30 58.29 77.67 0.28 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.351 0.596 . . . . 1.5600000000000001 110.918 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.423 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 11.2 t -77.81 144.1 68.06 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.386 -0.968 . . . . 2.0800000000000001 108.386 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 45.1 Cg_exo -27.51 92.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.984 3.789 . . . . 1.48 114.388 -173.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -100.1 -157.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 123.398 2.732 . . . . 0.84999999999999998 113.791 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.17 -91.06 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.683 -1.367 . . . . 0.76000000000000001 109.683 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -125.75 119.35 27.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.305 -0.628 . . . . 2.04 109.305 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 58' ' ' SER . 24.6 m-85 -108.81 128.42 54.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.352 0.596 . . . . 1.1100000000000001 110.293 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.1 m -105.87 122.29 45.81 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.927 -1.033 . . . . 1.3400000000000001 110.369 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.897 HD23 HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -136.86 121.59 18.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.928 -0.578 . . . . 1.1699999999999999 109.688 176.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 6.5 m -112.08 128.42 56.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.797 -0.638 . . . . 1.4099999999999999 109.296 -174.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.414 ' N ' HD21 ' A' ' 116' ' ' LEU . 3.0 mm? -121.57 119.7 32.67 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.02 0.438 . . . . 1.8 110.527 -173.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.2 m -94.65 117.7 30.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.074 -0.512 . . . . 1.3200000000000001 110.605 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.15 146.72 49.4 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.838 -0.696 . . . . 0.97999999999999998 112.318 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.48 156.98 9.91 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 111.544 -0.623 . . . . 0.64000000000000001 111.544 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -89.48 -176.66 5.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.223 0.535 . . . . 1.2 110.762 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.7 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 1.3 t-105 -142.08 151.92 42.81 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.182 -0.917 . . . . 0.65000000000000002 110.02 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.56 144.33 51.08 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.0 -0.546 . . . . 1.55 111.23 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.67 ' HG2' ' H ' ' A' ' 124' ' ' ASP . 34.3 tttp 67.61 -147.79 0.15 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.455 1.102 . . . . 3.8700000000000001 111.906 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.67 ' H ' ' HG2' ' A' ' 123' ' ' LYS . 6.7 m-20 -139.67 118.65 12.57 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.573 0.583 . . . . 2.0800000000000001 112.573 -173.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.661 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.7 OUTLIER 45.49 14.02 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.427 1.639 . . . . 3.0899999999999999 115.427 175.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.552 ' HE2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -92.32 -2.18 56.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.56 0.695 . . . . 2.3799999999999999 109.832 175.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.7 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 20.5 mt-30 72.71 54.19 0.15 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 114.37 -1.286 . . . . 2.1099999999999999 111.923 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.522 ' N ' ' HD2' ' A' ' 126' ' ' LYS . . . -89.86 93.44 1.88 Allowed Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 108.826 -1.71 . . . . 0.77000000000000002 108.826 165.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.552 ' HB2' ' HZ2' ' A' ' 43' ' ' LYS . 50.8 p90 -134.84 134.91 41.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 117.91 0.855 . . . . 1.49 110.863 -173.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.8 m -115.78 134.88 22.64 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 116.091 -0.504 . . . . 1.8999999999999999 110.217 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.34 106.03 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.882 2.388 . . . . 1.1699999999999999 111.084 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.8 m -146.6 99.3 3.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.042 0.449 . . . . 1.96 110.342 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 141.61 -141.52 11.12 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.383 -0.913 . . . . 1.1699999999999999 112.603 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 6' ' ' ARG . 2.7 m -100.13 143.27 30.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.627 0.251 . . . . 2.9300000000000002 110.86 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 24.1 m -94.73 95.86 9.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.147 -0.686 . . . . 2.1800000000000002 109.147 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.45 155.65 21.83 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.777 -0.725 . . . . 0.72999999999999998 112.049 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -124.78 114.56 19.41 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.655 0.265 . . . . 1.23 110.647 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.768 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 3.5 m -89.69 119.88 30.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.221 -1.029 . . . . 1.1799999999999999 108.221 172.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -117.48 109.36 16.64 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.687 0.756 . . . . 2.6299999999999999 110.392 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.402 ' HG ' ' NH2' ' A' ' 16' ' ' ARG . 23.9 tp -101.93 106.1 16.99 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.425 -1.262 . . . . 1.3100000000000001 111.112 -172.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 6.2 m -105.02 143.77 32.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.49 -0.777 . . . . 1.1799999999999999 109.32 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.484 HG21 HG22 ' A' ' 15' ' ' THR . 7.3 p -89.22 128.77 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.162 0.506 . . . . 2.3900000000000001 111.065 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.624 -0.716 . . . . 2.5899999999999999 110.082 177.947 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 120.628 0.251 . . . . 5.7300000000000004 110.46 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.423 ' OE2' ' HB2' ' A' ' 4' ' ' GLN . 41.1 tt0 -127.06 143.17 51.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.823 0.344 . . . . 3.0800000000000001 110.996 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.414 ' SG ' ' HG2' ' A' ' 38' ' ' ARG . 42.3 t -101.97 91.25 4.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.374 -0.973 . . . . 1.8300000000000001 108.374 172.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 1.11 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 5.4 tt0 -108.6 119.52 39.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.729 -0.669 . . . . 2.29 111.593 -172.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.423 HG23 HG12 ' A' ' 40' ' ' VAL . 22.5 t -91.61 111.54 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.046 -0.724 . . . . 2.1000000000000001 109.046 173.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 88.2 mtt180 -87.83 109.49 19.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.254 -0.43 . . . . 4.25 111.654 -177.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 116' ' ' LEU . 48.9 t -125.21 115.37 43.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.293 -0.867 . . . . 1.8200000000000001 109.152 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.37 -179.37 35.33 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.598 -0.81 . . . . 1.1899999999999999 111.965 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -99.02 147.25 25.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.922 0.391 . . . . 2.1800000000000002 109.978 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.48 147.36 20.48 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.364 -0.606 . . . . 2.0 109.364 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.7 m -116.94 117.68 30.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.907 0.384 . . . . 1.5600000000000001 111.09 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.15 109.48 28.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.884 -0.598 . . . . 2.04 109.431 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -83.61 96.65 8.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.229 -0.441 . . . . 1.23 111.188 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -149.9 179.41 8.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.16 0.505 . . . . 3.9100000000000001 110.94 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.407 ' HA ' HH11 ' A' ' 16' ' ' ARG . 52.9 p -101.77 167.43 10.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.738 -0.664 . . . . 1.21 109.875 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.566 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.3 OUTLIER -86.3 -11.62 51.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.792 -0.818 . . . . 4.0800000000000001 108.792 177.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.598 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -81.21 -24.98 56.25 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.959 -1.019 . . . . 0.75 111.038 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -61.7 -26.62 68.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.41 0.624 . . . . 2.6299999999999999 110.119 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.637 ' HG ' HG22 ' A' ' 100' ' ' VAL . 0.6 OUTLIER -67.27 -54.46 20.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.053 -0.976 . . . . 1.6100000000000001 109.917 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.8 m 56.81 49.02 14.97 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.825 -1.079 . . . . 2.2599999999999998 109.221 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' N ' ' HB3' ' A' ' 103' ' ' GLN . 20.9 t70 77.38 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.279 -1.328 . . . . 1.8300000000000001 110.428 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.416 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -109.69 87.35 2.48 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.272 0.471 . . . . 1.4299999999999999 112.272 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.87 113.65 3.15 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 1.3700000000000001 109.916 169.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' HD3' ' HE2' ' A' ' 99' ' ' TYR . 50.8 Cg_endo -68.46 94.05 0.43 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.689 2.259 . . . . 1.1200000000000001 111.814 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.611 HG13 HD21 ' A' ' 19' ' ' LEU . 51.3 mm -89.34 -42.94 14.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.988 -0.551 . . . . 3.0499999999999998 111.639 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.77 51.98 0.75 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 119.636 -1.269 . . . . 1.04 113.9 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.534 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 8.9 Cg_endo -50.21 123.46 11.09 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.312 2.675 . . . . 1.0 112.481 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.69 139.7 24.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.21 -0.45 . . . . 1.8300000000000001 110.047 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 t -82.75 102.88 11.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.92 0.867 . . . . 2.2000000000000002 110.751 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 67.0 t -94.17 114.52 30.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.963 -1.017 . . . . 1.5600000000000001 110.292 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 57.5 tt0 -99.21 126.47 45.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.784 -0.45 . . . . 2.48 109.784 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.7 94.95 8.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.294 -0.412 . . . . 1.25 109.996 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . 6.4 tt -80.01 114.1 18.67 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.006 -0.739 . . . . 2.4700000000000002 109.006 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.98 -129.91 10.57 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.603 -0.808 . . . . 1.8100000000000001 111.252 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.0 m 64.05 23.14 13.15 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.603 0.237 . . . . 1.8799999999999999 111.593 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.499 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 3.6 t-20 -59.81 -29.67 68.4 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.157 0.429 . . . . 2.71 112.157 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.6 25.31 10.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.214 0.53 . . . . 1.3600000000000001 110.269 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.414 ' HG2' ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -123.92 154.71 39.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.133 -0.485 . . . . 5.3499999999999996 111.253 -172.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.704 ' HG3' HG13 ' A' ' 89' ' ' VAL . 16.1 mt-30 -93.14 128.75 39.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.945 -0.57 . . . . 1.9099999999999999 109.533 173.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 87.2 t -101.7 117.13 46.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.492 -0.322 . . . . 1.1699999999999999 110.669 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.73 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -114.44 167.09 11.03 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 123.402 0.439 . . . . 1.0900000000000001 110.381 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.3 mt -120.11 109.66 15.72 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.061 -0.518 . . . . 1.4399999999999999 109.632 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.94 ' HE2' HG23 ' A' ' 83' ' ' VAL . 20.4 mmtp -105.86 119.77 40.02 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.552 0.691 . . . . 2.5299999999999998 110.131 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.632 ' HB2' ' ND2' ' A' ' 48' ' ' ASN . . . -71.48 155.3 40.75 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.553 -1.203 . . . . 1.0700000000000001 110.363 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 13.5 t70 -72.19 153.73 41.44 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.937 -0.764 . . . . 0.70999999999999996 108.937 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -58.56 -18.81 32.7 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.183 0.438 . . . . 1.71 112.183 -172.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -62.89 -37.57 87.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.821 0.343 . . . . 2.2200000000000002 110.985 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.632 ' ND2' ' HB2' ' A' ' 44' ' ' ALA . 8.0 p-10 -125.18 20.28 8.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.178 0.514 . . . . 1.5800000000000001 110.335 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.702 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 27.3 t80 -127.92 107.42 9.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.296 -0.866 . . . . 0.72999999999999998 108.708 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 7.2 pt-20 -106.96 107.01 17.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.501 -0.318 . . . . 2.4100000000000001 110.454 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 70.79 -56.26 0.62 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.03 0.532 . . . . 4.1399999999999997 111.294 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.702 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -176.03 34.05 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.78 -0.928 . . . . 0.72999999999999998 110.78 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 18.5 mmtp -132.34 135.0 45.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.639 -0.874 . . . . 2.6800000000000002 108.639 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.499 ' CD2' ' HA2' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -107.49 140.11 40.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.47 0.652 . . . . 0.65000000000000002 110.934 171.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.777 ' CD2' ' HB2' ' A' ' 64' ' ' LYS . 40.6 p90 -147.49 174.36 11.78 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.208 -0.905 . . . . 0.73999999999999999 110.353 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.498 HD21 HD21 ' A' ' 114' ' ' LEU . 16.9 mt -88.31 116.95 26.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.392 -0.966 . . . . 2.0800000000000001 108.392 171.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.574 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 8.0 tp -106.42 128.54 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.546 0.689 . . . . 1.21 110.927 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.6 p -66.56 129.23 39.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.254 -0.885 . . . . 1.9299999999999999 110.161 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.15 -30.33 70.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.325 0.583 . . . . 2.3100000000000001 109.67 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.91 -14.29 62.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.046 -0.979 . . . . 3.6600000000000001 110.487 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 59.66 81.91 0.16 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.244 -0.889 . . . . 3.0600000000000001 110.559 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.429 ' NH1' ' HB2' ' A' ' 108' ' ' PRO . 9.3 ptp180 -144.07 -41.44 0.27 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.68 -0.691 . . . . 5.1799999999999997 111.218 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -147.36 174.59 11.52 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.497 -0.481 . . . . 2.5099999999999998 111.483 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.777 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -160.29 142.77 13.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.706 -0.679 . . . . 2.6200000000000001 110.526 -177.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 65' ' ' LEU . 1.8 pt? -140.6 132.44 27.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.551 0.215 . . . . 2.48 110.96 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.432 ' CZ ' ' HE3' ' A' ' 64' ' ' LYS . 17.0 m-85 -72.22 141.67 48.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.381 . . . . 1.1299999999999999 110.749 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.67 HG11 ' HA ' ' A' ' 100' ' ' VAL . 13.3 m -135.31 128.85 49.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.056 -0.52 . . . . 1.29 110.547 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -94.51 113.36 25.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.555 0.693 . . . . 2.1000000000000001 110.336 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -76.93 85.5 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.424 -0.807 . . . . 1.55 109.907 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.668 ' HG2' ' HD2' ' A' ' 71' ' ' PRO . 13.8 ttp180 -98.32 140.59 21.95 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.36 -0.836 . . . . 4.3300000000000001 109.216 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.668 ' HD2' ' HG2' ' A' ' 70' ' ' ARG . 97.4 Cg_exo -43.42 136.56 5.97 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.816 2.344 . . . . 0.90000000000000002 112.807 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.2 tpt -63.41 -58.91 5.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.876 -0.602 . . . . 2.23 110.3 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -159.66 105.04 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.991 -0.55 . . . . 1.9199999999999999 111.142 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.459 HD22 ' HZ2' ' A' ' 92' ' ' TRP . 2.8 p30 -174.47 -88.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.416 0.448 . . . . 1.8899999999999999 111.594 172.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.4 m -127.13 -175.44 3.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.638 0.256 . . . . 2.0699999999999998 110.522 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.29 139.37 36.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.348 -0.387 . . . . 1.5800000000000001 111.264 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.484 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 11.2 m0 -114.0 151.18 32.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.669 -0.696 . . . . 0.54000000000000004 109.779 176.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.2 m -70.69 116.29 10.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.31 -0.626 . . . . 1.22 109.31 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t -96.49 117.45 30.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.469 0.652 . . . . 1.29 112.584 -171.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.18 161.99 26.42 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.287 -1.005 . . . . 1.7 108.287 170.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -21.02 63.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.818 0.303 . . . . 1.3899999999999999 111.818 -171.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.499 ' HA2' ' CD2' ' A' ' 54' ' ' PHE . . . -139.44 16.23 3.15 Favored Glycine 0 CA--C 1.509 -0.285 0 N-CA-C 111.519 -0.632 . . . . 0.85999999999999999 111.519 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.94 HG23 ' HE2' ' A' ' 43' ' ' LYS . 95.8 t -139.2 124.63 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.867 -0.79 . . . . 1.73 108.867 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.73 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -139.22 105.47 5.26 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.087 -0.708 . . . . 0.41999999999999998 109.087 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 1.3 p90 -145.86 141.75 28.15 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.56 0.538 . . . . 1.1499999999999999 110.529 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.484 ' HB3' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -75.93 138.93 41.33 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.56 -0.456 . . . . 2.0299999999999998 109.81 177.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.84 -29.14 68.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.369 -0.832 . . . . 2.6600000000000001 110.259 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 16.6 m-20 -75.13 137.6 41.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.225 -0.898 . . . . 2.1000000000000001 110.75 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.704 HG13 ' HG3' ' A' ' 39' ' ' GLN . 27.7 m -90.46 132.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.729 -0.471 . . . . 1.6599999999999999 109.729 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 36' ' ' ASN . . . 146.55 -170.4 27.59 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.645 -0.788 . . . . 0.63 111.179 -174.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.5 m -77.65 -175.1 3.72 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 109.573 -0.528 . . . . 1.5800000000000001 109.573 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.459 ' HZ2' HD22 ' A' ' 74' ' ' ASN . 76.2 t90 -163.3 -56.47 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.752 -0.462 . . . . 0.75 109.752 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 32.15 95.15 0.01 OUTLIER Glycine 0 N--CA 1.47 0.917 0 O-C-N 124.843 1.34 . . . . 1.25 115.674 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.64 -165.62 27.31 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.515 -0.634 . . . . 1.0 111.515 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 p -101.35 128.74 47.38 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.063 0.459 . . . . 1.3200000000000001 111.908 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.602 HG21 ' HA ' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -112.71 158.54 13.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.442 -0.948 . . . . 2.2400000000000002 108.442 167.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -116.97 153.69 17.21 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.244 -0.979 . . . . 0.53000000000000003 112.449 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.512 HG21 ' HB ' ' A' ' 67' ' ' VAL . 2.8 mp -91.07 114.34 28.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.766 -0.457 . . . . 1.53 109.766 175.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.545 ' HE2' ' HD3' ' A' ' 24' ' ' PRO . 2.3 m-85 -116.63 139.43 50.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.443 -0.947 . . . . 1.7 108.443 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.67 ' HA ' HG11 ' A' ' 67' ' ' VAL . 86.7 t -74.74 123.52 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.952 -0.388 . . . . 1.6799999999999999 109.952 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -78.58 86.42 4.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.693 -0.854 . . . . 1.02 108.693 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.72 83.44 1.4 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.684 -0.77 . . . . 1.53 111.742 -174.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.49 ' HB3' ' N ' ' A' ' 21' ' ' ASP . 2.6 pt20 -40.11 117.82 0.82 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.663 0.616 . . . . 2.5699999999999998 112.663 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.433 HE21 ' HB2' ' A' ' 104' ' ' GLN . 6.9 tt0 -90.56 5.14 49.04 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.53 -0.759 . . . . 3.1699999999999999 110.058 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.455 ' O ' HG21 ' A' ' 105' ' ' THR . 11.1 m 62.23 23.54 13.93 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.697 -0.683 . . . . 2.8599999999999999 111.287 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.598 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 8.2 t30 66.92 92.97 0.08 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.632 -0.713 . . . . 1.5600000000000001 111.86 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.591 HG21 ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -74.73 147.64 84.47 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-O 118.51 -0.757 . . . . 2.0800000000000001 109.427 172.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.591 ' HD2' HG21 ' A' ' 107' ' ' THR . 1.6 Cg_endo -43.11 93.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 124.106 3.204 . . . . 1.48 112.539 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -97.74 -165.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.265 2.643 . . . . 0.84999999999999998 114.615 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.88 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 108.789 -1.724 . . . . 0.76000000000000001 108.789 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -115.29 122.92 47.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.799 -0.815 . . . . 2.04 108.799 169.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.475 ' HB2' HH21 ' A' ' 16' ' ' ARG . 6.5 m-85 -109.24 113.91 27.15 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.63 0.728 . . . . 1.1100000000000001 109.913 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 57' ' ' ILE . 47.3 m -94.82 135.49 36.25 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.553 -1.203 . . . . 1.3400000000000001 110.791 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.498 HD21 HD21 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -147.84 91.01 1.89 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.497 0.665 . . . . 1.1699999999999999 109.687 173.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.714 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 44.7 m -82.5 135.63 35.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.651 -0.704 . . . . 1.4099999999999999 110.055 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.494 ' HB2' HG13 ' A' ' 7' ' ' VAL . 95.2 mt -118.34 120.04 36.43 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.118 -0.492 . . . . 1.8 109.705 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.3 m -92.69 110.83 22.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.306 -0.406 . . . . 1.3200000000000001 109.926 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.84 118.46 12.03 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.665 -0.779 . . . . 0.97999999999999998 111.555 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.512 ' HA2' ' H ' ' A' ' 132' ' ' SER . . . -165.8 145.0 9.67 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.851 -0.69 . . . . 0.64000000000000001 111.521 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.421 ' CZ ' ' HB ' ' A' ' 130' ' ' THR . 47.3 p90 -88.41 172.97 8.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.303 0.573 . . . . 1.2 110.621 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.702 ' HE3' ' HZ2' ' A' ' 43' ' ' LYS . 2.3 t-105 -123.2 148.47 45.77 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.471 -0.786 . . . . 0.65000000000000002 110.017 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.33 145.95 49.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.672 -0.694 . . . . 1.55 110.431 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.912 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER 70.27 -140.97 0.07 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.762 0.825 . . . . 3.8700000000000001 110.519 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 126' ' ' LYS . 7.9 p-10 -159.74 125.38 4.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.067 0.46 . . . . 2.0800000000000001 111.604 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.632 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 17.6 m120 63.13 -24.7 0.06 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.002 1.482 . . . . 3.0899999999999999 115.002 177.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.446 ' HG2' ' HG2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -70.55 -3.25 17.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.925 0.393 . . . . 2.3799999999999999 111.435 -178.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.557 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 22.7 tt0 74.45 61.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.365 -0.834 . . . . 2.1099999999999999 111.22 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -102.53 113.17 4.5 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.619 -0.992 . . . . 0.77000000000000002 110.619 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.532 ' HB3' ' HZ3' ' A' ' 43' ' ' LYS . 50.0 p90 -135.75 163.91 29.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.571 0.685 . . . . 1.49 110.296 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.421 ' HB ' ' CZ ' ' A' ' 120' ' ' TYR . 37.9 m -152.38 110.45 2.8 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.82 -0.437 . . . . 1.8999999999999999 109.82 173.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.467 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 16.5 Cg_exo -65.37 116.36 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.617 2.211 . . . . 1.1699999999999999 112.228 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.512 ' H ' ' HA2' ' A' ' 119' ' ' GLY . 12.1 t -155.05 108.19 2.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.455 -0.793 . . . . 1.96 108.87 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 1.11 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 151.37 -138.07 6.36 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.519 -0.848 . . . . 1.1699999999999999 111.808 -176.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.4 m -111.72 138.61 48.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.648 0.261 . . . . 2.9300000000000002 110.394 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.6 m -94.44 98.46 10.89 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.72 -0.474 . . . . 2.1800000000000002 109.72 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.33 130.29 9.51 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.449 -0.881 . . . . 0.72999999999999998 112.504 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.714 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 86.1 m -96.25 114.82 26.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.629 0.252 . . . . 1.23 110.426 178.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.472 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 13.9 m -78.32 116.86 19.04 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.222 -1.029 . . . . 1.1799999999999999 108.222 173.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -102.74 108.58 19.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.502 0.668 . . . . 2.6299999999999999 110.281 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.425 ' CD2' HD11 ' A' ' 56' ' ' LEU . 10.6 tp -106.28 94.67 5.28 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.938 -1.028 . . . . 1.3100000000000001 109.844 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 12.1 m -102.28 144.4 30.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.707 -0.679 . . . . 1.1799999999999999 109.431 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.0 p -83.63 133.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.397 -0.521 . . . . 2.3900000000000001 110.585 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 13' ' ' ALA . 43.9 m . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.607 -0.711 . . . . 2.5899999999999999 109.516 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.043 0.449 . . . . 5.7300000000000004 110.224 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.87 131.1 47.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.174 -0.676 . . . . 3.0800000000000001 109.174 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 t -167.17 67.36 0.09 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.809 -1.182 . . . . 1.8300000000000001 107.809 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 10.1 mm100 -86.8 112.2 21.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.101 -0.954 . . . . 2.29 110.647 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.426 HG11 HG12 ' A' ' 7' ' ' VAL . 61.5 t -82.16 110.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.877 -0.786 . . . . 2.1000000000000001 108.877 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -80.77 91.25 5.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.65 0.738 . . . . 4.25 110.616 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.426 HG12 HG11 ' A' ' 5' ' ' VAL . 3.5 m -104.85 140.34 23.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.646 -1.161 . . . . 1.8200000000000001 109.734 175.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.6 167.29 24.84 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.157 -1.021 . . . . 1.1899999999999999 112.706 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.47 131.42 35.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.079 -0.341 . . . . 2.1800000000000002 110.079 175.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.18 137.75 24.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.125 -0.489 . . . . 2.0 109.929 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.6 m -103.29 122.42 44.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.043 -0.526 . . . . 1.5600000000000001 110.442 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.735 HG12 ' HB ' ' A' ' 25' ' ' ILE . 45.2 t -118.76 111.3 33.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.918 -0.583 . . . . 2.04 109.877 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -92.54 101.41 13.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.41 -0.359 . . . . 1.23 110.444 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 5.7 tppt? -163.39 165.47 23.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.981 0.419 . . . . 3.9100000000000001 110.566 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.579 ' HA ' HG13 ' A' ' 142' ' ' VAL . 82.4 p -89.79 159.01 17.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.017 -0.538 . . . . 1.21 110.558 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -0.03 27.31 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.393 -0.595 . . . . 4.0800000000000001 109.393 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.55 -20.81 76.22 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.586 -1.006 . . . . 0.75 110.586 171.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -66.39 -48.48 69.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.812 -0.81 . . . . 2.6299999999999999 108.812 168.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.602 HD22 HG12 ' A' ' 25' ' ' ILE . 11.0 mt -73.04 92.72 1.7 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.9 -1.046 . . . . 1.6100000000000001 110.276 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.671 ' H ' ' HB1' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -96.35 69.24 2.64 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.318 -0.623 . . . . 2.2599999999999998 109.318 177.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.5 t70 63.89 -90.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 114.639 -1.164 . . . . 1.8300000000000001 109.89 -172.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.68 63.66 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.345 0.593 . . . . 1.4299999999999999 110.726 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HB1' ' H ' ' A' ' 20' ' ' THR . . . -140.39 116.74 7.85 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.442 -0.799 . . . . 1.3700000000000001 109.805 175.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 93.0 Cg_endo -87.24 150.82 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.464 2.776 . . . . 1.1200000000000001 113.469 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.735 ' HB ' HG12 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -102.75 -62.76 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.3 -0.864 . . . . 3.0499999999999998 111.125 175.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.445 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -127.73 90.93 0.34 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.5 -0.857 . . . . 1.04 112.646 -177.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.78 117.28 3.82 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.82 2.347 . . . . 1.0 111.857 172.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -83.75 133.23 29.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 1.8300000000000001 109.825 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.9 p -75.91 83.77 2.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.3 0.571 . . . . 2.2000000000000002 110.36 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.6 t -94.07 115.18 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.709 -0.678 . . . . 1.5600000000000001 110.315 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.63 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 63.7 tt0 -112.71 135.54 53.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.881 -0.6 . . . . 2.48 109.993 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.44 103.03 13.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.512 -0.551 . . . . 1.25 109.512 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 4' ' ' GLN . 51.6 tp -82.25 112.29 19.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.367 -0.379 . . . . 2.4700000000000002 110.359 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 -117.73 5.1 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.779 -0.724 . . . . 1.8100000000000001 112.094 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 57.0 m 69.43 -71.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.66 0.784 . . . . 1.8799999999999999 111.112 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 66.22 -56.57 0.37 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.999 0.92 . . . . 2.71 112.75 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.32 40.65 3.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.152 0.501 . . . . 1.3600000000000001 110.354 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.418 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 13.2 tpp180 -126.16 148.27 49.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.159 -0.473 . . . . 5.3499999999999996 111.509 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -87.6 124.15 33.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 1.9099999999999999 109.879 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 57.8 t -91.08 121.05 41.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.733 -0.469 . . . . 1.1699999999999999 109.733 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -121.81 147.94 45.32 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 120.758 0.313 . . . . 1.0900000000000001 110.472 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -102.02 105.39 16.14 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.254 0.549 . . . . 1.4399999999999999 109.95 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.643 ' HE3' ' HB3' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -96.2 151.47 19.46 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.84 -0.8 . . . . 2.5299999999999998 108.84 176.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.419 ' HB3' ' HD1' ' A' ' 49' ' ' PHE . . . -111.62 156.67 21.45 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 110.014 -0.365 . . . . 1.0700000000000001 110.014 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -79.9 152.93 29.34 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.506 -0.924 . . . . 0.70999999999999996 108.506 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -57.08 -13.67 3.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.946 0.339 . . . . 1.71 111.851 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -56.54 -37.38 70.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 2.2200000000000002 111.077 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.59 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 26.0 p-10 -134.05 19.87 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.578 -0.283 . . . . 1.5800000000000001 110.509 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.732 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 63.1 t80 -124.62 102.55 7.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.78 -0.452 . . . . 0.72999999999999998 109.78 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.732 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 15.3 pt-20 -101.26 105.44 16.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.395 -0.366 . . . . 2.4100000000000001 110.585 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 71.61 -55.96 0.65 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.804 0.842 . . . . 4.1399999999999997 111.154 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.732 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -174.11 37.52 0.12 Allowed Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.932 -0.652 . . . . 0.72999999999999998 111.973 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 29.4 mmtm -146.15 139.07 25.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.009 -0.367 . . . . 2.6800000000000002 110.009 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -113.5 150.16 33.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.268 0.556 . . . . 0.65000000000000002 111.948 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.732 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 22.5 p90 -157.61 177.84 10.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.265 -0.88 . . . . 0.73999999999999999 111.159 -172.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.741 HD23 HD23 ' A' ' 114' ' ' LEU . 14.9 mt -81.12 115.51 20.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.328 -0.99 . . . . 2.0800000000000001 108.328 170.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.584 HG21 ' O ' ' A' ' 113' ' ' THR . 9.2 tp -105.13 120.12 55.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.806 -0.757 . . . . 1.21 109.828 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.567 ' HB2' ' CE1' ' A' ' 112' ' ' TYR . 42.6 t -75.12 147.56 40.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.341 -0.845 . . . . 1.9299999999999999 111.465 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.59 -29.53 70.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.526 -0.761 . . . . 2.3100000000000001 109.753 170.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -81.29 -24.05 37.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.297 -0.865 . . . . 3.6600000000000001 110.124 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.4 t30 65.67 21.09 11.62 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.418 -0.81 . . . . 3.0600000000000001 111.948 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 62' ' ' ARG . 63.6 mtt180 -98.21 -6.66 30.81 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.077 -0.389 . . . . 5.1799999999999997 110.815 176.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.5 143.72 30.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.108 -0.497 . . . . 2.5099999999999998 111.249 -175.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -150.22 130.5 13.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.729 -0.669 . . . . 2.6200000000000001 110.232 172.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.598 ' HB2' HD12 ' A' ' 56' ' ' LEU . 2.9 mm? -120.21 130.11 54.4 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.315 -0.402 . . . . 2.48 110.329 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 94.4 m-85 -68.57 146.53 52.99 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.77 -0.372 . . . . 1.1299999999999999 110.052 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.35 149.89 20.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.059 0.457 . . . . 1.29 110.904 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -114.41 110.4 19.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.779 -0.823 . . . . 2.1000000000000001 108.779 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.425 HG21 HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -91.88 107.1 18.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.906 -0.775 . . . . 1.55 108.906 177.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.482 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 64.5 mtp180 -122.77 143.05 39.25 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.346 -0.388 . . . . 4.3300000000000001 110.93 -168.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.615 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 32.3 Cg_exo -59.29 139.33 89.47 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.026 2.484 . . . . 0.90000000000000002 111.721 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.0 ttt -70.28 79.18 0.53 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.433 -0.349 . . . . 2.23 111.274 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.8 t70 55.05 45.98 25.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.553 -0.748 . . . . 1.9199999999999999 112.134 172.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -113.95 -89.45 0.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.048 -0.407 . . . . 1.8899999999999999 111.59 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -114.66 166.36 11.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.763 0.316 . . . . 2.0699999999999998 110.617 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.9 113.09 21.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.951 -0.568 . . . . 1.5800000000000001 110.583 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.566 ' CE2' ' HB3' ' A' ' 86' ' ' LYS . 11.2 m0 -104.56 137.43 42.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.652 -0.704 . . . . 0.54000000000000004 110.465 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.3 m -65.26 125.06 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.47 -0.567 . . . . 1.22 109.47 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -107.42 105.01 14.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.057 0.932 . . . . 1.29 112.797 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -122.3 145.0 48.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.16 -1.422 . . . . 1.7 107.16 163.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.504 ' HB2' ' CD ' ' A' ' 53' ' ' LYS . 7.9 m120 -71.83 5.07 2.78 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 120.388 -0.525 . . . . 1.3899999999999999 112.15 -176.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.03 -13.41 2.19 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.81 -0.709 . . . . 0.85999999999999999 111.578 170.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.596 ' HA ' ' HZ2' ' A' ' 43' ' ' LYS . 57.5 t -131.83 114.74 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.981 -0.377 . . . . 1.73 109.981 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.675 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.2 t80 -130.75 97.55 4.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.551 -0.907 . . . . 0.41999999999999998 108.551 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 12.2 p90 -137.35 150.1 47.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.975 0.417 . . . . 1.1499999999999999 111.124 -173.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 12.6 pttp -84.42 145.28 28.26 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.728 -0.669 . . . . 2.0299999999999998 110.951 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.16 -32.69 73.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.17 0.51 . . . . 2.6600000000000001 109.751 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.639 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -68.94 140.14 55.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.627 -0.715 . . . . 2.1000000000000001 110.412 174.106 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.2 m -101.38 131.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.214 0.531 . . . . 1.6599999999999999 110.612 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.77 -164.5 25.74 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.459 -0.656 . . . . 0.63 111.459 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.7 p -85.14 137.74 32.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.652 -0.499 . . . . 1.5800000000000001 109.652 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.615 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 89.7 t90 -102.47 -60.63 1.51 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.418 -0.956 . . . . 0.75 108.418 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 48.43 112.75 0.01 OUTLIER Glycine 0 N--CA 1.468 0.811 0 O-C-N 124.556 1.16 . . . . 1.25 115.663 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.52 -130.5 1.62 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.352 -0.699 . . . . 1.0 111.352 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 p -124.31 130.75 53.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.008 0.432 . . . . 1.3200000000000001 111.213 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.6 mm -111.5 126.21 68.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.31 -0.626 . . . . 2.2400000000000002 109.31 176.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.11 141.24 15.45 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.495 -0.86 . . . . 0.53000000000000003 111.869 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 mp -90.59 112.04 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.383 -0.599 . . . . 1.53 109.383 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CE1' ' HB2' ' A' ' 70' ' ' ARG . 28.6 m-85 -109.59 142.07 41.22 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.33 -0.989 . . . . 1.7 108.33 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' A' ' 103' ' ' GLN . 7.2 p -77.72 140.36 17.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.275 -0.57 . . . . 1.6799999999999999 109.63 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.16 88.97 3.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.277 -0.638 . . . . 1.02 109.277 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.78 107.23 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.823 -0.704 . . . . 1.53 111.45 -173.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 0.7 OUTLIER -46.74 127.82 10.1 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 121.226 0.536 . . . . 2.5699999999999998 112.031 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.497 ' HG2' HD22 ' A' ' 65' ' ' LEU . 57.3 tp60 -89.74 1.99 55.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.687 -0.688 . . . . 3.1699999999999999 110.095 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 m 60.91 22.91 13.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.717 -0.674 . . . . 2.8599999999999999 111.231 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 59.52 94.07 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.624 -0.716 . . . . 1.5600000000000001 111.207 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.473 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 11.3 t -102.98 146.11 31.82 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 107.435 -1.32 . . . . 2.0800000000000001 107.435 174.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.473 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 78.3 Cg_exo -24.19 90.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 1 C-N-CA 125.303 4.002 . . . . 1.48 114.313 -173.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.442 ' HG2' HG12 ' A' ' 142' ' ' VAL . 94.8 Cg_endo -104.37 -166.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 123.586 2.857 . . . . 0.84999999999999998 114.736 -171.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -175.35 -120.83 0.62 Allowed Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.202 -1.363 . . . . 0.76000000000000001 109.976 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -92.9 122.38 35.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.748 0.308 . . . . 2.04 110.315 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.567 ' HB3' ' HB3' ' A' ' 56' ' ' LEU . 91.6 m-85 -116.02 123.69 48.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.271 0.558 . . . . 1.1100000000000001 110.075 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.584 ' O ' HG21 ' A' ' 57' ' ' ILE . 16.2 m -100.58 140.34 34.99 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.434 -0.803 . . . . 1.3400000000000001 110.641 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.741 HD23 HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -143.36 92.43 2.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.447 0.642 . . . . 1.1699999999999999 109.634 173.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 32.3 m -86.72 116.84 25.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.562 -0.745 . . . . 1.4099999999999999 110.841 -176.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 93.8 mt -99.87 140.39 34.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.069 -0.514 . . . . 1.8 110.547 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.3 m -107.28 109.57 21.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.041 -0.527 . . . . 1.3200000000000001 109.82 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.1 129.11 29.03 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.785 -0.721 . . . . 0.97999999999999998 111.71 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.47 ' HA2' ' H ' ' A' ' 132' ' ' SER . . . -170.52 167.66 40.78 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.734 -0.746 . . . . 0.64000000000000001 111.824 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -102.64 161.43 13.74 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.009 0.433 . . . . 1.2 110.007 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.604 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 4.3 t-105 -119.03 152.31 36.65 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.483 -0.781 . . . . 0.65000000000000002 109.705 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -134.45 137.06 43.67 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.803 -0.635 . . . . 1.55 110.201 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.561 ' HG3' ' HE2' ' A' ' 126' ' ' LYS . 74.4 mmtt 82.21 -146.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.197 0.999 . . . . 3.8700000000000001 111.016 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 126' ' ' LYS . 8.2 p-10 -147.91 117.41 7.0 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.179 0.807 . . . . 2.0800000000000001 113.179 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.604 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 28.0 t-20 64.32 -19.85 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.892 1.277 . . . . 3.0899999999999999 114.126 171.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.561 ' HE2' ' HG3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -69.05 -2.99 11.4 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.493 0.317 . . . . 2.3799999999999999 111.491 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 72.04 69.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.21 -0.905 . . . . 2.1099999999999999 110.623 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -112.22 99.32 1.05 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 109.997 -1.241 . . . . 0.77000000000000002 109.997 168.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 40.5 p90 -144.57 145.86 32.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.103 0.952 . . . . 1.49 110.369 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 29.2 m -132.25 116.39 15.39 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.25 -0.432 . . . . 1.8999999999999999 109.988 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.442 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 29.3 Cg_exo -60.7 125.09 16.37 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.856 2.37 . . . . 1.1699999999999999 112.222 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.47 ' H ' ' HA2' ' A' ' 119' ' ' GLY . 5.8 t -152.05 96.3 2.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.985 -0.746 . . . . 1.96 108.985 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.09 -112.61 0.53 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.83 -0.908 . . . . 1.1699999999999999 110.83 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.93 171.61 14.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.095 0.448 . . . . 2.9300000000000002 111.029 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.3 96.06 7.8 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.274 -0.639 . . . . 2.1800000000000002 109.274 171.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -97.67 113.49 4.73 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.776 -0.726 . . . . 0.72999999999999998 112.18 -174.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 77.9 m -88.84 107.13 18.82 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.106 0.479 . . . . 1.23 110.546 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.582 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 10.2 m -78.83 120.55 23.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.958 -1.127 . . . . 1.1799999999999999 107.958 172.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -111.8 109.44 19.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.359 0.6 . . . . 2.6299999999999999 110.773 -173.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.676 HD22 HD21 ' A' ' 56' ' ' LEU . 7.7 tp -98.96 100.82 12.05 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.969 -1.014 . . . . 1.3100000000000001 109.742 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.672 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 31.8 m -107.38 118.37 36.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.742 -0.663 . . . . 1.1799999999999999 109.507 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.579 HG13 ' HA ' ' A' ' 15' ' ' THR . 58.2 t -79.28 108.95 13.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.012 0.434 . . . . 2.3900000000000001 111.327 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.701 -0.666 . . . . 2.5899999999999999 109.774 176.672 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.546 0.212 . . . . 5.7300000000000004 110.778 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.695 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 31.0 tt0 -93.62 97.09 10.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.622 -0.881 . . . . 3.0800000000000001 108.622 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.661 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 7.0 t -106.36 99.01 8.61 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.423 0.63 . . . . 1.8300000000000001 110.158 -174.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.61 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 58.9 tt0 -86.82 110.43 19.94 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.989 -1.005 . . . . 2.29 109.606 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.436 HG12 HG11 ' A' ' 30' ' ' VAL . 97.6 t -103.43 112.62 37.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.846 -0.616 . . . . 2.1000000000000001 110.234 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -93.1 111.06 22.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.942 -0.572 . . . . 4.25 110.075 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 116' ' ' LEU . 59.9 t -88.46 114.84 27.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.052 -0.721 . . . . 1.8200000000000001 109.052 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.34 112.28 4.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.137 -0.554 . . . . 1.1899999999999999 112.75 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.9 106.37 4.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.244 -0.651 . . . . 2.1800000000000002 109.244 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.509 HD22 HG21 ' A' ' 28' ' ' VAL . 3.4 pp -137.61 154.43 49.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.054 -0.521 . . . . 2.0 111.02 -175.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.5 m -119.08 123.6 44.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.804 -0.634 . . . . 1.5600000000000001 110.187 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.487 HG23 ' HG2' ' A' ' 14' ' ' LYS . 14.6 p -121.23 141.72 40.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.801 -0.444 . . . . 2.04 109.801 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -108.91 99.66 8.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.652 0.263 . . . . 1.23 110.966 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' HG2' HG23 ' A' ' 12' ' ' VAL . 75.3 mmtt -142.5 172.88 12.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.3 0.571 . . . . 3.9100000000000001 110.573 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 1.0 OUTLIER -104.0 154.13 20.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.161 -0.927 . . . . 1.21 109.592 172.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.938 ' NH2' ' HH ' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -86.61 -1.43 57.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.105 0.478 . . . . 4.0800000000000001 110.671 -176.371 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.526 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -85.8 -26.83 33.67 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.017 -0.611 . . . . 0.75 112.16 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 15' ' ' THR . 10.0 pt20 -79.83 -2.08 41.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.963 0.411 . . . . 2.6299999999999999 110.719 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.667 ' HA ' ' HB1' ' A' ' 23' ' ' ALA . 71.8 mt -76.4 -26.94 56.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.642 . . . . 1.6100000000000001 111.256 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 7.5 t 32.59 57.16 0.41 Allowed 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.215 0.947 . . . . 2.2599999999999998 113.286 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' THR . 70.4 m-20 76.72 -46.69 0.52 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.461 0.704 . . . . 1.8300000000000001 111.924 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.78 88.66 1.84 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.252 0.464 . . . . 1.4299999999999999 112.252 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.667 ' HB1' ' HA ' ' A' ' 19' ' ' LEU . . . -139.82 108.19 7.04 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.007 -0.542 . . . . 1.3700000000000001 110.493 171.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.637 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 38.6 Cg_endo -67.5 99.9 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.176 2.584 . . . . 1.1200000000000001 112.114 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.542 HG12 HD21 ' A' ' 19' ' ' LEU . 2.6 pp -101.08 -23.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.876 -0.602 . . . . 3.0499999999999998 111.829 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.445 ' N ' HD12 ' A' ' 25' ' ' ILE . . . -128.64 50.99 0.87 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.101 -1.047 . . . . 1.04 113.396 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 10.0 Cg_endo -53.9 109.97 0.44 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.554 2.169 . . . . 1.0 112.534 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.509 HG21 HD22 ' A' ' 10' ' ' LEU . 61.5 t -91.97 138.42 19.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.465 -0.788 . . . . 1.8300000000000001 110.543 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 p -78.62 97.92 5.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.944 0.402 . . . . 2.2000000000000002 110.844 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.667 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 97.4 t -103.51 113.93 41.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.114 -0.494 . . . . 1.5600000000000001 110.271 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.636 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -109.05 108.32 18.97 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.75 -0.833 . . . . 2.48 108.75 177.185 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.66 91.22 4.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.094 0.473 . . . . 1.25 110.448 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.25 112.75 21.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.708 -0.678 . . . . 2.4700000000000002 110.098 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' A' ' 2' ' ' GLU . . . 114.91 -17.97 17.05 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.531 -0.842 . . . . 1.8100000000000001 112.694 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 1.7 m -74.0 104.77 4.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.876 0.369 . . . . 1.8799999999999999 110.543 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -106.22 -39.75 5.84 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.301 -0.629 . . . . 2.71 109.301 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.44 64.19 1.35 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.241 -0.89 . . . . 1.3600000000000001 109.217 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.605 ' HD3' ' H ' ' A' ' 39' ' ' GLN . 8.7 tpp180 -146.76 149.89 34.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.677 -0.692 . . . . 5.3499999999999996 110.756 -174.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.605 ' H ' ' HD3' ' A' ' 38' ' ' ARG . 36.6 mt-30 -84.81 125.96 33.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.912 -0.585 . . . . 1.9099999999999999 109.669 176.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 22.1 t -92.29 125.36 44.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.838 -0.43 . . . . 1.1699999999999999 109.838 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.576 ' HB1' ' HE2' ' A' ' 43' ' ' LYS . . . -121.36 142.37 50.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.046 0.45 . . . . 1.0900000000000001 111.053 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 96' ' ' ILE . 14.5 mt -103.0 112.42 25.24 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.149 -0.686 . . . . 1.4399999999999999 109.149 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.576 ' HE2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -109.32 151.32 26.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.179 -0.464 . . . . 2.5299999999999998 110.244 -178.545 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.61 167.44 10.34 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.978 -0.556 . . . . 1.0700000000000001 110.362 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 23.4 t70 -94.65 157.72 15.84 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.149 -0.686 . . . . 0.70999999999999996 109.149 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -53.22 -18.69 2.49 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.382 0.426 . . . . 1.71 111.848 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.6 -37.37 68.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.726 -0.67 . . . . 2.2200000000000002 111.683 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 6.4 p30 -135.58 16.94 3.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.926 0.393 . . . . 1.5800000000000001 110.66 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 60.3 t80 -118.85 102.53 8.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 0.72999999999999998 109.382 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 14.4 pt-20 -102.06 100.6 10.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.824 0.345 . . . . 2.4100000000000001 110.409 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 71.31 -53.29 0.68 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.615 -0.72 . . . . 4.1399999999999997 111.289 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.1 39.17 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.604 -0.999 . . . . 0.72999999999999998 110.604 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 22.0 mmmt -137.7 133.7 34.51 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.986 -0.746 . . . . 2.6800000000000002 108.986 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -115.1 151.35 34.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.18 0.514 . . . . 0.65000000000000002 110.995 173.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.499 ' CE1' ' HB ' ' A' ' 57' ' ' ILE . 13.8 p90 -156.24 176.94 12.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.534 -0.757 . . . . 0.73999999999999999 110.805 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.552 HD12 HD12 ' A' ' 65' ' ' LEU . 29.7 mt -80.34 111.22 16.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.176 -1.046 . . . . 2.0800000000000001 108.176 170.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 48' ' ' ASN . 8.7 tp -107.6 127.94 63.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.287 0.565 . . . . 1.21 110.32 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.524 ' HB2' ' OD2' ' A' ' 63' ' ' ASP . 47.4 t -70.86 152.4 43.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.793 -0.64 . . . . 1.9299999999999999 109.34 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.27 -32.87 72.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.087 0.47 . . . . 2.3100000000000001 110.269 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -80.34 -0.43 36.77 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.002 -0.544 . . . . 3.6600000000000001 110.699 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 p30 37.3 60.81 1.02 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.454 1.102 . . . . 3.0600000000000001 113.394 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -127.56 -11.71 5.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.941 -0.572 . . . . 5.1799999999999997 110.037 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.524 ' OD2' ' HB2' ' A' ' 58' ' ' SER . 1.9 p-10 -136.63 152.02 49.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.484 -0.78 . . . . 2.5099999999999998 110.481 -176.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.622 ' O ' HD21 ' A' ' 65' ' ' LEU . 9.5 ptpp? -156.89 152.98 27.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.544 -0.298 . . . . 2.6200000000000001 111.013 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.799 ' HB3' ' HG3' ' A' ' 104' ' ' GLN . 1.6 mt -141.29 124.98 16.86 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.149 -1.426 . . . . 2.48 107.149 170.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 99.2 m-85 -69.26 133.88 48.46 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.121 0.486 . . . . 1.1299999999999999 110.806 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.944 HG13 ' HA ' ' A' ' 100' ' ' VAL . 29.2 m -128.83 175.23 10.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.388 -0.824 . . . . 1.29 109.796 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.839 ' HB2' ' HE2' ' A' ' 84' ' ' PHE . 2.2 p30 -152.34 128.27 10.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.235 0.54 . . . . 2.1000000000000001 109.918 172.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.585 HG23 HD11 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -79.85 87.67 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 1.55 110.382 -174.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.409 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 79.3 mtt180 -86.4 137.6 34.45 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.637 -0.711 . . . . 4.3300000000000001 110.206 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.409 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 74.1 Cg_exo -51.15 124.65 14.43 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.453 2.102 . . . . 0.90000000000000002 112.047 174.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.2 ttt -75.4 82.47 2.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.828 0.347 . . . . 2.23 110.678 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 61.87 21.15 12.05 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.536 -0.756 . . . . 1.9199999999999999 112.063 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.96 -51.55 5.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.618 -0.265 . . . . 1.8899999999999999 111.432 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.7 t -167.72 179.15 4.93 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.738 -0.467 . . . . 2.0699999999999998 109.738 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.15 123.88 45.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 1.5800000000000001 110.576 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.456 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 12.0 m0 -116.32 160.99 19.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.89 -0.596 . . . . 0.54000000000000004 110.057 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.1 m -81.86 113.46 19.81 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.356 -0.609 . . . . 1.22 109.356 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 t -95.56 108.55 20.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.579 0.704 . . . . 1.29 112.484 -171.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -117.44 162.26 18.24 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.228 -1.027 . . . . 1.7 108.228 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 10.6 m120 -85.28 -8.52 58.47 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.377 -0.529 . . . . 1.3899999999999999 110.984 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.42 ' O ' ' HE1' ' A' ' 49' ' ' PHE . . . -100.93 -35.98 4.09 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.305 -0.95 . . . . 0.85999999999999999 111.725 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.545 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 27.5 m -140.08 156.27 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.626 -0.509 . . . . 1.73 109.626 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.839 ' HE2' ' HB2' ' A' ' 68' ' ' ASN . 1.0 OUTLIER -134.5 97.96 3.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.201 -1.037 . . . . 0.41999999999999998 108.201 178.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.643 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 2.4 p90 -132.56 144.99 50.78 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.488 -0.485 . . . . 1.1499999999999999 111.456 -172.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.909 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 40.9 pttt -78.56 148.92 33.16 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.656 -0.702 . . . . 2.0299999999999998 110.555 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.3 -23.36 61.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 2.6600000000000001 109.443 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.909 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 5.7 m-20 -72.38 162.3 29.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.247 -0.888 . . . . 2.1000000000000001 110.297 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.9 m -121.86 139.52 48.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.783 0.325 . . . . 1.6599999999999999 110.578 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.0 -159.03 17.68 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.674 -0.774 . . . . 0.63 111.926 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.7 m -69.21 166.79 17.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.971 0.415 . . . . 1.5800000000000001 110.473 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.409 ' HZ2' ' HB3' ' A' ' 71' ' ' PRO . 63.2 t90 -152.46 -52.05 0.11 Allowed 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.263 -0.643 . . . . 0.75 109.263 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.667 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 27.21 89.8 0.01 OUTLIER Glycine 0 N--CA 1.466 0.654 0 O-C-N 125.12 1.513 . . . . 1.25 115.448 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.18 -150.17 5.73 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.39 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 p -112.4 125.58 54.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.446 0.536 . . . . 1.3200000000000001 112.446 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 69' ' ' ILE . 1.2 pt -115.75 129.42 72.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.77 -0.65 . . . . 2.2400000000000002 109.685 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -108.4 160.32 13.82 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.211 -0.995 . . . . 0.53000000000000003 112.743 -173.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -91.34 113.65 27.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.905 0.384 . . . . 1.53 110.189 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.637 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -116.5 126.83 53.92 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.92 -1.141 . . . . 1.7 107.92 174.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.944 ' HA ' HG13 ' A' ' 67' ' ' VAL . 13.9 p -62.98 124.96 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.316 -0.994 . . . . 1.6799999999999999 108.316 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.07 88.04 2.4 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.225 -0.657 . . . . 1.02 109.225 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA2' ' OD1' ' A' ' 21' ' ' ASP . . . 90.51 112.32 1.56 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.567 -1.013 . . . . 1.53 110.567 -171.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -51.08 114.23 1.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.354 0.597 . . . . 2.5699999999999998 110.967 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.799 ' HG3' ' HB3' ' A' ' 65' ' ' LEU . 11.9 mm-40 -91.98 20.81 5.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.476 -0.784 . . . . 3.1699999999999999 111.094 -174.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.6 m 72.7 -21.72 0.24 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.589 -0.732 . . . . 2.8599999999999999 112.816 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.526 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 8.9 t30 70.57 84.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.704 0.764 . . . . 1.5600000000000001 110.238 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.549 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 12.2 t -103.93 149.22 36.97 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.974 -1.121 . . . . 2.0800000000000001 107.974 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.549 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 91.4 Cg_exo -18.11 89.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 1 C-N-CA 125.76 4.307 . . . . 1.48 115.001 -172.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.68 ' CB ' HG13 ' A' ' 142' ' ' VAL . 3.3 Cg_exo -81.01 -150.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.693 2.929 . . . . 0.84999999999999998 114.214 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.91 -163.69 37.11 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 109.071 -1.612 . . . . 0.76000000000000001 109.071 -173.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.444 ' C ' HD21 ' A' ' 111' ' ' ASN . 0.2 OUTLIER -80.2 101.69 8.99 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.299 -0.63 . . . . 2.04 109.299 178.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.938 ' HH ' ' NH2' ' A' ' 16' ' ' ARG . 47.8 m-85 -84.9 126.59 33.61 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.003 0.43 . . . . 1.1100000000000001 109.965 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.9 m -130.71 97.36 4.33 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.906 -0.588 . . . . 1.3400000000000001 109.594 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -104.27 105.6 15.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.483 0.659 . . . . 1.1699999999999999 110.51 -176.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 1.3 m -78.27 121.57 24.58 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.148 -0.933 . . . . 1.4099999999999999 110.527 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.544 ' HB2' HG11 ' A' ' 7' ' ' VAL . 96.0 mt -107.29 146.0 32.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.87 0.367 . . . . 1.8 110.635 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.0 m -119.19 109.16 15.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.373 -0.376 . . . . 1.3200000000000001 110.415 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.97 162.09 54.07 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.957 -0.64 . . . . 0.97999999999999998 112.952 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 151.16 166.35 13.7 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.032 -0.604 . . . . 0.64000000000000001 111.621 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.661 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 46.9 p90 -89.19 -173.53 4.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.16 0.505 . . . . 1.2 111.043 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.626 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 2.3 t-105 -137.76 149.97 46.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.631 -0.713 . . . . 0.65000000000000002 110.276 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.79 147.66 50.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.308 -0.406 . . . . 1.55 110.49 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.553 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 5.8 tmtt? 70.41 -142.36 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.66 0.6 . . . . 3.8700000000000001 110.432 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.517 ' HA ' ' HZ2' ' A' ' 121' ' ' TRP . 6.9 p-10 -160.08 132.66 6.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.622 0.248 . . . . 2.0800000000000001 111.405 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.555 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 8.9 t30 66.86 -30.06 0.15 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.939 1.089 . . . . 3.0899999999999999 113.939 174.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.626 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -68.81 -3.51 12.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 2.3799999999999999 110.951 178.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.626 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 20.4 tt0 68.57 59.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.208 -0.905 . . . . 2.1099999999999999 110.856 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.626 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -89.06 48.55 3.46 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.603 -0.808 . . . . 0.77000000000000002 111.358 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.579 ' HD1' ' HG2' ' A' ' 127' ' ' GLN . 16.4 p90 -78.81 140.85 38.13 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 110.026 -0.361 . . . . 1.49 110.026 -174.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.544 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 36.6 m -118.94 137.59 25.21 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.315 -0.254 . . . . 1.8999999999999999 110.315 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.08 111.09 2.39 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.977 2.451 . . . . 1.1699999999999999 111.274 172.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.1 m -153.08 108.68 3.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.851 0.357 . . . . 1.96 110.489 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.61 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 137.4 -127.51 3.99 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.534 -0.841 . . . . 1.1699999999999999 111.907 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 m -124.96 145.7 49.74 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.282 -0.266 . . . . 2.9300000000000002 110.282 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.2 m -92.31 95.75 9.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.103 -0.702 . . . . 2.1800000000000002 109.103 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -92.17 128.7 9.5 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.918 -0.658 . . . . 0.72999999999999998 111.975 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.88 105.44 17.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.888 0.375 . . . . 1.23 110.211 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.531 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 21.7 m -78.32 108.8 11.92 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.845 -0.798 . . . . 1.1799999999999999 108.845 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -103.45 109.06 20.56 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.551 0.691 . . . . 2.6299999999999999 110.535 -174.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.4 tp -100.82 97.12 7.77 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.617 -1.174 . . . . 1.3100000000000001 109.092 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.716 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 24.8 m -97.64 122.28 40.54 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.613 -0.721 . . . . 1.1799999999999999 109.802 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.68 HG13 ' CB ' ' A' ' 109' ' ' PRO . 33.2 m -75.24 114.66 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-O 121.55 0.69 . . . . 2.3900000000000001 111.29 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.7 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 38.4 m . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.301 -0.856 . . . . 2.5899999999999999 109.834 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.844 0.354 . . . . 5.7300000000000004 110.141 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -170.73 161.33 7.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.853 -0.612 . . . . 3.0800000000000001 110.004 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 53.9 m -78.83 89.01 4.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.414 -0.357 . . . . 1.8300000000000001 110.623 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -86.46 110.17 19.56 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.565 -0.454 . . . . 2.29 110.018 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.43 117.92 49.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.894 -0.594 . . . . 2.1000000000000001 109.73 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -82.7 109.59 17.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.946 -0.57 . . . . 4.25 111.618 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.35 117.13 52.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.509 -0.923 . . . . 1.8200000000000001 108.509 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.38 144.39 17.05 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.443 -0.884 . . . . 1.1899999999999999 113.23 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -62.05 146.84 49.13 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.492 0.317 . . . . 2.1800000000000002 110.227 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -156.14 126.66 6.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.937 0.399 . . . . 2.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.442 ' HA ' ' HB3' ' A' ' 139' ' ' LYS . 28.0 m -108.75 114.58 28.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.111 -0.495 . . . . 1.5600000000000001 109.827 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.508 ' HB ' ' NZ ' ' A' ' 14' ' ' LYS . 61.9 t -144.17 146.04 21.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.595 -0.73 . . . . 2.04 109.328 -176.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -92.99 124.85 37.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.524 0.565 . . . . 1.23 112.524 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.508 ' NZ ' ' HB ' ' A' ' 12' ' ' VAL . 1.1 mptt -147.6 168.44 22.0 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.889 0.376 . . . . 3.9100000000000001 110.043 172.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.529 ' O ' HD21 ' A' ' 19' ' ' LEU . 73.4 p -112.66 161.89 16.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.313 -0.995 . . . . 1.21 108.313 169.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.414 ' CZ ' ' HH ' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -76.1 0.29 19.35 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.555 -0.858 . . . . 4.0800000000000001 110.236 175.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.99 -26.91 25.14 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 110.251 -1.139 . . . . 0.75 110.251 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -62.57 -29.61 70.72 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.442 -0.947 . . . . 2.6299999999999999 108.442 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.866 HD23 HD12 ' A' ' 25' ' ' ILE . 2.3 mm? -75.33 129.16 36.93 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.394 -1.275 . . . . 1.6100000000000001 109.593 171.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.633 HG22 ' HB2' ' A' ' 23' ' ' ALA . 13.7 t -127.94 42.18 3.37 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.391 1.091 . . . . 2.2599999999999998 108.262 -176.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.486 ' HB2' ' NE2' ' A' ' 103' ' ' GLN . 29.4 t70 75.3 -69.72 0.17 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.54 -1.663 . . . . 1.8300000000000001 109.607 -171.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.438 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -99.15 85.02 3.14 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.799 -0.445 . . . . 1.4299999999999999 109.799 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HB2' HG22 ' A' ' 20' ' ' THR . . . -142.51 94.63 6.7 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.219 -0.446 . . . . 1.3700000000000001 110.923 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 32.9 Cg_endo -68.43 85.9 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 123.189 2.593 . . . . 1.1200000000000001 111.72 177.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.866 HD12 HD23 ' A' ' 19' ' ' LEU . 12.3 pt -83.31 -16.62 11.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.734 -1.121 . . . . 3.0499999999999998 111.392 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.35 69.74 0.4 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.542 -0.837 . . . . 1.04 112.802 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.16 108.16 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.631 2.221 . . . . 1.0 111.697 173.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.6 t -84.47 141.69 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.016 -0.538 . . . . 1.8300000000000001 110.299 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.5 p -71.05 97.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.391 . . . . 2.2000000000000002 110.371 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.747 HG22 ' HA ' ' A' ' 95' ' ' THR . 6.6 t -83.59 142.27 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.933 0.873 . . . . 1.5600000000000001 111.397 -174.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.17 114.18 5.44 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.18 -1.373 . . . . 2.48 107.658 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.82 104.63 11.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.785 0.326 . . . . 1.25 110.911 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 46.3 tp -81.7 120.16 24.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.868 -0.605 . . . . 2.4700000000000002 109.963 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.9 -144.44 17.26 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.604 -0.808 . . . . 1.8100000000000001 111.923 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 4.2 m 59.75 32.33 21.33 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 122.192 0.197 . . . . 1.8799999999999999 111.503 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -55.46 -30.36 60.42 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.102 0.477 . . . . 2.71 110.77 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.56 54.6 1.93 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.901 -0.59 . . . . 1.3600000000000001 110.083 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.407 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.9 tpp180 -140.28 150.49 44.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.263 -0.426 . . . . 5.3499999999999996 111.287 -176.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -93.22 92.53 7.78 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.312 -0.625 . . . . 1.9099999999999999 109.312 178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 58.1 t -56.61 134.08 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.678 -0.692 . . . . 1.1699999999999999 110.639 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.969 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -143.82 149.88 37.67 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.962 0.41 . . . . 1.0900000000000001 111.045 -176.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.454 HD13 ' HB ' ' A' ' 69' ' ' ILE . 11.7 mt -102.96 155.17 18.54 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.011 -0.54 . . . . 1.4399999999999999 109.549 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.579 ' HE3' ' HB2' ' A' ' 129' ' ' PHE . 1.7 mptp? -140.05 150.92 44.96 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.862 -0.792 . . . . 2.5299999999999998 108.862 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -86.25 155.45 20.68 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.307 -0.627 . . . . 1.0700000000000001 109.307 171.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.603 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 27.6 t70 -71.78 161.45 30.95 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.667 -0.494 . . . . 0.70999999999999996 109.667 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -55.96 -23.1 30.14 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.929 0.715 . . . . 1.71 112.929 -173.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.0 -16.61 54.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 2.2200000000000002 111.424 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.594 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 20.3 m120 -123.04 8.19 9.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.215 -0.448 . . . . 1.5800000000000001 110.292 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 83.2 t80 -131.71 109.47 10.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.776 -0.647 . . . . 0.72999999999999998 110.24 -174.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HG2' ' HE1' ' A' ' 55' ' ' PHE . 14.2 pt-20 -134.0 124.11 25.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.357 -0.383 . . . . 2.4100000000000001 110.193 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 54.68 39.04 31.04 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.98 -0.554 . . . . 4.1399999999999997 111.586 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.93 36.72 65.06 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.758 -0.655 . . . . 0.72999999999999998 112.854 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.506 ' HB3' ' HE2' ' A' ' 66' ' ' TYR . 47.2 mmtm -132.8 134.91 45.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.304 -0.628 . . . . 2.6800000000000002 109.304 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -116.98 141.18 48.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.418 0.628 . . . . 0.65000000000000002 111.639 176.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.531 ' HE1' ' HG2' ' A' ' 50' ' ' GLU . 41.8 p90 -155.04 160.87 41.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.453 -0.794 . . . . 0.73999999999999999 109.912 -175.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.749 ' HB3' HD23 ' A' ' 114' ' ' LEU . 1.7 pp -81.21 143.08 32.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.64 -0.504 . . . . 2.0800000000000001 109.64 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 113' ' ' THR . 11.1 tp -121.05 146.9 25.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.697 -0.401 . . . . 1.21 110.36 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.435 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 2.8 p -100.3 174.4 6.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.963 -0.562 . . . . 1.9299999999999999 111.666 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -53.86 -41.37 67.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.54 -0.755 . . . . 2.3100000000000001 110.54 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.68 -14.04 46.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.156 -0.929 . . . . 3.6600000000000001 111.138 -174.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.408 ' HA ' HD11 ' A' ' 57' ' ' ILE . 43.3 m-80 62.29 18.97 10.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.167 0.508 . . . . 3.0600000000000001 110.285 -171.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -90.62 -50.01 6.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.857 -0.61 . . . . 5.1799999999999997 110.883 -175.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -100.75 134.22 44.04 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.712 -0.477 . . . . 2.5099999999999998 109.712 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' HD2' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -144.39 154.67 43.22 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.846 -0.616 . . . . 2.6200000000000001 109.854 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.727 HD22 HG22 ' A' ' 100' ' ' VAL . 23.3 tp -150.95 134.74 16.52 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.11 -0.495 . . . . 2.48 109.88 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.506 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 65.3 m-85 -78.71 131.37 36.58 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.679 -0.691 . . . . 1.1299999999999999 110.033 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.579 HG21 HD12 ' A' ' 114' ' ' LEU . 11.0 m -125.34 130.9 72.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.975 -0.557 . . . . 1.29 110.702 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -99.77 121.78 41.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.102 -0.499 . . . . 2.1000000000000001 110.027 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.504 HD11 HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -83.17 87.64 2.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.165 -0.47 . . . . 1.55 109.969 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.479 ' HE ' ' HB2' ' A' ' 99' ' ' TYR . 33.1 mtt180 -99.71 144.44 28.33 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.185 -0.461 . . . . 4.3300000000000001 109.929 -173.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.601 ' HA ' HG21 ' A' ' 96' ' ' ILE . 77.7 Cg_exo -50.89 140.38 38.85 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.711 2.274 . . . . 0.90000000000000002 112.439 174.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tpt -77.5 74.63 4.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.25 -0.648 . . . . 2.23 109.25 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 43.02 84.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.01 -0.996 . . . . 1.9199999999999999 111.386 -174.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.748 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 2.2 t-20 -145.98 -67.08 0.29 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.241 -0.436 . . . . 1.8899999999999999 110.591 -173.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 m -142.88 164.52 29.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.71 -0.478 . . . . 2.0699999999999998 109.71 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.06 107.33 17.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.212 0.53 . . . . 1.5800000000000001 110.604 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.726 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.4 m0 -101.89 137.45 40.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.663 -0.699 . . . . 0.54000000000000004 110.067 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.7 m -69.75 114.51 8.02 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.568 -0.53 . . . . 1.22 109.568 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -93.14 105.2 17.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.906 0.86 . . . . 1.29 112.176 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -105.79 161.2 14.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.078 -1.082 . . . . 1.7 108.078 167.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -85.62 3.64 39.9 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.628 -0.429 . . . . 1.3899999999999999 111.1 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.65 -40.06 0.87 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.333 -0.937 . . . . 0.85999999999999999 111.826 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.572 HG22 ' CZ3' ' A' ' 121' ' ' TRP . 30.9 m -133.03 156.88 42.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.988 -0.375 . . . . 1.73 109.988 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.709 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -133.72 97.64 3.97 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.961 -1.126 . . . . 0.41999999999999998 107.961 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.969 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -125.71 142.21 51.63 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 120.754 0.312 . . . . 1.1499999999999999 110.717 -175.472 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.931 ' HZ3' ' HB2' ' A' ' 92' ' ' TRP . 18.5 pttm -72.45 144.12 48.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.353 -0.61 . . . . 2.0299999999999998 109.353 173.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.65 43.8 0.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.009 0.909 . . . . 2.6600000000000001 108.88 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.774 ' HB3' ' HD2' ' A' ' 86' ' ' LYS . 17.4 t70 -149.16 154.41 39.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.591 -1.186 . . . . 2.1000000000000001 109.411 -171.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -115.71 124.38 72.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.094 0.473 . . . . 1.6599999999999999 110.564 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.66 174.97 22.94 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.502 -0.856 . . . . 0.63 112.432 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 p -74.66 124.15 26.19 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.99 -0.374 . . . . 1.5800000000000001 109.99 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.931 ' HB2' ' HZ3' ' A' ' 86' ' ' LYS . 13.4 t90 -100.64 -43.84 6.03 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.844 -0.342 . . . . 0.75 111.677 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.577 ' O ' ' HB ' ' A' ' 30' ' ' VAL . . . 51.34 -122.1 14.07 Favored Glycine 0 C--O 1.213 -1.175 0 N-CA-C 110.968 -0.853 . . . . 1.25 110.968 -173.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 73.17 -144.68 35.04 Favored Glycine 0 C--N 1.321 -0.271 0 C-N-CA 120.908 -0.663 . . . . 1.0 113.9 166.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.747 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -152.09 134.06 14.94 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 122.647 0.379 . . . . 1.3200000000000001 110.746 -179.08 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.654 HG13 HG21 ' A' ' 30' ' ' VAL . 2.2 pp -124.92 151.58 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.601 -0.518 . . . . 2.2400000000000002 109.601 174.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.35 167.77 23.33 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.364 -0.922 . . . . 0.53000000000000003 112.56 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.572 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.9 mp -91.11 113.26 26.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.743 0.306 . . . . 1.53 110.252 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 1.6 m-85 -113.89 124.14 51.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.864 -0.791 . . . . 1.7 108.864 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.727 HG22 HD22 ' A' ' 65' ' ' LEU . 11.4 p -55.58 139.07 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.632 0.253 . . . . 1.6799999999999999 110.709 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -86.61 82.75 7.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.813 -0.81 . . . . 1.02 108.813 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.8 100.7 0.41 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.266 -0.734 . . . . 1.53 111.266 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.486 ' NE2' ' HB2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -43.01 120.25 1.74 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.543 0.687 . . . . 2.5699999999999998 111.87 -179.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.487 ' HG3' ' OG1' ' A' ' 107' ' ' THR . 21.1 tp60 -75.94 -3.13 33.8 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.813 -0.63 . . . . 3.1699999999999999 110.719 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.9 m 66.73 24.81 9.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.345 0.593 . . . . 2.8599999999999999 111.446 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 60.71 71.34 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.77 0.795 . . . . 1.5600000000000001 111.529 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.487 ' OG1' ' HG3' ' A' ' 104' ' ' GLN . 3.1 m -82.64 139.62 44.01 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.971 -1.013 . . . . 2.0800000000000001 108.501 168.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 107' ' ' THR . 66.6 Cg_exo -24.9 94.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.096 1 C-N-CA 125.481 4.12 . . . . 1.48 114.558 -176.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.472 ' CB ' ' HE2' ' A' ' 112' ' ' TYR . 57.1 Cg_endo -87.67 -174.89 1.33 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.14 2.56 . . . . 0.84999999999999998 113.532 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.45 -121.18 0.57 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.215 -1.154 . . . . 0.76000000000000001 110.215 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -99.45 109.81 22.34 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.129 -0.693 . . . . 2.04 109.129 171.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.53 ' CD1' HD13 ' A' ' 56' ' ' LEU . 53.4 m-85 -107.11 104.77 14.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.803 0.811 . . . . 1.1100000000000001 110.667 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.452 ' O ' HG21 ' A' ' 57' ' ' ILE . 86.6 m -98.04 118.21 34.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.889 -1.051 . . . . 1.3400000000000001 109.897 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.749 HD23 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -133.78 96.76 3.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.22 0.533 . . . . 1.1699999999999999 110.214 175.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 7.6 m -75.12 127.61 33.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.089 -0.505 . . . . 1.4099999999999999 110.157 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.504 HD11 HD11 ' A' ' 69' ' ' ILE . 90.2 mt -116.59 126.13 52.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.009 -0.367 . . . . 1.8 110.009 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 131' ' ' PRO . 17.3 m -106.75 126.51 52.39 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.849 0.357 . . . . 1.3200000000000001 110.63 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.69 157.54 45.81 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.809 -0.71 . . . . 0.97999999999999998 111.619 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 171.79 -169.56 42.62 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.629 -0.796 . . . . 0.64000000000000001 111.923 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -111.97 179.92 3.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.181 0.515 . . . . 1.2 110.325 177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.772 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 1.7 t-105 -145.48 148.31 33.12 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.495 -0.775 . . . . 0.65000000000000002 109.272 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.47 144.26 50.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.831 0.348 . . . . 1.55 111.155 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.694 ' HD3' ' H ' ' A' ' 124' ' ' ASP . 4.7 tmtm? 67.83 -136.69 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.918 0.887 . . . . 3.8700000000000001 110.212 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.694 ' H ' ' HD3' ' A' ' 123' ' ' LYS . 4.1 p30 -161.56 138.59 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.067 0.394 . . . . 2.0800000000000001 110.934 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.521 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 55.9 m-80 64.85 -40.8 0.28 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.702 1.201 . . . . 3.0899999999999999 113.891 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.467 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -62.9 -3.63 1.72 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.21 0.604 . . . . 2.3799999999999999 112.339 -174.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.772 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 44.1 mt-30 68.01 67.1 0.35 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.491 0.662 . . . . 2.1099999999999999 111.576 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.467 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -95.13 39.61 2.84 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.948 -0.861 . . . . 0.77000000000000002 110.948 173.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.579 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 41.8 p90 -81.81 151.39 27.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.692 0.282 . . . . 1.49 110.611 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 74.6 m -147.37 125.79 6.13 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.598 -0.273 . . . . 1.8999999999999999 110.707 174.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.478 ' HB3' HG23 ' A' ' 117' ' ' THR . 9.2 Cg_exo -72.17 114.18 3.91 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.933 2.422 . . . . 1.1699999999999999 111.51 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 p -151.04 126.98 10.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.045 0.45 . . . . 1.96 110.931 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.85 -113.55 2.69 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.633 -0.794 . . . . 1.1699999999999999 112.17 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.3 m -130.44 135.37 47.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.63 0.252 . . . . 2.9300000000000002 110.582 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.2 t -99.78 140.53 33.86 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.49 -0.559 . . . . 2.1800000000000002 109.49 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -130.41 119.84 2.87 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.45 -0.881 . . . . 0.72999999999999998 112.355 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 6.0 m -77.77 104.72 8.48 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.781 -0.452 . . . . 1.23 109.781 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.419 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 50.7 m -78.59 108.26 11.86 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.062 -0.718 . . . . 1.1799999999999999 109.062 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 12.4 tppt? -98.68 112.97 24.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.762 0.791 . . . . 2.6299999999999999 110.405 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.61 HD23 HD21 ' A' ' 56' ' ' LEU . 9.4 tp -102.06 94.42 5.76 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 114.676 -1.147 . . . . 1.3100000000000001 109.409 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.72 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 17.1 m -105.69 144.82 31.9 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.265 -0.642 . . . . 1.1799999999999999 109.265 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.4 p -95.41 135.97 27.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.157 0.503 . . . . 2.3900000000000001 110.21 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.4 m . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.714 -0.66 . . . . 2.5899999999999999 109.728 178.888 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 121.029 0.442 . . . . 5.7300000000000004 111.005 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -115.25 -166.5 1.13 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.622 -0.717 . . . . 3.0800000000000001 109.424 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 51.9 t -67.95 86.96 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.502 0.668 . . . . 1.8300000000000001 109.538 172.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -94.62 120.46 34.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.385 -0.825 . . . . 2.29 110.392 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.6 115.78 42.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.184 -0.462 . . . . 2.1000000000000001 110.669 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 31' ' ' GLN . 37.5 ttm180 -80.12 108.16 13.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.688 -0.687 . . . . 4.25 109.802 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -114.83 122.55 69.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.808 -0.633 . . . . 1.8200000000000001 109.829 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.51 169.38 27.4 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.815 -0.707 . . . . 1.1899999999999999 112.389 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.57 123.39 40.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.049 -0.352 . . . . 2.1800000000000002 110.049 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.444 ' HB2' HG21 ' A' ' 138' ' ' THR . 55.8 mt -107.45 121.49 44.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.927 0.394 . . . . 2.0 111.582 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.1 m -112.82 113.32 25.36 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.029 -0.73 . . . . 1.5600000000000001 109.029 170.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.419 HG12 ' HZ3' ' A' ' 14' ' ' LYS . 11.4 t -142.76 147.78 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.913 -0.403 . . . . 2.04 109.913 -176.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -112.28 135.43 52.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.625 -0.261 . . . . 1.23 110.99 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.474 ' HE2' ' HB ' ' A' ' 25' ' ' ILE . 10.9 ptpp? 178.5 163.82 0.75 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.982 -0.554 . . . . 3.9100000000000001 109.957 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.812 ' HA ' HG11 ' A' ' 142' ' ' VAL . 76.1 p -85.44 161.71 19.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.132 -0.485 . . . . 1.21 109.865 175.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.967 ' NH2' ' HH ' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -80.32 -0.4 36.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.3 -0.63 . . . . 4.0800000000000001 109.3 174.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.502 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -96.53 -18.41 30.62 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.197 -0.91 . . . . 0.75 110.962 176.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -71.12 -23.82 62.16 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.538 -0.912 . . . . 2.6299999999999999 108.538 172.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.403 ' CB ' HG11 ' A' ' 100' ' ' VAL . 46.9 mt -86.49 116.99 24.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.641 -1.163 . . . . 1.6100000000000001 108.989 173.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 p -111.42 77.13 1.02 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.77 0.319 . . . . 2.2599999999999998 110.682 -175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 29.5 t70 61.39 -83.56 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.155 -0.93 . . . . 1.8300000000000001 110.835 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.648 ' HA ' ' CD2' ' A' ' 99' ' ' TYR . . . -107.07 84.6 2.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.304 0.574 . . . . 1.4299999999999999 110.309 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.47 ' O ' HG13 ' A' ' 25' ' ' ILE . . . -146.68 87.72 6.28 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.191 -0.913 . . . . 1.3700000000000001 109.304 175.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.518 ' CB ' ' HA3' ' A' ' 97' ' ' GLY . 59.8 Cg_endo -69.57 94.86 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.657 2.238 . . . . 1.1200000000000001 112.683 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.474 ' HB ' ' HE2' ' A' ' 14' ' ' LYS . 4.9 mt -111.82 23.46 4.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 122.005 0.907 . . . . 3.0499999999999998 110.056 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.507 ' N ' ' HD3' ' A' ' 27' ' ' PRO . . . -140.66 53.17 0.67 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.89 -1.05 . . . . 1.04 111.578 168.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.766 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 48.4 Cg_exo -55.81 115.06 2.19 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.299 1.999 . . . . 1.0 113.433 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.2 t -88.58 129.89 38.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.361 -0.836 . . . . 1.8300000000000001 109.282 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 p -76.95 88.13 3.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.244 0.545 . . . . 2.2000000000000002 110.868 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.1 115.44 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.673 -0.694 . . . . 1.5600000000000001 110.755 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . 52.1 tt0 -114.35 113.01 23.98 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.251 -0.431 . . . . 2.48 109.988 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.598 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -95.98 101.27 12.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.843 -0.617 . . . . 1.25 110.306 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 tt -95.83 126.35 41.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.765 -0.652 . . . . 2.4700000000000002 110.592 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.2 69.9 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.087 -0.577 . . . . 1.8100000000000001 114.4 169.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.598 ' SG ' ' HB1' ' A' ' 32' ' ' ALA . 31.3 m -80.54 -66.96 0.82 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.343 0.572 . . . . 1.8799999999999999 110.112 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.581 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 3.2 m-20 67.81 -45.98 0.5 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.136 1.162 . . . . 2.71 114.136 172.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.52 29.08 2.69 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.062 -0.399 . . . . 1.3600000000000001 111.905 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -133.26 161.06 35.5 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.23 -0.285 . . . . 5.3499999999999996 110.23 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -91.73 141.14 29.01 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.904 -0.406 . . . . 1.9099999999999999 109.904 172.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 53.1 t -94.03 136.28 26.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.849 -0.796 . . . . 1.1699999999999999 108.849 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -127.53 135.39 50.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.851 0.358 . . . . 1.0900000000000001 110.803 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 mt -103.54 105.57 15.84 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.164 -0.68 . . . . 1.4399999999999999 109.164 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.805 ' HG3' HG12 ' A' ' 83' ' ' VAL . 1.4 mppt? -108.4 125.41 51.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.52 -0.919 . . . . 2.5299999999999998 108.52 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.616 ' HB2' HD22 ' A' ' 48' ' ' ASN . . . -72.94 156.95 38.33 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.686 -0.406 . . . . 1.0700000000000001 110.248 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.7 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 21.5 t70 -71.77 147.4 47.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.205 -0.452 . . . . 0.70999999999999996 109.839 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -61.66 -6.27 2.43 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.91 0.707 . . . . 1.71 112.91 -171.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.83 -29.24 44.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.992 0.425 . . . . 2.2200000000000002 110.378 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.616 HD22 ' HB2' ' A' ' 44' ' ' ALA . 5.5 p-10 -124.28 19.79 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 1.5800000000000001 109.553 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.456 ' CE1' ' HA2' ' A' ' 52' ' ' GLY . 84.7 t80 -137.45 107.4 6.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.281 -0.872 . . . . 0.72999999999999998 109.916 -175.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -103.07 96.91 7.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.411 -0.358 . . . . 2.4100000000000001 110.653 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 68.2 -52.32 0.54 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.983 0.802 . . . . 4.1399999999999997 112.047 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 49' ' ' PHE . . . -174.33 37.08 0.12 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 111.671 -0.572 . . . . 0.72999999999999998 111.671 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.766 ' HD2' ' HB3' ' A' ' 81' ' ' ASN . 8.7 mmmm -138.95 133.52 31.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.64 -1.244 . . . . 2.6800000000000002 107.64 172.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.15 147.03 43.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.667 0.746 . . . . 0.65000000000000002 112.055 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.488 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 9.2 p90 -150.19 -179.63 7.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.568 -1.196 . . . . 0.73999999999999999 109.603 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.951 HD11 HD21 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -89.37 121.55 31.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.979 -1.119 . . . . 2.0800000000000001 107.979 169.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.569 HG23 ' HB3' ' A' ' 48' ' ' ASN . 8.8 tp -106.79 116.86 51.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.571 0.701 . . . . 1.21 109.439 177.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 22.6 t -72.51 147.65 45.79 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.06 -0.518 . . . . 1.9299999999999999 110.214 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.84 -8.07 33.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.456 0.646 . . . . 2.3100000000000001 109.703 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -95.26 -3.12 48.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.385 -0.825 . . . . 3.6600000000000001 110.023 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.07 28.01 0.35 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.884 1.273 . . . . 3.0600000000000001 113.553 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -86.46 -53.83 4.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.087 -0.383 . . . . 5.1799999999999997 111.118 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.513 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 7.2 m-20 -125.66 159.64 31.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.414 -0.357 . . . . 2.5099999999999998 110.705 -175.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.488 ' HB2' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -145.63 133.11 20.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.78 -0.646 . . . . 2.6200000000000001 109.718 176.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.611 ' O ' HD23 ' A' ' 56' ' ' LEU . 2.0 mm? -128.37 133.35 48.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.336 -0.616 . . . . 2.48 109.336 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -75.25 138.34 41.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.147 0.498 . . . . 1.1299999999999999 110.376 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.47 HG12 HD12 ' A' ' 56' ' ' LEU . 2.4 m -117.48 167.19 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-N 115.734 -0.667 . . . . 1.29 110.476 177.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -121.78 110.34 15.79 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.775 -0.648 . . . . 2.1000000000000001 109.339 173.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.1 pt -88.77 84.93 2.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.021 -0.733 . . . . 1.55 109.021 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.571 ' HB3' ' OH ' ' A' ' 99' ' ' TYR . 44.9 ttt180 -116.69 136.2 23.13 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 115.445 -0.798 . . . . 4.3300000000000001 109.132 -173.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.574 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 91.9 Cg_exo -42.92 121.0 2.08 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.0 2.467 . . . . 0.90000000000000002 112.284 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.9 ttt -68.18 87.83 0.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 2.23 110.424 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t0 49.35 66.76 1.02 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.143 -0.935 . . . . 1.9199999999999999 111.019 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -140.17 -53.19 0.51 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 1.8899999999999999 111.559 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.0 m -149.57 161.42 42.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.576 0.227 . . . . 2.0699999999999998 110.624 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.6 86.45 3.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.94 0.4 . . . . 1.5800000000000001 110.081 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 17.2 m0 -77.25 158.27 30.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.706 -0.679 . . . . 0.54000000000000004 110.3 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.9 m -69.63 116.33 9.91 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.063 -0.717 . . . . 1.22 109.063 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 t -98.01 97.31 8.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.819 0.819 . . . . 1.29 112.094 -170.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.33 159.85 14.67 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.295 -1.002 . . . . 1.7 108.295 168.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.766 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -79.73 -7.31 58.54 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.335 -0.546 . . . . 1.3899999999999999 110.017 -178.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.452 ' CA ' ' HE1' ' A' ' 49' ' ' PHE . . . -118.64 -36.74 0.88 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.13 -1.033 . . . . 0.85999999999999999 112.887 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.805 HG12 ' HG3' ' A' ' 43' ' ' LYS . 33.4 m -124.52 151.76 30.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.275 -0.639 . . . . 1.73 109.275 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -135.03 102.48 5.23 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.297 -1.001 . . . . 0.41999999999999998 108.297 -178.422 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.668 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 15.6 p90 -135.9 140.87 44.4 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.137 0.494 . . . . 1.1499999999999999 110.903 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 17.1 pttp -82.44 140.98 33.1 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.562 -0.745 . . . . 2.0299999999999998 110.986 -178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -67.47 -34.4 77.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.291 -1.003 . . . . 2.6600000000000001 108.291 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.595 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 2.2 m-20 -58.44 124.48 19.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.636 -1.166 . . . . 2.1000000000000001 110.31 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.8 131.46 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.512 -0.475 . . . . 1.6599999999999999 109.818 174.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.581 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 146.07 -165.19 28.18 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.584 -0.817 . . . . 0.63 111.832 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.8 p -81.82 -172.78 4.08 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.619 -0.511 . . . . 1.5800000000000001 109.619 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.574 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 22.5 t90 -154.0 -59.99 0.13 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.953 -0.388 . . . . 0.75 109.953 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 39.69 88.44 0.01 OUTLIER Glycine 0 N--CA 1.467 0.724 0 O-C-N 124.275 0.985 . . . . 1.25 114.901 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.69 -139.6 2.68 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.022 -0.609 . . . . 1.0 111.669 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 p -131.77 124.62 30.07 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.43 0.634 . . . . 1.3200000000000001 112.167 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 37.5 pt -100.0 161.54 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.375 -0.972 . . . . 2.2400000000000002 108.375 172.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.518 ' HA3' ' CB ' ' A' ' 24' ' ' PRO . . . -128.02 147.9 17.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.53 -1.319 . . . . 0.53000000000000003 113.126 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 79.8 mt -101.75 120.73 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 120.731 0.3 . . . . 1.53 110.886 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.648 ' CD2' ' HA ' ' A' ' 22' ' ' ALA . 1.4 p90 -138.6 155.2 48.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.85 -0.614 . . . . 1.7 110.392 173.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.464 HG13 ' HA ' ' A' ' 103' ' ' GLN . 12.8 p -85.58 136.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.822 -0.626 . . . . 1.6799999999999999 110.761 -170.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.13 101.87 0.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.825 -0.625 . . . . 1.02 111.391 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.75 34.83 66.4 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-O 119.451 -0.638 . . . . 1.53 113.848 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.464 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.4 pt20 38.92 96.88 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.984 0.897 . . . . 2.5699999999999998 113.187 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.518 ' HG3' ' HB3' ' A' ' 65' ' ' LEU . 14.7 mm100 -80.39 17.45 1.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.49 -0.777 . . . . 3.1699999999999999 111.927 -172.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 8.8 m 76.32 -29.15 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.392 0.677 . . . . 2.8599999999999999 112.671 168.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.502 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 15.0 t30 77.8 84.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.851 0.834 . . . . 1.5600000000000001 111.08 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.445 ' N ' HH12 ' A' ' 16' ' ' ARG . 25.9 m -93.79 137.43 23.17 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.542 -1.208 . . . . 2.0800000000000001 109.535 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.414 ' HD2' ' CG2' ' A' ' 107' ' ' THR . 72.2 Cg_exo -19.58 92.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 1 C-N-CA 126.198 4.598 . . . . 1.48 115.461 -174.228 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.783 ' HG2' HG13 ' A' ' 142' ' ' VAL . 10.2 Cg_endo -96.96 -155.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.355 3.37 . . . . 0.84999999999999998 114.31 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -172.94 -105.25 0.18 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 114.118 -1.401 . . . . 0.76000000000000001 109.603 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -102.74 130.11 49.59 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.57 -0.53 . . . . 2.04 109.57 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.967 ' HH ' ' NH2' ' A' ' 16' ' ' ARG . 6.7 m-85 -118.58 120.66 38.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.036 0.446 . . . . 1.1100000000000001 110.587 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.2 m -97.48 135.36 39.45 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 1.3400000000000001 110.768 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.951 HD21 HD11 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -153.84 94.06 1.72 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.463 0.649 . . . . 1.1699999999999999 109.783 175.08 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.7 ' HB ' ' CB ' ' A' ' 45' ' ' ASP . 14.8 m -84.45 140.65 31.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.741 -0.663 . . . . 1.4099999999999999 109.95 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.5 mt -118.42 119.93 36.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.409 -0.359 . . . . 1.8 110.496 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 43.5 m -98.47 121.34 40.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.014 0.435 . . . . 1.3200000000000001 110.236 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.12 -159.4 19.05 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.842 -0.694 . . . . 0.97999999999999998 112.673 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.69 ' HA2' ' HB2' ' A' ' 132' ' ' SER . . . 109.64 165.88 20.0 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.518 -0.633 . . . . 0.64000000000000001 111.518 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -89.34 177.26 6.64 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.142 -0.623 . . . . 1.2 111.017 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.661 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 4.6 t-105 -129.25 151.95 49.35 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.804 -1.089 . . . . 0.65000000000000002 109.902 -174.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.45 149.85 52.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.105 -0.498 . . . . 1.55 110.175 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.441 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 6.4 mmtt 64.25 -146.52 0.28 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.21 0.604 . . . . 3.8700000000000001 111.053 -176.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 126' ' ' LYS . 4.2 p30 -151.02 136.14 17.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.516 0.198 . . . . 2.0800000000000001 110.945 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.6 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.7 OUTLIER 51.97 -7.9 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.306 1.842 . . . . 3.0899999999999999 115.883 176.569 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -80.5 -2.52 46.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.362 0.601 . . . . 2.3799999999999999 109.999 176.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.661 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 7.7 tt0 68.47 54.43 0.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.432 -1.258 . . . . 2.1099999999999999 110.839 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -89.47 110.68 3.75 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 109.823 -1.311 . . . . 0.77000000000000002 109.823 170.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 26.7 p90 -151.0 171.26 17.58 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.297 -0.631 . . . . 1.49 109.297 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.571 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 5.9 t -150.19 146.03 19.54 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 110.009 -0.367 . . . . 1.8999999999999999 110.009 173.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.12 106.76 1.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.7 2.267 . . . . 1.1699999999999999 111.47 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.69 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 10.6 m -131.95 122.07 24.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.913 -0.585 . . . . 1.96 109.78 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.75 -110.57 3.78 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.714 -0.755 . . . . 1.1699999999999999 111.483 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.6 p -144.01 176.2 9.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.052 0.453 . . . . 2.9300000000000002 110.957 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.1 t -126.86 129.71 48.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.31 -0.626 . . . . 2.1800000000000002 109.31 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.49 138.18 14.65 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.647 -0.787 . . . . 0.72999999999999998 112.155 -175.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 19.2 m -99.06 103.73 15.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.992 -0.373 . . . . 1.23 109.992 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.453 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 21.6 m -81.81 113.18 19.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.355 -0.609 . . . . 1.1799999999999999 109.355 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -100.22 109.08 21.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.471 0.653 . . . . 2.6299999999999999 109.506 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.5 HD23 ' HG ' ' A' ' 56' ' ' LEU . 13.7 tp -92.58 95.85 9.85 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.711 -1.132 . . . . 1.3100000000000001 109.415 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 24.7 m -93.64 126.8 39.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.76 -0.654 . . . . 1.1799999999999999 109.576 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.812 HG11 ' HA ' ' A' ' 15' ' ' THR . 30.7 t -107.23 106.18 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.675 -0.41 . . . . 2.3900000000000001 111.242 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.289 -0.863 . . . . 2.5899999999999999 109.498 173.737 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.407 0.146 . . . . 5.7300000000000004 110.966 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -162.0 121.61 2.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.987 0.423 . . . . 3.0800000000000001 111.337 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.958 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 4.8 t -92.52 103.39 15.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.656 -0.868 . . . . 1.8300000000000001 108.656 168.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -97.67 141.42 30.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.25 -0.432 . . . . 2.29 110.928 -175.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.536 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 74.9 t -117.37 117.2 54.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.749 -0.659 . . . . 2.1000000000000001 110.397 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -88.86 106.22 18.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.112 -0.495 . . . . 4.25 110.79 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.435 HG23 HG13 ' A' ' 5' ' ' VAL . 66.9 t -113.76 115.02 48.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.115 -0.493 . . . . 1.8200000000000001 109.937 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.77 -178.53 25.72 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.63 -0.795 . . . . 1.1899999999999999 112.029 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.27 146.47 24.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.959 -0.385 . . . . 2.1800000000000002 109.959 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.9 pt? -140.92 142.11 34.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.12 -0.491 . . . . 2.0 109.718 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -116.65 117.59 30.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.405 -0.362 . . . . 1.5600000000000001 110.697 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.35 140.37 47.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.938 0.399 . . . . 2.04 110.534 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.438 ' HB3' ' OG1' ' A' ' 143' ' ' THR . . . -116.67 112.5 21.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 1.23 110.222 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -163.81 179.7 6.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.049 0.452 . . . . 3.9100000000000001 110.417 -178.617 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.563 ' H ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -103.42 158.73 16.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 1.21 110.328 178.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.638 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -80.46 -9.2 59.76 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.961 -0.462 . . . . 4.0800000000000001 111.023 -175.81 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.57 -15.36 79.25 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.081 -0.807 . . . . 0.75 111.081 172.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HA ' HE21 ' A' ' 18' ' ' GLN . 0.0 OUTLIER -66.07 -31.79 72.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.124 -0.538 . . . . 2.6299999999999999 110.856 176.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.845 ' HB2' HG12 ' A' ' 100' ' ' VAL . 12.2 mt -91.25 19.8 5.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.889 -0.596 . . . . 1.6100000000000001 112.183 -168.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -36.25 93.59 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 N-CA-C 114.007 1.114 . . . . 2.2599999999999998 114.007 -172.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 69.9 -53.34 0.62 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.858 -1.064 . . . . 1.8300000000000001 111.923 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.807 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -158.13 78.41 0.82 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.189 0.518 . . . . 1.4299999999999999 111.26 176.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 19' ' ' LEU . . . -138.93 117.87 9.25 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.488 -0.778 . . . . 1.3700000000000001 109.096 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD3' ' HE1' ' A' ' 99' ' ' TYR . 96.0 Cg_endo -79.74 132.48 9.79 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.88 2.387 . . . . 1.1200000000000001 114.417 -170.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.731 HG21 HD22 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -77.49 -56.61 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.425 -0.807 . . . . 3.0499999999999998 110.162 169.104 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.44 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -138.91 98.24 0.25 Allowed Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.388 -0.824 . . . . 1.04 111.67 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.606 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 31.3 Cg_endo -67.66 126.58 14.95 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.271 1.98 . . . . 1.0 111.378 176.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.75 124.44 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 1.8300000000000001 109.653 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 t -77.7 74.98 4.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.472 0.654 . . . . 2.2000000000000002 110.508 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.484 HG11 ' CG1' ' A' ' 5' ' ' VAL . 70.0 t -72.42 113.2 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.728 -0.669 . . . . 1.5600000000000001 109.949 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -116.12 125.82 52.87 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.778 -0.646 . . . . 2.48 109.833 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.483 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -111.61 130.61 55.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.408 -0.815 . . . . 1.25 110.351 -177.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 35.2 tp -111.44 116.45 30.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.137 -0.483 . . . . 2.4700000000000002 111.324 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.09 71.63 0.84 Allowed Glycine 0 C--N 1.331 0.304 0 O-C-N 123.573 0.545 . . . . 1.8100000000000001 113.423 173.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.958 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 9.9 m -106.71 -68.83 0.86 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.883 -0.327 . . . . 1.8799999999999999 111.465 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 68.41 -48.22 0.55 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.466 0.706 . . . . 2.71 112.32 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.81 69.89 1.26 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.206 0.527 . . . . 1.3600000000000001 110.348 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.628 HH11 ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -149.95 131.8 15.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.994 -0.548 . . . . 5.3499999999999996 110.586 -177.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.686 ' HG3' HG11 ' A' ' 89' ' ' VAL . 98.6 mt-30 -85.48 124.19 31.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.109 0.48 . . . . 1.9099999999999999 110.078 178.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.628 ' HA ' HH11 ' A' ' 38' ' ' ARG . 71.0 t -95.14 110.55 24.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.088 -0.506 . . . . 1.1699999999999999 109.946 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.817 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . . . -117.72 144.44 45.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 123.624 0.578 . . . . 1.0900000000000001 111.039 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.82 HD11 HD12 ' A' ' 96' ' ' ILE . 64.5 mt -103.7 129.07 51.0 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.488 -0.56 . . . . 1.4399999999999999 109.488 172.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.817 ' HE2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -120.28 152.12 38.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.858 -0.793 . . . . 2.5299999999999998 108.858 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.47 ' HB1' ' OD1' ' A' ' 48' ' ' ASN . . . -92.67 159.2 15.56 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.719 -0.392 . . . . 1.0700000000000001 110.036 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 14.8 t70 -87.61 170.01 11.66 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.563 -0.903 . . . . 0.70999999999999996 108.563 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -65.54 -1.98 3.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.975 0.361 . . . . 1.71 111.975 -173.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -88.94 -26.34 21.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.72 -0.218 . . . . 2.2200000000000002 111.262 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 28.9 p-10 -131.73 12.16 4.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.732 0.301 . . . . 1.5800000000000001 111.699 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.447 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 55.2 t80 -114.44 101.37 9.07 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.537 -0.542 . . . . 0.72999999999999998 109.537 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.799 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 8.3 pt-20 -95.35 93.71 7.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.877 0.37 . . . . 2.4100000000000001 110.387 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 68.39 -50.95 0.56 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.428 -0.805 . . . . 4.1399999999999997 112.036 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.447 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -172.04 36.58 0.15 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.183 -0.767 . . . . 0.72999999999999998 111.183 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.606 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 10.3 mmmm -137.84 134.87 35.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.946 -0.761 . . . . 2.6800000000000002 108.946 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -117.9 148.69 41.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.493 0.663 . . . . 0.65000000000000002 112.307 177.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.799 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 7.6 p90 -156.58 176.94 12.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.019 -0.991 . . . . 0.73999999999999999 111.1 -174.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 20.1 mt -89.24 111.05 21.76 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.351 -0.981 . . . . 2.0800000000000001 108.351 168.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.526 ' HB ' ' HE1' ' A' ' 55' ' ' PHE . 8.3 tp -107.33 138.69 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.703 -0.48 . . . . 1.21 109.703 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 3.1 t -102.41 152.73 20.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.529 -0.305 . . . . 1.9299999999999999 110.372 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -49.11 -42.48 39.27 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.053 0.846 . . . . 2.3100000000000001 113.023 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.31 -21.8 66.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.711 0.263 . . . . 3.6600000000000001 111.711 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 63.34 84.43 0.15 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.365 0.602 . . . . 3.0600000000000001 109.95 -176.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -154.79 -40.7 0.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.615 . . . . 5.1799999999999997 111.034 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.87 153.52 50.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.915 -0.584 . . . . 2.5099999999999998 110.322 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.6 pptp? -152.25 128.04 10.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.804 -0.635 . . . . 2.6200000000000001 109.739 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.487 HD22 ' HG2' ' A' ' 104' ' ' GLN . 4.5 mt -114.27 119.12 35.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.261 -0.427 . . . . 2.48 110.026 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.439 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 93.4 m-85 -67.85 128.73 37.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 1.1299999999999999 110.156 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 100' ' ' VAL . 11.2 m -121.27 123.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.878 -0.601 . . . . 1.29 111.428 -175.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -97.21 111.67 23.81 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.961 -0.563 . . . . 2.1000000000000001 109.53 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.434 HG23 ' HB ' ' A' ' 96' ' ' ILE . 2.6 mt -76.32 86.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.562 -0.745 . . . . 1.55 110.454 -176.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -93.62 142.84 25.68 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.995 -0.548 . . . . 4.3300000000000001 109.866 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.564 ' HA ' HG22 ' A' ' 96' ' ' ILE . 77.1 Cg_exo -51.12 134.08 42.64 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.693 2.262 . . . . 0.90000000000000002 112.52 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tpt -75.14 72.75 2.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.984 -0.553 . . . . 2.23 109.948 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.4 t70 52.58 75.59 0.23 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.363 -0.835 . . . . 1.9199999999999999 110.785 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -146.56 -59.94 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.866 -0.606 . . . . 1.8899999999999999 111.248 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 m -151.02 178.83 8.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 2.0699999999999998 111.055 -175.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.26 121.75 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.751 -0.658 . . . . 1.5800000000000001 109.891 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.512 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 17.8 m0 -113.07 168.21 9.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.256 -0.429 . . . . 0.54000000000000004 111.001 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -87.97 131.37 34.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.018 -0.734 . . . . 1.22 109.018 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 t -107.93 113.59 26.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.605 0.717 . . . . 1.29 112.353 -171.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -127.24 161.33 28.82 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.782 -1.192 . . . . 1.7 107.782 170.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.481 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 15.8 m120 -85.91 -5.52 59.22 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.295 -0.562 . . . . 1.3899999999999999 110.812 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.82 -38.37 3.66 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.19 -1.005 . . . . 0.85999999999999999 111.81 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.687 HG13 ' HG3' ' A' ' 43' ' ' LYS . 27.0 m -140.49 156.72 23.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.971 0.415 . . . . 1.73 110.403 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.671 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -132.15 108.87 9.56 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.659 -0.867 . . . . 0.41999999999999998 108.659 177.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 12.7 p90 -145.75 149.24 34.03 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.22 0.325 . . . . 1.1499999999999999 110.675 -174.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.745 ' HZ2' ' HB2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -80.55 141.36 35.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.948 -0.701 . . . . 2.0299999999999998 109.205 174.306 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -57.97 -33.81 69.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.843 -0.617 . . . . 2.6600000000000001 110.412 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -61.99 122.14 14.74 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.741 -0.663 . . . . 2.1000000000000001 111.587 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.686 HG11 ' HG3' ' A' ' 39' ' ' GLN . 13.1 m -80.94 105.59 11.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.141 0.496 . . . . 1.6599999999999999 109.95 173.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.75 -162.77 35.83 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.134 -1.032 . . . . 0.63 112.603 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -84.0 163.81 19.71 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.013 0.435 . . . . 1.5800000000000001 110.447 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.745 ' HB2' ' HZ2' ' A' ' 86' ' ' LYS . 41.3 t90 -148.86 -62.41 0.24 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.344 -0.613 . . . . 0.75 109.344 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 38.54 91.72 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 O-C-N 124.341 1.026 . . . . 1.25 115.161 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.16 -127.45 0.91 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.701 -0.761 . . . . 1.0 112.377 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 p -135.85 133.02 37.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.054 0.454 . . . . 1.3200000000000001 111.805 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.82 HD12 HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -130.87 134.26 62.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 2.2400000000000002 109.692 176.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -106.61 156.26 16.22 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.34 -0.933 . . . . 0.53000000000000003 113.005 -170.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 mp -97.56 117.75 42.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.9 0.381 . . . . 1.53 110.089 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.807 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 1.1 m-85 -126.19 133.56 51.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.631 -0.713 . . . . 1.7 109.509 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.845 HG12 ' HB2' ' A' ' 19' ' ' LEU . 12.3 p -66.21 119.77 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.855 -0.794 . . . . 1.6799999999999999 108.855 173.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.92 83.54 1.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.579 0.704 . . . . 1.02 109.477 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.99 93.83 2.3 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 114.799 -1.091 . . . . 1.53 110.961 -171.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.535 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 16.5 pt20 -31.48 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.276 0.843 . . . . 2.5699999999999998 113.276 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.487 ' HG2' HD22 ' A' ' 65' ' ' LEU . 55.9 tp60 -82.59 -15.37 52.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 3.1699999999999999 110.692 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 m 62.6 26.31 15.61 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.361 0.6 . . . . 2.8599999999999999 111.134 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.638 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 7.2 t30 64.08 89.41 0.09 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.589 -0.732 . . . . 1.5600000000000001 112.204 172.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.3 m -89.6 133.87 33.55 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.819 -0.808 . . . . 2.0800000000000001 108.819 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -19.46 90.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.794 4.329 . . . . 1.48 115.1 -171.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.613 ' CB ' ' HE1' ' A' ' 112' ' ' TYR . 90.0 Cg_endo -99.99 -161.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.968 3.112 . . . . 0.84999999999999998 113.889 -174.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.55 -101.98 0.15 Allowed Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.926 -1.034 . . . . 0.76000000000000001 110.633 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -112.38 111.41 22.25 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.339 -0.615 . . . . 2.04 109.339 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.613 ' HE1' ' CB ' ' A' ' 109' ' ' PRO . 27.6 m-85 -95.35 128.09 41.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.233 0.54 . . . . 1.1100000000000001 110.303 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.7 m -116.06 98.46 6.64 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.071 -0.968 . . . . 1.3400000000000001 110.395 -175.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.461 ' HG ' ' HB ' ' A' ' 138' ' ' THR . 0.2 OUTLIER -119.34 100.55 7.38 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.042 -0.527 . . . . 1.1699999999999999 110.367 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 23.8 m -88.37 132.52 34.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.148 -0.478 . . . . 1.4099999999999999 110.527 -178.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -114.63 124.84 52.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.083 0.468 . . . . 1.8 110.556 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.434 ' HA ' HG23 ' A' ' 135' ' ' THR . 27.5 m -91.06 113.04 25.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.752 -0.658 . . . . 1.3200000000000001 110.478 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.1 122.65 6.25 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.737 -0.744 . . . . 0.97999999999999998 111.754 177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.57 -176.33 39.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.241 -0.98 . . . . 0.64000000000000001 112.426 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -102.96 177.84 4.73 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.278 0.561 . . . . 1.2 110.294 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.803 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.9 OUTLIER -147.29 149.32 32.62 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.323 -0.992 . . . . 0.65000000000000002 108.323 -177.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.61 144.14 51.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.421 0.153 . . . . 1.55 110.79 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HG3' ' HE2' ' A' ' 126' ' ' LYS . 32.9 mmtp 74.97 -144.34 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.62 0.768 . . . . 3.8700000000000001 111.368 175.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 126' ' ' LYS . 11.6 p-10 -150.68 123.21 8.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.322 0.582 . . . . 2.0800000000000001 112.275 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.565 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 27.6 t-20 68.44 -28.58 0.15 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.445 1.098 . . . . 3.0899999999999999 113.947 174.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HE2' ' HG3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -65.34 -3.19 3.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.219 0.533 . . . . 2.3799999999999999 111.164 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.803 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 46.1 tt0 66.79 66.45 0.44 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.12 -0.946 . . . . 2.1099999999999999 110.862 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 121' ' ' TRP . . . -90.89 46.96 2.93 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.329 -0.938 . . . . 0.77000000000000002 111.37 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.668 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 3.9 p90 -86.69 144.66 27.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.773 0.321 . . . . 1.49 110.856 -170.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 46.3 m -150.3 132.26 7.83 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 110.37 -0.233 . . . . 1.8999999999999999 110.37 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.71 132.74 47.14 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.708 2.272 . . . . 1.1699999999999999 112.345 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -156.28 95.17 1.57 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.234 -0.439 . . . . 1.96 110.4 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 5' ' ' VAL . . . 130.25 -102.71 0.54 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.776 -0.726 . . . . 1.1699999999999999 112.162 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.4 m -152.3 147.45 26.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.711 0.256 . . . . 2.9300000000000002 110.741 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 117' ' ' THR . 28.9 m -101.2 127.49 47.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.649 -0.5 . . . . 2.1800000000000002 109.649 174.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.96 141.11 12.41 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.467 -0.873 . . . . 0.72999999999999998 112.524 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 72.8 m -94.3 123.15 37.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.025 0.44 . . . . 1.23 110.913 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.461 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 24.9 m -85.88 115.26 23.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.514 -0.921 . . . . 1.1799999999999999 108.514 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -100.88 111.91 24.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.21 0.528 . . . . 2.6299999999999999 110.208 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 tp -108.64 100.45 9.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.048 -0.978 . . . . 1.3100000000000001 110.385 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 m -93.15 143.67 26.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.852 -0.613 . . . . 1.1799999999999999 109.809 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.587 ' HA ' HH12 ' A' ' 16' ' ' ARG . 7.3 p -71.02 132.79 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.467 0.651 . . . . 2.3900000000000001 112.349 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 85.5 m . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.133 -0.94 . . . . 2.5899999999999999 109.129 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.864 0.364 . . . . 5.7300000000000004 110.465 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -98.48 137.94 36.43 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.343 0.592 . . . . 3.0800000000000001 110.067 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.849 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 48.2 t -147.84 131.51 16.89 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.989 -1.005 . . . . 1.8300000000000001 108.3 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -85.68 123.71 31.38 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.285 -0.566 . . . . 2.29 110.393 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.51 HG23 HH22 ' A' ' 38' ' ' ARG . 61.3 t -95.56 112.06 27.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.718 -0.673 . . . . 2.1000000000000001 110.045 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.704 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 14.5 mmm180 -81.64 93.74 6.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.706 -0.679 . . . . 4.25 110.834 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.554 HG11 ' HA3' ' A' ' 136' ' ' GLY . 37.2 t -107.62 115.62 49.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.394 -0.965 . . . . 1.8200000000000001 108.394 171.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.76 -175.77 21.65 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.498 -0.858 . . . . 1.1899999999999999 112.261 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -100.59 146.15 27.49 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.926 -0.398 . . . . 2.1800000000000002 109.926 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -152.6 139.26 18.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.552 -0.536 . . . . 2.0 109.552 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.9 m -107.77 115.89 30.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.183 -0.462 . . . . 1.5600000000000001 110.305 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 140' ' ' LEU . 4.1 p -110.61 126.01 67.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.14 -0.482 . . . . 2.04 109.9 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -105.31 104.21 13.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.898 -0.592 . . . . 1.23 110.452 -176.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -172.9 -178.68 1.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 3.9100000000000001 110.478 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.5 p -107.43 162.77 13.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.127 -0.488 . . . . 1.21 111.065 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.956 ' NH2' ' HH ' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -80.27 -0.44 36.48 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.644 -0.502 . . . . 4.0800000000000001 109.644 176.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.596 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -79.39 -17.58 75.76 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.367 -0.693 . . . . 0.75 111.367 177.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -74.17 -22.62 59.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.847 -0.797 . . . . 2.6299999999999999 108.847 173.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.898 HD23 HG12 ' A' ' 25' ' ' ILE . 67.2 mt -87.16 95.9 10.12 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.699 -1.137 . . . . 1.6100000000000001 110.985 -175.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.0 m -101.3 68.05 1.2 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.045 -0.724 . . . . 2.2599999999999998 109.045 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.4 t70 69.56 -62.68 0.41 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.753 -1.112 . . . . 1.8300000000000001 111.036 -175.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.411 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -114.31 98.09 6.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.797 0.332 . . . . 1.4299999999999999 110.887 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 19' ' ' LEU . . . -154.54 92.08 2.98 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.439 . . . . 1.3700000000000001 111.071 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.493 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 28.7 Cg_endo -64.19 80.82 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.349 2.699 . . . . 1.1200000000000001 112.372 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.898 HG12 HD23 ' A' ' 19' ' ' LEU . 1.1 pp -70.7 -53.71 21.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.405 -0.816 . . . . 3.0499999999999998 112.336 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.24 63.88 0.57 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.203 -0.998 . . . . 1.04 113.249 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.654 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 5.5 Cg_endo -47.07 111.59 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.601 2.867 . . . . 1.0 113.004 172.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 p -84.63 134.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.896 -0.593 . . . . 1.8300000000000001 109.813 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -88.64 102.87 15.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.672 0.748 . . . . 2.2000000000000002 110.804 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.641 ' CG2' HD11 ' A' ' 96' ' ' ILE . 41.5 t -94.79 116.26 35.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.556 -0.747 . . . . 1.5600000000000001 110.204 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.704 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 34.7 tt0 -102.01 125.14 48.62 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.641 -0.709 . . . . 2.48 110.182 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . . . -112.89 113.98 26.29 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.956 -0.387 . . . . 1.25 109.956 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.1 mt -104.99 111.52 24.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.969 0.414 . . . . 2.4700000000000002 111.986 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.95 55.32 8.18 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.508 -0.769 . . . . 1.8100000000000001 113.283 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.849 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 84.1 m -87.14 -49.31 7.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.857 0.329 . . . . 1.8799999999999999 110.585 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.8 t30 71.14 -63.78 0.41 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.708 0.803 . . . . 2.71 112.69 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.91 71.0 1.25 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.676 0.75 . . . . 1.3600000000000001 109.19 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.617 ' NE ' ' HB3' ' A' ' 120' ' ' TYR . 41.0 ttt-85 -146.54 133.19 19.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.178 -0.919 . . . . 5.3499999999999996 111.012 -169.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -83.17 96.86 8.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.615 -0.513 . . . . 1.9099999999999999 109.615 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 46.7 t -73.6 117.22 17.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 1.1699999999999999 110.315 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -119.48 148.31 43.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.129 -0.487 . . . . 1.0900000000000001 110.977 -176.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 mt -102.77 113.79 27.5 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.115 -0.698 . . . . 1.4399999999999999 109.115 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.552 ' CE ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -104.75 125.8 51.19 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.632 -0.507 . . . . 2.5299999999999998 109.632 -178.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB3' ' ND2' ' A' ' 48' ' ' ASN . . . -76.81 143.26 39.9 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.517 -0.549 . . . . 1.0700000000000001 109.517 174.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.597 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 27.2 t70 -76.02 148.34 38.11 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.918 -0.771 . . . . 0.70999999999999996 108.918 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.687 ' HA ' ' HB3' ' A' ' 49' ' ' PHE . 10.1 t -56.56 -16.51 6.18 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.866 0.691 . . . . 1.71 112.866 -172.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.28 -31.45 72.04 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.239 0.543 . . . . 2.2200000000000002 110.289 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.603 ' ND2' ' HB3' ' A' ' 44' ' ' ALA . 5.1 p-10 -129.43 24.31 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.773 -0.648 . . . . 1.5800000000000001 109.479 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.687 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 10.1 t80 -134.03 108.5 8.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.257 -0.883 . . . . 0.72999999999999998 109.16 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.782 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 10.9 pt-20 -116.65 116.61 27.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.649 0.261 . . . . 2.4100000000000001 110.448 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 71.34 -51.45 0.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.793 0.837 . . . . 4.1399999999999997 111.805 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . 170.02 31.17 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.719 -0.952 . . . . 0.72999999999999998 110.719 -177.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.678 ' HA ' ' HB3' ' A' ' 81' ' ' ASN . 14.5 mptt -129.88 140.23 51.02 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.178 -0.675 . . . . 2.6800000000000002 109.178 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.41 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -120.69 147.68 44.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.585 0.707 . . . . 0.65000000000000002 111.636 176.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.782 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 16.9 p90 -157.46 174.93 14.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.886 -1.052 . . . . 0.73999999999999999 110.752 -170.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.544 HD13 HD23 ' A' ' 140' ' ' LEU . 8.6 mt -84.16 111.84 19.71 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.146 -1.057 . . . . 2.0800000000000001 108.146 170.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.583 ' HB ' ' HE1' ' A' ' 55' ' ' PHE . 8.4 tp -105.3 125.83 60.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.805 0.812 . . . . 1.21 110.021 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.571 ' HB2' ' CE1' ' A' ' 112' ' ' TYR . 33.5 t -76.84 135.74 38.89 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.073 -0.967 . . . . 1.9299999999999999 110.714 -177.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.52 -34.17 72.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.868 -0.79 . . . . 2.3100000000000001 108.868 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -69.28 -24.67 63.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.566 -1.197 . . . . 3.6600000000000001 110.611 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 t30 63.83 97.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.701 -0.681 . . . . 3.0600000000000001 111.27 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -166.27 -44.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.716 -0.674 . . . . 5.1799999999999997 110.584 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.39 139.78 53.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.902 -0.59 . . . . 2.5099999999999998 109.955 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.777 ' HE3' ' HH ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -135.35 106.51 6.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.989 0.899 . . . . 2.6200000000000001 109.429 170.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.759 HD23 HG23 ' A' ' 100' ' ' VAL . 7.9 tp -108.19 126.32 52.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.24 -0.891 . . . . 2.48 110.927 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.777 ' HH ' ' HE3' ' A' ' 64' ' ' LYS . 5.2 m-85 -72.95 141.4 47.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.956 -1.02 . . . . 1.1299999999999999 110.306 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.558 HG13 ' HA ' ' A' ' 100' ' ' VAL . 16.4 m -136.65 142.61 37.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.549 -0.296 . . . . 1.29 110.468 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -102.89 120.54 40.8 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.788 -0.449 . . . . 2.1000000000000001 109.788 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.455 HG22 ' HB ' ' A' ' 96' ' ' ILE . 0.9 OUTLIER -82.61 87.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.816 -0.629 . . . . 1.55 109.876 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.489 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 60.0 ttt180 -93.99 128.63 40.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.414 -0.357 . . . . 4.3300000000000001 110.812 -174.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.623 ' HA ' HG23 ' A' ' 96' ' ' ILE . 4.2 Cg_endo -50.36 139.77 36.01 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.319 2.679 . . . . 0.90000000000000002 112.216 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.6 ttt -72.66 64.11 0.63 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.661 -0.7 . . . . 2.23 111.304 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 t70 62.89 14.96 7.89 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.715 0.806 . . . . 1.9199999999999999 112.302 175.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -78.13 -35.0 49.61 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.829 -0.544 . . . . 1.8899999999999999 111.559 -175.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.2 p -170.78 172.74 5.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.378 -0.23 . . . . 2.0699999999999998 110.378 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.72 129.06 35.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.981 0.42 . . . . 1.5800000000000001 110.101 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.695 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 13.8 m0 -117.28 155.84 28.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.07 -0.513 . . . . 0.54000000000000004 110.535 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.8 m -89.6 113.22 24.62 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.265 -0.643 . . . . 1.22 109.265 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 t -88.58 124.25 33.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.796 0.807 . . . . 1.29 111.91 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -130.56 160.98 32.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.44 -1.318 . . . . 1.7 107.44 168.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.678 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 16.1 m120 -85.94 -3.55 58.95 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.368 -0.533 . . . . 1.3899999999999999 111.262 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.92 -36.92 2.65 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.303 -0.951 . . . . 0.85999999999999999 111.664 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.517 HG12 ' HG3' ' A' ' 43' ' ' LYS . 29.3 m -137.01 156.67 34.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.997 0.427 . . . . 1.73 110.306 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.612 ' HD1' ' HE3' ' A' ' 77' ' ' TRP . 0.7 OUTLIER -136.64 106.74 6.33 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.95 -1.13 . . . . 0.41999999999999998 107.95 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 8.7 p90 -138.19 146.5 42.76 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.913 -0.315 . . . . 1.1499999999999999 111.377 -174.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.721 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 49.3 pttt -78.22 157.57 29.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 2.0299999999999998 110.826 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -85.21 7.47 21.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.795 . . . . 2.6600000000000001 110.041 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.721 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 35.8 m-20 -106.48 128.04 53.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.538 -0.755 . . . . 2.1000000000000001 109.331 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -90.04 106.36 17.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.555 0.693 . . . . 1.6599999999999999 111.002 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.28 -162.71 36.5 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.051 -0.819 . . . . 0.63 111.051 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.4 m -84.14 147.25 27.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.976 0.417 . . . . 1.5800000000000001 109.941 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.487 ' CD2' ' HZ2' ' A' ' 77' ' ' TRP . 55.3 t90 -120.07 -59.05 1.83 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.65 -0.5 . . . . 0.75 109.65 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 34.53 90.42 0.01 OUTLIER Glycine 0 N--CA 1.464 0.548 0 O-C-N 124.637 1.21 . . . . 1.25 115.477 176.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.16 -125.09 0.75 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.004 -0.617 . . . . 1.0 111.955 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.456 ' O ' ' HH2' ' A' ' 92' ' ' TRP . 1.2 p -137.18 132.42 33.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 1.3200000000000001 111.571 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.641 HD11 ' CG2' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -118.46 134.8 60.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.169 -0.678 . . . . 2.2400000000000002 109.169 174.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -99.58 158.52 19.81 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.331 -0.937 . . . . 0.53000000000000003 112.555 -175.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.502 HG21 ' HB ' ' A' ' 67' ' ' VAL . 2.8 mp -95.03 112.81 28.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.649 -0.5 . . . . 1.53 109.649 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.493 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 1.6 m-85 -110.95 120.91 43.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.817 -0.808 . . . . 1.7 108.817 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.759 HG23 HD23 ' A' ' 65' ' ' LEU . 14.5 p -58.68 137.34 21.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.816 0.341 . . . . 1.6799999999999999 110.993 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.65 81.94 8.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.715 -0.846 . . . . 1.02 108.715 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.65 110.34 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.525 -0.762 . . . . 1.53 111.815 -172.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -40.09 125.11 1.95 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.493 0.663 . . . . 2.5699999999999998 112.582 177.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.559 ' HB2' HD12 ' A' ' 65' ' ' LEU . 7.7 tp-100 -92.69 21.27 5.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.559 . . . . 3.1699999999999999 110.461 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 6.1 m 69.25 -11.58 0.47 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.696 -0.684 . . . . 2.8599999999999999 112.714 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.596 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 1.9 t-20 68.18 88.21 0.11 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.73 0.776 . . . . 1.5600000000000001 110.629 -175.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.63 146.8 34.93 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 114.689 -1.141 . . . . 2.0800000000000001 109.007 173.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -38.26 93.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.999 3.132 . . . . 1.48 112.509 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.588 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 3.0 Cg_exo -76.84 -179.56 5.51 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.198 2.598 . . . . 0.84999999999999998 113.333 -169.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.06 -124.42 0.89 Allowed Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.151 -1.18 . . . . 0.76000000000000001 110.151 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 58' ' ' SER . 51.6 t-20 -97.5 107.4 19.9 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.129 -0.693 . . . . 2.04 109.129 172.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.956 ' HH ' ' NH2' ' A' ' 16' ' ' ARG . 68.4 m-85 -102.16 107.34 18.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.468 0.651 . . . . 1.1100000000000001 109.524 174.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -97.85 126.79 43.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.017 -0.992 . . . . 1.3400000000000001 110.534 -175.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 138' ' ' THR . 0.1 OUTLIER -135.01 107.14 7.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.548 0.689 . . . . 1.1699999999999999 109.927 176.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 11.9 m -94.02 139.76 30.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.456 -0.793 . . . . 1.4099999999999999 110.299 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 44' ' ' ALA . 95.4 mt -124.96 126.14 45.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.909 0.385 . . . . 1.8 110.569 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 m -101.18 117.0 34.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.216 -0.447 . . . . 1.3200000000000001 110.219 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.27 147.71 47.79 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.748 -0.739 . . . . 0.97999999999999998 112.576 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.04 179.73 39.71 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.783 -0.722 . . . . 0.64000000000000001 112.214 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.617 ' HB3' ' NE ' ' A' ' 38' ' ' ARG . 48.6 p90 -102.63 174.16 6.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.051 0.453 . . . . 1.2 110.325 177.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.725 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.8 OUTLIER -132.69 146.53 51.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.413 -0.812 . . . . 0.65000000000000002 109.101 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -118.85 141.28 48.78 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.069 0.461 . . . . 1.55 111.208 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 7.0 tptm 71.97 -145.07 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.676 -1.147 . . . . 3.8700000000000001 111.265 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 126' ' ' LYS . 4.9 t70 -146.98 124.42 11.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.615 -0.266 . . . . 2.0800000000000001 111.496 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.598 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.5 OUTLIER 53.64 -5.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.132 1.773 . . . . 3.0899999999999999 115.542 176.312 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.596 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -79.03 -3.38 44.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 2.3799999999999999 110.216 177.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.725 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 33.6 tt0 69.08 71.61 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.792 -1.095 . . . . 2.1099999999999999 110.644 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.596 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -106.97 43.01 1.78 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.698 -0.763 . . . . 0.77000000000000002 112.134 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.43 ' HB2' ' HZ3' ' A' ' 43' ' ' LYS . 21.5 p90 -78.19 130.08 35.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.15 0.5 . . . . 1.49 110.857 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.6 m -121.56 118.91 29.49 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.215 -0.448 . . . . 1.8999999999999999 110.559 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.93 123.37 11.83 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.964 2.443 . . . . 1.1699999999999999 112.27 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.01 94.15 1.5 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.967 -0.56 . . . . 1.96 110.193 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 145.58 -145.95 15.64 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.284 -0.726 . . . . 1.1699999999999999 111.284 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.531 HG22 ' NH1' ' A' ' 6' ' ' ARG . 38.3 p -110.12 158.08 18.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.989 0.423 . . . . 2.9300000000000002 111.398 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.0 m -99.93 100.32 11.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.824 -0.626 . . . . 2.1800000000000002 109.786 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.554 ' HA3' HG11 ' A' ' 7' ' ' VAL . . . -93.79 160.76 24.44 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.847 -0.692 . . . . 0.72999999999999998 111.775 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.1 m -126.82 109.51 12.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.026 0.413 . . . . 1.23 111.311 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.591 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 3.7 m -82.23 116.43 21.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.634 -0.876 . . . . 1.1799999999999999 108.634 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -112.1 108.83 18.24 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.27 0.557 . . . . 2.6299999999999999 110.544 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.544 HD23 HD13 ' A' ' 56' ' ' LEU . 15.2 tp -96.56 109.16 21.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.031 -0.986 . . . . 1.3100000000000001 109.072 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.0 m -121.52 144.47 48.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.529 -0.759 . . . . 1.1799999999999999 110.947 -173.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 109' ' ' PRO . 13.0 p -83.16 141.73 14.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.433 -0.581 . . . . 2.3900000000000001 109.433 172.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.243 0.749 0 CA-C-O 118.426 -0.797 . . . . 2.5899999999999999 109.723 178.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 110.246 -0.279 . . . . 5.7300000000000004 110.246 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 14.9 pt-20 44.88 -151.34 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.487 1.117 . . . . 3.0800000000000001 112.466 175.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 120' ' ' TYR . 43.5 t -111.37 87.22 2.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.656 -0.498 . . . . 1.8300000000000001 109.656 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -103.61 111.84 24.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.192 -0.458 . . . . 2.29 110.766 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.679 HG23 HG13 ' A' ' 40' ' ' VAL . 38.5 t -107.49 125.32 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.118 -0.492 . . . . 2.1000000000000001 110.701 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.586 ' HG2' ' HB3' ' A' ' 31' ' ' GLN . 11.1 ptp180 -92.18 142.54 27.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.036 0.446 . . . . 4.25 110.684 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.7 t -120.53 115.43 47.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.781 -0.822 . . . . 1.8200000000000001 108.781 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.38 126.6 11.5 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.554 -0.831 . . . . 1.1899999999999999 112.38 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -68.34 104.04 1.77 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.574 -0.528 . . . . 2.1800000000000002 109.574 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.427 ' HB2' HG22 ' A' ' 138' ' ' THR . 72.8 mt -105.37 152.43 22.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.95 -0.568 . . . . 2.0 110.739 -176.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 m -133.09 114.42 13.89 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.035 -0.728 . . . . 1.5600000000000001 109.035 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.414 HG11 HG22 ' A' ' 25' ' ' ILE . 41.3 t -118.16 140.32 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.386 -0.37 . . . . 2.04 110.313 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.99 103.21 11.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.284 -0.416 . . . . 1.23 110.028 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -165.02 176.04 8.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.433 -0.58 . . . . 3.9100000000000001 109.433 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.485 HG23 HG22 ' A' ' 142' ' ' VAL . 31.9 p -96.43 163.34 13.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.613 -0.267 . . . . 1.21 110.911 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.43 ' HD2' ' H ' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -86.98 -3.42 59.09 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.91 -0.774 . . . . 4.0800000000000001 108.91 176.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -79.77 -28.22 51.59 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.79 -0.924 . . . . 0.75 110.79 173.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.89 -39.08 87.92 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.624 -0.88 . . . . 2.6299999999999999 108.624 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.464 ' HB3' ' CG1' ' A' ' 100' ' ' VAL . 62.8 mt -63.95 113.33 3.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.912 -1.04 . . . . 1.6100000000000001 109.746 171.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 m -130.4 85.28 2.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.562 0.22 . . . . 2.2599999999999998 110.536 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 7.9 m-20 63.48 -74.66 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.664 -0.698 . . . . 1.8300000000000001 111.854 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.13 81.71 1.87 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.191 0.52 . . . . 1.4299999999999999 110.671 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.18 100.27 4.2 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.544 -0.753 . . . . 1.3700000000000001 109.89 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 59.5 Cg_endo -72.1 105.51 1.85 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.816 2.344 . . . . 1.1200000000000001 112.847 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.414 HG22 HG11 ' A' ' 12' ' ' VAL . 49.4 mm -96.3 -26.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.181 -0.463 . . . . 3.0499999999999998 110.734 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.75 54.65 0.62 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.897 -1.144 . . . . 1.04 113.689 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 12.1 Cg_endo -57.03 114.1 1.77 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.281 1.987 . . . . 1.0 112.064 170.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.421 ' HA ' HD11 ' A' ' 10' ' ' LEU . 45.9 t -87.75 135.82 24.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.881 -0.6 . . . . 1.8300000000000001 110.433 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.95 102.24 4.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.603 0.716 . . . . 2.2000000000000002 110.133 174.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.864 HG21 HG12 ' A' ' 96' ' ' ILE . 6.7 t -94.08 141.96 14.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.862 -1.063 . . . . 1.5600000000000001 111.879 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.586 ' HB3' ' HG2' ' A' ' 6' ' ' ARG . 31.4 tt0 -146.87 117.41 7.5 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.651 -1.159 . . . . 2.48 109.079 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -110.46 105.73 14.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.287 -0.415 . . . . 1.25 110.144 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.4 tp -77.61 112.76 14.76 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.508 -0.553 . . . . 2.4700000000000002 109.508 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 2' ' ' GLU . . . 88.64 -121.97 6.2 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.704 -0.76 . . . . 1.8100000000000001 111.773 -177.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 32' ' ' ALA . 66.7 m 65.13 11.6 7.3 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 122.598 0.359 . . . . 1.8799999999999999 111.707 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.637 ' HA ' ' HA2' ' A' ' 90' ' ' GLY . 19.3 m120 -63.36 -11.44 22.51 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.631 0.604 . . . . 2.71 112.631 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.8 ' HA ' ' CG1' ' A' ' 89' ' ' VAL . . . -144.62 60.95 1.33 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.5 -0.556 . . . . 1.3600000000000001 109.5 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 38' ' ' ARG . 0.8 OUTLIER -170.07 159.96 7.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.361 -0.836 . . . . 5.3499999999999996 109.68 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.447 ' HA ' ' HZ1' ' A' ' 86' ' ' LYS . 1.6 mp0 -94.22 143.38 26.43 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.116 -0.698 . . . . 1.9099999999999999 109.116 173.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.679 HG13 HG23 ' A' ' 5' ' ' VAL . 71.8 t -97.99 122.05 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.424 -0.584 . . . . 1.1699999999999999 109.424 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -122.48 141.33 51.75 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 123.368 0.418 . . . . 1.0900000000000001 111.099 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.428 ' CD1' HG23 ' A' ' 96' ' ' ILE . 31.3 mt -102.72 126.21 49.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.194 -0.669 . . . . 1.4399999999999999 109.194 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.767 ' HE2' ' HB2' ' A' ' 129' ' ' PHE . 6.3 mptt -119.2 152.12 37.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.571 -0.529 . . . . 2.5299999999999998 109.571 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.415 ' CB ' ' HB3' ' A' ' 54' ' ' PHE . . . -96.22 153.62 17.7 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.803 -0.443 . . . . 1.0700000000000001 109.803 173.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.686 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 31.2 t70 -82.44 164.79 20.74 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.719 -0.845 . . . . 0.70999999999999996 108.719 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -56.17 -18.48 10.24 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.336 0.588 . . . . 1.71 110.677 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.77 -38.8 72.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.271 -0.877 . . . . 2.2200000000000002 111.526 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 27.0 p-10 -139.57 22.31 2.52 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.723 0.268 . . . . 1.5800000000000001 111.723 -176.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.527 ' HE1' ' HA2' ' A' ' 82' ' ' GLY . 60.0 t80 -123.48 102.39 7.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.435 -0.58 . . . . 0.72999999999999998 109.435 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -103.3 105.8 16.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 2.4100000000000001 110.385 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 67.19 -56.43 0.44 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.107 0.879 . . . . 4.1399999999999997 112.04 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.472 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -175.58 35.08 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.006 -0.838 . . . . 0.72999999999999998 111.006 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 81' ' ' ASN . 34.7 mmtp -135.07 135.57 41.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.001 -0.74 . . . . 2.6800000000000002 109.001 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -110.72 142.33 42.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.611 0.719 . . . . 0.65000000000000002 111.965 175.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.62 ' CD2' ' HB2' ' A' ' 64' ' ' LYS . 44.1 p90 -151.32 -177.0 5.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.974 -1.012 . . . . 0.73999999999999999 110.014 -176.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.888 HD23 HD22 ' A' ' 114' ' ' LEU . 13.8 mt -99.53 123.81 44.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.579 -0.897 . . . . 2.0800000000000001 108.579 172.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 113' ' ' THR . 9.0 tp -106.81 124.6 62.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.472 0.653 . . . . 1.21 111.035 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.5 t -68.88 125.08 25.49 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.275 -1.009 . . . . 1.9299999999999999 108.275 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -57.8 -26.2 61.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.119 0.415 . . . . 2.3100000000000001 112.119 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -84.26 -1.64 55.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.61 -0.268 . . . . 3.6600000000000001 111.368 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 57.99 89.21 0.05 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.167 0.587 . . . . 3.0600000000000001 111.244 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -155.79 -38.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 5.1799999999999997 111.055 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.408 ' OD1' ' HB ' ' A' ' 107' ' ' THR . 24.2 t70 -139.74 144.71 37.6 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.415 -0.357 . . . . 2.5099999999999998 110.35 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.62 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 2.4 pptp? -146.7 145.77 30.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.971 -0.559 . . . . 2.6200000000000001 110.134 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.503 HD11 HG22 ' A' ' 100' ' ' VAL . 1.3 pt? -138.03 132.13 31.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.139 -0.482 . . . . 2.48 110.415 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -75.64 128.61 35.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 1.1299999999999999 110.129 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.526 ' HB ' HG22 ' A' ' 98' ' ' ILE . 15.9 m -118.33 136.89 54.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.862 -0.608 . . . . 1.29 110.544 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.476 ' N ' HD21 ' A' ' 68' ' ' ASN . 0.8 OUTLIER -96.5 110.65 22.99 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.707 -0.679 . . . . 2.1000000000000001 109.356 178.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.411 HG22 HG12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -79.99 102.09 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.928 -0.767 . . . . 1.55 108.928 174.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.55 ' HG2' ' CZ ' ' A' ' 84' ' ' PHE . 89.3 mtt180 -122.99 140.47 33.5 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.244 -0.434 . . . . 4.3300000000000001 110.181 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.785 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 1.7 Cg_endo -48.3 132.93 24.58 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.942 2.428 . . . . 0.90000000000000002 111.927 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.4 ttt -63.22 -49.96 72.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.408 -0.36 . . . . 2.23 110.275 -177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -177.79 105.95 0.05 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.121 -0.49 . . . . 1.9199999999999999 110.566 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -161.81 -62.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 1.8899999999999999 111.198 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.8 t -154.69 163.68 39.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.915 -0.402 . . . . 2.0699999999999998 109.915 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.9 127.58 32.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.069 0.461 . . . . 1.5800000000000001 111.252 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.637 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.1 m0 -112.28 150.75 30.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.651 -0.704 . . . . 0.54000000000000004 110.27 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.6 m -83.21 125.1 31.2 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.142 -0.688 . . . . 1.22 109.142 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -100.47 122.36 43.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.798 0.808 . . . . 1.29 112.54 -171.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -135.42 159.71 40.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.725 -1.213 . . . . 1.7 107.725 167.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.461 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 11.4 m120 -82.93 -4.38 58.12 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.276 -0.57 . . . . 1.3899999999999999 110.833 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.527 ' HA2' ' HE1' ' A' ' 49' ' ' PHE . . . -100.48 -41.33 2.77 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.203 -0.998 . . . . 0.85999999999999999 111.885 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.68 155.4 30.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.963 -0.384 . . . . 1.73 109.963 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -137.99 109.85 7.17 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.291 -1.003 . . . . 0.41999999999999998 108.291 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.652 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 13.5 p90 -140.09 143.89 36.52 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.15 0.281 . . . . 1.1499999999999999 111.498 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -77.91 137.5 38.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 120.328 -0.549 . . . . 2.0299999999999998 109.542 177.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -63.68 -24.47 67.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.734 -0.667 . . . . 2.6600000000000001 110.204 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 4.6 m-20 -73.92 147.14 43.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.519 -0.764 . . . . 2.1000000000000001 110.671 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.8 ' CG1' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -94.84 143.0 12.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.666 -0.864 . . . . 1.6599999999999999 108.666 168.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 36' ' ' ASN . . . 131.77 -175.59 19.64 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.411 -0.9 . . . . 0.63 111.636 -177.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m -72.39 -178.73 2.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.976 -0.379 . . . . 1.5800000000000001 109.976 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.785 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 21.1 t90 -157.38 -42.54 0.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.733 -0.212 . . . . 0.75 110.575 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.707 ' O ' ' HB ' ' A' ' 30' ' ' VAL . . . 50.84 -120.35 8.92 Favored Glycine 0 C--O 1.21 -1.366 0 N-CA-C 111.292 -0.723 . . . . 1.25 111.292 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.45 -151.68 43.68 Favored Glycine 0 C--N 1.318 -0.434 0 C-N-CA 121.142 -0.552 . . . . 1.0 114.225 163.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.527 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -147.84 133.51 18.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.085 -0.557 . . . . 1.3200000000000001 110.427 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.864 HG12 HG21 ' A' ' 30' ' ' VAL . 6.8 mm -107.52 129.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.357 -0.609 . . . . 2.2400000000000002 109.357 177.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -100.82 149.2 18.45 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.712 -0.756 . . . . 0.53000000000000003 111.704 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.526 HG22 ' HB ' ' A' ' 67' ' ' VAL . 71.3 mt -99.58 114.45 37.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 120.897 0.38 . . . . 1.53 110.567 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.549 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 8.6 m-85 -115.22 131.97 56.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 1.7 108.818 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.508 ' CG1' ' HA ' ' A' ' 103' ' ' GLN . 13.8 p -71.34 134.48 29.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.799 0.333 . . . . 1.6799999999999999 110.558 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -74.89 91.47 2.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.059 0.457 . . . . 1.02 110.902 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.13 13.34 62.15 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.132 -0.556 . . . . 1.53 113.918 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.508 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 64.9 tt0 62.22 113.71 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.709 0.766 . . . . 2.5699999999999998 112.367 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -76.8 -27.29 55.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.479 -0.782 . . . . 3.1699999999999999 109.645 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.1 m 65.42 20.52 11.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.126 -0.943 . . . . 2.8599999999999999 110.195 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.53 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 7.6 t30 60.79 87.94 0.09 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.905 -1.043 . . . . 1.5600000000000001 112.358 173.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.656 HG23 ' HD2' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -92.09 143.55 27.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.295 -1.002 . . . . 2.0800000000000001 108.295 174.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.656 ' HD2' HG23 ' A' ' 107' ' ' THR . 94.2 Cg_exo -20.3 88.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.348 1 C-N-CA 125.617 4.212 . . . . 1.48 114.818 -175.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.454 ' HG2' HG21 ' A' ' 142' ' ' VAL . 9.9 Cg_endo -92.2 -154.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.687 2.925 . . . . 0.84999999999999998 114.354 -171.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.42 -131.08 1.85 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.364 -1.895 . . . . 0.76000000000000001 108.364 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -97.22 123.43 41.0 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.101 -0.703 . . . . 2.04 109.101 170.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -105.84 128.45 53.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.002 0.43 . . . . 1.1100000000000001 109.916 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 57' ' ' ILE . 91.4 m -106.38 134.22 49.86 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.334 -0.848 . . . . 1.3400000000000001 109.405 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.888 HD22 HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -138.91 89.55 2.37 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.487 0.66 . . . . 1.1699999999999999 109.358 175.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 7.4 m -78.39 116.05 18.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.124 -0.944 . . . . 1.4099999999999999 110.607 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 97.8 mt -105.11 136.41 44.66 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.04 0.448 . . . . 1.8 110.939 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.5 m -110.17 115.02 28.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.147 -0.478 . . . . 1.3200000000000001 110.441 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.16 167.88 47.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.702 -0.761 . . . . 0.97999999999999998 112.103 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.42 ' HA2' ' HB2' ' A' ' 132' ' ' SER . . . 145.35 -175.15 25.07 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.557 -0.83 . . . . 0.64000000000000001 112.096 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.49 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 52.8 p90 -97.7 -176.52 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.358 0.599 . . . . 1.2 111.403 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.641 ' HZ2' ' H ' ' A' ' 125' ' ' ASN . 0.5 OUTLIER -150.33 149.72 30.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.989 -1.005 . . . . 0.65000000000000002 108.687 178.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.42 144.48 49.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.893 0.378 . . . . 1.55 111.578 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.634 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 22.9 mtpp 65.3 -143.71 0.22 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.067 0.947 . . . . 3.8700000000000001 111.807 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 126' ' ' LYS . 6.0 p-10 -149.46 124.39 9.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.075 0.464 . . . . 2.0800000000000001 112.239 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.641 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 7.7 t30 63.52 -18.0 0.06 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.698 1.199 . . . . 3.0899999999999999 113.676 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.634 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -71.36 -4.07 24.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.796 0.331 . . . . 2.3799999999999999 110.82 178.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.616 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 8.9 tt0 70.08 77.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.39 -0.823 . . . . 2.1099999999999999 110.923 -177.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.427 ' CA ' ' HE3' ' A' ' 126' ' ' LYS . . . -107.88 32.22 7.27 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.442 -0.885 . . . . 0.77000000000000002 111.431 173.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.767 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 3.9 p90 -74.08 144.1 45.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.014 0.435 . . . . 1.49 110.661 -175.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 28.9 m -143.61 134.62 12.48 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.303 -0.408 . . . . 1.8999999999999999 110.169 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.92 126.29 11.16 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.785 2.323 . . . . 1.1699999999999999 111.782 175.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.42 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 17.2 m -152.84 113.46 4.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.319 -0.4 . . . . 1.96 110.122 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 125.1 -105.21 0.82 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.088 -0.577 . . . . 1.1699999999999999 111.74 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.9 t -150.34 153.45 36.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.836 0.351 . . . . 2.9300000000000002 110.314 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.9 m -93.55 97.06 10.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.026 -0.534 . . . . 2.1800000000000002 109.775 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -83.99 132.29 10.98 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.954 -0.641 . . . . 0.72999999999999998 112.285 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 m -102.72 108.77 20.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.683 0.278 . . . . 1.23 110.316 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.669 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 24.0 m -86.25 117.53 25.12 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.754 -0.832 . . . . 1.1799999999999999 108.754 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -104.08 127.31 51.65 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.879 -0.6 . . . . 2.6299999999999999 109.984 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.639 HD23 HD13 ' A' ' 56' ' ' LEU . 18.6 tp -125.58 102.25 7.28 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.542 -0.754 . . . . 1.3100000000000001 110.829 -176.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.5 m -99.06 142.75 30.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.792 -0.64 . . . . 1.1799999999999999 109.966 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.485 HG22 HG23 ' A' ' 15' ' ' THR . 7.3 p -93.27 104.82 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.689 0.757 . . . . 2.3900000000000001 111.323 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.06 -0.971 . . . . 2.5899999999999999 109.352 176.219 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 56.6 m . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.11 0.481 . . . . 1.43 111.206 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 31.8 mm-40 -85.49 110.97 19.57 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.914 -0.773 . . . . 2.29 108.914 174.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.664 HG23 HG13 ' A' ' 30' ' ' VAL . 7.6 p -109.92 127.72 66.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.495 0.664 . . . . 1.51 111.167 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -87.61 107.27 18.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.183 -0.917 . . . . 3.57 109.977 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.47 HG12 ' HA3' ' A' ' 136' ' ' GLY . 44.6 t -110.97 121.27 63.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.642 -0.503 . . . . 1.26 109.642 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.17 134.25 12.32 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.713 -0.756 . . . . 0.96 112.725 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.33 117.85 14.5 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.31 -0.626 . . . . 2.18 109.31 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.6 mt -117.25 98.54 6.49 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.873 -0.331 . . . . 1.41 111.708 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.0 t -102.04 113.25 26.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.122 -0.696 . . . . 1.03 109.122 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.646 ' HB ' ' NZ ' ' A' ' 14' ' ' LYS . 76.8 t -152.41 148.67 14.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.093 -0.706 . . . . 1.45 109.093 -174.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -89.96 121.35 31.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.412 0.523 . . . . 0.59 112.412 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.646 ' NZ ' ' HB ' ' A' ' 12' ' ' VAL . 2.7 mptt -143.38 175.99 9.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.119 0.485 . . . . 3.42 110.335 172.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.502 ' HA ' ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -111.08 150.0 30.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.503 -0.771 . . . . 0.63 109.994 171.265 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.511 HH12 ' HB ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -86.5 -4.47 59.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.328 -0.619 . . . . 3.14 109.328 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.478 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -88.24 -27.97 24.04 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.505 -1.038 . . . . 0.75 110.505 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -66.16 -34.08 77.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.734 -0.839 . . . . 2.17 108.734 171.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.464 ' HB3' HG12 ' A' ' 100' ' ' VAL . 94.4 mt -65.99 96.34 0.31 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.876 -1.056 . . . . 1.61 108.867 169.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 t -102.95 66.22 0.91 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.022 0.915 . . . . 1.65 109.728 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.664 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 28.4 t70 65.48 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.515 -1.22 . . . . 1.83 110.695 -174.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.443 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -95.11 76.05 3.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.17 0.51 . . . . 0.82 110.686 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -142.69 99.32 5.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.992 -0.549 . . . . 0.79 110.276 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.455 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 71.4 Cg_endo -75.98 100.27 1.36 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.748 2.299 . . . . 1.12 112.484 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.573 ' CG2' ' HG2' ' A' ' 14' ' ' LYS . 5.4 mt -114.96 12.48 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.98 0.895 . . . . 2.58 110.125 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.07 60.36 0.65 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.18 -0.918 . . . . 0.74 111.829 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.67 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 34.3 Cg_endo -65.0 104.19 0.56 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.423 2.082 . . . . 0.67 112.779 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.51 123.65 41.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.65 -0.705 . . . . 1.18 109.874 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -78.98 89.41 4.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.271 0.558 . . . . 1.64 110.663 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.664 HG13 HG23 ' A' ' 5' ' ' VAL . 23.7 t -91.4 118.36 36.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.701 . . . . 1.01 111.345 -176.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.445 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 53.6 tt0 -112.82 123.85 51.26 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.464 -0.789 . . . . 2.48 109.155 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.51 116.75 28.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.404 -0.362 . . . . 0.7 111.013 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 8.9 mp -80.33 120.05 23.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 1.94 110.504 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.79 -124.99 7.09 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.797 -0.716 . . . . 1.81 112.303 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.4 m 63.85 24.06 13.6 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.693 0.397 . . . . 1.88 111.217 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -49.76 -42.36 46.25 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.434 0.459 . . . . 2.14 111.84 -171.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.1 25.03 10.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.258 -0.428 . . . . 0.94 110.687 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 1.4 tpm_? -121.63 145.35 48.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.042 0.449 . . . . 4.64 111.688 -172.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -82.71 149.58 27.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.103 -0.702 . . . . 1.75 109.103 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 93.1 t -109.37 129.86 63.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.851 -0.796 . . . . 0.54 108.851 177.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 1.02 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -135.96 140.5 44.03 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 123.302 0.376 . . . . 0.36 110.735 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 mt -103.19 150.55 23.57 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.127 -0.488 . . . . 0.84 109.761 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.877 ' HE3' ' HB2' ' A' ' 129' ' ' PHE . 1.5 mptp? -134.84 151.66 51.1 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.297 -1.001 . . . . 1.93 108.297 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -88.32 156.93 18.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.489 -0.559 . . . . 0.41 109.489 174.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.642 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 5.8 t70 -89.5 172.57 8.89 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.899 -0.778 . . . . 0.71 108.899 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.8 p -49.84 -25.26 2.98 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.816 1.043 . . . . 1.4 113.816 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -65.57 -38.68 90.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.786 0.327 . . . . 2.22 111.217 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.645 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 26.5 p-10 -131.3 18.95 4.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 1.35 111.282 -174.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 52.3 t80 -122.55 101.5 7.52 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.417 -0.586 . . . . 0.56 109.417 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.669 ' HG2' ' HE1' ' A' ' 55' ' ' PHE . 5.5 pt-20 -106.83 98.75 8.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.295 -0.411 . . . . 2.41 110.5 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 73.13 -49.33 0.69 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.197 -0.911 . . . . 3.43 111.337 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 177.7 38.52 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.696 -0.562 . . . . 0.56 111.696 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.507 ' HD3' ' HB3' ' A' ' 81' ' ' ASN . 32.1 mmtp -136.48 135.17 38.37 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.491 -0.929 . . . . 2.12 108.491 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.645 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -115.55 149.47 38.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.442 0.639 . . . . 0.56 111.67 175.334 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.669 ' HE1' ' HG2' ' A' ' 50' ' ' GLU . 16.7 p90 -157.83 -179.96 8.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.039 -0.982 . . . . 0.59 110.341 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.51 HD22 HD22 ' A' ' 114' ' ' LEU . 30.7 mt -94.08 112.12 23.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.662 -0.866 . . . . 1.53 108.662 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.617 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 9.8 tp -107.75 140.4 26.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.544 -0.539 . . . . 0.62 109.544 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 37.1 t -78.96 156.02 28.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.247 -0.433 . . . . 1.44 110.52 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -54.79 -27.59 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 2.31 111.425 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -109.7 13.49 23.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.476 -0.329 . . . . 3.09 111.184 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 52.1 33.54 12.36 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.556 0.576 . . . . 2.62 112.556 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -79.34 -27.35 42.04 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.963 0.357 . . . . 4.66 111.963 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -149.77 140.55 22.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.592 -0.522 . . . . 2.51 109.592 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -128.89 132.5 47.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.763 -0.458 . . . . 2.07 109.763 177.116 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.087 ' HB2' ' HG3' ' A' ' 104' ' ' GLN . 1.3 pt? -140.18 125.17 18.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.853 0.358 . . . . 1.98 110.927 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -69.71 143.08 53.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.869 -0.605 . . . . 0.75 111.682 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.897 HG12 ' HA ' ' A' ' 100' ' ' VAL . 14.2 m -133.14 171.43 18.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.428 -0.805 . . . . 0.73 110.015 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.483 ' HB2' ' HE2' ' A' ' 84' ' ' PHE . 5.4 p30 -130.89 129.13 41.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.289 -0.414 . . . . 1.81 110.038 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.53 85.41 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.809 -0.811 . . . . 0.81 108.809 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.572 ' O ' ' HE1' ' A' ' 99' ' ' TYR . 6.7 ttp180 -108.78 139.99 21.41 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.48 -0.782 . . . . 3.79 110.024 -170.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HA ' HG22 ' A' ' 96' ' ' ILE . 50.3 Cg_exo -52.55 135.75 55.93 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.356 2.037 . . . . 0.59 112.155 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.402 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 15.5 tmm? -59.16 -58.9 6.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 1.71 109.761 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -172.97 103.45 0.13 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.541 -0.754 . . . . 1.92 109.457 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -177.65 -32.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 1.89 111.811 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 p -164.4 179.02 7.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.797 0.332 . . . . 1.7 111.128 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.28 130.54 56.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.818 -0.628 . . . . 0.94 110.222 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.584 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 12.6 m0 -118.44 150.83 38.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.114 -0.494 . . . . 0.5 110.216 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.4 m -79.7 114.09 18.35 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.929 -0.397 . . . . 0.51 109.929 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 t -87.48 114.43 24.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.998 0.904 . . . . 0.59 112.409 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -114.63 162.49 16.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 106.949 -1.501 . . . . 1.7 106.949 167.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.507 ' HB3' ' HD3' ' A' ' 53' ' ' LYS . 7.3 t-20 -82.39 -16.47 48.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.724 -0.79 . . . . 1.39 110.277 -177.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.59 -37.51 3.71 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.601 -0.809 . . . . 0.65 112.341 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.536 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 27.8 m -132.27 156.9 42.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.864 0.364 . . . . 1.16 110.519 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.721 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -135.84 105.3 6.06 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.202 -1.036 . . . . 0.36 108.202 179.621 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 1.02 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 4.0 p90 -134.92 144.19 47.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.196 0.522 . . . . 0.59 111.48 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.876 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 15.5 pttm -75.11 149.97 38.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.469 -0.787 . . . . 1.39 110.392 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -76.11 -15.56 60.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.779 0.8 . . . . 2.12 108.878 173.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.876 ' HB3' ' HD2' ' A' ' 86' ' ' LYS . 28.6 t70 -78.87 155.65 29.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.677 -1.147 . . . . 2.1 110.431 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.0 m -121.84 131.02 74.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.005 0.431 . . . . 1.05 109.861 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.79 172.83 16.49 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.845 -0.693 . . . . 0.46 111.714 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.1 p -65.64 124.35 22.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.591 -0.522 . . . . 1.17 109.591 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.814 ' HB2' ' HZ2' ' A' ' 86' ' ' LYS . 32.0 t90 -91.29 -51.13 5.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.189 -0.46 . . . . 0.51 110.436 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 30.53 82.64 0.01 OUTLIER Glycine 0 N--CA 1.468 0.803 0 O-C-N 124.75 1.281 . . . . 1.25 115.26 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.35 -150.2 5.75 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.861 -0.685 . . . . 0.72 112.005 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.5 p -123.13 124.64 43.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.42 0.629 . . . . 0.6 112.449 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.67 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -110.85 168.73 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.175 -1.046 . . . . 1.63 108.175 169.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.61 161.0 27.43 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.11 -1.043 . . . . 0.45 112.243 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.42 113.44 24.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.107 0.48 . . . . 0.83 110.139 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.664 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 5.9 m-85 -110.49 126.66 54.6 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.924 -1.139 . . . . 1.28 107.924 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.897 ' HA ' HG12 ' A' ' 67' ' ' VAL . 9.2 p -71.47 136.97 24.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.06 -0.719 . . . . 1.14 109.06 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.23 98.91 1.08 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.864 0.364 . . . . 1.02 111.149 -175.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.87 20.73 79.74 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-O 119.17 -0.795 . . . . 1.53 114.207 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.432 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 18.4 tt0 51.98 99.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.49 0.645 . . . . 2.11 110.742 -174.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 1.087 ' HG3' ' HB2' ' A' ' 65' ' ' LEU . 79.9 mm-40 -69.55 -63.99 0.97 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.18 -0.464 . . . . 2.62 111.279 -172.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 62.5 m -178.86 -56.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.893 -0.594 . . . . 2.43 110.858 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.492 ' OD1' ' HD2' ' A' ' 16' ' ' ARG . 8.2 t30 72.21 79.24 0.15 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.156 -0.929 . . . . 1.56 109.471 -167.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.13 125.96 66.62 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.508 -0.769 . . . . 1.68 109.145 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -21.95 88.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 1 C-N-CA 125.425 4.084 . . . . 1.26 114.275 -172.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.742 ' HB3' ' HE1' ' A' ' 112' ' ' TYR . 1.1 Cg_endo -85.16 -157.76 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.092 3.195 . . . . 0.76 114.087 -171.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.89 -81.04 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.742 -1.343 . . . . 0.76 109.742 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -126.83 137.56 53.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.643 -0.502 . . . . 2.04 109.643 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.742 ' HE1' ' HB3' ' A' ' 109' ' ' PRO . 13.7 m-85 -125.55 141.76 51.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.395 -0.366 . . . . 0.75 110.298 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.1 m -125.56 112.84 16.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.148 -0.478 . . . . 0.83 110.778 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.51 HD22 HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -126.69 87.29 2.63 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.44 0.638 . . . . 0.51 110.181 176.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.642 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 2.8 m -72.0 122.5 20.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.413 -0.812 . . . . 0.59 110.099 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -111.17 120.2 41.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.083 0.468 . . . . 1.27 110.57 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.472 ' HA ' HG23 ' A' ' 135' ' ' THR . 19.3 m -92.18 121.22 33.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.7 110.224 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -76.97 164.57 53.05 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.567 -0.825 . . . . 0.8 111.866 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.18 179.62 36.92 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.87 -0.681 . . . . 0.53 111.766 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.603 ' HB3' ' HB2' ' A' ' 3' ' ' CYS . 55.5 p90 -110.75 178.97 4.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.265 0.555 . . . . 0.89 110.298 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.668 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 8.5 t-105 -140.9 143.22 34.52 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.378 -0.828 . . . . 0.56 109.087 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.609 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -140.96 60.73 1.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.139 0.792 . . . . 1.42 113.139 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 1.052 ' HA ' ' HE2' ' A' ' 123' ' ' LYS . 0.3 OUTLIER 169.88 -123.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.627 0.579 . . . . 3.47 109.887 171.012 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -166.31 117.26 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 2.08 111.455 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.668 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 23.3 t-20 61.43 -30.86 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.261 1.578 . . . . 2.47 115.261 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -1.97 2.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 118.011 0.369 . . . . 1.96 111.434 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.542 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 40.1 mt-30 72.79 45.85 0.29 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.657 -0.701 . . . . 2.02 110.971 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.72 59.46 4.69 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.74 -0.944 . . . . 0.77 110.74 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.877 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 50.3 p90 -105.19 146.56 29.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 110.071 -0.344 . . . . 1.21 110.071 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.4 m -131.12 113.47 15.99 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 110.148 -0.316 . . . . 1.47 110.148 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -62.11 118.51 5.4 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.822 2.348 . . . . 0.92 111.595 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.9 m -145.82 154.71 42.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.924 -0.58 . . . . 1.52 110.259 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.33 -123.36 6.19 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.671 -0.776 . . . . 1.17 112.647 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.7 m -125.04 143.02 51.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.71 0.291 . . . . 2.47 111.291 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 117' ' ' THR . 12.4 m -93.21 113.2 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.407 -0.59 . . . . 1.82 109.407 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.47 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -96.99 126.14 8.73 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.771 -0.728 . . . . 0.67 112.035 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 25.1 m -94.48 99.63 11.77 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.029 0.442 . . . . 0.58 110.31 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.443 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 24.9 m -79.78 119.08 22.19 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.178 -0.675 . . . . 0.52 109.178 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -113.72 119.48 37.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.589 0.709 . . . . 2.18 109.591 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 112' ' ' TYR . 4.7 tp -108.36 94.65 5.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.048 -0.978 . . . . 0.63 110.847 -173.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.2 m -91.07 147.5 23.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.909 -1.041 . . . . 0.58 109.18 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.511 ' HB ' HH12 ' A' ' 16' ' ' ARG . 9.1 p -102.28 124.11 55.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.914 -0.714 . . . . 1.74 110.715 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.338 -0.839 . . . . 2.58 109.497 178.759 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.859 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 19.2 t . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 121.208 0.528 . . . . 1.43 110.595 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -86.18 140.18 30.4 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.61 -0.723 . . . . 2.29 110.359 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 30' ' ' VAL . 3.2 p -111.69 124.22 68.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.696 -0.684 . . . . 1.51 109.674 175.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.546 ' HA ' ' OG1' ' A' ' 134' ' ' THR . 99.3 mtt180 -96.29 104.01 15.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.333 0.587 . . . . 3.57 110.797 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.422 HG13 HG11 ' A' ' 28' ' ' VAL . 57.4 t -103.43 116.72 47.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.202 -0.908 . . . . 1.26 109.456 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.78 150.35 34.29 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.63 -0.795 . . . . 0.96 112.378 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -74.43 111.88 10.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.771 -0.455 . . . . 2.18 109.771 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.616 HD11 HG22 ' A' ' 28' ' ' VAL . 92.8 mt -93.49 94.01 8.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.22 -0.446 . . . . 1.41 111.202 -177.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.1 m -94.9 112.69 24.39 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.052 -0.721 . . . . 1.03 109.052 171.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.14 144.23 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.425 -0.352 . . . . 1.45 110.387 -174.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.521 ' HB1' ' OG1' ' A' ' 143' ' ' THR . . . -101.42 96.83 7.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.149 -0.478 . . . . 0.59 109.963 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.711 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 9.0 mmpt? -145.72 173.25 12.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 3.42 110.453 -176.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.527 HG22 HG13 ' A' ' 142' ' ' VAL . 35.2 p -106.71 168.95 8.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.122 -0.49 . . . . 0.63 109.721 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.683 HH21 ' HD1' ' A' ' 112' ' ' TYR . 0.3 OUTLIER -87.01 -15.61 38.18 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.753 -0.832 . . . . 3.14 108.753 178.276 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.8 -23.52 70.88 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.297 -0.865 . . . . 0.75 111.558 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -58.49 -31.15 67.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.4 0.619 . . . . 2.17 109.707 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.612 HD21 HG23 ' A' ' 25' ' ' ILE . 9.9 mt -96.48 105.5 17.6 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.233 -0.894 . . . . 1.61 109.711 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.593 ' H ' ' HB3' ' A' ' 23' ' ' ALA . 4.2 t -107.42 70.35 0.78 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.126 -0.694 . . . . 1.65 109.126 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 17.8 t70 67.61 -80.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.7 -1.137 . . . . 1.83 110.488 -174.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.34 63.69 0.99 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.613 0.72 . . . . 0.82 110.646 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.593 ' HB3' ' H ' ' A' ' 20' ' ' THR . . . -143.35 117.87 6.22 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 114.897 -1.047 . . . . 0.79 108.901 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -90.83 163.66 4.04 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.59 2.86 . . . . 1.12 113.603 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.612 HG23 HD21 ' A' ' 19' ' ' LEU . 1.5 pt -118.7 -57.15 3.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.466 -0.788 . . . . 2.58 110.899 174.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.515 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -116.15 99.17 0.86 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.85 -0.69 . . . . 0.74 112.553 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 60.4 Cg_endo -80.41 105.17 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.714 2.276 . . . . 0.67 112.051 173.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.616 HG22 HD11 ' A' ' 10' ' ' LEU . 18.1 t -74.96 125.96 35.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.701 -0.481 . . . . 1.18 109.701 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 6.7 t -82.72 83.62 7.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.02 0.914 . . . . 1.64 110.24 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.788 HG13 HG23 ' A' ' 5' ' ' VAL . 84.9 t -69.18 115.73 8.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.053 -0.976 . . . . 1.01 110.833 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.494 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 28.6 pt20 -110.38 132.89 53.78 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.159 -0.682 . . . . 2.48 109.159 173.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.518 ' HB1' ' SG ' ' A' ' 3' ' ' CYS . . . -101.67 127.95 48.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.095 -0.502 . . . . 0.7 110.999 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.734 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 85.2 mt -107.59 111.78 24.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.511 -0.313 . . . . 1.94 110.656 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.98 59.11 8.4 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.266 -0.492 . . . . 1.81 113.211 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.859 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -87.08 -70.38 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.679 0.252 . . . . 1.88 111.679 -177.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 69.25 -61.83 0.42 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.644 0.778 . . . . 2.14 111.632 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.416 ' HA ' ' HB ' ' A' ' 89' ' ' VAL . . . -141.8 71.41 1.35 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.338 0.59 . . . . 0.94 109.889 -176.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.713 ' HD2' ' SG ' ' A' ' 35' ' ' CYS . 1.4 tmt_? -143.42 131.81 22.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.544 -0.753 . . . . 4.64 110.886 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.508 ' HG2' HG12 ' A' ' 89' ' ' VAL . 31.3 mt-30 -87.36 107.17 18.4 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.675 -0.861 . . . . 1.75 108.675 174.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 41.7 t -62.66 109.21 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 0.54 109.954 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 1.018 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -127.11 137.63 53.03 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 123.531 0.519 . . . . 0.36 109.895 -176.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.756 HD12 HG21 ' A' ' 69' ' ' ILE . 65.6 mt -104.21 128.65 51.95 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.946 -0.39 . . . . 0.84 109.946 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.553 ' HG3' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -110.33 151.77 27.02 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.618 -0.882 . . . . 1.93 108.618 175.027 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.62 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -100.32 155.17 17.94 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.379 -0.529 . . . . 0.41 110.024 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -73.67 149.0 42.25 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.978 -0.749 . . . . 0.71 108.978 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -58.6 -18.08 27.26 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.286 0.476 . . . . 1.4 112.286 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.24 -27.18 68.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.151 0.5 . . . . 2.22 110.33 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.62 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 4.1 p-10 -134.75 27.11 3.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.656 -0.702 . . . . 1.35 109.916 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.609 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 75.1 t80 -140.75 102.41 4.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.436 -0.802 . . . . 0.56 109.653 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.24 117.04 33.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.296 -0.411 . . . . 2.41 110.583 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 68.46 -57.62 0.49 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.279 0.987 . . . . 3.43 111.884 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.609 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -179.29 32.26 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.971 -0.633 . . . . 0.56 111.93 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 81' ' ' ASN . 1.6 mptm? -129.9 134.28 47.39 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.396 -0.594 . . . . 2.12 109.396 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.475 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -98.91 139.05 35.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.42 0.628 . . . . 0.56 110.818 174.378 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.615 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 51.5 p90 -155.43 172.76 17.69 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.177 -0.919 . . . . 0.59 110.338 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.991 ' HG ' HD22 ' A' ' 114' ' ' LEU . 5.9 mp -83.35 130.72 35.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.095 -0.705 . . . . 1.53 109.095 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 113' ' ' THR . 10.4 tp -104.93 134.7 45.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.13 -0.628 . . . . 0.62 109.322 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.5 t -68.06 179.96 1.38 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.294 -0.866 . . . . 1.44 111.298 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -56.0 -43.2 77.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.883 -0.599 . . . . 2.31 111.456 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -115.07 -62.26 1.63 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.549 -0.296 . . . . 3.09 110.594 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.1 p30 177.28 25.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.829 -0.623 . . . . 2.62 109.595 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -73.03 -46.31 52.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.428 -0.805 . . . . 4.66 111.406 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.99 156.16 47.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.837 -0.62 . . . . 2.51 110.491 -172.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -142.59 139.73 31.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.883 -0.599 . . . . 2.07 109.776 174.252 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.741 ' HG ' HD13 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -141.14 122.04 14.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.37 -0.377 . . . . 1.98 110.237 178.016 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.443 ' HA ' ' CB ' ' A' ' 55' ' ' PHE . 62.8 m-85 -72.18 153.15 41.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.347 -0.388 . . . . 0.75 111.515 -173.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.486 ' HB ' HG23 ' A' ' 98' ' ' ILE . 29.2 m -117.24 161.78 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.73 111.404 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -126.65 121.67 32.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 1.81 108.952 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.756 HG21 HD12 ' A' ' 42' ' ' LEU . 3.6 mm -95.37 86.23 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.745 -0.382 . . . . 0.81 110.04 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.514 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 8.1 mmm180 -93.55 128.27 42.85 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 120.491 -0.484 . . . . 3.79 110.974 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.74 ' HA ' HG22 ' A' ' 96' ' ' ILE . 49.2 Cg_exo -51.53 133.41 43.53 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.526 2.151 . . . . 0.59 112.229 172.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.6 ttt -78.8 81.45 5.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.572 -0.529 . . . . 1.71 109.572 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 66.35 20.16 10.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.823 -0.626 . . . . 1.92 112.227 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -119.7 107.59 13.4 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.464 0.542 . . . . 1.89 112.464 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.6 p 61.18 179.71 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.648 1.179 . . . . 1.7 113.503 170.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.07 119.52 39.42 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.276 -0.874 . . . . 0.94 110.485 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.685 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.6 m0 -110.18 149.08 30.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.93 -0.577 . . . . 0.5 110.388 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.0 m -83.23 112.92 20.3 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.003 -0.74 . . . . 0.51 109.003 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 t -87.48 90.19 8.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.936 0.874 . . . . 0.59 112.433 -171.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.25 148.44 23.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.91 -1.145 . . . . 1.7 107.91 166.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 1.1 t-20 -87.17 11.06 14.93 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.226 -0.59 . . . . 1.39 110.526 -174.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.88 -27.46 1.25 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.597 -0.601 . . . . 0.65 111.597 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.553 HG12 ' HG3' ' A' ' 43' ' ' LYS . 36.0 m -140.54 137.77 36.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.005 -0.739 . . . . 1.16 109.005 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.85 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -121.68 109.11 14.35 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.67 -0.812 . . . . 0.36 108.946 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 1.018 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 2.0 p90 -137.35 139.26 40.7 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.512 0.508 . . . . 0.59 111.394 -173.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.772 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 53.4 pttt -73.96 143.49 45.64 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.057 -0.72 . . . . 1.39 109.057 171.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -64.72 -26.53 68.41 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.97 -0.559 . . . . 2.12 110.103 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.772 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 12.6 m-20 -72.12 151.07 43.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.526 -0.761 . . . . 2.1 110.573 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.508 HG12 ' HG2' ' A' ' 39' ' ' GLN . 30.9 m -114.04 123.26 69.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.026 0.441 . . . . 1.05 110.276 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.8 -173.32 24.7 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.387 -0.911 . . . . 0.46 112.011 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.5 p -55.37 145.45 22.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.084 0.469 . . . . 1.17 111.428 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.458 ' CH2' HG23 ' A' ' 96' ' ' ILE . 41.2 t90 -126.74 -53.86 1.43 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.912 -0.586 . . . . 0.51 109.82 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 35.23 87.54 0.01 OUTLIER Glycine 0 N--CA 1.465 0.577 0 O-C-N 124.835 1.334 . . . . 1.25 114.978 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 29' ' ' THR . . . -159.01 -131.77 1.29 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.9 -0.667 . . . . 0.72 112.126 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.64 132.92 23.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.951 0.405 . . . . 0.6 111.459 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.74 HG22 ' HA ' ' A' ' 71' ' ' PRO . 1.7 pp -124.29 144.1 35.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.365 -0.605 . . . . 1.63 109.365 172.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -117.97 151.8 17.81 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.118 -1.039 . . . . 0.45 112.233 -174.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.486 HG23 ' HB ' ' A' ' 67' ' ' VAL . 77.1 mt -96.18 112.62 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.417 0.627 . . . . 0.83 110.639 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 70' ' ' ARG . 1.2 m-85 -103.88 156.86 17.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.807 -1.088 . . . . 1.28 108.099 176.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.479 ' CG1' ' HA ' ' A' ' 103' ' ' GLN . 5.5 p -87.24 133.12 30.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.035 -0.666 . . . . 1.14 109.393 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.92 101.83 0.3 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.381 -0.372 . . . . 1.02 111.756 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.11 23.4 77.21 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.804 -0.635 . . . . 1.53 114.026 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.479 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 62.9 tt0 57.93 97.98 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.237 0.541 . . . . 2.11 110.905 -175.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.656 ' HG3' ' HB2' ' A' ' 65' ' ' LEU . 78.3 mm-40 -84.32 14.21 4.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 2.62 111.312 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.1 m 74.01 -3.79 2.43 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.584 -0.735 . . . . 2.43 112.239 170.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.54 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 7.3 t30 63.41 86.18 0.12 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.593 0.711 . . . . 1.56 110.214 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.8 m -74.54 139.91 74.97 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.006 -0.997 . . . . 1.68 109.355 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -30.5 89.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 125.162 3.908 . . . . 1.26 113.456 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.58 ' HB2' ' CG2' ' A' ' 142' ' ' VAL . 81.2 Cg_endo -93.23 -168.54 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.191 2.594 . . . . 0.76 114.949 -167.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.13 -73.92 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.752 -1.339 . . . . 0.76 109.752 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -135.13 126.93 29.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.546 -0.539 . . . . 2.04 109.546 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.683 ' HD1' HH21 ' A' ' 16' ' ' ARG . 69.6 m-85 -129.25 139.33 51.86 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.065 0.46 . . . . 0.75 110.922 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.597 ' O ' HG22 ' A' ' 57' ' ' ILE . 70.8 m -111.68 129.15 56.2 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.318 -0.856 . . . . 0.83 110.021 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.991 HD22 ' HG ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -142.84 86.91 1.95 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.733 0.777 . . . . 0.51 109.602 174.4 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.7 m -88.06 135.83 33.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.003 -0.999 . . . . 0.59 110.476 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 8.6 mp -119.01 116.49 26.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 1.27 110.682 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 38.5 m -89.08 114.02 25.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.81 -0.632 . . . . 0.7 110.125 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.403 ' HA3' HG13 ' A' ' 5' ' ' VAL . . . -67.84 145.11 44.6 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.724 -0.751 . . . . 0.8 112.365 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.434 ' HA2' ' N ' ' A' ' 132' ' ' SER . . . -175.59 177.34 47.43 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.892 -0.67 . . . . 0.53 111.484 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.408 ' CE2' ' HB ' ' A' ' 130' ' ' THR . 28.9 p90 -101.26 -178.33 3.71 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.918 -0.713 . . . . 0.89 110.184 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.856 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 3.4 t-105 -151.69 144.45 24.35 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.253 -0.885 . . . . 0.56 108.818 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.39 145.65 49.95 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.256 0.347 . . . . 1.42 110.466 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.93 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER 72.17 -136.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.745 0.818 . . . . 3.47 110.741 178.121 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.597 ' HA ' ' HZ2' ' A' ' 121' ' ' TRP . 5.6 p-10 -162.96 133.87 4.77 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.132 0.173 . . . . 2.08 110.631 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.475 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 52.4 t30 67.76 -38.76 0.37 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.901 1.075 . . . . 2.47 113.901 174.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.416 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -64.89 -5.04 5.18 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.341 0.591 . . . . 1.96 111.19 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.856 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 33.7 tt0 65.21 72.56 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.723 -1.126 . . . . 2.02 111.246 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.416 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -96.01 41.75 2.38 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.62 -0.8 . . . . 0.77 111.213 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.514 ' CD1' ' HG2' ' A' ' 127' ' ' GLN . 3.7 p90 -82.74 154.44 24.79 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.783 0.325 . . . . 1.21 110.894 -172.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.408 ' HB ' ' CE2' ' A' ' 120' ' ' TYR . 50.2 m -154.93 123.99 3.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.436 -0.347 . . . . 1.47 110.082 173.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.2 128.81 31.18 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.975 2.45 . . . . 0.92 112.254 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.434 ' N ' ' HA2' ' A' ' 119' ' ' GLY . 27.1 m -155.27 108.3 2.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.31 -0.404 . . . . 1.52 110.349 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.9 -127.85 7.52 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.45 -0.881 . . . . 1.17 112.46 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 6' ' ' ARG . 5.2 p -118.71 154.53 32.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.951 0.405 . . . . 2.47 111.417 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 t -108.98 114.64 28.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.412 -0.588 . . . . 1.82 109.412 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.96 126.87 9.0 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.716 -0.754 . . . . 0.67 112.122 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.3 m -91.82 101.3 13.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.745 0.307 . . . . 0.58 110.725 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.523 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 28.3 m -80.63 108.65 14.45 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.14 -0.689 . . . . 0.52 109.14 173.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -109.38 109.55 20.45 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.989 -0.745 . . . . 2.18 108.989 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.604 ' HG ' ' NH2' ' A' ' 16' ' ' ARG . 16.1 tp -106.78 105.96 16.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.902 -1.045 . . . . 0.63 110.913 -174.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 30.3 m -99.45 143.99 29.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.159 -0.928 . . . . 0.58 109.36 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.58 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 92.9 t -74.32 129.56 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 112.793 0.664 . . . . 1.74 112.793 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.521 ' OG1' ' HB1' ' A' ' 13' ' ' ALA . 95.0 m . . . . . 0 C--O 1.248 1.009 0 CA-C-N 115.06 -0.973 . . . . 2.58 109.188 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.908 0.385 . . . . 1.43 110.922 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -86.39 109.73 19.22 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.41 -0.589 . . . . 2.29 109.41 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.6 t -95.96 111.89 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.588 -0.523 . . . . 1.51 109.588 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.82 ' HB2' ' HB2' ' A' ' 31' ' ' GLN . 31.2 mmt180 -84.39 99.55 10.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.628 -0.715 . . . . 3.57 110.451 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.95 115.59 48.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.382 -0.826 . . . . 1.26 109.238 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.24 -169.88 27.04 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.465 -0.874 . . . . 0.96 112.082 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -99.83 142.39 31.37 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.676 -0.491 . . . . 2.18 109.676 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.72 126.84 12.91 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.02 -0.537 . . . . 1.41 109.911 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.9 m -108.93 115.69 30.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.987 -0.551 . . . . 1.03 110.479 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.458 HG12 ' HG2' ' A' ' 14' ' ' LYS . 44.3 t -122.69 117.9 53.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.152 -0.476 . . . . 1.45 110.17 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -91.4 97.03 10.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.97 0.414 . . . . 0.59 110.893 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HG2' HG12 ' A' ' 12' ' ' VAL . 73.9 mmtt -143.64 -174.44 4.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.561 -0.745 . . . . 3.42 109.454 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.627 ' HB ' ' OD1' ' A' ' 106' ' ' ASN . 20.4 p -100.68 159.78 14.89 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.135 -0.32 . . . . 0.63 110.135 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.902 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -86.35 -26.22 24.96 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.629 -0.428 . . . . 3.14 109.992 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.79 -28.63 73.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.919 -0.658 . . . . 0.75 111.613 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -51.14 -34.81 32.72 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.594 0.757 . . . . 2.17 111.442 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.841 ' HB2' HG23 ' A' ' 100' ' ' VAL . 49.8 mt -70.51 -17.61 62.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.591 -0.731 . . . . 1.61 112.816 -170.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.3 m 34.25 55.42 0.63 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.256 0.972 . . . . 1.65 112.778 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.757 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 31.0 t70 70.27 -62.84 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.631 -0.713 . . . . 1.83 111.809 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.49 ' HA ' ' CG ' ' A' ' 99' ' ' TYR . . . -139.46 69.59 1.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.311 0.577 . . . . 0.82 112.068 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.65 98.42 16.41 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.38 -0.827 . . . . 0.79 109.056 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.487 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 54.4 Cg_endo -70.02 119.81 6.67 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.817 2.345 . . . . 1.12 113.411 -172.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.731 HG12 HD21 ' A' ' 19' ' ' LEU . 2.9 pt -80.67 -65.11 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 2.58 111.524 173.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.654 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -117.83 101.55 0.92 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.879 -0.676 . . . . 0.74 111.935 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.612 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 37.7 Cg_endo -70.51 121.16 7.7 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.437 2.091 . . . . 0.67 112.083 177.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.34 122.16 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.86 -0.609 . . . . 1.18 109.431 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.5 m -74.59 101.96 4.39 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.218 -0.446 . . . . 1.64 110.298 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.45 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 48.9 t -95.81 114.49 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.157 -0.474 . . . . 1.01 110.398 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.82 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 14.9 mm100 -103.07 133.91 47.38 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.343 -0.614 . . . . 2.48 109.343 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.4 108.29 13.94 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.172 -0.307 . . . . 0.7 110.172 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.16 134.24 55.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.129 -0.487 . . . . 1.94 110.724 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.55 -7.83 68.59 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.819 -0.628 . . . . 1.81 112.264 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.0 m -84.32 93.56 8.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.001 0.429 . . . . 1.88 110.73 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -96.32 -18.92 19.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.962 0.411 . . . . 2.14 110.218 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -167.76 83.66 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.776 -0.647 . . . . 0.94 110.048 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -165.11 150.09 9.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.898 -0.592 . . . . 4.64 110.096 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -80.91 125.41 30.09 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.245 -0.65 . . . . 1.75 109.245 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 61.0 t -92.99 124.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.46 -0.57 . . . . 0.54 109.46 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -119.66 146.52 45.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.087 0.47 . . . . 0.36 110.963 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.493 HD13 HD13 ' A' ' 96' ' ' ILE . 14.6 mt -103.87 117.72 35.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.663 -0.698 . . . . 0.84 109.329 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.62 ' NZ ' ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -118.73 152.02 36.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.552 -0.536 . . . . 1.93 109.552 -177.316 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.523 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -104.23 157.19 17.3 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.369 -0.378 . . . . 0.41 110.081 175.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 21.9 t70 -75.8 151.72 37.46 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.428 -0.582 . . . . 0.71 109.428 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -56.75 -16.5 6.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.563 0.579 . . . . 1.4 112.563 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.58 -32.37 73.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.981 0.42 . . . . 2.22 110.628 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.523 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 6.0 p-10 -133.85 24.2 3.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 1.35 110.247 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 82.0 t80 -132.33 101.33 5.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.492 -0.777 . . . . 0.56 109.334 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 51' ' ' GLN . 56.5 mt-10 -95.07 100.26 12.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.422 -0.353 . . . . 2.41 110.403 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 23.8 tt0 70.79 -58.56 0.56 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.875 0.734 . . . . 3.43 111.184 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -172.32 38.12 0.16 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.6 -0.727 . . . . 0.56 111.435 -177.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 2.1 mptm? -136.37 133.87 37.24 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.944 -0.762 . . . . 2.12 108.944 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.42 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -106.08 141.67 37.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.245 0.545 . . . . 0.56 110.96 174.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.511 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 16.9 p90 -147.27 167.04 25.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.674 -0.694 . . . . 0.59 111.255 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.667 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 13.0 mt -85.33 113.66 21.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.457 -0.942 . . . . 1.53 108.457 171.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.7 tp -106.26 125.08 61.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.595 0.712 . . . . 0.62 110.85 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 112' ' ' TYR . 40.3 t -84.39 153.34 23.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.982 -1.008 . . . . 1.44 111.21 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.16 -35.39 73.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.471 -0.786 . . . . 2.31 110.368 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -78.3 -13.23 59.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.662 -0.699 . . . . 3.09 110.775 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 53.77 30.44 11.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.661 -0.699 . . . . 2.62 111.122 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.661 ' HE ' ' HA ' ' A' ' 62' ' ' ARG . 8.3 mmp_? -83.79 -39.95 19.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.244 0.545 . . . . 4.66 109.871 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.672 ' HB3' HD21 ' A' ' 65' ' ' LEU . 1.1 m-20 -123.09 124.77 43.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.377 -0.828 . . . . 2.51 111.111 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.667 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -127.18 98.89 5.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.208 1.004 . . . . 2.07 108.737 168.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.676 HD13 ' HB2' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -99.4 118.72 36.65 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.987 -1.006 . . . . 1.98 109.853 -168.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.448 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 73.0 m-85 -67.51 122.15 17.37 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.285 -0.635 . . . . 0.75 109.285 -177.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.475 HG13 ' HG ' ' A' ' 56' ' ' LEU . 12.9 m -99.63 168.57 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.605 -0.725 . . . . 0.73 111.62 -174.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -126.12 110.2 13.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.839 -1.073 . . . . 1.81 108.841 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.469 HG23 HG12 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -91.46 84.25 2.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.506 0.669 . . . . 0.81 109.196 173.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.804 ' HB3' ' OH ' ' A' ' 99' ' ' TYR . 32.6 ttm180 -101.82 131.78 22.42 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.979 -1.01 . . . . 3.79 108.317 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.621 ' HA ' HG22 ' A' ' 96' ' ' ILE . 45.0 Cg_endo -63.25 148.02 93.35 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.431 2.087 . . . . 0.59 112.208 -173.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.0 tpt -74.03 84.6 1.78 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.668 -0.696 . . . . 1.71 110.412 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 74.21 -46.84 0.63 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.134 0.974 . . . . 1.92 113.211 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.422 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 56.8 m-80 -60.22 114.28 2.81 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.433 0.901 . . . . 1.89 113.433 -171.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.7 t 74.4 159.48 0.22 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.722 -1.126 . . . . 1.7 112.323 170.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.42 118.86 33.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.421 -0.809 . . . . 0.94 110.113 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.857 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.4 m95 -112.39 142.49 44.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.16 -0.473 . . . . 0.5 109.945 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.2 m -82.65 110.63 17.88 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.249 -0.648 . . . . 0.51 109.249 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -82.09 117.71 22.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.319 1.057 . . . . 0.59 112.521 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 22.3 t70 -121.59 154.87 36.16 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.898 -1.519 . . . . 1.7 106.898 167.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 1.1 t-20 -83.94 2.6 37.92 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.009 -0.676 . . . . 1.39 110.924 -174.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -122.67 -31.47 1.04 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.156 -0.545 . . . . 0.65 112.134 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 80' ' ' ASP . 26.6 m -131.51 148.64 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.847 -0.427 . . . . 1.16 109.847 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -134.15 104.22 6.11 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.244 -1.021 . . . . 0.36 108.244 -177.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.613 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 12.1 p90 -131.51 135.0 46.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.468 0.651 . . . . 0.59 111.659 -174.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.857 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 18.9 pttp -74.42 139.68 44.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.829 -1.078 . . . . 1.39 109.713 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -72.7 -17.86 61.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.176 -0.675 . . . . 2.12 109.176 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 4.0 t70 -69.4 135.13 49.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.101 -0.954 . . . . 2.1 109.684 172.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.0 m -99.57 122.79 51.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.232 0.539 . . . . 1.05 110.651 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.3 -155.2 24.48 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.616 -0.802 . . . . 0.46 111.747 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.0 p -82.75 -173.56 4.73 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 122.501 0.321 . . . . 1.17 110.276 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' A' ' 74' ' ' ASN . 33.3 t90 -157.68 -57.13 0.08 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.799 -0.445 . . . . 0.51 109.799 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 42.15 92.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.42 1.075 . . . . 1.25 114.731 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.86 -141.83 3.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.663 -0.78 . . . . 0.72 112.286 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 27' ' ' PRO . 11.1 p -133.12 140.43 47.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.139 0.495 . . . . 0.6 112.218 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 71' ' ' PRO . 18.7 pt -118.38 142.87 31.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.807 -0.633 . . . . 1.63 109.501 174.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 24' ' ' PRO . . . -105.1 141.09 15.26 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.23 -0.986 . . . . 0.45 112.386 -174.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.469 HG12 HG23 ' A' ' 69' ' ' ILE . 59.7 mt -96.57 120.31 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.985 0.421 . . . . 0.83 111.088 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.804 ' OH ' ' HB3' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -139.26 164.96 28.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.335 -0.848 . . . . 1.28 110.153 173.482 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.841 HG23 ' HB2' ' A' ' 19' ' ' LEU . 3.6 t -90.13 125.94 43.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.98 -0.554 . . . . 1.14 110.791 -174.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.5 97.04 0.4 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.934 -0.395 . . . . 1.02 109.934 177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.62 -15.82 44.98 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.892 -0.67 . . . . 1.53 113.759 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.418 ' HB2' ' N ' ' A' ' 21' ' ' ASP . 65.2 tt0 67.27 118.35 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.067 0.547 . . . . 2.11 110.769 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.676 ' HB2' HD13 ' A' ' 65' ' ' LEU . 72.0 mm-40 -104.47 -6.83 20.3 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.316 0.487 . . . . 2.62 112.316 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 m 71.16 14.63 6.63 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.984 0.421 . . . . 2.43 111.317 168.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.902 ' HB3' ' HB2' ' A' ' 16' ' ' ARG . 0.3 OUTLIER 41.86 91.51 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.68 1.363 . . . . 1.56 114.68 177.388 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.775 HG22 ' HD2' ' A' ' 108' ' ' PRO . 1.2 m -82.07 143.74 49.81 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 107.914 -1.143 . . . . 1.68 107.914 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.775 ' HD2' HG22 ' A' ' 107' ' ' THR . 75.0 Cg_exo -12.04 83.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.669 1 C-N-CA 125.737 4.292 . . . . 1.26 114.705 -168.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -74.13 -157.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.849 3.033 . . . . 0.76 113.993 -172.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.58 -140.74 6.62 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 109.878 -1.289 . . . . 0.76 109.878 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -82.22 120.7 25.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.953 0.406 . . . . 2.04 110.097 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 58' ' ' SER . 14.1 m-85 -108.74 119.83 40.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.167 0.508 . . . . 0.75 109.972 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 77.0 m -106.74 98.54 8.19 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.414 -0.812 . . . . 0.83 111.051 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.521 HD13 HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -120.57 107.97 13.49 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.268 0.556 . . . . 0.51 110.526 178.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 20.2 m -96.18 140.21 31.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.59 110.181 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 96.5 mt -117.5 125.79 51.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.893 0.378 . . . . 1.27 110.252 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.5 m -103.36 119.61 39.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.982 0.42 . . . . 0.7 110.302 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -74.56 163.43 54.38 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.79 -0.719 . . . . 0.8 112.632 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.49 166.57 14.38 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.494 -0.642 . . . . 0.53 111.494 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -91.02 176.11 6.71 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.707 -0.397 . . . . 0.89 110.663 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 129' ' ' PHE . 1.9 t-105 -133.09 152.8 51.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.265 -0.879 . . . . 0.56 108.69 176.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.09 140.91 46.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.966 0.413 . . . . 1.42 111.615 175.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 74.55 -143.31 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.381 1.073 . . . . 3.47 111.358 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 126' ' ' LYS . 6.1 p-10 -147.62 124.38 11.2 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.336 -0.546 . . . . 2.08 112.135 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.444 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 8.6 t30 65.53 -22.81 0.09 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.862 1.06 . . . . 2.47 113.862 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.448 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -71.43 -3.36 20.52 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.873 0.469 . . . . 1.96 110.951 -178.336 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.859 ' HG3' ' CE2' ' A' ' 129' ' ' PHE . 51.4 tt0 70.37 79.24 0.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.433 -0.803 . . . . 2.02 110.384 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -109.61 27.69 11.88 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 119.793 -1.194 . . . . 0.77 112.655 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.859 ' CE2' ' HG3' ' A' ' 127' ' ' GLN . 38.9 p90 -87.72 126.39 34.96 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.041 -0.664 . . . . 1.21 111.239 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 85.8 m -114.25 132.02 22.97 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.936 -0.575 . . . . 1.47 109.767 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.92 122.61 11.21 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.771 2.314 . . . . 0.92 112.097 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.9 m -155.61 122.55 5.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.218 -0.446 . . . . 1.52 110.185 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 120.0 -117.62 3.63 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.267 -0.733 . . . . 1.17 111.267 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 p -131.81 178.44 6.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.004 0.402 . . . . 2.47 110.621 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 135' ' ' THR . 9.0 t -126.59 104.22 8.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.796 0.807 . . . . 1.82 108.943 171.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.78 143.45 16.03 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.637 -0.711 . . . . 0.67 112.414 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 73.8 m -101.0 117.41 34.98 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.958 0.409 . . . . 0.58 110.903 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.449 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 18.7 m -86.61 111.44 20.63 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.664 -0.865 . . . . 0.52 108.664 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -99.34 109.29 21.92 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.809 0.814 . . . . 2.18 110.065 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.503 HD21 ' HG3' ' A' ' 16' ' ' ARG . 22.6 tp -103.21 95.98 6.47 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.444 -1.253 . . . . 0.63 109.765 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 12.0 m -100.07 144.02 29.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.546 -0.752 . . . . 0.58 109.441 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.5 p -82.45 142.96 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.551 -0.537 . . . . 1.74 109.551 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.758 -0.639 . . . . 2.58 111.472 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.1 t . . . . . 0 N--CA 1.445 -0.675 0 CA-C-O 121.16 0.505 . . . . 1.43 110.363 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.436 ' HG3' ' HA3' ' A' ' 133' ' ' GLY . 46.5 tt0 -98.64 128.03 44.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.722 -0.672 . . . . 2.29 109.274 176.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.551 HG13 HG13 ' A' ' 30' ' ' VAL . 51.2 t -104.99 135.4 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.506 -0.553 . . . . 1.51 109.506 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.479 ' HA ' ' HE ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -92.57 101.21 13.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.084 0.468 . . . . 3.57 110.99 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.497 HG12 ' HA3' ' A' ' 136' ' ' GLY . 73.4 t -129.73 115.32 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.873 -0.788 . . . . 1.26 108.873 173.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.83 -147.67 6.81 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.859 -0.686 . . . . 0.96 112.412 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.29 142.16 27.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.209 0.528 . . . . 2.18 111.413 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.75 124.38 7.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.276 -0.875 . . . . 1.41 109.658 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 139' ' ' LYS . 31.1 m -116.03 116.57 28.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.212 -0.449 . . . . 1.03 110.709 -178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.465 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 27.8 t -121.49 116.75 50.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.931 0.396 . . . . 1.45 110.182 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -83.64 109.06 17.13 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.924 -0.58 . . . . 0.59 111.436 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.5 ' HE3' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -168.63 175.9 5.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.703 -0.681 . . . . 3.42 110.136 178.09 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.546 HG22 HG23 ' A' ' 142' ' ' VAL . 51.6 p -100.81 174.93 5.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.305 -0.407 . . . . 0.63 110.723 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.508 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -84.47 -6.56 59.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.774 -0.824 . . . . 3.14 108.774 173.264 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.588 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -89.84 -22.0 37.69 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.128 -0.942 . . . . 0.75 111.569 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.47 -25.97 65.25 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.712 -0.848 . . . . 2.17 108.712 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.663 HD13 ' HB ' ' A' ' 100' ' ' VAL . 18.5 mt -74.85 159.79 31.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.092 -0.958 . . . . 1.61 109.087 172.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -153.8 60.29 0.73 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.467 -0.938 . . . . 1.65 108.467 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 22.6 t70 61.28 -84.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.033 -1.439 . . . . 1.83 110.255 -171.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.483 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -88.72 74.94 8.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.137 0.494 . . . . 0.82 110.641 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.76 99.99 3.51 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.838 -0.619 . . . . 0.79 110.134 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 91.5 Cg_endo -82.52 109.5 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.762 2.308 . . . . 1.12 112.616 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -116.24 28.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.94 0.876 . . . . 2.58 109.868 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.88 60.1 0.42 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.105 -0.952 . . . . 0.74 112.265 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.63 97.89 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.328 2.019 . . . . 0.67 112.948 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.1 t -80.31 126.22 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.856 -0.611 . . . . 1.18 109.758 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -84.37 94.16 8.42 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 121.03 0.443 . . . . 1.64 110.657 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.707 ' CG2' HD11 ' A' ' 96' ' ' ILE . 14.5 t -94.49 115.21 32.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.308 0.575 . . . . 1.01 111.065 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -102.71 124.92 49.13 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.29 -0.868 . . . . 2.48 109.687 174.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.74 93.97 6.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.019 -0.537 . . . . 0.7 110.695 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 tp -87.28 112.76 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.811 -0.632 . . . . 1.94 110.83 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.22 56.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.553 -0.832 . . . . 1.81 112.306 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -83.72 95.7 8.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.962 0.411 . . . . 1.88 110.444 177.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -103.09 -35.03 8.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.884 -0.598 . . . . 2.14 110.155 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.42 ' C ' ' HB ' ' A' ' 89' ' ' VAL . . . -144.81 35.81 1.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.822 -0.626 . . . . 0.94 110.417 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.549 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.7 tpp180 -120.34 148.01 44.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.044 0.45 . . . . 4.64 111.649 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.532 ' HG3' HG12 ' A' ' 89' ' ' VAL . 91.8 mt-30 -92.48 128.23 38.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.173 -0.677 . . . . 1.75 109.173 173.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 72.1 t -92.9 128.97 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.141 -0.689 . . . . 0.54 109.141 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.893 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -129.9 144.29 51.24 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.335 0.588 . . . . 0.36 110.887 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 31.1 mt -102.08 143.95 31.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.495 -0.775 . . . . 0.84 109.821 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.761 ' HE3' ' CB ' ' A' ' 129' ' ' PHE . 1.2 mptp? -143.73 152.99 41.97 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.284 -0.636 . . . . 1.93 109.284 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -102.88 160.54 14.51 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.008 -0.542 . . . . 0.41 109.606 171.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -83.36 159.65 21.8 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.129 -1.063 . . . . 0.71 108.129 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -58.76 -9.64 1.89 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.982 0.42 . . . . 1.4 111.744 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.44 -38.11 71.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.682 -0.69 . . . . 2.22 111.449 171.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -141.66 23.18 2.12 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.971 0.415 . . . . 1.35 110.406 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 62.8 t80 -126.14 108.15 11.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.56 110.189 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -112.82 107.85 16.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.214 -0.291 . . . . 2.41 110.214 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 71.11 -58.86 0.56 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.982 0.801 . . . . 3.43 110.957 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.512 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -178.52 40.92 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.443 -0.799 . . . . 0.56 111.148 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 3.4 mptp? -131.76 133.9 45.26 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.64 -0.874 . . . . 2.12 108.64 173.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -109.91 135.96 49.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.148 0.499 . . . . 0.56 110.507 172.253 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 21.7 p90 -142.52 167.5 21.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.553 0.692 . . . . 0.59 111.85 -175.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 65' ' ' LEU . 16.0 mt -80.02 104.64 10.73 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.939 -1.028 . . . . 1.53 109.591 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.3 tp -108.2 138.51 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.751 -0.463 . . . . 0.62 109.751 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 p -83.55 166.16 18.47 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.935 -0.395 . . . . 1.44 109.935 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.28 -28.14 68.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.939 -0.763 . . . . 2.31 108.939 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -80.96 -20.38 42.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.031 -0.986 . . . . 3.09 110.479 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.0 m120 67.25 27.78 8.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.647 -0.706 . . . . 2.62 111.268 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 63' ' ' ASP . 19.7 ptt180 -88.09 -46.4 9.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.485 -0.325 . . . . 4.66 111.287 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.471 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 7.5 m-20 -107.52 143.52 35.8 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.91 -0.404 . . . . 2.51 109.91 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.75 153.87 47.28 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.297 0.373 . . . . 2.07 110.277 174.414 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.682 ' HG ' ' HG3' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -154.09 118.61 4.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.442 -0.947 . . . . 1.98 108.442 177.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 1.5 m-85 -69.91 138.97 52.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.933 0.397 . . . . 0.75 109.945 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.472 HG11 HD21 ' A' ' 56' ' ' LEU . 15.1 m -117.38 176.53 2.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.139 -0.482 . . . . 0.73 110.846 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.49 111.65 10.89 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.822 -0.626 . . . . 1.81 109.673 175.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.402 HD12 HD13 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -86.85 85.46 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.719 0.771 . . . . 0.81 109.196 171.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.684 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 37.7 ttt-85 -102.23 136.46 19.43 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 114.756 -1.111 . . . . 3.79 110.396 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.633 ' HA ' HG22 ' A' ' 96' ' ' ILE . 6.1 Cg_exo -46.05 110.63 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.178 2.585 . . . . 0.59 112.267 176.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.08 97.34 8.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.72 -0.673 . . . . 1.71 110.033 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 71.61 17.7 5.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.094 -0.957 . . . . 1.92 110.881 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -128.59 79.11 1.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.084 0.402 . . . . 1.89 112.084 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.4 t 68.56 -172.2 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.837 -0.62 . . . . 1.7 111.804 172.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.57 141.48 48.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.792 -0.64 . . . . 0.94 110.433 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.448 ' CG ' ' HG3' ' A' ' 71' ' ' PRO . 19.9 m0 -123.45 162.92 21.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.3 -0.409 . . . . 0.5 110.602 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 m -76.41 104.85 7.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.74 -0.837 . . . . 0.51 108.74 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 t -93.43 110.5 22.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.813 0.816 . . . . 0.59 112.515 -170.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -110.86 159.35 17.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.017 -1.105 . . . . 1.7 108.017 166.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -76.59 -5.1 46.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.469 -0.197 . . . . 1.39 110.469 -176.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.435 ' CA ' ' HE1' ' A' ' 49' ' ' PHE . . . -126.74 -32.62 0.69 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.026 -0.607 . . . . 0.65 112.822 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 15.8 m -121.51 148.22 25.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 122.325 -0.515 . . . . 1.16 110.594 175.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.782 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -140.27 100.35 3.88 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.56 -0.533 . . . . 0.36 109.56 -177.609 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.893 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 3.6 p90 -131.06 146.05 52.23 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.318 -0.252 . . . . 0.59 110.318 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -81.86 150.58 27.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.01 -0.676 . . . . 1.39 109.804 176.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -76.45 -13.52 60.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.59 0.709 . . . . 2.12 110.069 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 19.4 m-20 -86.01 145.72 26.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.511 -0.768 . . . . 2.1 110.136 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.532 HG12 ' HG3' ' A' ' 39' ' ' GLN . 19.5 m -103.85 123.39 57.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.282 0.563 . . . . 1.05 110.586 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.47 -147.17 18.85 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.701 -0.762 . . . . 0.46 112.347 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.3 p -75.0 178.68 5.45 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.421 0.629 . . . . 1.17 111.618 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.436 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 83.6 t90 -170.92 -55.63 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.087 -0.96 . . . . 0.51 108.729 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 29.19 97.72 0.01 OUTLIER Glycine 0 N--CA 1.469 0.898 0 O-C-N 125.057 1.473 . . . . 1.25 115.894 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.55 -153.37 10.25 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.58 -0.819 . . . . 0.72 112.964 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 p -101.38 129.66 47.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.871 0.693 . . . . 0.6 112.871 -173.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.707 HD11 ' CG2' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -119.34 130.66 73.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.496 -0.928 . . . . 1.63 108.496 170.278 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.17 153.23 17.06 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.137 -1.03 . . . . 0.45 112.59 -171.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 mp -87.58 112.01 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.014 0.435 . . . . 0.83 110.334 175.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.684 ' CE1' ' HB3' ' A' ' 70' ' ' ARG . 7.4 m-85 -101.66 153.48 19.73 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.935 -1.135 . . . . 1.28 107.935 171.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.663 ' HB ' HD13 ' A' ' 19' ' ' LEU . 3.6 p -87.48 124.7 40.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.323 -0.621 . . . . 1.14 109.323 172.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -83.37 95.35 8.19 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.958 -0.697 . . . . 1.02 109.559 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.58 78.49 0.71 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.55 -0.833 . . . . 1.53 111.535 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.47 ' HA ' HG21 ' A' ' 100' ' ' VAL . 5.7 pt20 -37.97 120.66 0.87 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.724 0.773 . . . . 2.11 112.527 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.682 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 9.7 mm-40 -92.41 19.79 6.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.326 -0.852 . . . . 2.62 110.683 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 m 65.45 5.34 3.15 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.512 -0.767 . . . . 2.43 112.302 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.588 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 12.5 t30 63.78 86.04 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.507 0.67 . . . . 1.56 111.211 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.0 t -80.94 140.53 50.22 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 107.84 -1.17 . . . . 1.68 107.84 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -26.76 92.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.835 3.69 . . . . 1.26 113.943 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -90.74 -161.05 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.192 2.594 . . . . 0.76 112.682 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.73 -76.51 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.342 -1.103 . . . . 0.76 110.342 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -140.58 122.27 15.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.678 -0.49 . . . . 2.04 109.678 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -117.62 124.46 48.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.438 0.637 . . . . 0.75 110.18 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.4 HG23 ' HE2' ' A' ' 139' ' ' LYS . 51.5 m -116.14 97.62 6.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.907 -1.042 . . . . 0.83 109.509 -173.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -104.05 100.83 10.6 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.413 0.625 . . . . 0.51 110.108 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.9 m -73.14 117.94 15.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.033 -0.985 . . . . 0.59 110.002 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -111.44 136.23 50.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.133 0.492 . . . . 1.27 110.857 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 45.8 m -129.32 106.18 8.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.223 -0.658 . . . . 0.7 109.223 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.603 ' H ' ' HB ' ' A' ' 134' ' ' THR . . . -89.01 -156.76 32.01 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.736 -0.745 . . . . 0.8 111.767 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.64 -162.85 28.28 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.469 -0.872 . . . . 0.53 111.932 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.559 ' CZ ' ' HB ' ' A' ' 130' ' ' THR . 52.6 p90 -101.65 144.82 29.9 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.987 0.422 . . . . 0.89 110.269 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.648 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 15.1 t-105 -101.23 131.82 47.03 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.749 -0.834 . . . . 0.56 108.749 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.18 54.87 1.55 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.233 0.54 . . . . 1.42 112.22 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.705 ' CG ' ' HA3' ' A' ' 128' ' ' GLY . 29.0 mmtp -158.98 -142.28 0.09 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.566 -1.272 . . . . 3.47 107.566 174.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -151.57 107.08 3.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.238 0.542 . . . . 2.08 111.926 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.648 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 84.4 m-20 63.91 -36.74 0.17 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.474 -1.239 . . . . 2.47 114.272 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -55.04 -51.48 66.18 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.478 0.547 . . . . 1.96 112.478 -170.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.687 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 36.4 tt0 152.82 22.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.082 0.864 . . . . 2.02 110.801 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.705 ' HA3' ' CG ' ' A' ' 123' ' ' LYS . . . -80.79 88.39 1.34 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 119.957 -1.116 . . . . 0.77 112.222 -175.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.761 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 28.4 p90 -140.82 155.17 46.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.592 0.234 . . . . 1.21 110.395 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.559 ' HB ' ' CZ ' ' A' ' 120' ' ' TYR . 99.5 m -139.74 125.27 11.73 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.594 -0.275 . . . . 1.47 110.695 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 47.8 Cg_exo -56.59 134.06 61.95 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.076 2.517 . . . . 0.92 112.018 177.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.7 t -151.84 103.51 2.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.44 -0.345 . . . . 1.52 110.78 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.436 ' HA3' ' HG3' ' A' ' 4' ' ' GLN . . . 82.08 -4.89 73.94 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.938 -0.648 . . . . 1.17 112.901 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.603 ' HB ' ' H ' ' A' ' 118' ' ' GLY . 25.2 p -109.93 113.93 27.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.98 0.733 . . . . 2.47 112.98 -170.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.6 m -140.11 95.18 2.85 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.954 -1.128 . . . . 1.82 107.954 162.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.497 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -118.1 160.94 13.62 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.063 -1.065 . . . . 0.67 113.02 -171.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -143.02 103.98 4.24 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.77 -0.456 . . . . 0.58 109.77 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.509 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 39.5 m -79.97 108.45 13.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.937 -0.764 . . . . 0.52 108.937 174.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.413 ' HB3' HG23 ' A' ' 11' ' ' THR . 2.7 tppp? -94.7 109.39 21.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.222 0.534 . . . . 2.18 110.052 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.5 HD13 ' HE3' ' A' ' 14' ' ' LYS . 2.3 tp -98.99 104.27 16.29 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.176 -0.92 . . . . 0.63 109.317 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 9.2 m -119.23 140.02 50.92 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.848 -0.614 . . . . 0.58 109.771 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.546 HG23 HG22 ' A' ' 15' ' ' THR . 12.3 p -82.07 149.12 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.459 . . . . 1.74 110.711 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.512 -0.756 . . . . 2.58 109.449 175.639 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 41.8 t . . . . . 0 C--O 1.237 0.399 0 N-CA-C 109.61 -0.515 . . . . 1.43 109.61 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -113.47 128.51 56.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.013 -0.539 . . . . 2.29 109.55 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.522 ' HB ' HG23 ' A' ' 134' ' ' THR . 35.1 t -106.56 111.79 36.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.407 -0.59 . . . . 1.51 109.407 -175.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 49.5 mtp180 -84.99 92.51 8.35 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.014 0.435 . . . . 3.57 110.961 -176.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.637 HG23 HG22 ' A' ' 134' ' ' THR . 81.1 t -102.66 115.45 44.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.643 -0.873 . . . . 1.26 108.643 171.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.2 169.22 23.74 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.601 -0.809 . . . . 0.96 112.984 -174.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -88.12 152.93 21.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.933 0.397 . . . . 2.18 110.393 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.951 HD11 ' HB ' ' A' ' 28' ' ' VAL . 89.2 mt -134.74 144.67 47.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.844 -0.616 . . . . 1.41 110.214 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 m -134.41 115.77 14.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.793 -0.447 . . . . 1.03 109.793 171.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.714 HG11 HG22 ' A' ' 25' ' ' ILE . 21.0 t -130.95 130.58 64.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.471 -0.332 . . . . 1.45 110.947 -176.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -99.89 99.67 10.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.377 -0.374 . . . . 0.59 110.517 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -165.86 167.69 16.58 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.426 -0.352 . . . . 3.42 110.256 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.506 ' HA ' HG22 ' A' ' 142' ' ' VAL . 70.4 p -87.25 167.24 14.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 0.63 111.095 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -88.18 -12.16 44.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.83 -0.804 . . . . 3.14 108.83 173.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.72 -29.88 74.18 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.541 -0.754 . . . . 0.75 111.423 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -62.91 -35.02 78.68 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.601 -0.518 . . . . 2.17 109.601 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.552 HD13 ' HB ' ' A' ' 100' ' ' VAL . 48.9 mt -64.8 95.14 0.14 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.421 -0.809 . . . . 1.61 110.118 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -98.16 72.57 2.16 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.973 -0.751 . . . . 1.65 108.973 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 34.0 t70 56.18 -95.7 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.828 -1.078 . . . . 1.83 109.814 -169.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -84.6 77.15 10.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.164 0.507 . . . . 0.82 111.016 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -132.41 96.75 18.66 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.718 -0.674 . . . . 0.79 109.734 175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.45 ' HD3' ' HE1' ' A' ' 99' ' ' TYR . 55.2 Cg_endo -71.9 96.89 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.54 2.16 . . . . 1.12 112.457 -177.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.714 HG22 HG11 ' A' ' 12' ' ' VAL . 16.2 mt -86.64 -30.09 5.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.366 0.603 . . . . 2.58 110.513 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.18 63.51 0.63 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.374 -0.917 . . . . 0.74 112.712 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 14.1 Cg_endo -58.67 106.32 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.342 2.028 . . . . 0.67 111.494 172.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.951 ' HB ' HD11 ' A' ' 10' ' ' LEU . 7.6 p -91.78 130.66 40.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.163 -0.471 . . . . 1.18 110.24 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.9 m -85.7 98.04 10.47 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.9 -0.591 . . . . 1.64 110.626 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.654 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 52.1 t -89.96 115.11 28.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.915 -0.584 . . . . 1.01 110.213 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.484 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 0.2 OUTLIER -104.38 110.13 22.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.948 -0.569 . . . . 2.48 109.551 -176.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.31 105.51 17.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.245 -0.434 . . . . 0.7 110.793 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.61 121.03 23.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.6 -0.727 . . . . 1.94 110.002 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.74 -120.3 8.8 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.741 -0.742 . . . . 1.81 112.141 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 56.4 m 70.36 -58.03 0.56 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.25 0.62 . . . . 1.88 110.722 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.469 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 93.4 m-20 70.1 -48.13 0.63 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.921 0.888 . . . . 2.14 113.272 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.1 77.91 1.22 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.239 -0.652 . . . . 0.94 109.239 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.541 ' HG3' ' HB2' ' A' ' 120' ' ' TYR . 2.9 tpp85 -156.05 146.87 22.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.61 -0.723 . . . . 4.64 110.493 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.729 ' HG3' HG12 ' A' ' 89' ' ' VAL . 55.3 mt-30 -83.2 116.43 22.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.365 -0.38 . . . . 1.75 110.518 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 59.3 t -84.15 124.67 39.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.69 -0.485 . . . . 0.54 109.69 176.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.696 ' HB1' ' HE3' ' A' ' 43' ' ' LYS . . . -125.23 139.51 53.67 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.765 0.317 . . . . 0.36 110.402 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 mt -102.85 129.28 49.48 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.79 -0.448 . . . . 0.84 109.79 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.696 ' HE3' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -120.57 151.3 39.6 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.243 -0.651 . . . . 1.93 109.243 176.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.601 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -100.54 152.91 19.84 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.081 0.467 . . . . 0.41 110.632 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 17.7 t70 -75.18 148.46 39.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.359 -0.837 . . . . 0.71 109.678 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.5 t -57.91 -17.07 14.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.026 0.75 . . . . 1.4 113.026 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.62 -32.17 70.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.975 0.417 . . . . 2.22 110.202 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 4.8 p-10 -123.73 20.1 9.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.05 -0.523 . . . . 1.35 110.237 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.588 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 61.6 t80 -139.97 106.22 5.26 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.619 -0.719 . . . . 0.56 109.932 -177.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -107.36 108.21 19.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.641 -0.254 . . . . 2.41 110.36 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 71.23 -53.87 0.67 Allowed 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.974 0.796 . . . . 3.43 111.778 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.588 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -179.96 31.88 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.904 -0.665 . . . . 0.56 112.578 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 75.1 mmtt -134.63 134.91 41.72 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.757 -0.831 . . . . 2.12 108.757 173.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -112.51 148.62 34.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.447 0.642 . . . . 0.56 112.181 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.609 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 9.5 p90 -156.12 171.51 20.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.975 -1.012 . . . . 0.59 110.304 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.629 HD22 HD22 ' A' ' 114' ' ' LEU . 10.2 mt -84.57 115.42 22.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.531 -0.914 . . . . 1.53 108.531 172.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.464 HG22 ' HB3' ' A' ' 48' ' ' ASN . 7.7 tp -107.54 116.43 51.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.687 0.756 . . . . 0.62 110.96 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 23.8 p -62.43 151.36 37.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.33 -0.85 . . . . 1.44 111.561 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.65 -24.11 64.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.168 0.509 . . . . 2.31 110.355 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -93.5 17.56 11.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.815 -0.629 . . . . 3.09 110.581 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 25.82 67.3 0.05 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.438 1.095 . . . . 2.62 112.771 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.522 HH21 HG22 ' A' ' 107' ' ' THR . 7.1 ptm85 -120.41 -44.59 2.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.552 -0.749 . . . . 4.66 111.895 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.433 ' HB3' ' OH ' ' A' ' 112' ' ' TYR . 26.4 t0 -138.5 139.66 38.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.754 -0.462 . . . . 2.51 109.754 -175.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 2.2 pptp? -128.68 138.92 52.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.08 0.467 . . . . 2.07 110.703 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.647 HD23 ' HB2' ' A' ' 104' ' ' GLN . 6.1 mp -129.16 120.53 26.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.189 -0.46 . . . . 1.98 110.666 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -70.7 131.79 44.42 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.0 -0.37 . . . . 0.75 110.0 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 100' ' ' VAL . 15.7 m -128.6 124.47 61.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.248 -0.433 . . . . 0.73 110.759 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.53 120.12 32.68 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.266 0.555 . . . . 1.81 110.16 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.453 HG22 ' HB ' ' A' ' 96' ' ' ILE . 2.9 mt -82.6 85.3 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 0.81 110.237 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.514 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 65.7 mtp180 -90.26 133.58 32.99 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.0 -0.741 . . . . 3.79 109.0 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.701 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 40.3 Cg_endo -66.87 134.99 36.48 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.569 1.513 . . . . 0.59 111.157 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.5 ttt -79.32 92.1 5.12 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.855 -0.612 . . . . 1.71 110.666 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 68.24 36.04 3.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.465 -0.789 . . . . 1.92 112.064 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -139.11 115.23 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.055 0.761 . . . . 1.89 113.055 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.8 m 63.21 -167.15 0.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.076 -0.965 . . . . 1.7 113.0 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.41 114.31 19.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.655 -0.702 . . . . 0.94 110.137 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.642 ' CD1' ' HG3' ' A' ' 71' ' ' PRO . 11.8 m95 -109.49 141.43 41.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.826 -0.625 . . . . 0.5 110.705 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.1 m -80.44 111.35 16.76 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.53 -0.544 . . . . 0.51 109.53 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.6 t -86.04 113.47 22.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.798 0.809 . . . . 0.59 112.079 -173.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -129.29 156.07 44.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.154 -0.93 . . . . 1.7 108.509 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -82.87 -0.53 48.63 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.716 -0.394 . . . . 1.39 111.61 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.57 -34.23 2.3 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.467 -0.873 . . . . 0.65 111.868 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.593 HG11 ' HZ3' ' A' ' 121' ' ' TRP . 10.7 m -138.73 154.64 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.634 -0.506 . . . . 1.16 109.634 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -140.48 106.86 5.27 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.105 -1.072 . . . . 0.36 108.105 178.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 2.0 p90 -139.49 141.98 37.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.757 0.789 . . . . 0.59 112.895 -170.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.602 ' HB2' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -70.64 128.22 35.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.987 -1.46 . . . . 1.39 111.04 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.56 -35.34 79.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.59 . . . . 2.12 109.69 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.602 ' OD1' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -68.5 125.75 27.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.364 -0.834 . . . . 2.1 109.673 175.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.729 HG12 ' HG3' ' A' ' 39' ' ' GLN . 16.4 m -91.91 118.4 37.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.159 0.504 . . . . 1.05 110.958 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.469 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 159.6 -169.14 35.6 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.393 -0.908 . . . . 0.46 112.348 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.3 p -70.4 151.27 45.37 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.127 -0.694 . . . . 1.17 109.127 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 37.0 t90 -135.71 -64.89 0.61 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.755 -0.378 . . . . 0.51 110.121 -175.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.654 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 35.86 85.28 0.01 OUTLIER Glycine 0 N--CA 1.468 0.776 0 O-C-N 124.307 1.004 . . . . 1.25 114.618 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.17 -153.91 6.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.922 -0.656 . . . . 0.72 112.236 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -106.11 132.9 51.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.198 0.523 . . . . 0.6 112.363 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.701 ' HA ' ' HA ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -125.22 141.04 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.857 -0.794 . . . . 1.63 108.857 171.306 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -114.56 151.1 18.55 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.16 -1.019 . . . . 0.45 112.647 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -92.7 114.34 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.514 -0.55 . . . . 0.83 109.514 174.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.54 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 10.1 m-85 -120.97 129.87 53.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.437 -0.802 . . . . 1.28 108.892 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.732 ' HA ' HG12 ' A' ' 67' ' ' VAL . 8.6 p -71.03 142.66 15.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.035 -0.357 . . . . 1.14 110.035 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.57 95.45 0.33 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.385 -0.37 . . . . 1.02 110.867 176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 50.38 48.81 40.4 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.973 -0.558 . . . . 1.53 113.67 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.502 ' H ' HG13 ' A' ' 100' ' ' VAL . 10.5 pt20 38.41 88.47 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.005 0.907 . . . . 2.11 112.34 -174.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.647 ' HB2' HD23 ' A' ' 65' ' ' LEU . 38.5 mm-40 -56.98 -76.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.816 -1.083 . . . . 2.62 113.129 -175.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -146.37 -64.66 0.3 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.388 -0.369 . . . . 2.43 111.979 -169.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 15.7 t30 60.85 47.2 7.98 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 122.259 1.028 . . . . 1.56 108.393 -170.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.522 HG22 HH21 ' A' ' 62' ' ' ARG . 16.2 m -72.45 123.31 89.35 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 114.84 -1.073 . . . . 1.68 109.246 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -11.82 84.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.342 1 C-N-CA 125.966 4.444 . . . . 1.26 114.44 -164.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 2.8 Cg_endo -87.0 -169.09 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.634 2.889 . . . . 0.76 114.035 -168.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.35 -111.82 0.25 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.224 -1.55 . . . . 0.76 109.224 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -89.39 131.23 35.56 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.848 0.356 . . . . 2.04 110.311 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 6.3 m-85 -125.35 125.31 43.27 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.778 -0.452 . . . . 0.75 109.778 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.9 m -96.63 129.36 44.04 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.698 -0.683 . . . . 0.83 110.23 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.629 HD22 HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -144.68 104.57 4.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.522 -0.918 . . . . 0.51 108.522 171.042 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 32.5 m -108.19 123.97 49.57 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.527 -0.916 . . . . 0.59 108.527 -174.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 116' ' ' LEU . 2.8 mm? -113.35 110.92 21.14 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.397 0.618 . . . . 1.27 110.755 -173.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 9.8 m -98.27 103.71 15.68 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.256 -0.884 . . . . 0.7 108.733 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.775 ' H ' ' HB ' ' A' ' 134' ' ' THR . . . -92.29 -157.13 33.36 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 120.378 -0.915 . . . . 0.8 112.023 -173.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 147.87 -167.9 28.77 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.707 -0.957 . . . . 0.53 110.707 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.541 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 50.5 p90 -98.86 138.24 36.27 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.83 -0.748 . . . . 0.89 109.945 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.612 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 11.2 t-105 -91.72 141.7 28.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.473 -1.24 . . . . 0.56 109.142 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.17 57.33 1.2 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.162 0.43 . . . . 1.42 112.162 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.54 ' C ' ' HE1' ' A' ' 121' ' ' TRP . 55.5 mmtt -158.96 -139.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.364 -0.976 . . . . 3.47 108.364 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -154.84 100.47 2.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.32 0.581 . . . . 2.08 112.087 173.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.612 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 27.1 t-20 60.65 -41.58 0.11 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.454 1.502 . . . . 2.47 114.309 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.514 ' HG3' ' N ' ' A' ' 127' ' ' GLN . 19.4 ptpt -52.56 -51.18 60.95 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.753 0.649 . . . . 1.96 112.753 -172.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.514 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 51.9 tt0 152.37 88.96 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.236 1.014 . . . . 2.02 109.239 -176.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 123' ' ' LYS . . . -142.31 90.65 0.17 Allowed Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.33 -0.938 . . . . 0.77 111.129 172.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.442 ' CB ' ' HZ2' ' A' ' 43' ' ' LYS . 44.7 p90 -144.78 168.51 20.04 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.869 -0.419 . . . . 1.21 109.869 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 4.1 t -156.68 129.25 4.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.897 0.379 . . . . 1.47 110.615 173.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 24.0 Cg_exo -64.2 110.71 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.939 2.426 . . . . 0.92 111.776 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.1 t -131.57 91.93 3.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.395 -0.366 . . . . 1.52 110.314 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.25 -3.18 85.54 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.98 -0.629 . . . . 1.17 112.702 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.775 ' HB ' ' H ' ' A' ' 118' ' ' GLY . 16.5 p -100.5 113.6 26.52 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 113.376 0.88 . . . . 2.47 113.376 -168.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 54.4 m -141.3 94.88 2.75 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.624 -0.51 . . . . 1.82 109.624 165.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.505 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -110.01 85.03 0.39 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.205 -0.998 . . . . 0.67 112.729 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.8 m -81.15 95.01 6.75 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.618 -0.512 . . . . 0.58 109.618 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.609 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 27.5 m -89.15 108.5 19.64 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.106 -0.701 . . . . 0.52 109.106 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 139' ' ' LYS . 29.1 ttmt -103.89 108.79 20.28 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.848 0.832 . . . . 2.18 109.583 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.505 HD23 HD13 ' A' ' 56' ' ' LEU . 21.6 tp -105.35 104.05 13.7 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.281 -1.327 . . . . 0.63 109.343 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.72 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.8 m -117.74 138.11 52.25 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.937 -0.574 . . . . 0.58 110.883 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 15' ' ' THR . 40.3 t -91.58 111.35 23.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.518 -0.919 . . . . 1.74 108.518 170.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.407 -0.806 . . . . 2.58 110.743 -176.555 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.764 0.316 . . . . 1.43 111.786 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -86.64 111.26 20.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.216 -0.661 . . . . 2.29 109.216 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.97 HG21 ' HA3' ' A' ' 118' ' ' GLY . 33.1 m -80.93 137.68 20.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.176 0.513 . . . . 1.51 110.417 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.564 ' NE ' ' HA ' ' A' ' 6' ' ' ARG . 5.2 mmp_? -96.46 95.07 7.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.146 -0.479 . . . . 3.57 110.078 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.412 HG22 ' HA3' ' A' ' 136' ' ' GLY . 11.9 p -116.77 140.15 40.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.503 -0.771 . . . . 1.26 109.163 177.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.62 136.08 9.54 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.388 -0.911 . . . . 0.96 111.895 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.81 106.52 2.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.803 -0.443 . . . . 2.18 109.803 177.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.56 HD21 HG22 ' A' ' 28' ' ' VAL . 4.1 pp -116.73 151.29 36.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.308 -0.405 . . . . 1.41 110.779 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -120.61 123.64 43.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.038 -0.528 . . . . 1.03 110.194 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.459 HG12 ' HG2' ' A' ' 14' ' ' LYS . 39.2 t -130.12 135.46 60.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.268 -0.424 . . . . 1.45 110.493 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.687 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -103.67 96.15 6.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.879 0.371 . . . . 0.59 110.658 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.459 ' HG2' HG12 ' A' ' 12' ' ' VAL . 33.8 mmtp -144.32 163.44 33.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 3.42 110.288 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.798 ' HA ' HG13 ' A' ' 142' ' ' VAL . 31.3 p -91.8 149.89 21.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.339 -0.392 . . . . 0.63 110.433 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.769 ' NH1' ' HG3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -81.97 -0.03 42.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.198 0.523 . . . . 3.14 110.062 177.659 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.694 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -84.33 -22.75 53.54 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.816 -0.914 . . . . 0.75 110.816 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -56.61 -31.08 63.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.774 0.797 . . . . 2.17 109.361 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.846 HD21 HG23 ' A' ' 25' ' ' ILE . 7.1 mt -89.61 111.27 22.17 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.832 -1.076 . . . . 1.61 109.765 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -107.97 75.35 0.99 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.491 -0.929 . . . . 1.65 108.491 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.639 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 36.4 t70 62.6 -93.18 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.401 -1.272 . . . . 1.83 110.336 -170.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.23 73.84 10.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.321 0.581 . . . . 0.82 111.065 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -152.79 121.6 3.23 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.259 -0.882 . . . . 0.79 108.88 174.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 48.2 Cg_endo -89.85 151.06 4.97 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.074 2.516 . . . . 1.12 113.654 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.846 HG23 HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.68 -64.46 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.627 -0.715 . . . . 2.58 110.781 175.037 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.95 77.52 0.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.679 -0.772 . . . . 0.74 112.898 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.524 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 5.2 Cg_endo -48.24 111.1 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.32 2.68 . . . . 0.67 112.327 168.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.56 HG22 HD21 ' A' ' 10' ' ' LEU . 26.0 t -87.13 134.37 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.533 -0.758 . . . . 1.18 110.305 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 32.4 p -78.09 79.26 4.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 1.64 110.392 175.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.5 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 40.3 t -82.94 114.62 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.271 0.557 . . . . 1.01 110.46 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.669 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 58.1 tt0 -110.94 135.07 52.01 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.13 -0.941 . . . . 2.48 109.96 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.486 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -104.76 123.8 48.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.084 -0.507 . . . . 0.7 110.572 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.39 123.05 49.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.258 -0.428 . . . . 1.94 110.882 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.71 28.7 8.19 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.861 -0.685 . . . . 1.81 111.939 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.486 ' SG ' ' HB1' ' A' ' 32' ' ' ALA . 19.6 m -120.74 94.65 4.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.893 0.378 . . . . 1.88 111.019 -176.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.404 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 16.3 m120 -98.48 -19.37 17.7 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.372 -0.603 . . . . 2.14 109.372 174.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.43 ' HA ' ' H ' ' A' ' 90' ' ' GLY . . . -167.78 72.35 0.11 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.78 -0.645 . . . . 0.94 111.138 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 5.8 tpt180 -152.36 146.9 25.71 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 110.319 -0.252 . . . . 4.64 110.319 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.89 131.52 36.44 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.408 -0.59 . . . . 1.75 109.408 174.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 95.1 t -103.1 120.34 52.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.193 -0.669 . . . . 0.54 109.193 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.7 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -114.12 143.2 45.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.105 0.479 . . . . 0.36 111.453 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.3 mt -102.78 114.75 29.27 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.719 -0.673 . . . . 0.84 109.767 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 152.55 27.72 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.441 -0.8 . . . . 1.93 109.093 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 116' ' ' LEU . . . -92.38 154.42 18.55 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.305 -0.628 . . . . 0.41 109.305 170.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.72 159.13 31.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.203 -1.036 . . . . 0.71 108.203 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.66 -20.58 34.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.707 1.003 . . . . 1.4 113.707 -168.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.25 -32.89 73.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.016 0.436 . . . . 2.22 110.903 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -115.36 13.23 16.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.634 0.73 . . . . 1.35 109.924 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -130.52 101.75 5.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.848 -0.614 . . . . 0.56 109.506 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.45 103.31 14.2 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.988 -0.375 . . . . 2.41 109.988 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 71.48 -56.64 0.63 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 124.084 0.865 . . . . 3.43 111.322 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.28 39.08 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.036 -0.826 . . . . 0.56 111.036 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 81' ' ' ASN . 43.6 mmtm -138.36 135.03 34.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.172 -1.048 . . . . 2.12 108.172 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.4 148.5 37.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.607 0.717 . . . . 0.56 111.211 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.736 ' CE2' ' HB ' ' A' ' 57' ' ' ILE . 0.8 OUTLIER -145.93 -169.11 3.16 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.994 -1.003 . . . . 0.59 110.755 -170.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.78 ' HG ' HD22 ' A' ' 114' ' ' LEU . 1.1 mp -111.2 104.24 12.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.567 -1.271 . . . . 1.53 107.567 167.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.736 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 9.4 tp -107.81 136.5 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.273 0.559 . . . . 0.62 111.669 -172.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.2 t -70.72 140.55 51.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.003 -0.74 . . . . 1.44 109.003 171.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.21 -16.97 64.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.981 0.42 . . . . 2.31 111.118 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -87.32 -14.43 40.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 3.09 110.657 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.5 t30 59.89 94.46 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.798 -0.637 . . . . 2.62 110.966 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -153.74 -46.5 0.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 4.66 110.126 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -117.31 138.63 51.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.508 -0.769 . . . . 2.51 109.555 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.94 153.27 46.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.227 1.013 . . . . 2.07 111.499 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 6.4 mp -120.65 175.58 5.94 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 113.377 -1.738 . . . . 1.98 106.82 169.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -126.56 145.13 50.65 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.58 -0.896 . . . . 0.75 108.58 151.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.544 HG11 HD13 ' A' ' 56' ' ' LEU . 29.4 m -134.22 160.07 41.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.861 0.362 . . . . 0.73 110.867 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 99' ' ' TYR . 14.4 p-10 -126.11 111.99 15.31 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.853 -0.612 . . . . 1.81 109.865 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.425 HG23 HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -72.88 101.44 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.033 -0.729 . . . . 0.81 109.033 173.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -122.14 139.86 31.28 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.825 -0.625 . . . . 3.79 110.215 -170.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.51 122.61 5.93 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.67 2.246 . . . . 0.59 111.793 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 53.7 ttp -53.09 -54.01 41.89 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.702 0.626 . . . . 1.71 111.706 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -155.96 15.03 0.34 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.954 0.407 . . . . 1.92 110.504 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -80.81 -81.83 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.032 -0.531 . . . . 1.89 111.658 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.492 ' HB2' ' HE1' ' A' ' 92' ' ' TRP . 3.7 m -136.56 172.35 13.15 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.472 -0.196 . . . . 1.7 110.472 -175.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.98 122.46 32.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.989 0.423 . . . . 0.94 110.859 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.497 ' HE3' ' HD1' ' A' ' 84' ' ' PHE . 12.5 m0 -107.79 156.94 18.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.892 -0.595 . . . . 0.5 110.319 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 m -72.44 121.03 18.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.958 -0.756 . . . . 0.51 108.958 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 t -103.42 101.24 11.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.928 0.87 . . . . 0.59 112.979 -168.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 83' ' ' VAL . 3.7 m-20 -110.33 161.29 15.78 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.721 -1.214 . . . . 1.7 107.721 168.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 53' ' ' LYS . 2.1 t-20 -86.82 -7.26 58.4 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.696 -0.801 . . . . 1.39 110.154 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.53 -30.29 3.6 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.525 -0.845 . . . . 0.65 112.556 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 32.1 m -135.68 149.39 28.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 110.047 -0.353 . . . . 1.16 110.047 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -139.44 110.8 7.01 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.224 -0.658 . . . . 0.36 109.224 -179.622 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 8.2 p90 -142.87 149.3 38.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.13 -0.322 . . . . 0.59 110.13 -174.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -74.47 145.07 43.9 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.037 -0.665 . . . . 1.39 110.524 -178.466 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.03 -27.45 65.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.215 -0.902 . . . . 2.12 110.969 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -95.09 -166.19 1.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.623 -0.717 . . . . 2.1 110.551 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.6 -169.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.838 -0.619 . . . . 1.05 109.413 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.43 ' H ' ' HA ' ' A' ' 37' ' ' ALA . . . 85.65 -154.0 27.84 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.623 -0.798 . . . . 0.46 111.9 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.7 m -87.35 -171.69 3.59 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.156 -0.683 . . . . 1.17 109.156 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.492 ' HE1' ' HB2' ' A' ' 75' ' ' SER . 77.9 t90 -168.33 -50.0 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.573 -0.529 . . . . 0.51 109.573 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 18.44 92.71 0.01 OUTLIER Glycine 0 N--CA 1.474 1.186 0 O-C-N 125.208 1.567 . . . . 1.25 115.862 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 29' ' ' THR . . . -150.33 -125.37 1.29 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.797 -0.716 . . . . 0.72 112.311 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.47 126.58 35.39 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.195 0.443 . . . . 0.6 112.195 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -119.8 129.26 75.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.053 -0.721 . . . . 1.63 109.053 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -112.79 152.34 17.95 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.257 -0.973 . . . . 0.45 112.071 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.6 mp -90.12 112.48 24.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.898 -0.408 . . . . 0.83 109.898 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.479 ' HD2' ' N ' ' A' ' 23' ' ' ALA . 2.9 m-85 -107.03 140.68 39.45 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.223 -1.029 . . . . 1.28 108.223 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 8.5 p -84.19 136.36 22.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.47 . . . . 1.14 109.919 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.57 112.33 16.73 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.193 -0.317 . . . . 1.02 110.658 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.9 37.01 60.96 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 1.53 113.238 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 17.9 pt20 39.82 103.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.481 1.289 . . . . 2.11 114.481 177.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -62.8 -27.09 69.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.873 -0.603 . . . . 2.62 109.897 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.9 m 65.11 14.84 9.65 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.846 0.832 . . . . 2.43 110.069 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.694 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 20.6 t30 59.83 92.04 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.416 -1.265 . . . . 1.56 112.488 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.41 ' N ' HH12 ' A' ' 16' ' ' ARG . 21.1 m -94.93 124.51 54.14 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.621 -0.881 . . . . 1.68 108.621 173.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -26.28 93.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.414 4.076 . . . . 1.26 114.934 -171.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.769 ' HG3' ' NH1' ' A' ' 16' ' ' ARG . 55.6 Cg_endo -100.18 -153.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 124.633 3.556 . . . . 0.76 113.682 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.89 -104.73 0.18 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.504 -1.038 . . . . 0.76 110.504 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.41 113.2 26.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.868 0.366 . . . . 2.04 110.323 175.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -107.52 135.64 48.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.208 0.527 . . . . 0.75 109.937 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 42.5 m -116.97 98.97 6.76 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.176 -0.92 . . . . 0.83 110.447 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.78 HD22 ' HG ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -110.61 91.63 3.73 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.494 0.664 . . . . 0.51 110.173 178.178 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 1.2 m -82.84 125.65 31.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.314 -0.857 . . . . 0.59 110.195 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 91.0 mt -115.72 110.65 19.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.882 0.372 . . . . 1.27 111.158 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 135' ' ' THR . 28.7 m -90.19 108.52 19.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.112 -0.495 . . . . 0.7 110.25 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.97 ' HA3' HG21 ' A' ' 5' ' ' VAL . . . -74.4 178.26 44.99 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.952 -0.642 . . . . 0.8 113.289 -176.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 153.56 -170.24 32.33 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 121.073 -0.584 . . . . 0.53 111.663 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -103.52 -176.23 3.02 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.452 -0.499 . . . . 0.89 110.273 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.669 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 6.3 t-105 -144.8 151.63 39.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.655 -0.702 . . . . 0.56 109.634 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -129.51 141.58 50.96 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.722 0.296 . . . . 1.42 111.471 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 20.5 mmtp 71.66 -152.21 0.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.101 0.961 . . . . 3.47 112.078 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.456 ' H ' ' HB3' ' A' ' 123' ' ' LYS . 19.9 m-20 -132.9 110.86 10.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.68 0.622 . . . . 2.08 112.68 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.669 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 12.3 m120 59.43 -7.72 0.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.781 1.232 . . . . 2.47 114.3 174.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -3.68 36.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.841 0.353 . . . . 1.96 110.767 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.93 HE21 ' HE2' ' A' ' 129' ' ' PHE . 59.7 tt0 74.61 85.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.978 -1.01 . . . . 2.02 110.83 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -120.48 33.0 4.65 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.484 -0.865 . . . . 0.77 111.466 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.93 ' HE2' HE21 ' A' ' 127' ' ' GLN . 11.4 p90 -78.89 152.3 31.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.11 0.481 . . . . 1.21 110.535 -172.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 34.5 m -134.99 133.28 20.82 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.792 -0.64 . . . . 1.47 109.561 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.11 112.24 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.286 1.991 . . . . 0.92 111.818 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.404 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 13.5 m -139.22 105.99 5.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.739 -0.664 . . . . 1.52 109.69 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 126.91 -128.12 6.15 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.561 -0.828 . . . . 1.17 111.492 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.2 m -133.12 159.16 40.93 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.627 -0.508 . . . . 2.47 109.627 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 12.6 t -97.18 110.37 22.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.616 0.722 . . . . 1.82 109.342 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.412 ' HA3' HG22 ' A' ' 7' ' ' VAL . . . -90.16 118.39 5.28 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.754 -0.736 . . . . 0.67 112.144 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 7.4 m -84.77 101.29 12.12 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.715 -0.476 . . . . 0.58 109.715 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.547 HG23 HD11 ' A' ' 10' ' ' LEU . 19.6 m -77.91 108.9 11.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.244 -1.021 . . . . 0.52 108.244 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.448 ' HE3' ' HB2' ' A' ' 139' ' ' LYS . 32.5 ttmt -97.05 108.99 21.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.688 0.756 . . . . 2.18 110.439 -172.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 tp -107.11 108.15 19.48 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.461 -1.245 . . . . 0.63 110.253 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.687 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 10.6 m -108.43 117.32 33.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.37 -0.832 . . . . 0.58 109.077 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.798 HG13 ' HA ' ' A' ' 15' ' ' THR . 39.5 t -93.11 116.26 33.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.206 0.527 . . . . 1.74 112.058 -172.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.5 m . . . . . 0 C--O 1.249 1.067 0 CA-C-N 115.262 -0.881 . . . . 2.58 109.249 172.945 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 91.5 m . . . . . 0 CA--C 1.52 -0.205 0 N-CA-C 112.146 0.425 . . . . 1.43 112.146 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -87.86 108.65 19.27 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.873 -1.158 . . . . 2.29 107.873 171.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -93.21 111.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.597 -0.52 . . . . 1.51 109.597 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.447 ' HA ' ' OG1' ' A' ' 134' ' ' THR . 71.4 mtm180 -94.45 97.42 10.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.951 -0.568 . . . . 3.57 110.77 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.0 t -103.5 115.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.114 -0.948 . . . . 1.26 108.651 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.1 155.44 23.62 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.399 -0.905 . . . . 0.96 112.249 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -73.34 142.95 47.06 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.973 -0.38 . . . . 2.18 109.973 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -157.16 148.49 22.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.085 -0.507 . . . . 1.41 109.95 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.5 t -109.55 133.58 52.93 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.093 0.473 . . . . 1.03 109.887 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.9 t -117.34 126.2 74.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.761 -0.654 . . . . 1.45 109.378 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -106.16 104.12 13.75 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.409 -0.219 . . . . 0.59 110.409 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 mtmm -172.59 -178.67 1.99 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.155 -0.475 . . . . 3.42 110.835 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 142' ' ' VAL . 46.3 p -102.93 167.09 10.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.89 -0.595 . . . . 0.63 110.933 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.773 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -87.8 -10.34 51.2 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.863 -0.791 . . . . 3.14 108.863 175.294 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.614 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -71.29 -20.32 78.08 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.293 -0.867 . . . . 0.75 111.578 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -58.57 -41.33 85.46 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.596 0.712 . . . . 2.17 109.365 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.627 HD21 HG12 ' A' ' 25' ' ' ILE . 4.5 mt -80.19 100.07 8.11 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.615 -1.175 . . . . 1.61 110.449 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.436 ' H ' ' HB3' ' A' ' 23' ' ' ALA . 0.8 OUTLIER -103.66 70.76 1.04 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.784 -0.821 . . . . 1.65 108.784 174.269 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 1.0 OUTLIER 67.16 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.647 -1.16 . . . . 1.83 110.295 -171.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.63 66.01 5.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.308 0.575 . . . . 0.82 111.194 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -141.94 115.36 6.61 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.39 -0.823 . . . . 0.79 109.858 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.5 Cg_endo -91.52 151.12 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.51 2.806 . . . . 1.12 113.341 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.627 HG12 HD21 ' A' ' 19' ' ' LEU . 3.3 pt -116.97 -56.58 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 2.58 112.174 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.487 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -114.04 88.97 0.5 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.475 -0.869 . . . . 0.74 112.914 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 38.2 Cg_exo -60.46 126.93 21.24 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.601 2.201 . . . . 0.67 112.067 172.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.5 t -98.66 127.7 50.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.984 -0.553 . . . . 1.18 110.273 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 m -74.45 101.24 4.07 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 116.156 -0.475 . . . . 1.64 110.489 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 99.3 t -104.04 115.6 46.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.101 -0.5 . . . . 1.01 110.525 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.64 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 47.3 tt0 -113.61 107.02 15.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.999 0.428 . . . . 2.48 110.713 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.75 109.06 20.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.644 -0.707 . . . . 0.7 109.835 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.28 130.29 48.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.025 -0.534 . . . . 1.94 110.287 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.68 29.51 10.73 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.798 -0.715 . . . . 1.81 113.203 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.5 m -94.07 -74.07 0.55 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.926 0.343 . . . . 1.88 111.926 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.549 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 9.1 t30 71.2 -44.69 0.6 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.85 0.46 . . . . 2.14 112.062 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.14 76.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.205 0.526 . . . . 0.94 110.282 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.564 ' H ' ' N ' ' A' ' 90' ' ' GLY . 1.7 tpm_? -157.82 148.52 20.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.436 -0.802 . . . . 4.64 110.455 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -86.2 134.67 33.76 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.098 -0.705 . . . . 1.75 109.098 172.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 93.3 t -110.53 125.3 67.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.943 -0.391 . . . . 0.54 109.943 -176.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.604 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -117.54 152.62 34.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 123.485 0.491 . . . . 0.36 111.293 -173.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.447 HD12 ' HB3' ' A' ' 84' ' ' PHE . 28.2 mt -103.76 104.41 14.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.734 -0.666 . . . . 0.84 109.868 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.604 ' HE2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -98.38 122.75 41.95 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.311 -0.626 . . . . 1.93 109.311 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . . . -83.48 158.21 22.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.332 -0.395 . . . . 0.41 110.774 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.714 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 13.6 t70 -87.19 152.2 22.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.188 -0.46 . . . . 0.71 109.782 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -54.74 -20.37 8.26 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.803 0.668 . . . . 1.4 112.803 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.9 -37.54 74.21 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.936 0.398 . . . . 2.22 111.269 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.624 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 5.6 p-10 -129.27 16.14 6.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.895 -0.593 . . . . 1.35 109.956 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 82.2 t80 -132.85 101.73 5.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.308 -0.86 . . . . 0.56 109.148 -176.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -93.58 93.83 8.29 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.198 -0.456 . . . . 2.41 110.571 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 69.46 -50.3 0.61 Allowed 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.154 0.909 . . . . 3.43 112.103 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.51 35.73 0.16 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.772 -0.531 . . . . 0.56 111.772 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 43.4 mmtm -137.49 133.28 34.42 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.404 -0.961 . . . . 2.12 108.404 172.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -117.43 136.57 53.09 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.004 0.907 . . . . 0.56 112.077 178.261 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.624 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 30.8 p90 -141.06 -176.7 4.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.049 -1.432 . . . . 0.59 108.51 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.937 HD22 HD22 ' A' ' 114' ' ' LEU . 10.9 mt -102.7 127.58 49.77 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.549 -0.908 . . . . 1.53 108.549 172.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.45 133.88 49.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.406 0.622 . . . . 0.62 110.636 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 112' ' ' TYR . 29.5 t -83.87 150.06 25.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.323 -0.853 . . . . 1.44 110.654 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.18 -26.41 68.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.962 -0.563 . . . . 2.31 110.239 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -75.32 -13.62 60.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.658 . . . . 3.09 110.537 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 61.09 20.04 10.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.568 -0.742 . . . . 2.62 111.999 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.888 ' HE ' ' HA ' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -95.49 -70.42 0.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.875 0.369 . . . . 4.66 110.989 -177.313 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.67 158.48 16.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.788 -0.642 . . . . 2.51 111.845 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.452 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -143.66 175.08 10.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.24 -0.891 . . . . 2.07 110.319 -178.531 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.488 HD12 HG23 ' A' ' 100' ' ' VAL . 1.5 pt? -157.17 125.57 5.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.28 -0.418 . . . . 1.98 110.29 173.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 94.2 m-85 -72.83 144.74 47.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.052 -0.722 . . . . 0.75 109.052 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.442 HG11 HD21 ' A' ' 56' ' ' LEU . 15.7 m -123.66 157.18 30.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.308 0.575 . . . . 0.73 111.784 -175.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.464 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -118.94 111.54 18.48 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.438 -0.949 . . . . 1.81 108.438 171.522 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.407 HG22 HD12 ' A' ' 96' ' ' ILE . 0.9 OUTLIER -92.52 86.17 2.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.33 -0.619 . . . . 0.81 109.33 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HG3' ' HD2' ' A' ' 71' ' ' PRO . 57.7 ttp180 -112.41 142.15 26.47 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.41 -0.589 . . . . 3.79 109.41 -174.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 84.9 Cg_exo -44.26 140.23 5.83 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.052 2.501 . . . . 0.59 112.927 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 52.8 ttp -60.56 -52.96 62.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.693 -0.855 . . . . 1.71 108.693 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -153.34 107.63 3.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.138 -0.937 . . . . 1.92 109.315 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -168.73 -163.15 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.737 0.303 . . . . 1.89 111.191 -175.461 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 p -60.32 168.06 2.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.882 -0.599 . . . . 1.7 112.02 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 120.16 23.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.73 -0.668 . . . . 0.94 111.153 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.802 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.8 m95 -107.34 134.11 50.89 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.543 -0.753 . . . . 0.5 109.967 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.9 m -76.35 116.73 17.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.524 -0.547 . . . . 0.51 109.524 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 t -88.57 115.51 26.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.492 0.663 . . . . 0.59 112.329 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -129.06 159.79 34.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.69 -1.226 . . . . 1.7 107.69 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -84.26 -6.71 59.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.42 -0.512 . . . . 1.39 111.57 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.57 -35.39 3.83 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.126 -1.035 . . . . 0.65 111.761 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.563 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 30.4 m -140.32 154.24 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.885 0.374 . . . . 1.16 110.134 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.1 t80 -138.18 106.82 5.88 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.019 -1.104 . . . . 0.36 108.019 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 6.0 p90 -140.65 144.08 35.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.817 0.341 . . . . 0.59 111.662 -171.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.802 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 25.7 pttm -72.58 142.24 48.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 1.39 109.625 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -77.63 -5.54 50.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.293 0.568 . . . . 2.12 110.35 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -86.08 142.93 28.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.392 -0.822 . . . . 2.1 110.182 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 m -99.5 108.62 22.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.483 0.658 . . . . 1.05 110.633 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.564 ' N ' ' H ' ' A' ' 38' ' ' ARG . . . 167.11 -164.12 37.63 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.648 -0.705 . . . . 0.46 111.707 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.3 m -79.97 -178.19 6.36 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.2 -0.667 . . . . 1.17 109.2 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.466 ' CH2' HG23 ' A' ' 96' ' ' ILE . 29.0 t90 -154.9 -61.84 0.12 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.571 -0.451 . . . . 0.51 110.367 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 34.15 85.63 0.01 OUTLIER Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.436 1.085 . . . . 1.25 115.242 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.58 -151.35 6.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.771 -0.728 . . . . 0.72 112.5 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -118.34 124.17 47.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.461 0.648 . . . . 0.6 112.514 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 71' ' ' PRO . 13.7 pt -108.5 148.75 12.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.319 -0.855 . . . . 1.63 109.159 174.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.35 151.25 17.55 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.303 -0.951 . . . . 0.45 111.365 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 70.1 mt -95.11 112.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 120.295 -0.562 . . . . 0.83 110.339 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.464 ' HD1' ' O ' ' A' ' 68' ' ' ASN . 10.5 m-85 -104.7 151.95 23.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.972 -1.013 . . . . 1.28 108.514 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 104' ' ' GLN . 8.1 p -83.07 140.03 16.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.441 -0.504 . . . . 1.14 109.693 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.81 82.27 2.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.937 -0.764 . . . . 1.02 108.937 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.55 114.69 0.58 Allowed Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.636 -0.711 . . . . 1.53 111.459 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.466 ' HA ' HG11 ' A' ' 100' ' ' VAL . 4.5 tt0 -32.53 107.11 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.973 0.909 . . . . 2.11 112.64 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.506 ' HB2' HG21 ' A' ' 100' ' ' VAL . 48.8 tp60 -78.01 -13.26 59.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.571 . . . . 2.62 110.461 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.2 m 64.71 15.85 10.02 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.791 -0.64 . . . . 2.43 111.036 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.773 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 10.4 t30 58.29 77.67 0.28 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.351 0.596 . . . . 1.56 110.918 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.423 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 11.2 t -77.81 144.1 68.06 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.386 -0.968 . . . . 1.68 108.386 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 45.1 Cg_exo -27.51 92.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.984 3.789 . . . . 1.26 114.388 -173.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -100.1 -157.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 123.398 2.732 . . . . 0.76 113.791 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.17 -91.06 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.683 -1.367 . . . . 0.76 109.683 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -125.75 119.35 27.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.305 -0.628 . . . . 2.04 109.305 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 58' ' ' SER . 24.6 m-85 -108.81 128.42 54.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.352 0.596 . . . . 0.75 110.293 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.1 m -105.87 122.29 45.81 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.927 -1.033 . . . . 0.83 110.369 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.937 HD22 HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -136.86 121.59 18.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.928 -0.578 . . . . 0.51 109.688 176.763 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.714 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 6.5 m -112.08 128.42 56.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.797 -0.638 . . . . 0.59 109.296 -174.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -121.57 119.7 32.67 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.02 0.438 . . . . 1.27 110.527 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.2 m -94.65 117.7 30.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.074 -0.512 . . . . 0.7 110.605 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.15 146.72 49.4 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.838 -0.696 . . . . 0.8 112.318 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.48 156.98 9.91 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 111.544 -0.623 . . . . 0.53 111.544 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -89.48 -176.66 5.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.223 0.535 . . . . 0.89 110.762 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.702 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 1.3 t-105 -142.08 151.92 42.81 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.182 -0.917 . . . . 0.56 110.02 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.56 144.33 51.08 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.0 -0.546 . . . . 1.42 111.23 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.676 ' HG2' ' H ' ' A' ' 124' ' ' ASP . 34.3 tttp 67.61 -147.79 0.15 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.455 1.102 . . . . 3.47 111.906 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.676 ' H ' ' HG2' ' A' ' 123' ' ' LYS . 6.7 m-20 -139.67 118.65 12.57 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.573 0.583 . . . . 2.08 112.573 -173.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.651 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.7 OUTLIER 45.49 14.02 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.427 1.639 . . . . 2.47 115.427 175.143 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.572 ' HE2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -92.32 -2.18 56.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.56 0.695 . . . . 1.96 109.832 175.69 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.702 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 58.2 mt-30 72.71 54.19 0.15 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 114.37 -1.286 . . . . 2.02 111.923 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.532 ' N ' ' HD2' ' A' ' 126' ' ' LYS . . . -89.86 93.44 1.88 Allowed Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 108.826 -1.71 . . . . 0.77 108.826 165.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.482 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 50.8 p90 -134.84 134.91 41.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 117.91 0.855 . . . . 1.21 110.863 -173.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.8 m -115.78 134.88 22.64 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 116.091 -0.504 . . . . 1.47 110.217 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.34 106.03 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.882 2.388 . . . . 0.92 111.084 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.8 m -146.6 99.3 3.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.042 0.449 . . . . 1.52 110.342 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 141.61 -141.52 11.12 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.383 -0.913 . . . . 1.17 112.603 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 6' ' ' ARG . 2.7 m -100.13 143.27 30.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.627 0.251 . . . . 2.47 110.86 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 24.1 m -94.73 95.86 9.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.147 -0.686 . . . . 1.82 109.147 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.45 155.65 21.83 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.777 -0.725 . . . . 0.67 112.049 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -124.78 114.56 19.41 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.655 0.265 . . . . 0.58 110.647 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.77 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 3.5 m -89.69 119.88 30.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.221 -1.029 . . . . 0.52 108.221 172.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -117.48 109.36 16.64 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.687 0.756 . . . . 2.18 110.392 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.413 ' HG ' ' NH2' ' A' ' 16' ' ' ARG . 23.9 tp -101.93 106.1 16.99 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.425 -1.262 . . . . 0.63 111.112 -172.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 6.2 m -105.02 143.77 32.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.49 -0.777 . . . . 0.58 109.32 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 15' ' ' THR . 7.3 p -89.22 128.77 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.162 0.506 . . . . 1.74 111.065 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.624 -0.716 . . . . 2.58 110.082 177.947 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.416 ' SG ' ' HG2' ' A' ' 38' ' ' ARG . 42.3 t . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 108.374 -0.973 . . . . 1.43 108.374 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 1.127 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 5.4 tt0 -108.6 119.52 39.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.729 -0.669 . . . . 2.29 111.593 -172.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.437 HG22 HG13 ' A' ' 40' ' ' VAL . 22.5 t -91.61 111.54 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.046 -0.724 . . . . 1.51 109.046 173.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 88.2 mtt180 -87.83 109.49 19.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.254 -0.43 . . . . 3.57 111.654 -177.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.535 HG11 ' HB2' ' A' ' 116' ' ' LEU . 48.9 t -125.21 115.37 43.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.293 -0.867 . . . . 1.26 109.152 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.37 -179.37 35.33 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.598 -0.81 . . . . 0.96 111.965 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -99.02 147.25 25.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.922 0.391 . . . . 2.18 109.978 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.48 147.36 20.48 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.364 -0.606 . . . . 1.41 109.364 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.7 m -116.94 117.68 30.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.907 0.384 . . . . 1.03 111.09 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.15 109.48 28.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.884 -0.598 . . . . 1.45 109.431 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -83.61 96.65 8.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.229 -0.441 . . . . 0.59 111.188 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -149.9 179.41 8.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.16 0.505 . . . . 3.42 110.94 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.41 ' HA ' HH11 ' A' ' 16' ' ' ARG . 52.9 p -101.77 167.43 10.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.738 -0.664 . . . . 0.63 109.875 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.577 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.3 OUTLIER -86.3 -11.62 51.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.792 -0.818 . . . . 3.14 108.792 177.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' A' ' 106' ' ' ASN . . . -81.21 -24.98 56.25 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.959 -1.019 . . . . 0.75 111.038 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -61.7 -26.62 68.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.41 0.624 . . . . 2.17 110.119 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.661 ' HG ' HG23 ' A' ' 100' ' ' VAL . 0.6 OUTLIER -67.27 -54.46 20.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.053 -0.976 . . . . 1.61 109.917 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.8 m 56.81 49.02 14.97 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.825 -1.079 . . . . 1.65 109.221 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.496 ' N ' ' HB3' ' A' ' 103' ' ' GLN . 20.9 t70 77.38 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.279 -1.328 . . . . 1.83 110.428 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -109.69 87.35 2.48 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.272 0.471 . . . . 0.82 112.272 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.87 113.65 3.15 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.79 109.916 169.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.604 ' HD3' ' HE2' ' A' ' 99' ' ' TYR . 50.8 Cg_endo -68.46 94.05 0.43 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.689 2.259 . . . . 1.12 111.814 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.64 HG13 HD22 ' A' ' 19' ' ' LEU . 51.3 mm -89.34 -42.94 14.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.988 -0.551 . . . . 2.58 111.639 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.77 51.98 0.75 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 119.636 -1.269 . . . . 0.74 113.9 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.486 ' HD2' ' C ' ' A' ' 25' ' ' ILE . 8.9 Cg_endo -50.21 123.46 11.09 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.312 2.675 . . . . 0.67 112.481 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.69 139.7 24.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.21 -0.45 . . . . 1.18 110.047 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 t -82.75 102.88 11.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.92 0.867 . . . . 1.64 110.751 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 67.0 t -94.17 114.52 30.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.963 -1.017 . . . . 1.01 110.292 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 57.5 tt0 -99.21 126.47 45.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.784 -0.45 . . . . 2.48 109.784 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.7 94.95 8.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.294 -0.412 . . . . 0.7 109.996 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . 6.4 tt -80.01 114.1 18.67 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.006 -0.739 . . . . 1.94 109.006 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.98 -129.91 10.57 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.603 -0.808 . . . . 1.81 111.252 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.0 m 64.05 23.14 13.15 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.603 0.237 . . . . 1.88 111.593 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.509 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 67.1 t30 -59.81 -29.67 68.4 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.157 0.429 . . . . 2.14 112.157 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.6 25.31 10.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.214 0.53 . . . . 0.94 110.269 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.416 ' HG2' ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -123.92 154.71 39.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.133 -0.485 . . . . 4.64 111.253 -172.557 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.728 ' HG3' HG12 ' A' ' 89' ' ' VAL . 88.3 mt-30 -93.14 128.75 39.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.945 -0.57 . . . . 1.75 109.533 173.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 87.2 t -101.7 117.13 46.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.492 -0.322 . . . . 0.54 110.669 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.742 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -114.44 167.09 11.03 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 123.402 0.439 . . . . 0.36 110.381 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.3 mt -120.11 109.66 15.72 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.061 -0.518 . . . . 0.84 109.632 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.937 ' HE2' HG22 ' A' ' 83' ' ' VAL . 20.4 mmtp -105.86 119.77 40.02 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.552 0.691 . . . . 1.93 110.131 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.65 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -71.48 155.3 40.75 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.553 -1.203 . . . . 0.41 110.363 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 13.5 t70 -72.19 153.73 41.44 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.937 -0.764 . . . . 0.71 108.937 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -58.56 -18.81 32.7 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.183 0.438 . . . . 1.4 112.183 -172.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -62.89 -37.57 87.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.821 0.343 . . . . 2.22 110.985 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.65 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 8.0 p-10 -125.18 20.28 8.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.178 0.514 . . . . 1.35 110.335 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 27.3 t80 -127.92 107.42 9.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.296 -0.866 . . . . 0.56 108.708 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 7.2 pt-20 -106.96 107.01 17.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.501 -0.318 . . . . 2.41 110.454 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 70.79 -56.26 0.62 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.03 0.532 . . . . 3.43 111.294 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.7 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -176.03 34.05 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.78 -0.928 . . . . 0.56 110.78 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 18.5 mmtp -132.34 135.0 45.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.639 -0.874 . . . . 2.12 108.639 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.494 ' CD2' ' HA2' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -107.49 140.11 40.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.47 0.652 . . . . 0.56 110.934 171.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.794 ' CD2' ' HB2' ' A' ' 64' ' ' LYS . 40.6 p90 -147.49 174.36 11.78 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.208 -0.905 . . . . 0.59 110.353 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.495 HD22 HD22 ' A' ' 114' ' ' LEU . 16.9 mt -88.31 116.95 26.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.392 -0.966 . . . . 1.53 108.392 171.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.587 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 8.0 tp -106.42 128.54 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.546 0.689 . . . . 0.62 110.927 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.6 p -66.56 129.23 39.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.254 -0.885 . . . . 1.44 110.161 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.15 -30.33 70.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.325 0.583 . . . . 2.31 109.67 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.91 -14.29 62.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.046 -0.979 . . . . 3.09 110.487 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 59.66 81.91 0.16 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.244 -0.889 . . . . 2.62 110.559 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.438 ' NH1' ' HB2' ' A' ' 108' ' ' PRO . 9.3 ptp180 -144.07 -41.44 0.27 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.68 -0.691 . . . . 4.66 111.218 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -147.36 174.59 11.52 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.497 -0.481 . . . . 2.51 111.483 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.794 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -160.29 142.77 13.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.706 -0.679 . . . . 2.07 110.526 -177.146 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.427 ' HB3' ' NE2' ' A' ' 104' ' ' GLN . 1.8 pt? -140.6 132.44 27.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.551 0.215 . . . . 1.98 110.96 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 64' ' ' LYS . 17.0 m-85 -72.22 141.67 48.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.381 . . . . 0.75 110.749 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.704 HG12 ' HA ' ' A' ' 100' ' ' VAL . 13.3 m -135.31 128.85 49.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.056 -0.52 . . . . 0.73 110.547 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -94.51 113.36 25.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.555 0.693 . . . . 1.81 110.336 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -76.93 85.5 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.424 -0.807 . . . . 0.81 109.907 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.688 ' HG2' ' HD2' ' A' ' 71' ' ' PRO . 13.8 ttp180 -98.32 140.59 21.95 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.36 -0.836 . . . . 3.79 109.216 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.688 ' HD2' ' HG2' ' A' ' 70' ' ' ARG . 97.4 Cg_exo -43.42 136.56 5.97 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.816 2.344 . . . . 0.59 112.807 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.2 tpt -63.41 -58.91 5.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.876 -0.602 . . . . 1.71 110.3 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -159.66 105.04 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.991 -0.55 . . . . 1.92 111.142 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.446 HD21 ' HZ2' ' A' ' 92' ' ' TRP . 2.8 p30 -174.47 -88.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.416 0.448 . . . . 1.89 111.594 172.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.4 m -127.13 -175.44 3.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.638 0.256 . . . . 1.7 110.522 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.29 139.37 36.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.348 -0.387 . . . . 0.94 111.264 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.496 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 11.2 m0 -114.0 151.18 32.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.669 -0.696 . . . . 0.5 109.779 176.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.2 m -70.69 116.29 10.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.31 -0.626 . . . . 0.51 109.31 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t -96.49 117.45 30.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.469 0.652 . . . . 0.59 112.584 -171.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.403 ' CB ' ' HB ' ' A' ' 83' ' ' VAL . 0.4 OUTLIER -126.18 161.99 26.42 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.287 -1.005 . . . . 1.7 108.287 170.563 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -69.29 -21.02 63.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.818 0.303 . . . . 1.39 111.818 -171.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA2' ' CD2' ' A' ' 54' ' ' PHE . . . -139.44 16.23 3.15 Favored Glycine 0 CA--C 1.509 -0.285 0 N-CA-C 111.519 -0.632 . . . . 0.65 111.519 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.937 HG22 ' HE2' ' A' ' 43' ' ' LYS . 95.8 t -139.2 124.63 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.867 -0.79 . . . . 1.16 108.867 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.742 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -139.22 105.47 5.26 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.087 -0.708 . . . . 0.36 109.087 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 1.3 p90 -145.86 141.75 28.15 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.56 0.538 . . . . 0.59 110.529 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.496 ' HB3' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -75.93 138.93 41.33 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.56 -0.456 . . . . 1.39 109.81 177.709 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -59.84 -29.14 68.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.369 -0.832 . . . . 2.12 110.259 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 16.6 m-20 -75.13 137.6 41.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.225 -0.898 . . . . 2.1 110.75 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.728 HG12 ' HG3' ' A' ' 39' ' ' GLN . 27.7 m -90.46 132.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.729 -0.471 . . . . 1.05 109.729 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 36' ' ' ASN . . . 146.55 -170.4 27.59 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.645 -0.788 . . . . 0.46 111.179 -174.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.5 m -77.65 -175.1 3.72 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 109.573 -0.528 . . . . 1.17 109.573 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.446 ' HZ2' HD21 ' A' ' 74' ' ' ASN . 76.2 t90 -163.3 -56.47 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.752 -0.462 . . . . 0.51 109.752 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 32.15 95.15 0.01 OUTLIER Glycine 0 N--CA 1.47 0.917 0 O-C-N 124.843 1.34 . . . . 1.25 115.674 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.64 -165.62 27.31 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.515 -0.634 . . . . 0.72 111.515 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 p -101.35 128.74 47.38 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.063 0.459 . . . . 0.6 111.908 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.572 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -112.71 158.54 13.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.442 -0.948 . . . . 1.63 108.442 167.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -116.97 153.69 17.21 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.244 -0.979 . . . . 0.45 112.449 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.8 mp -91.07 114.34 28.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.766 -0.457 . . . . 0.83 109.766 175.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.604 ' HE2' ' HD3' ' A' ' 24' ' ' PRO . 2.3 m-85 -116.63 139.43 50.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.443 -0.947 . . . . 1.28 108.443 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.704 ' HA ' HG12 ' A' ' 67' ' ' VAL . 86.7 t -74.74 123.52 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.952 -0.388 . . . . 1.14 109.952 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -78.58 86.42 4.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.693 -0.854 . . . . 1.02 108.693 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.72 83.44 1.4 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.684 -0.77 . . . . 1.53 111.742 -174.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.496 ' HB3' ' N ' ' A' ' 21' ' ' ASP . 15.3 pt20 -40.11 117.82 0.82 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.663 0.616 . . . . 2.11 112.663 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.427 ' NE2' ' HB3' ' A' ' 65' ' ' LEU . 6.9 tt0 -90.56 5.14 49.04 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.53 -0.759 . . . . 2.62 110.058 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.448 ' O ' HG22 ' A' ' 105' ' ' THR . 11.1 m 62.23 23.54 13.93 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.697 -0.683 . . . . 2.43 111.287 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.614 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 8.2 t30 66.92 92.97 0.08 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.632 -0.713 . . . . 1.56 111.86 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.599 HG22 ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -74.73 147.64 84.47 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-O 118.51 -0.757 . . . . 1.68 109.427 172.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.599 ' HD2' HG22 ' A' ' 107' ' ' THR . 1.6 Cg_endo -43.11 93.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 124.106 3.204 . . . . 1.26 112.539 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -97.74 -165.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.265 2.643 . . . . 0.76 114.615 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.88 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 108.789 -1.724 . . . . 0.76 108.789 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -115.29 122.92 47.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.799 -0.815 . . . . 2.04 108.799 169.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.466 ' HB2' HH21 ' A' ' 16' ' ' ARG . 6.5 m-85 -109.24 113.91 27.15 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.63 0.728 . . . . 0.75 109.913 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 57' ' ' ILE . 47.3 m -94.82 135.49 36.25 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.553 -1.203 . . . . 0.83 110.791 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.495 HD22 HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -147.84 91.01 1.89 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.497 0.665 . . . . 0.51 109.687 173.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 44.7 m -82.5 135.63 35.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.651 -0.704 . . . . 0.59 110.055 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.535 ' HB2' HG11 ' A' ' 7' ' ' VAL . 95.2 mt -118.34 120.04 36.43 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.118 -0.492 . . . . 1.27 109.705 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.3 m -92.69 110.83 22.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.306 -0.406 . . . . 0.7 109.926 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.84 118.46 12.03 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.665 -0.779 . . . . 0.8 111.555 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.568 ' HA2' ' H ' ' A' ' 132' ' ' SER . . . -165.8 145.0 9.67 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.851 -0.69 . . . . 0.53 111.521 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 130' ' ' THR . 47.3 p90 -88.41 172.97 8.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.303 0.573 . . . . 0.89 110.621 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.625 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 2.3 t-105 -123.2 148.47 45.77 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.471 -0.786 . . . . 0.56 110.017 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.33 145.95 49.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.672 -0.694 . . . . 1.42 110.431 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.948 ' HA ' ' HE2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER 70.27 -140.97 0.07 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.762 0.825 . . . . 3.47 110.519 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -159.74 125.38 4.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.067 0.46 . . . . 2.08 111.604 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.625 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 17.6 m120 63.13 -24.7 0.06 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.002 1.482 . . . . 2.47 115.002 177.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.473 ' HG2' ' HG2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -70.55 -3.25 17.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.925 0.393 . . . . 1.96 111.435 -178.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.557 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 22.7 tt0 74.45 61.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.365 -0.834 . . . . 2.02 111.22 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -102.53 113.17 4.5 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.619 -0.992 . . . . 0.77 110.619 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 50.0 p90 -135.75 163.91 29.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.571 0.685 . . . . 1.21 110.296 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 120' ' ' TYR . 37.9 m -152.38 110.45 2.8 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.82 -0.437 . . . . 1.47 109.82 173.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 16.5 Cg_exo -65.37 116.36 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.617 2.211 . . . . 0.92 112.228 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.568 ' H ' ' HA2' ' A' ' 119' ' ' GLY . 12.1 t -155.05 108.19 2.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.455 -0.793 . . . . 1.52 108.87 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 1.127 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 151.37 -138.07 6.36 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.519 -0.848 . . . . 1.17 111.808 -176.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.4 m -111.72 138.61 48.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.648 0.261 . . . . 2.47 110.394 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.6 m -94.44 98.46 10.89 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.72 -0.474 . . . . 1.82 109.72 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.33 130.29 9.51 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.449 -0.881 . . . . 0.67 112.504 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 86.1 m -96.25 114.82 26.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.629 0.252 . . . . 0.58 110.426 178.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.493 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 13.9 m -78.32 116.86 19.04 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.222 -1.029 . . . . 0.52 108.222 173.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -102.74 108.58 19.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.502 0.668 . . . . 2.18 110.281 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.429 ' CD2' HD13 ' A' ' 56' ' ' LEU . 10.6 tp -106.28 94.67 5.28 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.938 -1.028 . . . . 0.63 109.844 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 12.1 m -102.28 144.4 30.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.707 -0.679 . . . . 0.58 109.431 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.0 p -83.63 133.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.397 -0.521 . . . . 1.74 110.585 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.541 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 43.9 m . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.607 -0.711 . . . . 2.58 109.516 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 t . . . . . 0 CA--C 1.514 -0.408 0 N-CA-C 107.809 -1.182 . . . . 1.43 107.809 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 10.1 mm100 -86.8 112.2 21.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.101 -0.954 . . . . 2.29 110.647 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 7' ' ' VAL . 61.5 t -82.16 110.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.877 -0.786 . . . . 1.51 108.877 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -80.77 91.25 5.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.65 0.738 . . . . 3.57 110.616 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 5' ' ' VAL . 3.5 m -104.85 140.34 23.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.646 -1.161 . . . . 1.26 109.734 175.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.6 167.29 24.84 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.157 -1.021 . . . . 0.96 112.706 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.47 131.42 35.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.079 -0.341 . . . . 2.18 110.079 175.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.18 137.75 24.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.125 -0.489 . . . . 1.41 109.929 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.6 m -103.29 122.42 44.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.043 -0.526 . . . . 1.03 110.442 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.749 HG11 ' HB ' ' A' ' 25' ' ' ILE . 45.2 t -118.76 111.3 33.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.918 -0.583 . . . . 1.45 109.877 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -92.54 101.41 13.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.41 -0.359 . . . . 0.59 110.444 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 5.7 tppt? -163.39 165.47 23.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.981 0.419 . . . . 3.42 110.566 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.622 ' HA ' HG13 ' A' ' 142' ' ' VAL . 82.4 p -89.79 159.01 17.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.017 -0.538 . . . . 0.63 110.558 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -0.03 27.31 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.393 -0.595 . . . . 3.14 109.393 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.55 -20.81 76.22 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.586 -1.006 . . . . 0.75 110.586 171.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -66.39 -48.48 69.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.812 -0.81 . . . . 2.17 108.812 168.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 25' ' ' ILE . 11.0 mt -73.04 92.72 1.7 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.9 -1.046 . . . . 1.61 110.276 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.684 ' H ' ' HB3' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -96.35 69.24 2.64 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.318 -0.623 . . . . 1.65 109.318 177.053 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.5 t70 63.89 -90.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 114.639 -1.164 . . . . 1.83 109.89 -172.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.68 63.66 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.345 0.593 . . . . 0.82 110.726 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.684 ' HB3' ' H ' ' A' ' 20' ' ' THR . . . -140.39 116.74 7.85 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.442 -0.799 . . . . 0.79 109.805 175.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 93.0 Cg_endo -87.24 150.82 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.464 2.776 . . . . 1.12 113.469 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.749 ' HB ' HG11 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -102.75 -62.76 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.3 -0.864 . . . . 2.58 111.125 175.41 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.422 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -127.73 90.93 0.34 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.5 -0.857 . . . . 0.74 112.646 -177.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.78 117.28 3.82 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.82 2.347 . . . . 0.67 111.857 172.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -83.75 133.23 29.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 1.18 109.825 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.9 p -75.91 83.77 2.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.3 0.571 . . . . 1.64 110.36 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.6 t -94.07 115.18 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.709 -0.678 . . . . 1.01 110.315 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.659 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 63.7 tt0 -112.71 135.54 53.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.881 -0.6 . . . . 2.48 109.993 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.44 103.03 13.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.512 -0.551 . . . . 0.7 109.512 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 4' ' ' GLN . 51.6 tp -82.25 112.29 19.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.367 -0.379 . . . . 1.94 110.359 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 -117.73 5.1 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.779 -0.724 . . . . 1.81 112.094 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 57.0 m 69.43 -71.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.66 0.784 . . . . 1.88 111.112 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.416 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 51.1 m-80 66.22 -56.57 0.37 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.999 0.92 . . . . 2.14 112.75 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.32 40.65 3.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.152 0.501 . . . . 0.94 110.354 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 13.2 tpp180 -126.16 148.27 49.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.159 -0.473 . . . . 4.64 111.509 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.428 ' HG3' HG12 ' A' ' 89' ' ' VAL . 41.5 mt-30 -87.6 124.15 33.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 1.75 109.879 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 57.8 t -91.08 121.05 41.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.733 -0.469 . . . . 0.54 109.733 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.778 ' HB1' ' HE3' ' A' ' 43' ' ' LYS . . . -121.81 147.94 45.32 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 120.758 0.313 . . . . 0.36 110.472 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -102.02 105.39 16.14 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.254 0.549 . . . . 0.84 109.95 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.778 ' HE3' ' HB1' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -96.2 151.47 19.46 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.84 -0.8 . . . . 1.93 108.84 176.622 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HB3' ' HD1' ' A' ' 49' ' ' PHE . . . -111.62 156.67 21.45 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 110.014 -0.365 . . . . 0.41 110.014 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -79.9 152.93 29.34 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.506 -0.924 . . . . 0.71 108.506 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -57.08 -13.67 3.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.946 0.339 . . . . 1.4 111.851 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -56.54 -37.38 70.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 2.22 111.077 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 26.0 p-10 -134.05 19.87 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.578 -0.283 . . . . 1.35 110.509 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.734 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 63.1 t80 -124.62 102.55 7.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.78 -0.452 . . . . 0.56 109.78 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.746 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 15.3 pt-20 -101.26 105.44 16.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.395 -0.366 . . . . 2.41 110.585 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? 71.61 -55.96 0.65 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.804 0.842 . . . . 3.43 111.154 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.734 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -174.11 37.52 0.12 Allowed Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.932 -0.652 . . . . 0.56 111.973 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 29.4 mmtm -146.15 139.07 25.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.009 -0.367 . . . . 2.12 110.009 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.602 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -113.5 150.16 33.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.268 0.556 . . . . 0.56 111.948 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.746 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 22.5 p90 -157.61 177.84 10.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.265 -0.88 . . . . 0.59 111.159 -172.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.749 HD23 HD22 ' A' ' 114' ' ' LEU . 14.9 mt -81.12 115.51 20.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.328 -0.99 . . . . 1.53 108.328 170.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 113' ' ' THR . 9.2 tp -105.13 120.12 55.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.806 -0.757 . . . . 0.62 109.828 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.569 ' HB2' ' CE1' ' A' ' 112' ' ' TYR . 42.6 t -75.12 147.56 40.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.341 -0.845 . . . . 1.44 111.465 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.59 -29.53 70.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.526 -0.761 . . . . 2.31 109.753 170.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -81.29 -24.05 37.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.297 -0.865 . . . . 3.09 110.124 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.4 t30 65.67 21.09 11.62 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.418 -0.81 . . . . 2.62 111.948 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 62' ' ' ARG . 63.6 mtt180 -98.21 -6.66 30.81 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.077 -0.389 . . . . 4.66 110.815 176.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.5 143.72 30.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.108 -0.497 . . . . 2.51 111.249 -175.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -150.22 130.5 13.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.729 -0.669 . . . . 2.07 110.232 172.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.632 ' HB2' HD12 ' A' ' 56' ' ' LEU . 2.9 mm? -120.21 130.11 54.4 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.315 -0.402 . . . . 1.98 110.329 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.445 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 94.4 m-85 -68.57 146.53 52.99 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.77 -0.372 . . . . 0.75 110.052 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.35 149.89 20.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.059 0.457 . . . . 0.73 110.904 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -114.41 110.4 19.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.779 -0.823 . . . . 1.81 108.779 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.431 HG23 HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -91.88 107.1 18.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.906 -0.775 . . . . 0.81 108.906 177.226 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 64.5 mtp180 -122.77 143.05 39.25 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.346 -0.388 . . . . 3.79 110.93 -168.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 32.3 Cg_exo -59.29 139.33 89.47 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.026 2.484 . . . . 0.59 111.721 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.0 ttt -70.28 79.18 0.53 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.433 -0.349 . . . . 1.71 111.274 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.8 t70 55.05 45.98 25.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.553 -0.748 . . . . 1.92 112.134 172.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -113.95 -89.45 0.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.048 -0.407 . . . . 1.89 111.59 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -114.66 166.36 11.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.763 0.316 . . . . 1.7 110.617 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.9 113.09 21.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.951 -0.568 . . . . 0.94 110.583 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.572 ' CE2' ' HB3' ' A' ' 86' ' ' LYS . 11.2 m0 -104.56 137.43 42.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.652 -0.704 . . . . 0.5 110.465 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.3 m -65.26 125.06 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.47 -0.567 . . . . 0.51 109.47 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -107.42 105.01 14.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.057 0.932 . . . . 0.59 112.797 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -122.3 145.0 48.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.16 -1.422 . . . . 1.7 107.16 163.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.525 ' HB2' ' CD ' ' A' ' 53' ' ' LYS . 7.9 m120 -71.83 5.07 2.78 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 120.388 -0.525 . . . . 1.39 112.15 -176.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.03 -13.41 2.19 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.81 -0.709 . . . . 0.65 111.578 170.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.451 HG22 ' HZ1' ' A' ' 43' ' ' LYS . 57.5 t -131.83 114.74 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.981 -0.377 . . . . 1.16 109.981 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.688 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.2 t80 -130.75 97.55 4.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.551 -0.907 . . . . 0.36 108.551 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.59 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 12.2 p90 -137.35 150.1 47.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.975 0.417 . . . . 0.59 111.124 -173.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 12.6 pttp -84.42 145.28 28.26 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.728 -0.669 . . . . 1.39 110.951 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.16 -32.69 73.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.17 0.51 . . . . 2.12 109.751 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.645 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -68.94 140.14 55.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.627 -0.715 . . . . 2.1 110.412 174.106 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.428 HG12 ' HG3' ' A' ' 39' ' ' GLN . 31.2 m -101.38 131.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.214 0.531 . . . . 1.05 110.612 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 138.77 -164.5 25.74 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.459 -0.656 . . . . 0.46 111.459 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.7 p -85.14 137.74 32.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.652 -0.499 . . . . 1.17 109.652 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.618 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 89.7 t90 -102.47 -60.63 1.51 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.418 -0.956 . . . . 0.51 108.418 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 48.43 112.75 0.01 OUTLIER Glycine 0 N--CA 1.468 0.811 0 O-C-N 124.556 1.16 . . . . 1.25 115.663 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.52 -130.5 1.62 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.352 -0.699 . . . . 0.72 111.352 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 p -124.31 130.75 53.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.008 0.432 . . . . 0.6 111.213 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.6 mm -111.5 126.21 68.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.31 -0.626 . . . . 1.63 109.31 176.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.11 141.24 15.45 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.495 -0.86 . . . . 0.45 111.869 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 mp -90.59 112.04 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.383 -0.599 . . . . 0.83 109.383 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 70' ' ' ARG . 28.6 m-85 -109.59 142.07 41.22 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.33 -0.989 . . . . 1.28 108.33 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 103' ' ' GLN . 7.2 p -77.72 140.36 17.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.275 -0.57 . . . . 1.14 109.63 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.16 88.97 3.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.277 -0.638 . . . . 1.02 109.277 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.78 107.23 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.823 -0.704 . . . . 1.53 111.45 -173.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.588 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 0.7 OUTLIER -46.74 127.82 10.1 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 121.226 0.536 . . . . 2.11 112.031 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.5 ' HG2' HD21 ' A' ' 65' ' ' LEU . 57.3 tp60 -89.74 1.99 55.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.687 -0.688 . . . . 2.62 110.095 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 m 60.91 22.91 13.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.717 -0.674 . . . . 2.43 111.231 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.3 t30 59.52 94.07 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.624 -0.716 . . . . 1.56 111.207 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.468 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 11.3 t -102.98 146.11 31.82 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 107.435 -1.32 . . . . 1.68 107.435 174.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 78.3 Cg_exo -24.19 90.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 1 C-N-CA 125.303 4.002 . . . . 1.26 114.313 -173.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.505 ' HG2' HG11 ' A' ' 142' ' ' VAL . 94.8 Cg_endo -104.37 -166.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 123.586 2.857 . . . . 0.76 114.736 -171.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -175.35 -120.83 0.62 Allowed Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.202 -1.363 . . . . 0.76 109.976 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -92.9 122.38 35.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.748 0.308 . . . . 2.04 110.315 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 56' ' ' LEU . 91.6 m-85 -116.02 123.69 48.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.271 0.558 . . . . 0.75 110.075 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.596 ' O ' HG22 ' A' ' 57' ' ' ILE . 16.2 m -100.58 140.34 34.99 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.434 -0.803 . . . . 0.83 110.641 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.749 HD22 HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -143.36 92.43 2.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.447 0.642 . . . . 0.51 109.634 173.534 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 32.3 m -86.72 116.84 25.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.562 -0.745 . . . . 0.59 110.841 -176.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 93.8 mt -99.87 140.39 34.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.069 -0.514 . . . . 1.27 110.547 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.3 m -107.28 109.57 21.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.041 -0.527 . . . . 0.7 109.82 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.1 129.11 29.03 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.785 -0.721 . . . . 0.8 111.71 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.528 ' HA2' ' H ' ' A' ' 132' ' ' SER . . . -170.52 167.66 40.78 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.734 -0.746 . . . . 0.53 111.824 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -102.64 161.43 13.74 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.009 0.433 . . . . 0.89 110.007 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.605 ' HZ2' ' H ' ' A' ' 125' ' ' ASN . 4.3 t-105 -119.03 152.31 36.65 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.483 -0.781 . . . . 0.56 109.705 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -134.45 137.06 43.67 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.803 -0.635 . . . . 1.42 110.201 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.583 ' HG3' ' HE2' ' A' ' 126' ' ' LYS . 74.4 mmtt 82.21 -146.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.197 0.999 . . . . 3.47 111.016 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 126' ' ' LYS . 8.2 p-10 -147.91 117.41 7.0 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.179 0.807 . . . . 2.08 113.179 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.605 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 28.0 t-20 64.32 -19.85 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.892 1.277 . . . . 2.47 114.126 171.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.583 ' HE2' ' HG3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -69.05 -2.99 11.4 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.493 0.317 . . . . 1.96 111.491 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 72.04 69.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.21 -0.905 . . . . 2.02 110.623 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -112.22 99.32 1.05 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 109.997 -1.241 . . . . 0.77 109.997 168.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 40.5 p90 -144.57 145.86 32.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.103 0.952 . . . . 1.21 110.369 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 29.2 m -132.25 116.39 15.39 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.25 -0.432 . . . . 1.47 109.988 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.507 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 29.3 Cg_exo -60.7 125.09 16.37 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.856 2.37 . . . . 0.92 112.222 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.528 ' H ' ' HA2' ' A' ' 119' ' ' GLY . 5.8 t -152.05 96.3 2.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.985 -0.746 . . . . 1.52 108.985 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.09 -112.61 0.53 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.83 -0.908 . . . . 1.17 110.83 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.93 171.61 14.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.095 0.448 . . . . 2.47 111.029 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.3 96.06 7.8 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.274 -0.639 . . . . 1.82 109.274 171.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -97.67 113.49 4.73 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.776 -0.726 . . . . 0.67 112.18 -174.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 77.9 m -88.84 107.13 18.82 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.106 0.479 . . . . 0.58 110.546 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.591 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 10.2 m -78.83 120.55 23.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.958 -1.127 . . . . 0.52 107.958 172.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -111.8 109.44 19.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.359 0.6 . . . . 2.18 110.773 -173.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.666 HD23 HD22 ' A' ' 56' ' ' LEU . 7.7 tp -98.96 100.82 12.05 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.969 -1.014 . . . . 0.63 109.742 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 31.8 m -107.38 118.37 36.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.742 -0.663 . . . . 0.58 109.507 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 15' ' ' THR . 58.2 t -79.28 108.95 13.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.012 0.434 . . . . 1.74 111.327 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.701 -0.666 . . . . 2.58 109.774 176.672 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 7.0 t . . . . . 0 N--CA 1.445 -0.711 0 CA-C-O 121.423 0.63 . . . . 1.43 110.158 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.643 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 58.9 tt0 -86.82 110.43 19.94 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.989 -1.005 . . . . 2.29 109.606 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.449 HG13 HG13 ' A' ' 30' ' ' VAL . 97.6 t -103.43 112.62 37.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.846 -0.616 . . . . 1.51 110.234 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -93.1 111.06 22.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.942 -0.572 . . . . 3.57 110.075 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 116' ' ' LEU . 59.9 t -88.46 114.84 27.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.052 -0.721 . . . . 1.26 109.052 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.34 112.28 4.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.137 -0.554 . . . . 0.96 112.75 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.9 106.37 4.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.244 -0.651 . . . . 2.18 109.244 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.508 HD21 HG22 ' A' ' 28' ' ' VAL . 3.4 pp -137.61 154.43 49.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.054 -0.521 . . . . 1.41 111.02 -175.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.5 m -119.08 123.6 44.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.804 -0.634 . . . . 1.03 110.187 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.527 HG22 ' HG2' ' A' ' 14' ' ' LYS . 14.6 p -121.23 141.72 40.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.801 -0.444 . . . . 1.45 109.801 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.728 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -108.91 99.66 8.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.652 0.263 . . . . 0.59 110.966 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HG2' HG22 ' A' ' 12' ' ' VAL . 75.3 mmtt -142.5 172.88 12.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.3 0.571 . . . . 3.42 110.573 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.46 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 1.0 OUTLIER -104.0 154.13 20.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.161 -0.927 . . . . 0.63 109.592 172.295 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.674 ' NH1' ' HG3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -86.61 -1.43 57.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.105 0.478 . . . . 3.14 110.671 -176.371 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.534 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -85.8 -26.83 33.67 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.017 -0.611 . . . . 0.75 112.16 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 15' ' ' THR . 10.0 pt20 -79.83 -2.08 41.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.963 0.411 . . . . 2.17 110.719 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.717 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 71.8 mt -76.4 -26.94 56.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.642 . . . . 1.61 111.256 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 7.5 t 32.59 57.16 0.41 Allowed 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.215 0.947 . . . . 1.65 113.286 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 20' ' ' THR . 70.4 m-20 76.72 -46.69 0.52 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.461 0.704 . . . . 1.83 111.924 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.78 88.66 1.84 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.252 0.464 . . . . 0.82 112.252 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.717 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -139.82 108.19 7.04 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.007 -0.542 . . . . 0.79 110.493 171.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.619 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 38.6 Cg_endo -67.5 99.9 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.176 2.584 . . . . 1.12 112.114 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.586 HG12 HD21 ' A' ' 19' ' ' LEU . 2.6 pp -101.08 -23.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.876 -0.602 . . . . 2.58 111.829 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.45 ' N ' HD12 ' A' ' 25' ' ' ILE . . . -128.64 50.99 0.87 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.101 -1.047 . . . . 0.74 113.396 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 10.0 Cg_endo -53.9 109.97 0.44 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.554 2.169 . . . . 0.67 112.534 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.508 HG22 HD21 ' A' ' 10' ' ' LEU . 61.5 t -91.97 138.42 19.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.465 -0.788 . . . . 1.18 110.543 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 p -78.62 97.92 5.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.944 0.402 . . . . 1.64 110.844 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.663 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 97.4 t -103.51 113.93 41.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.114 -0.494 . . . . 1.01 110.271 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.653 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -109.05 108.32 18.97 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.75 -0.833 . . . . 2.48 108.75 177.185 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.66 91.22 4.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.094 0.473 . . . . 0.7 110.448 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.25 112.75 21.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.708 -0.678 . . . . 1.94 110.098 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.91 -17.97 17.05 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.531 -0.842 . . . . 1.81 112.694 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 1.7 m -74.0 104.77 4.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.876 0.369 . . . . 1.88 110.543 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -106.22 -39.75 5.84 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.301 -0.629 . . . . 2.14 109.301 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.44 64.19 1.35 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.241 -0.89 . . . . 0.94 109.217 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.592 ' HD3' ' H ' ' A' ' 39' ' ' GLN . 8.7 tpp180 -146.76 149.89 34.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.677 -0.692 . . . . 4.64 110.756 -174.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.592 ' H ' ' HD3' ' A' ' 38' ' ' ARG . 36.6 mt-30 -84.81 125.96 33.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.912 -0.585 . . . . 1.75 109.669 176.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 22.1 t -92.29 125.36 44.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.838 -0.43 . . . . 0.54 109.838 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.511 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -121.36 142.37 50.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.046 0.45 . . . . 0.36 111.053 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.634 HD13 HD13 ' A' ' 96' ' ' ILE . 14.5 mt -103.0 112.42 25.24 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.149 -0.686 . . . . 0.84 109.149 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.543 ' HG2' ' CD2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -109.32 151.32 26.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.179 -0.464 . . . . 1.93 110.244 -178.545 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.407 ' HB1' ' OD1' ' A' ' 48' ' ' ASN . . . -100.61 167.44 10.34 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.978 -0.556 . . . . 0.41 110.362 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 23.4 t70 -94.65 157.72 15.84 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.149 -0.686 . . . . 0.71 109.149 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -53.22 -18.69 2.49 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.382 0.426 . . . . 1.4 111.848 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.6 -37.37 68.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.726 -0.67 . . . . 2.22 111.683 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 6.4 p30 -135.58 16.94 3.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.926 0.393 . . . . 1.35 110.66 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 60.3 t80 -118.85 102.53 8.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 0.56 109.382 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 14.4 pt-20 -102.06 100.6 10.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.824 0.345 . . . . 2.41 110.409 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 71.31 -53.29 0.68 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.615 -0.72 . . . . 3.43 111.289 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.1 39.17 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.604 -0.999 . . . . 0.56 110.604 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 22.0 mmmt -137.7 133.7 34.51 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.986 -0.746 . . . . 2.12 108.986 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -115.1 151.35 34.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.18 0.514 . . . . 0.56 110.995 173.339 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HB3' ' HA ' ' A' ' 66' ' ' TYR . 13.8 p90 -156.24 176.94 12.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.534 -0.757 . . . . 0.59 110.805 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.575 ' HA ' HD22 ' A' ' 114' ' ' LEU . 29.7 mt -80.34 111.22 16.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.176 -1.046 . . . . 1.53 108.176 170.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.536 ' CG2' ' HB3' ' A' ' 48' ' ' ASN . 8.7 tp -107.6 127.94 63.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.287 0.565 . . . . 0.62 110.32 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.542 ' HB2' ' OD2' ' A' ' 63' ' ' ASP . 47.4 t -70.86 152.4 43.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.793 -0.64 . . . . 1.44 109.34 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.27 -32.87 72.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.087 0.47 . . . . 2.31 110.269 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -80.34 -0.43 36.77 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.002 -0.544 . . . . 3.09 110.699 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 p30 37.3 60.81 1.02 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.454 1.102 . . . . 2.62 113.394 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -127.56 -11.71 5.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.941 -0.572 . . . . 4.66 110.037 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.542 ' OD2' ' HB2' ' A' ' 58' ' ' SER . 1.9 p-10 -136.63 152.02 49.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.484 -0.78 . . . . 2.51 110.481 -176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.633 ' O ' HD23 ' A' ' 65' ' ' LEU . 9.5 ptpp? -156.89 152.98 27.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.544 -0.298 . . . . 2.07 111.013 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.817 ' HB3' ' HG3' ' A' ' 104' ' ' GLN . 1.6 mt -141.29 124.98 16.86 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.149 -1.426 . . . . 1.98 107.149 170.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 99.2 m-85 -69.26 133.88 48.46 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.121 0.486 . . . . 0.75 110.806 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.94 HG12 ' HA ' ' A' ' 100' ' ' VAL . 29.2 m -128.83 175.23 10.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.388 -0.824 . . . . 0.73 109.796 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.853 ' HB2' ' HE2' ' A' ' 84' ' ' PHE . 2.2 p30 -152.34 128.27 10.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.235 0.54 . . . . 1.81 109.918 172.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.588 HG21 HD12 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -79.85 87.67 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.81 110.382 -174.398 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.404 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 79.3 mtt180 -86.4 137.6 34.45 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.637 -0.711 . . . . 3.79 110.206 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 74.1 Cg_exo -51.15 124.65 14.43 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.453 2.102 . . . . 0.59 112.047 174.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.2 ttt -75.4 82.47 2.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.828 0.347 . . . . 1.71 110.678 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 61.87 21.15 12.05 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.536 -0.756 . . . . 1.92 112.063 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.96 -51.55 5.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.618 -0.265 . . . . 1.89 111.432 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.7 t -167.72 179.15 4.93 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.738 -0.467 . . . . 1.7 109.738 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.15 123.88 45.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.94 110.576 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 12.0 m0 -116.32 160.99 19.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.89 -0.596 . . . . 0.5 110.057 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.1 m -81.86 113.46 19.81 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.356 -0.609 . . . . 0.51 109.356 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 t -95.56 108.55 20.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.579 0.704 . . . . 0.59 112.484 -171.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -117.44 162.26 18.24 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.228 -1.027 . . . . 1.7 108.228 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.467 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 10.6 m120 -85.28 -8.52 58.47 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.377 -0.529 . . . . 1.39 110.984 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.421 ' O ' ' HE1' ' A' ' 49' ' ' PHE . . . -100.93 -35.98 4.09 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.305 -0.95 . . . . 0.65 111.725 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.559 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 27.5 m -140.08 156.27 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.626 -0.509 . . . . 1.16 109.626 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.853 ' HE2' ' HB2' ' A' ' 68' ' ' ASN . 1.0 OUTLIER -134.5 97.96 3.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.201 -1.037 . . . . 0.36 108.201 178.464 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.652 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 2.4 p90 -132.56 144.99 50.78 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.488 -0.485 . . . . 0.59 111.456 -172.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.928 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 40.9 pttt -78.56 148.92 33.16 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.656 -0.702 . . . . 1.39 110.555 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.3 -23.36 61.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 2.12 109.443 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.928 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 5.7 m-20 -72.38 162.3 29.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.247 -0.888 . . . . 2.1 110.297 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.9 m -121.86 139.52 48.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.783 0.325 . . . . 1.05 110.578 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.0 -159.03 17.68 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.674 -0.774 . . . . 0.46 111.926 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.7 m -69.21 166.79 17.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.971 0.415 . . . . 1.17 110.473 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.43 ' HZ2' ' HB3' ' A' ' 71' ' ' PRO . 63.2 t90 -152.46 -52.05 0.11 Allowed 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.263 -0.643 . . . . 0.51 109.263 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 27.21 89.8 0.01 OUTLIER Glycine 0 N--CA 1.466 0.654 0 O-C-N 125.12 1.513 . . . . 1.25 115.448 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.18 -150.17 5.73 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.96 -0.638 . . . . 0.72 112.39 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 p -112.4 125.58 54.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.446 0.536 . . . . 0.6 112.446 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.634 HD13 HD13 ' A' ' 42' ' ' LEU . 1.2 pt -115.75 129.42 72.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.77 -0.65 . . . . 1.63 109.685 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -108.4 160.32 13.82 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.211 -0.995 . . . . 0.45 112.743 -173.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -91.34 113.65 27.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.905 0.384 . . . . 0.83 110.189 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.619 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -116.5 126.83 53.92 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.92 -1.141 . . . . 1.28 107.92 174.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.94 ' HA ' HG12 ' A' ' 67' ' ' VAL . 13.9 p -62.98 124.96 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.316 -0.994 . . . . 1.14 108.316 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.07 88.04 2.4 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.225 -0.657 . . . . 1.02 109.225 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA2' ' OD1' ' A' ' 21' ' ' ASP . . . 90.51 112.32 1.56 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.567 -1.013 . . . . 1.53 110.567 -171.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -51.08 114.23 1.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.354 0.597 . . . . 2.11 110.967 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.817 ' HG3' ' HB3' ' A' ' 65' ' ' LEU . 11.9 mm-40 -91.98 20.81 5.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.476 -0.784 . . . . 2.62 111.094 -174.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.6 m 72.7 -21.72 0.24 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.589 -0.732 . . . . 2.43 112.816 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.534 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 8.9 t30 70.57 84.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.704 0.764 . . . . 1.56 110.238 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.541 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 12.2 t -103.93 149.22 36.97 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.974 -1.121 . . . . 1.68 107.974 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.541 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 91.4 Cg_exo -18.11 89.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 1 C-N-CA 125.76 4.307 . . . . 1.26 115.001 -172.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.687 ' CB ' HG11 ' A' ' 142' ' ' VAL . 3.3 Cg_exo -81.01 -150.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.693 2.929 . . . . 0.76 114.214 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.91 -163.69 37.11 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 109.071 -1.612 . . . . 0.76 109.071 -173.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -80.2 101.69 8.99 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.299 -0.63 . . . . 2.04 109.299 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -84.9 126.59 33.61 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.003 0.43 . . . . 0.75 109.965 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.9 m -130.71 97.36 4.33 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.906 -0.588 . . . . 0.83 109.594 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.575 HD22 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -104.27 105.6 15.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.483 0.659 . . . . 0.51 110.51 -176.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 1.3 m -78.27 121.57 24.58 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.148 -0.933 . . . . 0.59 110.527 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.566 ' HB2' HG11 ' A' ' 7' ' ' VAL . 96.0 mt -107.29 146.0 32.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.87 0.367 . . . . 1.27 110.635 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.0 m -119.19 109.16 15.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.373 -0.376 . . . . 0.7 110.415 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.97 162.09 54.07 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.957 -0.64 . . . . 0.8 112.952 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 151.16 166.35 13.7 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.032 -0.604 . . . . 0.53 111.621 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.678 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 46.9 p90 -89.19 -173.53 4.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.16 0.505 . . . . 0.89 111.043 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.628 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 2.3 t-105 -137.76 149.97 46.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.631 -0.713 . . . . 0.56 110.276 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.79 147.66 50.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.308 -0.406 . . . . 1.42 110.49 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.577 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 5.8 tmtt? 70.41 -142.36 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.66 0.6 . . . . 3.47 110.432 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.528 ' HA ' ' HZ2' ' A' ' 121' ' ' TRP . 6.9 p-10 -160.08 132.66 6.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.622 0.248 . . . . 2.08 111.405 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.546 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 8.9 t30 66.86 -30.06 0.15 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.939 1.089 . . . . 2.47 113.939 174.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.648 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -68.81 -3.51 12.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 1.96 110.951 178.535 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.628 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 20.4 tt0 68.57 59.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.208 -0.905 . . . . 2.02 110.856 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.648 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -89.06 48.55 3.46 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.603 -0.808 . . . . 0.77 111.358 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.595 ' HD1' ' HG2' ' A' ' 127' ' ' GLN . 16.4 p90 -78.81 140.85 38.13 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 110.026 -0.361 . . . . 1.21 110.026 -174.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.549 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 36.6 m -118.94 137.59 25.21 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.315 -0.254 . . . . 1.47 110.315 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.08 111.09 2.39 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.977 2.451 . . . . 0.92 111.274 172.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.1 m -153.08 108.68 3.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.851 0.357 . . . . 1.52 110.489 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.643 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 137.4 -127.51 3.99 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.534 -0.841 . . . . 1.17 111.907 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 m -124.96 145.7 49.74 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.282 -0.266 . . . . 2.47 110.282 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.2 m -92.31 95.75 9.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.103 -0.702 . . . . 1.82 109.103 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -92.17 128.7 9.5 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.918 -0.658 . . . . 0.67 111.975 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.88 105.44 17.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.888 0.375 . . . . 0.58 110.211 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.538 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 21.7 m -78.32 108.8 11.92 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.845 -0.798 . . . . 0.52 108.845 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -103.45 109.06 20.56 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.551 0.691 . . . . 2.18 110.535 -174.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.4 tp -100.82 97.12 7.77 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.617 -1.174 . . . . 0.63 109.092 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.728 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 24.8 m -97.64 122.28 40.54 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.613 -0.721 . . . . 0.58 109.802 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.687 HG11 ' CB ' ' A' ' 109' ' ' PRO . 33.2 m -75.24 114.66 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-O 121.55 0.69 . . . . 1.74 111.29 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.715 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 38.4 m . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.301 -0.856 . . . . 2.58 109.834 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 53.9 m . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.633 0.254 . . . . 1.43 110.623 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -86.46 110.17 19.56 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.565 -0.454 . . . . 2.29 110.018 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.43 117.92 49.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.894 -0.594 . . . . 1.51 109.73 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -82.7 109.59 17.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.946 -0.57 . . . . 3.57 111.618 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.35 117.13 52.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.509 -0.923 . . . . 1.26 108.509 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.38 144.39 17.05 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.443 -0.884 . . . . 0.96 113.23 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -62.05 146.84 49.13 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.492 0.317 . . . . 2.18 110.227 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 2.2 pt? -156.14 126.66 6.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.937 0.399 . . . . 1.41 110.901 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.474 ' HA ' ' HB3' ' A' ' 139' ' ' LYS . 28.0 m -108.75 114.58 28.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.111 -0.495 . . . . 1.03 109.827 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.519 ' HB ' ' NZ ' ' A' ' 14' ' ' LYS . 61.9 t -144.17 146.04 21.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.595 -0.73 . . . . 1.45 109.328 -176.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.724 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -92.99 124.85 37.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.524 0.565 . . . . 0.59 112.524 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.519 ' NZ ' ' HB ' ' A' ' 12' ' ' VAL . 1.1 mptt -147.6 168.44 22.0 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.889 0.376 . . . . 3.42 110.043 172.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.536 ' O ' HD23 ' A' ' 19' ' ' LEU . 73.4 p -112.66 161.89 16.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.313 -0.995 . . . . 0.63 108.313 169.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.1 0.29 19.35 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.555 -0.858 . . . . 3.14 110.236 175.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.99 -26.91 25.14 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 110.251 -1.139 . . . . 0.75 110.251 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -62.57 -29.61 70.72 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.442 -0.947 . . . . 2.17 108.442 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.866 HD21 HD13 ' A' ' 25' ' ' ILE . 2.3 mm? -75.33 129.16 36.93 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.394 -1.275 . . . . 1.61 109.593 171.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.658 HG22 ' HB2' ' A' ' 23' ' ' ALA . 13.7 t -127.94 42.18 3.37 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.391 1.091 . . . . 1.65 108.262 -176.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.496 ' HA ' HG13 ' A' ' 100' ' ' VAL . 29.4 t70 75.3 -69.72 0.17 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.54 -1.663 . . . . 1.83 109.607 -171.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -99.15 85.02 3.14 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.799 -0.445 . . . . 0.82 109.799 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.658 ' HB2' HG22 ' A' ' 20' ' ' THR . . . -142.51 94.63 6.7 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.219 -0.446 . . . . 0.79 110.923 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.521 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 32.9 Cg_endo -68.43 85.9 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 123.189 2.593 . . . . 1.12 111.72 177.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.866 HD13 HD21 ' A' ' 19' ' ' LEU . 12.3 pt -83.31 -16.62 11.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.734 -1.121 . . . . 2.58 111.392 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.35 69.74 0.4 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.542 -0.837 . . . . 0.74 112.802 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 9.3 Cg_exo -71.16 108.16 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.631 2.221 . . . . 0.67 111.697 173.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.6 t -84.47 141.69 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.016 -0.538 . . . . 1.18 110.299 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.5 p -71.05 97.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.391 . . . . 1.64 110.371 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.746 HG23 ' HA ' ' A' ' 95' ' ' THR . 6.6 t -83.59 142.27 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.933 0.873 . . . . 1.01 111.397 -174.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.17 114.18 5.44 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.18 -1.373 . . . . 2.48 107.658 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.82 104.63 11.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.785 0.326 . . . . 0.7 110.911 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 46.3 tp -81.7 120.16 24.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.868 -0.605 . . . . 1.94 109.963 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.9 -144.44 17.26 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.604 -0.808 . . . . 1.81 111.923 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 4.2 m 59.75 32.33 21.33 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 122.192 0.197 . . . . 1.88 111.503 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -55.46 -30.36 60.42 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.102 0.477 . . . . 2.14 110.77 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.56 54.6 1.93 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.901 -0.59 . . . . 0.94 110.083 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.9 tpp180 -140.28 150.49 44.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.263 -0.426 . . . . 4.64 111.287 -176.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -93.22 92.53 7.78 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.312 -0.625 . . . . 1.75 109.312 178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 58.1 t -56.61 134.08 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.678 -0.692 . . . . 0.54 110.639 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 1.02 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -143.82 149.88 37.67 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.962 0.41 . . . . 0.36 111.045 -176.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.48 HD12 ' HB ' ' A' ' 69' ' ' ILE . 11.7 mt -102.96 155.17 18.54 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.011 -0.54 . . . . 0.84 109.549 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HZ1' ' HB3' ' A' ' 41' ' ' ALA . 1.7 mptp? -140.05 150.92 44.96 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.862 -0.792 . . . . 1.93 108.862 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -86.25 155.45 20.68 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.307 -0.627 . . . . 0.41 109.307 171.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 27.6 t70 -71.78 161.45 30.95 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.667 -0.494 . . . . 0.71 109.667 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -55.96 -23.1 30.14 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.929 0.715 . . . . 1.4 112.929 -173.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.0 -16.61 54.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 2.22 111.424 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 20.3 m120 -123.04 8.19 9.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.215 -0.448 . . . . 1.35 110.292 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 83.2 t80 -131.71 109.47 10.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.776 -0.647 . . . . 0.56 110.24 -174.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.538 ' HG2' ' HE1' ' A' ' 55' ' ' PHE . 14.2 pt-20 -134.0 124.11 25.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.357 -0.383 . . . . 2.41 110.193 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 54.68 39.04 31.04 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.98 -0.554 . . . . 3.43 111.586 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.93 36.72 65.06 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.758 -0.655 . . . . 0.56 112.854 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.523 ' HB3' ' HE2' ' A' ' 66' ' ' TYR . 47.2 mmtm -132.8 134.91 45.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.304 -0.628 . . . . 2.12 109.304 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -116.98 141.18 48.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.418 0.628 . . . . 0.56 111.639 176.606 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.538 ' HE1' ' HG2' ' A' ' 50' ' ' GLU . 41.8 p90 -155.04 160.87 41.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.453 -0.794 . . . . 0.59 109.912 -175.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.761 ' HB3' HD22 ' A' ' 114' ' ' LEU . 1.7 pp -81.21 143.08 32.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.64 -0.504 . . . . 1.53 109.64 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 113' ' ' THR . 11.1 tp -121.05 146.9 25.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.697 -0.401 . . . . 0.62 110.36 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.438 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 2.8 p -100.3 174.4 6.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.963 -0.562 . . . . 1.44 111.666 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -53.86 -41.37 67.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.54 -0.755 . . . . 2.31 110.54 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.68 -14.04 46.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.156 -0.929 . . . . 3.09 111.138 -174.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.403 ' HA ' HD11 ' A' ' 57' ' ' ILE . 43.3 m-80 62.29 18.97 10.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.167 0.508 . . . . 2.62 110.285 -171.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -90.62 -50.01 6.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.857 -0.61 . . . . 4.66 110.883 -175.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -100.75 134.22 44.04 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.712 -0.477 . . . . 2.51 109.712 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HD2' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -144.39 154.67 43.22 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.846 -0.616 . . . . 2.07 109.854 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.802 HD21 HG23 ' A' ' 100' ' ' VAL . 23.3 tp -150.95 134.74 16.52 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.11 -0.495 . . . . 1.98 109.88 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.523 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 65.3 m-85 -78.71 131.37 36.58 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.679 -0.691 . . . . 0.75 110.033 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.592 HG21 HD13 ' A' ' 114' ' ' LEU . 11.0 m -125.34 130.9 72.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.975 -0.557 . . . . 0.73 110.702 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -99.77 121.78 41.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.102 -0.499 . . . . 1.81 110.027 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.52 HD13 HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -83.17 87.64 2.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.165 -0.47 . . . . 0.81 109.969 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.465 ' HE ' ' HB2' ' A' ' 99' ' ' TYR . 33.1 mtt180 -99.71 144.44 28.33 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.185 -0.461 . . . . 3.79 109.929 -173.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.683 ' HA ' HG22 ' A' ' 96' ' ' ILE . 77.7 Cg_exo -50.89 140.38 38.85 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.711 2.274 . . . . 0.59 112.439 174.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tpt -77.5 74.63 4.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.25 -0.648 . . . . 1.71 109.25 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 43.02 84.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.01 -0.996 . . . . 1.92 111.386 -174.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.757 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 2.2 t-20 -145.98 -67.08 0.29 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.241 -0.436 . . . . 1.89 110.591 -173.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 m -142.88 164.52 29.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.71 -0.478 . . . . 1.7 109.71 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.06 107.33 17.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.212 0.53 . . . . 0.94 110.604 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.4 m0 -101.89 137.45 40.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.663 -0.699 . . . . 0.5 110.067 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.7 m -69.75 114.51 8.02 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.568 -0.53 . . . . 0.51 109.568 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -93.14 105.2 17.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.906 0.86 . . . . 0.59 112.176 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -105.79 161.2 14.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.078 -1.082 . . . . 1.7 108.078 167.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -85.62 3.64 39.9 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.628 -0.429 . . . . 1.39 111.1 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.65 -40.06 0.87 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.333 -0.937 . . . . 0.65 111.826 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.582 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 30.9 m -133.03 156.88 42.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.988 -0.375 . . . . 1.16 109.988 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.713 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -133.72 97.64 3.97 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.961 -1.126 . . . . 0.36 107.961 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 1.02 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -125.71 142.21 51.63 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 120.754 0.312 . . . . 0.59 110.717 -175.472 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.771 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 18.5 pttm -72.45 144.12 48.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.353 -0.61 . . . . 1.39 109.353 173.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.65 43.8 0.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.009 0.909 . . . . 2.12 108.88 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.771 ' HB3' ' HD2' ' A' ' 86' ' ' LYS . 17.4 t70 -149.16 154.41 39.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.591 -1.186 . . . . 2.1 109.411 -171.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -115.71 124.38 72.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.094 0.473 . . . . 1.05 110.564 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.66 174.97 22.94 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.502 -0.856 . . . . 0.46 112.432 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 p -74.66 124.15 26.19 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.99 -0.374 . . . . 1.17 109.99 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.757 ' HZ2' ' HB3' ' A' ' 74' ' ' ASN . 13.4 t90 -100.64 -43.84 6.03 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.844 -0.342 . . . . 0.51 111.677 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.579 ' O ' ' HB ' ' A' ' 30' ' ' VAL . . . 51.34 -122.1 14.07 Favored Glycine 0 C--O 1.213 -1.175 0 N-CA-C 110.968 -0.853 . . . . 1.25 110.968 -173.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 73.17 -144.68 35.04 Favored Glycine 0 C--N 1.321 -0.271 0 C-N-CA 120.908 -0.663 . . . . 0.72 113.9 166.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.746 ' HA ' HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -152.09 134.06 14.94 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 122.647 0.379 . . . . 0.6 110.746 -179.08 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.683 HG22 ' HA ' ' A' ' 71' ' ' PRO . 2.2 pp -124.92 151.58 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.601 -0.518 . . . . 1.63 109.601 174.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.35 167.77 23.33 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.364 -0.922 . . . . 0.45 112.56 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.587 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.9 mp -91.11 113.26 26.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.743 0.306 . . . . 0.83 110.252 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.521 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 1.6 m-85 -113.89 124.14 51.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.864 -0.791 . . . . 1.28 108.864 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.802 HG23 HD21 ' A' ' 65' ' ' LEU . 11.4 p -55.58 139.07 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.632 0.253 . . . . 1.14 110.709 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -86.61 82.75 7.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.813 -0.81 . . . . 1.02 108.813 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.8 100.7 0.41 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.266 -0.734 . . . . 1.53 111.266 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 103' ' ' GLN . 4.8 pm0 -43.01 120.25 1.74 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.543 0.687 . . . . 2.11 111.87 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.501 ' HG3' ' OG1' ' A' ' 107' ' ' THR . 21.1 tp60 -75.94 -3.13 33.8 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.813 -0.63 . . . . 2.62 110.719 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.9 m 66.73 24.81 9.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.345 0.593 . . . . 2.43 111.446 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.5 t30 60.71 71.34 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.77 0.795 . . . . 1.56 111.529 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.501 ' OG1' ' HG3' ' A' ' 104' ' ' GLN . 3.1 m -82.64 139.62 44.01 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.971 -1.013 . . . . 1.68 108.501 168.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 107' ' ' THR . 66.6 Cg_exo -24.9 94.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.096 1 C-N-CA 125.481 4.12 . . . . 1.26 114.558 -176.006 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.421 ' HB3' ' HE2' ' A' ' 112' ' ' TYR . 57.1 Cg_endo -87.67 -174.89 1.33 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.14 2.56 . . . . 0.76 113.532 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.45 -121.18 0.57 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.215 -1.154 . . . . 0.76 110.215 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -99.45 109.81 22.34 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.129 -0.693 . . . . 2.04 109.129 171.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.518 ' CD1' HD13 ' A' ' 56' ' ' LEU . 53.4 m-85 -107.11 104.77 14.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.803 0.811 . . . . 0.75 110.667 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 57' ' ' ILE . 86.6 m -98.04 118.21 34.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.889 -1.051 . . . . 0.83 109.897 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.761 HD22 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -133.78 96.76 3.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.22 0.533 . . . . 0.51 110.214 175.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 7.6 m -75.12 127.61 33.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.089 -0.505 . . . . 0.59 110.157 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.52 HD13 HD13 ' A' ' 69' ' ' ILE . 90.2 mt -116.59 126.13 52.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.009 -0.367 . . . . 1.27 110.009 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.501 HG21 ' HB3' ' A' ' 131' ' ' PRO . 17.3 m -106.75 126.51 52.39 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.849 0.357 . . . . 0.7 110.63 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.69 157.54 45.81 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.809 -0.71 . . . . 0.8 111.619 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 171.79 -169.56 42.62 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.629 -0.796 . . . . 0.53 111.923 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -111.97 179.92 3.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.181 0.515 . . . . 0.89 110.325 177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.777 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 1.7 t-105 -145.48 148.31 33.12 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.495 -0.775 . . . . 0.56 109.272 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.47 144.26 50.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.831 0.348 . . . . 1.42 111.155 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.719 ' HD3' ' H ' ' A' ' 124' ' ' ASP . 4.7 tmtm? 67.83 -136.69 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.918 0.887 . . . . 3.47 110.212 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.719 ' H ' ' HD3' ' A' ' 123' ' ' LYS . 4.1 p30 -161.56 138.59 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.067 0.394 . . . . 2.08 110.934 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.513 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 55.9 m-80 64.85 -40.8 0.28 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.702 1.201 . . . . 2.47 113.891 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.487 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -62.9 -3.63 1.72 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.21 0.604 . . . . 1.96 112.339 -174.796 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.777 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 44.1 mt-30 68.01 67.1 0.35 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.491 0.662 . . . . 2.02 111.576 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.487 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -95.13 39.61 2.84 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.948 -0.861 . . . . 0.77 110.948 173.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.576 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 41.8 p90 -81.81 151.39 27.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.692 0.282 . . . . 1.21 110.611 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 74.6 m -147.37 125.79 6.13 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.598 -0.273 . . . . 1.47 110.707 174.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.501 ' HB3' HG21 ' A' ' 117' ' ' THR . 9.2 Cg_exo -72.17 114.18 3.91 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.933 2.422 . . . . 0.92 111.51 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 p -151.04 126.98 10.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.045 0.45 . . . . 1.52 110.931 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.85 -113.55 2.69 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.633 -0.794 . . . . 1.17 112.17 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.3 m -130.44 135.37 47.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.63 0.252 . . . . 2.47 110.582 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.2 t -99.78 140.53 33.86 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.49 -0.559 . . . . 1.82 109.49 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -130.41 119.84 2.87 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.45 -0.881 . . . . 0.67 112.355 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 6.0 m -77.77 104.72 8.48 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.781 -0.452 . . . . 0.58 109.781 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.427 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 50.7 m -78.59 108.26 11.86 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.062 -0.718 . . . . 0.52 109.062 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.474 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 12.4 tppt? -98.68 112.97 24.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.762 0.791 . . . . 2.18 110.405 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.624 HD23 HD22 ' A' ' 56' ' ' LEU . 9.4 tp -102.06 94.42 5.76 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 114.676 -1.147 . . . . 0.63 109.409 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 17.1 m -105.69 144.82 31.9 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.265 -0.642 . . . . 0.58 109.265 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.4 p -95.41 135.97 27.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.157 0.503 . . . . 1.74 110.21 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.4 m . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.714 -0.66 . . . . 2.58 109.728 178.888 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 51.9 t . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.502 0.668 . . . . 1.43 109.538 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -94.62 120.46 34.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.385 -0.825 . . . . 2.29 110.392 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.6 115.78 42.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.184 -0.462 . . . . 1.51 110.669 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' A' ' 31' ' ' GLN . 37.5 ttm180 -80.12 108.16 13.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.688 -0.687 . . . . 3.57 109.802 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -114.83 122.55 69.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.808 -0.633 . . . . 1.26 109.829 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.51 169.38 27.4 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.815 -0.707 . . . . 0.96 112.389 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.57 123.39 40.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.049 -0.352 . . . . 2.18 110.049 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.48 ' HB2' HG23 ' A' ' 138' ' ' THR . 55.8 mt -107.45 121.49 44.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.927 0.394 . . . . 1.41 111.582 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.1 m -112.82 113.32 25.36 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.029 -0.73 . . . . 1.03 109.029 170.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.76 147.78 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.913 -0.403 . . . . 1.45 109.913 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -112.28 135.43 52.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.625 -0.261 . . . . 0.59 110.99 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HE2' ' HB ' ' A' ' 25' ' ' ILE . 10.9 ptpp? 178.5 163.82 0.75 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.982 -0.554 . . . . 3.42 109.957 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.861 ' HA ' HG13 ' A' ' 142' ' ' VAL . 76.1 p -85.44 161.71 19.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.132 -0.485 . . . . 0.63 109.865 175.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.705 ' NH1' ' HG3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -80.32 -0.4 36.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.3 -0.63 . . . . 3.14 109.3 174.401 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -96.53 -18.41 30.62 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.197 -0.91 . . . . 0.75 110.962 176.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -71.12 -23.82 62.16 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.538 -0.912 . . . . 2.17 108.538 172.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.402 HD23 HD12 ' A' ' 25' ' ' ILE . 46.9 mt -86.49 116.99 24.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.641 -1.163 . . . . 1.61 108.989 173.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 p -111.42 77.13 1.02 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.77 0.319 . . . . 1.65 110.682 -175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 29.5 t70 61.39 -83.56 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.155 -0.93 . . . . 1.83 110.835 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.657 ' HA ' ' CD2' ' A' ' 99' ' ' TYR . . . -107.07 84.6 2.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.304 0.574 . . . . 0.82 110.309 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.481 ' O ' HG13 ' A' ' 25' ' ' ILE . . . -146.68 87.72 6.28 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.191 -0.913 . . . . 0.79 109.304 175.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.53 ' CB ' ' HA3' ' A' ' 97' ' ' GLY . 59.8 Cg_endo -69.57 94.86 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.657 2.238 . . . . 1.12 112.683 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 23' ' ' ALA . 4.9 mt -111.82 23.46 4.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 122.005 0.907 . . . . 2.58 110.056 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.518 ' N ' ' HD3' ' A' ' 27' ' ' PRO . . . -140.66 53.17 0.67 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.89 -1.05 . . . . 0.74 111.578 168.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.789 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 48.4 Cg_exo -55.81 115.06 2.19 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.299 1.999 . . . . 0.67 113.433 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.2 t -88.58 129.89 38.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.361 -0.836 . . . . 1.18 109.282 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 p -76.95 88.13 3.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.244 0.545 . . . . 1.64 110.868 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.1 115.44 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.673 -0.694 . . . . 1.01 110.755 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.598 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . 52.1 tt0 -114.35 113.01 23.98 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.251 -0.431 . . . . 2.48 109.988 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.609 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -95.98 101.27 12.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.843 -0.617 . . . . 0.7 110.306 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 tt -95.83 126.35 41.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.765 -0.652 . . . . 1.94 110.592 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.2 69.9 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.087 -0.577 . . . . 1.81 114.4 169.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.609 ' SG ' ' HB1' ' A' ' 32' ' ' ALA . 31.3 m -80.54 -66.96 0.82 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.343 0.572 . . . . 1.88 110.112 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 3.2 m-20 67.81 -45.98 0.5 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.136 1.162 . . . . 2.14 114.136 172.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.52 29.08 2.69 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.062 -0.399 . . . . 0.94 111.905 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -133.26 161.06 35.5 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.23 -0.285 . . . . 4.64 110.23 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -91.73 141.14 29.01 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.904 -0.406 . . . . 1.75 109.904 172.207 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 53.1 t -94.03 136.28 26.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.849 -0.796 . . . . 0.54 108.849 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -127.53 135.39 50.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.851 0.358 . . . . 0.36 110.803 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 mt -103.54 105.57 15.84 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.164 -0.68 . . . . 0.84 109.164 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.833 ' HG3' HG12 ' A' ' 83' ' ' VAL . 1.4 mppt? -108.4 125.41 51.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.52 -0.919 . . . . 1.93 108.52 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.633 ' HB1' HD21 ' A' ' 48' ' ' ASN . . . -72.94 156.95 38.33 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.686 -0.406 . . . . 0.41 110.248 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.709 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 21.5 t70 -71.77 147.4 47.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.205 -0.452 . . . . 0.71 109.839 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -61.66 -6.27 2.43 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.91 0.707 . . . . 1.4 112.91 -171.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.83 -29.24 44.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.992 0.425 . . . . 2.22 110.378 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.633 HD21 ' HB1' ' A' ' 44' ' ' ALA . 5.5 p-10 -124.28 19.79 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 1.35 109.553 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 84.7 t80 -137.45 107.4 6.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.281 -0.872 . . . . 0.56 109.916 -175.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -103.07 96.91 7.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.411 -0.358 . . . . 2.41 110.653 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 68.2 -52.32 0.54 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.983 0.802 . . . . 3.43 112.047 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' CE1' ' A' ' 49' ' ' PHE . . . -174.33 37.08 0.12 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 111.671 -0.572 . . . . 0.56 111.671 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.781 ' HD2' ' HB3' ' A' ' 81' ' ' ASN . 8.7 mmmm -138.95 133.52 31.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.64 -1.244 . . . . 2.12 107.64 172.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.15 147.03 43.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.667 0.746 . . . . 0.56 112.055 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 9.2 p90 -150.19 -179.63 7.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.568 -1.196 . . . . 0.59 109.603 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.959 HD12 HD22 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -89.37 121.55 31.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.979 -1.119 . . . . 1.53 107.979 169.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.591 HG22 ' HB3' ' A' ' 48' ' ' ASN . 8.8 tp -106.79 116.86 51.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.571 0.701 . . . . 0.62 109.439 177.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 22.6 t -72.51 147.65 45.79 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.06 -0.518 . . . . 1.44 110.214 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.84 -8.07 33.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.456 0.646 . . . . 2.31 109.703 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -95.26 -3.12 48.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.385 -0.825 . . . . 3.09 110.023 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.07 28.01 0.35 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.884 1.273 . . . . 2.62 113.553 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -86.46 -53.83 4.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.087 -0.383 . . . . 4.66 111.118 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.523 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 7.2 m-20 -125.66 159.64 31.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.414 -0.357 . . . . 2.51 110.705 -175.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.503 ' HB2' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -145.63 133.11 20.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.78 -0.646 . . . . 2.07 109.718 176.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.625 ' O ' HD22 ' A' ' 56' ' ' LEU . 2.0 mm? -128.37 133.35 48.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.336 -0.616 . . . . 1.98 109.336 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -75.25 138.34 41.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.147 0.498 . . . . 0.75 110.376 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.488 HG11 HD11 ' A' ' 56' ' ' LEU . 2.4 m -117.48 167.19 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-N 115.734 -0.667 . . . . 0.73 110.476 177.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -121.78 110.34 15.79 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.775 -0.648 . . . . 1.81 109.339 173.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.42 HG23 HG12 ' A' ' 98' ' ' ILE . 1.1 pt -88.77 84.93 2.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.021 -0.733 . . . . 0.81 109.021 172.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.582 ' HB3' ' OH ' ' A' ' 99' ' ' TYR . 44.9 ttt180 -116.69 136.2 23.13 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 115.445 -0.798 . . . . 3.79 109.132 -173.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 91.9 Cg_exo -42.92 121.0 2.08 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.0 2.467 . . . . 0.59 112.284 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.9 ttt -68.18 87.83 0.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 1.71 110.424 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t0 49.35 66.76 1.02 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.143 -0.935 . . . . 1.92 111.019 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -140.17 -53.19 0.51 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 1.89 111.559 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.0 m -149.57 161.42 42.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.576 0.227 . . . . 1.7 110.624 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.6 86.45 3.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.94 0.4 . . . . 0.94 110.081 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.404 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 17.2 m0 -77.25 158.27 30.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.706 -0.679 . . . . 0.5 110.3 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.9 m -69.63 116.33 9.91 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.063 -0.717 . . . . 0.51 109.063 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 t -98.01 97.31 8.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.819 0.819 . . . . 0.59 112.094 -170.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.33 159.85 14.67 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.295 -1.002 . . . . 1.7 108.295 168.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.781 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -79.73 -7.31 58.54 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.335 -0.546 . . . . 1.39 110.017 -178.652 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.452 ' CA ' ' HE1' ' A' ' 49' ' ' PHE . . . -118.64 -36.74 0.88 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.13 -1.033 . . . . 0.65 112.887 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.833 HG12 ' HG3' ' A' ' 43' ' ' LYS . 33.4 m -124.52 151.76 30.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.275 -0.639 . . . . 1.16 109.275 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -135.03 102.48 5.23 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.297 -1.001 . . . . 0.36 108.297 -178.422 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.683 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 15.6 p90 -135.9 140.87 44.4 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.137 0.494 . . . . 0.59 110.903 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 17.1 pttp -82.44 140.98 33.1 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.562 -0.745 . . . . 1.39 110.986 -178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -67.47 -34.4 77.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.291 -1.003 . . . . 2.12 108.291 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 2.2 m-20 -58.44 124.48 19.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.636 -1.166 . . . . 2.1 110.31 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.8 131.46 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.512 -0.475 . . . . 1.05 109.818 174.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.589 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 146.07 -165.19 28.18 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.584 -0.817 . . . . 0.46 111.832 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.8 p -81.82 -172.78 4.08 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.619 -0.511 . . . . 1.17 109.619 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.586 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 22.5 t90 -154.0 -59.99 0.13 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.953 -0.388 . . . . 0.51 109.953 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 39.69 88.44 0.01 OUTLIER Glycine 0 N--CA 1.467 0.724 0 O-C-N 124.275 0.985 . . . . 1.25 114.901 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.69 -139.6 2.68 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.022 -0.609 . . . . 0.72 111.669 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 p -131.77 124.62 30.07 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.43 0.634 . . . . 0.6 112.167 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.789 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 37.5 pt -100.0 161.54 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.375 -0.972 . . . . 1.63 108.375 172.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 24' ' ' PRO . . . -128.02 147.9 17.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.53 -1.319 . . . . 0.45 113.126 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 69' ' ' ILE . 79.8 mt -101.75 120.73 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 120.731 0.3 . . . . 0.83 110.886 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.657 ' CD2' ' HA ' ' A' ' 22' ' ' ALA . 1.4 p90 -138.6 155.2 48.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.85 -0.614 . . . . 1.28 110.392 173.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 103' ' ' GLN . 12.8 p -85.58 136.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.822 -0.626 . . . . 1.14 110.761 -170.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.13 101.87 0.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.825 -0.625 . . . . 1.02 111.391 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.75 34.83 66.4 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-O 119.451 -0.638 . . . . 1.53 113.848 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.496 ' HA ' HG13 ' A' ' 100' ' ' VAL . 27.0 pt20 38.92 96.88 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.984 0.897 . . . . 2.11 113.187 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.528 ' HG3' ' HB3' ' A' ' 65' ' ' LEU . 84.2 mm-40 -80.39 17.45 1.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.49 -0.777 . . . . 2.62 111.927 -172.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.438 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 8.8 m 76.32 -29.15 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.392 0.677 . . . . 2.43 112.671 168.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.514 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 15.0 t30 77.8 84.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.851 0.834 . . . . 1.56 111.08 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.472 ' N ' HH12 ' A' ' 16' ' ' ARG . 25.9 m -93.79 137.43 23.17 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.542 -1.208 . . . . 1.68 109.535 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' CG2' ' A' ' 107' ' ' THR . 72.2 Cg_exo -19.58 92.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 1 C-N-CA 126.198 4.598 . . . . 1.26 115.461 -174.228 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.832 ' HG2' HG11 ' A' ' 142' ' ' VAL . 10.2 Cg_endo -96.96 -155.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.355 3.37 . . . . 0.76 114.31 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -172.94 -105.25 0.18 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 114.118 -1.401 . . . . 0.76 109.603 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -102.74 130.11 49.59 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.57 -0.53 . . . . 2.04 109.57 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.778 ' HE2' ' HB3' ' A' ' 109' ' ' PRO . 6.7 m-85 -118.58 120.66 38.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.036 0.446 . . . . 0.75 110.587 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.2 m -97.48 135.36 39.45 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 0.83 110.768 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.959 HD22 HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -153.84 94.06 1.72 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.463 0.649 . . . . 0.51 109.783 175.08 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.709 ' HB ' ' CB ' ' A' ' 45' ' ' ASP . 14.8 m -84.45 140.65 31.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.741 -0.663 . . . . 0.59 109.95 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.5 mt -118.42 119.93 36.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.409 -0.359 . . . . 1.27 110.496 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 43.5 m -98.47 121.34 40.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.014 0.435 . . . . 0.7 110.236 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.12 -159.4 19.05 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.842 -0.694 . . . . 0.8 112.673 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.702 ' HA2' ' HB2' ' A' ' 132' ' ' SER . . . 109.64 165.88 20.0 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.518 -0.633 . . . . 0.53 111.518 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -89.34 177.26 6.64 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.142 -0.623 . . . . 0.89 111.017 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.659 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 4.6 t-105 -129.25 151.95 49.35 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.804 -1.089 . . . . 0.56 109.902 -174.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.45 149.85 52.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.105 -0.498 . . . . 1.42 110.175 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt 64.25 -146.52 0.28 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.21 0.604 . . . . 3.47 111.053 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 126' ' ' LYS . 4.2 p30 -151.02 136.14 17.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.516 0.198 . . . . 2.08 110.945 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.594 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.7 OUTLIER 51.97 -7.9 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.306 1.842 . . . . 2.47 115.883 176.569 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -80.5 -2.52 46.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.362 0.601 . . . . 1.96 109.999 176.584 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.659 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 42.7 tt0 68.47 54.43 0.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.432 -1.258 . . . . 2.02 110.839 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.416 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -89.47 110.68 3.75 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 109.823 -1.311 . . . . 0.77 109.823 170.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 26.7 p90 -151.0 171.26 17.58 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.297 -0.631 . . . . 1.21 109.297 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.583 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 5.9 t -150.19 146.03 19.54 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 110.009 -0.367 . . . . 1.47 110.009 173.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.12 106.76 1.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.7 2.267 . . . . 0.92 111.47 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.702 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 10.6 m -131.95 122.07 24.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.913 -0.585 . . . . 1.52 109.78 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.75 -110.57 3.78 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.714 -0.755 . . . . 1.17 111.483 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.6 p -144.01 176.2 9.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.052 0.453 . . . . 2.47 110.957 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.1 t -126.86 129.71 48.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.31 -0.626 . . . . 1.82 109.31 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.49 138.18 14.65 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.647 -0.787 . . . . 0.67 112.155 -175.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 19.2 m -99.06 103.73 15.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.992 -0.373 . . . . 0.58 109.992 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 10' ' ' LEU . 21.6 m -81.81 113.18 19.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.355 -0.609 . . . . 0.52 109.355 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -100.22 109.08 21.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.471 0.653 . . . . 2.18 109.506 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.496 HD23 ' HG ' ' A' ' 56' ' ' LEU . 13.7 tp -92.58 95.85 9.85 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.711 -1.132 . . . . 0.63 109.415 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 24.7 m -93.64 126.8 39.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.76 -0.654 . . . . 0.58 109.576 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' ' 15' ' ' THR . 30.7 t -107.23 106.18 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.675 -0.41 . . . . 1.74 111.242 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.289 -0.863 . . . . 2.58 109.498 173.737 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.959 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 4.8 t . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 108.656 -0.868 . . . . 1.43 108.656 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -97.67 141.42 30.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.25 -0.432 . . . . 2.29 110.928 -175.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.548 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 74.9 t -117.37 117.2 54.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.749 -0.659 . . . . 1.51 110.397 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -88.86 106.22 18.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.112 -0.495 . . . . 3.57 110.79 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 5' ' ' VAL . 66.9 t -113.76 115.02 48.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.115 -0.493 . . . . 1.26 109.937 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.77 -178.53 25.72 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.63 -0.795 . . . . 0.96 112.029 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.27 146.47 24.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.959 -0.385 . . . . 2.18 109.959 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -140.92 142.11 34.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.12 -0.491 . . . . 1.41 109.718 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -116.65 117.59 30.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.405 -0.362 . . . . 1.03 110.697 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.35 140.37 47.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.938 0.399 . . . . 1.45 110.534 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.45 ' HB1' ' OG1' ' A' ' 143' ' ' THR . . . -116.67 112.5 21.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 0.59 110.222 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.561 ' HG3' ' H ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -163.81 179.7 6.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.049 0.452 . . . . 3.42 110.417 -178.617 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.561 ' H ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -103.42 158.73 16.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.63 110.328 178.199 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.634 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -80.46 -9.2 59.76 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.961 -0.462 . . . . 3.14 111.023 -175.81 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.57 -15.36 79.25 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.081 -0.807 . . . . 0.75 111.081 172.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.516 ' HA ' HE21 ' A' ' 18' ' ' GLN . 0.0 OUTLIER -66.07 -31.79 72.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.124 -0.538 . . . . 2.17 110.856 176.84 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.87 ' HB2' HG12 ' A' ' 100' ' ' VAL . 12.2 mt -91.25 19.8 5.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.889 -0.596 . . . . 1.61 112.183 -168.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -36.25 93.59 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 N-CA-C 114.007 1.114 . . . . 1.65 114.007 -172.709 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 69.9 -53.34 0.62 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.858 -1.064 . . . . 1.83 111.923 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.826 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -158.13 78.41 0.82 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.189 0.518 . . . . 0.82 111.26 176.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 19' ' ' LEU . . . -138.93 117.87 9.25 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.488 -0.778 . . . . 0.79 109.096 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.401 ' HD3' ' HE1' ' A' ' 99' ' ' TYR . 96.0 Cg_endo -79.74 132.48 9.79 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.88 2.387 . . . . 1.12 114.417 -170.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.733 HG23 HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -77.49 -56.61 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.425 -0.807 . . . . 2.58 110.162 169.104 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.444 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -138.91 98.24 0.25 Allowed Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.388 -0.824 . . . . 0.74 111.67 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.577 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 31.3 Cg_endo -67.66 126.58 14.95 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.271 1.98 . . . . 0.67 111.378 176.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.75 124.44 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 1.18 109.653 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 t -77.7 74.98 4.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.472 0.654 . . . . 1.64 110.508 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.486 HG13 ' CG1' ' A' ' 5' ' ' VAL . 70.0 t -72.42 113.2 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.728 -0.669 . . . . 1.01 109.949 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.409 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 14.0 pt20 -116.12 125.82 52.87 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.778 -0.646 . . . . 2.48 109.833 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.524 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -111.61 130.61 55.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.408 -0.815 . . . . 0.7 110.351 -177.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 35.2 tp -111.44 116.45 30.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.137 -0.483 . . . . 1.94 111.324 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.09 71.63 0.84 Allowed Glycine 0 C--N 1.331 0.304 0 O-C-N 123.573 0.545 . . . . 1.81 113.423 173.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.959 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 9.9 m -106.71 -68.83 0.86 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.883 -0.327 . . . . 1.88 111.465 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 68.41 -48.22 0.55 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.466 0.706 . . . . 2.14 112.32 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.81 69.89 1.26 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.206 0.527 . . . . 0.94 110.348 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.645 HH11 ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -149.95 131.8 15.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.994 -0.548 . . . . 4.64 110.586 -177.342 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.707 ' HG3' HG12 ' A' ' 89' ' ' VAL . 98.6 mt-30 -85.48 124.19 31.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.109 0.48 . . . . 1.75 110.078 178.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.645 ' HA ' HH11 ' A' ' 38' ' ' ARG . 71.0 t -95.14 110.55 24.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.088 -0.506 . . . . 0.54 109.946 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -117.72 144.44 45.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 123.624 0.578 . . . . 0.36 111.039 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.852 HD11 HD12 ' A' ' 96' ' ' ILE . 64.5 mt -103.7 129.07 51.0 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.488 -0.56 . . . . 0.84 109.488 172.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.718 ' HG3' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -120.28 152.12 38.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.858 -0.793 . . . . 1.93 108.858 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.496 ' HB1' ' OD1' ' A' ' 48' ' ' ASN . . . -92.67 159.2 15.56 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.719 -0.392 . . . . 0.41 110.036 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.588 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 14.8 t70 -87.61 170.01 11.66 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.563 -0.903 . . . . 0.71 108.563 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -65.54 -1.98 3.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.975 0.361 . . . . 1.4 111.975 -173.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -88.94 -26.34 21.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.72 -0.218 . . . . 2.22 111.262 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.496 ' OD1' ' HB1' ' A' ' 44' ' ' ALA . 28.9 p-10 -131.73 12.16 4.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.732 0.301 . . . . 1.35 111.699 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 55.2 t80 -114.44 101.37 9.07 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.537 -0.542 . . . . 0.56 109.537 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.779 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 8.3 pt-20 -95.35 93.71 7.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.877 0.37 . . . . 2.41 110.387 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 68.39 -50.95 0.56 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.428 -0.805 . . . . 3.43 112.036 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -172.04 36.58 0.15 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.183 -0.767 . . . . 0.56 111.183 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.629 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 10.3 mmmm -137.84 134.87 35.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.946 -0.761 . . . . 2.12 108.946 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -117.9 148.69 41.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.493 0.663 . . . . 0.56 112.307 177.445 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.779 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 7.6 p90 -156.58 176.94 12.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.019 -0.991 . . . . 0.59 111.1 -174.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 20.1 mt -89.24 111.05 21.76 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.351 -0.981 . . . . 1.53 108.351 168.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.534 ' HB ' ' HE1' ' A' ' 55' ' ' PHE . 8.3 tp -107.33 138.69 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.703 -0.48 . . . . 0.62 109.703 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 3.1 t -102.41 152.73 20.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.529 -0.305 . . . . 1.44 110.372 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -49.11 -42.48 39.27 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.053 0.846 . . . . 2.31 113.023 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.31 -21.8 66.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.711 0.263 . . . . 3.09 111.711 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 63.34 84.43 0.15 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.365 0.602 . . . . 2.62 109.95 -176.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -154.79 -40.7 0.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.615 . . . . 4.66 111.034 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.87 153.52 50.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.915 -0.584 . . . . 2.51 110.322 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.6 pptp? -152.25 128.04 10.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.804 -0.635 . . . . 2.07 109.739 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.472 HD22 ' HG2' ' A' ' 104' ' ' GLN . 4.5 mt -114.27 119.12 35.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.261 -0.427 . . . . 1.98 110.026 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.453 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 93.4 m-85 -67.85 128.73 37.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 0.75 110.156 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 100' ' ' VAL . 11.2 m -121.27 123.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.878 -0.601 . . . . 0.73 111.428 -175.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -97.21 111.67 23.81 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.961 -0.563 . . . . 1.81 109.53 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.537 HG22 ' HB ' ' A' ' 96' ' ' ILE . 2.6 mt -76.32 86.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.562 -0.745 . . . . 0.81 110.454 -176.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -93.62 142.84 25.68 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.995 -0.548 . . . . 3.79 109.866 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.541 ' HA ' HG23 ' A' ' 96' ' ' ILE . 77.1 Cg_exo -51.12 134.08 42.64 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.693 2.262 . . . . 0.59 112.52 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tpt -75.14 72.75 2.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.984 -0.553 . . . . 1.71 109.948 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.4 t70 52.58 75.59 0.23 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.363 -0.835 . . . . 1.92 110.785 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -146.56 -59.94 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.866 -0.606 . . . . 1.89 111.248 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 m -151.02 178.83 8.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 1.7 111.055 -175.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.26 121.75 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.751 -0.658 . . . . 0.94 109.891 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.521 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 17.8 m0 -113.07 168.21 9.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.256 -0.429 . . . . 0.5 111.001 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -87.97 131.37 34.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.018 -0.734 . . . . 0.51 109.018 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 t -107.93 113.59 26.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.605 0.717 . . . . 0.59 112.353 -171.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -127.24 161.33 28.82 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.782 -1.192 . . . . 1.7 107.782 170.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.515 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 15.8 m120 -85.91 -5.52 59.22 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.295 -0.562 . . . . 1.39 110.812 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.82 -38.37 3.66 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.19 -1.005 . . . . 0.65 111.81 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.718 HG12 ' HG3' ' A' ' 43' ' ' LYS . 27.0 m -140.49 156.72 23.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.971 0.415 . . . . 1.16 110.403 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.684 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -132.15 108.87 9.56 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.659 -0.867 . . . . 0.36 108.659 177.194 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.627 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 12.7 p90 -145.75 149.24 34.03 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.22 0.325 . . . . 0.59 110.675 -174.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.524 ' HZ1' ' HB2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -80.55 141.36 35.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.948 -0.701 . . . . 1.39 109.205 174.306 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -57.97 -33.81 69.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.843 -0.617 . . . . 2.12 110.412 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -61.99 122.14 14.74 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.741 -0.663 . . . . 2.1 111.587 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 39' ' ' GLN . 13.1 m -80.94 105.59 11.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.141 0.496 . . . . 1.05 109.95 173.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.42 ' N ' ' H ' ' A' ' 38' ' ' ARG . . . 170.75 -162.77 35.83 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.134 -1.032 . . . . 0.46 112.603 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -84.0 163.81 19.71 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.013 0.435 . . . . 1.17 110.447 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.524 ' HB2' ' HZ1' ' A' ' 86' ' ' LYS . 41.3 t90 -148.86 -62.41 0.24 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.344 -0.613 . . . . 0.51 109.344 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 38.54 91.72 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 O-C-N 124.341 1.026 . . . . 1.25 115.161 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.16 -127.45 0.91 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.701 -0.761 . . . . 0.72 112.377 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 p -135.85 133.02 37.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.054 0.454 . . . . 0.6 111.805 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.852 HD12 HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -130.87 134.26 62.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 1.63 109.692 176.742 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -106.61 156.26 16.22 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.34 -0.933 . . . . 0.45 113.005 -170.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 mp -97.56 117.75 42.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.9 0.381 . . . . 0.83 110.089 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.826 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 1.1 m-85 -126.19 133.56 51.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.631 -0.713 . . . . 1.28 109.509 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.87 HG12 ' HB2' ' A' ' 19' ' ' LEU . 12.3 p -66.21 119.77 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.855 -0.794 . . . . 1.14 108.855 173.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.92 83.54 1.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.579 0.704 . . . . 1.02 109.477 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.99 93.83 2.3 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 114.799 -1.091 . . . . 1.53 110.961 -171.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 16.5 pt20 -31.48 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.276 0.843 . . . . 2.11 113.276 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.472 ' HG2' HD22 ' A' ' 65' ' ' LEU . 55.9 tp60 -82.59 -15.37 52.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 2.62 110.692 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 m 62.6 26.31 15.61 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.361 0.6 . . . . 2.43 111.134 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.634 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 7.2 t30 64.08 89.41 0.09 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.589 -0.732 . . . . 1.56 112.204 172.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.3 m -89.6 133.87 33.55 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.819 -0.808 . . . . 1.68 108.819 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -19.46 90.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.794 4.329 . . . . 1.26 115.1 -171.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.616 ' CB ' ' HE1' ' A' ' 112' ' ' TYR . 90.0 Cg_endo -99.99 -161.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.968 3.112 . . . . 0.76 113.889 -174.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.55 -101.98 0.15 Allowed Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.926 -1.034 . . . . 0.76 110.633 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -112.38 111.41 22.25 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.339 -0.615 . . . . 2.04 109.339 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.616 ' HE1' ' CB ' ' A' ' 109' ' ' PRO . 27.6 m-85 -95.35 128.09 41.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.233 0.54 . . . . 0.75 110.303 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.7 m -116.06 98.46 6.64 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.071 -0.968 . . . . 0.83 110.395 -175.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.474 ' HG ' ' HB ' ' A' ' 138' ' ' THR . 0.2 OUTLIER -119.34 100.55 7.38 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.042 -0.527 . . . . 0.51 110.367 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.711 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 23.8 m -88.37 132.52 34.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.148 -0.478 . . . . 0.59 110.527 -178.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -114.63 124.84 52.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.083 0.468 . . . . 1.27 110.556 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.473 ' HA ' HG23 ' A' ' 135' ' ' THR . 27.5 m -91.06 113.04 25.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.752 -0.658 . . . . 0.7 110.478 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.1 122.65 6.25 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.737 -0.744 . . . . 0.8 111.754 177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.57 -176.33 39.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.241 -0.98 . . . . 0.53 112.426 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 38' ' ' ARG . 39.3 p90 -102.96 177.84 4.73 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.278 0.561 . . . . 0.89 110.294 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.805 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.9 OUTLIER -147.29 149.32 32.62 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.323 -0.992 . . . . 0.56 108.323 -177.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.61 144.14 51.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.421 0.153 . . . . 1.42 110.79 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.438 ' HG3' ' HE2' ' A' ' 126' ' ' LYS . 32.9 mmtp 74.97 -144.34 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.62 0.768 . . . . 3.47 111.368 175.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -150.68 123.21 8.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.322 0.582 . . . . 2.08 112.275 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.544 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 27.6 t-20 68.44 -28.58 0.15 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.445 1.098 . . . . 2.47 113.947 174.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.438 ' HE2' ' HG3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -65.34 -3.19 3.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.219 0.533 . . . . 1.96 111.164 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.805 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 46.1 tt0 66.79 66.45 0.44 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.12 -0.946 . . . . 2.02 110.862 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 121' ' ' TRP . . . -90.89 46.96 2.93 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.329 -0.938 . . . . 0.77 111.37 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.619 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 3.9 p90 -86.69 144.66 27.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.773 0.321 . . . . 1.21 110.856 -170.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 46.3 m -150.3 132.26 7.83 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 110.37 -0.233 . . . . 1.47 110.37 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.71 132.74 47.14 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.708 2.272 . . . . 0.92 112.345 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -156.28 95.17 1.57 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.234 -0.439 . . . . 1.52 110.4 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 5' ' ' VAL . . . 130.25 -102.71 0.54 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.776 -0.726 . . . . 1.17 112.162 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.4 m -152.3 147.45 26.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.711 0.256 . . . . 2.47 110.741 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.473 HG23 ' HA ' ' A' ' 117' ' ' THR . 28.9 m -101.2 127.49 47.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.649 -0.5 . . . . 1.82 109.649 174.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.96 141.11 12.41 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.467 -0.873 . . . . 0.67 112.524 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.711 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 72.8 m -94.3 123.15 37.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.025 0.44 . . . . 0.58 110.913 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.474 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 24.9 m -85.88 115.26 23.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.514 -0.921 . . . . 0.52 108.514 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -100.88 111.91 24.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.21 0.528 . . . . 2.18 110.208 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 tp -108.64 100.45 9.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.048 -0.978 . . . . 0.63 110.385 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 m -93.15 143.67 26.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.852 -0.613 . . . . 0.58 109.809 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.631 ' HA ' HH12 ' A' ' 16' ' ' ARG . 7.3 p -71.02 132.79 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.467 0.651 . . . . 1.74 112.349 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.45 ' OG1' ' HB1' ' A' ' 13' ' ' ALA . 85.5 m . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.133 -0.94 . . . . 2.58 109.129 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.852 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 48.2 t . . . . . 0 N--CA 1.44 -0.938 0 N-CA-C 108.3 -1.0 . . . . 1.43 108.3 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -85.68 123.71 31.38 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.285 -0.566 . . . . 2.29 110.393 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.536 HG12 HG23 ' A' ' 7' ' ' VAL . 61.3 t -95.56 112.06 27.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.718 -0.673 . . . . 1.51 110.045 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.721 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 14.5 mmm180 -81.64 93.74 6.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.706 -0.679 . . . . 3.57 110.834 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.58 HG12 ' HA3' ' A' ' 136' ' ' GLY . 37.2 t -107.62 115.62 49.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.394 -0.965 . . . . 1.26 108.394 171.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.76 -175.77 21.65 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.498 -0.858 . . . . 0.96 112.261 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -100.59 146.15 27.49 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.926 -0.398 . . . . 2.18 109.926 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -152.6 139.26 18.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.552 -0.536 . . . . 1.41 109.552 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.9 m -107.77 115.89 30.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.183 -0.462 . . . . 1.03 110.305 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 140' ' ' LEU . 4.1 p -110.61 126.01 67.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.14 -0.482 . . . . 1.45 109.9 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -105.31 104.21 13.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.898 -0.592 . . . . 0.59 110.452 -176.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -172.9 -178.68 1.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 3.42 110.478 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.5 p -107.43 162.77 13.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.127 -0.488 . . . . 0.63 111.065 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.654 ' HB2' HH11 ' A' ' 16' ' ' ARG . 0.0 OUTLIER -80.27 -0.44 36.48 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.644 -0.502 . . . . 3.14 109.644 176.61 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.603 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -79.39 -17.58 75.76 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.367 -0.693 . . . . 0.75 111.367 177.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -74.17 -22.62 59.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.847 -0.797 . . . . 2.17 108.847 173.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.924 HD21 HG12 ' A' ' 25' ' ' ILE . 67.2 mt -87.16 95.9 10.12 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.699 -1.137 . . . . 1.61 110.985 -175.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.0 m -101.3 68.05 1.2 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.045 -0.724 . . . . 1.65 109.045 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.4 t70 69.56 -62.68 0.41 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.753 -1.112 . . . . 1.83 111.036 -175.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -114.31 98.09 6.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.797 0.332 . . . . 0.82 110.887 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -154.54 92.08 2.98 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.439 . . . . 0.79 111.071 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 28.7 Cg_endo -64.19 80.82 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.349 2.699 . . . . 1.12 112.372 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.924 HG12 HD21 ' A' ' 19' ' ' LEU . 1.1 pp -70.7 -53.71 21.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.405 -0.816 . . . . 2.58 112.336 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.24 63.88 0.57 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.203 -0.998 . . . . 0.74 113.249 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.634 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 5.5 Cg_endo -47.07 111.59 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.601 2.867 . . . . 0.67 113.004 172.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 p -84.63 134.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.896 -0.593 . . . . 1.18 109.813 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -88.64 102.87 15.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.672 0.748 . . . . 1.64 110.804 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.663 ' CG2' HD11 ' A' ' 96' ' ' ILE . 41.5 t -94.79 116.26 35.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.556 -0.747 . . . . 1.01 110.204 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.721 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 34.7 tt0 -102.01 125.14 48.62 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.641 -0.709 . . . . 2.48 110.182 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.667 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -112.89 113.98 26.29 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.956 -0.387 . . . . 0.7 109.956 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.1 mt -104.99 111.52 24.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.969 0.414 . . . . 1.94 111.986 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.95 55.32 8.18 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.508 -0.769 . . . . 1.81 113.283 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.852 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 84.1 m -87.14 -49.31 7.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.857 0.329 . . . . 1.88 110.585 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.8 t30 71.14 -63.78 0.41 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.708 0.803 . . . . 2.14 112.69 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.91 71.0 1.25 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.676 0.75 . . . . 0.94 109.19 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.619 ' NE ' ' HB3' ' A' ' 120' ' ' TYR . 41.0 ttt-85 -146.54 133.19 19.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.178 -0.919 . . . . 4.64 111.012 -169.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -83.17 96.86 8.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.615 -0.513 . . . . 1.75 109.615 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 46.7 t -73.6 117.22 17.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 0.54 110.315 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -119.48 148.31 43.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.129 -0.487 . . . . 0.36 110.977 -176.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 mt -102.77 113.79 27.5 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.115 -0.698 . . . . 0.84 109.115 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.541 ' HG3' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -104.75 125.8 51.19 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.632 -0.507 . . . . 1.93 109.632 -178.185 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.587 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -76.81 143.26 39.9 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.517 -0.549 . . . . 0.41 109.517 174.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.63 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 27.2 t70 -76.02 148.34 38.11 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.918 -0.771 . . . . 0.71 108.918 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.723 ' HA ' ' HB3' ' A' ' 49' ' ' PHE . 10.1 t -56.56 -16.51 6.18 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.866 0.691 . . . . 1.4 112.866 -172.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.28 -31.45 72.04 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.239 0.543 . . . . 2.22 110.289 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.587 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 5.1 p-10 -129.43 24.31 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.773 -0.648 . . . . 1.35 109.479 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.723 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 10.1 t80 -134.03 108.5 8.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.257 -0.883 . . . . 0.56 109.16 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.787 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 10.9 pt-20 -116.65 116.61 27.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.649 0.261 . . . . 2.41 110.448 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 71.34 -51.45 0.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.793 0.837 . . . . 3.43 111.805 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.468 ' O ' ' HD2' ' A' ' 53' ' ' LYS . . . 170.02 31.17 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.719 -0.952 . . . . 0.56 110.719 -177.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.702 ' HA ' ' HB3' ' A' ' 81' ' ' ASN . 14.5 mptt -129.88 140.23 51.02 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.178 -0.675 . . . . 2.12 109.178 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -120.69 147.68 44.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.585 0.707 . . . . 0.56 111.636 176.81 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.787 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 16.9 p90 -157.46 174.93 14.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.886 -1.052 . . . . 0.59 110.752 -170.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.557 HD13 HD23 ' A' ' 140' ' ' LEU . 8.6 mt -84.16 111.84 19.71 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.146 -1.057 . . . . 1.53 108.146 170.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.591 ' HB ' ' HE1' ' A' ' 55' ' ' PHE . 8.4 tp -105.3 125.83 60.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.805 0.812 . . . . 0.62 110.021 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.575 ' HB2' ' CE1' ' A' ' 112' ' ' TYR . 33.5 t -76.84 135.74 38.89 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.073 -0.967 . . . . 1.44 110.714 -177.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.52 -34.17 72.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.868 -0.79 . . . . 2.31 108.868 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -69.28 -24.67 63.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.566 -1.197 . . . . 3.09 110.611 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 t30 63.83 97.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.701 -0.681 . . . . 2.62 111.27 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -166.27 -44.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.716 -0.674 . . . . 4.66 110.584 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.39 139.78 53.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.902 -0.59 . . . . 2.51 109.955 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.59 ' HB2' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -135.35 106.51 6.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.989 0.899 . . . . 2.07 109.429 170.292 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.789 HD21 HG23 ' A' ' 100' ' ' VAL . 7.9 tp -108.19 126.32 52.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.24 -0.891 . . . . 1.98 110.927 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 5.2 m-85 -72.95 141.4 47.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.956 -1.02 . . . . 0.75 110.306 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.572 HG12 ' HA ' ' A' ' 100' ' ' VAL . 16.4 m -136.65 142.61 37.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.549 -0.296 . . . . 0.73 110.468 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -102.89 120.54 40.8 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.788 -0.449 . . . . 1.81 109.788 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.485 HG22 ' HB ' ' A' ' 96' ' ' ILE . 0.9 OUTLIER -82.61 87.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.816 -0.629 . . . . 0.81 109.876 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.498 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 60.0 ttt180 -93.99 128.63 40.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.414 -0.357 . . . . 3.79 110.812 -174.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.71 ' HA ' HG22 ' A' ' 96' ' ' ILE . 4.2 Cg_endo -50.36 139.77 36.01 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.319 2.679 . . . . 0.59 112.216 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.6 ttt -72.66 64.11 0.63 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.661 -0.7 . . . . 1.71 111.304 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 t70 62.89 14.96 7.89 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.715 0.806 . . . . 1.92 112.302 175.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.403 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 58.7 m-80 -78.13 -35.0 49.61 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.829 -0.544 . . . . 1.89 111.559 -175.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.2 p -170.78 172.74 5.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.378 -0.23 . . . . 1.7 110.378 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.72 129.06 35.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.981 0.42 . . . . 0.94 110.101 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.715 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 13.8 m0 -117.28 155.84 28.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.07 -0.513 . . . . 0.5 110.535 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.8 m -89.6 113.22 24.62 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.265 -0.643 . . . . 0.51 109.265 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 t -88.58 124.25 33.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.796 0.807 . . . . 0.59 111.91 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -130.56 160.98 32.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.44 -1.318 . . . . 1.7 107.44 168.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.702 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 16.1 m120 -85.94 -3.55 58.95 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.368 -0.533 . . . . 1.39 111.262 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.92 -36.92 2.65 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.303 -0.951 . . . . 0.65 111.664 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.541 HG12 ' HG3' ' A' ' 43' ' ' LYS . 29.3 m -137.01 156.67 34.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.997 0.427 . . . . 1.16 110.306 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.615 ' HD1' ' HE3' ' A' ' 77' ' ' TRP . 0.7 OUTLIER -136.64 106.74 6.33 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.95 -1.13 . . . . 0.36 107.95 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 8.7 p90 -138.19 146.5 42.76 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.913 -0.315 . . . . 0.59 111.377 -174.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.733 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 49.3 pttt -78.22 157.57 29.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 1.39 110.826 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -85.21 7.47 21.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.795 . . . . 2.12 110.041 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.733 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 35.8 m-20 -106.48 128.04 53.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.538 -0.755 . . . . 2.1 109.331 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -90.04 106.36 17.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.555 0.693 . . . . 1.05 111.002 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.28 -162.71 36.5 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.051 -0.819 . . . . 0.46 111.051 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.4 m -84.14 147.25 27.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.976 0.417 . . . . 1.17 109.941 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.487 ' CD2' ' HZ2' ' A' ' 77' ' ' TRP . 55.3 t90 -120.07 -59.05 1.83 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.65 -0.5 . . . . 0.51 109.65 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 34.53 90.42 0.01 OUTLIER Glycine 0 N--CA 1.464 0.548 0 O-C-N 124.637 1.21 . . . . 1.25 115.477 176.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.16 -125.09 0.75 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.004 -0.617 . . . . 0.72 111.955 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.457 ' O ' ' HH2' ' A' ' 92' ' ' TRP . 1.2 p -137.18 132.42 33.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 0.6 111.571 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.71 HG22 ' HA ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -118.46 134.8 60.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.169 -0.678 . . . . 1.63 109.169 174.318 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.634 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -99.58 158.52 19.81 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.331 -0.937 . . . . 0.45 112.555 -175.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.513 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.8 mp -95.03 112.81 28.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.649 -0.5 . . . . 0.83 109.649 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 70' ' ' ARG . 1.6 m-85 -110.95 120.91 43.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.817 -0.808 . . . . 1.28 108.817 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.789 HG23 HD21 ' A' ' 65' ' ' LEU . 14.5 p -58.68 137.34 21.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.816 0.341 . . . . 1.14 110.993 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.65 81.94 8.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.715 -0.846 . . . . 1.02 108.715 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.65 110.34 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.525 -0.762 . . . . 1.53 111.815 -172.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -40.09 125.11 1.95 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.493 0.663 . . . . 2.11 112.582 177.428 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.563 ' HB2' HD13 ' A' ' 65' ' ' LEU . 45.9 tp60 -92.69 21.27 5.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.559 . . . . 2.62 110.461 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 6.1 m 69.25 -11.58 0.47 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.696 -0.684 . . . . 2.43 112.714 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.603 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 19.3 t30 68.18 88.21 0.11 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.73 0.776 . . . . 1.56 110.629 -175.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.63 146.8 34.93 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 114.689 -1.141 . . . . 1.68 109.007 173.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -38.26 93.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.999 3.132 . . . . 1.26 112.509 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.605 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 3.0 Cg_exo -76.84 -179.56 5.51 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.198 2.598 . . . . 0.76 113.333 -169.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.06 -124.42 0.89 Allowed Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.151 -1.18 . . . . 0.76 110.151 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 58' ' ' SER . 51.6 t-20 -97.5 107.4 19.9 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.129 -0.693 . . . . 2.04 109.129 172.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 58' ' ' SER . 68.4 m-85 -102.16 107.34 18.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.468 0.651 . . . . 0.75 109.524 174.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -97.85 126.79 43.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.017 -0.992 . . . . 0.83 110.534 -175.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 138' ' ' THR . 0.1 OUTLIER -135.01 107.14 7.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.548 0.689 . . . . 0.51 109.927 176.095 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 11.9 m -94.02 139.76 30.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.456 -0.793 . . . . 0.59 110.299 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 44' ' ' ALA . 95.4 mt -124.96 126.14 45.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.909 0.385 . . . . 1.27 110.569 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 m -101.18 117.0 34.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.216 -0.447 . . . . 0.7 110.219 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.27 147.71 47.79 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.748 -0.739 . . . . 0.8 112.576 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.04 179.73 39.71 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.783 -0.722 . . . . 0.53 112.214 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.619 ' HB3' ' NE ' ' A' ' 38' ' ' ARG . 48.6 p90 -102.63 174.16 6.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.051 0.453 . . . . 0.89 110.325 177.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.724 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.8 OUTLIER -132.69 146.53 51.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.413 -0.812 . . . . 0.56 109.101 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -118.85 141.28 48.78 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.069 0.461 . . . . 1.42 111.208 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.537 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 7.0 tptm 71.97 -145.07 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.676 -1.147 . . . . 3.47 111.265 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 126' ' ' LYS . 4.9 t70 -146.98 124.42 11.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.615 -0.266 . . . . 2.08 111.496 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.589 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.5 OUTLIER 53.64 -5.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.132 1.773 . . . . 2.47 115.542 176.312 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.608 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -79.03 -3.38 44.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 1.96 110.216 177.466 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.724 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 33.6 tt0 69.08 71.61 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.792 -1.095 . . . . 2.02 110.644 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.608 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -106.97 43.01 1.78 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.698 -0.763 . . . . 0.77 112.134 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -78.19 130.08 35.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.15 0.5 . . . . 1.21 110.857 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 17.6 m -121.56 118.91 29.49 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.215 -0.448 . . . . 1.47 110.559 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 130' ' ' THR . 25.0 Cg_exo -63.93 123.37 11.83 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.964 2.443 . . . . 0.92 112.27 177.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.01 94.15 1.5 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.967 -0.56 . . . . 1.52 110.193 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 145.58 -145.95 15.64 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.284 -0.726 . . . . 1.17 111.284 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.532 HG21 ' NH1' ' A' ' 6' ' ' ARG . 38.3 p -110.12 158.08 18.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.989 0.423 . . . . 2.47 111.398 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.0 m -99.93 100.32 11.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.824 -0.626 . . . . 1.82 109.786 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.58 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -93.79 160.76 24.44 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.847 -0.692 . . . . 0.67 111.775 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.1 m -126.82 109.51 12.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.026 0.413 . . . . 0.58 111.311 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.602 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 3.7 m -82.23 116.43 21.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.634 -0.876 . . . . 0.52 108.634 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -112.1 108.83 18.24 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.27 0.557 . . . . 2.18 110.544 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.557 HD23 HD13 ' A' ' 56' ' ' LEU . 15.2 tp -96.56 109.16 21.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.031 -0.986 . . . . 0.63 109.072 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.0 m -121.52 144.47 48.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.529 -0.759 . . . . 0.58 110.947 -173.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.605 ' HB ' ' HB2' ' A' ' 109' ' ' PRO . 13.0 p -83.16 141.73 14.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.433 -0.581 . . . . 1.74 109.433 172.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.243 0.749 0 CA-C-O 118.426 -0.797 . . . . 2.58 109.723 178.923 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 120' ' ' TYR . 43.5 t . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.656 -0.498 . . . . 1.43 109.656 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.414 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 63.6 tt0 -103.61 111.84 24.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.192 -0.458 . . . . 2.29 110.766 -177.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.703 HG21 HG13 ' A' ' 40' ' ' VAL . 38.5 t -107.49 125.32 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.118 -0.492 . . . . 1.51 110.701 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.594 ' HG2' ' HB3' ' A' ' 31' ' ' GLN . 11.1 ptp180 -92.18 142.54 27.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.036 0.446 . . . . 3.57 110.684 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.7 t -120.53 115.43 47.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.781 -0.822 . . . . 1.26 108.781 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.38 126.6 11.5 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.554 -0.831 . . . . 0.96 112.38 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -68.34 104.04 1.77 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.574 -0.528 . . . . 2.18 109.574 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' A' ' 28' ' ' VAL . 72.8 mt -105.37 152.43 22.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.95 -0.568 . . . . 1.41 110.739 -176.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 m -133.09 114.42 13.89 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.035 -0.728 . . . . 1.03 109.035 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.422 HG11 HG22 ' A' ' 25' ' ' ILE . 41.3 t -118.16 140.32 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.386 -0.37 . . . . 1.45 110.313 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.99 103.21 11.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.284 -0.416 . . . . 0.59 110.028 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -165.02 176.04 8.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.433 -0.58 . . . . 3.42 109.433 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.515 HG22 HG23 ' A' ' 142' ' ' VAL . 31.9 p -96.43 163.34 13.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.613 -0.267 . . . . 0.63 110.911 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.519 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -86.98 -3.42 59.09 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.91 -0.774 . . . . 3.14 108.91 176.821 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -79.77 -28.22 51.59 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.79 -0.924 . . . . 0.75 110.79 173.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.89 -39.08 87.92 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.624 -0.88 . . . . 2.17 108.624 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 100' ' ' VAL . 62.8 mt -63.95 113.33 3.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.912 -1.04 . . . . 1.61 109.746 171.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 m -130.4 85.28 2.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.562 0.22 . . . . 1.65 110.536 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 7.9 m-20 63.48 -74.66 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.664 -0.698 . . . . 1.83 111.854 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.13 81.71 1.87 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.191 0.52 . . . . 0.82 110.671 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.18 100.27 4.2 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.544 -0.753 . . . . 0.79 109.89 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.53 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 59.5 Cg_endo -72.1 105.51 1.85 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.816 2.344 . . . . 1.12 112.847 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.422 HG22 HG11 ' A' ' 12' ' ' VAL . 49.4 mm -96.3 -26.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.181 -0.463 . . . . 2.58 110.734 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.75 54.65 0.62 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.897 -1.144 . . . . 0.74 113.689 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 12.1 Cg_endo -57.03 114.1 1.77 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.281 1.987 . . . . 0.67 112.064 170.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.468 ' HA ' HD11 ' A' ' 10' ' ' LEU . 45.9 t -87.75 135.82 24.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.881 -0.6 . . . . 1.18 110.433 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.95 102.24 4.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.603 0.716 . . . . 1.64 110.133 174.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.899 HG21 HG12 ' A' ' 96' ' ' ILE . 6.7 t -94.08 141.96 14.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.862 -1.063 . . . . 1.01 111.879 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.594 ' HB3' ' HG2' ' A' ' 6' ' ' ARG . 31.4 tt0 -146.87 117.41 7.5 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.651 -1.159 . . . . 2.48 109.079 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.437 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -110.46 105.73 14.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.287 -0.415 . . . . 0.7 110.144 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.4 tp -77.61 112.76 14.76 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.508 -0.553 . . . . 1.94 109.508 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.64 -121.97 6.2 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.704 -0.76 . . . . 1.81 111.773 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.437 ' SG ' ' HB1' ' A' ' 32' ' ' ALA . 66.7 m 65.13 11.6 7.3 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 122.598 0.359 . . . . 1.88 111.707 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.661 ' HA ' ' HA2' ' A' ' 90' ' ' GLY . 19.3 m120 -63.36 -11.44 22.51 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.631 0.604 . . . . 2.14 112.631 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.787 ' HA ' ' CG1' ' A' ' 89' ' ' VAL . . . -144.62 60.95 1.33 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.5 -0.556 . . . . 0.94 109.5 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 38' ' ' ARG . 0.8 OUTLIER -170.07 159.96 7.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.361 -0.836 . . . . 4.64 109.68 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.443 ' NE2' HG23 ' A' ' 89' ' ' VAL . 25.1 mp0 -94.22 143.38 26.43 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.116 -0.698 . . . . 1.75 109.116 173.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.703 HG13 HG21 ' A' ' 5' ' ' VAL . 71.8 t -97.99 122.05 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.424 -0.584 . . . . 0.54 109.424 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -122.48 141.33 51.75 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 123.368 0.418 . . . . 0.36 111.099 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.445 ' CD1' HG21 ' A' ' 96' ' ' ILE . 31.3 mt -102.72 126.21 49.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.194 -0.669 . . . . 0.84 109.194 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.8 ' HE2' ' HB2' ' A' ' 129' ' ' PHE . 6.3 mptt -119.2 152.12 37.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.571 -0.529 . . . . 1.93 109.571 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -96.22 153.62 17.7 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.803 -0.443 . . . . 0.41 109.803 173.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.712 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 31.2 t70 -82.44 164.79 20.74 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.719 -0.845 . . . . 0.71 108.719 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -56.17 -18.48 10.24 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.336 0.588 . . . . 1.4 110.677 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.77 -38.8 72.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.271 -0.877 . . . . 2.22 111.526 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 27.0 p-10 -139.57 22.31 2.52 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.723 0.268 . . . . 1.35 111.723 -176.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.67 ' HE1' ' HA2' ' A' ' 82' ' ' GLY . 60.0 t80 -123.48 102.39 7.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.435 -0.58 . . . . 0.56 109.435 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -103.3 105.8 16.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 2.41 110.385 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 67.19 -56.43 0.44 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.107 0.879 . . . . 3.43 112.04 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -175.58 35.08 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.006 -0.838 . . . . 0.56 111.006 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 81' ' ' ASN . 34.7 mmtp -135.07 135.57 41.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.001 -0.74 . . . . 2.12 109.001 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -110.72 142.33 42.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.611 0.719 . . . . 0.56 111.965 175.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 64' ' ' LYS . 44.1 p90 -151.32 -177.0 5.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.974 -1.012 . . . . 0.59 110.014 -176.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.887 HD22 HD22 ' A' ' 114' ' ' LEU . 13.8 mt -99.53 123.81 44.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.579 -0.897 . . . . 1.53 108.579 172.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 113' ' ' THR . 9.0 tp -106.81 124.6 62.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.472 0.653 . . . . 0.62 111.035 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.5 t -68.88 125.08 25.49 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.275 -1.009 . . . . 1.44 108.275 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -57.8 -26.2 61.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.119 0.415 . . . . 2.31 112.119 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -84.26 -1.64 55.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.61 -0.268 . . . . 3.09 111.368 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 57.99 89.21 0.05 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.167 0.587 . . . . 2.62 111.244 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -155.79 -38.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 4.66 111.055 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.74 144.71 37.6 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.415 -0.357 . . . . 2.51 110.35 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.636 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 2.4 pptp? -146.7 145.77 30.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.971 -0.559 . . . . 2.07 110.134 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.63 HD12 HG23 ' A' ' 100' ' ' VAL . 1.3 pt? -138.03 132.13 31.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.139 -0.482 . . . . 1.98 110.415 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -75.64 128.61 35.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.75 110.129 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.555 ' HB ' HG23 ' A' ' 98' ' ' ILE . 15.9 m -118.33 136.89 54.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.862 -0.608 . . . . 0.73 110.544 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.51 ' HB3' ' HE ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -96.5 110.65 22.99 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.707 -0.679 . . . . 1.81 109.356 178.296 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.429 HG23 HG12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -79.99 102.09 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.928 -0.767 . . . . 0.81 108.928 174.669 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.558 ' HG2' ' CZ ' ' A' ' 84' ' ' PHE . 89.3 mtt180 -122.99 140.47 33.5 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.244 -0.434 . . . . 3.79 110.181 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.798 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 1.7 Cg_endo -48.3 132.93 24.58 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.942 2.428 . . . . 0.59 111.927 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.4 ttt -63.22 -49.96 72.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.408 -0.36 . . . . 1.71 110.275 -177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -177.79 105.95 0.05 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.121 -0.49 . . . . 1.92 110.566 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 1.1 m-80 -161.81 -62.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 1.89 111.198 -177.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.8 t -154.69 163.68 39.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.915 -0.402 . . . . 1.7 109.915 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.9 127.58 32.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.069 0.461 . . . . 0.94 111.252 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.664 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.1 m0 -112.28 150.75 30.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.651 -0.704 . . . . 0.5 110.27 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.6 m -83.21 125.1 31.2 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.142 -0.688 . . . . 0.51 109.142 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -100.47 122.36 43.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.798 0.808 . . . . 0.59 112.54 -171.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -135.42 159.71 40.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.725 -1.213 . . . . 1.7 107.725 167.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 11.4 m120 -82.93 -4.38 58.12 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.276 -0.57 . . . . 1.39 110.833 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.67 ' HA2' ' HE1' ' A' ' 49' ' ' PHE . . . -100.48 -41.33 2.77 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.203 -0.998 . . . . 0.65 111.885 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.68 155.4 30.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.963 -0.384 . . . . 1.16 109.963 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -137.99 109.85 7.17 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.291 -1.003 . . . . 0.36 108.291 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 13.5 p90 -140.09 143.89 36.52 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.15 0.281 . . . . 0.59 111.498 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -77.91 137.5 38.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 120.328 -0.549 . . . . 1.39 109.542 177.269 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -63.68 -24.47 67.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.734 -0.667 . . . . 2.12 110.204 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 4.6 m-20 -73.92 147.14 43.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.519 -0.764 . . . . 2.1 110.671 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.787 ' CG1' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -94.84 143.0 12.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.666 -0.864 . . . . 1.05 108.666 168.502 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.661 ' HA2' ' HA ' ' A' ' 36' ' ' ASN . . . 131.77 -175.59 19.64 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.411 -0.9 . . . . 0.46 111.636 -177.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m -72.39 -178.73 2.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.976 -0.379 . . . . 1.17 109.976 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.798 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 21.1 t90 -157.38 -42.54 0.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.733 -0.212 . . . . 0.51 110.575 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.709 ' O ' ' HB ' ' A' ' 30' ' ' VAL . . . 50.84 -120.35 8.92 Favored Glycine 0 C--O 1.21 -1.366 0 N-CA-C 111.292 -0.723 . . . . 1.25 111.292 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.45 -151.68 43.68 Favored Glycine 0 C--N 1.318 -0.434 0 C-N-CA 121.142 -0.552 . . . . 0.72 114.225 163.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.534 ' HA ' HG23 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -147.84 133.51 18.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.085 -0.557 . . . . 0.6 110.427 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.899 HG12 HG21 ' A' ' 30' ' ' VAL . 6.8 mm -107.52 129.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.357 -0.609 . . . . 1.63 109.357 177.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -100.82 149.2 18.45 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.712 -0.756 . . . . 0.45 111.704 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.555 HG23 ' HB ' ' A' ' 67' ' ' VAL . 71.3 mt -99.58 114.45 37.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 120.897 0.38 . . . . 0.83 110.567 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 8.6 m-85 -115.22 131.97 56.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 1.28 108.818 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.63 HG23 HD12 ' A' ' 65' ' ' LEU . 13.8 p -71.34 134.48 29.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.799 0.333 . . . . 1.14 110.558 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -74.89 91.47 2.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.059 0.457 . . . . 1.02 110.902 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.13 13.34 62.15 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.132 -0.556 . . . . 1.53 113.918 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.585 ' HA ' HG11 ' A' ' 100' ' ' VAL . 64.9 tt0 62.22 113.71 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.709 0.766 . . . . 2.11 112.367 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.496 ' H ' HG21 ' A' ' 100' ' ' VAL . 7.5 tp60 -76.8 -27.29 55.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.479 -0.782 . . . . 2.62 109.645 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.1 m 65.42 20.52 11.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.126 -0.943 . . . . 2.43 110.195 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.541 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 7.6 t30 60.79 87.94 0.09 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.905 -1.043 . . . . 1.56 112.358 173.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.664 HG22 ' HD2' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -92.09 143.55 27.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.295 -1.002 . . . . 1.68 108.295 174.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.664 ' HD2' HG22 ' A' ' 107' ' ' THR . 94.2 Cg_exo -20.3 88.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.348 1 C-N-CA 125.617 4.212 . . . . 1.26 114.818 -175.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.477 ' HG2' HG21 ' A' ' 142' ' ' VAL . 9.9 Cg_endo -92.2 -154.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.687 2.925 . . . . 0.76 114.354 -171.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.42 -131.08 1.85 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.364 -1.895 . . . . 0.76 108.364 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -97.22 123.43 41.0 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.101 -0.703 . . . . 2.04 109.101 170.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -105.84 128.45 53.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.002 0.43 . . . . 0.75 109.916 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 57' ' ' ILE . 91.4 m -106.38 134.22 49.86 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.334 -0.848 . . . . 0.83 109.405 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.887 HD22 HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -138.91 89.55 2.37 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.487 0.66 . . . . 0.51 109.358 175.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 7.4 m -78.39 116.05 18.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.124 -0.944 . . . . 0.59 110.607 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 97.8 mt -105.11 136.41 44.66 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.04 0.448 . . . . 1.27 110.939 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.5 m -110.17 115.02 28.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.147 -0.478 . . . . 0.7 110.441 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.16 167.88 47.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.702 -0.761 . . . . 0.8 112.103 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 132' ' ' SER . . . 145.35 -175.15 25.07 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.557 -0.83 . . . . 0.53 112.096 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 52.8 p90 -97.7 -176.52 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.358 0.599 . . . . 0.89 111.403 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.616 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.5 OUTLIER -150.33 149.72 30.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.989 -1.005 . . . . 0.56 108.687 178.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.42 144.48 49.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.893 0.378 . . . . 1.42 111.578 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.639 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 22.9 mtpp 65.3 -143.71 0.22 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.067 0.947 . . . . 3.47 111.807 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 126' ' ' LYS . 6.0 p-10 -149.46 124.39 9.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.075 0.464 . . . . 2.08 112.239 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.597 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 7.7 t30 63.52 -18.0 0.06 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.698 1.199 . . . . 2.47 113.676 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.639 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -71.36 -4.07 24.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.796 0.331 . . . . 1.96 110.82 178.654 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.616 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 8.9 tt0 70.08 77.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.39 -0.823 . . . . 2.02 110.923 -177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.431 ' CA ' ' HE3' ' A' ' 126' ' ' LYS . . . -107.88 32.22 7.27 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.442 -0.885 . . . . 0.77 111.431 173.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.8 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 3.9 p90 -74.08 144.1 45.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.014 0.435 . . . . 1.21 110.661 -175.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 28.9 m -143.61 134.62 12.48 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.303 -0.408 . . . . 1.47 110.169 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.92 126.29 11.16 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.785 2.323 . . . . 0.92 111.782 175.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.432 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 17.2 m -152.84 113.46 4.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.319 -0.4 . . . . 1.52 110.122 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.414 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 125.1 -105.21 0.82 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.088 -0.577 . . . . 1.17 111.74 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.9 t -150.34 153.45 36.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.836 0.351 . . . . 2.47 110.314 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.9 m -93.55 97.06 10.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.026 -0.534 . . . . 1.82 109.775 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -83.99 132.29 10.98 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.954 -0.641 . . . . 0.67 112.285 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 m -102.72 108.77 20.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.683 0.278 . . . . 0.58 110.316 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.674 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 24.0 m -86.25 117.53 25.12 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.754 -0.832 . . . . 0.52 108.754 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -104.08 127.31 51.65 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.879 -0.6 . . . . 2.18 109.984 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.655 HD23 HD13 ' A' ' 56' ' ' LEU . 18.6 tp -125.58 102.25 7.28 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.542 -0.754 . . . . 0.63 110.829 -176.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.5 m -99.06 142.75 30.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.792 -0.64 . . . . 0.58 109.966 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 15' ' ' THR . 7.3 p -93.27 104.82 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.689 0.757 . . . . 1.74 111.323 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.06 -0.971 . . . . 2.58 109.352 176.219 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 110.262 -0.273 . . . . 5.73 110.262 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -101.05 104.69 15.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.448 -0.575 . . . . 3.08 109.448 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 56.6 m -84.11 103.93 13.74 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.617 -0.719 . . . . 1.43 111.206 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 31.8 mm-40 -85.49 110.97 19.57 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.914 -0.773 . . . . 2.29 108.914 174.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.664 HG23 HG13 ' A' ' 30' ' ' VAL . 7.6 p -109.92 127.72 66.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.495 0.664 . . . . 1.51 111.167 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -87.61 107.27 18.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.183 -0.917 . . . . 3.57 109.977 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.47 HG12 ' HA3' ' A' ' 136' ' ' GLY . 44.6 t -110.97 121.27 63.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.642 -0.503 . . . . 1.26 109.642 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.17 134.25 12.32 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.713 -0.756 . . . . 0.96 112.725 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.33 117.85 14.5 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.31 -0.626 . . . . 2.18 109.31 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.6 mt -117.25 98.54 6.49 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.873 -0.331 . . . . 1.41 111.708 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.0 t -102.04 113.25 26.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.122 -0.696 . . . . 1.03 109.122 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.646 ' HB ' ' NZ ' ' A' ' 14' ' ' LYS . 76.8 t -152.41 148.67 14.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.093 -0.706 . . . . 1.45 109.093 -174.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -89.96 121.35 31.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.412 0.523 . . . . 0.59 112.412 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.646 ' NZ ' ' HB ' ' A' ' 12' ' ' VAL . 2.7 mptt -143.38 175.99 9.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.119 0.485 . . . . 3.42 110.335 172.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.502 ' HA ' ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -111.08 150.0 30.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.503 -0.771 . . . . 0.63 109.994 171.265 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.511 HH12 ' HB ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -86.5 -4.47 59.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.328 -0.619 . . . . 3.14 109.328 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.478 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -88.24 -27.97 24.04 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.505 -1.038 . . . . 0.75 110.505 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -66.16 -34.08 77.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.734 -0.839 . . . . 2.17 108.734 171.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.464 ' HB3' HG12 ' A' ' 100' ' ' VAL . 94.4 mt -65.99 96.34 0.31 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.876 -1.056 . . . . 1.61 108.867 169.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 t -102.95 66.22 0.91 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.022 0.915 . . . . 1.65 109.728 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.664 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 28.4 t70 65.48 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.515 -1.22 . . . . 1.83 110.695 -174.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.443 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -95.11 76.05 3.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.17 0.51 . . . . 0.82 110.686 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -142.69 99.32 5.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.992 -0.549 . . . . 0.79 110.276 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.455 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 71.4 Cg_endo -75.98 100.27 1.36 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.748 2.299 . . . . 1.12 112.484 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.573 ' CG2' ' HG2' ' A' ' 14' ' ' LYS . 5.4 mt -114.96 12.48 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.98 0.895 . . . . 2.58 110.125 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.07 60.36 0.65 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.18 -0.918 . . . . 0.74 111.829 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.67 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 34.3 Cg_endo -65.0 104.19 0.56 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.423 2.082 . . . . 0.67 112.779 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.51 123.65 41.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.65 -0.705 . . . . 1.18 109.874 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -78.98 89.41 4.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.271 0.558 . . . . 1.64 110.663 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.664 HG13 HG23 ' A' ' 5' ' ' VAL . 23.7 t -91.4 118.36 36.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.701 . . . . 1.01 111.345 -176.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.445 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 53.6 tt0 -112.82 123.85 51.26 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.464 -0.789 . . . . 2.48 109.155 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.51 116.75 28.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.404 -0.362 . . . . 0.7 111.013 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 8.9 mp -80.33 120.05 23.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 1.94 110.504 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.79 -124.99 7.09 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.797 -0.716 . . . . 1.81 112.303 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.4 m 63.85 24.06 13.6 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.693 0.397 . . . . 1.88 111.217 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -49.76 -42.36 46.25 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.434 0.459 . . . . 2.14 111.84 -171.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.1 25.03 10.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.258 -0.428 . . . . 0.94 110.687 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 1.4 tpm_? -121.63 145.35 48.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.042 0.449 . . . . 4.64 111.688 -172.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -82.71 149.58 27.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.103 -0.702 . . . . 1.75 109.103 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 93.1 t -109.37 129.86 63.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.851 -0.796 . . . . 0.54 108.851 177.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 1.02 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -135.96 140.5 44.03 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 123.302 0.376 . . . . 0.36 110.735 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 mt -103.19 150.55 23.57 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.127 -0.488 . . . . 0.84 109.761 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.877 ' HE3' ' HB2' ' A' ' 129' ' ' PHE . 1.5 mptp? -134.84 151.66 51.1 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.297 -1.001 . . . . 1.93 108.297 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -88.32 156.93 18.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.489 -0.559 . . . . 0.41 109.489 174.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.642 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 5.8 t70 -89.5 172.57 8.89 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.899 -0.778 . . . . 0.71 108.899 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.8 p -49.84 -25.26 2.98 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.816 1.043 . . . . 1.4 113.816 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -65.57 -38.68 90.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.786 0.327 . . . . 2.22 111.217 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.645 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 26.5 p-10 -131.3 18.95 4.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 1.35 111.282 -174.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 52.3 t80 -122.55 101.5 7.52 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.417 -0.586 . . . . 0.56 109.417 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.669 ' HG2' ' HE1' ' A' ' 55' ' ' PHE . 5.5 pt-20 -106.83 98.75 8.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.295 -0.411 . . . . 2.41 110.5 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 73.13 -49.33 0.69 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.197 -0.911 . . . . 3.43 111.337 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 177.7 38.52 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.696 -0.562 . . . . 0.56 111.696 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.507 ' HD3' ' HB3' ' A' ' 81' ' ' ASN . 32.1 mmtp -136.48 135.17 38.37 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.491 -0.929 . . . . 2.12 108.491 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.645 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -115.55 149.47 38.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.442 0.639 . . . . 0.56 111.67 175.334 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.669 ' HE1' ' HG2' ' A' ' 50' ' ' GLU . 16.7 p90 -157.83 -179.96 8.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.039 -0.982 . . . . 0.59 110.341 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.51 HD22 HD22 ' A' ' 114' ' ' LEU . 30.7 mt -94.08 112.12 23.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.662 -0.866 . . . . 1.53 108.662 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.617 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 9.8 tp -107.75 140.4 26.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.544 -0.539 . . . . 0.62 109.544 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 37.1 t -78.96 156.02 28.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.247 -0.433 . . . . 1.44 110.52 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -54.79 -27.59 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 2.31 111.425 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -109.7 13.49 23.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.476 -0.329 . . . . 3.09 111.184 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 52.1 33.54 12.36 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.556 0.576 . . . . 2.62 112.556 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -79.34 -27.35 42.04 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.963 0.357 . . . . 4.66 111.963 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -149.77 140.55 22.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.592 -0.522 . . . . 2.51 109.592 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -128.89 132.5 47.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.763 -0.458 . . . . 2.07 109.763 177.116 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.087 ' HB2' ' HG3' ' A' ' 104' ' ' GLN . 1.3 pt? -140.18 125.17 18.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.853 0.358 . . . . 1.98 110.927 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -69.71 143.08 53.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.869 -0.605 . . . . 0.75 111.682 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.897 HG12 ' HA ' ' A' ' 100' ' ' VAL . 14.2 m -133.14 171.43 18.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.428 -0.805 . . . . 0.73 110.015 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.483 ' HB2' ' HE2' ' A' ' 84' ' ' PHE . 5.4 p30 -130.89 129.13 41.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.289 -0.414 . . . . 1.81 110.038 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.53 85.41 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.809 -0.811 . . . . 0.81 108.809 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.572 ' O ' ' HE1' ' A' ' 99' ' ' TYR . 6.7 ttp180 -108.78 139.99 21.41 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.48 -0.782 . . . . 3.79 110.024 -170.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HA ' HG22 ' A' ' 96' ' ' ILE . 50.3 Cg_exo -52.55 135.75 55.93 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.356 2.037 . . . . 0.59 112.155 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.402 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 15.5 tmm? -59.16 -58.9 6.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 1.71 109.761 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -172.97 103.45 0.13 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.541 -0.754 . . . . 1.92 109.457 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -177.65 -32.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 1.89 111.811 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 p -164.4 179.02 7.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.797 0.332 . . . . 1.7 111.128 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.28 130.54 56.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.818 -0.628 . . . . 0.94 110.222 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.584 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 12.6 m0 -118.44 150.83 38.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.114 -0.494 . . . . 0.5 110.216 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.4 m -79.7 114.09 18.35 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.929 -0.397 . . . . 0.51 109.929 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 t -87.48 114.43 24.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.998 0.904 . . . . 0.59 112.409 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -114.63 162.49 16.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 106.949 -1.501 . . . . 1.7 106.949 167.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.507 ' HB3' ' HD3' ' A' ' 53' ' ' LYS . 7.3 t-20 -82.39 -16.47 48.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.724 -0.79 . . . . 1.39 110.277 -177.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.59 -37.51 3.71 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.601 -0.809 . . . . 0.65 112.341 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.536 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 27.8 m -132.27 156.9 42.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.864 0.364 . . . . 1.16 110.519 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.721 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -135.84 105.3 6.06 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.202 -1.036 . . . . 0.36 108.202 179.621 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 1.02 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 4.0 p90 -134.92 144.19 47.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.196 0.522 . . . . 0.59 111.48 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.876 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 15.5 pttm -75.11 149.97 38.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.469 -0.787 . . . . 1.39 110.392 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -76.11 -15.56 60.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.779 0.8 . . . . 2.12 108.878 173.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.876 ' HB3' ' HD2' ' A' ' 86' ' ' LYS . 28.6 t70 -78.87 155.65 29.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.677 -1.147 . . . . 2.1 110.431 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.0 m -121.84 131.02 74.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.005 0.431 . . . . 1.05 109.861 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.79 172.83 16.49 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.845 -0.693 . . . . 0.46 111.714 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.1 p -65.64 124.35 22.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.591 -0.522 . . . . 1.17 109.591 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.814 ' HB2' ' HZ2' ' A' ' 86' ' ' LYS . 32.0 t90 -91.29 -51.13 5.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.189 -0.46 . . . . 0.51 110.436 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 30.53 82.64 0.01 OUTLIER Glycine 0 N--CA 1.468 0.803 0 O-C-N 124.75 1.281 . . . . 1.25 115.26 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.35 -150.2 5.75 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.861 -0.685 . . . . 0.72 112.005 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.5 p -123.13 124.64 43.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.42 0.629 . . . . 0.6 112.449 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.67 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -110.85 168.73 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.175 -1.046 . . . . 1.63 108.175 169.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.61 161.0 27.43 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.11 -1.043 . . . . 0.45 112.243 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.42 113.44 24.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.107 0.48 . . . . 0.83 110.139 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.664 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 5.9 m-85 -110.49 126.66 54.6 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.924 -1.139 . . . . 1.28 107.924 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.897 ' HA ' HG12 ' A' ' 67' ' ' VAL . 9.2 p -71.47 136.97 24.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.06 -0.719 . . . . 1.14 109.06 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.23 98.91 1.08 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.864 0.364 . . . . 1.02 111.149 -175.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.87 20.73 79.74 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-O 119.17 -0.795 . . . . 1.53 114.207 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.432 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 18.4 tt0 51.98 99.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.49 0.645 . . . . 2.11 110.742 -174.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 1.087 ' HG3' ' HB2' ' A' ' 65' ' ' LEU . 79.9 mm-40 -69.55 -63.99 0.97 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.18 -0.464 . . . . 2.62 111.279 -172.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 62.5 m -178.86 -56.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.893 -0.594 . . . . 2.43 110.858 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.492 ' OD1' ' HD2' ' A' ' 16' ' ' ARG . 8.2 t30 72.21 79.24 0.15 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.156 -0.929 . . . . 1.56 109.471 -167.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.13 125.96 66.62 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.508 -0.769 . . . . 1.68 109.145 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -21.95 88.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 1 C-N-CA 125.425 4.084 . . . . 1.26 114.275 -172.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.742 ' HB3' ' HE1' ' A' ' 112' ' ' TYR . 1.1 Cg_endo -85.16 -157.76 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.092 3.195 . . . . 0.76 114.087 -171.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.89 -81.04 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.742 -1.343 . . . . 0.76 109.742 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -126.83 137.56 53.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.643 -0.502 . . . . 2.04 109.643 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.742 ' HE1' ' HB3' ' A' ' 109' ' ' PRO . 13.7 m-85 -125.55 141.76 51.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.395 -0.366 . . . . 0.75 110.298 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.1 m -125.56 112.84 16.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.148 -0.478 . . . . 0.83 110.778 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.51 HD22 HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -126.69 87.29 2.63 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.44 0.638 . . . . 0.51 110.181 176.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.642 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 2.8 m -72.0 122.5 20.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.413 -0.812 . . . . 0.59 110.099 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -111.17 120.2 41.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.083 0.468 . . . . 1.27 110.57 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.472 ' HA ' HG23 ' A' ' 135' ' ' THR . 19.3 m -92.18 121.22 33.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.7 110.224 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -76.97 164.57 53.05 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.567 -0.825 . . . . 0.8 111.866 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.18 179.62 36.92 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.87 -0.681 . . . . 0.53 111.766 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.603 ' HB3' ' HB2' ' A' ' 3' ' ' CYS . 55.5 p90 -110.75 178.97 4.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.265 0.555 . . . . 0.89 110.298 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.668 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 8.5 t-105 -140.9 143.22 34.52 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.378 -0.828 . . . . 0.56 109.087 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.609 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -140.96 60.73 1.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.139 0.792 . . . . 1.42 113.139 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 1.052 ' HA ' ' HE2' ' A' ' 123' ' ' LYS . 0.3 OUTLIER 169.88 -123.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.627 0.579 . . . . 3.47 109.887 171.012 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -166.31 117.26 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 2.08 111.455 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.668 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 23.3 t-20 61.43 -30.86 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.261 1.578 . . . . 2.47 115.261 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -1.97 2.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 118.011 0.369 . . . . 1.96 111.434 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.542 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 40.1 mt-30 72.79 45.85 0.29 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.657 -0.701 . . . . 2.02 110.971 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.72 59.46 4.69 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.74 -0.944 . . . . 0.77 110.74 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.877 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 50.3 p90 -105.19 146.56 29.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 110.071 -0.344 . . . . 1.21 110.071 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.4 m -131.12 113.47 15.99 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 110.148 -0.316 . . . . 1.47 110.148 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -62.11 118.51 5.4 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.822 2.348 . . . . 0.92 111.595 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.9 m -145.82 154.71 42.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.924 -0.58 . . . . 1.52 110.259 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.33 -123.36 6.19 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.671 -0.776 . . . . 1.17 112.647 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.7 m -125.04 143.02 51.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.71 0.291 . . . . 2.47 111.291 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 117' ' ' THR . 12.4 m -93.21 113.2 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.407 -0.59 . . . . 1.82 109.407 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.47 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -96.99 126.14 8.73 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.771 -0.728 . . . . 0.67 112.035 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 25.1 m -94.48 99.63 11.77 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.029 0.442 . . . . 0.58 110.31 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.443 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 24.9 m -79.78 119.08 22.19 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.178 -0.675 . . . . 0.52 109.178 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -113.72 119.48 37.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.589 0.709 . . . . 2.18 109.591 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 112' ' ' TYR . 4.7 tp -108.36 94.65 5.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.048 -0.978 . . . . 0.63 110.847 -173.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.2 m -91.07 147.5 23.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.909 -1.041 . . . . 0.58 109.18 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.511 ' HB ' HH12 ' A' ' 16' ' ' ARG . 9.1 p -102.28 124.11 55.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.914 -0.714 . . . . 1.74 110.715 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.338 -0.839 . . . . 2.58 109.497 178.759 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 121.131 0.491 . . . . 5.73 110.373 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -151.86 97.38 2.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.891 -0.781 . . . . 3.08 108.891 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.859 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 19.2 t -85.5 99.72 11.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.208 0.528 . . . . 1.43 110.595 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -86.18 140.18 30.4 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.61 -0.723 . . . . 2.29 110.359 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 30' ' ' VAL . 3.2 p -111.69 124.22 68.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.696 -0.684 . . . . 1.51 109.674 175.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.546 ' HA ' ' OG1' ' A' ' 134' ' ' THR . 99.3 mtt180 -96.29 104.01 15.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.333 0.587 . . . . 3.57 110.797 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.422 HG13 HG11 ' A' ' 28' ' ' VAL . 57.4 t -103.43 116.72 47.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.202 -0.908 . . . . 1.26 109.456 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.78 150.35 34.29 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.63 -0.795 . . . . 0.96 112.378 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -74.43 111.88 10.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.771 -0.455 . . . . 2.18 109.771 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.616 HD11 HG22 ' A' ' 28' ' ' VAL . 92.8 mt -93.49 94.01 8.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.22 -0.446 . . . . 1.41 111.202 -177.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.1 m -94.9 112.69 24.39 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.052 -0.721 . . . . 1.03 109.052 171.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.14 144.23 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.425 -0.352 . . . . 1.45 110.387 -174.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.521 ' HB1' ' OG1' ' A' ' 143' ' ' THR . . . -101.42 96.83 7.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.149 -0.478 . . . . 0.59 109.963 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.711 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 9.0 mmpt? -145.72 173.25 12.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 3.42 110.453 -176.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.527 HG22 HG13 ' A' ' 142' ' ' VAL . 35.2 p -106.71 168.95 8.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.122 -0.49 . . . . 0.63 109.721 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.683 HH21 ' HD1' ' A' ' 112' ' ' TYR . 0.3 OUTLIER -87.01 -15.61 38.18 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.753 -0.832 . . . . 3.14 108.753 178.276 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.8 -23.52 70.88 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.297 -0.865 . . . . 0.75 111.558 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -58.49 -31.15 67.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.4 0.619 . . . . 2.17 109.707 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.612 HD21 HG23 ' A' ' 25' ' ' ILE . 9.9 mt -96.48 105.5 17.6 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.233 -0.894 . . . . 1.61 109.711 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.593 ' H ' ' HB3' ' A' ' 23' ' ' ALA . 4.2 t -107.42 70.35 0.78 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.126 -0.694 . . . . 1.65 109.126 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 17.8 t70 67.61 -80.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.7 -1.137 . . . . 1.83 110.488 -174.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.34 63.69 0.99 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.613 0.72 . . . . 0.82 110.646 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.593 ' HB3' ' H ' ' A' ' 20' ' ' THR . . . -143.35 117.87 6.22 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 114.897 -1.047 . . . . 0.79 108.901 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -90.83 163.66 4.04 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.59 2.86 . . . . 1.12 113.603 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.612 HG23 HD21 ' A' ' 19' ' ' LEU . 1.5 pt -118.7 -57.15 3.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.466 -0.788 . . . . 2.58 110.899 174.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.515 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -116.15 99.17 0.86 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.85 -0.69 . . . . 0.74 112.553 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 60.4 Cg_endo -80.41 105.17 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.714 2.276 . . . . 0.67 112.051 173.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.616 HG22 HD11 ' A' ' 10' ' ' LEU . 18.1 t -74.96 125.96 35.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.701 -0.481 . . . . 1.18 109.701 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 6.7 t -82.72 83.62 7.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.02 0.914 . . . . 1.64 110.24 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.788 HG13 HG23 ' A' ' 5' ' ' VAL . 84.9 t -69.18 115.73 8.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.053 -0.976 . . . . 1.01 110.833 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.494 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 28.6 pt20 -110.38 132.89 53.78 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.159 -0.682 . . . . 2.48 109.159 173.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.518 ' HB1' ' SG ' ' A' ' 3' ' ' CYS . . . -101.67 127.95 48.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.095 -0.502 . . . . 0.7 110.999 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.734 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 85.2 mt -107.59 111.78 24.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.511 -0.313 . . . . 1.94 110.656 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.98 59.11 8.4 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.266 -0.492 . . . . 1.81 113.211 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.859 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -87.08 -70.38 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.679 0.252 . . . . 1.88 111.679 -177.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 69.25 -61.83 0.42 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.644 0.778 . . . . 2.14 111.632 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.416 ' HA ' ' HB ' ' A' ' 89' ' ' VAL . . . -141.8 71.41 1.35 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.338 0.59 . . . . 0.94 109.889 -176.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.713 ' HD2' ' SG ' ' A' ' 35' ' ' CYS . 1.4 tmt_? -143.42 131.81 22.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.544 -0.753 . . . . 4.64 110.886 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.508 ' HG2' HG12 ' A' ' 89' ' ' VAL . 31.3 mt-30 -87.36 107.17 18.4 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.675 -0.861 . . . . 1.75 108.675 174.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 41.7 t -62.66 109.21 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 0.54 109.954 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 1.018 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -127.11 137.63 53.03 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 123.531 0.519 . . . . 0.36 109.895 -176.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.756 HD12 HG21 ' A' ' 69' ' ' ILE . 65.6 mt -104.21 128.65 51.95 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.946 -0.39 . . . . 0.84 109.946 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.553 ' HG3' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -110.33 151.77 27.02 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.618 -0.882 . . . . 1.93 108.618 175.027 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.62 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -100.32 155.17 17.94 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.379 -0.529 . . . . 0.41 110.024 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -73.67 149.0 42.25 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.978 -0.749 . . . . 0.71 108.978 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -58.6 -18.08 27.26 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.286 0.476 . . . . 1.4 112.286 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.24 -27.18 68.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.151 0.5 . . . . 2.22 110.33 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.62 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 4.1 p-10 -134.75 27.11 3.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.656 -0.702 . . . . 1.35 109.916 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.609 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 75.1 t80 -140.75 102.41 4.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.436 -0.802 . . . . 0.56 109.653 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.24 117.04 33.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.296 -0.411 . . . . 2.41 110.583 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 68.46 -57.62 0.49 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.279 0.987 . . . . 3.43 111.884 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.609 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -179.29 32.26 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.971 -0.633 . . . . 0.56 111.93 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 81' ' ' ASN . 1.6 mptm? -129.9 134.28 47.39 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.396 -0.594 . . . . 2.12 109.396 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.475 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -98.91 139.05 35.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.42 0.628 . . . . 0.56 110.818 174.378 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.615 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 51.5 p90 -155.43 172.76 17.69 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.177 -0.919 . . . . 0.59 110.338 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.991 ' HG ' HD22 ' A' ' 114' ' ' LEU . 5.9 mp -83.35 130.72 35.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.095 -0.705 . . . . 1.53 109.095 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 113' ' ' THR . 10.4 tp -104.93 134.7 45.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.13 -0.628 . . . . 0.62 109.322 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.5 t -68.06 179.96 1.38 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.294 -0.866 . . . . 1.44 111.298 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -56.0 -43.2 77.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.883 -0.599 . . . . 2.31 111.456 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -115.07 -62.26 1.63 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.549 -0.296 . . . . 3.09 110.594 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.1 p30 177.28 25.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.829 -0.623 . . . . 2.62 109.595 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -73.03 -46.31 52.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.428 -0.805 . . . . 4.66 111.406 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.99 156.16 47.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.837 -0.62 . . . . 2.51 110.491 -172.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -142.59 139.73 31.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.883 -0.599 . . . . 2.07 109.776 174.252 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.741 ' HG ' HD13 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -141.14 122.04 14.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.37 -0.377 . . . . 1.98 110.237 178.016 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.443 ' HA ' ' CB ' ' A' ' 55' ' ' PHE . 62.8 m-85 -72.18 153.15 41.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.347 -0.388 . . . . 0.75 111.515 -173.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.486 ' HB ' HG23 ' A' ' 98' ' ' ILE . 29.2 m -117.24 161.78 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.73 111.404 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -126.65 121.67 32.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 1.81 108.952 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.756 HG21 HD12 ' A' ' 42' ' ' LEU . 3.6 mm -95.37 86.23 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.745 -0.382 . . . . 0.81 110.04 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.514 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 8.1 mmm180 -93.55 128.27 42.85 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 120.491 -0.484 . . . . 3.79 110.974 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.74 ' HA ' HG22 ' A' ' 96' ' ' ILE . 49.2 Cg_exo -51.53 133.41 43.53 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.526 2.151 . . . . 0.59 112.229 172.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.6 ttt -78.8 81.45 5.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.572 -0.529 . . . . 1.71 109.572 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 66.35 20.16 10.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.823 -0.626 . . . . 1.92 112.227 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -119.7 107.59 13.4 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.464 0.542 . . . . 1.89 112.464 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.6 p 61.18 179.71 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.648 1.179 . . . . 1.7 113.503 170.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.07 119.52 39.42 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.276 -0.874 . . . . 0.94 110.485 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.685 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.6 m0 -110.18 149.08 30.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.93 -0.577 . . . . 0.5 110.388 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.0 m -83.23 112.92 20.3 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.003 -0.74 . . . . 0.51 109.003 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 t -87.48 90.19 8.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.936 0.874 . . . . 0.59 112.433 -171.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.25 148.44 23.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.91 -1.145 . . . . 1.7 107.91 166.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 1.1 t-20 -87.17 11.06 14.93 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.226 -0.59 . . . . 1.39 110.526 -174.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.88 -27.46 1.25 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.597 -0.601 . . . . 0.65 111.597 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.553 HG12 ' HG3' ' A' ' 43' ' ' LYS . 36.0 m -140.54 137.77 36.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.005 -0.739 . . . . 1.16 109.005 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.85 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -121.68 109.11 14.35 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.67 -0.812 . . . . 0.36 108.946 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 1.018 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 2.0 p90 -137.35 139.26 40.7 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.512 0.508 . . . . 0.59 111.394 -173.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.772 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 53.4 pttt -73.96 143.49 45.64 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.057 -0.72 . . . . 1.39 109.057 171.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -64.72 -26.53 68.41 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.97 -0.559 . . . . 2.12 110.103 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.772 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 12.6 m-20 -72.12 151.07 43.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.526 -0.761 . . . . 2.1 110.573 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.508 HG12 ' HG2' ' A' ' 39' ' ' GLN . 30.9 m -114.04 123.26 69.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.026 0.441 . . . . 1.05 110.276 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.8 -173.32 24.7 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.387 -0.911 . . . . 0.46 112.011 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.5 p -55.37 145.45 22.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.084 0.469 . . . . 1.17 111.428 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.458 ' CH2' HG23 ' A' ' 96' ' ' ILE . 41.2 t90 -126.74 -53.86 1.43 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.912 -0.586 . . . . 0.51 109.82 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 35.23 87.54 0.01 OUTLIER Glycine 0 N--CA 1.465 0.577 0 O-C-N 124.835 1.334 . . . . 1.25 114.978 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 29' ' ' THR . . . -159.01 -131.77 1.29 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.9 -0.667 . . . . 0.72 112.126 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.64 132.92 23.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.951 0.405 . . . . 0.6 111.459 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.74 HG22 ' HA ' ' A' ' 71' ' ' PRO . 1.7 pp -124.29 144.1 35.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.365 -0.605 . . . . 1.63 109.365 172.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -117.97 151.8 17.81 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.118 -1.039 . . . . 0.45 112.233 -174.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.486 HG23 ' HB ' ' A' ' 67' ' ' VAL . 77.1 mt -96.18 112.62 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.417 0.627 . . . . 0.83 110.639 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 70' ' ' ARG . 1.2 m-85 -103.88 156.86 17.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.807 -1.088 . . . . 1.28 108.099 176.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.479 ' CG1' ' HA ' ' A' ' 103' ' ' GLN . 5.5 p -87.24 133.12 30.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.035 -0.666 . . . . 1.14 109.393 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.92 101.83 0.3 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.381 -0.372 . . . . 1.02 111.756 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.11 23.4 77.21 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.804 -0.635 . . . . 1.53 114.026 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.479 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 62.9 tt0 57.93 97.98 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.237 0.541 . . . . 2.11 110.905 -175.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.656 ' HG3' ' HB2' ' A' ' 65' ' ' LEU . 78.3 mm-40 -84.32 14.21 4.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 2.62 111.312 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.1 m 74.01 -3.79 2.43 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.584 -0.735 . . . . 2.43 112.239 170.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.54 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 7.3 t30 63.41 86.18 0.12 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.593 0.711 . . . . 1.56 110.214 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.8 m -74.54 139.91 74.97 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.006 -0.997 . . . . 1.68 109.355 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -30.5 89.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 125.162 3.908 . . . . 1.26 113.456 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.58 ' HB2' ' CG2' ' A' ' 142' ' ' VAL . 81.2 Cg_endo -93.23 -168.54 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.191 2.594 . . . . 0.76 114.949 -167.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.13 -73.92 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.752 -1.339 . . . . 0.76 109.752 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -135.13 126.93 29.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.546 -0.539 . . . . 2.04 109.546 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.683 ' HD1' HH21 ' A' ' 16' ' ' ARG . 69.6 m-85 -129.25 139.33 51.86 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.065 0.46 . . . . 0.75 110.922 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.597 ' O ' HG22 ' A' ' 57' ' ' ILE . 70.8 m -111.68 129.15 56.2 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.318 -0.856 . . . . 0.83 110.021 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.991 HD22 ' HG ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -142.84 86.91 1.95 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.733 0.777 . . . . 0.51 109.602 174.4 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.7 m -88.06 135.83 33.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.003 -0.999 . . . . 0.59 110.476 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 8.6 mp -119.01 116.49 26.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 1.27 110.682 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 38.5 m -89.08 114.02 25.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.81 -0.632 . . . . 0.7 110.125 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.403 ' HA3' HG13 ' A' ' 5' ' ' VAL . . . -67.84 145.11 44.6 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.724 -0.751 . . . . 0.8 112.365 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.434 ' HA2' ' N ' ' A' ' 132' ' ' SER . . . -175.59 177.34 47.43 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.892 -0.67 . . . . 0.53 111.484 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.408 ' CE2' ' HB ' ' A' ' 130' ' ' THR . 28.9 p90 -101.26 -178.33 3.71 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.918 -0.713 . . . . 0.89 110.184 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.856 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 3.4 t-105 -151.69 144.45 24.35 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.253 -0.885 . . . . 0.56 108.818 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.39 145.65 49.95 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.256 0.347 . . . . 1.42 110.466 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.93 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER 72.17 -136.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.745 0.818 . . . . 3.47 110.741 178.121 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.597 ' HA ' ' HZ2' ' A' ' 121' ' ' TRP . 5.6 p-10 -162.96 133.87 4.77 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.132 0.173 . . . . 2.08 110.631 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.475 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 52.4 t30 67.76 -38.76 0.37 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.901 1.075 . . . . 2.47 113.901 174.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.416 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -64.89 -5.04 5.18 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.341 0.591 . . . . 1.96 111.19 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.856 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 33.7 tt0 65.21 72.56 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.723 -1.126 . . . . 2.02 111.246 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.416 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -96.01 41.75 2.38 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.62 -0.8 . . . . 0.77 111.213 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.514 ' CD1' ' HG2' ' A' ' 127' ' ' GLN . 3.7 p90 -82.74 154.44 24.79 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.783 0.325 . . . . 1.21 110.894 -172.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.408 ' HB ' ' CE2' ' A' ' 120' ' ' TYR . 50.2 m -154.93 123.99 3.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.436 -0.347 . . . . 1.47 110.082 173.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.2 128.81 31.18 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.975 2.45 . . . . 0.92 112.254 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.434 ' N ' ' HA2' ' A' ' 119' ' ' GLY . 27.1 m -155.27 108.3 2.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.31 -0.404 . . . . 1.52 110.349 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.9 -127.85 7.52 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.45 -0.881 . . . . 1.17 112.46 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 6' ' ' ARG . 5.2 p -118.71 154.53 32.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.951 0.405 . . . . 2.47 111.417 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 t -108.98 114.64 28.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.412 -0.588 . . . . 1.82 109.412 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.96 126.87 9.0 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.716 -0.754 . . . . 0.67 112.122 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.3 m -91.82 101.3 13.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.745 0.307 . . . . 0.58 110.725 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.523 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 28.3 m -80.63 108.65 14.45 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.14 -0.689 . . . . 0.52 109.14 173.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -109.38 109.55 20.45 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.989 -0.745 . . . . 2.18 108.989 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.604 ' HG ' ' NH2' ' A' ' 16' ' ' ARG . 16.1 tp -106.78 105.96 16.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.902 -1.045 . . . . 0.63 110.913 -174.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 30.3 m -99.45 143.99 29.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.159 -0.928 . . . . 0.58 109.36 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.58 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 92.9 t -74.32 129.56 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 112.793 0.664 . . . . 1.74 112.793 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.521 ' OG1' ' HB1' ' A' ' 13' ' ' ALA . 95.0 m . . . . . 0 C--O 1.248 1.009 0 CA-C-N 115.06 -0.973 . . . . 2.58 109.188 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.046 0.45 . . . . 5.73 110.905 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -92.73 121.43 34.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.629 -0.714 . . . . 3.08 109.831 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.3 m -119.45 100.51 7.33 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.34 -0.391 . . . . 1.43 110.922 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -86.39 109.73 19.22 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.41 -0.589 . . . . 2.29 109.41 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.6 t -95.96 111.89 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.588 -0.523 . . . . 1.51 109.588 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.82 ' HB2' ' HB2' ' A' ' 31' ' ' GLN . 31.2 mmt180 -84.39 99.55 10.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.628 -0.715 . . . . 3.57 110.451 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.95 115.59 48.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.382 -0.826 . . . . 1.26 109.238 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.24 -169.88 27.04 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.465 -0.874 . . . . 0.96 112.082 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -99.83 142.39 31.37 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.676 -0.491 . . . . 2.18 109.676 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.72 126.84 12.91 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.02 -0.537 . . . . 1.41 109.911 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.9 m -108.93 115.69 30.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.987 -0.551 . . . . 1.03 110.479 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.458 HG12 ' HG2' ' A' ' 14' ' ' LYS . 44.3 t -122.69 117.9 53.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.152 -0.476 . . . . 1.45 110.17 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -91.4 97.03 10.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.97 0.414 . . . . 0.59 110.893 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HG2' HG12 ' A' ' 12' ' ' VAL . 73.9 mmtt -143.64 -174.44 4.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.561 -0.745 . . . . 3.42 109.454 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.627 ' HB ' ' OD1' ' A' ' 106' ' ' ASN . 20.4 p -100.68 159.78 14.89 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.135 -0.32 . . . . 0.63 110.135 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.902 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -86.35 -26.22 24.96 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.629 -0.428 . . . . 3.14 109.992 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.79 -28.63 73.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.919 -0.658 . . . . 0.75 111.613 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -51.14 -34.81 32.72 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.594 0.757 . . . . 2.17 111.442 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.841 ' HB2' HG23 ' A' ' 100' ' ' VAL . 49.8 mt -70.51 -17.61 62.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.591 -0.731 . . . . 1.61 112.816 -170.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.3 m 34.25 55.42 0.63 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.256 0.972 . . . . 1.65 112.778 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.757 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 31.0 t70 70.27 -62.84 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.631 -0.713 . . . . 1.83 111.809 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.49 ' HA ' ' CG ' ' A' ' 99' ' ' TYR . . . -139.46 69.59 1.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.311 0.577 . . . . 0.82 112.068 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.65 98.42 16.41 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.38 -0.827 . . . . 0.79 109.056 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.487 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 54.4 Cg_endo -70.02 119.81 6.67 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.817 2.345 . . . . 1.12 113.411 -172.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.731 HG12 HD21 ' A' ' 19' ' ' LEU . 2.9 pt -80.67 -65.11 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 2.58 111.524 173.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.654 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -117.83 101.55 0.92 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.879 -0.676 . . . . 0.74 111.935 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.612 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 37.7 Cg_endo -70.51 121.16 7.7 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.437 2.091 . . . . 0.67 112.083 177.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.34 122.16 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.86 -0.609 . . . . 1.18 109.431 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.5 m -74.59 101.96 4.39 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.218 -0.446 . . . . 1.64 110.298 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.45 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 48.9 t -95.81 114.49 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.157 -0.474 . . . . 1.01 110.398 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.82 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 14.9 mm100 -103.07 133.91 47.38 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.343 -0.614 . . . . 2.48 109.343 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.4 108.29 13.94 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.172 -0.307 . . . . 0.7 110.172 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.16 134.24 55.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.129 -0.487 . . . . 1.94 110.724 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.55 -7.83 68.59 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.819 -0.628 . . . . 1.81 112.264 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.0 m -84.32 93.56 8.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.001 0.429 . . . . 1.88 110.73 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -96.32 -18.92 19.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.962 0.411 . . . . 2.14 110.218 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -167.76 83.66 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.776 -0.647 . . . . 0.94 110.048 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -165.11 150.09 9.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.898 -0.592 . . . . 4.64 110.096 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -80.91 125.41 30.09 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.245 -0.65 . . . . 1.75 109.245 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 61.0 t -92.99 124.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.46 -0.57 . . . . 0.54 109.46 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -119.66 146.52 45.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.087 0.47 . . . . 0.36 110.963 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.493 HD13 HD13 ' A' ' 96' ' ' ILE . 14.6 mt -103.87 117.72 35.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.663 -0.698 . . . . 0.84 109.329 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.62 ' NZ ' ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -118.73 152.02 36.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.552 -0.536 . . . . 1.93 109.552 -177.316 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.523 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -104.23 157.19 17.3 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.369 -0.378 . . . . 0.41 110.081 175.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 21.9 t70 -75.8 151.72 37.46 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.428 -0.582 . . . . 0.71 109.428 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -56.75 -16.5 6.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.563 0.579 . . . . 1.4 112.563 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.58 -32.37 73.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.981 0.42 . . . . 2.22 110.628 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.523 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 6.0 p-10 -133.85 24.2 3.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 1.35 110.247 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 82.0 t80 -132.33 101.33 5.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.492 -0.777 . . . . 0.56 109.334 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 51' ' ' GLN . 56.5 mt-10 -95.07 100.26 12.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.422 -0.353 . . . . 2.41 110.403 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 23.8 tt0 70.79 -58.56 0.56 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.875 0.734 . . . . 3.43 111.184 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -172.32 38.12 0.16 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.6 -0.727 . . . . 0.56 111.435 -177.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 2.1 mptm? -136.37 133.87 37.24 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.944 -0.762 . . . . 2.12 108.944 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -106.08 141.67 37.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.245 0.545 . . . . 0.56 110.96 174.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.511 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 16.9 p90 -147.27 167.04 25.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.674 -0.694 . . . . 0.59 111.255 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.667 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 13.0 mt -85.33 113.66 21.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.457 -0.942 . . . . 1.53 108.457 171.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.7 tp -106.26 125.08 61.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.595 0.712 . . . . 0.62 110.85 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 112' ' ' TYR . 40.3 t -84.39 153.34 23.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.982 -1.008 . . . . 1.44 111.21 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.16 -35.39 73.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.471 -0.786 . . . . 2.31 110.368 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -78.3 -13.23 59.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.662 -0.699 . . . . 3.09 110.775 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 53.77 30.44 11.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.661 -0.699 . . . . 2.62 111.122 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.661 ' HE ' ' HA ' ' A' ' 62' ' ' ARG . 8.3 mmp_? -83.79 -39.95 19.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.244 0.545 . . . . 4.66 109.871 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.672 ' HB3' HD21 ' A' ' 65' ' ' LEU . 1.1 m-20 -123.09 124.77 43.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.377 -0.828 . . . . 2.51 111.111 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.667 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -127.18 98.89 5.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.208 1.004 . . . . 2.07 108.737 168.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.676 HD13 ' HB2' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -99.4 118.72 36.65 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.987 -1.006 . . . . 1.98 109.853 -168.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.448 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 73.0 m-85 -67.51 122.15 17.37 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.285 -0.635 . . . . 0.75 109.285 -177.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.475 HG13 ' HG ' ' A' ' 56' ' ' LEU . 12.9 m -99.63 168.57 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.605 -0.725 . . . . 0.73 111.62 -174.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -126.12 110.2 13.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.839 -1.073 . . . . 1.81 108.841 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.469 HG23 HG12 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -91.46 84.25 2.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.506 0.669 . . . . 0.81 109.196 173.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.804 ' HB3' ' OH ' ' A' ' 99' ' ' TYR . 32.6 ttm180 -101.82 131.78 22.42 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.979 -1.01 . . . . 3.79 108.317 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.621 ' HA ' HG22 ' A' ' 96' ' ' ILE . 45.0 Cg_endo -63.25 148.02 93.35 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.431 2.087 . . . . 0.59 112.208 -173.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.0 tpt -74.03 84.6 1.78 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.668 -0.696 . . . . 1.71 110.412 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 74.21 -46.84 0.63 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.134 0.974 . . . . 1.92 113.211 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.422 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 56.8 m-80 -60.22 114.28 2.81 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.433 0.901 . . . . 1.89 113.433 -171.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.7 t 74.4 159.48 0.22 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.722 -1.126 . . . . 1.7 112.323 170.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.42 118.86 33.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.421 -0.809 . . . . 0.94 110.113 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.857 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.4 m95 -112.39 142.49 44.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.16 -0.473 . . . . 0.5 109.945 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.2 m -82.65 110.63 17.88 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.249 -0.648 . . . . 0.51 109.249 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -82.09 117.71 22.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.319 1.057 . . . . 0.59 112.521 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 22.3 t70 -121.59 154.87 36.16 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.898 -1.519 . . . . 1.7 106.898 167.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 1.1 t-20 -83.94 2.6 37.92 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.009 -0.676 . . . . 1.39 110.924 -174.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -122.67 -31.47 1.04 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.156 -0.545 . . . . 0.65 112.134 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 80' ' ' ASP . 26.6 m -131.51 148.64 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.847 -0.427 . . . . 1.16 109.847 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -134.15 104.22 6.11 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.244 -1.021 . . . . 0.36 108.244 -177.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.613 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 12.1 p90 -131.51 135.0 46.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.468 0.651 . . . . 0.59 111.659 -174.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.857 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 18.9 pttp -74.42 139.68 44.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.829 -1.078 . . . . 1.39 109.713 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -72.7 -17.86 61.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.176 -0.675 . . . . 2.12 109.176 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 4.0 t70 -69.4 135.13 49.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.101 -0.954 . . . . 2.1 109.684 172.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.0 m -99.57 122.79 51.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.232 0.539 . . . . 1.05 110.651 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.3 -155.2 24.48 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.616 -0.802 . . . . 0.46 111.747 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.0 p -82.75 -173.56 4.73 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 122.501 0.321 . . . . 1.17 110.276 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' A' ' 74' ' ' ASN . 33.3 t90 -157.68 -57.13 0.08 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.799 -0.445 . . . . 0.51 109.799 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 42.15 92.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.42 1.075 . . . . 1.25 114.731 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.86 -141.83 3.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.663 -0.78 . . . . 0.72 112.286 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 27' ' ' PRO . 11.1 p -133.12 140.43 47.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.139 0.495 . . . . 0.6 112.218 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 71' ' ' PRO . 18.7 pt -118.38 142.87 31.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.807 -0.633 . . . . 1.63 109.501 174.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 24' ' ' PRO . . . -105.1 141.09 15.26 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.23 -0.986 . . . . 0.45 112.386 -174.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.469 HG12 HG23 ' A' ' 69' ' ' ILE . 59.7 mt -96.57 120.31 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.985 0.421 . . . . 0.83 111.088 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.804 ' OH ' ' HB3' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -139.26 164.96 28.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.335 -0.848 . . . . 1.28 110.153 173.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.841 HG23 ' HB2' ' A' ' 19' ' ' LEU . 3.6 t -90.13 125.94 43.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.98 -0.554 . . . . 1.14 110.791 -174.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.5 97.04 0.4 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.934 -0.395 . . . . 1.02 109.934 177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.62 -15.82 44.98 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.892 -0.67 . . . . 1.53 113.759 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.418 ' HB2' ' N ' ' A' ' 21' ' ' ASP . 65.2 tt0 67.27 118.35 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.067 0.547 . . . . 2.11 110.769 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.676 ' HB2' HD13 ' A' ' 65' ' ' LEU . 72.0 mm-40 -104.47 -6.83 20.3 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.316 0.487 . . . . 2.62 112.316 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 m 71.16 14.63 6.63 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.984 0.421 . . . . 2.43 111.317 168.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.902 ' HB3' ' HB2' ' A' ' 16' ' ' ARG . 0.3 OUTLIER 41.86 91.51 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.68 1.363 . . . . 1.56 114.68 177.388 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.775 HG22 ' HD2' ' A' ' 108' ' ' PRO . 1.2 m -82.07 143.74 49.81 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 107.914 -1.143 . . . . 1.68 107.914 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.775 ' HD2' HG22 ' A' ' 107' ' ' THR . 75.0 Cg_exo -12.04 83.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.669 1 C-N-CA 125.737 4.292 . . . . 1.26 114.705 -168.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -74.13 -157.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.849 3.033 . . . . 0.76 113.993 -172.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.58 -140.74 6.62 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 109.878 -1.289 . . . . 0.76 109.878 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -82.22 120.7 25.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.953 0.406 . . . . 2.04 110.097 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 58' ' ' SER . 14.1 m-85 -108.74 119.83 40.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.167 0.508 . . . . 0.75 109.972 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 77.0 m -106.74 98.54 8.19 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.414 -0.812 . . . . 0.83 111.051 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.521 HD13 HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -120.57 107.97 13.49 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.268 0.556 . . . . 0.51 110.526 178.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 20.2 m -96.18 140.21 31.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.59 110.181 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 96.5 mt -117.5 125.79 51.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.893 0.378 . . . . 1.27 110.252 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.5 m -103.36 119.61 39.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.982 0.42 . . . . 0.7 110.302 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -74.56 163.43 54.38 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.79 -0.719 . . . . 0.8 112.632 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.49 166.57 14.38 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.494 -0.642 . . . . 0.53 111.494 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -91.02 176.11 6.71 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.707 -0.397 . . . . 0.89 110.663 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 129' ' ' PHE . 1.9 t-105 -133.09 152.8 51.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.265 -0.879 . . . . 0.56 108.69 176.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.09 140.91 46.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.966 0.413 . . . . 1.42 111.615 175.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 74.55 -143.31 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.381 1.073 . . . . 3.47 111.358 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 126' ' ' LYS . 6.1 p-10 -147.62 124.38 11.2 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.336 -0.546 . . . . 2.08 112.135 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.444 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 8.6 t30 65.53 -22.81 0.09 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.862 1.06 . . . . 2.47 113.862 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.448 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -71.43 -3.36 20.52 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.873 0.469 . . . . 1.96 110.951 -178.336 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.859 ' HG3' ' CE2' ' A' ' 129' ' ' PHE . 51.4 tt0 70.37 79.24 0.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.433 -0.803 . . . . 2.02 110.384 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -109.61 27.69 11.88 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 119.793 -1.194 . . . . 0.77 112.655 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.859 ' CE2' ' HG3' ' A' ' 127' ' ' GLN . 38.9 p90 -87.72 126.39 34.96 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.041 -0.664 . . . . 1.21 111.239 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 85.8 m -114.25 132.02 22.97 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.936 -0.575 . . . . 1.47 109.767 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.92 122.61 11.21 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.771 2.314 . . . . 0.92 112.097 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.9 m -155.61 122.55 5.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.218 -0.446 . . . . 1.52 110.185 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 120.0 -117.62 3.63 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.267 -0.733 . . . . 1.17 111.267 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 p -131.81 178.44 6.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.004 0.402 . . . . 2.47 110.621 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 135' ' ' THR . 9.0 t -126.59 104.22 8.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.796 0.807 . . . . 1.82 108.943 171.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.78 143.45 16.03 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.637 -0.711 . . . . 0.67 112.414 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 73.8 m -101.0 117.41 34.98 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.958 0.409 . . . . 0.58 110.903 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.449 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 18.7 m -86.61 111.44 20.63 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.664 -0.865 . . . . 0.52 108.664 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -99.34 109.29 21.92 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.809 0.814 . . . . 2.18 110.065 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.503 HD21 ' HG3' ' A' ' 16' ' ' ARG . 22.6 tp -103.21 95.98 6.47 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.444 -1.253 . . . . 0.63 109.765 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 12.0 m -100.07 144.02 29.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.546 -0.752 . . . . 0.58 109.441 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.5 p -82.45 142.96 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.551 -0.537 . . . . 1.74 109.551 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.758 -0.639 . . . . 2.58 111.472 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.885 -0.413 . . . . 5.73 109.885 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -172.4 156.51 3.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.679 -0.86 . . . . 3.08 108.679 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.1 t -90.49 110.29 21.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.16 0.505 . . . . 1.43 110.363 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.436 ' HG3' ' HA3' ' A' ' 133' ' ' GLY . 46.5 tt0 -98.64 128.03 44.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.722 -0.672 . . . . 2.29 109.274 176.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.551 HG13 HG13 ' A' ' 30' ' ' VAL . 51.2 t -104.99 135.4 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.506 -0.553 . . . . 1.51 109.506 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.479 ' HA ' ' HE ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -92.57 101.21 13.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.084 0.468 . . . . 3.57 110.99 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.497 HG12 ' HA3' ' A' ' 136' ' ' GLY . 73.4 t -129.73 115.32 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.873 -0.788 . . . . 1.26 108.873 173.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.83 -147.67 6.81 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.859 -0.686 . . . . 0.96 112.412 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.29 142.16 27.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.209 0.528 . . . . 2.18 111.413 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.75 124.38 7.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.276 -0.875 . . . . 1.41 109.658 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 139' ' ' LYS . 31.1 m -116.03 116.57 28.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.212 -0.449 . . . . 1.03 110.709 -178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.465 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 27.8 t -121.49 116.75 50.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.931 0.396 . . . . 1.45 110.182 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -83.64 109.06 17.13 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.924 -0.58 . . . . 0.59 111.436 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.5 ' HE3' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -168.63 175.9 5.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.703 -0.681 . . . . 3.42 110.136 178.09 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.546 HG22 HG23 ' A' ' 142' ' ' VAL . 51.6 p -100.81 174.93 5.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.305 -0.407 . . . . 0.63 110.723 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.508 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -84.47 -6.56 59.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.774 -0.824 . . . . 3.14 108.774 173.264 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.588 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -89.84 -22.0 37.69 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.128 -0.942 . . . . 0.75 111.569 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.47 -25.97 65.25 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.712 -0.848 . . . . 2.17 108.712 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.663 HD13 ' HB ' ' A' ' 100' ' ' VAL . 18.5 mt -74.85 159.79 31.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.092 -0.958 . . . . 1.61 109.087 172.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -153.8 60.29 0.73 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.467 -0.938 . . . . 1.65 108.467 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 22.6 t70 61.28 -84.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.033 -1.439 . . . . 1.83 110.255 -171.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.483 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -88.72 74.94 8.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.137 0.494 . . . . 0.82 110.641 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.76 99.99 3.51 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.838 -0.619 . . . . 0.79 110.134 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 91.5 Cg_endo -82.52 109.5 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.762 2.308 . . . . 1.12 112.616 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -116.24 28.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.94 0.876 . . . . 2.58 109.868 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.88 60.1 0.42 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.105 -0.952 . . . . 0.74 112.265 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.63 97.89 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.328 2.019 . . . . 0.67 112.948 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.1 t -80.31 126.22 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.856 -0.611 . . . . 1.18 109.758 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -84.37 94.16 8.42 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 121.03 0.443 . . . . 1.64 110.657 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.707 ' CG2' HD11 ' A' ' 96' ' ' ILE . 14.5 t -94.49 115.21 32.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.308 0.575 . . . . 1.01 111.065 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -102.71 124.92 49.13 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.29 -0.868 . . . . 2.48 109.687 174.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.74 93.97 6.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.019 -0.537 . . . . 0.7 110.695 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 tp -87.28 112.76 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.811 -0.632 . . . . 1.94 110.83 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.22 56.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.553 -0.832 . . . . 1.81 112.306 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -83.72 95.7 8.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.962 0.411 . . . . 1.88 110.444 177.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -103.09 -35.03 8.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.884 -0.598 . . . . 2.14 110.155 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.42 ' C ' ' HB ' ' A' ' 89' ' ' VAL . . . -144.81 35.81 1.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.822 -0.626 . . . . 0.94 110.417 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.549 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.7 tpp180 -120.34 148.01 44.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.044 0.45 . . . . 4.64 111.649 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.532 ' HG3' HG12 ' A' ' 89' ' ' VAL . 91.8 mt-30 -92.48 128.23 38.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.173 -0.677 . . . . 1.75 109.173 173.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 72.1 t -92.9 128.97 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.141 -0.689 . . . . 0.54 109.141 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.893 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -129.9 144.29 51.24 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.335 0.588 . . . . 0.36 110.887 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 31.1 mt -102.08 143.95 31.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.495 -0.775 . . . . 0.84 109.821 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.761 ' HE3' ' CB ' ' A' ' 129' ' ' PHE . 1.2 mptp? -143.73 152.99 41.97 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.284 -0.636 . . . . 1.93 109.284 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -102.88 160.54 14.51 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.008 -0.542 . . . . 0.41 109.606 171.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -83.36 159.65 21.8 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.129 -1.063 . . . . 0.71 108.129 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -58.76 -9.64 1.89 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.982 0.42 . . . . 1.4 111.744 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.44 -38.11 71.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.682 -0.69 . . . . 2.22 111.449 171.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -141.66 23.18 2.12 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.971 0.415 . . . . 1.35 110.406 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 62.8 t80 -126.14 108.15 11.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.56 110.189 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -112.82 107.85 16.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.214 -0.291 . . . . 2.41 110.214 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 71.11 -58.86 0.56 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.982 0.801 . . . . 3.43 110.957 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.512 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -178.52 40.92 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.443 -0.799 . . . . 0.56 111.148 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 3.4 mptp? -131.76 133.9 45.26 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.64 -0.874 . . . . 2.12 108.64 173.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -109.91 135.96 49.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.148 0.499 . . . . 0.56 110.507 172.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 21.7 p90 -142.52 167.5 21.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.553 0.692 . . . . 0.59 111.85 -175.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 65' ' ' LEU . 16.0 mt -80.02 104.64 10.73 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.939 -1.028 . . . . 1.53 109.591 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.3 tp -108.2 138.51 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.751 -0.463 . . . . 0.62 109.751 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 p -83.55 166.16 18.47 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.935 -0.395 . . . . 1.44 109.935 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.28 -28.14 68.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.939 -0.763 . . . . 2.31 108.939 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -80.96 -20.38 42.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.031 -0.986 . . . . 3.09 110.479 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.0 m120 67.25 27.78 8.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.647 -0.706 . . . . 2.62 111.268 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 63' ' ' ASP . 19.7 ptt180 -88.09 -46.4 9.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.485 -0.325 . . . . 4.66 111.287 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.471 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 7.5 m-20 -107.52 143.52 35.8 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.91 -0.404 . . . . 2.51 109.91 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.75 153.87 47.28 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.297 0.373 . . . . 2.07 110.277 174.414 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.682 ' HG ' ' HG3' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -154.09 118.61 4.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.442 -0.947 . . . . 1.98 108.442 177.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 1.5 m-85 -69.91 138.97 52.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.933 0.397 . . . . 0.75 109.945 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.472 HG11 HD21 ' A' ' 56' ' ' LEU . 15.1 m -117.38 176.53 2.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.139 -0.482 . . . . 0.73 110.846 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.49 111.65 10.89 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.822 -0.626 . . . . 1.81 109.673 175.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.402 HD12 HD13 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -86.85 85.46 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.719 0.771 . . . . 0.81 109.196 171.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.684 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 37.7 ttt-85 -102.23 136.46 19.43 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 114.756 -1.111 . . . . 3.79 110.396 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.633 ' HA ' HG22 ' A' ' 96' ' ' ILE . 6.1 Cg_exo -46.05 110.63 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.178 2.585 . . . . 0.59 112.267 176.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.08 97.34 8.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.72 -0.673 . . . . 1.71 110.033 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 71.61 17.7 5.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.094 -0.957 . . . . 1.92 110.881 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -128.59 79.11 1.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.084 0.402 . . . . 1.89 112.084 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.4 t 68.56 -172.2 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.837 -0.62 . . . . 1.7 111.804 172.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.57 141.48 48.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.792 -0.64 . . . . 0.94 110.433 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.448 ' CG ' ' HG3' ' A' ' 71' ' ' PRO . 19.9 m0 -123.45 162.92 21.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.3 -0.409 . . . . 0.5 110.602 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 m -76.41 104.85 7.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.74 -0.837 . . . . 0.51 108.74 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 t -93.43 110.5 22.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.813 0.816 . . . . 0.59 112.515 -170.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -110.86 159.35 17.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.017 -1.105 . . . . 1.7 108.017 166.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -76.59 -5.1 46.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.469 -0.197 . . . . 1.39 110.469 -176.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.435 ' CA ' ' HE1' ' A' ' 49' ' ' PHE . . . -126.74 -32.62 0.69 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.026 -0.607 . . . . 0.65 112.822 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 15.8 m -121.51 148.22 25.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 122.325 -0.515 . . . . 1.16 110.594 175.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.782 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -140.27 100.35 3.88 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.56 -0.533 . . . . 0.36 109.56 -177.609 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.893 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 3.6 p90 -131.06 146.05 52.23 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.318 -0.252 . . . . 0.59 110.318 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -81.86 150.58 27.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.01 -0.676 . . . . 1.39 109.804 176.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -76.45 -13.52 60.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.59 0.709 . . . . 2.12 110.069 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 19.4 m-20 -86.01 145.72 26.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.511 -0.768 . . . . 2.1 110.136 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.532 HG12 ' HG3' ' A' ' 39' ' ' GLN . 19.5 m -103.85 123.39 57.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.282 0.563 . . . . 1.05 110.586 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.47 -147.17 18.85 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.701 -0.762 . . . . 0.46 112.347 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.3 p -75.0 178.68 5.45 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.421 0.629 . . . . 1.17 111.618 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.436 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 83.6 t90 -170.92 -55.63 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.087 -0.96 . . . . 0.51 108.729 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 29.19 97.72 0.01 OUTLIER Glycine 0 N--CA 1.469 0.898 0 O-C-N 125.057 1.473 . . . . 1.25 115.894 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.55 -153.37 10.25 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.58 -0.819 . . . . 0.72 112.964 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 p -101.38 129.66 47.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.871 0.693 . . . . 0.6 112.871 -173.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.707 HD11 ' CG2' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -119.34 130.66 73.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.496 -0.928 . . . . 1.63 108.496 170.278 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.17 153.23 17.06 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.137 -1.03 . . . . 0.45 112.59 -171.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 mp -87.58 112.01 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.014 0.435 . . . . 0.83 110.334 175.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.684 ' CE1' ' HB3' ' A' ' 70' ' ' ARG . 7.4 m-85 -101.66 153.48 19.73 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.935 -1.135 . . . . 1.28 107.935 171.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.663 ' HB ' HD13 ' A' ' 19' ' ' LEU . 3.6 p -87.48 124.7 40.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.323 -0.621 . . . . 1.14 109.323 172.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -83.37 95.35 8.19 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.958 -0.697 . . . . 1.02 109.559 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.58 78.49 0.71 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.55 -0.833 . . . . 1.53 111.535 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.47 ' HA ' HG21 ' A' ' 100' ' ' VAL . 5.7 pt20 -37.97 120.66 0.87 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.724 0.773 . . . . 2.11 112.527 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.682 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 9.7 mm-40 -92.41 19.79 6.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.326 -0.852 . . . . 2.62 110.683 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 m 65.45 5.34 3.15 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.512 -0.767 . . . . 2.43 112.302 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.588 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 12.5 t30 63.78 86.04 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.507 0.67 . . . . 1.56 111.211 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.0 t -80.94 140.53 50.22 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 107.84 -1.17 . . . . 1.68 107.84 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -26.76 92.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.835 3.69 . . . . 1.26 113.943 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -90.74 -161.05 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.192 2.594 . . . . 0.76 112.682 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.73 -76.51 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.342 -1.103 . . . . 0.76 110.342 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -140.58 122.27 15.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.678 -0.49 . . . . 2.04 109.678 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -117.62 124.46 48.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.438 0.637 . . . . 0.75 110.18 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.4 HG23 ' HE2' ' A' ' 139' ' ' LYS . 51.5 m -116.14 97.62 6.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.907 -1.042 . . . . 0.83 109.509 -173.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -104.05 100.83 10.6 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.413 0.625 . . . . 0.51 110.108 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.9 m -73.14 117.94 15.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.033 -0.985 . . . . 0.59 110.002 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -111.44 136.23 50.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.133 0.492 . . . . 1.27 110.857 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 45.8 m -129.32 106.18 8.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.223 -0.658 . . . . 0.7 109.223 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.603 ' H ' ' HB ' ' A' ' 134' ' ' THR . . . -89.01 -156.76 32.01 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.736 -0.745 . . . . 0.8 111.767 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.64 -162.85 28.28 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.469 -0.872 . . . . 0.53 111.932 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.559 ' CZ ' ' HB ' ' A' ' 130' ' ' THR . 52.6 p90 -101.65 144.82 29.9 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.987 0.422 . . . . 0.89 110.269 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.648 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 15.1 t-105 -101.23 131.82 47.03 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.749 -0.834 . . . . 0.56 108.749 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.18 54.87 1.55 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.233 0.54 . . . . 1.42 112.22 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.705 ' CG ' ' HA3' ' A' ' 128' ' ' GLY . 29.0 mmtp -158.98 -142.28 0.09 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.566 -1.272 . . . . 3.47 107.566 174.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -151.57 107.08 3.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.238 0.542 . . . . 2.08 111.926 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.648 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 84.4 m-20 63.91 -36.74 0.17 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.474 -1.239 . . . . 2.47 114.272 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -55.04 -51.48 66.18 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.478 0.547 . . . . 1.96 112.478 -170.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.687 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 36.4 tt0 152.82 22.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.082 0.864 . . . . 2.02 110.801 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.705 ' HA3' ' CG ' ' A' ' 123' ' ' LYS . . . -80.79 88.39 1.34 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 119.957 -1.116 . . . . 0.77 112.222 -175.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.761 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 28.4 p90 -140.82 155.17 46.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.592 0.234 . . . . 1.21 110.395 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.559 ' HB ' ' CZ ' ' A' ' 120' ' ' TYR . 99.5 m -139.74 125.27 11.73 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.594 -0.275 . . . . 1.47 110.695 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 47.8 Cg_exo -56.59 134.06 61.95 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.076 2.517 . . . . 0.92 112.018 177.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.7 t -151.84 103.51 2.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.44 -0.345 . . . . 1.52 110.78 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.436 ' HA3' ' HG3' ' A' ' 4' ' ' GLN . . . 82.08 -4.89 73.94 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.938 -0.648 . . . . 1.17 112.901 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.603 ' HB ' ' H ' ' A' ' 118' ' ' GLY . 25.2 p -109.93 113.93 27.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.98 0.733 . . . . 2.47 112.98 -170.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.6 m -140.11 95.18 2.85 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.954 -1.128 . . . . 1.82 107.954 162.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.497 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -118.1 160.94 13.62 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.063 -1.065 . . . . 0.67 113.02 -171.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -143.02 103.98 4.24 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.77 -0.456 . . . . 0.58 109.77 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.509 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 39.5 m -79.97 108.45 13.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.937 -0.764 . . . . 0.52 108.937 174.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.413 ' HB3' HG23 ' A' ' 11' ' ' THR . 2.7 tppp? -94.7 109.39 21.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.222 0.534 . . . . 2.18 110.052 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.5 HD13 ' HE3' ' A' ' 14' ' ' LYS . 2.3 tp -98.99 104.27 16.29 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.176 -0.92 . . . . 0.63 109.317 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 9.2 m -119.23 140.02 50.92 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.848 -0.614 . . . . 0.58 109.771 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.546 HG23 HG22 ' A' ' 15' ' ' THR . 12.3 p -82.07 149.12 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.459 . . . . 1.74 110.711 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.512 -0.756 . . . . 2.58 109.449 175.639 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.752 0.311 . . . . 5.73 111.611 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -131.59 140.31 49.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.673 0.273 . . . . 3.08 110.929 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 41.8 t -80.9 98.09 7.71 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.61 -0.515 . . . . 1.43 109.61 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -113.47 128.51 56.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.013 -0.539 . . . . 2.29 109.55 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.522 ' HB ' HG23 ' A' ' 134' ' ' THR . 35.1 t -106.56 111.79 36.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.407 -0.59 . . . . 1.51 109.407 -175.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 49.5 mtp180 -84.99 92.51 8.35 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.014 0.435 . . . . 3.57 110.961 -176.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.637 HG23 HG22 ' A' ' 134' ' ' THR . 81.1 t -102.66 115.45 44.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.643 -0.873 . . . . 1.26 108.643 171.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.2 169.22 23.74 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.601 -0.809 . . . . 0.96 112.984 -174.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -88.12 152.93 21.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.933 0.397 . . . . 2.18 110.393 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.951 HD11 ' HB ' ' A' ' 28' ' ' VAL . 89.2 mt -134.74 144.67 47.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.844 -0.616 . . . . 1.41 110.214 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 m -134.41 115.77 14.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.793 -0.447 . . . . 1.03 109.793 171.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.714 HG11 HG22 ' A' ' 25' ' ' ILE . 21.0 t -130.95 130.58 64.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.471 -0.332 . . . . 1.45 110.947 -176.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -99.89 99.67 10.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.377 -0.374 . . . . 0.59 110.517 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -165.86 167.69 16.58 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.426 -0.352 . . . . 3.42 110.256 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.506 ' HA ' HG22 ' A' ' 142' ' ' VAL . 70.4 p -87.25 167.24 14.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 0.63 111.095 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -88.18 -12.16 44.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.83 -0.804 . . . . 3.14 108.83 173.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.72 -29.88 74.18 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.541 -0.754 . . . . 0.75 111.423 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -62.91 -35.02 78.68 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.601 -0.518 . . . . 2.17 109.601 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.552 HD13 ' HB ' ' A' ' 100' ' ' VAL . 48.9 mt -64.8 95.14 0.14 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.421 -0.809 . . . . 1.61 110.118 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -98.16 72.57 2.16 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.973 -0.751 . . . . 1.65 108.973 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 34.0 t70 56.18 -95.7 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.828 -1.078 . . . . 1.83 109.814 -169.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -84.6 77.15 10.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.164 0.507 . . . . 0.82 111.016 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -132.41 96.75 18.66 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.718 -0.674 . . . . 0.79 109.734 175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.45 ' HD3' ' HE1' ' A' ' 99' ' ' TYR . 55.2 Cg_endo -71.9 96.89 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.54 2.16 . . . . 1.12 112.457 -177.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.714 HG22 HG11 ' A' ' 12' ' ' VAL . 16.2 mt -86.64 -30.09 5.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.366 0.603 . . . . 2.58 110.513 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.18 63.51 0.63 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.374 -0.917 . . . . 0.74 112.712 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 14.1 Cg_endo -58.67 106.32 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.342 2.028 . . . . 0.67 111.494 172.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.951 ' HB ' HD11 ' A' ' 10' ' ' LEU . 7.6 p -91.78 130.66 40.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.163 -0.471 . . . . 1.18 110.24 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.9 m -85.7 98.04 10.47 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.9 -0.591 . . . . 1.64 110.626 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.654 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 52.1 t -89.96 115.11 28.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.915 -0.584 . . . . 1.01 110.213 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.484 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 0.2 OUTLIER -104.38 110.13 22.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.948 -0.569 . . . . 2.48 109.551 -176.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.31 105.51 17.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.245 -0.434 . . . . 0.7 110.793 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.61 121.03 23.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.6 -0.727 . . . . 1.94 110.002 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.74 -120.3 8.8 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.741 -0.742 . . . . 1.81 112.141 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 56.4 m 70.36 -58.03 0.56 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.25 0.62 . . . . 1.88 110.722 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.469 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 93.4 m-20 70.1 -48.13 0.63 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.921 0.888 . . . . 2.14 113.272 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.1 77.91 1.22 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.239 -0.652 . . . . 0.94 109.239 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.541 ' HG3' ' HB2' ' A' ' 120' ' ' TYR . 2.9 tpp85 -156.05 146.87 22.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.61 -0.723 . . . . 4.64 110.493 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.729 ' HG3' HG12 ' A' ' 89' ' ' VAL . 55.3 mt-30 -83.2 116.43 22.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.365 -0.38 . . . . 1.75 110.518 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 59.3 t -84.15 124.67 39.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.69 -0.485 . . . . 0.54 109.69 176.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.696 ' HB1' ' HE3' ' A' ' 43' ' ' LYS . . . -125.23 139.51 53.67 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.765 0.317 . . . . 0.36 110.402 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 mt -102.85 129.28 49.48 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.79 -0.448 . . . . 0.84 109.79 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.696 ' HE3' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -120.57 151.3 39.6 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.243 -0.651 . . . . 1.93 109.243 176.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.601 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -100.54 152.91 19.84 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.081 0.467 . . . . 0.41 110.632 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 17.7 t70 -75.18 148.46 39.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.359 -0.837 . . . . 0.71 109.678 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.5 t -57.91 -17.07 14.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.026 0.75 . . . . 1.4 113.026 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.62 -32.17 70.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.975 0.417 . . . . 2.22 110.202 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 4.8 p-10 -123.73 20.1 9.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.05 -0.523 . . . . 1.35 110.237 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.588 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 61.6 t80 -139.97 106.22 5.26 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.619 -0.719 . . . . 0.56 109.932 -177.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -107.36 108.21 19.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.641 -0.254 . . . . 2.41 110.36 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 71.23 -53.87 0.67 Allowed 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.974 0.796 . . . . 3.43 111.778 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.588 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -179.96 31.88 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.904 -0.665 . . . . 0.56 112.578 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 75.1 mmtt -134.63 134.91 41.72 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.757 -0.831 . . . . 2.12 108.757 173.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -112.51 148.62 34.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.447 0.642 . . . . 0.56 112.181 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.609 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 9.5 p90 -156.12 171.51 20.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.975 -1.012 . . . . 0.59 110.304 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.629 HD22 HD22 ' A' ' 114' ' ' LEU . 10.2 mt -84.57 115.42 22.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.531 -0.914 . . . . 1.53 108.531 172.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.464 HG22 ' HB3' ' A' ' 48' ' ' ASN . 7.7 tp -107.54 116.43 51.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.687 0.756 . . . . 0.62 110.96 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 23.8 p -62.43 151.36 37.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.33 -0.85 . . . . 1.44 111.561 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.65 -24.11 64.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.168 0.509 . . . . 2.31 110.355 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -93.5 17.56 11.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.815 -0.629 . . . . 3.09 110.581 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 25.82 67.3 0.05 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.438 1.095 . . . . 2.62 112.771 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.522 HH21 HG22 ' A' ' 107' ' ' THR . 7.1 ptm85 -120.41 -44.59 2.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.552 -0.749 . . . . 4.66 111.895 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' HB3' ' OH ' ' A' ' 112' ' ' TYR . 26.4 t0 -138.5 139.66 38.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.754 -0.462 . . . . 2.51 109.754 -175.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 2.2 pptp? -128.68 138.92 52.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.08 0.467 . . . . 2.07 110.703 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.647 HD23 ' HB2' ' A' ' 104' ' ' GLN . 6.1 mp -129.16 120.53 26.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.189 -0.46 . . . . 1.98 110.666 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -70.7 131.79 44.42 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.0 -0.37 . . . . 0.75 110.0 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 100' ' ' VAL . 15.7 m -128.6 124.47 61.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.248 -0.433 . . . . 0.73 110.759 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.53 120.12 32.68 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.266 0.555 . . . . 1.81 110.16 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.453 HG22 ' HB ' ' A' ' 96' ' ' ILE . 2.9 mt -82.6 85.3 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 0.81 110.237 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.514 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 65.7 mtp180 -90.26 133.58 32.99 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.0 -0.741 . . . . 3.79 109.0 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.701 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 40.3 Cg_endo -66.87 134.99 36.48 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.569 1.513 . . . . 0.59 111.157 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.5 ttt -79.32 92.1 5.12 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.855 -0.612 . . . . 1.71 110.666 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 68.24 36.04 3.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.465 -0.789 . . . . 1.92 112.064 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -139.11 115.23 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.055 0.761 . . . . 1.89 113.055 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.8 m 63.21 -167.15 0.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.076 -0.965 . . . . 1.7 113.0 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.41 114.31 19.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.655 -0.702 . . . . 0.94 110.137 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.642 ' CD1' ' HG3' ' A' ' 71' ' ' PRO . 11.8 m95 -109.49 141.43 41.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.826 -0.625 . . . . 0.5 110.705 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.1 m -80.44 111.35 16.76 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.53 -0.544 . . . . 0.51 109.53 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.6 t -86.04 113.47 22.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.798 0.809 . . . . 0.59 112.079 -173.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -129.29 156.07 44.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.154 -0.93 . . . . 1.7 108.509 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -82.87 -0.53 48.63 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.716 -0.394 . . . . 1.39 111.61 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.57 -34.23 2.3 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.467 -0.873 . . . . 0.65 111.868 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.593 HG11 ' HZ3' ' A' ' 121' ' ' TRP . 10.7 m -138.73 154.64 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.634 -0.506 . . . . 1.16 109.634 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -140.48 106.86 5.27 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.105 -1.072 . . . . 0.36 108.105 178.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 2.0 p90 -139.49 141.98 37.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.757 0.789 . . . . 0.59 112.895 -170.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.602 ' HB2' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -70.64 128.22 35.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.987 -1.46 . . . . 1.39 111.04 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.56 -35.34 79.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.59 . . . . 2.12 109.69 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.602 ' OD1' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -68.5 125.75 27.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.364 -0.834 . . . . 2.1 109.673 175.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.729 HG12 ' HG3' ' A' ' 39' ' ' GLN . 16.4 m -91.91 118.4 37.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.159 0.504 . . . . 1.05 110.958 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.469 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 159.6 -169.14 35.6 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.393 -0.908 . . . . 0.46 112.348 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.3 p -70.4 151.27 45.37 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.127 -0.694 . . . . 1.17 109.127 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 37.0 t90 -135.71 -64.89 0.61 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.755 -0.378 . . . . 0.51 110.121 -175.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.654 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 35.86 85.28 0.01 OUTLIER Glycine 0 N--CA 1.468 0.776 0 O-C-N 124.307 1.004 . . . . 1.25 114.618 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.17 -153.91 6.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.922 -0.656 . . . . 0.72 112.236 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -106.11 132.9 51.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.198 0.523 . . . . 0.6 112.363 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.701 ' HA ' ' HA ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -125.22 141.04 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.857 -0.794 . . . . 1.63 108.857 171.306 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -114.56 151.1 18.55 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.16 -1.019 . . . . 0.45 112.647 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -92.7 114.34 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.514 -0.55 . . . . 0.83 109.514 174.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.54 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 10.1 m-85 -120.97 129.87 53.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.437 -0.802 . . . . 1.28 108.892 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.732 ' HA ' HG12 ' A' ' 67' ' ' VAL . 8.6 p -71.03 142.66 15.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.035 -0.357 . . . . 1.14 110.035 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.57 95.45 0.33 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.385 -0.37 . . . . 1.02 110.867 176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 50.38 48.81 40.4 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.973 -0.558 . . . . 1.53 113.67 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.502 ' H ' HG13 ' A' ' 100' ' ' VAL . 10.5 pt20 38.41 88.47 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.005 0.907 . . . . 2.11 112.34 -174.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.647 ' HB2' HD23 ' A' ' 65' ' ' LEU . 38.5 mm-40 -56.98 -76.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.816 -1.083 . . . . 2.62 113.129 -175.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -146.37 -64.66 0.3 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.388 -0.369 . . . . 2.43 111.979 -169.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 15.7 t30 60.85 47.2 7.98 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 122.259 1.028 . . . . 1.56 108.393 -170.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.522 HG22 HH21 ' A' ' 62' ' ' ARG . 16.2 m -72.45 123.31 89.35 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 114.84 -1.073 . . . . 1.68 109.246 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -11.82 84.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.342 1 C-N-CA 125.966 4.444 . . . . 1.26 114.44 -164.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 2.8 Cg_endo -87.0 -169.09 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.634 2.889 . . . . 0.76 114.035 -168.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.35 -111.82 0.25 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.224 -1.55 . . . . 0.76 109.224 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -89.39 131.23 35.56 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.848 0.356 . . . . 2.04 110.311 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 6.3 m-85 -125.35 125.31 43.27 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.778 -0.452 . . . . 0.75 109.778 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.9 m -96.63 129.36 44.04 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.698 -0.683 . . . . 0.83 110.23 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.629 HD22 HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -144.68 104.57 4.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.522 -0.918 . . . . 0.51 108.522 171.042 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 32.5 m -108.19 123.97 49.57 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.527 -0.916 . . . . 0.59 108.527 -174.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 116' ' ' LEU . 2.8 mm? -113.35 110.92 21.14 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.397 0.618 . . . . 1.27 110.755 -173.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 9.8 m -98.27 103.71 15.68 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.256 -0.884 . . . . 0.7 108.733 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.775 ' H ' ' HB ' ' A' ' 134' ' ' THR . . . -92.29 -157.13 33.36 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 120.378 -0.915 . . . . 0.8 112.023 -173.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 147.87 -167.9 28.77 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.707 -0.957 . . . . 0.53 110.707 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.541 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 50.5 p90 -98.86 138.24 36.27 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.83 -0.748 . . . . 0.89 109.945 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.612 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 11.2 t-105 -91.72 141.7 28.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.473 -1.24 . . . . 0.56 109.142 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.17 57.33 1.2 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.162 0.43 . . . . 1.42 112.162 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.54 ' C ' ' HE1' ' A' ' 121' ' ' TRP . 55.5 mmtt -158.96 -139.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.364 -0.976 . . . . 3.47 108.364 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -154.84 100.47 2.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.32 0.581 . . . . 2.08 112.087 173.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.612 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 27.1 t-20 60.65 -41.58 0.11 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.454 1.502 . . . . 2.47 114.309 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.514 ' HG3' ' N ' ' A' ' 127' ' ' GLN . 19.4 ptpt -52.56 -51.18 60.95 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.753 0.649 . . . . 1.96 112.753 -172.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.514 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 51.9 tt0 152.37 88.96 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.236 1.014 . . . . 2.02 109.239 -176.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 123' ' ' LYS . . . -142.31 90.65 0.17 Allowed Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.33 -0.938 . . . . 0.77 111.129 172.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.442 ' CB ' ' HZ2' ' A' ' 43' ' ' LYS . 44.7 p90 -144.78 168.51 20.04 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.869 -0.419 . . . . 1.21 109.869 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 4.1 t -156.68 129.25 4.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.897 0.379 . . . . 1.47 110.615 173.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 24.0 Cg_exo -64.2 110.71 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.939 2.426 . . . . 0.92 111.776 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.1 t -131.57 91.93 3.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.395 -0.366 . . . . 1.52 110.314 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.25 -3.18 85.54 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.98 -0.629 . . . . 1.17 112.702 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.775 ' HB ' ' H ' ' A' ' 118' ' ' GLY . 16.5 p -100.5 113.6 26.52 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 113.376 0.88 . . . . 2.47 113.376 -168.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 54.4 m -141.3 94.88 2.75 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.624 -0.51 . . . . 1.82 109.624 165.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.505 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -110.01 85.03 0.39 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.205 -0.998 . . . . 0.67 112.729 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.8 m -81.15 95.01 6.75 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.618 -0.512 . . . . 0.58 109.618 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.609 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 27.5 m -89.15 108.5 19.64 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.106 -0.701 . . . . 0.52 109.106 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 139' ' ' LYS . 29.1 ttmt -103.89 108.79 20.28 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.848 0.832 . . . . 2.18 109.583 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.505 HD23 HD13 ' A' ' 56' ' ' LEU . 21.6 tp -105.35 104.05 13.7 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.281 -1.327 . . . . 0.63 109.343 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.72 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.8 m -117.74 138.11 52.25 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.937 -0.574 . . . . 0.58 110.883 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 15' ' ' THR . 40.3 t -91.58 111.35 23.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.518 -0.919 . . . . 1.74 108.518 170.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.407 -0.806 . . . . 2.58 110.743 -176.555 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 109.111 -0.7 . . . . 5.73 109.111 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.12 115.64 28.17 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.437 -0.579 . . . . 3.08 109.437 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.1 m -91.68 109.54 20.85 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.0 -0.546 . . . . 1.43 111.786 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -86.64 111.26 20.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.216 -0.661 . . . . 2.29 109.216 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.97 HG21 ' HA3' ' A' ' 118' ' ' GLY . 33.1 m -80.93 137.68 20.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.176 0.513 . . . . 1.51 110.417 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.564 ' NE ' ' HA ' ' A' ' 6' ' ' ARG . 5.2 mmp_? -96.46 95.07 7.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.146 -0.479 . . . . 3.57 110.078 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.412 HG22 ' HA3' ' A' ' 136' ' ' GLY . 11.9 p -116.77 140.15 40.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.503 -0.771 . . . . 1.26 109.163 177.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.62 136.08 9.54 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.388 -0.911 . . . . 0.96 111.895 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.81 106.52 2.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.803 -0.443 . . . . 2.18 109.803 177.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.56 HD21 HG22 ' A' ' 28' ' ' VAL . 4.1 pp -116.73 151.29 36.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.308 -0.405 . . . . 1.41 110.779 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -120.61 123.64 43.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.038 -0.528 . . . . 1.03 110.194 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.459 HG12 ' HG2' ' A' ' 14' ' ' LYS . 39.2 t -130.12 135.46 60.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.268 -0.424 . . . . 1.45 110.493 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.687 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -103.67 96.15 6.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.879 0.371 . . . . 0.59 110.658 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.459 ' HG2' HG12 ' A' ' 12' ' ' VAL . 33.8 mmtp -144.32 163.44 33.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 3.42 110.288 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.798 ' HA ' HG13 ' A' ' 142' ' ' VAL . 31.3 p -91.8 149.89 21.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.339 -0.392 . . . . 0.63 110.433 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.769 ' NH1' ' HG3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -81.97 -0.03 42.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.198 0.523 . . . . 3.14 110.062 177.659 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.694 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -84.33 -22.75 53.54 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.816 -0.914 . . . . 0.75 110.816 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -56.61 -31.08 63.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.774 0.797 . . . . 2.17 109.361 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.846 HD21 HG23 ' A' ' 25' ' ' ILE . 7.1 mt -89.61 111.27 22.17 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.832 -1.076 . . . . 1.61 109.765 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -107.97 75.35 0.99 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.491 -0.929 . . . . 1.65 108.491 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.639 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 36.4 t70 62.6 -93.18 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.401 -1.272 . . . . 1.83 110.336 -170.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.23 73.84 10.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.321 0.581 . . . . 0.82 111.065 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -152.79 121.6 3.23 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.259 -0.882 . . . . 0.79 108.88 174.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 48.2 Cg_endo -89.85 151.06 4.97 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.074 2.516 . . . . 1.12 113.654 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.846 HG23 HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.68 -64.46 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.627 -0.715 . . . . 2.58 110.781 175.037 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.95 77.52 0.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.679 -0.772 . . . . 0.74 112.898 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.524 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 5.2 Cg_endo -48.24 111.1 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.32 2.68 . . . . 0.67 112.327 168.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.56 HG22 HD21 ' A' ' 10' ' ' LEU . 26.0 t -87.13 134.37 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.533 -0.758 . . . . 1.18 110.305 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 32.4 p -78.09 79.26 4.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 1.64 110.392 175.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.5 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 40.3 t -82.94 114.62 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.271 0.557 . . . . 1.01 110.46 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.669 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 58.1 tt0 -110.94 135.07 52.01 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.13 -0.941 . . . . 2.48 109.96 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.486 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -104.76 123.8 48.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.084 -0.507 . . . . 0.7 110.572 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.39 123.05 49.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.258 -0.428 . . . . 1.94 110.882 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.71 28.7 8.19 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.861 -0.685 . . . . 1.81 111.939 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.486 ' SG ' ' HB1' ' A' ' 32' ' ' ALA . 19.6 m -120.74 94.65 4.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.893 0.378 . . . . 1.88 111.019 -176.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.404 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 16.3 m120 -98.48 -19.37 17.7 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.372 -0.603 . . . . 2.14 109.372 174.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.43 ' HA ' ' H ' ' A' ' 90' ' ' GLY . . . -167.78 72.35 0.11 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.78 -0.645 . . . . 0.94 111.138 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 5.8 tpt180 -152.36 146.9 25.71 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 110.319 -0.252 . . . . 4.64 110.319 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.89 131.52 36.44 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.408 -0.59 . . . . 1.75 109.408 174.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 95.1 t -103.1 120.34 52.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.193 -0.669 . . . . 0.54 109.193 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.7 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -114.12 143.2 45.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.105 0.479 . . . . 0.36 111.453 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.3 mt -102.78 114.75 29.27 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.719 -0.673 . . . . 0.84 109.767 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 152.55 27.72 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.441 -0.8 . . . . 1.93 109.093 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 116' ' ' LEU . . . -92.38 154.42 18.55 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.305 -0.628 . . . . 0.41 109.305 170.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.72 159.13 31.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.203 -1.036 . . . . 0.71 108.203 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.66 -20.58 34.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.707 1.003 . . . . 1.4 113.707 -168.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.25 -32.89 73.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.016 0.436 . . . . 2.22 110.903 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -115.36 13.23 16.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.634 0.73 . . . . 1.35 109.924 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -130.52 101.75 5.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.848 -0.614 . . . . 0.56 109.506 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.45 103.31 14.2 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.988 -0.375 . . . . 2.41 109.988 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 71.48 -56.64 0.63 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 124.084 0.865 . . . . 3.43 111.322 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.28 39.08 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.036 -0.826 . . . . 0.56 111.036 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 81' ' ' ASN . 43.6 mmtm -138.36 135.03 34.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.172 -1.048 . . . . 2.12 108.172 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.4 148.5 37.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.607 0.717 . . . . 0.56 111.211 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.736 ' CE2' ' HB ' ' A' ' 57' ' ' ILE . 0.8 OUTLIER -145.93 -169.11 3.16 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.994 -1.003 . . . . 0.59 110.755 -170.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.78 ' HG ' HD22 ' A' ' 114' ' ' LEU . 1.1 mp -111.2 104.24 12.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.567 -1.271 . . . . 1.53 107.567 167.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.736 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 9.4 tp -107.81 136.5 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.273 0.559 . . . . 0.62 111.669 -172.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.2 t -70.72 140.55 51.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.003 -0.74 . . . . 1.44 109.003 171.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.21 -16.97 64.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.981 0.42 . . . . 2.31 111.118 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -87.32 -14.43 40.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 3.09 110.657 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.5 t30 59.89 94.46 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.798 -0.637 . . . . 2.62 110.966 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -153.74 -46.5 0.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 4.66 110.126 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -117.31 138.63 51.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.508 -0.769 . . . . 2.51 109.555 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.94 153.27 46.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.227 1.013 . . . . 2.07 111.499 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 6.4 mp -120.65 175.58 5.94 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 113.377 -1.738 . . . . 1.98 106.82 169.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -126.56 145.13 50.65 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.58 -0.896 . . . . 0.75 108.58 151.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.544 HG11 HD13 ' A' ' 56' ' ' LEU . 29.4 m -134.22 160.07 41.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.861 0.362 . . . . 0.73 110.867 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 99' ' ' TYR . 14.4 p-10 -126.11 111.99 15.31 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.853 -0.612 . . . . 1.81 109.865 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.425 HG23 HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -72.88 101.44 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.033 -0.729 . . . . 0.81 109.033 173.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -122.14 139.86 31.28 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.825 -0.625 . . . . 3.79 110.215 -170.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.51 122.61 5.93 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.67 2.246 . . . . 0.59 111.793 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 53.7 ttp -53.09 -54.01 41.89 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.702 0.626 . . . . 1.71 111.706 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -155.96 15.03 0.34 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.954 0.407 . . . . 1.92 110.504 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -80.81 -81.83 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.032 -0.531 . . . . 1.89 111.658 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.492 ' HB2' ' HE1' ' A' ' 92' ' ' TRP . 3.7 m -136.56 172.35 13.15 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.472 -0.196 . . . . 1.7 110.472 -175.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.98 122.46 32.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.989 0.423 . . . . 0.94 110.859 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.497 ' HE3' ' HD1' ' A' ' 84' ' ' PHE . 12.5 m0 -107.79 156.94 18.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.892 -0.595 . . . . 0.5 110.319 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 m -72.44 121.03 18.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.958 -0.756 . . . . 0.51 108.958 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 t -103.42 101.24 11.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.928 0.87 . . . . 0.59 112.979 -168.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 83' ' ' VAL . 3.7 m-20 -110.33 161.29 15.78 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.721 -1.214 . . . . 1.7 107.721 168.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 53' ' ' LYS . 2.1 t-20 -86.82 -7.26 58.4 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.696 -0.801 . . . . 1.39 110.154 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.53 -30.29 3.6 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.525 -0.845 . . . . 0.65 112.556 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 32.1 m -135.68 149.39 28.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 110.047 -0.353 . . . . 1.16 110.047 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -139.44 110.8 7.01 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.224 -0.658 . . . . 0.36 109.224 -179.622 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 8.2 p90 -142.87 149.3 38.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.13 -0.322 . . . . 0.59 110.13 -174.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -74.47 145.07 43.9 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.037 -0.665 . . . . 1.39 110.524 -178.466 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.03 -27.45 65.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.215 -0.902 . . . . 2.12 110.969 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -95.09 -166.19 1.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.623 -0.717 . . . . 2.1 110.551 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.6 -169.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.838 -0.619 . . . . 1.05 109.413 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.43 ' H ' ' HA ' ' A' ' 37' ' ' ALA . . . 85.65 -154.0 27.84 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.623 -0.798 . . . . 0.46 111.9 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.7 m -87.35 -171.69 3.59 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.156 -0.683 . . . . 1.17 109.156 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.492 ' HE1' ' HB2' ' A' ' 75' ' ' SER . 77.9 t90 -168.33 -50.0 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.573 -0.529 . . . . 0.51 109.573 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 18.44 92.71 0.01 OUTLIER Glycine 0 N--CA 1.474 1.186 0 O-C-N 125.208 1.567 . . . . 1.25 115.862 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 29' ' ' THR . . . -150.33 -125.37 1.29 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.797 -0.716 . . . . 0.72 112.311 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.47 126.58 35.39 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.195 0.443 . . . . 0.6 112.195 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -119.8 129.26 75.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.053 -0.721 . . . . 1.63 109.053 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -112.79 152.34 17.95 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.257 -0.973 . . . . 0.45 112.071 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.6 mp -90.12 112.48 24.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.898 -0.408 . . . . 0.83 109.898 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.479 ' HD2' ' N ' ' A' ' 23' ' ' ALA . 2.9 m-85 -107.03 140.68 39.45 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.223 -1.029 . . . . 1.28 108.223 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 8.5 p -84.19 136.36 22.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.47 . . . . 1.14 109.919 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.57 112.33 16.73 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.193 -0.317 . . . . 1.02 110.658 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.9 37.01 60.96 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 1.53 113.238 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 17.9 pt20 39.82 103.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.481 1.289 . . . . 2.11 114.481 177.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -62.8 -27.09 69.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.873 -0.603 . . . . 2.62 109.897 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.9 m 65.11 14.84 9.65 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.846 0.832 . . . . 2.43 110.069 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.694 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 20.6 t30 59.83 92.04 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.416 -1.265 . . . . 1.56 112.488 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.41 ' N ' HH12 ' A' ' 16' ' ' ARG . 21.1 m -94.93 124.51 54.14 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.621 -0.881 . . . . 1.68 108.621 173.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -26.28 93.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.414 4.076 . . . . 1.26 114.934 -171.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.769 ' HG3' ' NH1' ' A' ' 16' ' ' ARG . 55.6 Cg_endo -100.18 -153.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 124.633 3.556 . . . . 0.76 113.682 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.89 -104.73 0.18 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.504 -1.038 . . . . 0.76 110.504 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.41 113.2 26.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.868 0.366 . . . . 2.04 110.323 175.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -107.52 135.64 48.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.208 0.527 . . . . 0.75 109.937 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 42.5 m -116.97 98.97 6.76 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.176 -0.92 . . . . 0.83 110.447 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.78 HD22 ' HG ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -110.61 91.63 3.73 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.494 0.664 . . . . 0.51 110.173 178.178 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 1.2 m -82.84 125.65 31.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.314 -0.857 . . . . 0.59 110.195 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 91.0 mt -115.72 110.65 19.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.882 0.372 . . . . 1.27 111.158 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 135' ' ' THR . 28.7 m -90.19 108.52 19.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.112 -0.495 . . . . 0.7 110.25 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.97 ' HA3' HG21 ' A' ' 5' ' ' VAL . . . -74.4 178.26 44.99 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.952 -0.642 . . . . 0.8 113.289 -176.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 153.56 -170.24 32.33 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 121.073 -0.584 . . . . 0.53 111.663 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -103.52 -176.23 3.02 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.452 -0.499 . . . . 0.89 110.273 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.669 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 6.3 t-105 -144.8 151.63 39.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.655 -0.702 . . . . 0.56 109.634 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -129.51 141.58 50.96 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.722 0.296 . . . . 1.42 111.471 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 20.5 mmtp 71.66 -152.21 0.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.101 0.961 . . . . 3.47 112.078 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.456 ' H ' ' HB3' ' A' ' 123' ' ' LYS . 19.9 m-20 -132.9 110.86 10.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.68 0.622 . . . . 2.08 112.68 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.669 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 12.3 m120 59.43 -7.72 0.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.781 1.232 . . . . 2.47 114.3 174.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -3.68 36.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.841 0.353 . . . . 1.96 110.767 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.93 HE21 ' HE2' ' A' ' 129' ' ' PHE . 59.7 tt0 74.61 85.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.978 -1.01 . . . . 2.02 110.83 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -120.48 33.0 4.65 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.484 -0.865 . . . . 0.77 111.466 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.93 ' HE2' HE21 ' A' ' 127' ' ' GLN . 11.4 p90 -78.89 152.3 31.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.11 0.481 . . . . 1.21 110.535 -172.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 34.5 m -134.99 133.28 20.82 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.792 -0.64 . . . . 1.47 109.561 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.11 112.24 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.286 1.991 . . . . 0.92 111.818 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.404 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 13.5 m -139.22 105.99 5.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.739 -0.664 . . . . 1.52 109.69 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 126.91 -128.12 6.15 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.561 -0.828 . . . . 1.17 111.492 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.2 m -133.12 159.16 40.93 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.627 -0.508 . . . . 2.47 109.627 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 12.6 t -97.18 110.37 22.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.616 0.722 . . . . 1.82 109.342 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.412 ' HA3' HG22 ' A' ' 7' ' ' VAL . . . -90.16 118.39 5.28 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.754 -0.736 . . . . 0.67 112.144 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 7.4 m -84.77 101.29 12.12 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.715 -0.476 . . . . 0.58 109.715 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.547 HG23 HD11 ' A' ' 10' ' ' LEU . 19.6 m -77.91 108.9 11.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.244 -1.021 . . . . 0.52 108.244 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.448 ' HE3' ' HB2' ' A' ' 139' ' ' LYS . 32.5 ttmt -97.05 108.99 21.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.688 0.756 . . . . 2.18 110.439 -172.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 tp -107.11 108.15 19.48 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.461 -1.245 . . . . 0.63 110.253 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.687 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 10.6 m -108.43 117.32 33.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.37 -0.832 . . . . 0.58 109.077 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.798 HG13 ' HA ' ' A' ' 15' ' ' THR . 39.5 t -93.11 116.26 33.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.206 0.527 . . . . 1.74 112.058 -172.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.5 m . . . . . 0 C--O 1.249 1.067 0 CA-C-N 115.262 -0.881 . . . . 2.58 109.249 172.945 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.469 0.652 . . . . 5.73 111.377 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -120.76 169.21 10.63 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.91 -0.774 . . . . 3.08 108.91 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 91.5 m -62.36 88.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.527 0.517 . . . . 1.43 112.146 -176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -87.86 108.65 19.27 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.873 -1.158 . . . . 2.29 107.873 171.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -93.21 111.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.597 -0.52 . . . . 1.51 109.597 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.447 ' HA ' ' OG1' ' A' ' 134' ' ' THR . 71.4 mtm180 -94.45 97.42 10.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.951 -0.568 . . . . 3.57 110.77 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.0 t -103.5 115.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.114 -0.948 . . . . 1.26 108.651 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.1 155.44 23.62 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.399 -0.905 . . . . 0.96 112.249 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -73.34 142.95 47.06 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.973 -0.38 . . . . 2.18 109.973 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -157.16 148.49 22.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.085 -0.507 . . . . 1.41 109.95 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.5 t -109.55 133.58 52.93 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.093 0.473 . . . . 1.03 109.887 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.9 t -117.34 126.2 74.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.761 -0.654 . . . . 1.45 109.378 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -106.16 104.12 13.75 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.409 -0.219 . . . . 0.59 110.409 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 mtmm -172.59 -178.67 1.99 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.155 -0.475 . . . . 3.42 110.835 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 142' ' ' VAL . 46.3 p -102.93 167.09 10.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.89 -0.595 . . . . 0.63 110.933 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.773 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -87.8 -10.34 51.2 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.863 -0.791 . . . . 3.14 108.863 175.294 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.614 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -71.29 -20.32 78.08 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.293 -0.867 . . . . 0.75 111.578 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -58.57 -41.33 85.46 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.596 0.712 . . . . 2.17 109.365 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.627 HD21 HG12 ' A' ' 25' ' ' ILE . 4.5 mt -80.19 100.07 8.11 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.615 -1.175 . . . . 1.61 110.449 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.436 ' H ' ' HB3' ' A' ' 23' ' ' ALA . 0.8 OUTLIER -103.66 70.76 1.04 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.784 -0.821 . . . . 1.65 108.784 174.269 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 1.0 OUTLIER 67.16 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.647 -1.16 . . . . 1.83 110.295 -171.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.63 66.01 5.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.308 0.575 . . . . 0.82 111.194 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -141.94 115.36 6.61 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.39 -0.823 . . . . 0.79 109.858 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.5 Cg_endo -91.52 151.12 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.51 2.806 . . . . 1.12 113.341 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.627 HG12 HD21 ' A' ' 19' ' ' LEU . 3.3 pt -116.97 -56.58 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 2.58 112.174 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.487 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -114.04 88.97 0.5 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.475 -0.869 . . . . 0.74 112.914 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 38.2 Cg_exo -60.46 126.93 21.24 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.601 2.201 . . . . 0.67 112.067 172.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.5 t -98.66 127.7 50.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.984 -0.553 . . . . 1.18 110.273 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 m -74.45 101.24 4.07 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 116.156 -0.475 . . . . 1.64 110.489 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 99.3 t -104.04 115.6 46.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.101 -0.5 . . . . 1.01 110.525 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.64 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 47.3 tt0 -113.61 107.02 15.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.999 0.428 . . . . 2.48 110.713 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.75 109.06 20.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.644 -0.707 . . . . 0.7 109.835 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.28 130.29 48.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.025 -0.534 . . . . 1.94 110.287 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.68 29.51 10.73 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.798 -0.715 . . . . 1.81 113.203 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.5 m -94.07 -74.07 0.55 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.926 0.343 . . . . 1.88 111.926 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.549 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 9.1 t30 71.2 -44.69 0.6 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.85 0.46 . . . . 2.14 112.062 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.14 76.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.205 0.526 . . . . 0.94 110.282 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.564 ' H ' ' N ' ' A' ' 90' ' ' GLY . 1.7 tpm_? -157.82 148.52 20.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.436 -0.802 . . . . 4.64 110.455 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -86.2 134.67 33.76 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.098 -0.705 . . . . 1.75 109.098 172.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 93.3 t -110.53 125.3 67.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.943 -0.391 . . . . 0.54 109.943 -176.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.604 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -117.54 152.62 34.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 123.485 0.491 . . . . 0.36 111.293 -173.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.447 HD12 ' HB3' ' A' ' 84' ' ' PHE . 28.2 mt -103.76 104.41 14.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.734 -0.666 . . . . 0.84 109.868 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.604 ' HE2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -98.38 122.75 41.95 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.311 -0.626 . . . . 1.93 109.311 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . . . -83.48 158.21 22.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.332 -0.395 . . . . 0.41 110.774 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.714 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 13.6 t70 -87.19 152.2 22.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.188 -0.46 . . . . 0.71 109.782 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -54.74 -20.37 8.26 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.803 0.668 . . . . 1.4 112.803 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.9 -37.54 74.21 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.936 0.398 . . . . 2.22 111.269 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.624 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 5.6 p-10 -129.27 16.14 6.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.895 -0.593 . . . . 1.35 109.956 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 82.2 t80 -132.85 101.73 5.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.308 -0.86 . . . . 0.56 109.148 -176.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -93.58 93.83 8.29 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.198 -0.456 . . . . 2.41 110.571 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 69.46 -50.3 0.61 Allowed 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.154 0.909 . . . . 3.43 112.103 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.51 35.73 0.16 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.772 -0.531 . . . . 0.56 111.772 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 43.4 mmtm -137.49 133.28 34.42 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.404 -0.961 . . . . 2.12 108.404 172.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -117.43 136.57 53.09 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.004 0.907 . . . . 0.56 112.077 178.261 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.624 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 30.8 p90 -141.06 -176.7 4.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.049 -1.432 . . . . 0.59 108.51 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.937 HD22 HD22 ' A' ' 114' ' ' LEU . 10.9 mt -102.7 127.58 49.77 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.549 -0.908 . . . . 1.53 108.549 172.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.45 133.88 49.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.406 0.622 . . . . 0.62 110.636 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 112' ' ' TYR . 29.5 t -83.87 150.06 25.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.323 -0.853 . . . . 1.44 110.654 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.18 -26.41 68.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.962 -0.563 . . . . 2.31 110.239 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -75.32 -13.62 60.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.658 . . . . 3.09 110.537 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 61.09 20.04 10.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.568 -0.742 . . . . 2.62 111.999 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.888 ' HE ' ' HA ' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -95.49 -70.42 0.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.875 0.369 . . . . 4.66 110.989 -177.313 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.67 158.48 16.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.788 -0.642 . . . . 2.51 111.845 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -143.66 175.08 10.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.24 -0.891 . . . . 2.07 110.319 -178.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.488 HD12 HG23 ' A' ' 100' ' ' VAL . 1.5 pt? -157.17 125.57 5.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.28 -0.418 . . . . 1.98 110.29 173.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 94.2 m-85 -72.83 144.74 47.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.052 -0.722 . . . . 0.75 109.052 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.442 HG11 HD21 ' A' ' 56' ' ' LEU . 15.7 m -123.66 157.18 30.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.308 0.575 . . . . 0.73 111.784 -175.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.464 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -118.94 111.54 18.48 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.438 -0.949 . . . . 1.81 108.438 171.522 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.407 HG22 HD12 ' A' ' 96' ' ' ILE . 0.9 OUTLIER -92.52 86.17 2.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.33 -0.619 . . . . 0.81 109.33 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HG3' ' HD2' ' A' ' 71' ' ' PRO . 57.7 ttp180 -112.41 142.15 26.47 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.41 -0.589 . . . . 3.79 109.41 -174.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 84.9 Cg_exo -44.26 140.23 5.83 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.052 2.501 . . . . 0.59 112.927 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 52.8 ttp -60.56 -52.96 62.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.693 -0.855 . . . . 1.71 108.693 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -153.34 107.63 3.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.138 -0.937 . . . . 1.92 109.315 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -168.73 -163.15 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.737 0.303 . . . . 1.89 111.191 -175.461 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 p -60.32 168.06 2.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.882 -0.599 . . . . 1.7 112.02 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 120.16 23.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.73 -0.668 . . . . 0.94 111.153 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.802 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.8 m95 -107.34 134.11 50.89 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.543 -0.753 . . . . 0.5 109.967 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.9 m -76.35 116.73 17.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.524 -0.547 . . . . 0.51 109.524 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 t -88.57 115.51 26.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.492 0.663 . . . . 0.59 112.329 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -129.06 159.79 34.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.69 -1.226 . . . . 1.7 107.69 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -84.26 -6.71 59.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.42 -0.512 . . . . 1.39 111.57 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.57 -35.39 3.83 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.126 -1.035 . . . . 0.65 111.761 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.563 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 30.4 m -140.32 154.24 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.885 0.374 . . . . 1.16 110.134 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.1 t80 -138.18 106.82 5.88 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.019 -1.104 . . . . 0.36 108.019 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 6.0 p90 -140.65 144.08 35.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.817 0.341 . . . . 0.59 111.662 -171.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.802 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 25.7 pttm -72.58 142.24 48.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 1.39 109.625 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -77.63 -5.54 50.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.293 0.568 . . . . 2.12 110.35 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -86.08 142.93 28.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.392 -0.822 . . . . 2.1 110.182 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 m -99.5 108.62 22.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.483 0.658 . . . . 1.05 110.633 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.564 ' N ' ' H ' ' A' ' 38' ' ' ARG . . . 167.11 -164.12 37.63 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.648 -0.705 . . . . 0.46 111.707 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.3 m -79.97 -178.19 6.36 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.2 -0.667 . . . . 1.17 109.2 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.466 ' CH2' HG23 ' A' ' 96' ' ' ILE . 29.0 t90 -154.9 -61.84 0.12 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.571 -0.451 . . . . 0.51 110.367 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 34.15 85.63 0.01 OUTLIER Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.436 1.085 . . . . 1.25 115.242 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.58 -151.35 6.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.771 -0.728 . . . . 0.72 112.5 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -118.34 124.17 47.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.461 0.648 . . . . 0.6 112.514 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 71' ' ' PRO . 13.7 pt -108.5 148.75 12.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.319 -0.855 . . . . 1.63 109.159 174.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.35 151.25 17.55 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.303 -0.951 . . . . 0.45 111.365 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 70.1 mt -95.11 112.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 120.295 -0.562 . . . . 0.83 110.339 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.464 ' HD1' ' O ' ' A' ' 68' ' ' ASN . 10.5 m-85 -104.7 151.95 23.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.972 -1.013 . . . . 1.28 108.514 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 104' ' ' GLN . 8.1 p -83.07 140.03 16.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.441 -0.504 . . . . 1.14 109.693 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.81 82.27 2.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.937 -0.764 . . . . 1.02 108.937 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.55 114.69 0.58 Allowed Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.636 -0.711 . . . . 1.53 111.459 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.466 ' HA ' HG11 ' A' ' 100' ' ' VAL . 4.5 tt0 -32.53 107.11 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.973 0.909 . . . . 2.11 112.64 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.506 ' HB2' HG21 ' A' ' 100' ' ' VAL . 48.8 tp60 -78.01 -13.26 59.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.571 . . . . 2.62 110.461 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.2 m 64.71 15.85 10.02 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.791 -0.64 . . . . 2.43 111.036 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.773 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 10.4 t30 58.29 77.67 0.28 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.351 0.596 . . . . 1.56 110.918 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.423 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 11.2 t -77.81 144.1 68.06 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.386 -0.968 . . . . 1.68 108.386 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 45.1 Cg_exo -27.51 92.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.984 3.789 . . . . 1.26 114.388 -173.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -100.1 -157.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 123.398 2.732 . . . . 0.76 113.791 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.17 -91.06 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.683 -1.367 . . . . 0.76 109.683 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -125.75 119.35 27.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.305 -0.628 . . . . 2.04 109.305 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 58' ' ' SER . 24.6 m-85 -108.81 128.42 54.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.352 0.596 . . . . 0.75 110.293 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.1 m -105.87 122.29 45.81 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.927 -1.033 . . . . 0.83 110.369 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.937 HD22 HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -136.86 121.59 18.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.928 -0.578 . . . . 0.51 109.688 176.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.714 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 6.5 m -112.08 128.42 56.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.797 -0.638 . . . . 0.59 109.296 -174.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -121.57 119.7 32.67 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.02 0.438 . . . . 1.27 110.527 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.2 m -94.65 117.7 30.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.074 -0.512 . . . . 0.7 110.605 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.15 146.72 49.4 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.838 -0.696 . . . . 0.8 112.318 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.48 156.98 9.91 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 111.544 -0.623 . . . . 0.53 111.544 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -89.48 -176.66 5.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.223 0.535 . . . . 0.89 110.762 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.702 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 1.3 t-105 -142.08 151.92 42.81 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.182 -0.917 . . . . 0.56 110.02 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.56 144.33 51.08 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.0 -0.546 . . . . 1.42 111.23 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.676 ' HG2' ' H ' ' A' ' 124' ' ' ASP . 34.3 tttp 67.61 -147.79 0.15 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.455 1.102 . . . . 3.47 111.906 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.676 ' H ' ' HG2' ' A' ' 123' ' ' LYS . 6.7 m-20 -139.67 118.65 12.57 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.573 0.583 . . . . 2.08 112.573 -173.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.651 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.7 OUTLIER 45.49 14.02 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.427 1.639 . . . . 2.47 115.427 175.143 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.572 ' HE2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -92.32 -2.18 56.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.56 0.695 . . . . 1.96 109.832 175.69 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.702 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 58.2 mt-30 72.71 54.19 0.15 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 114.37 -1.286 . . . . 2.02 111.923 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.532 ' N ' ' HD2' ' A' ' 126' ' ' LYS . . . -89.86 93.44 1.88 Allowed Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 108.826 -1.71 . . . . 0.77 108.826 165.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.482 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 50.8 p90 -134.84 134.91 41.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 117.91 0.855 . . . . 1.21 110.863 -173.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.8 m -115.78 134.88 22.64 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 116.091 -0.504 . . . . 1.47 110.217 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.34 106.03 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.882 2.388 . . . . 0.92 111.084 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.8 m -146.6 99.3 3.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.042 0.449 . . . . 1.52 110.342 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 141.61 -141.52 11.12 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.383 -0.913 . . . . 1.17 112.603 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 6' ' ' ARG . 2.7 m -100.13 143.27 30.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.627 0.251 . . . . 2.47 110.86 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 24.1 m -94.73 95.86 9.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.147 -0.686 . . . . 1.82 109.147 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.45 155.65 21.83 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.777 -0.725 . . . . 0.67 112.049 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -124.78 114.56 19.41 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.655 0.265 . . . . 0.58 110.647 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.77 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 3.5 m -89.69 119.88 30.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.221 -1.029 . . . . 0.52 108.221 172.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -117.48 109.36 16.64 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.687 0.756 . . . . 2.18 110.392 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.413 ' HG ' ' NH2' ' A' ' 16' ' ' ARG . 23.9 tp -101.93 106.1 16.99 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.425 -1.262 . . . . 0.63 111.112 -172.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 6.2 m -105.02 143.77 32.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.49 -0.777 . . . . 0.58 109.32 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 15' ' ' THR . 7.3 p -89.22 128.77 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.162 0.506 . . . . 1.74 111.065 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.624 -0.716 . . . . 2.58 110.082 177.947 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 1' ' ' GLU . 5.5 mm-40 . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 120.628 0.251 . . . . 5.73 110.46 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.432 ' OE2' ' HB2' ' A' ' 4' ' ' GLN . 41.1 tt0 -127.06 143.17 51.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.823 0.344 . . . . 3.08 110.996 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.416 ' SG ' ' HG2' ' A' ' 38' ' ' ARG . 42.3 t -101.97 91.25 4.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.374 -0.973 . . . . 1.43 108.374 172.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 1.127 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 5.4 tt0 -108.6 119.52 39.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.729 -0.669 . . . . 2.29 111.593 -172.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG22 HG13 ' A' ' 40' ' ' VAL . 22.5 t -91.61 111.54 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.046 -0.724 . . . . 1.51 109.046 173.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 88.2 mtt180 -87.83 109.49 19.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.254 -0.43 . . . . 3.57 111.654 -177.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.535 HG11 ' HB2' ' A' ' 116' ' ' LEU . 48.9 t -125.21 115.37 43.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.293 -0.867 . . . . 1.26 109.152 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.37 -179.37 35.33 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.598 -0.81 . . . . 0.96 111.965 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -99.02 147.25 25.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.922 0.391 . . . . 2.18 109.978 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.48 147.36 20.48 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.364 -0.606 . . . . 1.41 109.364 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.7 m -116.94 117.68 30.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.907 0.384 . . . . 1.03 111.09 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.15 109.48 28.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.884 -0.598 . . . . 1.45 109.431 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -83.61 96.65 8.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.229 -0.441 . . . . 0.59 111.188 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -149.9 179.41 8.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.16 0.505 . . . . 3.42 110.94 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.41 ' HA ' HH11 ' A' ' 16' ' ' ARG . 52.9 p -101.77 167.43 10.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.738 -0.664 . . . . 0.63 109.875 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.577 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.3 OUTLIER -86.3 -11.62 51.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.792 -0.818 . . . . 3.14 108.792 177.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' A' ' 106' ' ' ASN . . . -81.21 -24.98 56.25 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.959 -1.019 . . . . 0.75 111.038 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -61.7 -26.62 68.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.41 0.624 . . . . 2.17 110.119 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.661 ' HG ' HG23 ' A' ' 100' ' ' VAL . 0.6 OUTLIER -67.27 -54.46 20.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.053 -0.976 . . . . 1.61 109.917 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.8 m 56.81 49.02 14.97 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.825 -1.079 . . . . 1.65 109.221 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.496 ' N ' ' HB3' ' A' ' 103' ' ' GLN . 20.9 t70 77.38 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.279 -1.328 . . . . 1.83 110.428 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -109.69 87.35 2.48 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.272 0.471 . . . . 0.82 112.272 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.87 113.65 3.15 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.79 109.916 169.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.604 ' HD3' ' HE2' ' A' ' 99' ' ' TYR . 50.8 Cg_endo -68.46 94.05 0.43 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.689 2.259 . . . . 1.12 111.814 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.64 HG13 HD22 ' A' ' 19' ' ' LEU . 51.3 mm -89.34 -42.94 14.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.988 -0.551 . . . . 2.58 111.639 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.77 51.98 0.75 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 119.636 -1.269 . . . . 0.74 113.9 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.486 ' HD2' ' C ' ' A' ' 25' ' ' ILE . 8.9 Cg_endo -50.21 123.46 11.09 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.312 2.675 . . . . 0.67 112.481 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.69 139.7 24.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.21 -0.45 . . . . 1.18 110.047 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 t -82.75 102.88 11.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.92 0.867 . . . . 1.64 110.751 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 67.0 t -94.17 114.52 30.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.963 -1.017 . . . . 1.01 110.292 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 57.5 tt0 -99.21 126.47 45.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.784 -0.45 . . . . 2.48 109.784 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.7 94.95 8.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.294 -0.412 . . . . 0.7 109.996 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . 6.4 tt -80.01 114.1 18.67 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.006 -0.739 . . . . 1.94 109.006 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.98 -129.91 10.57 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.603 -0.808 . . . . 1.81 111.252 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.0 m 64.05 23.14 13.15 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.603 0.237 . . . . 1.88 111.593 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.509 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 67.1 t30 -59.81 -29.67 68.4 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.157 0.429 . . . . 2.14 112.157 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.6 25.31 10.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.214 0.53 . . . . 0.94 110.269 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.416 ' HG2' ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -123.92 154.71 39.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.133 -0.485 . . . . 4.64 111.253 -172.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.728 ' HG3' HG12 ' A' ' 89' ' ' VAL . 88.3 mt-30 -93.14 128.75 39.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.945 -0.57 . . . . 1.75 109.533 173.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 87.2 t -101.7 117.13 46.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.492 -0.322 . . . . 0.54 110.669 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.742 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -114.44 167.09 11.03 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 123.402 0.439 . . . . 0.36 110.381 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.3 mt -120.11 109.66 15.72 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.061 -0.518 . . . . 0.84 109.632 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.937 ' HE2' HG22 ' A' ' 83' ' ' VAL . 20.4 mmtp -105.86 119.77 40.02 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.552 0.691 . . . . 1.93 110.131 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.65 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -71.48 155.3 40.75 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.553 -1.203 . . . . 0.41 110.363 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 13.5 t70 -72.19 153.73 41.44 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.937 -0.764 . . . . 0.71 108.937 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -58.56 -18.81 32.7 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.183 0.438 . . . . 1.4 112.183 -172.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -62.89 -37.57 87.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.821 0.343 . . . . 2.22 110.985 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.65 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 8.0 p-10 -125.18 20.28 8.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.178 0.514 . . . . 1.35 110.335 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 27.3 t80 -127.92 107.42 9.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.296 -0.866 . . . . 0.56 108.708 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 7.2 pt-20 -106.96 107.01 17.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.501 -0.318 . . . . 2.41 110.454 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 70.79 -56.26 0.62 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.03 0.532 . . . . 3.43 111.294 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.7 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -176.03 34.05 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.78 -0.928 . . . . 0.56 110.78 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 18.5 mmtp -132.34 135.0 45.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.639 -0.874 . . . . 2.12 108.639 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.494 ' CD2' ' HA2' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -107.49 140.11 40.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.47 0.652 . . . . 0.56 110.934 171.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.794 ' CD2' ' HB2' ' A' ' 64' ' ' LYS . 40.6 p90 -147.49 174.36 11.78 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.208 -0.905 . . . . 0.59 110.353 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.495 HD22 HD22 ' A' ' 114' ' ' LEU . 16.9 mt -88.31 116.95 26.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.392 -0.966 . . . . 1.53 108.392 171.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.587 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 8.0 tp -106.42 128.54 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.546 0.689 . . . . 0.62 110.927 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.6 p -66.56 129.23 39.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.254 -0.885 . . . . 1.44 110.161 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.15 -30.33 70.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.325 0.583 . . . . 2.31 109.67 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.91 -14.29 62.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.046 -0.979 . . . . 3.09 110.487 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 59.66 81.91 0.16 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.244 -0.889 . . . . 2.62 110.559 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.438 ' NH1' ' HB2' ' A' ' 108' ' ' PRO . 9.3 ptp180 -144.07 -41.44 0.27 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.68 -0.691 . . . . 4.66 111.218 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -147.36 174.59 11.52 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.497 -0.481 . . . . 2.51 111.483 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.794 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -160.29 142.77 13.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.706 -0.679 . . . . 2.07 110.526 -177.146 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' HB3' ' NE2' ' A' ' 104' ' ' GLN . 1.8 pt? -140.6 132.44 27.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.551 0.215 . . . . 1.98 110.96 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 64' ' ' LYS . 17.0 m-85 -72.22 141.67 48.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.381 . . . . 0.75 110.749 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.704 HG12 ' HA ' ' A' ' 100' ' ' VAL . 13.3 m -135.31 128.85 49.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.056 -0.52 . . . . 0.73 110.547 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -94.51 113.36 25.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.555 0.693 . . . . 1.81 110.336 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -76.93 85.5 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.424 -0.807 . . . . 0.81 109.907 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.688 ' HG2' ' HD2' ' A' ' 71' ' ' PRO . 13.8 ttp180 -98.32 140.59 21.95 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.36 -0.836 . . . . 3.79 109.216 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.688 ' HD2' ' HG2' ' A' ' 70' ' ' ARG . 97.4 Cg_exo -43.42 136.56 5.97 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.816 2.344 . . . . 0.59 112.807 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.2 tpt -63.41 -58.91 5.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.876 -0.602 . . . . 1.71 110.3 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -159.66 105.04 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.991 -0.55 . . . . 1.92 111.142 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.446 HD21 ' HZ2' ' A' ' 92' ' ' TRP . 2.8 p30 -174.47 -88.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.416 0.448 . . . . 1.89 111.594 172.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.4 m -127.13 -175.44 3.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.638 0.256 . . . . 1.7 110.522 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.29 139.37 36.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.348 -0.387 . . . . 0.94 111.264 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.496 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 11.2 m0 -114.0 151.18 32.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.669 -0.696 . . . . 0.5 109.779 176.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.2 m -70.69 116.29 10.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.31 -0.626 . . . . 0.51 109.31 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t -96.49 117.45 30.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.469 0.652 . . . . 0.59 112.584 -171.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.403 ' CB ' ' HB ' ' A' ' 83' ' ' VAL . 0.4 OUTLIER -126.18 161.99 26.42 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.287 -1.005 . . . . 1.7 108.287 170.563 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -69.29 -21.02 63.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.818 0.303 . . . . 1.39 111.818 -171.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA2' ' CD2' ' A' ' 54' ' ' PHE . . . -139.44 16.23 3.15 Favored Glycine 0 CA--C 1.509 -0.285 0 N-CA-C 111.519 -0.632 . . . . 0.65 111.519 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.937 HG22 ' HE2' ' A' ' 43' ' ' LYS . 95.8 t -139.2 124.63 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.867 -0.79 . . . . 1.16 108.867 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.742 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -139.22 105.47 5.26 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.087 -0.708 . . . . 0.36 109.087 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 1.3 p90 -145.86 141.75 28.15 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.56 0.538 . . . . 0.59 110.529 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.496 ' HB3' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -75.93 138.93 41.33 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.56 -0.456 . . . . 1.39 109.81 177.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -59.84 -29.14 68.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.369 -0.832 . . . . 2.12 110.259 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 16.6 m-20 -75.13 137.6 41.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.225 -0.898 . . . . 2.1 110.75 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.728 HG12 ' HG3' ' A' ' 39' ' ' GLN . 27.7 m -90.46 132.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.729 -0.471 . . . . 1.05 109.729 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 36' ' ' ASN . . . 146.55 -170.4 27.59 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.645 -0.788 . . . . 0.46 111.179 -174.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.5 m -77.65 -175.1 3.72 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 109.573 -0.528 . . . . 1.17 109.573 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.446 ' HZ2' HD21 ' A' ' 74' ' ' ASN . 76.2 t90 -163.3 -56.47 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.752 -0.462 . . . . 0.51 109.752 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 32.15 95.15 0.01 OUTLIER Glycine 0 N--CA 1.47 0.917 0 O-C-N 124.843 1.34 . . . . 1.25 115.674 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.64 -165.62 27.31 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.515 -0.634 . . . . 0.72 111.515 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 p -101.35 128.74 47.38 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.063 0.459 . . . . 0.6 111.908 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.572 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -112.71 158.54 13.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.442 -0.948 . . . . 1.63 108.442 167.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -116.97 153.69 17.21 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.244 -0.979 . . . . 0.45 112.449 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.8 mp -91.07 114.34 28.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.766 -0.457 . . . . 0.83 109.766 175.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.604 ' HE2' ' HD3' ' A' ' 24' ' ' PRO . 2.3 m-85 -116.63 139.43 50.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.443 -0.947 . . . . 1.28 108.443 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.704 ' HA ' HG12 ' A' ' 67' ' ' VAL . 86.7 t -74.74 123.52 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.952 -0.388 . . . . 1.14 109.952 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -78.58 86.42 4.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.693 -0.854 . . . . 1.02 108.693 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.72 83.44 1.4 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.684 -0.77 . . . . 1.53 111.742 -174.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.496 ' HB3' ' N ' ' A' ' 21' ' ' ASP . 15.3 pt20 -40.11 117.82 0.82 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.663 0.616 . . . . 2.11 112.663 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.427 ' NE2' ' HB3' ' A' ' 65' ' ' LEU . 6.9 tt0 -90.56 5.14 49.04 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.53 -0.759 . . . . 2.62 110.058 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.448 ' O ' HG22 ' A' ' 105' ' ' THR . 11.1 m 62.23 23.54 13.93 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.697 -0.683 . . . . 2.43 111.287 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.614 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 8.2 t30 66.92 92.97 0.08 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.632 -0.713 . . . . 1.56 111.86 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.599 HG22 ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -74.73 147.64 84.47 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-O 118.51 -0.757 . . . . 1.68 109.427 172.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.599 ' HD2' HG22 ' A' ' 107' ' ' THR . 1.6 Cg_endo -43.11 93.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 124.106 3.204 . . . . 1.26 112.539 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -97.74 -165.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.265 2.643 . . . . 0.76 114.615 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.88 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 108.789 -1.724 . . . . 0.76 108.789 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -115.29 122.92 47.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.799 -0.815 . . . . 2.04 108.799 169.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.466 ' HB2' HH21 ' A' ' 16' ' ' ARG . 6.5 m-85 -109.24 113.91 27.15 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.63 0.728 . . . . 0.75 109.913 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 57' ' ' ILE . 47.3 m -94.82 135.49 36.25 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.553 -1.203 . . . . 0.83 110.791 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.495 HD22 HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -147.84 91.01 1.89 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.497 0.665 . . . . 0.51 109.687 173.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 44.7 m -82.5 135.63 35.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.651 -0.704 . . . . 0.59 110.055 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.535 ' HB2' HG11 ' A' ' 7' ' ' VAL . 95.2 mt -118.34 120.04 36.43 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.118 -0.492 . . . . 1.27 109.705 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.3 m -92.69 110.83 22.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.306 -0.406 . . . . 0.7 109.926 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.84 118.46 12.03 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.665 -0.779 . . . . 0.8 111.555 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.568 ' HA2' ' H ' ' A' ' 132' ' ' SER . . . -165.8 145.0 9.67 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.851 -0.69 . . . . 0.53 111.521 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 130' ' ' THR . 47.3 p90 -88.41 172.97 8.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.303 0.573 . . . . 0.89 110.621 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.625 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 2.3 t-105 -123.2 148.47 45.77 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.471 -0.786 . . . . 0.56 110.017 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.33 145.95 49.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.672 -0.694 . . . . 1.42 110.431 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.948 ' HA ' ' HE2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER 70.27 -140.97 0.07 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.762 0.825 . . . . 3.47 110.519 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -159.74 125.38 4.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.067 0.46 . . . . 2.08 111.604 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.625 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 17.6 m120 63.13 -24.7 0.06 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.002 1.482 . . . . 2.47 115.002 177.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.473 ' HG2' ' HG2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -70.55 -3.25 17.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.925 0.393 . . . . 1.96 111.435 -178.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.557 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 22.7 tt0 74.45 61.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.365 -0.834 . . . . 2.02 111.22 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -102.53 113.17 4.5 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.619 -0.992 . . . . 0.77 110.619 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 50.0 p90 -135.75 163.91 29.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.571 0.685 . . . . 1.21 110.296 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 120' ' ' TYR . 37.9 m -152.38 110.45 2.8 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.82 -0.437 . . . . 1.47 109.82 173.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 16.5 Cg_exo -65.37 116.36 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.617 2.211 . . . . 0.92 112.228 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.568 ' H ' ' HA2' ' A' ' 119' ' ' GLY . 12.1 t -155.05 108.19 2.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.455 -0.793 . . . . 1.52 108.87 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 1.127 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 151.37 -138.07 6.36 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.519 -0.848 . . . . 1.17 111.808 -176.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.4 m -111.72 138.61 48.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.648 0.261 . . . . 2.47 110.394 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.6 m -94.44 98.46 10.89 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.72 -0.474 . . . . 1.82 109.72 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.33 130.29 9.51 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.449 -0.881 . . . . 0.67 112.504 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 86.1 m -96.25 114.82 26.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.629 0.252 . . . . 0.58 110.426 178.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.493 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 13.9 m -78.32 116.86 19.04 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.222 -1.029 . . . . 0.52 108.222 173.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -102.74 108.58 19.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.502 0.668 . . . . 2.18 110.281 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.429 ' CD2' HD13 ' A' ' 56' ' ' LEU . 10.6 tp -106.28 94.67 5.28 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.938 -1.028 . . . . 0.63 109.844 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 12.1 m -102.28 144.4 30.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.707 -0.679 . . . . 0.58 109.431 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.0 p -83.63 133.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.397 -0.521 . . . . 1.74 110.585 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.541 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 43.9 m . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.607 -0.711 . . . . 2.58 109.516 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.043 0.449 . . . . 5.73 110.224 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.87 131.1 47.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.174 -0.676 . . . . 3.08 109.174 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 t -167.17 67.36 0.09 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.809 -1.182 . . . . 1.43 107.809 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 10.1 mm100 -86.8 112.2 21.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.101 -0.954 . . . . 2.29 110.647 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 7' ' ' VAL . 61.5 t -82.16 110.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.877 -0.786 . . . . 1.51 108.877 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -80.77 91.25 5.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.65 0.738 . . . . 3.57 110.616 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 5' ' ' VAL . 3.5 m -104.85 140.34 23.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.646 -1.161 . . . . 1.26 109.734 175.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.6 167.29 24.84 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.157 -1.021 . . . . 0.96 112.706 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.47 131.42 35.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.079 -0.341 . . . . 2.18 110.079 175.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.18 137.75 24.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.125 -0.489 . . . . 1.41 109.929 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.6 m -103.29 122.42 44.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.043 -0.526 . . . . 1.03 110.442 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.749 HG11 ' HB ' ' A' ' 25' ' ' ILE . 45.2 t -118.76 111.3 33.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.918 -0.583 . . . . 1.45 109.877 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -92.54 101.41 13.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.41 -0.359 . . . . 0.59 110.444 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 5.7 tppt? -163.39 165.47 23.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.981 0.419 . . . . 3.42 110.566 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.622 ' HA ' HG13 ' A' ' 142' ' ' VAL . 82.4 p -89.79 159.01 17.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.017 -0.538 . . . . 0.63 110.558 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -0.03 27.31 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.393 -0.595 . . . . 3.14 109.393 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.55 -20.81 76.22 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.586 -1.006 . . . . 0.75 110.586 171.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -66.39 -48.48 69.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.812 -0.81 . . . . 2.17 108.812 168.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 25' ' ' ILE . 11.0 mt -73.04 92.72 1.7 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.9 -1.046 . . . . 1.61 110.276 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.684 ' H ' ' HB3' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -96.35 69.24 2.64 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.318 -0.623 . . . . 1.65 109.318 177.053 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.5 t70 63.89 -90.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 114.639 -1.164 . . . . 1.83 109.89 -172.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.68 63.66 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.345 0.593 . . . . 0.82 110.726 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.684 ' HB3' ' H ' ' A' ' 20' ' ' THR . . . -140.39 116.74 7.85 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.442 -0.799 . . . . 0.79 109.805 175.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 93.0 Cg_endo -87.24 150.82 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.464 2.776 . . . . 1.12 113.469 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.749 ' HB ' HG11 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -102.75 -62.76 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.3 -0.864 . . . . 2.58 111.125 175.41 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.422 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -127.73 90.93 0.34 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.5 -0.857 . . . . 0.74 112.646 -177.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.78 117.28 3.82 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.82 2.347 . . . . 0.67 111.857 172.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -83.75 133.23 29.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 1.18 109.825 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.9 p -75.91 83.77 2.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.3 0.571 . . . . 1.64 110.36 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.6 t -94.07 115.18 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.709 -0.678 . . . . 1.01 110.315 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.659 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 63.7 tt0 -112.71 135.54 53.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.881 -0.6 . . . . 2.48 109.993 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.44 103.03 13.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.512 -0.551 . . . . 0.7 109.512 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 4' ' ' GLN . 51.6 tp -82.25 112.29 19.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.367 -0.379 . . . . 1.94 110.359 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 -117.73 5.1 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.779 -0.724 . . . . 1.81 112.094 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 57.0 m 69.43 -71.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.66 0.784 . . . . 1.88 111.112 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.416 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 51.1 m-80 66.22 -56.57 0.37 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.999 0.92 . . . . 2.14 112.75 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.32 40.65 3.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.152 0.501 . . . . 0.94 110.354 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 13.2 tpp180 -126.16 148.27 49.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.159 -0.473 . . . . 4.64 111.509 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.428 ' HG3' HG12 ' A' ' 89' ' ' VAL . 41.5 mt-30 -87.6 124.15 33.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 1.75 109.879 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 57.8 t -91.08 121.05 41.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.733 -0.469 . . . . 0.54 109.733 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.778 ' HB1' ' HE3' ' A' ' 43' ' ' LYS . . . -121.81 147.94 45.32 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 120.758 0.313 . . . . 0.36 110.472 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -102.02 105.39 16.14 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.254 0.549 . . . . 0.84 109.95 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.778 ' HE3' ' HB1' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -96.2 151.47 19.46 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.84 -0.8 . . . . 1.93 108.84 176.622 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HB3' ' HD1' ' A' ' 49' ' ' PHE . . . -111.62 156.67 21.45 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 110.014 -0.365 . . . . 0.41 110.014 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -79.9 152.93 29.34 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.506 -0.924 . . . . 0.71 108.506 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -57.08 -13.67 3.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.946 0.339 . . . . 1.4 111.851 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -56.54 -37.38 70.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 2.22 111.077 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 26.0 p-10 -134.05 19.87 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.578 -0.283 . . . . 1.35 110.509 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.734 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 63.1 t80 -124.62 102.55 7.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.78 -0.452 . . . . 0.56 109.78 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.746 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 15.3 pt-20 -101.26 105.44 16.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.395 -0.366 . . . . 2.41 110.585 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? 71.61 -55.96 0.65 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.804 0.842 . . . . 3.43 111.154 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.734 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -174.11 37.52 0.12 Allowed Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.932 -0.652 . . . . 0.56 111.973 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 29.4 mmtm -146.15 139.07 25.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.009 -0.367 . . . . 2.12 110.009 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.602 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -113.5 150.16 33.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.268 0.556 . . . . 0.56 111.948 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.746 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 22.5 p90 -157.61 177.84 10.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.265 -0.88 . . . . 0.59 111.159 -172.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.749 HD23 HD22 ' A' ' 114' ' ' LEU . 14.9 mt -81.12 115.51 20.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.328 -0.99 . . . . 1.53 108.328 170.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 113' ' ' THR . 9.2 tp -105.13 120.12 55.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.806 -0.757 . . . . 0.62 109.828 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.569 ' HB2' ' CE1' ' A' ' 112' ' ' TYR . 42.6 t -75.12 147.56 40.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.341 -0.845 . . . . 1.44 111.465 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.59 -29.53 70.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.526 -0.761 . . . . 2.31 109.753 170.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -81.29 -24.05 37.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.297 -0.865 . . . . 3.09 110.124 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.4 t30 65.67 21.09 11.62 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.418 -0.81 . . . . 2.62 111.948 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 62' ' ' ARG . 63.6 mtt180 -98.21 -6.66 30.81 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.077 -0.389 . . . . 4.66 110.815 176.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.5 143.72 30.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.108 -0.497 . . . . 2.51 111.249 -175.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -150.22 130.5 13.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.729 -0.669 . . . . 2.07 110.232 172.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.632 ' HB2' HD12 ' A' ' 56' ' ' LEU . 2.9 mm? -120.21 130.11 54.4 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.315 -0.402 . . . . 1.98 110.329 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.445 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 94.4 m-85 -68.57 146.53 52.99 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.77 -0.372 . . . . 0.75 110.052 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.35 149.89 20.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.059 0.457 . . . . 0.73 110.904 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -114.41 110.4 19.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.779 -0.823 . . . . 1.81 108.779 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.431 HG23 HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -91.88 107.1 18.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.906 -0.775 . . . . 0.81 108.906 177.226 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 64.5 mtp180 -122.77 143.05 39.25 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.346 -0.388 . . . . 3.79 110.93 -168.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 32.3 Cg_exo -59.29 139.33 89.47 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.026 2.484 . . . . 0.59 111.721 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.0 ttt -70.28 79.18 0.53 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.433 -0.349 . . . . 1.71 111.274 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.8 t70 55.05 45.98 25.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.553 -0.748 . . . . 1.92 112.134 172.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -113.95 -89.45 0.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.048 -0.407 . . . . 1.89 111.59 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -114.66 166.36 11.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.763 0.316 . . . . 1.7 110.617 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.9 113.09 21.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.951 -0.568 . . . . 0.94 110.583 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.572 ' CE2' ' HB3' ' A' ' 86' ' ' LYS . 11.2 m0 -104.56 137.43 42.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.652 -0.704 . . . . 0.5 110.465 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.3 m -65.26 125.06 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.47 -0.567 . . . . 0.51 109.47 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -107.42 105.01 14.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.057 0.932 . . . . 0.59 112.797 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -122.3 145.0 48.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.16 -1.422 . . . . 1.7 107.16 163.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.525 ' HB2' ' CD ' ' A' ' 53' ' ' LYS . 7.9 m120 -71.83 5.07 2.78 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 120.388 -0.525 . . . . 1.39 112.15 -176.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.03 -13.41 2.19 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.81 -0.709 . . . . 0.65 111.578 170.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.451 HG22 ' HZ1' ' A' ' 43' ' ' LYS . 57.5 t -131.83 114.74 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.981 -0.377 . . . . 1.16 109.981 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.688 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.2 t80 -130.75 97.55 4.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.551 -0.907 . . . . 0.36 108.551 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.59 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 12.2 p90 -137.35 150.1 47.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.975 0.417 . . . . 0.59 111.124 -173.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 12.6 pttp -84.42 145.28 28.26 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.728 -0.669 . . . . 1.39 110.951 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.16 -32.69 73.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.17 0.51 . . . . 2.12 109.751 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.645 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -68.94 140.14 55.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.627 -0.715 . . . . 2.1 110.412 174.106 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.428 HG12 ' HG3' ' A' ' 39' ' ' GLN . 31.2 m -101.38 131.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.214 0.531 . . . . 1.05 110.612 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 138.77 -164.5 25.74 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.459 -0.656 . . . . 0.46 111.459 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.7 p -85.14 137.74 32.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.652 -0.499 . . . . 1.17 109.652 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.618 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 89.7 t90 -102.47 -60.63 1.51 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.418 -0.956 . . . . 0.51 108.418 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 48.43 112.75 0.01 OUTLIER Glycine 0 N--CA 1.468 0.811 0 O-C-N 124.556 1.16 . . . . 1.25 115.663 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.52 -130.5 1.62 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.352 -0.699 . . . . 0.72 111.352 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 p -124.31 130.75 53.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.008 0.432 . . . . 0.6 111.213 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.6 mm -111.5 126.21 68.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.31 -0.626 . . . . 1.63 109.31 176.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.11 141.24 15.45 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.495 -0.86 . . . . 0.45 111.869 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 mp -90.59 112.04 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.383 -0.599 . . . . 0.83 109.383 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 70' ' ' ARG . 28.6 m-85 -109.59 142.07 41.22 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.33 -0.989 . . . . 1.28 108.33 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 103' ' ' GLN . 7.2 p -77.72 140.36 17.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.275 -0.57 . . . . 1.14 109.63 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.16 88.97 3.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.277 -0.638 . . . . 1.02 109.277 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.78 107.23 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.823 -0.704 . . . . 1.53 111.45 -173.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.588 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 0.7 OUTLIER -46.74 127.82 10.1 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 121.226 0.536 . . . . 2.11 112.031 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.5 ' HG2' HD21 ' A' ' 65' ' ' LEU . 57.3 tp60 -89.74 1.99 55.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.687 -0.688 . . . . 2.62 110.095 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 m 60.91 22.91 13.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.717 -0.674 . . . . 2.43 111.231 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.3 t30 59.52 94.07 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.624 -0.716 . . . . 1.56 111.207 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.468 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 11.3 t -102.98 146.11 31.82 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 107.435 -1.32 . . . . 1.68 107.435 174.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 78.3 Cg_exo -24.19 90.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 1 C-N-CA 125.303 4.002 . . . . 1.26 114.313 -173.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.505 ' HG2' HG11 ' A' ' 142' ' ' VAL . 94.8 Cg_endo -104.37 -166.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 123.586 2.857 . . . . 0.76 114.736 -171.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -175.35 -120.83 0.62 Allowed Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.202 -1.363 . . . . 0.76 109.976 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -92.9 122.38 35.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.748 0.308 . . . . 2.04 110.315 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 56' ' ' LEU . 91.6 m-85 -116.02 123.69 48.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.271 0.558 . . . . 0.75 110.075 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.596 ' O ' HG22 ' A' ' 57' ' ' ILE . 16.2 m -100.58 140.34 34.99 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.434 -0.803 . . . . 0.83 110.641 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.749 HD22 HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -143.36 92.43 2.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.447 0.642 . . . . 0.51 109.634 173.534 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 32.3 m -86.72 116.84 25.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.562 -0.745 . . . . 0.59 110.841 -176.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 93.8 mt -99.87 140.39 34.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.069 -0.514 . . . . 1.27 110.547 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.3 m -107.28 109.57 21.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.041 -0.527 . . . . 0.7 109.82 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.1 129.11 29.03 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.785 -0.721 . . . . 0.8 111.71 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.528 ' HA2' ' H ' ' A' ' 132' ' ' SER . . . -170.52 167.66 40.78 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.734 -0.746 . . . . 0.53 111.824 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -102.64 161.43 13.74 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.009 0.433 . . . . 0.89 110.007 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.605 ' HZ2' ' H ' ' A' ' 125' ' ' ASN . 4.3 t-105 -119.03 152.31 36.65 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.483 -0.781 . . . . 0.56 109.705 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -134.45 137.06 43.67 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.803 -0.635 . . . . 1.42 110.201 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.583 ' HG3' ' HE2' ' A' ' 126' ' ' LYS . 74.4 mmtt 82.21 -146.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.197 0.999 . . . . 3.47 111.016 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 126' ' ' LYS . 8.2 p-10 -147.91 117.41 7.0 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.179 0.807 . . . . 2.08 113.179 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.605 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 28.0 t-20 64.32 -19.85 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.892 1.277 . . . . 2.47 114.126 171.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.583 ' HE2' ' HG3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -69.05 -2.99 11.4 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.493 0.317 . . . . 1.96 111.491 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 72.04 69.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.21 -0.905 . . . . 2.02 110.623 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -112.22 99.32 1.05 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 109.997 -1.241 . . . . 0.77 109.997 168.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 40.5 p90 -144.57 145.86 32.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.103 0.952 . . . . 1.21 110.369 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 29.2 m -132.25 116.39 15.39 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.25 -0.432 . . . . 1.47 109.988 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.507 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 29.3 Cg_exo -60.7 125.09 16.37 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.856 2.37 . . . . 0.92 112.222 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.528 ' H ' ' HA2' ' A' ' 119' ' ' GLY . 5.8 t -152.05 96.3 2.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.985 -0.746 . . . . 1.52 108.985 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.09 -112.61 0.53 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.83 -0.908 . . . . 1.17 110.83 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.93 171.61 14.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.095 0.448 . . . . 2.47 111.029 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.3 96.06 7.8 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.274 -0.639 . . . . 1.82 109.274 171.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -97.67 113.49 4.73 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.776 -0.726 . . . . 0.67 112.18 -174.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 77.9 m -88.84 107.13 18.82 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.106 0.479 . . . . 0.58 110.546 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.591 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 10.2 m -78.83 120.55 23.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.958 -1.127 . . . . 0.52 107.958 172.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -111.8 109.44 19.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.359 0.6 . . . . 2.18 110.773 -173.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.666 HD23 HD22 ' A' ' 56' ' ' LEU . 7.7 tp -98.96 100.82 12.05 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.969 -1.014 . . . . 0.63 109.742 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 31.8 m -107.38 118.37 36.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.742 -0.663 . . . . 0.58 109.507 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 15' ' ' THR . 58.2 t -79.28 108.95 13.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.012 0.434 . . . . 1.74 111.327 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.701 -0.666 . . . . 2.58 109.774 176.672 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.546 0.212 . . . . 5.73 110.778 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.703 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 31.0 tt0 -93.62 97.09 10.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.622 -0.881 . . . . 3.08 108.622 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 7.0 t -106.36 99.01 8.61 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.423 0.63 . . . . 1.43 110.158 -174.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.643 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 58.9 tt0 -86.82 110.43 19.94 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.989 -1.005 . . . . 2.29 109.606 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.449 HG13 HG13 ' A' ' 30' ' ' VAL . 97.6 t -103.43 112.62 37.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.846 -0.616 . . . . 1.51 110.234 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -93.1 111.06 22.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.942 -0.572 . . . . 3.57 110.075 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 116' ' ' LEU . 59.9 t -88.46 114.84 27.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.052 -0.721 . . . . 1.26 109.052 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.34 112.28 4.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.137 -0.554 . . . . 0.96 112.75 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.9 106.37 4.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.244 -0.651 . . . . 2.18 109.244 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.508 HD21 HG22 ' A' ' 28' ' ' VAL . 3.4 pp -137.61 154.43 49.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.054 -0.521 . . . . 1.41 111.02 -175.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.5 m -119.08 123.6 44.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.804 -0.634 . . . . 1.03 110.187 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.527 HG22 ' HG2' ' A' ' 14' ' ' LYS . 14.6 p -121.23 141.72 40.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.801 -0.444 . . . . 1.45 109.801 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.728 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -108.91 99.66 8.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.652 0.263 . . . . 0.59 110.966 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HG2' HG22 ' A' ' 12' ' ' VAL . 75.3 mmtt -142.5 172.88 12.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.3 0.571 . . . . 3.42 110.573 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.46 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 1.0 OUTLIER -104.0 154.13 20.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.161 -0.927 . . . . 0.63 109.592 172.295 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.674 ' NH1' ' HG3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -86.61 -1.43 57.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.105 0.478 . . . . 3.14 110.671 -176.371 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.534 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -85.8 -26.83 33.67 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.017 -0.611 . . . . 0.75 112.16 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 15' ' ' THR . 10.0 pt20 -79.83 -2.08 41.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.963 0.411 . . . . 2.17 110.719 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.717 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 71.8 mt -76.4 -26.94 56.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.642 . . . . 1.61 111.256 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 7.5 t 32.59 57.16 0.41 Allowed 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.215 0.947 . . . . 1.65 113.286 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 20' ' ' THR . 70.4 m-20 76.72 -46.69 0.52 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.461 0.704 . . . . 1.83 111.924 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.78 88.66 1.84 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.252 0.464 . . . . 0.82 112.252 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.717 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -139.82 108.19 7.04 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.007 -0.542 . . . . 0.79 110.493 171.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.619 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 38.6 Cg_endo -67.5 99.9 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.176 2.584 . . . . 1.12 112.114 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.586 HG12 HD21 ' A' ' 19' ' ' LEU . 2.6 pp -101.08 -23.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.876 -0.602 . . . . 2.58 111.829 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' N ' HD12 ' A' ' 25' ' ' ILE . . . -128.64 50.99 0.87 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.101 -1.047 . . . . 0.74 113.396 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 10.0 Cg_endo -53.9 109.97 0.44 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.554 2.169 . . . . 0.67 112.534 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.508 HG22 HD21 ' A' ' 10' ' ' LEU . 61.5 t -91.97 138.42 19.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.465 -0.788 . . . . 1.18 110.543 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 p -78.62 97.92 5.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.944 0.402 . . . . 1.64 110.844 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.663 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 97.4 t -103.51 113.93 41.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.114 -0.494 . . . . 1.01 110.271 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.653 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -109.05 108.32 18.97 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.75 -0.833 . . . . 2.48 108.75 177.185 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.66 91.22 4.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.094 0.473 . . . . 0.7 110.448 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.25 112.75 21.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.708 -0.678 . . . . 1.94 110.098 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.703 ' HA3' ' O ' ' A' ' 2' ' ' GLU . . . 114.91 -17.97 17.05 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.531 -0.842 . . . . 1.81 112.694 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 1.7 m -74.0 104.77 4.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.876 0.369 . . . . 1.88 110.543 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -106.22 -39.75 5.84 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.301 -0.629 . . . . 2.14 109.301 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.44 64.19 1.35 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.241 -0.89 . . . . 0.94 109.217 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.592 ' HD3' ' H ' ' A' ' 39' ' ' GLN . 8.7 tpp180 -146.76 149.89 34.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.677 -0.692 . . . . 4.64 110.756 -174.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.592 ' H ' ' HD3' ' A' ' 38' ' ' ARG . 36.6 mt-30 -84.81 125.96 33.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.912 -0.585 . . . . 1.75 109.669 176.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 22.1 t -92.29 125.36 44.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.838 -0.43 . . . . 0.54 109.838 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.511 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -121.36 142.37 50.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.046 0.45 . . . . 0.36 111.053 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.634 HD13 HD13 ' A' ' 96' ' ' ILE . 14.5 mt -103.0 112.42 25.24 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.149 -0.686 . . . . 0.84 109.149 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.543 ' HG2' ' CD2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -109.32 151.32 26.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.179 -0.464 . . . . 1.93 110.244 -178.545 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.407 ' HB1' ' OD1' ' A' ' 48' ' ' ASN . . . -100.61 167.44 10.34 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.978 -0.556 . . . . 0.41 110.362 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 23.4 t70 -94.65 157.72 15.84 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.149 -0.686 . . . . 0.71 109.149 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -53.22 -18.69 2.49 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.382 0.426 . . . . 1.4 111.848 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.6 -37.37 68.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.726 -0.67 . . . . 2.22 111.683 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 6.4 p30 -135.58 16.94 3.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.926 0.393 . . . . 1.35 110.66 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 60.3 t80 -118.85 102.53 8.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 0.56 109.382 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 14.4 pt-20 -102.06 100.6 10.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.824 0.345 . . . . 2.41 110.409 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 71.31 -53.29 0.68 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.615 -0.72 . . . . 3.43 111.289 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.1 39.17 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.604 -0.999 . . . . 0.56 110.604 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 22.0 mmmt -137.7 133.7 34.51 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.986 -0.746 . . . . 2.12 108.986 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -115.1 151.35 34.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.18 0.514 . . . . 0.56 110.995 173.339 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HB3' ' HA ' ' A' ' 66' ' ' TYR . 13.8 p90 -156.24 176.94 12.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.534 -0.757 . . . . 0.59 110.805 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.575 ' HA ' HD22 ' A' ' 114' ' ' LEU . 29.7 mt -80.34 111.22 16.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.176 -1.046 . . . . 1.53 108.176 170.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.536 ' CG2' ' HB3' ' A' ' 48' ' ' ASN . 8.7 tp -107.6 127.94 63.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.287 0.565 . . . . 0.62 110.32 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.542 ' HB2' ' OD2' ' A' ' 63' ' ' ASP . 47.4 t -70.86 152.4 43.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.793 -0.64 . . . . 1.44 109.34 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.27 -32.87 72.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.087 0.47 . . . . 2.31 110.269 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -80.34 -0.43 36.77 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.002 -0.544 . . . . 3.09 110.699 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 p30 37.3 60.81 1.02 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.454 1.102 . . . . 2.62 113.394 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -127.56 -11.71 5.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.941 -0.572 . . . . 4.66 110.037 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.542 ' OD2' ' HB2' ' A' ' 58' ' ' SER . 1.9 p-10 -136.63 152.02 49.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.484 -0.78 . . . . 2.51 110.481 -176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.633 ' O ' HD23 ' A' ' 65' ' ' LEU . 9.5 ptpp? -156.89 152.98 27.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.544 -0.298 . . . . 2.07 111.013 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.817 ' HB3' ' HG3' ' A' ' 104' ' ' GLN . 1.6 mt -141.29 124.98 16.86 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.149 -1.426 . . . . 1.98 107.149 170.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 99.2 m-85 -69.26 133.88 48.46 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.121 0.486 . . . . 0.75 110.806 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.94 HG12 ' HA ' ' A' ' 100' ' ' VAL . 29.2 m -128.83 175.23 10.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.388 -0.824 . . . . 0.73 109.796 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.853 ' HB2' ' HE2' ' A' ' 84' ' ' PHE . 2.2 p30 -152.34 128.27 10.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.235 0.54 . . . . 1.81 109.918 172.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.588 HG21 HD12 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -79.85 87.67 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.81 110.382 -174.398 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.404 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 79.3 mtt180 -86.4 137.6 34.45 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.637 -0.711 . . . . 3.79 110.206 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 74.1 Cg_exo -51.15 124.65 14.43 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.453 2.102 . . . . 0.59 112.047 174.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.2 ttt -75.4 82.47 2.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.828 0.347 . . . . 1.71 110.678 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 61.87 21.15 12.05 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.536 -0.756 . . . . 1.92 112.063 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.96 -51.55 5.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.618 -0.265 . . . . 1.89 111.432 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.7 t -167.72 179.15 4.93 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.738 -0.467 . . . . 1.7 109.738 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.15 123.88 45.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.94 110.576 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 12.0 m0 -116.32 160.99 19.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.89 -0.596 . . . . 0.5 110.057 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.1 m -81.86 113.46 19.81 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.356 -0.609 . . . . 0.51 109.356 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 t -95.56 108.55 20.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.579 0.704 . . . . 0.59 112.484 -171.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -117.44 162.26 18.24 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.228 -1.027 . . . . 1.7 108.228 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.467 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 10.6 m120 -85.28 -8.52 58.47 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.377 -0.529 . . . . 1.39 110.984 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.421 ' O ' ' HE1' ' A' ' 49' ' ' PHE . . . -100.93 -35.98 4.09 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.305 -0.95 . . . . 0.65 111.725 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.559 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 27.5 m -140.08 156.27 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.626 -0.509 . . . . 1.16 109.626 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.853 ' HE2' ' HB2' ' A' ' 68' ' ' ASN . 1.0 OUTLIER -134.5 97.96 3.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.201 -1.037 . . . . 0.36 108.201 178.464 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.652 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 2.4 p90 -132.56 144.99 50.78 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.488 -0.485 . . . . 0.59 111.456 -172.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.928 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 40.9 pttt -78.56 148.92 33.16 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.656 -0.702 . . . . 1.39 110.555 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.3 -23.36 61.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 2.12 109.443 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.928 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 5.7 m-20 -72.38 162.3 29.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.247 -0.888 . . . . 2.1 110.297 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.9 m -121.86 139.52 48.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.783 0.325 . . . . 1.05 110.578 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.0 -159.03 17.68 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.674 -0.774 . . . . 0.46 111.926 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.7 m -69.21 166.79 17.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.971 0.415 . . . . 1.17 110.473 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.43 ' HZ2' ' HB3' ' A' ' 71' ' ' PRO . 63.2 t90 -152.46 -52.05 0.11 Allowed 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.263 -0.643 . . . . 0.51 109.263 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 27.21 89.8 0.01 OUTLIER Glycine 0 N--CA 1.466 0.654 0 O-C-N 125.12 1.513 . . . . 1.25 115.448 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.18 -150.17 5.73 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.96 -0.638 . . . . 0.72 112.39 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 p -112.4 125.58 54.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.446 0.536 . . . . 0.6 112.446 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.634 HD13 HD13 ' A' ' 42' ' ' LEU . 1.2 pt -115.75 129.42 72.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.77 -0.65 . . . . 1.63 109.685 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -108.4 160.32 13.82 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.211 -0.995 . . . . 0.45 112.743 -173.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -91.34 113.65 27.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.905 0.384 . . . . 0.83 110.189 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.619 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -116.5 126.83 53.92 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.92 -1.141 . . . . 1.28 107.92 174.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.94 ' HA ' HG12 ' A' ' 67' ' ' VAL . 13.9 p -62.98 124.96 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.316 -0.994 . . . . 1.14 108.316 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.07 88.04 2.4 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.225 -0.657 . . . . 1.02 109.225 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA2' ' OD1' ' A' ' 21' ' ' ASP . . . 90.51 112.32 1.56 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.567 -1.013 . . . . 1.53 110.567 -171.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -51.08 114.23 1.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.354 0.597 . . . . 2.11 110.967 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.817 ' HG3' ' HB3' ' A' ' 65' ' ' LEU . 11.9 mm-40 -91.98 20.81 5.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.476 -0.784 . . . . 2.62 111.094 -174.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.6 m 72.7 -21.72 0.24 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.589 -0.732 . . . . 2.43 112.816 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.534 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 8.9 t30 70.57 84.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.704 0.764 . . . . 1.56 110.238 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.541 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 12.2 t -103.93 149.22 36.97 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.974 -1.121 . . . . 1.68 107.974 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.541 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 91.4 Cg_exo -18.11 89.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 1 C-N-CA 125.76 4.307 . . . . 1.26 115.001 -172.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.687 ' CB ' HG11 ' A' ' 142' ' ' VAL . 3.3 Cg_exo -81.01 -150.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.693 2.929 . . . . 0.76 114.214 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.91 -163.69 37.11 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 109.071 -1.612 . . . . 0.76 109.071 -173.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -80.2 101.69 8.99 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.299 -0.63 . . . . 2.04 109.299 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -84.9 126.59 33.61 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.003 0.43 . . . . 0.75 109.965 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.9 m -130.71 97.36 4.33 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.906 -0.588 . . . . 0.83 109.594 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.575 HD22 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -104.27 105.6 15.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.483 0.659 . . . . 0.51 110.51 -176.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 1.3 m -78.27 121.57 24.58 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.148 -0.933 . . . . 0.59 110.527 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.566 ' HB2' HG11 ' A' ' 7' ' ' VAL . 96.0 mt -107.29 146.0 32.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.87 0.367 . . . . 1.27 110.635 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.0 m -119.19 109.16 15.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.373 -0.376 . . . . 0.7 110.415 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.97 162.09 54.07 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.957 -0.64 . . . . 0.8 112.952 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 151.16 166.35 13.7 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.032 -0.604 . . . . 0.53 111.621 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.678 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 46.9 p90 -89.19 -173.53 4.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.16 0.505 . . . . 0.89 111.043 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.628 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 2.3 t-105 -137.76 149.97 46.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.631 -0.713 . . . . 0.56 110.276 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.79 147.66 50.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.308 -0.406 . . . . 1.42 110.49 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.577 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 5.8 tmtt? 70.41 -142.36 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.66 0.6 . . . . 3.47 110.432 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.528 ' HA ' ' HZ2' ' A' ' 121' ' ' TRP . 6.9 p-10 -160.08 132.66 6.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.622 0.248 . . . . 2.08 111.405 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.546 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 8.9 t30 66.86 -30.06 0.15 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.939 1.089 . . . . 2.47 113.939 174.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.648 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -68.81 -3.51 12.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 1.96 110.951 178.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.628 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 20.4 tt0 68.57 59.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.208 -0.905 . . . . 2.02 110.856 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.648 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -89.06 48.55 3.46 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.603 -0.808 . . . . 0.77 111.358 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.595 ' HD1' ' HG2' ' A' ' 127' ' ' GLN . 16.4 p90 -78.81 140.85 38.13 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 110.026 -0.361 . . . . 1.21 110.026 -174.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.549 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 36.6 m -118.94 137.59 25.21 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.315 -0.254 . . . . 1.47 110.315 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.08 111.09 2.39 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.977 2.451 . . . . 0.92 111.274 172.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.1 m -153.08 108.68 3.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.851 0.357 . . . . 1.52 110.489 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.643 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 137.4 -127.51 3.99 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.534 -0.841 . . . . 1.17 111.907 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 m -124.96 145.7 49.74 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.282 -0.266 . . . . 2.47 110.282 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.2 m -92.31 95.75 9.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.103 -0.702 . . . . 1.82 109.103 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -92.17 128.7 9.5 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.918 -0.658 . . . . 0.67 111.975 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.88 105.44 17.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.888 0.375 . . . . 0.58 110.211 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.538 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 21.7 m -78.32 108.8 11.92 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.845 -0.798 . . . . 0.52 108.845 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -103.45 109.06 20.56 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.551 0.691 . . . . 2.18 110.535 -174.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.4 tp -100.82 97.12 7.77 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.617 -1.174 . . . . 0.63 109.092 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.728 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 24.8 m -97.64 122.28 40.54 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.613 -0.721 . . . . 0.58 109.802 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.687 HG11 ' CB ' ' A' ' 109' ' ' PRO . 33.2 m -75.24 114.66 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-O 121.55 0.69 . . . . 1.74 111.29 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.715 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 38.4 m . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.301 -0.856 . . . . 2.58 109.834 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.844 0.354 . . . . 5.73 110.141 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 4' ' ' GLN . 12.8 pt-20 -170.73 161.33 7.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.853 -0.612 . . . . 3.08 110.004 -174.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 53.9 m -78.83 89.01 4.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.414 -0.357 . . . . 1.43 110.623 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.421 ' HG3' ' HG3' ' A' ' 2' ' ' GLU . 93.8 mt-30 -86.46 110.17 19.56 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.565 -0.454 . . . . 2.29 110.018 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.43 117.92 49.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.894 -0.594 . . . . 1.51 109.73 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -82.7 109.59 17.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.946 -0.57 . . . . 3.57 111.618 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.35 117.13 52.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.509 -0.923 . . . . 1.26 108.509 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.38 144.39 17.05 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.443 -0.884 . . . . 0.96 113.23 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -62.05 146.84 49.13 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.492 0.317 . . . . 2.18 110.227 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 2.2 pt? -156.14 126.66 6.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.937 0.399 . . . . 1.41 110.901 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.474 ' HA ' ' HB3' ' A' ' 139' ' ' LYS . 28.0 m -108.75 114.58 28.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.111 -0.495 . . . . 1.03 109.827 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.519 ' HB ' ' NZ ' ' A' ' 14' ' ' LYS . 61.9 t -144.17 146.04 21.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.595 -0.73 . . . . 1.45 109.328 -176.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.724 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -92.99 124.85 37.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.524 0.565 . . . . 0.59 112.524 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.519 ' NZ ' ' HB ' ' A' ' 12' ' ' VAL . 1.1 mptt -147.6 168.44 22.0 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.889 0.376 . . . . 3.42 110.043 172.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.536 ' O ' HD23 ' A' ' 19' ' ' LEU . 73.4 p -112.66 161.89 16.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.313 -0.995 . . . . 0.63 108.313 169.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.1 0.29 19.35 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.555 -0.858 . . . . 3.14 110.236 175.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.99 -26.91 25.14 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 110.251 -1.139 . . . . 0.75 110.251 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -62.57 -29.61 70.72 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.442 -0.947 . . . . 2.17 108.442 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.866 HD21 HD13 ' A' ' 25' ' ' ILE . 2.3 mm? -75.33 129.16 36.93 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.394 -1.275 . . . . 1.61 109.593 171.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.658 HG22 ' HB2' ' A' ' 23' ' ' ALA . 13.7 t -127.94 42.18 3.37 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.391 1.091 . . . . 1.65 108.262 -176.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.496 ' HA ' HG13 ' A' ' 100' ' ' VAL . 29.4 t70 75.3 -69.72 0.17 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.54 -1.663 . . . . 1.83 109.607 -171.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -99.15 85.02 3.14 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.799 -0.445 . . . . 0.82 109.799 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.658 ' HB2' HG22 ' A' ' 20' ' ' THR . . . -142.51 94.63 6.7 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.219 -0.446 . . . . 0.79 110.923 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.521 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 32.9 Cg_endo -68.43 85.9 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 123.189 2.593 . . . . 1.12 111.72 177.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.866 HD13 HD21 ' A' ' 19' ' ' LEU . 12.3 pt -83.31 -16.62 11.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.734 -1.121 . . . . 2.58 111.392 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.35 69.74 0.4 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.542 -0.837 . . . . 0.74 112.802 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 9.3 Cg_exo -71.16 108.16 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.631 2.221 . . . . 0.67 111.697 173.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.6 t -84.47 141.69 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.016 -0.538 . . . . 1.18 110.299 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.5 p -71.05 97.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.391 . . . . 1.64 110.371 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.746 HG23 ' HA ' ' A' ' 95' ' ' THR . 6.6 t -83.59 142.27 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.933 0.873 . . . . 1.01 111.397 -174.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.17 114.18 5.44 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.18 -1.373 . . . . 2.48 107.658 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.82 104.63 11.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.785 0.326 . . . . 0.7 110.911 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 46.3 tp -81.7 120.16 24.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.868 -0.605 . . . . 1.94 109.963 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.9 -144.44 17.26 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.604 -0.808 . . . . 1.81 111.923 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 4.2 m 59.75 32.33 21.33 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 122.192 0.197 . . . . 1.88 111.503 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -55.46 -30.36 60.42 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.102 0.477 . . . . 2.14 110.77 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.56 54.6 1.93 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.901 -0.59 . . . . 0.94 110.083 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.9 tpp180 -140.28 150.49 44.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.263 -0.426 . . . . 4.64 111.287 -176.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -93.22 92.53 7.78 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.312 -0.625 . . . . 1.75 109.312 178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 58.1 t -56.61 134.08 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.678 -0.692 . . . . 0.54 110.639 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 1.02 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -143.82 149.88 37.67 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.962 0.41 . . . . 0.36 111.045 -176.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.48 HD12 ' HB ' ' A' ' 69' ' ' ILE . 11.7 mt -102.96 155.17 18.54 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.011 -0.54 . . . . 0.84 109.549 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HZ1' ' HB3' ' A' ' 41' ' ' ALA . 1.7 mptp? -140.05 150.92 44.96 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.862 -0.792 . . . . 1.93 108.862 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -86.25 155.45 20.68 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.307 -0.627 . . . . 0.41 109.307 171.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 27.6 t70 -71.78 161.45 30.95 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.667 -0.494 . . . . 0.71 109.667 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -55.96 -23.1 30.14 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.929 0.715 . . . . 1.4 112.929 -173.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.0 -16.61 54.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 2.22 111.424 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 20.3 m120 -123.04 8.19 9.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.215 -0.448 . . . . 1.35 110.292 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 83.2 t80 -131.71 109.47 10.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.776 -0.647 . . . . 0.56 110.24 -174.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.538 ' HG2' ' HE1' ' A' ' 55' ' ' PHE . 14.2 pt-20 -134.0 124.11 25.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.357 -0.383 . . . . 2.41 110.193 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 54.68 39.04 31.04 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.98 -0.554 . . . . 3.43 111.586 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.93 36.72 65.06 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.758 -0.655 . . . . 0.56 112.854 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.523 ' HB3' ' HE2' ' A' ' 66' ' ' TYR . 47.2 mmtm -132.8 134.91 45.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.304 -0.628 . . . . 2.12 109.304 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -116.98 141.18 48.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.418 0.628 . . . . 0.56 111.639 176.606 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.538 ' HE1' ' HG2' ' A' ' 50' ' ' GLU . 41.8 p90 -155.04 160.87 41.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.453 -0.794 . . . . 0.59 109.912 -175.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.761 ' HB3' HD22 ' A' ' 114' ' ' LEU . 1.7 pp -81.21 143.08 32.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.64 -0.504 . . . . 1.53 109.64 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 113' ' ' THR . 11.1 tp -121.05 146.9 25.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.697 -0.401 . . . . 0.62 110.36 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.438 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 2.8 p -100.3 174.4 6.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.963 -0.562 . . . . 1.44 111.666 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -53.86 -41.37 67.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.54 -0.755 . . . . 2.31 110.54 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.68 -14.04 46.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.156 -0.929 . . . . 3.09 111.138 -174.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.403 ' HA ' HD11 ' A' ' 57' ' ' ILE . 43.3 m-80 62.29 18.97 10.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.167 0.508 . . . . 2.62 110.285 -171.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -90.62 -50.01 6.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.857 -0.61 . . . . 4.66 110.883 -175.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -100.75 134.22 44.04 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.712 -0.477 . . . . 2.51 109.712 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HD2' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -144.39 154.67 43.22 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.846 -0.616 . . . . 2.07 109.854 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.802 HD21 HG23 ' A' ' 100' ' ' VAL . 23.3 tp -150.95 134.74 16.52 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.11 -0.495 . . . . 1.98 109.88 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.523 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 65.3 m-85 -78.71 131.37 36.58 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.679 -0.691 . . . . 0.75 110.033 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.592 HG21 HD13 ' A' ' 114' ' ' LEU . 11.0 m -125.34 130.9 72.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.975 -0.557 . . . . 0.73 110.702 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -99.77 121.78 41.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.102 -0.499 . . . . 1.81 110.027 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.52 HD13 HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -83.17 87.64 2.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.165 -0.47 . . . . 0.81 109.969 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.465 ' HE ' ' HB2' ' A' ' 99' ' ' TYR . 33.1 mtt180 -99.71 144.44 28.33 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.185 -0.461 . . . . 3.79 109.929 -173.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.683 ' HA ' HG22 ' A' ' 96' ' ' ILE . 77.7 Cg_exo -50.89 140.38 38.85 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.711 2.274 . . . . 0.59 112.439 174.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tpt -77.5 74.63 4.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.25 -0.648 . . . . 1.71 109.25 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 43.02 84.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.01 -0.996 . . . . 1.92 111.386 -174.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.757 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 2.2 t-20 -145.98 -67.08 0.29 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.241 -0.436 . . . . 1.89 110.591 -173.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 m -142.88 164.52 29.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.71 -0.478 . . . . 1.7 109.71 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.06 107.33 17.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.212 0.53 . . . . 0.94 110.604 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.4 m0 -101.89 137.45 40.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.663 -0.699 . . . . 0.5 110.067 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.7 m -69.75 114.51 8.02 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.568 -0.53 . . . . 0.51 109.568 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -93.14 105.2 17.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.906 0.86 . . . . 0.59 112.176 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -105.79 161.2 14.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.078 -1.082 . . . . 1.7 108.078 167.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -85.62 3.64 39.9 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.628 -0.429 . . . . 1.39 111.1 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.65 -40.06 0.87 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.333 -0.937 . . . . 0.65 111.826 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.582 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 30.9 m -133.03 156.88 42.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.988 -0.375 . . . . 1.16 109.988 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.713 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -133.72 97.64 3.97 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.961 -1.126 . . . . 0.36 107.961 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 1.02 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -125.71 142.21 51.63 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 120.754 0.312 . . . . 0.59 110.717 -175.472 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.771 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 18.5 pttm -72.45 144.12 48.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.353 -0.61 . . . . 1.39 109.353 173.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.65 43.8 0.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.009 0.909 . . . . 2.12 108.88 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.771 ' HB3' ' HD2' ' A' ' 86' ' ' LYS . 17.4 t70 -149.16 154.41 39.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.591 -1.186 . . . . 2.1 109.411 -171.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -115.71 124.38 72.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.094 0.473 . . . . 1.05 110.564 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.66 174.97 22.94 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.502 -0.856 . . . . 0.46 112.432 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 p -74.66 124.15 26.19 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.99 -0.374 . . . . 1.17 109.99 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.757 ' HZ2' ' HB3' ' A' ' 74' ' ' ASN . 13.4 t90 -100.64 -43.84 6.03 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.844 -0.342 . . . . 0.51 111.677 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.579 ' O ' ' HB ' ' A' ' 30' ' ' VAL . . . 51.34 -122.1 14.07 Favored Glycine 0 C--O 1.213 -1.175 0 N-CA-C 110.968 -0.853 . . . . 1.25 110.968 -173.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 73.17 -144.68 35.04 Favored Glycine 0 C--N 1.321 -0.271 0 C-N-CA 120.908 -0.663 . . . . 0.72 113.9 166.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.746 ' HA ' HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -152.09 134.06 14.94 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 122.647 0.379 . . . . 0.6 110.746 -179.08 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.683 HG22 ' HA ' ' A' ' 71' ' ' PRO . 2.2 pp -124.92 151.58 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.601 -0.518 . . . . 1.63 109.601 174.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.35 167.77 23.33 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.364 -0.922 . . . . 0.45 112.56 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.587 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.9 mp -91.11 113.26 26.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.743 0.306 . . . . 0.83 110.252 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.521 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 1.6 m-85 -113.89 124.14 51.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.864 -0.791 . . . . 1.28 108.864 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.802 HG23 HD21 ' A' ' 65' ' ' LEU . 11.4 p -55.58 139.07 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.632 0.253 . . . . 1.14 110.709 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -86.61 82.75 7.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.813 -0.81 . . . . 1.02 108.813 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.8 100.7 0.41 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.266 -0.734 . . . . 1.53 111.266 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 103' ' ' GLN . 4.8 pm0 -43.01 120.25 1.74 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.543 0.687 . . . . 2.11 111.87 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.501 ' HG3' ' OG1' ' A' ' 107' ' ' THR . 21.1 tp60 -75.94 -3.13 33.8 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.813 -0.63 . . . . 2.62 110.719 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.9 m 66.73 24.81 9.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.345 0.593 . . . . 2.43 111.446 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.5 t30 60.71 71.34 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.77 0.795 . . . . 1.56 111.529 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.501 ' OG1' ' HG3' ' A' ' 104' ' ' GLN . 3.1 m -82.64 139.62 44.01 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.971 -1.013 . . . . 1.68 108.501 168.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 107' ' ' THR . 66.6 Cg_exo -24.9 94.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.096 1 C-N-CA 125.481 4.12 . . . . 1.26 114.558 -176.006 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.421 ' HB3' ' HE2' ' A' ' 112' ' ' TYR . 57.1 Cg_endo -87.67 -174.89 1.33 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.14 2.56 . . . . 0.76 113.532 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.45 -121.18 0.57 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.215 -1.154 . . . . 0.76 110.215 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -99.45 109.81 22.34 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.129 -0.693 . . . . 2.04 109.129 171.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.518 ' CD1' HD13 ' A' ' 56' ' ' LEU . 53.4 m-85 -107.11 104.77 14.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.803 0.811 . . . . 0.75 110.667 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 57' ' ' ILE . 86.6 m -98.04 118.21 34.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.889 -1.051 . . . . 0.83 109.897 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.761 HD22 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -133.78 96.76 3.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.22 0.533 . . . . 0.51 110.214 175.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 7.6 m -75.12 127.61 33.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.089 -0.505 . . . . 0.59 110.157 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.52 HD13 HD13 ' A' ' 69' ' ' ILE . 90.2 mt -116.59 126.13 52.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.009 -0.367 . . . . 1.27 110.009 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.501 HG21 ' HB3' ' A' ' 131' ' ' PRO . 17.3 m -106.75 126.51 52.39 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.849 0.357 . . . . 0.7 110.63 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.69 157.54 45.81 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.809 -0.71 . . . . 0.8 111.619 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 171.79 -169.56 42.62 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.629 -0.796 . . . . 0.53 111.923 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -111.97 179.92 3.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.181 0.515 . . . . 0.89 110.325 177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.777 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 1.7 t-105 -145.48 148.31 33.12 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.495 -0.775 . . . . 0.56 109.272 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.47 144.26 50.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.831 0.348 . . . . 1.42 111.155 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.719 ' HD3' ' H ' ' A' ' 124' ' ' ASP . 4.7 tmtm? 67.83 -136.69 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.918 0.887 . . . . 3.47 110.212 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.719 ' H ' ' HD3' ' A' ' 123' ' ' LYS . 4.1 p30 -161.56 138.59 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.067 0.394 . . . . 2.08 110.934 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.513 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 55.9 m-80 64.85 -40.8 0.28 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.702 1.201 . . . . 2.47 113.891 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.487 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -62.9 -3.63 1.72 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.21 0.604 . . . . 1.96 112.339 -174.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.777 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 44.1 mt-30 68.01 67.1 0.35 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.491 0.662 . . . . 2.02 111.576 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.487 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -95.13 39.61 2.84 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.948 -0.861 . . . . 0.77 110.948 173.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.576 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 41.8 p90 -81.81 151.39 27.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.692 0.282 . . . . 1.21 110.611 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 74.6 m -147.37 125.79 6.13 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.598 -0.273 . . . . 1.47 110.707 174.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.501 ' HB3' HG21 ' A' ' 117' ' ' THR . 9.2 Cg_exo -72.17 114.18 3.91 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.933 2.422 . . . . 0.92 111.51 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 p -151.04 126.98 10.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.045 0.45 . . . . 1.52 110.931 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.85 -113.55 2.69 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.633 -0.794 . . . . 1.17 112.17 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.3 m -130.44 135.37 47.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.63 0.252 . . . . 2.47 110.582 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.2 t -99.78 140.53 33.86 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.49 -0.559 . . . . 1.82 109.49 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -130.41 119.84 2.87 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.45 -0.881 . . . . 0.67 112.355 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 6.0 m -77.77 104.72 8.48 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.781 -0.452 . . . . 0.58 109.781 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.427 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 50.7 m -78.59 108.26 11.86 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.062 -0.718 . . . . 0.52 109.062 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.474 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 12.4 tppt? -98.68 112.97 24.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.762 0.791 . . . . 2.18 110.405 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.624 HD23 HD22 ' A' ' 56' ' ' LEU . 9.4 tp -102.06 94.42 5.76 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 114.676 -1.147 . . . . 0.63 109.409 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 17.1 m -105.69 144.82 31.9 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.265 -0.642 . . . . 0.58 109.265 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.4 p -95.41 135.97 27.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.157 0.503 . . . . 1.74 110.21 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.4 m . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.714 -0.66 . . . . 2.58 109.728 178.888 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 121.029 0.442 . . . . 5.73 111.005 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -115.25 -166.5 1.13 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.622 -0.717 . . . . 3.08 109.424 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 51.9 t -67.95 86.96 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.502 0.668 . . . . 1.43 109.538 172.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -94.62 120.46 34.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.385 -0.825 . . . . 2.29 110.392 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.6 115.78 42.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.184 -0.462 . . . . 1.51 110.669 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' A' ' 31' ' ' GLN . 37.5 ttm180 -80.12 108.16 13.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.688 -0.687 . . . . 3.57 109.802 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -114.83 122.55 69.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.808 -0.633 . . . . 1.26 109.829 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.51 169.38 27.4 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.815 -0.707 . . . . 0.96 112.389 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.57 123.39 40.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.049 -0.352 . . . . 2.18 110.049 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.48 ' HB2' HG23 ' A' ' 138' ' ' THR . 55.8 mt -107.45 121.49 44.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.927 0.394 . . . . 1.41 111.582 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.1 m -112.82 113.32 25.36 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.029 -0.73 . . . . 1.03 109.029 170.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.76 147.78 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.913 -0.403 . . . . 1.45 109.913 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -112.28 135.43 52.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.625 -0.261 . . . . 0.59 110.99 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HE2' ' HB ' ' A' ' 25' ' ' ILE . 10.9 ptpp? 178.5 163.82 0.75 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.982 -0.554 . . . . 3.42 109.957 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.861 ' HA ' HG13 ' A' ' 142' ' ' VAL . 76.1 p -85.44 161.71 19.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.132 -0.485 . . . . 0.63 109.865 175.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.705 ' NH1' ' HG3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -80.32 -0.4 36.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.3 -0.63 . . . . 3.14 109.3 174.401 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -96.53 -18.41 30.62 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.197 -0.91 . . . . 0.75 110.962 176.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -71.12 -23.82 62.16 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.538 -0.912 . . . . 2.17 108.538 172.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.402 HD23 HD12 ' A' ' 25' ' ' ILE . 46.9 mt -86.49 116.99 24.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.641 -1.163 . . . . 1.61 108.989 173.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 p -111.42 77.13 1.02 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.77 0.319 . . . . 1.65 110.682 -175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 29.5 t70 61.39 -83.56 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.155 -0.93 . . . . 1.83 110.835 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.657 ' HA ' ' CD2' ' A' ' 99' ' ' TYR . . . -107.07 84.6 2.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.304 0.574 . . . . 0.82 110.309 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.481 ' O ' HG13 ' A' ' 25' ' ' ILE . . . -146.68 87.72 6.28 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.191 -0.913 . . . . 0.79 109.304 175.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.53 ' CB ' ' HA3' ' A' ' 97' ' ' GLY . 59.8 Cg_endo -69.57 94.86 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.657 2.238 . . . . 1.12 112.683 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 23' ' ' ALA . 4.9 mt -111.82 23.46 4.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 122.005 0.907 . . . . 2.58 110.056 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.518 ' N ' ' HD3' ' A' ' 27' ' ' PRO . . . -140.66 53.17 0.67 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.89 -1.05 . . . . 0.74 111.578 168.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.789 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 48.4 Cg_exo -55.81 115.06 2.19 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.299 1.999 . . . . 0.67 113.433 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.2 t -88.58 129.89 38.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.361 -0.836 . . . . 1.18 109.282 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 p -76.95 88.13 3.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.244 0.545 . . . . 1.64 110.868 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.1 115.44 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.673 -0.694 . . . . 1.01 110.755 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.598 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . 52.1 tt0 -114.35 113.01 23.98 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.251 -0.431 . . . . 2.48 109.988 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.609 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -95.98 101.27 12.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.843 -0.617 . . . . 0.7 110.306 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 tt -95.83 126.35 41.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.765 -0.652 . . . . 1.94 110.592 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.2 69.9 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.087 -0.577 . . . . 1.81 114.4 169.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.609 ' SG ' ' HB1' ' A' ' 32' ' ' ALA . 31.3 m -80.54 -66.96 0.82 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.343 0.572 . . . . 1.88 110.112 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 3.2 m-20 67.81 -45.98 0.5 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.136 1.162 . . . . 2.14 114.136 172.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.52 29.08 2.69 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.062 -0.399 . . . . 0.94 111.905 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -133.26 161.06 35.5 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.23 -0.285 . . . . 4.64 110.23 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -91.73 141.14 29.01 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.904 -0.406 . . . . 1.75 109.904 172.207 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 53.1 t -94.03 136.28 26.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.849 -0.796 . . . . 0.54 108.849 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -127.53 135.39 50.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.851 0.358 . . . . 0.36 110.803 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 mt -103.54 105.57 15.84 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.164 -0.68 . . . . 0.84 109.164 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.833 ' HG3' HG12 ' A' ' 83' ' ' VAL . 1.4 mppt? -108.4 125.41 51.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.52 -0.919 . . . . 1.93 108.52 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.633 ' HB1' HD21 ' A' ' 48' ' ' ASN . . . -72.94 156.95 38.33 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.686 -0.406 . . . . 0.41 110.248 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.709 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 21.5 t70 -71.77 147.4 47.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.205 -0.452 . . . . 0.71 109.839 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -61.66 -6.27 2.43 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.91 0.707 . . . . 1.4 112.91 -171.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.83 -29.24 44.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.992 0.425 . . . . 2.22 110.378 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.633 HD21 ' HB1' ' A' ' 44' ' ' ALA . 5.5 p-10 -124.28 19.79 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 1.35 109.553 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 84.7 t80 -137.45 107.4 6.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.281 -0.872 . . . . 0.56 109.916 -175.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -103.07 96.91 7.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.411 -0.358 . . . . 2.41 110.653 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 68.2 -52.32 0.54 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.983 0.802 . . . . 3.43 112.047 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' CE1' ' A' ' 49' ' ' PHE . . . -174.33 37.08 0.12 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 111.671 -0.572 . . . . 0.56 111.671 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.781 ' HD2' ' HB3' ' A' ' 81' ' ' ASN . 8.7 mmmm -138.95 133.52 31.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.64 -1.244 . . . . 2.12 107.64 172.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.15 147.03 43.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.667 0.746 . . . . 0.56 112.055 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 9.2 p90 -150.19 -179.63 7.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.568 -1.196 . . . . 0.59 109.603 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.959 HD12 HD22 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -89.37 121.55 31.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.979 -1.119 . . . . 1.53 107.979 169.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.591 HG22 ' HB3' ' A' ' 48' ' ' ASN . 8.8 tp -106.79 116.86 51.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.571 0.701 . . . . 0.62 109.439 177.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 22.6 t -72.51 147.65 45.79 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.06 -0.518 . . . . 1.44 110.214 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.84 -8.07 33.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.456 0.646 . . . . 2.31 109.703 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -95.26 -3.12 48.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.385 -0.825 . . . . 3.09 110.023 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.07 28.01 0.35 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.884 1.273 . . . . 2.62 113.553 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -86.46 -53.83 4.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.087 -0.383 . . . . 4.66 111.118 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.523 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 7.2 m-20 -125.66 159.64 31.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.414 -0.357 . . . . 2.51 110.705 -175.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.503 ' HB2' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -145.63 133.11 20.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.78 -0.646 . . . . 2.07 109.718 176.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.625 ' O ' HD22 ' A' ' 56' ' ' LEU . 2.0 mm? -128.37 133.35 48.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.336 -0.616 . . . . 1.98 109.336 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -75.25 138.34 41.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.147 0.498 . . . . 0.75 110.376 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.488 HG11 HD11 ' A' ' 56' ' ' LEU . 2.4 m -117.48 167.19 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-N 115.734 -0.667 . . . . 0.73 110.476 177.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -121.78 110.34 15.79 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.775 -0.648 . . . . 1.81 109.339 173.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.42 HG23 HG12 ' A' ' 98' ' ' ILE . 1.1 pt -88.77 84.93 2.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.021 -0.733 . . . . 0.81 109.021 172.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.582 ' HB3' ' OH ' ' A' ' 99' ' ' TYR . 44.9 ttt180 -116.69 136.2 23.13 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 115.445 -0.798 . . . . 3.79 109.132 -173.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 91.9 Cg_exo -42.92 121.0 2.08 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.0 2.467 . . . . 0.59 112.284 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.9 ttt -68.18 87.83 0.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 1.71 110.424 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t0 49.35 66.76 1.02 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.143 -0.935 . . . . 1.92 111.019 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -140.17 -53.19 0.51 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 1.89 111.559 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.0 m -149.57 161.42 42.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.576 0.227 . . . . 1.7 110.624 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.6 86.45 3.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.94 0.4 . . . . 0.94 110.081 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.404 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 17.2 m0 -77.25 158.27 30.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.706 -0.679 . . . . 0.5 110.3 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.9 m -69.63 116.33 9.91 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.063 -0.717 . . . . 0.51 109.063 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 t -98.01 97.31 8.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.819 0.819 . . . . 0.59 112.094 -170.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.33 159.85 14.67 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.295 -1.002 . . . . 1.7 108.295 168.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.781 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -79.73 -7.31 58.54 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.335 -0.546 . . . . 1.39 110.017 -178.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.452 ' CA ' ' HE1' ' A' ' 49' ' ' PHE . . . -118.64 -36.74 0.88 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.13 -1.033 . . . . 0.65 112.887 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.833 HG12 ' HG3' ' A' ' 43' ' ' LYS . 33.4 m -124.52 151.76 30.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.275 -0.639 . . . . 1.16 109.275 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -135.03 102.48 5.23 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.297 -1.001 . . . . 0.36 108.297 -178.422 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.683 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 15.6 p90 -135.9 140.87 44.4 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.137 0.494 . . . . 0.59 110.903 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 17.1 pttp -82.44 140.98 33.1 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.562 -0.745 . . . . 1.39 110.986 -178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -67.47 -34.4 77.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.291 -1.003 . . . . 2.12 108.291 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 2.2 m-20 -58.44 124.48 19.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.636 -1.166 . . . . 2.1 110.31 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.8 131.46 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.512 -0.475 . . . . 1.05 109.818 174.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.589 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 146.07 -165.19 28.18 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.584 -0.817 . . . . 0.46 111.832 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.8 p -81.82 -172.78 4.08 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.619 -0.511 . . . . 1.17 109.619 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.586 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 22.5 t90 -154.0 -59.99 0.13 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.953 -0.388 . . . . 0.51 109.953 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 39.69 88.44 0.01 OUTLIER Glycine 0 N--CA 1.467 0.724 0 O-C-N 124.275 0.985 . . . . 1.25 114.901 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.69 -139.6 2.68 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.022 -0.609 . . . . 0.72 111.669 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 p -131.77 124.62 30.07 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.43 0.634 . . . . 0.6 112.167 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.789 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 37.5 pt -100.0 161.54 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.375 -0.972 . . . . 1.63 108.375 172.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 24' ' ' PRO . . . -128.02 147.9 17.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.53 -1.319 . . . . 0.45 113.126 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 69' ' ' ILE . 79.8 mt -101.75 120.73 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 120.731 0.3 . . . . 0.83 110.886 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.657 ' CD2' ' HA ' ' A' ' 22' ' ' ALA . 1.4 p90 -138.6 155.2 48.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.85 -0.614 . . . . 1.28 110.392 173.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 103' ' ' GLN . 12.8 p -85.58 136.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.822 -0.626 . . . . 1.14 110.761 -170.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.13 101.87 0.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.825 -0.625 . . . . 1.02 111.391 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.75 34.83 66.4 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-O 119.451 -0.638 . . . . 1.53 113.848 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.496 ' HA ' HG13 ' A' ' 100' ' ' VAL . 27.0 pt20 38.92 96.88 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.984 0.897 . . . . 2.11 113.187 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.528 ' HG3' ' HB3' ' A' ' 65' ' ' LEU . 84.2 mm-40 -80.39 17.45 1.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.49 -0.777 . . . . 2.62 111.927 -172.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.438 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 8.8 m 76.32 -29.15 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.392 0.677 . . . . 2.43 112.671 168.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.514 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 15.0 t30 77.8 84.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.851 0.834 . . . . 1.56 111.08 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.472 ' N ' HH12 ' A' ' 16' ' ' ARG . 25.9 m -93.79 137.43 23.17 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.542 -1.208 . . . . 1.68 109.535 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' CG2' ' A' ' 107' ' ' THR . 72.2 Cg_exo -19.58 92.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 1 C-N-CA 126.198 4.598 . . . . 1.26 115.461 -174.228 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.832 ' HG2' HG11 ' A' ' 142' ' ' VAL . 10.2 Cg_endo -96.96 -155.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.355 3.37 . . . . 0.76 114.31 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -172.94 -105.25 0.18 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 114.118 -1.401 . . . . 0.76 109.603 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -102.74 130.11 49.59 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.57 -0.53 . . . . 2.04 109.57 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.778 ' HE2' ' HB3' ' A' ' 109' ' ' PRO . 6.7 m-85 -118.58 120.66 38.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.036 0.446 . . . . 0.75 110.587 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.2 m -97.48 135.36 39.45 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 0.83 110.768 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.959 HD22 HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -153.84 94.06 1.72 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.463 0.649 . . . . 0.51 109.783 175.08 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.709 ' HB ' ' CB ' ' A' ' 45' ' ' ASP . 14.8 m -84.45 140.65 31.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.741 -0.663 . . . . 0.59 109.95 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.5 mt -118.42 119.93 36.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.409 -0.359 . . . . 1.27 110.496 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 43.5 m -98.47 121.34 40.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.014 0.435 . . . . 0.7 110.236 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.12 -159.4 19.05 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.842 -0.694 . . . . 0.8 112.673 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.702 ' HA2' ' HB2' ' A' ' 132' ' ' SER . . . 109.64 165.88 20.0 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.518 -0.633 . . . . 0.53 111.518 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -89.34 177.26 6.64 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.142 -0.623 . . . . 0.89 111.017 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.659 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 4.6 t-105 -129.25 151.95 49.35 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.804 -1.089 . . . . 0.56 109.902 -174.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.45 149.85 52.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.105 -0.498 . . . . 1.42 110.175 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt 64.25 -146.52 0.28 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.21 0.604 . . . . 3.47 111.053 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 126' ' ' LYS . 4.2 p30 -151.02 136.14 17.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.516 0.198 . . . . 2.08 110.945 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.594 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.7 OUTLIER 51.97 -7.9 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.306 1.842 . . . . 2.47 115.883 176.569 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -80.5 -2.52 46.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.362 0.601 . . . . 1.96 109.999 176.584 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.659 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 42.7 tt0 68.47 54.43 0.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.432 -1.258 . . . . 2.02 110.839 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.416 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -89.47 110.68 3.75 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 109.823 -1.311 . . . . 0.77 109.823 170.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 26.7 p90 -151.0 171.26 17.58 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.297 -0.631 . . . . 1.21 109.297 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.583 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 5.9 t -150.19 146.03 19.54 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 110.009 -0.367 . . . . 1.47 110.009 173.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.12 106.76 1.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.7 2.267 . . . . 0.92 111.47 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.702 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 10.6 m -131.95 122.07 24.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.913 -0.585 . . . . 1.52 109.78 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.75 -110.57 3.78 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.714 -0.755 . . . . 1.17 111.483 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.6 p -144.01 176.2 9.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.052 0.453 . . . . 2.47 110.957 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.1 t -126.86 129.71 48.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.31 -0.626 . . . . 1.82 109.31 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.49 138.18 14.65 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.647 -0.787 . . . . 0.67 112.155 -175.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 19.2 m -99.06 103.73 15.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.992 -0.373 . . . . 0.58 109.992 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 10' ' ' LEU . 21.6 m -81.81 113.18 19.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.355 -0.609 . . . . 0.52 109.355 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -100.22 109.08 21.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.471 0.653 . . . . 2.18 109.506 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.496 HD23 ' HG ' ' A' ' 56' ' ' LEU . 13.7 tp -92.58 95.85 9.85 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.711 -1.132 . . . . 0.63 109.415 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 24.7 m -93.64 126.8 39.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.76 -0.654 . . . . 0.58 109.576 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' ' 15' ' ' THR . 30.7 t -107.23 106.18 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.675 -0.41 . . . . 1.74 111.242 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.289 -0.863 . . . . 2.58 109.498 173.737 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.407 0.146 . . . . 5.73 110.966 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -162.0 121.61 2.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.987 0.423 . . . . 3.08 111.337 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.959 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 4.8 t -92.52 103.39 15.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.656 -0.868 . . . . 1.43 108.656 168.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -97.67 141.42 30.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.25 -0.432 . . . . 2.29 110.928 -175.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.548 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 74.9 t -117.37 117.2 54.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.749 -0.659 . . . . 1.51 110.397 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -88.86 106.22 18.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.112 -0.495 . . . . 3.57 110.79 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 5' ' ' VAL . 66.9 t -113.76 115.02 48.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.115 -0.493 . . . . 1.26 109.937 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.77 -178.53 25.72 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.63 -0.795 . . . . 0.96 112.029 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.27 146.47 24.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.959 -0.385 . . . . 2.18 109.959 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -140.92 142.11 34.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.12 -0.491 . . . . 1.41 109.718 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -116.65 117.59 30.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.405 -0.362 . . . . 1.03 110.697 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.35 140.37 47.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.938 0.399 . . . . 1.45 110.534 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.45 ' HB1' ' OG1' ' A' ' 143' ' ' THR . . . -116.67 112.5 21.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 0.59 110.222 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.561 ' HG3' ' H ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -163.81 179.7 6.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.049 0.452 . . . . 3.42 110.417 -178.617 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.561 ' H ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -103.42 158.73 16.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.63 110.328 178.199 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.634 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -80.46 -9.2 59.76 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.961 -0.462 . . . . 3.14 111.023 -175.81 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.57 -15.36 79.25 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.081 -0.807 . . . . 0.75 111.081 172.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.516 ' HA ' HE21 ' A' ' 18' ' ' GLN . 0.0 OUTLIER -66.07 -31.79 72.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.124 -0.538 . . . . 2.17 110.856 176.84 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.87 ' HB2' HG12 ' A' ' 100' ' ' VAL . 12.2 mt -91.25 19.8 5.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.889 -0.596 . . . . 1.61 112.183 -168.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -36.25 93.59 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 N-CA-C 114.007 1.114 . . . . 1.65 114.007 -172.709 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 69.9 -53.34 0.62 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.858 -1.064 . . . . 1.83 111.923 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.826 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -158.13 78.41 0.82 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.189 0.518 . . . . 0.82 111.26 176.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 19' ' ' LEU . . . -138.93 117.87 9.25 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.488 -0.778 . . . . 0.79 109.096 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.401 ' HD3' ' HE1' ' A' ' 99' ' ' TYR . 96.0 Cg_endo -79.74 132.48 9.79 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.88 2.387 . . . . 1.12 114.417 -170.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.733 HG23 HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -77.49 -56.61 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.425 -0.807 . . . . 2.58 110.162 169.104 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.444 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -138.91 98.24 0.25 Allowed Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.388 -0.824 . . . . 0.74 111.67 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.577 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 31.3 Cg_endo -67.66 126.58 14.95 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.271 1.98 . . . . 0.67 111.378 176.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.75 124.44 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 1.18 109.653 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 t -77.7 74.98 4.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.472 0.654 . . . . 1.64 110.508 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.486 HG13 ' CG1' ' A' ' 5' ' ' VAL . 70.0 t -72.42 113.2 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.728 -0.669 . . . . 1.01 109.949 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.409 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 14.0 pt20 -116.12 125.82 52.87 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.778 -0.646 . . . . 2.48 109.833 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.524 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -111.61 130.61 55.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.408 -0.815 . . . . 0.7 110.351 -177.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 35.2 tp -111.44 116.45 30.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.137 -0.483 . . . . 1.94 111.324 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.09 71.63 0.84 Allowed Glycine 0 C--N 1.331 0.304 0 O-C-N 123.573 0.545 . . . . 1.81 113.423 173.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.959 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 9.9 m -106.71 -68.83 0.86 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.883 -0.327 . . . . 1.88 111.465 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 68.41 -48.22 0.55 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.466 0.706 . . . . 2.14 112.32 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.81 69.89 1.26 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.206 0.527 . . . . 0.94 110.348 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.645 HH11 ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -149.95 131.8 15.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.994 -0.548 . . . . 4.64 110.586 -177.342 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.707 ' HG3' HG12 ' A' ' 89' ' ' VAL . 98.6 mt-30 -85.48 124.19 31.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.109 0.48 . . . . 1.75 110.078 178.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.645 ' HA ' HH11 ' A' ' 38' ' ' ARG . 71.0 t -95.14 110.55 24.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.088 -0.506 . . . . 0.54 109.946 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -117.72 144.44 45.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 123.624 0.578 . . . . 0.36 111.039 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.852 HD11 HD12 ' A' ' 96' ' ' ILE . 64.5 mt -103.7 129.07 51.0 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.488 -0.56 . . . . 0.84 109.488 172.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.718 ' HG3' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -120.28 152.12 38.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.858 -0.793 . . . . 1.93 108.858 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.496 ' HB1' ' OD1' ' A' ' 48' ' ' ASN . . . -92.67 159.2 15.56 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.719 -0.392 . . . . 0.41 110.036 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.588 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 14.8 t70 -87.61 170.01 11.66 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.563 -0.903 . . . . 0.71 108.563 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -65.54 -1.98 3.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.975 0.361 . . . . 1.4 111.975 -173.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -88.94 -26.34 21.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.72 -0.218 . . . . 2.22 111.262 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.496 ' OD1' ' HB1' ' A' ' 44' ' ' ALA . 28.9 p-10 -131.73 12.16 4.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.732 0.301 . . . . 1.35 111.699 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 55.2 t80 -114.44 101.37 9.07 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.537 -0.542 . . . . 0.56 109.537 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.779 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 8.3 pt-20 -95.35 93.71 7.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.877 0.37 . . . . 2.41 110.387 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 68.39 -50.95 0.56 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.428 -0.805 . . . . 3.43 112.036 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -172.04 36.58 0.15 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.183 -0.767 . . . . 0.56 111.183 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.629 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 10.3 mmmm -137.84 134.87 35.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.946 -0.761 . . . . 2.12 108.946 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -117.9 148.69 41.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.493 0.663 . . . . 0.56 112.307 177.445 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.779 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 7.6 p90 -156.58 176.94 12.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.019 -0.991 . . . . 0.59 111.1 -174.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 20.1 mt -89.24 111.05 21.76 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.351 -0.981 . . . . 1.53 108.351 168.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.534 ' HB ' ' HE1' ' A' ' 55' ' ' PHE . 8.3 tp -107.33 138.69 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.703 -0.48 . . . . 0.62 109.703 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 3.1 t -102.41 152.73 20.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.529 -0.305 . . . . 1.44 110.372 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -49.11 -42.48 39.27 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.053 0.846 . . . . 2.31 113.023 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.31 -21.8 66.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.711 0.263 . . . . 3.09 111.711 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 63.34 84.43 0.15 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.365 0.602 . . . . 2.62 109.95 -176.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -154.79 -40.7 0.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.615 . . . . 4.66 111.034 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.87 153.52 50.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.915 -0.584 . . . . 2.51 110.322 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.6 pptp? -152.25 128.04 10.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.804 -0.635 . . . . 2.07 109.739 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.472 HD22 ' HG2' ' A' ' 104' ' ' GLN . 4.5 mt -114.27 119.12 35.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.261 -0.427 . . . . 1.98 110.026 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.453 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 93.4 m-85 -67.85 128.73 37.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 0.75 110.156 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 100' ' ' VAL . 11.2 m -121.27 123.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.878 -0.601 . . . . 0.73 111.428 -175.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -97.21 111.67 23.81 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.961 -0.563 . . . . 1.81 109.53 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.537 HG22 ' HB ' ' A' ' 96' ' ' ILE . 2.6 mt -76.32 86.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.562 -0.745 . . . . 0.81 110.454 -176.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -93.62 142.84 25.68 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.995 -0.548 . . . . 3.79 109.866 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.541 ' HA ' HG23 ' A' ' 96' ' ' ILE . 77.1 Cg_exo -51.12 134.08 42.64 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.693 2.262 . . . . 0.59 112.52 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tpt -75.14 72.75 2.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.984 -0.553 . . . . 1.71 109.948 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.4 t70 52.58 75.59 0.23 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.363 -0.835 . . . . 1.92 110.785 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -146.56 -59.94 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.866 -0.606 . . . . 1.89 111.248 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 m -151.02 178.83 8.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 1.7 111.055 -175.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.26 121.75 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.751 -0.658 . . . . 0.94 109.891 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.521 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 17.8 m0 -113.07 168.21 9.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.256 -0.429 . . . . 0.5 111.001 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -87.97 131.37 34.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.018 -0.734 . . . . 0.51 109.018 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 t -107.93 113.59 26.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.605 0.717 . . . . 0.59 112.353 -171.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -127.24 161.33 28.82 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.782 -1.192 . . . . 1.7 107.782 170.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.515 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 15.8 m120 -85.91 -5.52 59.22 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.295 -0.562 . . . . 1.39 110.812 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.82 -38.37 3.66 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.19 -1.005 . . . . 0.65 111.81 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.718 HG12 ' HG3' ' A' ' 43' ' ' LYS . 27.0 m -140.49 156.72 23.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.971 0.415 . . . . 1.16 110.403 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.684 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -132.15 108.87 9.56 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.659 -0.867 . . . . 0.36 108.659 177.194 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.627 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 12.7 p90 -145.75 149.24 34.03 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.22 0.325 . . . . 0.59 110.675 -174.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.524 ' HZ1' ' HB2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -80.55 141.36 35.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.948 -0.701 . . . . 1.39 109.205 174.306 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -57.97 -33.81 69.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.843 -0.617 . . . . 2.12 110.412 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -61.99 122.14 14.74 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.741 -0.663 . . . . 2.1 111.587 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 39' ' ' GLN . 13.1 m -80.94 105.59 11.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.141 0.496 . . . . 1.05 109.95 173.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.42 ' N ' ' H ' ' A' ' 38' ' ' ARG . . . 170.75 -162.77 35.83 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.134 -1.032 . . . . 0.46 112.603 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -84.0 163.81 19.71 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.013 0.435 . . . . 1.17 110.447 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.524 ' HB2' ' HZ1' ' A' ' 86' ' ' LYS . 41.3 t90 -148.86 -62.41 0.24 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.344 -0.613 . . . . 0.51 109.344 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 38.54 91.72 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 O-C-N 124.341 1.026 . . . . 1.25 115.161 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.16 -127.45 0.91 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.701 -0.761 . . . . 0.72 112.377 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 p -135.85 133.02 37.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.054 0.454 . . . . 0.6 111.805 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.852 HD12 HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -130.87 134.26 62.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 1.63 109.692 176.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -106.61 156.26 16.22 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.34 -0.933 . . . . 0.45 113.005 -170.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 mp -97.56 117.75 42.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.9 0.381 . . . . 0.83 110.089 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.826 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 1.1 m-85 -126.19 133.56 51.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.631 -0.713 . . . . 1.28 109.509 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.87 HG12 ' HB2' ' A' ' 19' ' ' LEU . 12.3 p -66.21 119.77 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.855 -0.794 . . . . 1.14 108.855 173.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.92 83.54 1.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.579 0.704 . . . . 1.02 109.477 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.99 93.83 2.3 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 114.799 -1.091 . . . . 1.53 110.961 -171.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 16.5 pt20 -31.48 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.276 0.843 . . . . 2.11 113.276 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.472 ' HG2' HD22 ' A' ' 65' ' ' LEU . 55.9 tp60 -82.59 -15.37 52.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 2.62 110.692 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 m 62.6 26.31 15.61 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.361 0.6 . . . . 2.43 111.134 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.634 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 7.2 t30 64.08 89.41 0.09 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.589 -0.732 . . . . 1.56 112.204 172.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.3 m -89.6 133.87 33.55 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.819 -0.808 . . . . 1.68 108.819 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -19.46 90.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.794 4.329 . . . . 1.26 115.1 -171.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.616 ' CB ' ' HE1' ' A' ' 112' ' ' TYR . 90.0 Cg_endo -99.99 -161.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.968 3.112 . . . . 0.76 113.889 -174.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.55 -101.98 0.15 Allowed Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.926 -1.034 . . . . 0.76 110.633 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -112.38 111.41 22.25 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.339 -0.615 . . . . 2.04 109.339 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.616 ' HE1' ' CB ' ' A' ' 109' ' ' PRO . 27.6 m-85 -95.35 128.09 41.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.233 0.54 . . . . 0.75 110.303 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.7 m -116.06 98.46 6.64 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.071 -0.968 . . . . 0.83 110.395 -175.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.474 ' HG ' ' HB ' ' A' ' 138' ' ' THR . 0.2 OUTLIER -119.34 100.55 7.38 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.042 -0.527 . . . . 0.51 110.367 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.711 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 23.8 m -88.37 132.52 34.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.148 -0.478 . . . . 0.59 110.527 -178.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -114.63 124.84 52.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.083 0.468 . . . . 1.27 110.556 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.473 ' HA ' HG23 ' A' ' 135' ' ' THR . 27.5 m -91.06 113.04 25.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.752 -0.658 . . . . 0.7 110.478 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.1 122.65 6.25 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.737 -0.744 . . . . 0.8 111.754 177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.57 -176.33 39.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.241 -0.98 . . . . 0.53 112.426 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 38' ' ' ARG . 39.3 p90 -102.96 177.84 4.73 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.278 0.561 . . . . 0.89 110.294 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.805 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.9 OUTLIER -147.29 149.32 32.62 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.323 -0.992 . . . . 0.56 108.323 -177.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.61 144.14 51.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.421 0.153 . . . . 1.42 110.79 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.438 ' HG3' ' HE2' ' A' ' 126' ' ' LYS . 32.9 mmtp 74.97 -144.34 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.62 0.768 . . . . 3.47 111.368 175.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -150.68 123.21 8.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.322 0.582 . . . . 2.08 112.275 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.544 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 27.6 t-20 68.44 -28.58 0.15 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.445 1.098 . . . . 2.47 113.947 174.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.438 ' HE2' ' HG3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -65.34 -3.19 3.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.219 0.533 . . . . 1.96 111.164 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.805 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 46.1 tt0 66.79 66.45 0.44 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.12 -0.946 . . . . 2.02 110.862 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 121' ' ' TRP . . . -90.89 46.96 2.93 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.329 -0.938 . . . . 0.77 111.37 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.619 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 3.9 p90 -86.69 144.66 27.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.773 0.321 . . . . 1.21 110.856 -170.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 46.3 m -150.3 132.26 7.83 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 110.37 -0.233 . . . . 1.47 110.37 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.71 132.74 47.14 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.708 2.272 . . . . 0.92 112.345 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -156.28 95.17 1.57 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.234 -0.439 . . . . 1.52 110.4 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 5' ' ' VAL . . . 130.25 -102.71 0.54 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.776 -0.726 . . . . 1.17 112.162 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.4 m -152.3 147.45 26.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.711 0.256 . . . . 2.47 110.741 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.473 HG23 ' HA ' ' A' ' 117' ' ' THR . 28.9 m -101.2 127.49 47.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.649 -0.5 . . . . 1.82 109.649 174.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.96 141.11 12.41 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.467 -0.873 . . . . 0.67 112.524 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.711 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 72.8 m -94.3 123.15 37.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.025 0.44 . . . . 0.58 110.913 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.474 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 24.9 m -85.88 115.26 23.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.514 -0.921 . . . . 0.52 108.514 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -100.88 111.91 24.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.21 0.528 . . . . 2.18 110.208 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 tp -108.64 100.45 9.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.048 -0.978 . . . . 0.63 110.385 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 m -93.15 143.67 26.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.852 -0.613 . . . . 0.58 109.809 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.631 ' HA ' HH12 ' A' ' 16' ' ' ARG . 7.3 p -71.02 132.79 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.467 0.651 . . . . 1.74 112.349 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.45 ' OG1' ' HB1' ' A' ' 13' ' ' ALA . 85.5 m . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.133 -0.94 . . . . 2.58 109.129 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.864 0.364 . . . . 5.73 110.465 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -98.48 137.94 36.43 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.343 0.592 . . . . 3.08 110.067 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.852 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 48.2 t -147.84 131.51 16.89 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.989 -1.005 . . . . 1.43 108.3 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -85.68 123.71 31.38 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.285 -0.566 . . . . 2.29 110.393 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.536 HG12 HG23 ' A' ' 7' ' ' VAL . 61.3 t -95.56 112.06 27.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.718 -0.673 . . . . 1.51 110.045 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.721 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 14.5 mmm180 -81.64 93.74 6.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.706 -0.679 . . . . 3.57 110.834 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.58 HG12 ' HA3' ' A' ' 136' ' ' GLY . 37.2 t -107.62 115.62 49.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.394 -0.965 . . . . 1.26 108.394 171.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.76 -175.77 21.65 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.498 -0.858 . . . . 0.96 112.261 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -100.59 146.15 27.49 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.926 -0.398 . . . . 2.18 109.926 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -152.6 139.26 18.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.552 -0.536 . . . . 1.41 109.552 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.9 m -107.77 115.89 30.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.183 -0.462 . . . . 1.03 110.305 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 140' ' ' LEU . 4.1 p -110.61 126.01 67.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.14 -0.482 . . . . 1.45 109.9 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -105.31 104.21 13.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.898 -0.592 . . . . 0.59 110.452 -176.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -172.9 -178.68 1.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 3.42 110.478 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.5 p -107.43 162.77 13.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.127 -0.488 . . . . 0.63 111.065 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.654 ' HB2' HH11 ' A' ' 16' ' ' ARG . 0.0 OUTLIER -80.27 -0.44 36.48 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.644 -0.502 . . . . 3.14 109.644 176.61 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.603 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -79.39 -17.58 75.76 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.367 -0.693 . . . . 0.75 111.367 177.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -74.17 -22.62 59.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.847 -0.797 . . . . 2.17 108.847 173.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.924 HD21 HG12 ' A' ' 25' ' ' ILE . 67.2 mt -87.16 95.9 10.12 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.699 -1.137 . . . . 1.61 110.985 -175.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.0 m -101.3 68.05 1.2 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.045 -0.724 . . . . 1.65 109.045 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.4 t70 69.56 -62.68 0.41 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.753 -1.112 . . . . 1.83 111.036 -175.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -114.31 98.09 6.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.797 0.332 . . . . 0.82 110.887 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -154.54 92.08 2.98 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.439 . . . . 0.79 111.071 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 28.7 Cg_endo -64.19 80.82 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.349 2.699 . . . . 1.12 112.372 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.924 HG12 HD21 ' A' ' 19' ' ' LEU . 1.1 pp -70.7 -53.71 21.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.405 -0.816 . . . . 2.58 112.336 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.24 63.88 0.57 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.203 -0.998 . . . . 0.74 113.249 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.634 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 5.5 Cg_endo -47.07 111.59 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.601 2.867 . . . . 0.67 113.004 172.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 p -84.63 134.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.896 -0.593 . . . . 1.18 109.813 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -88.64 102.87 15.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.672 0.748 . . . . 1.64 110.804 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.663 ' CG2' HD11 ' A' ' 96' ' ' ILE . 41.5 t -94.79 116.26 35.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.556 -0.747 . . . . 1.01 110.204 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.721 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 34.7 tt0 -102.01 125.14 48.62 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.641 -0.709 . . . . 2.48 110.182 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.667 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -112.89 113.98 26.29 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.956 -0.387 . . . . 0.7 109.956 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.1 mt -104.99 111.52 24.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.969 0.414 . . . . 1.94 111.986 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.95 55.32 8.18 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.508 -0.769 . . . . 1.81 113.283 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.852 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 84.1 m -87.14 -49.31 7.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.857 0.329 . . . . 1.88 110.585 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.8 t30 71.14 -63.78 0.41 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.708 0.803 . . . . 2.14 112.69 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.91 71.0 1.25 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.676 0.75 . . . . 0.94 109.19 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.619 ' NE ' ' HB3' ' A' ' 120' ' ' TYR . 41.0 ttt-85 -146.54 133.19 19.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.178 -0.919 . . . . 4.64 111.012 -169.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -83.17 96.86 8.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.615 -0.513 . . . . 1.75 109.615 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 46.7 t -73.6 117.22 17.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 0.54 110.315 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -119.48 148.31 43.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.129 -0.487 . . . . 0.36 110.977 -176.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 mt -102.77 113.79 27.5 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.115 -0.698 . . . . 0.84 109.115 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.541 ' HG3' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -104.75 125.8 51.19 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.632 -0.507 . . . . 1.93 109.632 -178.185 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.587 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -76.81 143.26 39.9 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.517 -0.549 . . . . 0.41 109.517 174.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.63 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 27.2 t70 -76.02 148.34 38.11 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.918 -0.771 . . . . 0.71 108.918 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.723 ' HA ' ' HB3' ' A' ' 49' ' ' PHE . 10.1 t -56.56 -16.51 6.18 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.866 0.691 . . . . 1.4 112.866 -172.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.28 -31.45 72.04 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.239 0.543 . . . . 2.22 110.289 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.587 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 5.1 p-10 -129.43 24.31 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.773 -0.648 . . . . 1.35 109.479 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.723 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 10.1 t80 -134.03 108.5 8.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.257 -0.883 . . . . 0.56 109.16 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.787 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 10.9 pt-20 -116.65 116.61 27.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.649 0.261 . . . . 2.41 110.448 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 71.34 -51.45 0.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.793 0.837 . . . . 3.43 111.805 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.468 ' O ' ' HD2' ' A' ' 53' ' ' LYS . . . 170.02 31.17 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.719 -0.952 . . . . 0.56 110.719 -177.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.702 ' HA ' ' HB3' ' A' ' 81' ' ' ASN . 14.5 mptt -129.88 140.23 51.02 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.178 -0.675 . . . . 2.12 109.178 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -120.69 147.68 44.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.585 0.707 . . . . 0.56 111.636 176.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.787 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 16.9 p90 -157.46 174.93 14.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.886 -1.052 . . . . 0.59 110.752 -170.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.557 HD13 HD23 ' A' ' 140' ' ' LEU . 8.6 mt -84.16 111.84 19.71 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.146 -1.057 . . . . 1.53 108.146 170.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.591 ' HB ' ' HE1' ' A' ' 55' ' ' PHE . 8.4 tp -105.3 125.83 60.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.805 0.812 . . . . 0.62 110.021 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.575 ' HB2' ' CE1' ' A' ' 112' ' ' TYR . 33.5 t -76.84 135.74 38.89 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.073 -0.967 . . . . 1.44 110.714 -177.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.52 -34.17 72.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.868 -0.79 . . . . 2.31 108.868 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -69.28 -24.67 63.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.566 -1.197 . . . . 3.09 110.611 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 t30 63.83 97.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.701 -0.681 . . . . 2.62 111.27 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -166.27 -44.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.716 -0.674 . . . . 4.66 110.584 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.39 139.78 53.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.902 -0.59 . . . . 2.51 109.955 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.59 ' HB2' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -135.35 106.51 6.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.989 0.899 . . . . 2.07 109.429 170.292 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.789 HD21 HG23 ' A' ' 100' ' ' VAL . 7.9 tp -108.19 126.32 52.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.24 -0.891 . . . . 1.98 110.927 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 5.2 m-85 -72.95 141.4 47.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.956 -1.02 . . . . 0.75 110.306 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.572 HG12 ' HA ' ' A' ' 100' ' ' VAL . 16.4 m -136.65 142.61 37.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.549 -0.296 . . . . 0.73 110.468 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -102.89 120.54 40.8 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.788 -0.449 . . . . 1.81 109.788 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.485 HG22 ' HB ' ' A' ' 96' ' ' ILE . 0.9 OUTLIER -82.61 87.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.816 -0.629 . . . . 0.81 109.876 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.498 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 60.0 ttt180 -93.99 128.63 40.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.414 -0.357 . . . . 3.79 110.812 -174.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.71 ' HA ' HG22 ' A' ' 96' ' ' ILE . 4.2 Cg_endo -50.36 139.77 36.01 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.319 2.679 . . . . 0.59 112.216 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.6 ttt -72.66 64.11 0.63 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.661 -0.7 . . . . 1.71 111.304 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 t70 62.89 14.96 7.89 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.715 0.806 . . . . 1.92 112.302 175.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.403 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 58.7 m-80 -78.13 -35.0 49.61 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.829 -0.544 . . . . 1.89 111.559 -175.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.2 p -170.78 172.74 5.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.378 -0.23 . . . . 1.7 110.378 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.72 129.06 35.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.981 0.42 . . . . 0.94 110.101 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.715 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 13.8 m0 -117.28 155.84 28.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.07 -0.513 . . . . 0.5 110.535 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.8 m -89.6 113.22 24.62 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.265 -0.643 . . . . 0.51 109.265 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 t -88.58 124.25 33.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.796 0.807 . . . . 0.59 111.91 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -130.56 160.98 32.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.44 -1.318 . . . . 1.7 107.44 168.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.702 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 16.1 m120 -85.94 -3.55 58.95 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.368 -0.533 . . . . 1.39 111.262 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.92 -36.92 2.65 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.303 -0.951 . . . . 0.65 111.664 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.541 HG12 ' HG3' ' A' ' 43' ' ' LYS . 29.3 m -137.01 156.67 34.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.997 0.427 . . . . 1.16 110.306 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.615 ' HD1' ' HE3' ' A' ' 77' ' ' TRP . 0.7 OUTLIER -136.64 106.74 6.33 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.95 -1.13 . . . . 0.36 107.95 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 8.7 p90 -138.19 146.5 42.76 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.913 -0.315 . . . . 0.59 111.377 -174.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.733 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 49.3 pttt -78.22 157.57 29.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 1.39 110.826 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -85.21 7.47 21.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.795 . . . . 2.12 110.041 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.733 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 35.8 m-20 -106.48 128.04 53.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.538 -0.755 . . . . 2.1 109.331 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -90.04 106.36 17.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.555 0.693 . . . . 1.05 111.002 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.28 -162.71 36.5 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.051 -0.819 . . . . 0.46 111.051 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.4 m -84.14 147.25 27.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.976 0.417 . . . . 1.17 109.941 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.487 ' CD2' ' HZ2' ' A' ' 77' ' ' TRP . 55.3 t90 -120.07 -59.05 1.83 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.65 -0.5 . . . . 0.51 109.65 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 34.53 90.42 0.01 OUTLIER Glycine 0 N--CA 1.464 0.548 0 O-C-N 124.637 1.21 . . . . 1.25 115.477 176.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.16 -125.09 0.75 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.004 -0.617 . . . . 0.72 111.955 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.457 ' O ' ' HH2' ' A' ' 92' ' ' TRP . 1.2 p -137.18 132.42 33.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 0.6 111.571 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.71 HG22 ' HA ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -118.46 134.8 60.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.169 -0.678 . . . . 1.63 109.169 174.318 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.634 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -99.58 158.52 19.81 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.331 -0.937 . . . . 0.45 112.555 -175.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.513 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.8 mp -95.03 112.81 28.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.649 -0.5 . . . . 0.83 109.649 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 70' ' ' ARG . 1.6 m-85 -110.95 120.91 43.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.817 -0.808 . . . . 1.28 108.817 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.789 HG23 HD21 ' A' ' 65' ' ' LEU . 14.5 p -58.68 137.34 21.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.816 0.341 . . . . 1.14 110.993 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.65 81.94 8.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.715 -0.846 . . . . 1.02 108.715 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.65 110.34 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.525 -0.762 . . . . 1.53 111.815 -172.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -40.09 125.11 1.95 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.493 0.663 . . . . 2.11 112.582 177.428 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.563 ' HB2' HD13 ' A' ' 65' ' ' LEU . 45.9 tp60 -92.69 21.27 5.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.559 . . . . 2.62 110.461 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 6.1 m 69.25 -11.58 0.47 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.696 -0.684 . . . . 2.43 112.714 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.603 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 19.3 t30 68.18 88.21 0.11 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.73 0.776 . . . . 1.56 110.629 -175.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.63 146.8 34.93 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 114.689 -1.141 . . . . 1.68 109.007 173.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -38.26 93.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.999 3.132 . . . . 1.26 112.509 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.605 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 3.0 Cg_exo -76.84 -179.56 5.51 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.198 2.598 . . . . 0.76 113.333 -169.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.06 -124.42 0.89 Allowed Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.151 -1.18 . . . . 0.76 110.151 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 58' ' ' SER . 51.6 t-20 -97.5 107.4 19.9 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.129 -0.693 . . . . 2.04 109.129 172.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 58' ' ' SER . 68.4 m-85 -102.16 107.34 18.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.468 0.651 . . . . 0.75 109.524 174.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -97.85 126.79 43.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.017 -0.992 . . . . 0.83 110.534 -175.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 138' ' ' THR . 0.1 OUTLIER -135.01 107.14 7.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.548 0.689 . . . . 0.51 109.927 176.095 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 11.9 m -94.02 139.76 30.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.456 -0.793 . . . . 0.59 110.299 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 44' ' ' ALA . 95.4 mt -124.96 126.14 45.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.909 0.385 . . . . 1.27 110.569 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 m -101.18 117.0 34.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.216 -0.447 . . . . 0.7 110.219 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.27 147.71 47.79 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.748 -0.739 . . . . 0.8 112.576 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.04 179.73 39.71 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.783 -0.722 . . . . 0.53 112.214 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.619 ' HB3' ' NE ' ' A' ' 38' ' ' ARG . 48.6 p90 -102.63 174.16 6.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.051 0.453 . . . . 0.89 110.325 177.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.724 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.8 OUTLIER -132.69 146.53 51.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.413 -0.812 . . . . 0.56 109.101 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -118.85 141.28 48.78 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.069 0.461 . . . . 1.42 111.208 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.537 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 7.0 tptm 71.97 -145.07 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.676 -1.147 . . . . 3.47 111.265 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 126' ' ' LYS . 4.9 t70 -146.98 124.42 11.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.615 -0.266 . . . . 2.08 111.496 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.589 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.5 OUTLIER 53.64 -5.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.132 1.773 . . . . 2.47 115.542 176.312 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.608 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -79.03 -3.38 44.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 1.96 110.216 177.466 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.724 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 33.6 tt0 69.08 71.61 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.792 -1.095 . . . . 2.02 110.644 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.608 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -106.97 43.01 1.78 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.698 -0.763 . . . . 0.77 112.134 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -78.19 130.08 35.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.15 0.5 . . . . 1.21 110.857 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 17.6 m -121.56 118.91 29.49 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.215 -0.448 . . . . 1.47 110.559 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 130' ' ' THR . 25.0 Cg_exo -63.93 123.37 11.83 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.964 2.443 . . . . 0.92 112.27 177.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.01 94.15 1.5 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.967 -0.56 . . . . 1.52 110.193 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 145.58 -145.95 15.64 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.284 -0.726 . . . . 1.17 111.284 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.532 HG21 ' NH1' ' A' ' 6' ' ' ARG . 38.3 p -110.12 158.08 18.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.989 0.423 . . . . 2.47 111.398 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.0 m -99.93 100.32 11.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.824 -0.626 . . . . 1.82 109.786 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.58 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -93.79 160.76 24.44 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.847 -0.692 . . . . 0.67 111.775 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.1 m -126.82 109.51 12.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.026 0.413 . . . . 0.58 111.311 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.602 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 3.7 m -82.23 116.43 21.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.634 -0.876 . . . . 0.52 108.634 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -112.1 108.83 18.24 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.27 0.557 . . . . 2.18 110.544 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.557 HD23 HD13 ' A' ' 56' ' ' LEU . 15.2 tp -96.56 109.16 21.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.031 -0.986 . . . . 0.63 109.072 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.0 m -121.52 144.47 48.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.529 -0.759 . . . . 0.58 110.947 -173.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.605 ' HB ' ' HB2' ' A' ' 109' ' ' PRO . 13.0 p -83.16 141.73 14.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.433 -0.581 . . . . 1.74 109.433 172.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.243 0.749 0 CA-C-O 118.426 -0.797 . . . . 2.58 109.723 178.923 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 110.246 -0.279 . . . . 5.73 110.246 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.405 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 14.9 pt-20 44.88 -151.34 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.487 1.117 . . . . 3.08 112.466 175.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 120' ' ' TYR . 43.5 t -111.37 87.22 2.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.656 -0.498 . . . . 1.43 109.656 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.414 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 63.6 tt0 -103.61 111.84 24.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.192 -0.458 . . . . 2.29 110.766 -177.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.703 HG21 HG13 ' A' ' 40' ' ' VAL . 38.5 t -107.49 125.32 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.118 -0.492 . . . . 1.51 110.701 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.594 ' HG2' ' HB3' ' A' ' 31' ' ' GLN . 11.1 ptp180 -92.18 142.54 27.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.036 0.446 . . . . 3.57 110.684 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.7 t -120.53 115.43 47.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.781 -0.822 . . . . 1.26 108.781 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.38 126.6 11.5 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.554 -0.831 . . . . 0.96 112.38 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -68.34 104.04 1.77 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.574 -0.528 . . . . 2.18 109.574 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' A' ' 28' ' ' VAL . 72.8 mt -105.37 152.43 22.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.95 -0.568 . . . . 1.41 110.739 -176.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 m -133.09 114.42 13.89 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.035 -0.728 . . . . 1.03 109.035 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.422 HG11 HG22 ' A' ' 25' ' ' ILE . 41.3 t -118.16 140.32 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.386 -0.37 . . . . 1.45 110.313 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.99 103.21 11.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.284 -0.416 . . . . 0.59 110.028 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -165.02 176.04 8.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.433 -0.58 . . . . 3.42 109.433 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.515 HG22 HG23 ' A' ' 142' ' ' VAL . 31.9 p -96.43 163.34 13.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.613 -0.267 . . . . 0.63 110.911 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.519 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -86.98 -3.42 59.09 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.91 -0.774 . . . . 3.14 108.91 176.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -79.77 -28.22 51.59 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.79 -0.924 . . . . 0.75 110.79 173.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.89 -39.08 87.92 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.624 -0.88 . . . . 2.17 108.624 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 100' ' ' VAL . 62.8 mt -63.95 113.33 3.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.912 -1.04 . . . . 1.61 109.746 171.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 m -130.4 85.28 2.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.562 0.22 . . . . 1.65 110.536 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 7.9 m-20 63.48 -74.66 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.664 -0.698 . . . . 1.83 111.854 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.13 81.71 1.87 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.191 0.52 . . . . 0.82 110.671 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.18 100.27 4.2 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.544 -0.753 . . . . 0.79 109.89 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.53 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 59.5 Cg_endo -72.1 105.51 1.85 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.816 2.344 . . . . 1.12 112.847 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.422 HG22 HG11 ' A' ' 12' ' ' VAL . 49.4 mm -96.3 -26.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.181 -0.463 . . . . 2.58 110.734 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.75 54.65 0.62 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.897 -1.144 . . . . 0.74 113.689 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 12.1 Cg_endo -57.03 114.1 1.77 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.281 1.987 . . . . 0.67 112.064 170.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.468 ' HA ' HD11 ' A' ' 10' ' ' LEU . 45.9 t -87.75 135.82 24.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.881 -0.6 . . . . 1.18 110.433 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.95 102.24 4.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.603 0.716 . . . . 1.64 110.133 174.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.899 HG21 HG12 ' A' ' 96' ' ' ILE . 6.7 t -94.08 141.96 14.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.862 -1.063 . . . . 1.01 111.879 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.594 ' HB3' ' HG2' ' A' ' 6' ' ' ARG . 31.4 tt0 -146.87 117.41 7.5 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.651 -1.159 . . . . 2.48 109.079 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.437 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -110.46 105.73 14.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.287 -0.415 . . . . 0.7 110.144 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.4 tp -77.61 112.76 14.76 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.508 -0.553 . . . . 1.94 109.508 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 2' ' ' GLU . . . 88.64 -121.97 6.2 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.704 -0.76 . . . . 1.81 111.773 -177.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.437 ' SG ' ' HB1' ' A' ' 32' ' ' ALA . 66.7 m 65.13 11.6 7.3 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 122.598 0.359 . . . . 1.88 111.707 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.661 ' HA ' ' HA2' ' A' ' 90' ' ' GLY . 19.3 m120 -63.36 -11.44 22.51 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.631 0.604 . . . . 2.14 112.631 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.787 ' HA ' ' CG1' ' A' ' 89' ' ' VAL . . . -144.62 60.95 1.33 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.5 -0.556 . . . . 0.94 109.5 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 38' ' ' ARG . 0.8 OUTLIER -170.07 159.96 7.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.361 -0.836 . . . . 4.64 109.68 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.443 ' NE2' HG23 ' A' ' 89' ' ' VAL . 25.1 mp0 -94.22 143.38 26.43 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.116 -0.698 . . . . 1.75 109.116 173.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.703 HG13 HG21 ' A' ' 5' ' ' VAL . 71.8 t -97.99 122.05 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.424 -0.584 . . . . 0.54 109.424 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -122.48 141.33 51.75 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 123.368 0.418 . . . . 0.36 111.099 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.445 ' CD1' HG21 ' A' ' 96' ' ' ILE . 31.3 mt -102.72 126.21 49.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.194 -0.669 . . . . 0.84 109.194 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.8 ' HE2' ' HB2' ' A' ' 129' ' ' PHE . 6.3 mptt -119.2 152.12 37.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.571 -0.529 . . . . 1.93 109.571 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -96.22 153.62 17.7 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.803 -0.443 . . . . 0.41 109.803 173.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.712 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 31.2 t70 -82.44 164.79 20.74 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.719 -0.845 . . . . 0.71 108.719 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -56.17 -18.48 10.24 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.336 0.588 . . . . 1.4 110.677 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.77 -38.8 72.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.271 -0.877 . . . . 2.22 111.526 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 27.0 p-10 -139.57 22.31 2.52 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.723 0.268 . . . . 1.35 111.723 -176.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.67 ' HE1' ' HA2' ' A' ' 82' ' ' GLY . 60.0 t80 -123.48 102.39 7.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.435 -0.58 . . . . 0.56 109.435 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -103.3 105.8 16.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 2.41 110.385 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 67.19 -56.43 0.44 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.107 0.879 . . . . 3.43 112.04 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -175.58 35.08 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.006 -0.838 . . . . 0.56 111.006 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 81' ' ' ASN . 34.7 mmtp -135.07 135.57 41.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.001 -0.74 . . . . 2.12 109.001 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -110.72 142.33 42.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.611 0.719 . . . . 0.56 111.965 175.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 64' ' ' LYS . 44.1 p90 -151.32 -177.0 5.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.974 -1.012 . . . . 0.59 110.014 -176.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.887 HD22 HD22 ' A' ' 114' ' ' LEU . 13.8 mt -99.53 123.81 44.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.579 -0.897 . . . . 1.53 108.579 172.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 113' ' ' THR . 9.0 tp -106.81 124.6 62.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.472 0.653 . . . . 0.62 111.035 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.5 t -68.88 125.08 25.49 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.275 -1.009 . . . . 1.44 108.275 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -57.8 -26.2 61.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.119 0.415 . . . . 2.31 112.119 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -84.26 -1.64 55.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.61 -0.268 . . . . 3.09 111.368 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 57.99 89.21 0.05 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.167 0.587 . . . . 2.62 111.244 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -155.79 -38.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 4.66 111.055 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.74 144.71 37.6 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.415 -0.357 . . . . 2.51 110.35 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.636 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 2.4 pptp? -146.7 145.77 30.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.971 -0.559 . . . . 2.07 110.134 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.63 HD12 HG23 ' A' ' 100' ' ' VAL . 1.3 pt? -138.03 132.13 31.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.139 -0.482 . . . . 1.98 110.415 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -75.64 128.61 35.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.75 110.129 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.555 ' HB ' HG23 ' A' ' 98' ' ' ILE . 15.9 m -118.33 136.89 54.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.862 -0.608 . . . . 0.73 110.544 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.51 ' HB3' ' HE ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -96.5 110.65 22.99 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.707 -0.679 . . . . 1.81 109.356 178.296 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.429 HG23 HG12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -79.99 102.09 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.928 -0.767 . . . . 0.81 108.928 174.669 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.558 ' HG2' ' CZ ' ' A' ' 84' ' ' PHE . 89.3 mtt180 -122.99 140.47 33.5 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.244 -0.434 . . . . 3.79 110.181 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.798 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 1.7 Cg_endo -48.3 132.93 24.58 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.942 2.428 . . . . 0.59 111.927 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.4 ttt -63.22 -49.96 72.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.408 -0.36 . . . . 1.71 110.275 -177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -177.79 105.95 0.05 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.121 -0.49 . . . . 1.92 110.566 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 1.1 m-80 -161.81 -62.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 1.89 111.198 -177.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.8 t -154.69 163.68 39.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.915 -0.402 . . . . 1.7 109.915 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.9 127.58 32.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.069 0.461 . . . . 0.94 111.252 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.664 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.1 m0 -112.28 150.75 30.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.651 -0.704 . . . . 0.5 110.27 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.6 m -83.21 125.1 31.2 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.142 -0.688 . . . . 0.51 109.142 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -100.47 122.36 43.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.798 0.808 . . . . 0.59 112.54 -171.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -135.42 159.71 40.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.725 -1.213 . . . . 1.7 107.725 167.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 11.4 m120 -82.93 -4.38 58.12 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.276 -0.57 . . . . 1.39 110.833 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.67 ' HA2' ' HE1' ' A' ' 49' ' ' PHE . . . -100.48 -41.33 2.77 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.203 -0.998 . . . . 0.65 111.885 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.68 155.4 30.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.963 -0.384 . . . . 1.16 109.963 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -137.99 109.85 7.17 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.291 -1.003 . . . . 0.36 108.291 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 13.5 p90 -140.09 143.89 36.52 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.15 0.281 . . . . 0.59 111.498 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -77.91 137.5 38.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 120.328 -0.549 . . . . 1.39 109.542 177.269 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -63.68 -24.47 67.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.734 -0.667 . . . . 2.12 110.204 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 4.6 m-20 -73.92 147.14 43.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.519 -0.764 . . . . 2.1 110.671 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.787 ' CG1' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -94.84 143.0 12.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.666 -0.864 . . . . 1.05 108.666 168.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.661 ' HA2' ' HA ' ' A' ' 36' ' ' ASN . . . 131.77 -175.59 19.64 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.411 -0.9 . . . . 0.46 111.636 -177.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m -72.39 -178.73 2.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.976 -0.379 . . . . 1.17 109.976 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.798 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 21.1 t90 -157.38 -42.54 0.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.733 -0.212 . . . . 0.51 110.575 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.709 ' O ' ' HB ' ' A' ' 30' ' ' VAL . . . 50.84 -120.35 8.92 Favored Glycine 0 C--O 1.21 -1.366 0 N-CA-C 111.292 -0.723 . . . . 1.25 111.292 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.45 -151.68 43.68 Favored Glycine 0 C--N 1.318 -0.434 0 C-N-CA 121.142 -0.552 . . . . 0.72 114.225 163.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.534 ' HA ' HG23 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -147.84 133.51 18.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.085 -0.557 . . . . 0.6 110.427 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.899 HG12 HG21 ' A' ' 30' ' ' VAL . 6.8 mm -107.52 129.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.357 -0.609 . . . . 1.63 109.357 177.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -100.82 149.2 18.45 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.712 -0.756 . . . . 0.45 111.704 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.555 HG23 ' HB ' ' A' ' 67' ' ' VAL . 71.3 mt -99.58 114.45 37.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 120.897 0.38 . . . . 0.83 110.567 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 8.6 m-85 -115.22 131.97 56.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 1.28 108.818 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.63 HG23 HD12 ' A' ' 65' ' ' LEU . 13.8 p -71.34 134.48 29.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.799 0.333 . . . . 1.14 110.558 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -74.89 91.47 2.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.059 0.457 . . . . 1.02 110.902 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.13 13.34 62.15 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.132 -0.556 . . . . 1.53 113.918 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.585 ' HA ' HG11 ' A' ' 100' ' ' VAL . 64.9 tt0 62.22 113.71 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.709 0.766 . . . . 2.11 112.367 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.496 ' H ' HG21 ' A' ' 100' ' ' VAL . 7.5 tp60 -76.8 -27.29 55.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.479 -0.782 . . . . 2.62 109.645 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.1 m 65.42 20.52 11.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.126 -0.943 . . . . 2.43 110.195 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.541 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 7.6 t30 60.79 87.94 0.09 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.905 -1.043 . . . . 1.56 112.358 173.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.664 HG22 ' HD2' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -92.09 143.55 27.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.295 -1.002 . . . . 1.68 108.295 174.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.664 ' HD2' HG22 ' A' ' 107' ' ' THR . 94.2 Cg_exo -20.3 88.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.348 1 C-N-CA 125.617 4.212 . . . . 1.26 114.818 -175.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.477 ' HG2' HG21 ' A' ' 142' ' ' VAL . 9.9 Cg_endo -92.2 -154.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.687 2.925 . . . . 0.76 114.354 -171.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.42 -131.08 1.85 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.364 -1.895 . . . . 0.76 108.364 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -97.22 123.43 41.0 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.101 -0.703 . . . . 2.04 109.101 170.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -105.84 128.45 53.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.002 0.43 . . . . 0.75 109.916 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 57' ' ' ILE . 91.4 m -106.38 134.22 49.86 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.334 -0.848 . . . . 0.83 109.405 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.887 HD22 HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -138.91 89.55 2.37 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.487 0.66 . . . . 0.51 109.358 175.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 7.4 m -78.39 116.05 18.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.124 -0.944 . . . . 0.59 110.607 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 97.8 mt -105.11 136.41 44.66 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.04 0.448 . . . . 1.27 110.939 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.5 m -110.17 115.02 28.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.147 -0.478 . . . . 0.7 110.441 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.16 167.88 47.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.702 -0.761 . . . . 0.8 112.103 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 132' ' ' SER . . . 145.35 -175.15 25.07 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.557 -0.83 . . . . 0.53 112.096 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 52.8 p90 -97.7 -176.52 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.358 0.599 . . . . 0.89 111.403 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.616 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.5 OUTLIER -150.33 149.72 30.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.989 -1.005 . . . . 0.56 108.687 178.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.42 144.48 49.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.893 0.378 . . . . 1.42 111.578 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.639 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 22.9 mtpp 65.3 -143.71 0.22 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.067 0.947 . . . . 3.47 111.807 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 126' ' ' LYS . 6.0 p-10 -149.46 124.39 9.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.075 0.464 . . . . 2.08 112.239 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.597 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 7.7 t30 63.52 -18.0 0.06 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.698 1.199 . . . . 2.47 113.676 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.639 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -71.36 -4.07 24.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.796 0.331 . . . . 1.96 110.82 178.654 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.616 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 8.9 tt0 70.08 77.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.39 -0.823 . . . . 2.02 110.923 -177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.431 ' CA ' ' HE3' ' A' ' 126' ' ' LYS . . . -107.88 32.22 7.27 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.442 -0.885 . . . . 0.77 111.431 173.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.8 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 3.9 p90 -74.08 144.1 45.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.014 0.435 . . . . 1.21 110.661 -175.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 28.9 m -143.61 134.62 12.48 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.303 -0.408 . . . . 1.47 110.169 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.92 126.29 11.16 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.785 2.323 . . . . 0.92 111.782 175.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.432 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 17.2 m -152.84 113.46 4.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.319 -0.4 . . . . 1.52 110.122 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.414 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 125.1 -105.21 0.82 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.088 -0.577 . . . . 1.17 111.74 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.9 t -150.34 153.45 36.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.836 0.351 . . . . 2.47 110.314 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.9 m -93.55 97.06 10.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.026 -0.534 . . . . 1.82 109.775 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -83.99 132.29 10.98 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.954 -0.641 . . . . 0.67 112.285 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 m -102.72 108.77 20.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.683 0.278 . . . . 0.58 110.316 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.674 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 24.0 m -86.25 117.53 25.12 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.754 -0.832 . . . . 0.52 108.754 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -104.08 127.31 51.65 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.879 -0.6 . . . . 2.18 109.984 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.655 HD23 HD13 ' A' ' 56' ' ' LEU . 18.6 tp -125.58 102.25 7.28 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.542 -0.754 . . . . 0.63 110.829 -176.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.5 m -99.06 142.75 30.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.792 -0.64 . . . . 0.58 109.966 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 15' ' ' THR . 7.3 p -93.27 104.82 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.689 0.757 . . . . 1.74 111.323 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.06 -0.971 . . . . 2.58 109.352 176.219 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 56.6 m . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.11 0.481 . . . . 1.4299999999999999 111.206 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 31.8 mm-40 -85.49 110.97 19.57 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.914 -0.773 . . . . 2.29 108.914 174.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.664 HG23 HG13 ' A' ' 30' ' ' VAL . 7.6 p -109.92 127.72 66.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.495 0.664 . . . . 1.51 111.167 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -87.61 107.27 18.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.183 -0.917 . . . . 3.5699999999999998 109.977 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.47 HG12 ' HA3' ' A' ' 136' ' ' GLY . 44.6 t -110.97 121.27 63.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.642 -0.503 . . . . 1.26 109.642 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.17 134.25 12.32 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.713 -0.756 . . . . 0.95999999999999996 112.725 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.33 117.85 14.5 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.31 -0.626 . . . . 2.1800000000000002 109.31 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.6 mt -117.25 98.54 6.49 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.873 -0.331 . . . . 1.4099999999999999 111.708 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.0 t -102.04 113.25 26.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.122 -0.696 . . . . 1.03 109.122 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.646 ' HB ' ' NZ ' ' A' ' 14' ' ' LYS . 76.8 t -152.41 148.67 14.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.093 -0.706 . . . . 1.45 109.093 -174.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -89.96 121.35 31.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.412 0.523 . . . . 0.58999999999999997 112.412 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.646 ' NZ ' ' HB ' ' A' ' 12' ' ' VAL . 2.7 mptt -143.38 175.99 9.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.119 0.485 . . . . 3.4199999999999999 110.335 172.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.502 ' HA ' ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -111.08 150.0 30.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.503 -0.771 . . . . 0.63 109.994 171.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.511 HH12 ' HB ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -86.5 -4.47 59.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.328 -0.619 . . . . 3.1400000000000001 109.328 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.478 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -88.24 -27.97 24.04 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.505 -1.038 . . . . 0.75 110.505 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -66.16 -34.08 77.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.734 -0.839 . . . . 2.1699999999999999 108.734 171.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.464 ' HB3' HG12 ' A' ' 100' ' ' VAL . 94.4 mt -65.99 96.34 0.31 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.876 -1.056 . . . . 1.6100000000000001 108.867 169.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 t -102.95 66.22 0.91 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.022 0.915 . . . . 1.6499999999999999 109.728 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.664 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 28.4 t70 65.48 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.515 -1.22 . . . . 1.8300000000000001 110.695 -174.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.443 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -95.11 76.05 3.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.17 0.51 . . . . 0.81999999999999995 110.686 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -142.69 99.32 5.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.992 -0.549 . . . . 0.79000000000000004 110.276 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.455 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 71.4 Cg_endo -75.98 100.27 1.36 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.748 2.299 . . . . 1.1200000000000001 112.484 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.573 ' CG2' ' HG2' ' A' ' 14' ' ' LYS . 5.4 mt -114.96 12.48 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.98 0.895 . . . . 2.5800000000000001 110.125 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.07 60.36 0.65 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.18 -0.918 . . . . 0.73999999999999999 111.829 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.67 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 34.3 Cg_endo -65.0 104.19 0.56 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.423 2.082 . . . . 0.67000000000000004 112.779 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.51 123.65 41.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.65 -0.705 . . . . 1.1799999999999999 109.874 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -78.98 89.41 4.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.271 0.558 . . . . 1.6399999999999999 110.663 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.664 HG13 HG23 ' A' ' 5' ' ' VAL . 23.7 t -91.4 118.36 36.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.701 . . . . 1.01 111.345 -176.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.445 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 8.4 tt0 -112.82 123.85 51.26 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.464 -0.789 . . . . 2.48 109.155 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.51 116.75 28.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.404 -0.362 . . . . 0.69999999999999996 111.013 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 8.9 mp -80.33 120.05 23.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 1.9399999999999999 110.504 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.79 -124.99 7.09 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.797 -0.716 . . . . 1.8100000000000001 112.303 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.4 m 63.85 24.06 13.6 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.693 0.397 . . . . 1.8799999999999999 111.217 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -49.76 -42.36 46.25 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.434 0.459 . . . . 2.1400000000000001 111.84 -171.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.1 25.03 10.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.258 -0.428 . . . . 0.93999999999999995 110.687 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.517 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 1.4 tpm_? -121.63 145.35 48.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.042 0.449 . . . . 4.6399999999999997 111.688 -172.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -82.71 149.58 27.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.103 -0.702 . . . . 1.75 109.103 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 93.1 t -109.37 129.86 63.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.851 -0.796 . . . . 0.54000000000000004 108.851 177.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 1.02 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -135.96 140.5 44.03 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 123.302 0.376 . . . . 0.35999999999999999 110.735 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 mt -103.19 150.55 23.57 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.127 -0.488 . . . . 0.83999999999999997 109.761 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.877 ' HE3' ' HB2' ' A' ' 129' ' ' PHE . 1.5 mptp? -134.84 151.66 51.1 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.297 -1.001 . . . . 1.9299999999999999 108.297 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -88.32 156.93 18.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.489 -0.559 . . . . 0.40999999999999998 109.489 174.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.642 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 5.8 t70 -89.5 172.57 8.89 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.899 -0.778 . . . . 0.70999999999999996 108.899 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.8 p -49.84 -25.26 2.98 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.816 1.043 . . . . 1.3999999999999999 113.816 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -65.57 -38.68 90.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.786 0.327 . . . . 2.2200000000000002 111.217 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.645 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 26.5 p-10 -131.3 18.95 4.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 1.3500000000000001 111.282 -174.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 52.3 t80 -122.55 101.5 7.52 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.417 -0.586 . . . . 0.56000000000000005 109.417 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.669 ' HG2' ' HE1' ' A' ' 55' ' ' PHE . 5.5 pt-20 -106.83 98.75 8.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.295 -0.411 . . . . 2.4100000000000001 110.5 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 73.13 -49.33 0.69 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.197 -0.911 . . . . 3.4300000000000002 111.337 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 177.7 38.52 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.696 -0.562 . . . . 0.56000000000000005 111.696 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.507 ' HD3' ' HB3' ' A' ' 81' ' ' ASN . 32.1 mmtp -136.48 135.17 38.37 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.491 -0.929 . . . . 2.1200000000000001 108.491 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.645 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -115.55 149.47 38.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.442 0.639 . . . . 0.56000000000000005 111.67 175.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.669 ' HE1' ' HG2' ' A' ' 50' ' ' GLU . 16.7 p90 -157.83 -179.96 8.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.039 -0.982 . . . . 0.58999999999999997 110.341 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.51 HD22 HD22 ' A' ' 114' ' ' LEU . 30.7 mt -94.08 112.12 23.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.662 -0.866 . . . . 1.53 108.662 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.617 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 9.8 tp -107.75 140.4 26.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.544 -0.539 . . . . 0.62 109.544 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 37.1 t -78.96 156.02 28.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.247 -0.433 . . . . 1.4399999999999999 110.52 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -54.79 -27.59 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 2.3100000000000001 111.425 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -109.7 13.49 23.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.476 -0.329 . . . . 3.0899999999999999 111.184 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 52.1 33.54 12.36 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.556 0.576 . . . . 2.6200000000000001 112.556 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -79.34 -27.35 42.04 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.963 0.357 . . . . 4.6600000000000001 111.963 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -149.77 140.55 22.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.592 -0.522 . . . . 2.5099999999999998 109.592 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -128.89 132.5 47.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.763 -0.458 . . . . 2.0699999999999998 109.763 177.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.087 ' HB2' ' HG3' ' A' ' 104' ' ' GLN . 1.3 pt? -140.18 125.17 18.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.853 0.358 . . . . 1.98 110.927 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -69.71 143.08 53.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.869 -0.605 . . . . 0.75 111.682 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.897 HG12 ' HA ' ' A' ' 100' ' ' VAL . 14.2 m -133.14 171.43 18.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.428 -0.805 . . . . 0.72999999999999998 110.015 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.483 ' HB2' ' HE2' ' A' ' 84' ' ' PHE . 5.4 p30 -130.89 129.13 41.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.289 -0.414 . . . . 1.8100000000000001 110.038 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.53 85.41 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.809 -0.811 . . . . 0.81000000000000005 108.809 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.572 ' O ' ' HE1' ' A' ' 99' ' ' TYR . 6.7 ttp180 -108.78 139.99 21.41 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.48 -0.782 . . . . 3.79 110.024 -170.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HA ' HG22 ' A' ' 96' ' ' ILE . 50.3 Cg_exo -52.55 135.75 55.93 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.356 2.037 . . . . 0.58999999999999997 112.155 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.402 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 15.5 tmm? -59.16 -58.9 6.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 1.71 109.761 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -172.97 103.45 0.13 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.541 -0.754 . . . . 1.9199999999999999 109.457 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -177.65 -32.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 1.8899999999999999 111.811 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 p -164.4 179.02 7.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.797 0.332 . . . . 1.7 111.128 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.28 130.54 56.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.818 -0.628 . . . . 0.93999999999999995 110.222 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.584 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 12.6 m0 -118.44 150.83 38.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.114 -0.494 . . . . 0.5 110.216 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.4 m -79.7 114.09 18.35 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.929 -0.397 . . . . 0.51000000000000001 109.929 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 t -87.48 114.43 24.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.998 0.904 . . . . 0.58999999999999997 112.409 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -114.63 162.49 16.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 106.949 -1.501 . . . . 1.7 106.949 167.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.507 ' HB3' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -82.39 -16.47 48.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.724 -0.79 . . . . 1.3899999999999999 110.277 -177.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.59 -37.51 3.71 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.601 -0.809 . . . . 0.65000000000000002 112.341 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.536 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 27.8 m -132.27 156.9 42.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.864 0.364 . . . . 1.1599999999999999 110.519 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.721 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -135.84 105.3 6.06 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.202 -1.036 . . . . 0.35999999999999999 108.202 179.621 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 1.02 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 4.0 p90 -134.92 144.19 47.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.196 0.522 . . . . 0.58999999999999997 111.48 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.876 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 15.5 pttm -75.11 149.97 38.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.469 -0.787 . . . . 1.3899999999999999 110.392 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -76.11 -15.56 60.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.779 0.8 . . . . 2.1200000000000001 108.878 173.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.876 ' HB3' ' HD2' ' A' ' 86' ' ' LYS . 28.6 t70 -78.87 155.65 29.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.677 -1.147 . . . . 2.1000000000000001 110.431 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.0 m -121.84 131.02 74.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.005 0.431 . . . . 1.05 109.861 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.79 172.83 16.49 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.845 -0.693 . . . . 0.46000000000000002 111.714 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.1 p -65.64 124.35 22.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.591 -0.522 . . . . 1.1699999999999999 109.591 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.814 ' HB2' ' HZ2' ' A' ' 86' ' ' LYS . 32.0 t90 -91.29 -51.13 5.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.189 -0.46 . . . . 0.51000000000000001 110.436 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 30.53 82.64 0.01 OUTLIER Glycine 0 N--CA 1.468 0.803 0 O-C-N 124.75 1.281 . . . . 1.25 115.26 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.35 -150.2 5.75 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.861 -0.685 . . . . 0.71999999999999997 112.005 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.5 p -123.13 124.64 43.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.42 0.629 . . . . 0.59999999999999998 112.449 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.67 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -110.85 168.73 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.175 -1.046 . . . . 1.6299999999999999 108.175 169.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.61 161.0 27.43 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.11 -1.043 . . . . 0.45000000000000001 112.243 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.42 113.44 24.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.107 0.48 . . . . 0.82999999999999996 110.139 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.664 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 5.9 m-85 -110.49 126.66 54.6 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.924 -1.139 . . . . 1.28 107.924 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.897 ' HA ' HG12 ' A' ' 67' ' ' VAL . 9.2 p -71.47 136.97 24.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.06 -0.719 . . . . 1.1399999999999999 109.06 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.23 98.91 1.08 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.864 0.364 . . . . 1.02 111.149 -175.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.87 20.73 79.74 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-O 119.17 -0.795 . . . . 1.53 114.207 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.432 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 18.4 tt0 51.98 99.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.49 0.645 . . . . 2.1099999999999999 110.742 -174.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 1.087 ' HG3' ' HB2' ' A' ' 65' ' ' LEU . 79.9 mm-40 -69.55 -63.99 0.97 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.18 -0.464 . . . . 2.6200000000000001 111.279 -172.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 62.5 m -178.86 -56.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.893 -0.594 . . . . 2.4300000000000002 110.858 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.492 ' OD1' ' HD2' ' A' ' 16' ' ' ARG . 8.2 t30 72.21 79.24 0.15 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.156 -0.929 . . . . 1.5600000000000001 109.471 -167.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.13 125.96 66.62 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.508 -0.769 . . . . 1.6799999999999999 109.145 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -21.95 88.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 1 C-N-CA 125.425 4.084 . . . . 1.26 114.275 -172.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.742 ' HB3' ' HE1' ' A' ' 112' ' ' TYR . 1.1 Cg_endo -85.16 -157.76 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.092 3.195 . . . . 0.76000000000000001 114.087 -171.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.89 -81.04 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.742 -1.343 . . . . 0.76000000000000001 109.742 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -126.83 137.56 53.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.643 -0.502 . . . . 2.04 109.643 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.742 ' HE1' ' HB3' ' A' ' 109' ' ' PRO . 13.7 m-85 -125.55 141.76 51.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.395 -0.366 . . . . 0.75 110.298 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.1 m -125.56 112.84 16.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.148 -0.478 . . . . 0.82999999999999996 110.778 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.51 HD22 HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -126.69 87.29 2.63 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.44 0.638 . . . . 0.51000000000000001 110.181 176.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.642 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 2.8 m -72.0 122.5 20.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.413 -0.812 . . . . 0.58999999999999997 110.099 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -111.17 120.2 41.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.083 0.468 . . . . 1.27 110.57 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.472 ' HA ' HG23 ' A' ' 135' ' ' THR . 19.3 m -92.18 121.22 33.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.69999999999999996 110.224 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -76.97 164.57 53.05 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.567 -0.825 . . . . 0.80000000000000004 111.866 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.18 179.62 36.92 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.87 -0.681 . . . . 0.53000000000000003 111.766 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.603 ' HB3' ' HB2' ' A' ' 3' ' ' CYS . 55.5 p90 -110.75 178.97 4.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.265 0.555 . . . . 0.89000000000000001 110.298 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.668 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 8.5 t-105 -140.9 143.22 34.52 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.378 -0.828 . . . . 0.56000000000000005 109.087 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.609 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -140.96 60.73 1.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.139 0.792 . . . . 1.4199999999999999 113.139 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 1.052 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER 169.88 -123.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.627 0.579 . . . . 3.4700000000000002 109.887 171.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -166.31 117.26 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 2.0800000000000001 111.455 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.668 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 23.3 t-20 61.43 -30.86 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.261 1.578 . . . . 2.4700000000000002 115.261 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -1.97 2.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 118.011 0.369 . . . . 1.96 111.434 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.542 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 40.1 mt-30 72.79 45.85 0.29 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.657 -0.701 . . . . 2.02 110.971 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.72 59.46 4.69 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.74 -0.944 . . . . 0.77000000000000002 110.74 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.877 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 50.3 p90 -105.19 146.56 29.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 110.071 -0.344 . . . . 1.21 110.071 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.4 m -131.12 113.47 15.99 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 110.148 -0.316 . . . . 1.47 110.148 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -62.11 118.51 5.4 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.822 2.348 . . . . 0.92000000000000004 111.595 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.9 m -145.82 154.71 42.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.924 -0.58 . . . . 1.52 110.259 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.33 -123.36 6.19 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.671 -0.776 . . . . 1.1699999999999999 112.647 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.7 m -125.04 143.02 51.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.71 0.291 . . . . 2.4700000000000002 111.291 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 117' ' ' THR . 12.4 m -93.21 113.2 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.407 -0.59 . . . . 1.8200000000000001 109.407 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.47 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -96.99 126.14 8.73 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.771 -0.728 . . . . 0.67000000000000004 112.035 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 25.1 m -94.48 99.63 11.77 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.029 0.442 . . . . 0.57999999999999996 110.31 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.443 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 24.9 m -79.78 119.08 22.19 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.178 -0.675 . . . . 0.52000000000000002 109.178 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -113.72 119.48 37.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.589 0.709 . . . . 2.1800000000000002 109.591 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 112' ' ' TYR . 4.7 tp -108.36 94.65 5.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.048 -0.978 . . . . 0.63 110.847 -173.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.2 m -91.07 147.5 23.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.909 -1.041 . . . . 0.57999999999999996 109.18 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.511 ' HB ' HH12 ' A' ' 16' ' ' ARG . 9.1 p -102.28 124.11 55.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.914 -0.714 . . . . 1.74 110.715 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.338 -0.839 . . . . 2.5800000000000001 109.497 178.759 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.859 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 19.2 t . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 121.208 0.528 . . . . 1.4299999999999999 110.595 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -86.18 140.18 30.4 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.61 -0.723 . . . . 2.29 110.359 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 30' ' ' VAL . 3.2 p -111.69 124.22 68.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.696 -0.684 . . . . 1.51 109.674 175.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.546 ' HA ' ' OG1' ' A' ' 134' ' ' THR . 99.3 mtt180 -96.29 104.01 15.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.333 0.587 . . . . 3.5699999999999998 110.797 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.422 HG13 HG11 ' A' ' 28' ' ' VAL . 57.4 t -103.43 116.72 47.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.202 -0.908 . . . . 1.26 109.456 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.78 150.35 34.29 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.63 -0.795 . . . . 0.95999999999999996 112.378 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -74.43 111.88 10.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.771 -0.455 . . . . 2.1800000000000002 109.771 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.616 HD11 HG22 ' A' ' 28' ' ' VAL . 92.8 mt -93.49 94.01 8.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.22 -0.446 . . . . 1.4099999999999999 111.202 -177.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.1 m -94.9 112.69 24.39 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.052 -0.721 . . . . 1.03 109.052 171.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.14 144.23 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.425 -0.352 . . . . 1.45 110.387 -174.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.521 ' HB1' ' OG1' ' A' ' 143' ' ' THR . . . -101.42 96.83 7.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.149 -0.478 . . . . 0.58999999999999997 109.963 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.711 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 9.0 mmpt? -145.72 173.25 12.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 3.4199999999999999 110.453 -176.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.527 HG22 HG13 ' A' ' 142' ' ' VAL . 35.2 p -106.71 168.95 8.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.122 -0.49 . . . . 0.63 109.721 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.683 HH21 ' HD1' ' A' ' 112' ' ' TYR . 0.3 OUTLIER -87.01 -15.61 38.18 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.753 -0.832 . . . . 3.1400000000000001 108.753 178.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.8 -23.52 70.88 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.297 -0.865 . . . . 0.75 111.558 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -58.49 -31.15 67.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.4 0.619 . . . . 2.1699999999999999 109.707 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.612 HD21 HG23 ' A' ' 25' ' ' ILE . 9.9 mt -96.48 105.5 17.6 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.233 -0.894 . . . . 1.6100000000000001 109.711 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.593 ' H ' ' HB3' ' A' ' 23' ' ' ALA . 4.2 t -107.42 70.35 0.78 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.126 -0.694 . . . . 1.6499999999999999 109.126 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 17.8 t70 67.61 -80.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.7 -1.137 . . . . 1.8300000000000001 110.488 -174.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.34 63.69 0.99 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.613 0.72 . . . . 0.81999999999999995 110.646 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.593 ' HB3' ' H ' ' A' ' 20' ' ' THR . . . -143.35 117.87 6.22 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 114.897 -1.047 . . . . 0.79000000000000004 108.901 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -90.83 163.66 4.04 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.59 2.86 . . . . 1.1200000000000001 113.603 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.612 HG23 HD21 ' A' ' 19' ' ' LEU . 1.5 pt -118.7 -57.15 3.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.466 -0.788 . . . . 2.5800000000000001 110.899 174.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.515 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -116.15 99.17 0.86 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.85 -0.69 . . . . 0.73999999999999999 112.553 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 60.4 Cg_endo -80.41 105.17 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.714 2.276 . . . . 0.67000000000000004 112.051 173.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.616 HG22 HD11 ' A' ' 10' ' ' LEU . 18.1 t -74.96 125.96 35.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.701 -0.481 . . . . 1.1799999999999999 109.701 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 6.7 t -82.72 83.62 7.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.02 0.914 . . . . 1.6399999999999999 110.24 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.788 HG13 HG23 ' A' ' 5' ' ' VAL . 84.9 t -69.18 115.73 8.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.053 -0.976 . . . . 1.01 110.833 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.494 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 4.4 pt20 -110.38 132.89 53.78 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.159 -0.682 . . . . 2.48 109.159 173.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.518 ' HB1' ' SG ' ' A' ' 3' ' ' CYS . . . -101.67 127.95 48.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.095 -0.502 . . . . 0.69999999999999996 110.999 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.734 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 85.2 mt -107.59 111.78 24.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.511 -0.313 . . . . 1.9399999999999999 110.656 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.98 59.11 8.4 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.266 -0.492 . . . . 1.8100000000000001 113.211 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.859 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -87.08 -70.38 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.679 0.252 . . . . 1.8799999999999999 111.679 -177.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 69.25 -61.83 0.42 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.644 0.778 . . . . 2.1400000000000001 111.632 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.416 ' HA ' ' HB ' ' A' ' 89' ' ' VAL . . . -141.8 71.41 1.35 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.338 0.59 . . . . 0.93999999999999995 109.889 -176.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.713 ' HD2' ' SG ' ' A' ' 35' ' ' CYS . 1.4 tmt_? -143.42 131.81 22.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.544 -0.753 . . . . 4.6399999999999997 110.886 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.508 ' HG2' HG12 ' A' ' 89' ' ' VAL . 6.2 mt-30 -87.36 107.17 18.4 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.675 -0.861 . . . . 1.75 108.675 174.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 41.7 t -62.66 109.21 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 0.54000000000000004 109.954 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 1.018 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -127.11 137.63 53.03 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 123.531 0.519 . . . . 0.35999999999999999 109.895 -176.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.756 HD12 HG21 ' A' ' 69' ' ' ILE . 65.6 mt -104.21 128.65 51.95 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.946 -0.39 . . . . 0.83999999999999997 109.946 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.553 ' HG3' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -110.33 151.77 27.02 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.618 -0.882 . . . . 1.9299999999999999 108.618 175.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.62 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -100.32 155.17 17.94 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.379 -0.529 . . . . 0.40999999999999998 110.024 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -73.67 149.0 42.25 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.978 -0.749 . . . . 0.70999999999999996 108.978 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -58.6 -18.08 27.26 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.286 0.476 . . . . 1.3999999999999999 112.286 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.24 -27.18 68.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.151 0.5 . . . . 2.2200000000000002 110.33 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.62 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 4.1 p-10 -134.75 27.11 3.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.656 -0.702 . . . . 1.3500000000000001 109.916 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.609 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 75.1 t80 -140.75 102.41 4.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.436 -0.802 . . . . 0.56000000000000005 109.653 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.24 117.04 33.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.296 -0.411 . . . . 2.4100000000000001 110.583 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 68.46 -57.62 0.49 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.279 0.987 . . . . 3.4300000000000002 111.884 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.609 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -179.29 32.26 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.971 -0.633 . . . . 0.56000000000000005 111.93 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 81' ' ' ASN . 1.6 mptm? -129.9 134.28 47.39 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.396 -0.594 . . . . 2.1200000000000001 109.396 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.475 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -98.91 139.05 35.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.42 0.628 . . . . 0.56000000000000005 110.818 174.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.615 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 51.5 p90 -155.43 172.76 17.69 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.177 -0.919 . . . . 0.58999999999999997 110.338 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.991 ' HG ' HD22 ' A' ' 114' ' ' LEU . 5.9 mp -83.35 130.72 35.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.095 -0.705 . . . . 1.53 109.095 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 113' ' ' THR . 10.4 tp -104.93 134.7 45.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.13 -0.628 . . . . 0.62 109.322 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.5 t -68.06 179.96 1.38 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.294 -0.866 . . . . 1.4399999999999999 111.298 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -56.0 -43.2 77.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.883 -0.599 . . . . 2.3100000000000001 111.456 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -115.07 -62.26 1.63 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.549 -0.296 . . . . 3.0899999999999999 110.594 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.1 p30 177.28 25.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.829 -0.623 . . . . 2.6200000000000001 109.595 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -73.03 -46.31 52.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.428 -0.805 . . . . 4.6600000000000001 111.406 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.99 156.16 47.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.837 -0.62 . . . . 2.5099999999999998 110.491 -172.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -142.59 139.73 31.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.883 -0.599 . . . . 2.0699999999999998 109.776 174.252 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.741 ' HG ' HD13 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -141.14 122.04 14.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.37 -0.377 . . . . 1.98 110.237 178.016 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.443 ' HA ' ' CB ' ' A' ' 55' ' ' PHE . 62.8 m-85 -72.18 153.15 41.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.347 -0.388 . . . . 0.75 111.515 -173.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.486 ' HB ' HG23 ' A' ' 98' ' ' ILE . 29.2 m -117.24 161.78 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.72999999999999998 111.404 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -126.65 121.67 32.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 1.8100000000000001 108.952 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.756 HG21 HD12 ' A' ' 42' ' ' LEU . 3.6 mm -95.37 86.23 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.745 -0.382 . . . . 0.81000000000000005 110.04 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.514 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 8.1 mmm180 -93.55 128.27 42.85 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 120.491 -0.484 . . . . 3.79 110.974 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.74 ' HA ' HG22 ' A' ' 96' ' ' ILE . 49.2 Cg_exo -51.53 133.41 43.53 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.526 2.151 . . . . 0.58999999999999997 112.229 172.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.6 ttt -78.8 81.45 5.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.572 -0.529 . . . . 1.71 109.572 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 66.35 20.16 10.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.823 -0.626 . . . . 1.9199999999999999 112.227 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -119.7 107.59 13.4 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.464 0.542 . . . . 1.8899999999999999 112.464 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.6 p 61.18 179.71 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.648 1.179 . . . . 1.7 113.503 170.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.07 119.52 39.42 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.276 -0.874 . . . . 0.93999999999999995 110.485 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.685 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.6 m0 -110.18 149.08 30.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.93 -0.577 . . . . 0.5 110.388 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.0 m -83.23 112.92 20.3 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.003 -0.74 . . . . 0.51000000000000001 109.003 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 t -87.48 90.19 8.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.936 0.874 . . . . 0.58999999999999997 112.433 -171.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.25 148.44 23.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.91 -1.145 . . . . 1.7 107.91 166.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -87.17 11.06 14.93 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.226 -0.59 . . . . 1.3899999999999999 110.526 -174.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.88 -27.46 1.25 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.597 -0.601 . . . . 0.65000000000000002 111.597 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.553 HG12 ' HG3' ' A' ' 43' ' ' LYS . 36.0 m -140.54 137.77 36.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.005 -0.739 . . . . 1.1599999999999999 109.005 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.85 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -121.68 109.11 14.35 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.67 -0.812 . . . . 0.35999999999999999 108.946 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 1.018 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 2.0 p90 -137.35 139.26 40.7 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.512 0.508 . . . . 0.58999999999999997 111.394 -173.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.772 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 53.4 pttt -73.96 143.49 45.64 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.057 -0.72 . . . . 1.3899999999999999 109.057 171.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -64.72 -26.53 68.41 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.97 -0.559 . . . . 2.1200000000000001 110.103 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.772 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 12.6 m-20 -72.12 151.07 43.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.526 -0.761 . . . . 2.1000000000000001 110.573 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.508 HG12 ' HG2' ' A' ' 39' ' ' GLN . 30.9 m -114.04 123.26 69.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.026 0.441 . . . . 1.05 110.276 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.8 -173.32 24.7 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.387 -0.911 . . . . 0.46000000000000002 112.011 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.5 p -55.37 145.45 22.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.084 0.469 . . . . 1.1699999999999999 111.428 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.458 ' CH2' HG23 ' A' ' 96' ' ' ILE . 41.2 t90 -126.74 -53.86 1.43 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.912 -0.586 . . . . 0.51000000000000001 109.82 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 35.23 87.54 0.01 OUTLIER Glycine 0 N--CA 1.465 0.577 0 O-C-N 124.835 1.334 . . . . 1.25 114.978 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 29' ' ' THR . . . -159.01 -131.77 1.29 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.9 -0.667 . . . . 0.71999999999999997 112.126 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.64 132.92 23.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.951 0.405 . . . . 0.59999999999999998 111.459 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.74 HG22 ' HA ' ' A' ' 71' ' ' PRO . 1.7 pp -124.29 144.1 35.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.365 -0.605 . . . . 1.6299999999999999 109.365 172.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -117.97 151.8 17.81 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.118 -1.039 . . . . 0.45000000000000001 112.233 -174.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.486 HG23 ' HB ' ' A' ' 67' ' ' VAL . 77.1 mt -96.18 112.62 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.417 0.627 . . . . 0.82999999999999996 110.639 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 70' ' ' ARG . 1.2 m-85 -103.88 156.86 17.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.807 -1.088 . . . . 1.28 108.099 176.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.479 ' CG1' ' HA ' ' A' ' 103' ' ' GLN . 5.5 p -87.24 133.12 30.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.035 -0.666 . . . . 1.1399999999999999 109.393 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.92 101.83 0.3 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.381 -0.372 . . . . 1.02 111.756 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.11 23.4 77.21 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.804 -0.635 . . . . 1.53 114.026 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.479 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 62.9 tt0 57.93 97.98 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.237 0.541 . . . . 2.1099999999999999 110.905 -175.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.656 ' HG3' ' HB2' ' A' ' 65' ' ' LEU . 78.3 mm-40 -84.32 14.21 4.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 2.6200000000000001 111.312 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.1 m 74.01 -3.79 2.43 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.584 -0.735 . . . . 2.4300000000000002 112.239 170.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.54 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 7.3 t30 63.41 86.18 0.12 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.593 0.711 . . . . 1.5600000000000001 110.214 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.8 m -74.54 139.91 74.97 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.006 -0.997 . . . . 1.6799999999999999 109.355 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -30.5 89.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 125.162 3.908 . . . . 1.26 113.456 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.58 ' HB2' ' CG2' ' A' ' 142' ' ' VAL . 81.2 Cg_endo -93.23 -168.54 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.191 2.594 . . . . 0.76000000000000001 114.949 -167.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.13 -73.92 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.752 -1.339 . . . . 0.76000000000000001 109.752 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -135.13 126.93 29.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.546 -0.539 . . . . 2.04 109.546 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.683 ' HD1' HH21 ' A' ' 16' ' ' ARG . 69.6 m-85 -129.25 139.33 51.86 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.065 0.46 . . . . 0.75 110.922 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.597 ' O ' HG22 ' A' ' 57' ' ' ILE . 70.8 m -111.68 129.15 56.2 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.318 -0.856 . . . . 0.82999999999999996 110.021 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.991 HD22 ' HG ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -142.84 86.91 1.95 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.733 0.777 . . . . 0.51000000000000001 109.602 174.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.7 m -88.06 135.83 33.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.003 -0.999 . . . . 0.58999999999999997 110.476 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 8.6 mp -119.01 116.49 26.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 1.27 110.682 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 38.5 m -89.08 114.02 25.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.81 -0.632 . . . . 0.69999999999999996 110.125 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.403 ' HA3' HG13 ' A' ' 5' ' ' VAL . . . -67.84 145.11 44.6 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.724 -0.751 . . . . 0.80000000000000004 112.365 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.434 ' HA2' ' N ' ' A' ' 132' ' ' SER . . . -175.59 177.34 47.43 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.892 -0.67 . . . . 0.53000000000000003 111.484 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.408 ' CE2' ' HB ' ' A' ' 130' ' ' THR . 28.9 p90 -101.26 -178.33 3.71 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.918 -0.713 . . . . 0.89000000000000001 110.184 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.856 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 3.4 t-105 -151.69 144.45 24.35 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.253 -0.885 . . . . 0.56000000000000005 108.818 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.39 145.65 49.95 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.256 0.347 . . . . 1.4199999999999999 110.466 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.93 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER 72.17 -136.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.745 0.818 . . . . 3.4700000000000002 110.741 178.121 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.597 ' HA ' ' HZ2' ' A' ' 121' ' ' TRP . 5.6 p-10 -162.96 133.87 4.77 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.132 0.173 . . . . 2.0800000000000001 110.631 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.475 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 52.4 t30 67.76 -38.76 0.37 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.901 1.075 . . . . 2.4700000000000002 113.901 174.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.416 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -64.89 -5.04 5.18 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.341 0.591 . . . . 1.96 111.19 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.856 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 6.1 tt0 65.21 72.56 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.723 -1.126 . . . . 2.02 111.246 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.416 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -96.01 41.75 2.38 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.62 -0.8 . . . . 0.77000000000000002 111.213 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.514 ' CD1' ' HG2' ' A' ' 127' ' ' GLN . 3.7 p90 -82.74 154.44 24.79 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.783 0.325 . . . . 1.21 110.894 -172.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.408 ' HB ' ' CE2' ' A' ' 120' ' ' TYR . 50.2 m -154.93 123.99 3.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.436 -0.347 . . . . 1.47 110.082 173.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.2 128.81 31.18 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.975 2.45 . . . . 0.92000000000000004 112.254 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.434 ' N ' ' HA2' ' A' ' 119' ' ' GLY . 27.1 m -155.27 108.3 2.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.31 -0.404 . . . . 1.52 110.349 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.9 -127.85 7.52 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.45 -0.881 . . . . 1.1699999999999999 112.46 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 6' ' ' ARG . 5.2 p -118.71 154.53 32.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.951 0.405 . . . . 2.4700000000000002 111.417 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 t -108.98 114.64 28.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.412 -0.588 . . . . 1.8200000000000001 109.412 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.96 126.87 9.0 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.716 -0.754 . . . . 0.67000000000000004 112.122 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.3 m -91.82 101.3 13.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.745 0.307 . . . . 0.57999999999999996 110.725 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.523 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 28.3 m -80.63 108.65 14.45 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.14 -0.689 . . . . 0.52000000000000002 109.14 173.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -109.38 109.55 20.45 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.989 -0.745 . . . . 2.1800000000000002 108.989 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.604 ' HG ' ' NH2' ' A' ' 16' ' ' ARG . 16.1 tp -106.78 105.96 16.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.902 -1.045 . . . . 0.63 110.913 -174.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 30.3 m -99.45 143.99 29.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.159 -0.928 . . . . 0.57999999999999996 109.36 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.58 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 92.9 t -74.32 129.56 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 112.793 0.664 . . . . 1.74 112.793 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.521 ' OG1' ' HB1' ' A' ' 13' ' ' ALA . 95.0 m . . . . . 0 C--O 1.248 1.009 0 CA-C-N 115.06 -0.973 . . . . 2.5800000000000001 109.188 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.908 0.385 . . . . 1.4299999999999999 110.922 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -86.39 109.73 19.22 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.41 -0.589 . . . . 2.29 109.41 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.6 t -95.96 111.89 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.588 -0.523 . . . . 1.51 109.588 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.82 ' HB2' ' HB2' ' A' ' 31' ' ' GLN . 31.2 mmt180 -84.39 99.55 10.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.628 -0.715 . . . . 3.5699999999999998 110.451 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.95 115.59 48.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.382 -0.826 . . . . 1.26 109.238 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.24 -169.88 27.04 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.465 -0.874 . . . . 0.95999999999999996 112.082 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -99.83 142.39 31.37 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.676 -0.491 . . . . 2.1800000000000002 109.676 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.72 126.84 12.91 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.02 -0.537 . . . . 1.4099999999999999 109.911 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.9 m -108.93 115.69 30.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.987 -0.551 . . . . 1.03 110.479 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.458 HG12 ' HG2' ' A' ' 14' ' ' LYS . 44.3 t -122.69 117.9 53.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.152 -0.476 . . . . 1.45 110.17 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -91.4 97.03 10.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.97 0.414 . . . . 0.58999999999999997 110.893 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HG2' HG12 ' A' ' 12' ' ' VAL . 73.9 mmtt -143.64 -174.44 4.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.561 -0.745 . . . . 3.4199999999999999 109.454 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.627 ' HB ' ' OD1' ' A' ' 106' ' ' ASN . 20.4 p -100.68 159.78 14.89 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.135 -0.32 . . . . 0.63 110.135 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.902 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -86.35 -26.22 24.96 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.629 -0.428 . . . . 3.1400000000000001 109.992 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.79 -28.63 73.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.919 -0.658 . . . . 0.75 111.613 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -51.14 -34.81 32.72 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.594 0.757 . . . . 2.1699999999999999 111.442 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.841 ' HB2' HG23 ' A' ' 100' ' ' VAL . 49.8 mt -70.51 -17.61 62.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.591 -0.731 . . . . 1.6100000000000001 112.816 -170.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.3 m 34.25 55.42 0.63 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.256 0.972 . . . . 1.6499999999999999 112.778 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.757 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 31.0 t70 70.27 -62.84 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.631 -0.713 . . . . 1.8300000000000001 111.809 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.49 ' HA ' ' CG ' ' A' ' 99' ' ' TYR . . . -139.46 69.59 1.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.311 0.577 . . . . 0.81999999999999995 112.068 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.65 98.42 16.41 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.38 -0.827 . . . . 0.79000000000000004 109.056 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.487 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 54.4 Cg_endo -70.02 119.81 6.67 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.817 2.345 . . . . 1.1200000000000001 113.411 -172.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.731 HG12 HD21 ' A' ' 19' ' ' LEU . 2.9 pt -80.67 -65.11 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 2.5800000000000001 111.524 173.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.654 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -117.83 101.55 0.92 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.879 -0.676 . . . . 0.73999999999999999 111.935 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.612 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 37.7 Cg_endo -70.51 121.16 7.7 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.437 2.091 . . . . 0.67000000000000004 112.083 177.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.34 122.16 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.86 -0.609 . . . . 1.1799999999999999 109.431 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.5 m -74.59 101.96 4.39 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.218 -0.446 . . . . 1.6399999999999999 110.298 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.45 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 48.9 t -95.81 114.49 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.157 -0.474 . . . . 1.01 110.398 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.82 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 14.9 mm100 -103.07 133.91 47.38 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.343 -0.614 . . . . 2.48 109.343 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.4 108.29 13.94 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.172 -0.307 . . . . 0.69999999999999996 110.172 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.16 134.24 55.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.129 -0.487 . . . . 1.9399999999999999 110.724 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.55 -7.83 68.59 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.819 -0.628 . . . . 1.8100000000000001 112.264 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.0 m -84.32 93.56 8.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.001 0.429 . . . . 1.8799999999999999 110.73 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -96.32 -18.92 19.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.962 0.411 . . . . 2.1400000000000001 110.218 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -167.76 83.66 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.776 -0.647 . . . . 0.93999999999999995 110.048 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -165.11 150.09 9.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.898 -0.592 . . . . 4.6399999999999997 110.096 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -80.91 125.41 30.09 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.245 -0.65 . . . . 1.75 109.245 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 61.0 t -92.99 124.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.46 -0.57 . . . . 0.54000000000000004 109.46 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -119.66 146.52 45.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.087 0.47 . . . . 0.35999999999999999 110.963 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.493 HD13 HD13 ' A' ' 96' ' ' ILE . 14.6 mt -103.87 117.72 35.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.663 -0.698 . . . . 0.83999999999999997 109.329 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.62 ' NZ ' ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -118.73 152.02 36.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.552 -0.536 . . . . 1.9299999999999999 109.552 -177.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.523 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -104.23 157.19 17.3 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.369 -0.378 . . . . 0.40999999999999998 110.081 175.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 21.9 t70 -75.8 151.72 37.46 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.428 -0.582 . . . . 0.70999999999999996 109.428 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -56.75 -16.5 6.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.563 0.579 . . . . 1.3999999999999999 112.563 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.58 -32.37 73.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.981 0.42 . . . . 2.2200000000000002 110.628 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.523 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 6.0 p-10 -133.85 24.2 3.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 1.3500000000000001 110.247 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 82.0 t80 -132.33 101.33 5.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.492 -0.777 . . . . 0.56000000000000005 109.334 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 51' ' ' GLN . 56.5 mt-10 -95.07 100.26 12.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.422 -0.353 . . . . 2.4100000000000001 110.403 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 23.8 tt0 70.79 -58.56 0.56 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.875 0.734 . . . . 3.4300000000000002 111.184 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -172.32 38.12 0.16 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.6 -0.727 . . . . 0.56000000000000005 111.435 -177.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 2.1 mptm? -136.37 133.87 37.24 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.944 -0.762 . . . . 2.1200000000000001 108.944 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.42 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -106.08 141.67 37.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.245 0.545 . . . . 0.56000000000000005 110.96 174.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.511 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 16.9 p90 -147.27 167.04 25.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.674 -0.694 . . . . 0.58999999999999997 111.255 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.667 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 13.0 mt -85.33 113.66 21.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.457 -0.942 . . . . 1.53 108.457 171.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.7 tp -106.26 125.08 61.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.595 0.712 . . . . 0.62 110.85 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 112' ' ' TYR . 40.3 t -84.39 153.34 23.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.982 -1.008 . . . . 1.4399999999999999 111.21 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.16 -35.39 73.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.471 -0.786 . . . . 2.3100000000000001 110.368 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -78.3 -13.23 59.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.662 -0.699 . . . . 3.0899999999999999 110.775 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 53.77 30.44 11.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.661 -0.699 . . . . 2.6200000000000001 111.122 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.661 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 8.3 mmp_? -83.79 -39.95 19.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.244 0.545 . . . . 4.6600000000000001 109.871 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.672 ' HB3' HD21 ' A' ' 65' ' ' LEU . 1.1 m-20 -123.09 124.77 43.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.377 -0.828 . . . . 2.5099999999999998 111.111 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.667 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -127.18 98.89 5.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.208 1.004 . . . . 2.0699999999999998 108.737 168.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.676 HD13 ' HB2' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -99.4 118.72 36.65 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.987 -1.006 . . . . 1.98 109.853 -168.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.448 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 73.0 m-85 -67.51 122.15 17.37 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.285 -0.635 . . . . 0.75 109.285 -177.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.475 HG13 ' HG ' ' A' ' 56' ' ' LEU . 12.9 m -99.63 168.57 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.605 -0.725 . . . . 0.72999999999999998 111.62 -174.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -126.12 110.2 13.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.839 -1.073 . . . . 1.8100000000000001 108.841 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.469 HG23 HG12 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -91.46 84.25 2.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.506 0.669 . . . . 0.81000000000000005 109.196 173.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.804 ' HB3' ' OH ' ' A' ' 99' ' ' TYR . 32.6 ttm180 -101.82 131.78 22.42 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.979 -1.01 . . . . 3.79 108.317 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.621 ' HA ' HG22 ' A' ' 96' ' ' ILE . 45.0 Cg_endo -63.25 148.02 93.35 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.431 2.087 . . . . 0.58999999999999997 112.208 -173.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.0 tpt -74.03 84.6 1.78 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.668 -0.696 . . . . 1.71 110.412 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 74.21 -46.84 0.63 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.134 0.974 . . . . 1.9199999999999999 113.211 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.422 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 56.8 m-80 -60.22 114.28 2.81 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.433 0.901 . . . . 1.8899999999999999 113.433 -171.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.7 t 74.4 159.48 0.22 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.722 -1.126 . . . . 1.7 112.323 170.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.42 118.86 33.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.421 -0.809 . . . . 0.93999999999999995 110.113 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.857 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.4 m95 -112.39 142.49 44.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.16 -0.473 . . . . 0.5 109.945 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.2 m -82.65 110.63 17.88 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.249 -0.648 . . . . 0.51000000000000001 109.249 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -82.09 117.71 22.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.319 1.057 . . . . 0.58999999999999997 112.521 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 22.3 t70 -121.59 154.87 36.16 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.898 -1.519 . . . . 1.7 106.898 167.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -83.94 2.6 37.92 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.009 -0.676 . . . . 1.3899999999999999 110.924 -174.059 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -122.67 -31.47 1.04 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.156 -0.545 . . . . 0.65000000000000002 112.134 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 80' ' ' ASP . 26.6 m -131.51 148.64 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.847 -0.427 . . . . 1.1599999999999999 109.847 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -134.15 104.22 6.11 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.244 -1.021 . . . . 0.35999999999999999 108.244 -177.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.613 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 12.1 p90 -131.51 135.0 46.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.468 0.651 . . . . 0.58999999999999997 111.659 -174.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.857 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 18.9 pttp -74.42 139.68 44.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.829 -1.078 . . . . 1.3899999999999999 109.713 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -72.7 -17.86 61.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.176 -0.675 . . . . 2.1200000000000001 109.176 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 4.0 t70 -69.4 135.13 49.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.101 -0.954 . . . . 2.1000000000000001 109.684 172.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.0 m -99.57 122.79 51.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.232 0.539 . . . . 1.05 110.651 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.3 -155.2 24.48 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.616 -0.802 . . . . 0.46000000000000002 111.747 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.0 p -82.75 -173.56 4.73 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 122.501 0.321 . . . . 1.1699999999999999 110.276 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' A' ' 74' ' ' ASN . 33.3 t90 -157.68 -57.13 0.08 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.799 -0.445 . . . . 0.51000000000000001 109.799 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 42.15 92.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.42 1.075 . . . . 1.25 114.731 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.86 -141.83 3.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.663 -0.78 . . . . 0.71999999999999997 112.286 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 27' ' ' PRO . 11.1 p -133.12 140.43 47.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.139 0.495 . . . . 0.59999999999999998 112.218 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 71' ' ' PRO . 18.7 pt -118.38 142.87 31.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.807 -0.633 . . . . 1.6299999999999999 109.501 174.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 24' ' ' PRO . . . -105.1 141.09 15.26 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.23 -0.986 . . . . 0.45000000000000001 112.386 -174.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.469 HG12 HG23 ' A' ' 69' ' ' ILE . 59.7 mt -96.57 120.31 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.985 0.421 . . . . 0.82999999999999996 111.088 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.804 ' OH ' ' HB3' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -139.26 164.96 28.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.335 -0.848 . . . . 1.28 110.153 173.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.841 HG23 ' HB2' ' A' ' 19' ' ' LEU . 3.6 t -90.13 125.94 43.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.98 -0.554 . . . . 1.1399999999999999 110.791 -174.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.5 97.04 0.4 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.934 -0.395 . . . . 1.02 109.934 177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.62 -15.82 44.98 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.892 -0.67 . . . . 1.53 113.759 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.418 ' HB2' ' N ' ' A' ' 21' ' ' ASP . 65.2 tt0 67.27 118.35 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.067 0.547 . . . . 2.1099999999999999 110.769 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.676 ' HB2' HD13 ' A' ' 65' ' ' LEU . 12.7 mm100 -104.47 -6.83 20.3 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.316 0.487 . . . . 2.6200000000000001 112.316 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 m 71.16 14.63 6.63 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.984 0.421 . . . . 2.4300000000000002 111.317 168.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.902 ' HB3' ' HB2' ' A' ' 16' ' ' ARG . 0.3 OUTLIER 41.86 91.51 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.68 1.363 . . . . 1.5600000000000001 114.68 177.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.775 HG22 ' HD2' ' A' ' 108' ' ' PRO . 1.2 m -82.07 143.74 49.81 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 107.914 -1.143 . . . . 1.6799999999999999 107.914 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.775 ' HD2' HG22 ' A' ' 107' ' ' THR . 75.0 Cg_exo -12.04 83.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.669 1 C-N-CA 125.737 4.292 . . . . 1.26 114.705 -168.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -74.13 -157.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.849 3.033 . . . . 0.76000000000000001 113.993 -172.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.58 -140.74 6.62 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 109.878 -1.289 . . . . 0.76000000000000001 109.878 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -82.22 120.7 25.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.953 0.406 . . . . 2.04 110.097 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 58' ' ' SER . 14.1 m-85 -108.74 119.83 40.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.167 0.508 . . . . 0.75 109.972 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 77.0 m -106.74 98.54 8.19 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.414 -0.812 . . . . 0.82999999999999996 111.051 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.521 HD13 HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -120.57 107.97 13.49 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.268 0.556 . . . . 0.51000000000000001 110.526 178.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 20.2 m -96.18 140.21 31.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.58999999999999997 110.181 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 96.5 mt -117.5 125.79 51.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.893 0.378 . . . . 1.27 110.252 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.5 m -103.36 119.61 39.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.982 0.42 . . . . 0.69999999999999996 110.302 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -74.56 163.43 54.38 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.79 -0.719 . . . . 0.80000000000000004 112.632 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.49 166.57 14.38 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.494 -0.642 . . . . 0.53000000000000003 111.494 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -91.02 176.11 6.71 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.707 -0.397 . . . . 0.89000000000000001 110.663 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 129' ' ' PHE . 1.9 t-105 -133.09 152.8 51.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.265 -0.879 . . . . 0.56000000000000005 108.69 176.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.09 140.91 46.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.966 0.413 . . . . 1.4199999999999999 111.615 175.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 74.55 -143.31 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.381 1.073 . . . . 3.4700000000000002 111.358 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 126' ' ' LYS . 6.1 p-10 -147.62 124.38 11.2 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.336 -0.546 . . . . 2.0800000000000001 112.135 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.444 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 8.6 t30 65.53 -22.81 0.09 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.862 1.06 . . . . 2.4700000000000002 113.862 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.448 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -71.43 -3.36 20.52 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.873 0.469 . . . . 1.96 110.951 -178.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.859 ' HG3' ' CE2' ' A' ' 129' ' ' PHE . 51.4 tt0 70.37 79.24 0.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.433 -0.803 . . . . 2.02 110.384 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -109.61 27.69 11.88 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 119.793 -1.194 . . . . 0.77000000000000002 112.655 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.859 ' CE2' ' HG3' ' A' ' 127' ' ' GLN . 38.9 p90 -87.72 126.39 34.96 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.041 -0.664 . . . . 1.21 111.239 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 85.8 m -114.25 132.02 22.97 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.936 -0.575 . . . . 1.47 109.767 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.92 122.61 11.21 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.771 2.314 . . . . 0.92000000000000004 112.097 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.9 m -155.61 122.55 5.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.218 -0.446 . . . . 1.52 110.185 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 120.0 -117.62 3.63 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.267 -0.733 . . . . 1.1699999999999999 111.267 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 p -131.81 178.44 6.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.004 0.402 . . . . 2.4700000000000002 110.621 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 135' ' ' THR . 9.0 t -126.59 104.22 8.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.796 0.807 . . . . 1.8200000000000001 108.943 171.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.78 143.45 16.03 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.637 -0.711 . . . . 0.67000000000000004 112.414 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 73.8 m -101.0 117.41 34.98 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.958 0.409 . . . . 0.57999999999999996 110.903 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.449 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 18.7 m -86.61 111.44 20.63 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.664 -0.865 . . . . 0.52000000000000002 108.664 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -99.34 109.29 21.92 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.809 0.814 . . . . 2.1800000000000002 110.065 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.503 HD21 ' HG3' ' A' ' 16' ' ' ARG . 22.6 tp -103.21 95.98 6.47 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.444 -1.253 . . . . 0.63 109.765 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 12.0 m -100.07 144.02 29.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.546 -0.752 . . . . 0.57999999999999996 109.441 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.5 p -82.45 142.96 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.551 -0.537 . . . . 1.74 109.551 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.758 -0.639 . . . . 2.5800000000000001 111.472 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.1 t . . . . . 0 N--CA 1.445 -0.675 0 CA-C-O 121.16 0.505 . . . . 1.4299999999999999 110.363 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.436 ' HG3' ' HA3' ' A' ' 133' ' ' GLY . 7.6 tt0 -98.64 128.03 44.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.722 -0.672 . . . . 2.29 109.274 176.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.551 HG13 HG13 ' A' ' 30' ' ' VAL . 51.2 t -104.99 135.4 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.506 -0.553 . . . . 1.51 109.506 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.479 ' HA ' ' HE ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -92.57 101.21 13.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.084 0.468 . . . . 3.5699999999999998 110.99 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.497 HG12 ' HA3' ' A' ' 136' ' ' GLY . 73.4 t -129.73 115.32 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.873 -0.788 . . . . 1.26 108.873 173.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.83 -147.67 6.81 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.859 -0.686 . . . . 0.95999999999999996 112.412 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.29 142.16 27.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.209 0.528 . . . . 2.1800000000000002 111.413 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.75 124.38 7.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.276 -0.875 . . . . 1.4099999999999999 109.658 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 139' ' ' LYS . 31.1 m -116.03 116.57 28.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.212 -0.449 . . . . 1.03 110.709 -178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.465 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 27.8 t -121.49 116.75 50.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.931 0.396 . . . . 1.45 110.182 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -83.64 109.06 17.13 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.924 -0.58 . . . . 0.58999999999999997 111.436 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.5 ' HE3' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -168.63 175.9 5.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.703 -0.681 . . . . 3.4199999999999999 110.136 178.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.546 HG22 HG23 ' A' ' 142' ' ' VAL . 51.6 p -100.81 174.93 5.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.305 -0.407 . . . . 0.63 110.723 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.508 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -84.47 -6.56 59.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.774 -0.824 . . . . 3.1400000000000001 108.774 173.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.588 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -89.84 -22.0 37.69 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.128 -0.942 . . . . 0.75 111.569 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.47 -25.97 65.25 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.712 -0.848 . . . . 2.1699999999999999 108.712 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.663 HD13 ' HB ' ' A' ' 100' ' ' VAL . 18.5 mt -74.85 159.79 31.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.092 -0.958 . . . . 1.6100000000000001 109.087 172.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -153.8 60.29 0.73 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.467 -0.938 . . . . 1.6499999999999999 108.467 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 22.6 t70 61.28 -84.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.033 -1.439 . . . . 1.8300000000000001 110.255 -171.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.483 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -88.72 74.94 8.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.137 0.494 . . . . 0.81999999999999995 110.641 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.76 99.99 3.51 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.838 -0.619 . . . . 0.79000000000000004 110.134 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 91.5 Cg_endo -82.52 109.5 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.762 2.308 . . . . 1.1200000000000001 112.616 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -116.24 28.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.94 0.876 . . . . 2.5800000000000001 109.868 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.88 60.1 0.42 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.105 -0.952 . . . . 0.73999999999999999 112.265 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.63 97.89 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.328 2.019 . . . . 0.67000000000000004 112.948 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.1 t -80.31 126.22 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.856 -0.611 . . . . 1.1799999999999999 109.758 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -84.37 94.16 8.42 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 121.03 0.443 . . . . 1.6399999999999999 110.657 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.707 ' CG2' HD11 ' A' ' 96' ' ' ILE . 14.5 t -94.49 115.21 32.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.308 0.575 . . . . 1.01 111.065 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -102.71 124.92 49.13 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.29 -0.868 . . . . 2.48 109.687 174.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.74 93.97 6.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.019 -0.537 . . . . 0.69999999999999996 110.695 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 tp -87.28 112.76 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.811 -0.632 . . . . 1.9399999999999999 110.83 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.22 56.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.553 -0.832 . . . . 1.8100000000000001 112.306 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -83.72 95.7 8.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.962 0.411 . . . . 1.8799999999999999 110.444 177.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -103.09 -35.03 8.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.884 -0.598 . . . . 2.1400000000000001 110.155 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.42 ' C ' ' HB ' ' A' ' 89' ' ' VAL . . . -144.81 35.81 1.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.822 -0.626 . . . . 0.93999999999999995 110.417 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.549 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.7 tpp180 -120.34 148.01 44.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.044 0.45 . . . . 4.6399999999999997 111.649 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.532 ' HG3' HG12 ' A' ' 89' ' ' VAL . 18.2 mt-30 -92.48 128.23 38.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.173 -0.677 . . . . 1.75 109.173 173.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 72.1 t -92.9 128.97 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.141 -0.689 . . . . 0.54000000000000004 109.141 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.893 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -129.9 144.29 51.24 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.335 0.588 . . . . 0.35999999999999999 110.887 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 31.1 mt -102.08 143.95 31.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.495 -0.775 . . . . 0.83999999999999997 109.821 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.761 ' HE3' ' CB ' ' A' ' 129' ' ' PHE . 1.2 mptp? -143.73 152.99 41.97 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.284 -0.636 . . . . 1.9299999999999999 109.284 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -102.88 160.54 14.51 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.008 -0.542 . . . . 0.40999999999999998 109.606 171.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -83.36 159.65 21.8 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.129 -1.063 . . . . 0.70999999999999996 108.129 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -58.76 -9.64 1.89 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.982 0.42 . . . . 1.3999999999999999 111.744 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.44 -38.11 71.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.682 -0.69 . . . . 2.2200000000000002 111.449 171.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -141.66 23.18 2.12 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.971 0.415 . . . . 1.3500000000000001 110.406 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 62.8 t80 -126.14 108.15 11.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.56000000000000005 110.189 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -112.82 107.85 16.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.214 -0.291 . . . . 2.4100000000000001 110.214 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 71.11 -58.86 0.56 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.982 0.801 . . . . 3.4300000000000002 110.957 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.512 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -178.52 40.92 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.443 -0.799 . . . . 0.56000000000000005 111.148 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 3.4 mptp? -131.76 133.9 45.26 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.64 -0.874 . . . . 2.1200000000000001 108.64 173.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -109.91 135.96 49.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.148 0.499 . . . . 0.56000000000000005 110.507 172.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 21.7 p90 -142.52 167.5 21.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.553 0.692 . . . . 0.58999999999999997 111.85 -175.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 65' ' ' LEU . 16.0 mt -80.02 104.64 10.73 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.939 -1.028 . . . . 1.53 109.591 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.3 tp -108.2 138.51 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.751 -0.463 . . . . 0.62 109.751 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 p -83.55 166.16 18.47 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.935 -0.395 . . . . 1.4399999999999999 109.935 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.28 -28.14 68.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.939 -0.763 . . . . 2.3100000000000001 108.939 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -80.96 -20.38 42.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.031 -0.986 . . . . 3.0899999999999999 110.479 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.0 m120 67.25 27.78 8.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.647 -0.706 . . . . 2.6200000000000001 111.268 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 63' ' ' ASP . 19.7 ptt180 -88.09 -46.4 9.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.485 -0.325 . . . . 4.6600000000000001 111.287 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.471 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 7.5 m-20 -107.52 143.52 35.8 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.91 -0.404 . . . . 2.5099999999999998 109.91 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.75 153.87 47.28 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.297 0.373 . . . . 2.0699999999999998 110.277 174.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.682 ' HG ' ' HG3' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -154.09 118.61 4.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.442 -0.947 . . . . 1.98 108.442 177.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 1.5 m-85 -69.91 138.97 52.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.933 0.397 . . . . 0.75 109.945 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.472 HG11 HD21 ' A' ' 56' ' ' LEU . 15.1 m -117.38 176.53 2.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.139 -0.482 . . . . 0.72999999999999998 110.846 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.49 111.65 10.89 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.822 -0.626 . . . . 1.8100000000000001 109.673 175.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.402 HD12 HD13 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -86.85 85.46 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.719 0.771 . . . . 0.81000000000000005 109.196 171.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.684 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 37.7 ttt-85 -102.23 136.46 19.43 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 114.756 -1.111 . . . . 3.79 110.396 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.633 ' HA ' HG22 ' A' ' 96' ' ' ILE . 6.1 Cg_exo -46.05 110.63 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.178 2.585 . . . . 0.58999999999999997 112.267 176.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.08 97.34 8.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.72 -0.673 . . . . 1.71 110.033 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 71.61 17.7 5.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.094 -0.957 . . . . 1.9199999999999999 110.881 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -128.59 79.11 1.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.084 0.402 . . . . 1.8899999999999999 112.084 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.4 t 68.56 -172.2 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.837 -0.62 . . . . 1.7 111.804 172.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.57 141.48 48.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.792 -0.64 . . . . 0.93999999999999995 110.433 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.448 ' CG ' ' HG3' ' A' ' 71' ' ' PRO . 19.9 m0 -123.45 162.92 21.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.3 -0.409 . . . . 0.5 110.602 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 m -76.41 104.85 7.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.74 -0.837 . . . . 0.51000000000000001 108.74 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 t -93.43 110.5 22.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.813 0.816 . . . . 0.58999999999999997 112.515 -170.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -110.86 159.35 17.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.017 -1.105 . . . . 1.7 108.017 166.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -76.59 -5.1 46.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.469 -0.197 . . . . 1.3899999999999999 110.469 -176.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.435 ' CA ' ' HE1' ' A' ' 49' ' ' PHE . . . -126.74 -32.62 0.69 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.026 -0.607 . . . . 0.65000000000000002 112.822 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 15.8 m -121.51 148.22 25.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 122.325 -0.515 . . . . 1.1599999999999999 110.594 175.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.782 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -140.27 100.35 3.88 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.56 -0.533 . . . . 0.35999999999999999 109.56 -177.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.893 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 3.6 p90 -131.06 146.05 52.23 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.318 -0.252 . . . . 0.58999999999999997 110.318 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -81.86 150.58 27.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.01 -0.676 . . . . 1.3899999999999999 109.804 176.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -76.45 -13.52 60.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.59 0.709 . . . . 2.1200000000000001 110.069 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 19.4 m-20 -86.01 145.72 26.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.511 -0.768 . . . . 2.1000000000000001 110.136 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.532 HG12 ' HG3' ' A' ' 39' ' ' GLN . 19.5 m -103.85 123.39 57.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.282 0.563 . . . . 1.05 110.586 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.47 -147.17 18.85 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.701 -0.762 . . . . 0.46000000000000002 112.347 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.3 p -75.0 178.68 5.45 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.421 0.629 . . . . 1.1699999999999999 111.618 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.436 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 83.6 t90 -170.92 -55.63 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.087 -0.96 . . . . 0.51000000000000001 108.729 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 29.19 97.72 0.01 OUTLIER Glycine 0 N--CA 1.469 0.898 0 O-C-N 125.057 1.473 . . . . 1.25 115.894 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.55 -153.37 10.25 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.58 -0.819 . . . . 0.71999999999999997 112.964 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 p -101.38 129.66 47.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.871 0.693 . . . . 0.59999999999999998 112.871 -173.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.707 HD11 ' CG2' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -119.34 130.66 73.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.496 -0.928 . . . . 1.6299999999999999 108.496 170.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.17 153.23 17.06 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.137 -1.03 . . . . 0.45000000000000001 112.59 -171.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 mp -87.58 112.01 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.014 0.435 . . . . 0.82999999999999996 110.334 175.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.684 ' CE1' ' HB3' ' A' ' 70' ' ' ARG . 7.4 m-85 -101.66 153.48 19.73 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.935 -1.135 . . . . 1.28 107.935 171.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.663 ' HB ' HD13 ' A' ' 19' ' ' LEU . 3.6 p -87.48 124.7 40.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.323 -0.621 . . . . 1.1399999999999999 109.323 172.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -83.37 95.35 8.19 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.958 -0.697 . . . . 1.02 109.559 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.58 78.49 0.71 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.55 -0.833 . . . . 1.53 111.535 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.47 ' HA ' HG21 ' A' ' 100' ' ' VAL . 5.7 pt20 -37.97 120.66 0.87 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.724 0.773 . . . . 2.1099999999999999 112.527 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.682 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 9.7 mm-40 -92.41 19.79 6.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.326 -0.852 . . . . 2.6200000000000001 110.683 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 m 65.45 5.34 3.15 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.512 -0.767 . . . . 2.4300000000000002 112.302 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.588 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 12.5 t30 63.78 86.04 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.507 0.67 . . . . 1.5600000000000001 111.211 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.0 t -80.94 140.53 50.22 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 107.84 -1.17 . . . . 1.6799999999999999 107.84 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -26.76 92.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.835 3.69 . . . . 1.26 113.943 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -90.74 -161.05 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.192 2.594 . . . . 0.76000000000000001 112.682 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.73 -76.51 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.342 -1.103 . . . . 0.76000000000000001 110.342 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -140.58 122.27 15.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.678 -0.49 . . . . 2.04 109.678 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -117.62 124.46 48.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.438 0.637 . . . . 0.75 110.18 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.4 HG23 ' HE2' ' A' ' 139' ' ' LYS . 51.5 m -116.14 97.62 6.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.907 -1.042 . . . . 0.82999999999999996 109.509 -173.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -104.05 100.83 10.6 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.413 0.625 . . . . 0.51000000000000001 110.108 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.9 m -73.14 117.94 15.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.033 -0.985 . . . . 0.58999999999999997 110.002 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -111.44 136.23 50.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.133 0.492 . . . . 1.27 110.857 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 45.8 m -129.32 106.18 8.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.223 -0.658 . . . . 0.69999999999999996 109.223 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.603 ' H ' ' HB ' ' A' ' 134' ' ' THR . . . -89.01 -156.76 32.01 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.736 -0.745 . . . . 0.80000000000000004 111.767 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.64 -162.85 28.28 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.469 -0.872 . . . . 0.53000000000000003 111.932 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.559 ' CZ ' ' HB ' ' A' ' 130' ' ' THR . 52.6 p90 -101.65 144.82 29.9 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.987 0.422 . . . . 0.89000000000000001 110.269 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.648 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 15.1 t-105 -101.23 131.82 47.03 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.749 -0.834 . . . . 0.56000000000000005 108.749 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.18 54.87 1.55 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.233 0.54 . . . . 1.4199999999999999 112.22 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.705 ' CG ' ' HA3' ' A' ' 128' ' ' GLY . 29.0 mmtp -158.98 -142.28 0.09 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.566 -1.272 . . . . 3.4700000000000002 107.566 174.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -151.57 107.08 3.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.238 0.542 . . . . 2.0800000000000001 111.926 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.648 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 84.4 m-20 63.91 -36.74 0.17 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.474 -1.239 . . . . 2.4700000000000002 114.272 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -55.04 -51.48 66.18 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.478 0.547 . . . . 1.96 112.478 -170.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.687 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 36.4 tt0 152.82 22.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.082 0.864 . . . . 2.02 110.801 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.705 ' HA3' ' CG ' ' A' ' 123' ' ' LYS . . . -80.79 88.39 1.34 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 119.957 -1.116 . . . . 0.77000000000000002 112.222 -175.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.761 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 28.4 p90 -140.82 155.17 46.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.592 0.234 . . . . 1.21 110.395 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.559 ' HB ' ' CZ ' ' A' ' 120' ' ' TYR . 99.5 m -139.74 125.27 11.73 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.594 -0.275 . . . . 1.47 110.695 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 47.8 Cg_exo -56.59 134.06 61.95 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.076 2.517 . . . . 0.92000000000000004 112.018 177.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.7 t -151.84 103.51 2.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.44 -0.345 . . . . 1.52 110.78 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.436 ' HA3' ' HG3' ' A' ' 4' ' ' GLN . . . 82.08 -4.89 73.94 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.938 -0.648 . . . . 1.1699999999999999 112.901 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.603 ' HB ' ' H ' ' A' ' 118' ' ' GLY . 25.2 p -109.93 113.93 27.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.98 0.733 . . . . 2.4700000000000002 112.98 -170.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.6 m -140.11 95.18 2.85 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.954 -1.128 . . . . 1.8200000000000001 107.954 162.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.497 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -118.1 160.94 13.62 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.063 -1.065 . . . . 0.67000000000000004 113.02 -171.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -143.02 103.98 4.24 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.77 -0.456 . . . . 0.57999999999999996 109.77 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.509 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 39.5 m -79.97 108.45 13.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.937 -0.764 . . . . 0.52000000000000002 108.937 174.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.413 ' HB3' HG23 ' A' ' 11' ' ' THR . 2.7 tppp? -94.7 109.39 21.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.222 0.534 . . . . 2.1800000000000002 110.052 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.5 HD13 ' HE3' ' A' ' 14' ' ' LYS . 2.3 tp -98.99 104.27 16.29 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.176 -0.92 . . . . 0.63 109.317 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 9.2 m -119.23 140.02 50.92 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.848 -0.614 . . . . 0.57999999999999996 109.771 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.546 HG23 HG22 ' A' ' 15' ' ' THR . 12.3 p -82.07 149.12 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.459 . . . . 1.74 110.711 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.512 -0.756 . . . . 2.5800000000000001 109.449 175.639 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 41.8 t . . . . . 0 C--O 1.237 0.399 0 N-CA-C 109.61 -0.515 . . . . 1.4299999999999999 109.61 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -113.47 128.51 56.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.013 -0.539 . . . . 2.29 109.55 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.522 ' HB ' HG23 ' A' ' 134' ' ' THR . 35.1 t -106.56 111.79 36.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.407 -0.59 . . . . 1.51 109.407 -175.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 49.5 mtp180 -84.99 92.51 8.35 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.014 0.435 . . . . 3.5699999999999998 110.961 -176.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.637 HG23 HG22 ' A' ' 134' ' ' THR . 81.1 t -102.66 115.45 44.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.643 -0.873 . . . . 1.26 108.643 171.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.2 169.22 23.74 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.601 -0.809 . . . . 0.95999999999999996 112.984 -174.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -88.12 152.93 21.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.933 0.397 . . . . 2.1800000000000002 110.393 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.951 HD11 ' HB ' ' A' ' 28' ' ' VAL . 89.2 mt -134.74 144.67 47.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.844 -0.616 . . . . 1.4099999999999999 110.214 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 m -134.41 115.77 14.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.793 -0.447 . . . . 1.03 109.793 171.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.714 HG11 HG22 ' A' ' 25' ' ' ILE . 21.0 t -130.95 130.58 64.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.471 -0.332 . . . . 1.45 110.947 -176.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -99.89 99.67 10.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.377 -0.374 . . . . 0.58999999999999997 110.517 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -165.86 167.69 16.58 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.426 -0.352 . . . . 3.4199999999999999 110.256 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.506 ' HA ' HG22 ' A' ' 142' ' ' VAL . 70.4 p -87.25 167.24 14.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 0.63 111.095 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -88.18 -12.16 44.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.83 -0.804 . . . . 3.1400000000000001 108.83 173.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.72 -29.88 74.18 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.541 -0.754 . . . . 0.75 111.423 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -62.91 -35.02 78.68 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.601 -0.518 . . . . 2.1699999999999999 109.601 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.552 HD13 ' HB ' ' A' ' 100' ' ' VAL . 48.9 mt -64.8 95.14 0.14 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.421 -0.809 . . . . 1.6100000000000001 110.118 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -98.16 72.57 2.16 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.973 -0.751 . . . . 1.6499999999999999 108.973 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 34.0 t70 56.18 -95.7 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.828 -1.078 . . . . 1.8300000000000001 109.814 -169.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -84.6 77.15 10.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.164 0.507 . . . . 0.81999999999999995 111.016 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -132.41 96.75 18.66 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.718 -0.674 . . . . 0.79000000000000004 109.734 175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.45 ' HD3' ' HE1' ' A' ' 99' ' ' TYR . 55.2 Cg_endo -71.9 96.89 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.54 2.16 . . . . 1.1200000000000001 112.457 -177.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.714 HG22 HG11 ' A' ' 12' ' ' VAL . 16.2 mt -86.64 -30.09 5.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.366 0.603 . . . . 2.5800000000000001 110.513 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.18 63.51 0.63 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.374 -0.917 . . . . 0.73999999999999999 112.712 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 14.1 Cg_endo -58.67 106.32 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.342 2.028 . . . . 0.67000000000000004 111.494 172.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.951 ' HB ' HD11 ' A' ' 10' ' ' LEU . 7.6 p -91.78 130.66 40.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.163 -0.471 . . . . 1.1799999999999999 110.24 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.9 m -85.7 98.04 10.47 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.9 -0.591 . . . . 1.6399999999999999 110.626 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.654 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 52.1 t -89.96 115.11 28.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.915 -0.584 . . . . 1.01 110.213 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.484 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 0.2 OUTLIER -104.38 110.13 22.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.948 -0.569 . . . . 2.48 109.551 -176.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.31 105.51 17.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.245 -0.434 . . . . 0.69999999999999996 110.793 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.61 121.03 23.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.6 -0.727 . . . . 1.9399999999999999 110.002 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.74 -120.3 8.8 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.741 -0.742 . . . . 1.8100000000000001 112.141 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 56.4 m 70.36 -58.03 0.56 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.25 0.62 . . . . 1.8799999999999999 110.722 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.469 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 93.4 m-20 70.1 -48.13 0.63 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.921 0.888 . . . . 2.1400000000000001 113.272 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.1 77.91 1.22 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.239 -0.652 . . . . 0.93999999999999995 109.239 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.541 ' HG3' ' HB2' ' A' ' 120' ' ' TYR . 2.9 tpp85 -156.05 146.87 22.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.61 -0.723 . . . . 4.6399999999999997 110.493 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.729 ' HG3' HG12 ' A' ' 89' ' ' VAL . 55.3 mt-30 -83.2 116.43 22.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.365 -0.38 . . . . 1.75 110.518 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 59.3 t -84.15 124.67 39.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.69 -0.485 . . . . 0.54000000000000004 109.69 176.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.696 ' HB1' ' HE3' ' A' ' 43' ' ' LYS . . . -125.23 139.51 53.67 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.765 0.317 . . . . 0.35999999999999999 110.402 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 mt -102.85 129.28 49.48 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.79 -0.448 . . . . 0.83999999999999997 109.79 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.696 ' HE3' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -120.57 151.3 39.6 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.243 -0.651 . . . . 1.9299999999999999 109.243 176.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.601 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -100.54 152.91 19.84 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.081 0.467 . . . . 0.40999999999999998 110.632 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 17.7 t70 -75.18 148.46 39.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.359 -0.837 . . . . 0.70999999999999996 109.678 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.5 t -57.91 -17.07 14.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.026 0.75 . . . . 1.3999999999999999 113.026 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.62 -32.17 70.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.975 0.417 . . . . 2.2200000000000002 110.202 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 4.8 p-10 -123.73 20.1 9.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.05 -0.523 . . . . 1.3500000000000001 110.237 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.588 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 61.6 t80 -139.97 106.22 5.26 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.619 -0.719 . . . . 0.56000000000000005 109.932 -177.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -107.36 108.21 19.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.641 -0.254 . . . . 2.4100000000000001 110.36 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 71.23 -53.87 0.67 Allowed 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.974 0.796 . . . . 3.4300000000000002 111.778 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.588 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -179.96 31.88 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.904 -0.665 . . . . 0.56000000000000005 112.578 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 75.1 mmtt -134.63 134.91 41.72 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.757 -0.831 . . . . 2.1200000000000001 108.757 173.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -112.51 148.62 34.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.447 0.642 . . . . 0.56000000000000005 112.181 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.609 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 9.5 p90 -156.12 171.51 20.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.975 -1.012 . . . . 0.58999999999999997 110.304 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.629 HD22 HD22 ' A' ' 114' ' ' LEU . 10.2 mt -84.57 115.42 22.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.531 -0.914 . . . . 1.53 108.531 172.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.464 HG22 ' HB3' ' A' ' 48' ' ' ASN . 7.7 tp -107.54 116.43 51.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.687 0.756 . . . . 0.62 110.96 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 23.8 p -62.43 151.36 37.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.33 -0.85 . . . . 1.4399999999999999 111.561 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.65 -24.11 64.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.168 0.509 . . . . 2.3100000000000001 110.355 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -93.5 17.56 11.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.815 -0.629 . . . . 3.0899999999999999 110.581 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 25.82 67.3 0.05 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.438 1.095 . . . . 2.6200000000000001 112.771 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.522 HH21 HG22 ' A' ' 107' ' ' THR . 7.1 ptm85 -120.41 -44.59 2.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.552 -0.749 . . . . 4.6600000000000001 111.895 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.433 ' HB3' ' OH ' ' A' ' 112' ' ' TYR . 26.4 t0 -138.5 139.66 38.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.754 -0.462 . . . . 2.5099999999999998 109.754 -175.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 2.2 pptp? -128.68 138.92 52.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.08 0.467 . . . . 2.0699999999999998 110.703 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.647 HD23 ' HB2' ' A' ' 104' ' ' GLN . 6.1 mp -129.16 120.53 26.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.189 -0.46 . . . . 1.98 110.666 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -70.7 131.79 44.42 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.0 -0.37 . . . . 0.75 110.0 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 100' ' ' VAL . 15.7 m -128.6 124.47 61.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.248 -0.433 . . . . 0.72999999999999998 110.759 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.53 120.12 32.68 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.266 0.555 . . . . 1.8100000000000001 110.16 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.453 HG22 ' HB ' ' A' ' 96' ' ' ILE . 2.9 mt -82.6 85.3 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 0.81000000000000005 110.237 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.514 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 65.7 mtp180 -90.26 133.58 32.99 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.0 -0.741 . . . . 3.79 109.0 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.701 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 40.3 Cg_endo -66.87 134.99 36.48 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.569 1.513 . . . . 0.58999999999999997 111.157 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.5 ttt -79.32 92.1 5.12 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.855 -0.612 . . . . 1.71 110.666 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 68.24 36.04 3.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.465 -0.789 . . . . 1.9199999999999999 112.064 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -139.11 115.23 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.055 0.761 . . . . 1.8899999999999999 113.055 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.8 m 63.21 -167.15 0.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.076 -0.965 . . . . 1.7 113.0 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.41 114.31 19.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.655 -0.702 . . . . 0.93999999999999995 110.137 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.642 ' CD1' ' HG3' ' A' ' 71' ' ' PRO . 11.8 m95 -109.49 141.43 41.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.826 -0.625 . . . . 0.5 110.705 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.1 m -80.44 111.35 16.76 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.53 -0.544 . . . . 0.51000000000000001 109.53 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.6 t -86.04 113.47 22.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.798 0.809 . . . . 0.58999999999999997 112.079 -173.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -129.29 156.07 44.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.154 -0.93 . . . . 1.7 108.509 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -82.87 -0.53 48.63 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.716 -0.394 . . . . 1.3899999999999999 111.61 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.57 -34.23 2.3 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.467 -0.873 . . . . 0.65000000000000002 111.868 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.593 HG11 ' HZ3' ' A' ' 121' ' ' TRP . 10.7 m -138.73 154.64 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.634 -0.506 . . . . 1.1599999999999999 109.634 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -140.48 106.86 5.27 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.105 -1.072 . . . . 0.35999999999999999 108.105 178.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 2.0 p90 -139.49 141.98 37.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.757 0.789 . . . . 0.58999999999999997 112.895 -170.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.602 ' HB2' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -70.64 128.22 35.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.987 -1.46 . . . . 1.3899999999999999 111.04 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.56 -35.34 79.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.59 . . . . 2.1200000000000001 109.69 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.602 ' OD1' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -68.5 125.75 27.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.364 -0.834 . . . . 2.1000000000000001 109.673 175.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.729 HG12 ' HG3' ' A' ' 39' ' ' GLN . 16.4 m -91.91 118.4 37.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.159 0.504 . . . . 1.05 110.958 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.469 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 159.6 -169.14 35.6 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.393 -0.908 . . . . 0.46000000000000002 112.348 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.3 p -70.4 151.27 45.37 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.127 -0.694 . . . . 1.1699999999999999 109.127 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 37.0 t90 -135.71 -64.89 0.61 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.755 -0.378 . . . . 0.51000000000000001 110.121 -175.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.654 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 35.86 85.28 0.01 OUTLIER Glycine 0 N--CA 1.468 0.776 0 O-C-N 124.307 1.004 . . . . 1.25 114.618 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.17 -153.91 6.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.922 -0.656 . . . . 0.71999999999999997 112.236 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -106.11 132.9 51.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.198 0.523 . . . . 0.59999999999999998 112.363 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.701 ' HA ' ' HA ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -125.22 141.04 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.857 -0.794 . . . . 1.6299999999999999 108.857 171.306 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -114.56 151.1 18.55 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.16 -1.019 . . . . 0.45000000000000001 112.647 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -92.7 114.34 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.514 -0.55 . . . . 0.82999999999999996 109.514 174.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.54 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 10.1 m-85 -120.97 129.87 53.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.437 -0.802 . . . . 1.28 108.892 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.732 ' HA ' HG12 ' A' ' 67' ' ' VAL . 8.6 p -71.03 142.66 15.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.035 -0.357 . . . . 1.1399999999999999 110.035 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.57 95.45 0.33 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.385 -0.37 . . . . 1.02 110.867 176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 50.38 48.81 40.4 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.973 -0.558 . . . . 1.53 113.67 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.502 ' H ' HG13 ' A' ' 100' ' ' VAL . 3.9 pt20 38.41 88.47 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.005 0.907 . . . . 2.1099999999999999 112.34 -174.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.647 ' HB2' HD23 ' A' ' 65' ' ' LEU . 38.5 mm-40 -56.98 -76.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.816 -1.083 . . . . 2.6200000000000001 113.129 -175.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -146.37 -64.66 0.3 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.388 -0.369 . . . . 2.4300000000000002 111.979 -169.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 15.7 t30 60.85 47.2 7.98 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 122.259 1.028 . . . . 1.5600000000000001 108.393 -170.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.522 HG22 HH21 ' A' ' 62' ' ' ARG . 16.2 m -72.45 123.31 89.35 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 114.84 -1.073 . . . . 1.6799999999999999 109.246 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -11.82 84.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.342 1 C-N-CA 125.966 4.444 . . . . 1.26 114.44 -164.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 2.8 Cg_endo -87.0 -169.09 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.634 2.889 . . . . 0.76000000000000001 114.035 -168.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.35 -111.82 0.25 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.224 -1.55 . . . . 0.76000000000000001 109.224 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -89.39 131.23 35.56 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.848 0.356 . . . . 2.04 110.311 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 6.3 m-85 -125.35 125.31 43.27 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.778 -0.452 . . . . 0.75 109.778 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.9 m -96.63 129.36 44.04 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.698 -0.683 . . . . 0.82999999999999996 110.23 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.629 HD22 HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -144.68 104.57 4.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.522 -0.918 . . . . 0.51000000000000001 108.522 171.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 32.5 m -108.19 123.97 49.57 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.527 -0.916 . . . . 0.58999999999999997 108.527 -174.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 116' ' ' LEU . 2.8 mm? -113.35 110.92 21.14 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.397 0.618 . . . . 1.27 110.755 -173.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 9.8 m -98.27 103.71 15.68 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.256 -0.884 . . . . 0.69999999999999996 108.733 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.775 ' H ' ' HB ' ' A' ' 134' ' ' THR . . . -92.29 -157.13 33.36 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 120.378 -0.915 . . . . 0.80000000000000004 112.023 -173.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 147.87 -167.9 28.77 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.707 -0.957 . . . . 0.53000000000000003 110.707 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.541 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 50.5 p90 -98.86 138.24 36.27 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.83 -0.748 . . . . 0.89000000000000001 109.945 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.612 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 11.2 t-105 -91.72 141.7 28.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.473 -1.24 . . . . 0.56000000000000005 109.142 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.17 57.33 1.2 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.162 0.43 . . . . 1.4199999999999999 112.162 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.54 ' C ' ' HE1' ' A' ' 121' ' ' TRP . 55.5 mmtt -158.96 -139.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.364 -0.976 . . . . 3.4700000000000002 108.364 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -154.84 100.47 2.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.32 0.581 . . . . 2.0800000000000001 112.087 173.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.612 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 27.1 t-20 60.65 -41.58 0.11 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.454 1.502 . . . . 2.4700000000000002 114.309 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.514 ' HG3' ' N ' ' A' ' 127' ' ' GLN . 19.4 ptpt -52.56 -51.18 60.95 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.753 0.649 . . . . 1.96 112.753 -172.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.514 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 8.1 tt0 152.37 88.96 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.236 1.014 . . . . 2.02 109.239 -176.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 123' ' ' LYS . . . -142.31 90.65 0.17 Allowed Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.33 -0.938 . . . . 0.77000000000000002 111.129 172.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.442 ' CB ' ' HZ2' ' A' ' 43' ' ' LYS . 44.7 p90 -144.78 168.51 20.04 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.869 -0.419 . . . . 1.21 109.869 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 4.1 t -156.68 129.25 4.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.897 0.379 . . . . 1.47 110.615 173.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 24.0 Cg_exo -64.2 110.71 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.939 2.426 . . . . 0.92000000000000004 111.776 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.1 t -131.57 91.93 3.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.395 -0.366 . . . . 1.52 110.314 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.25 -3.18 85.54 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.98 -0.629 . . . . 1.1699999999999999 112.702 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.775 ' HB ' ' H ' ' A' ' 118' ' ' GLY . 16.5 p -100.5 113.6 26.52 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 113.376 0.88 . . . . 2.4700000000000002 113.376 -168.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 54.4 m -141.3 94.88 2.75 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.624 -0.51 . . . . 1.8200000000000001 109.624 165.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.505 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -110.01 85.03 0.39 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.205 -0.998 . . . . 0.67000000000000004 112.729 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.8 m -81.15 95.01 6.75 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.618 -0.512 . . . . 0.57999999999999996 109.618 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.609 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 27.5 m -89.15 108.5 19.64 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.106 -0.701 . . . . 0.52000000000000002 109.106 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.435 ' HB2' ' HE3' ' A' ' 139' ' ' LYS . 29.1 ttmt -103.89 108.79 20.28 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.848 0.832 . . . . 2.1800000000000002 109.583 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.505 HD23 HD13 ' A' ' 56' ' ' LEU . 21.6 tp -105.35 104.05 13.7 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.281 -1.327 . . . . 0.63 109.343 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.72 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.8 m -117.74 138.11 52.25 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.937 -0.574 . . . . 0.57999999999999996 110.883 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 15' ' ' THR . 40.3 t -91.58 111.35 23.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.518 -0.919 . . . . 1.74 108.518 170.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.407 -0.806 . . . . 2.5800000000000001 110.743 -176.555 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.764 0.316 . . . . 1.4299999999999999 111.786 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -86.64 111.26 20.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.216 -0.661 . . . . 2.29 109.216 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.97 HG21 ' HA3' ' A' ' 118' ' ' GLY . 33.1 m -80.93 137.68 20.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.176 0.513 . . . . 1.51 110.417 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.564 ' HA ' ' NE ' ' A' ' 6' ' ' ARG . 5.2 mmp_? -96.46 95.07 7.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.146 -0.479 . . . . 3.5699999999999998 110.078 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.412 HG22 ' HA3' ' A' ' 136' ' ' GLY . 11.9 p -116.77 140.15 40.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.503 -0.771 . . . . 1.26 109.163 177.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.62 136.08 9.54 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.388 -0.911 . . . . 0.95999999999999996 111.895 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.81 106.52 2.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.803 -0.443 . . . . 2.1800000000000002 109.803 177.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.56 HD21 HG22 ' A' ' 28' ' ' VAL . 4.1 pp -116.73 151.29 36.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.308 -0.405 . . . . 1.4099999999999999 110.779 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -120.61 123.64 43.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.038 -0.528 . . . . 1.03 110.194 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.459 HG12 ' HG2' ' A' ' 14' ' ' LYS . 39.2 t -130.12 135.46 60.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.268 -0.424 . . . . 1.45 110.493 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.687 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -103.67 96.15 6.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.879 0.371 . . . . 0.58999999999999997 110.658 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.459 ' HG2' HG12 ' A' ' 12' ' ' VAL . 33.8 mmtp -144.32 163.44 33.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 3.4199999999999999 110.288 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.798 ' HA ' HG13 ' A' ' 142' ' ' VAL . 31.3 p -91.8 149.89 21.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.339 -0.392 . . . . 0.63 110.433 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.769 ' NH1' ' HG3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -81.97 -0.03 42.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.198 0.523 . . . . 3.1400000000000001 110.062 177.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.694 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -84.33 -22.75 53.54 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.816 -0.914 . . . . 0.75 110.816 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -56.61 -31.08 63.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.774 0.797 . . . . 2.1699999999999999 109.361 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.846 HD21 HG23 ' A' ' 25' ' ' ILE . 7.1 mt -89.61 111.27 22.17 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.832 -1.076 . . . . 1.6100000000000001 109.765 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -107.97 75.35 0.99 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.491 -0.929 . . . . 1.6499999999999999 108.491 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.639 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 36.4 t70 62.6 -93.18 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.401 -1.272 . . . . 1.8300000000000001 110.336 -170.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.23 73.84 10.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.321 0.581 . . . . 0.81999999999999995 111.065 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -152.79 121.6 3.23 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.259 -0.882 . . . . 0.79000000000000004 108.88 174.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 48.2 Cg_endo -89.85 151.06 4.97 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.074 2.516 . . . . 1.1200000000000001 113.654 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.846 HG23 HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.68 -64.46 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.627 -0.715 . . . . 2.5800000000000001 110.781 175.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.95 77.52 0.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.679 -0.772 . . . . 0.73999999999999999 112.898 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.524 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 5.2 Cg_endo -48.24 111.1 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.32 2.68 . . . . 0.67000000000000004 112.327 168.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.56 HG22 HD21 ' A' ' 10' ' ' LEU . 26.0 t -87.13 134.37 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.533 -0.758 . . . . 1.1799999999999999 110.305 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 32.4 p -78.09 79.26 4.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 1.6399999999999999 110.392 175.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.5 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 40.3 t -82.94 114.62 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.271 0.557 . . . . 1.01 110.46 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.669 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 8.9 tt0 -110.94 135.07 52.01 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.13 -0.941 . . . . 2.48 109.96 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.486 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -104.76 123.8 48.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.084 -0.507 . . . . 0.69999999999999996 110.572 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.39 123.05 49.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.258 -0.428 . . . . 1.9399999999999999 110.882 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.71 28.7 8.19 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.861 -0.685 . . . . 1.8100000000000001 111.939 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.486 ' SG ' ' HB1' ' A' ' 32' ' ' ALA . 19.6 m -120.74 94.65 4.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.893 0.378 . . . . 1.8799999999999999 111.019 -176.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.404 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 16.3 m120 -98.48 -19.37 17.7 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.372 -0.603 . . . . 2.1400000000000001 109.372 174.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.43 ' HA ' ' H ' ' A' ' 90' ' ' GLY . . . -167.78 72.35 0.11 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.78 -0.645 . . . . 0.93999999999999995 111.138 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 5.8 tpt180 -152.36 146.9 25.71 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 110.319 -0.252 . . . . 4.6399999999999997 110.319 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.89 131.52 36.44 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.408 -0.59 . . . . 1.75 109.408 174.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 95.1 t -103.1 120.34 52.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.193 -0.669 . . . . 0.54000000000000004 109.193 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.7 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -114.12 143.2 45.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.105 0.479 . . . . 0.35999999999999999 111.453 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.3 mt -102.78 114.75 29.27 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.719 -0.673 . . . . 0.83999999999999997 109.767 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 152.55 27.72 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.441 -0.8 . . . . 1.9299999999999999 109.093 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 116' ' ' LEU . . . -92.38 154.42 18.55 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.305 -0.628 . . . . 0.40999999999999998 109.305 170.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.72 159.13 31.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.203 -1.036 . . . . 0.70999999999999996 108.203 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.66 -20.58 34.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.707 1.003 . . . . 1.3999999999999999 113.707 -168.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.25 -32.89 73.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.016 0.436 . . . . 2.2200000000000002 110.903 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -115.36 13.23 16.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.634 0.73 . . . . 1.3500000000000001 109.924 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -130.52 101.75 5.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.848 -0.614 . . . . 0.56000000000000005 109.506 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.45 103.31 14.2 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.988 -0.375 . . . . 2.4100000000000001 109.988 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 71.48 -56.64 0.63 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 124.084 0.865 . . . . 3.4300000000000002 111.322 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.28 39.08 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.036 -0.826 . . . . 0.56000000000000005 111.036 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 81' ' ' ASN . 43.6 mmtm -138.36 135.03 34.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.172 -1.048 . . . . 2.1200000000000001 108.172 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.4 148.5 37.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.607 0.717 . . . . 0.56000000000000005 111.211 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.736 ' CE2' ' HB ' ' A' ' 57' ' ' ILE . 0.8 OUTLIER -145.93 -169.11 3.16 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.994 -1.003 . . . . 0.58999999999999997 110.755 -170.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.78 ' HG ' HD22 ' A' ' 114' ' ' LEU . 1.1 mp -111.2 104.24 12.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.567 -1.271 . . . . 1.53 107.567 167.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.736 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 9.4 tp -107.81 136.5 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.273 0.559 . . . . 0.62 111.669 -172.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.2 t -70.72 140.55 51.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.003 -0.74 . . . . 1.4399999999999999 109.003 171.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.21 -16.97 64.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.981 0.42 . . . . 2.3100000000000001 111.118 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -87.32 -14.43 40.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 3.0899999999999999 110.657 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.5 t30 59.89 94.46 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.798 -0.637 . . . . 2.6200000000000001 110.966 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -153.74 -46.5 0.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 4.6600000000000001 110.126 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -117.31 138.63 51.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.508 -0.769 . . . . 2.5099999999999998 109.555 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.94 153.27 46.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.227 1.013 . . . . 2.0699999999999998 111.499 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.776 ' HG ' HE21 ' A' ' 104' ' ' GLN . 6.4 mp -120.65 175.58 5.94 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 113.377 -1.738 . . . . 1.98 106.82 169.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -126.56 145.13 50.65 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.58 -0.896 . . . . 0.75 108.58 151.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.544 HG11 HD13 ' A' ' 56' ' ' LEU . 29.4 m -134.22 160.07 41.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.861 0.362 . . . . 0.72999999999999998 110.867 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 99' ' ' TYR . 14.4 p-10 -126.11 111.99 15.31 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.853 -0.612 . . . . 1.8100000000000001 109.865 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.425 HG23 HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -72.88 101.44 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.033 -0.729 . . . . 0.81000000000000005 109.033 173.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -122.14 139.86 31.28 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.825 -0.625 . . . . 3.79 110.215 -170.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.51 122.61 5.93 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.67 2.246 . . . . 0.58999999999999997 111.793 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 53.7 ttp -53.09 -54.01 41.89 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.702 0.626 . . . . 1.71 111.706 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -155.96 15.03 0.34 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.954 0.407 . . . . 1.9199999999999999 110.504 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -80.81 -81.83 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.032 -0.531 . . . . 1.8899999999999999 111.658 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.492 ' HB2' ' HE1' ' A' ' 92' ' ' TRP . 3.7 m -136.56 172.35 13.15 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.472 -0.196 . . . . 1.7 110.472 -175.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.98 122.46 32.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.989 0.423 . . . . 0.93999999999999995 110.859 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.497 ' HE3' ' HD1' ' A' ' 84' ' ' PHE . 12.5 m0 -107.79 156.94 18.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.892 -0.595 . . . . 0.5 110.319 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 m -72.44 121.03 18.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.958 -0.756 . . . . 0.51000000000000001 108.958 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 t -103.42 101.24 11.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.928 0.87 . . . . 0.58999999999999997 112.979 -168.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 83' ' ' VAL . 3.7 m-20 -110.33 161.29 15.78 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.721 -1.214 . . . . 1.7 107.721 168.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 53' ' ' LYS . 2.1 t-20 -86.82 -7.26 58.4 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.696 -0.801 . . . . 1.3899999999999999 110.154 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.53 -30.29 3.6 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.525 -0.845 . . . . 0.65000000000000002 112.556 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 32.1 m -135.68 149.39 28.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 110.047 -0.353 . . . . 1.1599999999999999 110.047 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -139.44 110.8 7.01 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.224 -0.658 . . . . 0.35999999999999999 109.224 -179.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 8.2 p90 -142.87 149.3 38.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.13 -0.322 . . . . 0.58999999999999997 110.13 -174.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -74.47 145.07 43.9 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.037 -0.665 . . . . 1.3899999999999999 110.524 -178.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.03 -27.45 65.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.215 -0.902 . . . . 2.1200000000000001 110.969 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -95.09 -166.19 1.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.623 -0.717 . . . . 2.1000000000000001 110.551 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.6 -169.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.838 -0.619 . . . . 1.05 109.413 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.43 ' H ' ' HA ' ' A' ' 37' ' ' ALA . . . 85.65 -154.0 27.84 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.623 -0.798 . . . . 0.46000000000000002 111.9 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.7 m -87.35 -171.69 3.59 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.156 -0.683 . . . . 1.1699999999999999 109.156 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.492 ' HE1' ' HB2' ' A' ' 75' ' ' SER . 77.9 t90 -168.33 -50.0 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.573 -0.529 . . . . 0.51000000000000001 109.573 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 18.44 92.71 0.01 OUTLIER Glycine 0 N--CA 1.474 1.186 0 O-C-N 125.208 1.567 . . . . 1.25 115.862 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 29' ' ' THR . . . -150.33 -125.37 1.29 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.797 -0.716 . . . . 0.71999999999999997 112.311 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.47 126.58 35.39 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.195 0.443 . . . . 0.59999999999999998 112.195 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -119.8 129.26 75.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.053 -0.721 . . . . 1.6299999999999999 109.053 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -112.79 152.34 17.95 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.257 -0.973 . . . . 0.45000000000000001 112.071 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.6 mp -90.12 112.48 24.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.898 -0.408 . . . . 0.82999999999999996 109.898 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.479 ' HD2' ' N ' ' A' ' 23' ' ' ALA . 2.9 m-85 -107.03 140.68 39.45 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.223 -1.029 . . . . 1.28 108.223 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 8.5 p -84.19 136.36 22.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.47 . . . . 1.1399999999999999 109.919 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.57 112.33 16.73 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.193 -0.317 . . . . 1.02 110.658 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.9 37.01 60.96 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 1.53 113.238 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 17.9 pt20 39.82 103.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.481 1.289 . . . . 2.1099999999999999 114.481 177.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.776 HE21 ' HG ' ' A' ' 65' ' ' LEU . 6.0 tp-100 -62.8 -27.09 69.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.873 -0.603 . . . . 2.6200000000000001 109.897 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.9 m 65.11 14.84 9.65 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.846 0.832 . . . . 2.4300000000000002 110.069 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.694 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 20.6 t30 59.83 92.04 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.416 -1.265 . . . . 1.5600000000000001 112.488 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.41 ' N ' HH12 ' A' ' 16' ' ' ARG . 21.1 m -94.93 124.51 54.14 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.621 -0.881 . . . . 1.6799999999999999 108.621 173.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -26.28 93.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.414 4.076 . . . . 1.26 114.934 -171.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.769 ' HG3' ' NH1' ' A' ' 16' ' ' ARG . 55.6 Cg_endo -100.18 -153.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 124.633 3.556 . . . . 0.76000000000000001 113.682 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.89 -104.73 0.18 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.504 -1.038 . . . . 0.76000000000000001 110.504 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.41 113.2 26.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.868 0.366 . . . . 2.04 110.323 175.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -107.52 135.64 48.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.208 0.527 . . . . 0.75 109.937 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 42.5 m -116.97 98.97 6.76 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.176 -0.92 . . . . 0.82999999999999996 110.447 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.78 HD22 ' HG ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -110.61 91.63 3.73 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.494 0.664 . . . . 0.51000000000000001 110.173 178.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 1.2 m -82.84 125.65 31.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.314 -0.857 . . . . 0.58999999999999997 110.195 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 91.0 mt -115.72 110.65 19.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.882 0.372 . . . . 1.27 111.158 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 135' ' ' THR . 28.7 m -90.19 108.52 19.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.112 -0.495 . . . . 0.69999999999999996 110.25 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.97 ' HA3' HG21 ' A' ' 5' ' ' VAL . . . -74.4 178.26 44.99 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.952 -0.642 . . . . 0.80000000000000004 113.289 -176.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 153.56 -170.24 32.33 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 121.073 -0.584 . . . . 0.53000000000000003 111.663 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -103.52 -176.23 3.02 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.452 -0.499 . . . . 0.89000000000000001 110.273 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.669 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 6.3 t-105 -144.8 151.63 39.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.655 -0.702 . . . . 0.56000000000000005 109.634 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -129.51 141.58 50.96 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.722 0.296 . . . . 1.4199999999999999 111.471 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 20.5 mmtp 71.66 -152.21 0.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.101 0.961 . . . . 3.4700000000000002 112.078 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.456 ' H ' ' HB3' ' A' ' 123' ' ' LYS . 19.9 m-20 -132.9 110.86 10.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.68 0.622 . . . . 2.0800000000000001 112.68 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.669 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 12.3 m120 59.43 -7.72 0.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.781 1.232 . . . . 2.4700000000000002 114.3 174.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -3.68 36.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.841 0.353 . . . . 1.96 110.767 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.93 HE21 ' HE2' ' A' ' 129' ' ' PHE . 59.7 tt0 74.61 85.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.978 -1.01 . . . . 2.02 110.83 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -120.48 33.0 4.65 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.484 -0.865 . . . . 0.77000000000000002 111.466 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.93 ' HE2' HE21 ' A' ' 127' ' ' GLN . 11.4 p90 -78.89 152.3 31.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.11 0.481 . . . . 1.21 110.535 -172.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 34.5 m -134.99 133.28 20.82 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.792 -0.64 . . . . 1.47 109.561 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.11 112.24 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.286 1.991 . . . . 0.92000000000000004 111.818 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.404 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 13.5 m -139.22 105.99 5.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.739 -0.664 . . . . 1.52 109.69 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 126.91 -128.12 6.15 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.561 -0.828 . . . . 1.1699999999999999 111.492 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.2 m -133.12 159.16 40.93 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.627 -0.508 . . . . 2.4700000000000002 109.627 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 12.6 t -97.18 110.37 22.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.616 0.722 . . . . 1.8200000000000001 109.342 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.412 ' HA3' HG22 ' A' ' 7' ' ' VAL . . . -90.16 118.39 5.28 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.754 -0.736 . . . . 0.67000000000000004 112.144 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 7.4 m -84.77 101.29 12.12 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.715 -0.476 . . . . 0.57999999999999996 109.715 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.547 HG23 HD11 ' A' ' 10' ' ' LEU . 19.6 m -77.91 108.9 11.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.244 -1.021 . . . . 0.52000000000000002 108.244 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.448 ' HB2' ' HE3' ' A' ' 139' ' ' LYS . 32.5 ttmt -97.05 108.99 21.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.688 0.756 . . . . 2.1800000000000002 110.439 -172.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 tp -107.11 108.15 19.48 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.461 -1.245 . . . . 0.63 110.253 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.687 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 10.6 m -108.43 117.32 33.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.37 -0.832 . . . . 0.57999999999999996 109.077 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.798 HG13 ' HA ' ' A' ' 15' ' ' THR . 39.5 t -93.11 116.26 33.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.206 0.527 . . . . 1.74 112.058 -172.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.5 m . . . . . 0 C--O 1.249 1.067 0 CA-C-N 115.262 -0.881 . . . . 2.5800000000000001 109.249 172.945 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 91.5 m . . . . . 0 CA--C 1.52 -0.205 0 N-CA-C 112.146 0.425 . . . . 1.4299999999999999 112.146 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -87.86 108.65 19.27 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.873 -1.158 . . . . 2.29 107.873 171.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -93.21 111.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.597 -0.52 . . . . 1.51 109.597 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.563 HH21 ' NE2' ' A' ' 31' ' ' GLN . 71.4 mtm180 -94.45 97.42 10.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.951 -0.568 . . . . 3.5699999999999998 110.77 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.0 t -103.5 115.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.114 -0.948 . . . . 1.26 108.651 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.1 155.44 23.62 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.399 -0.905 . . . . 0.95999999999999996 112.249 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -73.34 142.95 47.06 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.973 -0.38 . . . . 2.1800000000000002 109.973 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -157.16 148.49 22.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.085 -0.507 . . . . 1.4099999999999999 109.95 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.5 t -109.55 133.58 52.93 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.093 0.473 . . . . 1.03 109.887 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.9 t -117.34 126.2 74.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.761 -0.654 . . . . 1.45 109.378 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -106.16 104.12 13.75 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.409 -0.219 . . . . 0.58999999999999997 110.409 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 mtmm -172.59 -178.67 1.99 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.155 -0.475 . . . . 3.4199999999999999 110.835 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 142' ' ' VAL . 46.3 p -102.93 167.09 10.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.89 -0.595 . . . . 0.63 110.933 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.773 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -87.8 -10.34 51.2 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.863 -0.791 . . . . 3.1400000000000001 108.863 175.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.614 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -71.29 -20.32 78.08 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.293 -0.867 . . . . 0.75 111.578 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -58.57 -41.33 85.46 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.596 0.712 . . . . 2.1699999999999999 109.365 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.627 HD21 HG12 ' A' ' 25' ' ' ILE . 4.5 mt -80.19 100.07 8.11 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.615 -1.175 . . . . 1.6100000000000001 110.449 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.686 HG22 HE21 ' A' ' 103' ' ' GLN . 0.8 OUTLIER -103.66 70.76 1.04 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.784 -0.821 . . . . 1.6499999999999999 108.784 174.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 1.0 OUTLIER 67.16 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.647 -1.16 . . . . 1.8300000000000001 110.295 -171.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.63 66.01 5.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.308 0.575 . . . . 0.81999999999999995 111.194 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -141.94 115.36 6.61 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.39 -0.823 . . . . 0.79000000000000004 109.858 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.5 Cg_endo -91.52 151.12 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.51 2.806 . . . . 1.1200000000000001 113.341 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.627 HG12 HD21 ' A' ' 19' ' ' LEU . 3.3 pt -116.97 -56.58 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 2.5800000000000001 112.174 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.487 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -114.04 88.97 0.5 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.475 -0.869 . . . . 0.73999999999999999 112.914 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 38.2 Cg_exo -60.46 126.93 21.24 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.601 2.201 . . . . 0.67000000000000004 112.067 172.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.5 t -98.66 127.7 50.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.984 -0.553 . . . . 1.1799999999999999 110.273 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 m -74.45 101.24 4.07 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 116.156 -0.475 . . . . 1.6399999999999999 110.489 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 99.3 t -104.04 115.6 46.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.101 -0.5 . . . . 1.01 110.525 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.64 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 8.2 tt0 -113.61 107.02 15.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.999 0.428 . . . . 2.48 110.713 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.75 109.06 20.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.644 -0.707 . . . . 0.69999999999999996 109.835 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.28 130.29 48.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.025 -0.534 . . . . 1.9399999999999999 110.287 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.68 29.51 10.73 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.798 -0.715 . . . . 1.8100000000000001 113.203 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.5 m -94.07 -74.07 0.55 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.926 0.343 . . . . 1.8799999999999999 111.926 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.549 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 9.1 t30 71.2 -44.69 0.6 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.85 0.46 . . . . 2.1400000000000001 112.062 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.14 76.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.205 0.526 . . . . 0.93999999999999995 110.282 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.564 ' H ' ' N ' ' A' ' 90' ' ' GLY . 1.7 tpm_? -157.82 148.52 20.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.436 -0.802 . . . . 4.6399999999999997 110.455 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.504 HE21 ' HD1' ' A' ' 121' ' ' TRP . 19.8 mt-30 -86.2 134.67 33.76 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.098 -0.705 . . . . 1.75 109.098 172.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 93.3 t -110.53 125.3 67.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.943 -0.391 . . . . 0.54000000000000004 109.943 -176.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.604 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -117.54 152.62 34.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 123.485 0.491 . . . . 0.35999999999999999 111.293 -173.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.447 HD12 ' HB3' ' A' ' 84' ' ' PHE . 28.2 mt -103.76 104.41 14.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.734 -0.666 . . . . 0.83999999999999997 109.868 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.604 ' HE2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -98.38 122.75 41.95 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.311 -0.626 . . . . 1.9299999999999999 109.311 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . . . -83.48 158.21 22.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.332 -0.395 . . . . 0.40999999999999998 110.774 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.714 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 13.6 t70 -87.19 152.2 22.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.188 -0.46 . . . . 0.70999999999999996 109.782 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -54.74 -20.37 8.26 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.803 0.668 . . . . 1.3999999999999999 112.803 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.9 -37.54 74.21 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.936 0.398 . . . . 2.2200000000000002 111.269 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.624 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 5.6 p-10 -129.27 16.14 6.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.895 -0.593 . . . . 1.3500000000000001 109.956 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 82.2 t80 -132.85 101.73 5.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.308 -0.86 . . . . 0.56000000000000005 109.148 -176.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -93.58 93.83 8.29 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.198 -0.456 . . . . 2.4100000000000001 110.571 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 69.46 -50.3 0.61 Allowed 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.154 0.909 . . . . 3.4300000000000002 112.103 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.51 35.73 0.16 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.772 -0.531 . . . . 0.56000000000000005 111.772 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 43.4 mmtm -137.49 133.28 34.42 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.404 -0.961 . . . . 2.1200000000000001 108.404 172.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -117.43 136.57 53.09 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.004 0.907 . . . . 0.56000000000000005 112.077 178.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.624 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 30.8 p90 -141.06 -176.7 4.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.049 -1.432 . . . . 0.58999999999999997 108.51 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.937 HD22 HD22 ' A' ' 114' ' ' LEU . 10.9 mt -102.7 127.58 49.77 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.549 -0.908 . . . . 1.53 108.549 172.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.45 133.88 49.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.406 0.622 . . . . 0.62 110.636 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 112' ' ' TYR . 29.5 t -83.87 150.06 25.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.323 -0.853 . . . . 1.4399999999999999 110.654 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.18 -26.41 68.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.962 -0.563 . . . . 2.3100000000000001 110.239 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -75.32 -13.62 60.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.658 . . . . 3.0899999999999999 110.537 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.6 m120 61.09 20.04 10.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.568 -0.742 . . . . 2.6200000000000001 111.999 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.888 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -95.49 -70.42 0.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.875 0.369 . . . . 4.6600000000000001 110.989 -177.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.67 158.48 16.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.788 -0.642 . . . . 2.5099999999999998 111.845 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.452 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -143.66 175.08 10.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.24 -0.891 . . . . 2.0699999999999998 110.319 -178.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.488 HD12 HG23 ' A' ' 100' ' ' VAL . 1.5 pt? -157.17 125.57 5.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.28 -0.418 . . . . 1.98 110.29 173.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 94.2 m-85 -72.83 144.74 47.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.052 -0.722 . . . . 0.75 109.052 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.442 HG11 HD21 ' A' ' 56' ' ' LEU . 15.7 m -123.66 157.18 30.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.308 0.575 . . . . 0.72999999999999998 111.784 -175.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.464 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -118.94 111.54 18.48 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.438 -0.949 . . . . 1.8100000000000001 108.438 171.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.407 HG22 HD12 ' A' ' 96' ' ' ILE . 0.9 OUTLIER -92.52 86.17 2.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.33 -0.619 . . . . 0.81000000000000005 109.33 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HG3' ' HD2' ' A' ' 71' ' ' PRO . 57.7 ttp180 -112.41 142.15 26.47 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.41 -0.589 . . . . 3.79 109.41 -174.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 84.9 Cg_exo -44.26 140.23 5.83 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.052 2.501 . . . . 0.58999999999999997 112.927 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 52.8 ttp -60.56 -52.96 62.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.693 -0.855 . . . . 1.71 108.693 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -153.34 107.63 3.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.138 -0.937 . . . . 1.9199999999999999 109.315 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -168.73 -163.15 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.737 0.303 . . . . 1.8899999999999999 111.191 -175.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 p -60.32 168.06 2.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.882 -0.599 . . . . 1.7 112.02 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 120.16 23.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.73 -0.668 . . . . 0.93999999999999995 111.153 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.802 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.8 m95 -107.34 134.11 50.89 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.543 -0.753 . . . . 0.5 109.967 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.9 m -76.35 116.73 17.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.524 -0.547 . . . . 0.51000000000000001 109.524 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 t -88.57 115.51 26.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.492 0.663 . . . . 0.58999999999999997 112.329 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -129.06 159.79 34.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.69 -1.226 . . . . 1.7 107.69 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -84.26 -6.71 59.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.42 -0.512 . . . . 1.3899999999999999 111.57 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.57 -35.39 3.83 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.126 -1.035 . . . . 0.65000000000000002 111.761 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.563 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 30.4 m -140.32 154.24 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.885 0.374 . . . . 1.1599999999999999 110.134 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.1 t80 -138.18 106.82 5.88 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.019 -1.104 . . . . 0.35999999999999999 108.019 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 6.0 p90 -140.65 144.08 35.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.817 0.341 . . . . 0.58999999999999997 111.662 -171.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.802 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 25.7 pttm -72.58 142.24 48.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 1.3899999999999999 109.625 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.452 HD22 ' N ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -77.63 -5.54 50.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.293 0.568 . . . . 2.1200000000000001 110.35 178.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.452 ' N ' HD22 ' A' ' 87' ' ' ASN . 6.6 m-20 -86.08 142.93 28.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.392 -0.822 . . . . 2.1000000000000001 110.182 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 m -99.5 108.62 22.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.483 0.658 . . . . 1.05 110.633 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.564 ' N ' ' H ' ' A' ' 38' ' ' ARG . . . 167.11 -164.12 37.63 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.648 -0.705 . . . . 0.46000000000000002 111.707 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.3 m -79.97 -178.19 6.36 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.2 -0.667 . . . . 1.1699999999999999 109.2 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.466 ' CH2' HG23 ' A' ' 96' ' ' ILE . 29.0 t90 -154.9 -61.84 0.12 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.571 -0.451 . . . . 0.51000000000000001 110.367 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 34.15 85.63 0.01 OUTLIER Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.436 1.085 . . . . 1.25 115.242 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.58 -151.35 6.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.771 -0.728 . . . . 0.71999999999999997 112.5 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -118.34 124.17 47.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.461 0.648 . . . . 0.59999999999999998 112.514 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 71' ' ' PRO . 13.7 pt -108.5 148.75 12.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.319 -0.855 . . . . 1.6299999999999999 109.159 174.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.35 151.25 17.55 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.303 -0.951 . . . . 0.45000000000000001 111.365 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 70.1 mt -95.11 112.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 120.295 -0.562 . . . . 0.82999999999999996 110.339 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.464 ' HD1' ' O ' ' A' ' 68' ' ' ASN . 10.5 m-85 -104.7 151.95 23.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.972 -1.013 . . . . 1.28 108.514 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 104' ' ' GLN . 8.1 p -83.07 140.03 16.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.441 -0.504 . . . . 1.1399999999999999 109.693 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.81 82.27 2.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.937 -0.764 . . . . 1.02 108.937 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.55 114.69 0.58 Allowed Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.636 -0.711 . . . . 1.53 111.459 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.686 HE21 HG22 ' A' ' 20' ' ' THR . 7.2 tt0 -32.53 107.11 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.973 0.909 . . . . 2.1099999999999999 112.64 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.506 ' HB2' HG21 ' A' ' 100' ' ' VAL . 48.8 tp60 -78.01 -13.26 59.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.571 . . . . 2.6200000000000001 110.461 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.2 m 64.71 15.85 10.02 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.791 -0.64 . . . . 2.4300000000000002 111.036 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.773 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 10.4 t30 58.29 77.67 0.28 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.351 0.596 . . . . 1.5600000000000001 110.918 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.423 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 11.2 t -77.81 144.1 68.06 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.386 -0.968 . . . . 1.6799999999999999 108.386 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 45.1 Cg_exo -27.51 92.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.984 3.789 . . . . 1.26 114.388 -173.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -100.1 -157.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 123.398 2.732 . . . . 0.76000000000000001 113.791 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.17 -91.06 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.683 -1.367 . . . . 0.76000000000000001 109.683 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -125.75 119.35 27.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.305 -0.628 . . . . 2.04 109.305 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 58' ' ' SER . 24.6 m-85 -108.81 128.42 54.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.352 0.596 . . . . 0.75 110.293 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.1 m -105.87 122.29 45.81 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.927 -1.033 . . . . 0.82999999999999996 110.369 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.937 HD22 HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -136.86 121.59 18.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.928 -0.578 . . . . 0.51000000000000001 109.688 176.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.714 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 6.5 m -112.08 128.42 56.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.797 -0.638 . . . . 0.58999999999999997 109.296 -174.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -121.57 119.7 32.67 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.02 0.438 . . . . 1.27 110.527 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.2 m -94.65 117.7 30.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.074 -0.512 . . . . 0.69999999999999996 110.605 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.15 146.72 49.4 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.838 -0.696 . . . . 0.80000000000000004 112.318 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.48 156.98 9.91 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 111.544 -0.623 . . . . 0.53000000000000003 111.544 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -89.48 -176.66 5.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.223 0.535 . . . . 0.89000000000000001 110.762 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.702 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 1.3 t-105 -142.08 151.92 42.81 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.182 -0.917 . . . . 0.56000000000000005 110.02 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.56 144.33 51.08 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.0 -0.546 . . . . 1.4199999999999999 111.23 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.676 ' HG2' ' H ' ' A' ' 124' ' ' ASP . 34.3 tttp 67.61 -147.79 0.15 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.455 1.102 . . . . 3.4700000000000002 111.906 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.676 ' H ' ' HG2' ' A' ' 123' ' ' LYS . 6.7 m-20 -139.67 118.65 12.57 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.573 0.583 . . . . 2.0800000000000001 112.573 -173.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.651 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.7 OUTLIER 45.49 14.02 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.427 1.639 . . . . 2.4700000000000002 115.427 175.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.572 ' HE2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -92.32 -2.18 56.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.56 0.695 . . . . 1.96 109.832 175.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.702 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 20.5 mt-30 72.71 54.19 0.15 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 114.37 -1.286 . . . . 2.02 111.923 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.532 ' N ' ' HD2' ' A' ' 126' ' ' LYS . . . -89.86 93.44 1.88 Allowed Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 108.826 -1.71 . . . . 0.77000000000000002 108.826 165.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.482 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 50.8 p90 -134.84 134.91 41.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 117.91 0.855 . . . . 1.21 110.863 -173.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.8 m -115.78 134.88 22.64 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 116.091 -0.504 . . . . 1.47 110.217 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.34 106.03 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.882 2.388 . . . . 0.92000000000000004 111.084 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.8 m -146.6 99.3 3.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.042 0.449 . . . . 1.52 110.342 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 141.61 -141.52 11.12 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.383 -0.913 . . . . 1.1699999999999999 112.603 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 6' ' ' ARG . 2.7 m -100.13 143.27 30.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.627 0.251 . . . . 2.4700000000000002 110.86 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 24.1 m -94.73 95.86 9.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.147 -0.686 . . . . 1.8200000000000001 109.147 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.45 155.65 21.83 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.777 -0.725 . . . . 0.67000000000000004 112.049 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -124.78 114.56 19.41 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.655 0.265 . . . . 0.57999999999999996 110.647 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.77 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 3.5 m -89.69 119.88 30.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.221 -1.029 . . . . 0.52000000000000002 108.221 172.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -117.48 109.36 16.64 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.687 0.756 . . . . 2.1800000000000002 110.392 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.413 ' HG ' ' NH2' ' A' ' 16' ' ' ARG . 23.9 tp -101.93 106.1 16.99 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.425 -1.262 . . . . 0.63 111.112 -172.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 6.2 m -105.02 143.77 32.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.49 -0.777 . . . . 0.57999999999999996 109.32 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 15' ' ' THR . 7.3 p -89.22 128.77 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.162 0.506 . . . . 1.74 111.065 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.624 -0.716 . . . . 2.5800000000000001 110.082 177.947 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.416 ' SG ' ' HG2' ' A' ' 38' ' ' ARG . 42.3 t . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 108.374 -0.973 . . . . 1.4299999999999999 108.374 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 1.127 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 5.4 tt0 -108.6 119.52 39.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.729 -0.669 . . . . 2.29 111.593 -172.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.437 HG22 HG13 ' A' ' 40' ' ' VAL . 22.5 t -91.61 111.54 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.046 -0.724 . . . . 1.51 109.046 173.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 88.2 mtt180 -87.83 109.49 19.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.254 -0.43 . . . . 3.5699999999999998 111.654 -177.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.535 HG11 ' HB2' ' A' ' 116' ' ' LEU . 48.9 t -125.21 115.37 43.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.293 -0.867 . . . . 1.26 109.152 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.37 -179.37 35.33 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.598 -0.81 . . . . 0.95999999999999996 111.965 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -99.02 147.25 25.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.922 0.391 . . . . 2.1800000000000002 109.978 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.48 147.36 20.48 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.364 -0.606 . . . . 1.4099999999999999 109.364 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.7 m -116.94 117.68 30.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.907 0.384 . . . . 1.03 111.09 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.15 109.48 28.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.884 -0.598 . . . . 1.45 109.431 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -83.61 96.65 8.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.229 -0.441 . . . . 0.58999999999999997 111.188 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -149.9 179.41 8.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.16 0.505 . . . . 3.4199999999999999 110.94 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.41 ' HA ' HH11 ' A' ' 16' ' ' ARG . 52.9 p -101.77 167.43 10.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.738 -0.664 . . . . 0.63 109.875 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.577 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.3 OUTLIER -86.3 -11.62 51.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.792 -0.818 . . . . 3.1400000000000001 108.792 177.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' A' ' 106' ' ' ASN . . . -81.21 -24.98 56.25 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.959 -1.019 . . . . 0.75 111.038 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -61.7 -26.62 68.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.41 0.624 . . . . 2.1699999999999999 110.119 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.661 ' HG ' HG23 ' A' ' 100' ' ' VAL . 0.6 OUTLIER -67.27 -54.46 20.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.053 -0.976 . . . . 1.6100000000000001 109.917 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.8 m 56.81 49.02 14.97 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.825 -1.079 . . . . 1.6499999999999999 109.221 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.496 ' N ' ' HB3' ' A' ' 103' ' ' GLN . 20.9 t70 77.38 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.279 -1.328 . . . . 1.8300000000000001 110.428 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -109.69 87.35 2.48 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.272 0.471 . . . . 0.81999999999999995 112.272 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.87 113.65 3.15 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.79000000000000004 109.916 169.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.604 ' HD3' ' HE2' ' A' ' 99' ' ' TYR . 50.8 Cg_endo -68.46 94.05 0.43 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.689 2.259 . . . . 1.1200000000000001 111.814 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.64 HG13 HD22 ' A' ' 19' ' ' LEU . 51.3 mm -89.34 -42.94 14.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.988 -0.551 . . . . 2.5800000000000001 111.639 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.77 51.98 0.75 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 119.636 -1.269 . . . . 0.73999999999999999 113.9 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.486 ' HD2' ' C ' ' A' ' 25' ' ' ILE . 8.9 Cg_endo -50.21 123.46 11.09 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.312 2.675 . . . . 0.67000000000000004 112.481 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.69 139.7 24.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.21 -0.45 . . . . 1.1799999999999999 110.047 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 t -82.75 102.88 11.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.92 0.867 . . . . 1.6399999999999999 110.751 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 67.0 t -94.17 114.52 30.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.963 -1.017 . . . . 1.01 110.292 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 57.5 tt0 -99.21 126.47 45.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.784 -0.45 . . . . 2.48 109.784 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.7 94.95 8.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.294 -0.412 . . . . 0.69999999999999996 109.996 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . 6.4 tt -80.01 114.1 18.67 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.006 -0.739 . . . . 1.9399999999999999 109.006 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.98 -129.91 10.57 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.603 -0.808 . . . . 1.8100000000000001 111.252 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.0 m 64.05 23.14 13.15 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.603 0.237 . . . . 1.8799999999999999 111.593 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.509 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 3.6 t-20 -59.81 -29.67 68.4 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.157 0.429 . . . . 2.1400000000000001 112.157 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.6 25.31 10.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.214 0.53 . . . . 0.93999999999999995 110.269 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.416 ' HG2' ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -123.92 154.71 39.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.133 -0.485 . . . . 4.6399999999999997 111.253 -172.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.728 ' HG3' HG12 ' A' ' 89' ' ' VAL . 16.1 mt-30 -93.14 128.75 39.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.945 -0.57 . . . . 1.75 109.533 173.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 87.2 t -101.7 117.13 46.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.492 -0.322 . . . . 0.54000000000000004 110.669 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.742 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -114.44 167.09 11.03 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 123.402 0.439 . . . . 0.35999999999999999 110.381 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.3 mt -120.11 109.66 15.72 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.061 -0.518 . . . . 0.83999999999999997 109.632 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.937 ' HE2' HG22 ' A' ' 83' ' ' VAL . 20.4 mmtp -105.86 119.77 40.02 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.552 0.691 . . . . 1.9299999999999999 110.131 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.65 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -71.48 155.3 40.75 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.553 -1.203 . . . . 0.40999999999999998 110.363 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 13.5 t70 -72.19 153.73 41.44 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.937 -0.764 . . . . 0.70999999999999996 108.937 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -58.56 -18.81 32.7 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.183 0.438 . . . . 1.3999999999999999 112.183 -172.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -62.89 -37.57 87.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.821 0.343 . . . . 2.2200000000000002 110.985 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.65 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 8.0 p-10 -125.18 20.28 8.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.178 0.514 . . . . 1.3500000000000001 110.335 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 27.3 t80 -127.92 107.42 9.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.296 -0.866 . . . . 0.56000000000000005 108.708 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 7.2 pt-20 -106.96 107.01 17.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.501 -0.318 . . . . 2.4100000000000001 110.454 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 70.79 -56.26 0.62 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.03 0.532 . . . . 3.4300000000000002 111.294 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.7 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -176.03 34.05 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.78 -0.928 . . . . 0.56000000000000005 110.78 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 18.5 mmtp -132.34 135.0 45.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.639 -0.874 . . . . 2.1200000000000001 108.639 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.494 ' CD2' ' HA2' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -107.49 140.11 40.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.47 0.652 . . . . 0.56000000000000005 110.934 171.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.794 ' CD2' ' HB2' ' A' ' 64' ' ' LYS . 40.6 p90 -147.49 174.36 11.78 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.208 -0.905 . . . . 0.58999999999999997 110.353 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.495 HD22 HD22 ' A' ' 114' ' ' LEU . 16.9 mt -88.31 116.95 26.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.392 -0.966 . . . . 1.53 108.392 171.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.587 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 8.0 tp -106.42 128.54 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.546 0.689 . . . . 0.62 110.927 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.6 p -66.56 129.23 39.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.254 -0.885 . . . . 1.4399999999999999 110.161 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.15 -30.33 70.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.325 0.583 . . . . 2.3100000000000001 109.67 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.91 -14.29 62.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.046 -0.979 . . . . 3.0899999999999999 110.487 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 59.66 81.91 0.16 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.244 -0.889 . . . . 2.6200000000000001 110.559 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.438 ' NH1' ' HB2' ' A' ' 108' ' ' PRO . 9.3 ptp180 -144.07 -41.44 0.27 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.68 -0.691 . . . . 4.6600000000000001 111.218 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -147.36 174.59 11.52 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.497 -0.481 . . . . 2.5099999999999998 111.483 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.794 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -160.29 142.77 13.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.706 -0.679 . . . . 2.0699999999999998 110.526 -177.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.427 ' HB3' ' NE2' ' A' ' 104' ' ' GLN . 1.8 pt? -140.6 132.44 27.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.551 0.215 . . . . 1.98 110.96 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 64' ' ' LYS . 17.0 m-85 -72.22 141.67 48.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.381 . . . . 0.75 110.749 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.704 HG12 ' HA ' ' A' ' 100' ' ' VAL . 13.3 m -135.31 128.85 49.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.056 -0.52 . . . . 0.72999999999999998 110.547 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -94.51 113.36 25.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.555 0.693 . . . . 1.8100000000000001 110.336 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -76.93 85.5 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.424 -0.807 . . . . 0.81000000000000005 109.907 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.688 ' HG2' ' HD2' ' A' ' 71' ' ' PRO . 13.8 ttp180 -98.32 140.59 21.95 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.36 -0.836 . . . . 3.79 109.216 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.688 ' HD2' ' HG2' ' A' ' 70' ' ' ARG . 97.4 Cg_exo -43.42 136.56 5.97 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.816 2.344 . . . . 0.58999999999999997 112.807 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.2 tpt -63.41 -58.91 5.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.876 -0.602 . . . . 1.71 110.3 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -159.66 105.04 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.991 -0.55 . . . . 1.9199999999999999 111.142 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.446 HD21 ' HZ2' ' A' ' 92' ' ' TRP . 2.8 p30 -174.47 -88.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.416 0.448 . . . . 1.8899999999999999 111.594 172.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.4 m -127.13 -175.44 3.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.638 0.256 . . . . 1.7 110.522 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.29 139.37 36.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.348 -0.387 . . . . 0.93999999999999995 111.264 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.496 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 11.2 m0 -114.0 151.18 32.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.669 -0.696 . . . . 0.5 109.779 176.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.2 m -70.69 116.29 10.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.31 -0.626 . . . . 0.51000000000000001 109.31 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t -96.49 117.45 30.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.469 0.652 . . . . 0.58999999999999997 112.584 -171.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.403 ' CB ' ' HB ' ' A' ' 83' ' ' VAL . 0.4 OUTLIER -126.18 161.99 26.42 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.287 -1.005 . . . . 1.7 108.287 170.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -21.02 63.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.818 0.303 . . . . 1.3899999999999999 111.818 -171.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA2' ' CD2' ' A' ' 54' ' ' PHE . . . -139.44 16.23 3.15 Favored Glycine 0 CA--C 1.509 -0.285 0 N-CA-C 111.519 -0.632 . . . . 0.65000000000000002 111.519 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.937 HG22 ' HE2' ' A' ' 43' ' ' LYS . 95.8 t -139.2 124.63 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.867 -0.79 . . . . 1.1599999999999999 108.867 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.742 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -139.22 105.47 5.26 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.087 -0.708 . . . . 0.35999999999999999 109.087 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 1.3 p90 -145.86 141.75 28.15 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.56 0.538 . . . . 0.58999999999999997 110.529 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.496 ' HB3' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -75.93 138.93 41.33 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.56 -0.456 . . . . 1.3899999999999999 109.81 177.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.84 -29.14 68.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.369 -0.832 . . . . 2.1200000000000001 110.259 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 16.6 m-20 -75.13 137.6 41.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.225 -0.898 . . . . 2.1000000000000001 110.75 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.728 HG12 ' HG3' ' A' ' 39' ' ' GLN . 27.7 m -90.46 132.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.729 -0.471 . . . . 1.05 109.729 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 36' ' ' ASN . . . 146.55 -170.4 27.59 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.645 -0.788 . . . . 0.46000000000000002 111.179 -174.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.5 m -77.65 -175.1 3.72 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 109.573 -0.528 . . . . 1.1699999999999999 109.573 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.446 ' HZ2' HD21 ' A' ' 74' ' ' ASN . 76.2 t90 -163.3 -56.47 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.752 -0.462 . . . . 0.51000000000000001 109.752 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 32.15 95.15 0.01 OUTLIER Glycine 0 N--CA 1.47 0.917 0 O-C-N 124.843 1.34 . . . . 1.25 115.674 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.64 -165.62 27.31 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.515 -0.634 . . . . 0.71999999999999997 111.515 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 p -101.35 128.74 47.38 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.063 0.459 . . . . 0.59999999999999998 111.908 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.572 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -112.71 158.54 13.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.442 -0.948 . . . . 1.6299999999999999 108.442 167.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -116.97 153.69 17.21 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.244 -0.979 . . . . 0.45000000000000001 112.449 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.8 mp -91.07 114.34 28.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.766 -0.457 . . . . 0.82999999999999996 109.766 175.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.604 ' HE2' ' HD3' ' A' ' 24' ' ' PRO . 2.3 m-85 -116.63 139.43 50.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.443 -0.947 . . . . 1.28 108.443 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.704 ' HA ' HG12 ' A' ' 67' ' ' VAL . 86.7 t -74.74 123.52 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.952 -0.388 . . . . 1.1399999999999999 109.952 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -78.58 86.42 4.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.693 -0.854 . . . . 1.02 108.693 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.72 83.44 1.4 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.684 -0.77 . . . . 1.53 111.742 -174.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.496 ' HB3' ' N ' ' A' ' 21' ' ' ASP . 2.6 pt20 -40.11 117.82 0.82 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.663 0.616 . . . . 2.1099999999999999 112.663 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.427 ' NE2' ' HB3' ' A' ' 65' ' ' LEU . 6.9 tt0 -90.56 5.14 49.04 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.53 -0.759 . . . . 2.6200000000000001 110.058 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.448 ' O ' HG22 ' A' ' 105' ' ' THR . 11.1 m 62.23 23.54 13.93 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.697 -0.683 . . . . 2.4300000000000002 111.287 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.614 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 8.2 t30 66.92 92.97 0.08 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.632 -0.713 . . . . 1.5600000000000001 111.86 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.599 HG22 ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -74.73 147.64 84.47 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-O 118.51 -0.757 . . . . 1.6799999999999999 109.427 172.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.599 ' HD2' HG22 ' A' ' 107' ' ' THR . 1.6 Cg_endo -43.11 93.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 124.106 3.204 . . . . 1.26 112.539 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -97.74 -165.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.265 2.643 . . . . 0.76000000000000001 114.615 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.88 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 108.789 -1.724 . . . . 0.76000000000000001 108.789 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -115.29 122.92 47.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.799 -0.815 . . . . 2.04 108.799 169.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.466 ' HB2' HH21 ' A' ' 16' ' ' ARG . 6.5 m-85 -109.24 113.91 27.15 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.63 0.728 . . . . 0.75 109.913 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 57' ' ' ILE . 47.3 m -94.82 135.49 36.25 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.553 -1.203 . . . . 0.82999999999999996 110.791 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.495 HD22 HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -147.84 91.01 1.89 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.497 0.665 . . . . 0.51000000000000001 109.687 173.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 44.7 m -82.5 135.63 35.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.651 -0.704 . . . . 0.58999999999999997 110.055 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.535 ' HB2' HG11 ' A' ' 7' ' ' VAL . 95.2 mt -118.34 120.04 36.43 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.118 -0.492 . . . . 1.27 109.705 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.3 m -92.69 110.83 22.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.306 -0.406 . . . . 0.69999999999999996 109.926 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.84 118.46 12.03 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.665 -0.779 . . . . 0.80000000000000004 111.555 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.568 ' HA2' ' H ' ' A' ' 132' ' ' SER . . . -165.8 145.0 9.67 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.851 -0.69 . . . . 0.53000000000000003 111.521 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 130' ' ' THR . 47.3 p90 -88.41 172.97 8.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.303 0.573 . . . . 0.89000000000000001 110.621 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.625 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 2.3 t-105 -123.2 148.47 45.77 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.471 -0.786 . . . . 0.56000000000000005 110.017 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.33 145.95 49.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.672 -0.694 . . . . 1.4199999999999999 110.431 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.948 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER 70.27 -140.97 0.07 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.762 0.825 . . . . 3.4700000000000002 110.519 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -159.74 125.38 4.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.067 0.46 . . . . 2.0800000000000001 111.604 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.625 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 17.6 m120 63.13 -24.7 0.06 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.002 1.482 . . . . 2.4700000000000002 115.002 177.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.473 ' HG2' ' HG2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -70.55 -3.25 17.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.925 0.393 . . . . 1.96 111.435 -178.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.557 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 22.7 tt0 74.45 61.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.365 -0.834 . . . . 2.02 111.22 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -102.53 113.17 4.5 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.619 -0.992 . . . . 0.77000000000000002 110.619 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 50.0 p90 -135.75 163.91 29.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.571 0.685 . . . . 1.21 110.296 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 120' ' ' TYR . 37.9 m -152.38 110.45 2.8 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.82 -0.437 . . . . 1.47 109.82 173.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 16.5 Cg_exo -65.37 116.36 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.617 2.211 . . . . 0.92000000000000004 112.228 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.568 ' H ' ' HA2' ' A' ' 119' ' ' GLY . 12.1 t -155.05 108.19 2.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.455 -0.793 . . . . 1.52 108.87 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 1.127 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 151.37 -138.07 6.36 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.519 -0.848 . . . . 1.1699999999999999 111.808 -176.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.4 m -111.72 138.61 48.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.648 0.261 . . . . 2.4700000000000002 110.394 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.6 m -94.44 98.46 10.89 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.72 -0.474 . . . . 1.8200000000000001 109.72 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.33 130.29 9.51 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.449 -0.881 . . . . 0.67000000000000004 112.504 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 86.1 m -96.25 114.82 26.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.629 0.252 . . . . 0.57999999999999996 110.426 178.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.493 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 13.9 m -78.32 116.86 19.04 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.222 -1.029 . . . . 0.52000000000000002 108.222 173.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -102.74 108.58 19.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.502 0.668 . . . . 2.1800000000000002 110.281 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.429 ' CD2' HD13 ' A' ' 56' ' ' LEU . 10.6 tp -106.28 94.67 5.28 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.938 -1.028 . . . . 0.63 109.844 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 12.1 m -102.28 144.4 30.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.707 -0.679 . . . . 0.57999999999999996 109.431 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.0 p -83.63 133.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.397 -0.521 . . . . 1.74 110.585 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.541 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 43.9 m . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.607 -0.711 . . . . 2.5800000000000001 109.516 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 t . . . . . 0 CA--C 1.514 -0.408 0 N-CA-C 107.809 -1.182 . . . . 1.4299999999999999 107.809 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 10.1 mm100 -86.8 112.2 21.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.101 -0.954 . . . . 2.29 110.647 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 7' ' ' VAL . 61.5 t -82.16 110.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.877 -0.786 . . . . 1.51 108.877 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -80.77 91.25 5.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.65 0.738 . . . . 3.5699999999999998 110.616 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 5' ' ' VAL . 3.5 m -104.85 140.34 23.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.646 -1.161 . . . . 1.26 109.734 175.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.6 167.29 24.84 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.157 -1.021 . . . . 0.95999999999999996 112.706 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.47 131.42 35.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.079 -0.341 . . . . 2.1800000000000002 110.079 175.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.18 137.75 24.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.125 -0.489 . . . . 1.4099999999999999 109.929 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.6 m -103.29 122.42 44.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.043 -0.526 . . . . 1.03 110.442 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.749 HG11 ' HB ' ' A' ' 25' ' ' ILE . 45.2 t -118.76 111.3 33.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.918 -0.583 . . . . 1.45 109.877 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -92.54 101.41 13.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.41 -0.359 . . . . 0.58999999999999997 110.444 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 5.7 tppt? -163.39 165.47 23.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.981 0.419 . . . . 3.4199999999999999 110.566 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.622 ' HA ' HG13 ' A' ' 142' ' ' VAL . 82.4 p -89.79 159.01 17.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.017 -0.538 . . . . 0.63 110.558 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -0.03 27.31 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.393 -0.595 . . . . 3.1400000000000001 109.393 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.55 -20.81 76.22 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.586 -1.006 . . . . 0.75 110.586 171.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -66.39 -48.48 69.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.812 -0.81 . . . . 2.1699999999999999 108.812 168.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 25' ' ' ILE . 11.0 mt -73.04 92.72 1.7 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.9 -1.046 . . . . 1.6100000000000001 110.276 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.684 ' H ' ' HB3' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -96.35 69.24 2.64 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.318 -0.623 . . . . 1.6499999999999999 109.318 177.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.5 t70 63.89 -90.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 114.639 -1.164 . . . . 1.8300000000000001 109.89 -172.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.68 63.66 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.345 0.593 . . . . 0.81999999999999995 110.726 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.684 ' HB3' ' H ' ' A' ' 20' ' ' THR . . . -140.39 116.74 7.85 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.442 -0.799 . . . . 0.79000000000000004 109.805 175.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 93.0 Cg_endo -87.24 150.82 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.464 2.776 . . . . 1.1200000000000001 113.469 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.749 ' HB ' HG11 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -102.75 -62.76 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.3 -0.864 . . . . 2.5800000000000001 111.125 175.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.422 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -127.73 90.93 0.34 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.5 -0.857 . . . . 0.73999999999999999 112.646 -177.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.78 117.28 3.82 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.82 2.347 . . . . 0.67000000000000004 111.857 172.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -83.75 133.23 29.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 1.1799999999999999 109.825 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.9 p -75.91 83.77 2.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.3 0.571 . . . . 1.6399999999999999 110.36 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.6 t -94.07 115.18 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.709 -0.678 . . . . 1.01 110.315 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.659 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 63.7 tt0 -112.71 135.54 53.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.881 -0.6 . . . . 2.48 109.993 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.44 103.03 13.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.512 -0.551 . . . . 0.69999999999999996 109.512 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 4' ' ' GLN . 51.6 tp -82.25 112.29 19.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.367 -0.379 . . . . 1.9399999999999999 110.359 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 -117.73 5.1 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.779 -0.724 . . . . 1.8100000000000001 112.094 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 57.0 m 69.43 -71.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.66 0.784 . . . . 1.8799999999999999 111.112 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.416 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 51.1 m-80 66.22 -56.57 0.37 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.999 0.92 . . . . 2.1400000000000001 112.75 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.32 40.65 3.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.152 0.501 . . . . 0.93999999999999995 110.354 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 13.2 tpp180 -126.16 148.27 49.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.159 -0.473 . . . . 4.6399999999999997 111.509 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.428 ' HG3' HG12 ' A' ' 89' ' ' VAL . 41.5 mt-30 -87.6 124.15 33.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 1.75 109.879 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 57.8 t -91.08 121.05 41.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.733 -0.469 . . . . 0.54000000000000004 109.733 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.778 ' HB1' ' HE3' ' A' ' 43' ' ' LYS . . . -121.81 147.94 45.32 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 120.758 0.313 . . . . 0.35999999999999999 110.472 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -102.02 105.39 16.14 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.254 0.549 . . . . 0.83999999999999997 109.95 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.778 ' HE3' ' HB1' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -96.2 151.47 19.46 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.84 -0.8 . . . . 1.9299999999999999 108.84 176.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HB3' ' HD1' ' A' ' 49' ' ' PHE . . . -111.62 156.67 21.45 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 110.014 -0.365 . . . . 0.40999999999999998 110.014 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -79.9 152.93 29.34 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.506 -0.924 . . . . 0.70999999999999996 108.506 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -57.08 -13.67 3.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.946 0.339 . . . . 1.3999999999999999 111.851 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -56.54 -37.38 70.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 2.2200000000000002 111.077 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 26.0 p-10 -134.05 19.87 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.578 -0.283 . . . . 1.3500000000000001 110.509 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.734 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 63.1 t80 -124.62 102.55 7.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.78 -0.452 . . . . 0.56000000000000005 109.78 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.746 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 15.3 pt-20 -101.26 105.44 16.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.395 -0.366 . . . . 2.4100000000000001 110.585 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 71.61 -55.96 0.65 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.804 0.842 . . . . 3.4300000000000002 111.154 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.734 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -174.11 37.52 0.12 Allowed Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.932 -0.652 . . . . 0.56000000000000005 111.973 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 29.4 mmtm -146.15 139.07 25.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.009 -0.367 . . . . 2.1200000000000001 110.009 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.602 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -113.5 150.16 33.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.268 0.556 . . . . 0.56000000000000005 111.948 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.746 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 22.5 p90 -157.61 177.84 10.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.265 -0.88 . . . . 0.58999999999999997 111.159 -172.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.749 HD23 HD22 ' A' ' 114' ' ' LEU . 14.9 mt -81.12 115.51 20.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.328 -0.99 . . . . 1.53 108.328 170.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 113' ' ' THR . 9.2 tp -105.13 120.12 55.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.806 -0.757 . . . . 0.62 109.828 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.569 ' HB2' ' CE1' ' A' ' 112' ' ' TYR . 42.6 t -75.12 147.56 40.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.341 -0.845 . . . . 1.4399999999999999 111.465 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.59 -29.53 70.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.526 -0.761 . . . . 2.3100000000000001 109.753 170.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -81.29 -24.05 37.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.297 -0.865 . . . . 3.0899999999999999 110.124 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.4 t30 65.67 21.09 11.62 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.418 -0.81 . . . . 2.6200000000000001 111.948 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 62' ' ' ARG . 63.6 mtt180 -98.21 -6.66 30.81 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.077 -0.389 . . . . 4.6600000000000001 110.815 176.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.5 143.72 30.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.108 -0.497 . . . . 2.5099999999999998 111.249 -175.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -150.22 130.5 13.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.729 -0.669 . . . . 2.0699999999999998 110.232 172.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.632 ' HB2' HD12 ' A' ' 56' ' ' LEU . 2.9 mm? -120.21 130.11 54.4 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.315 -0.402 . . . . 1.98 110.329 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.445 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 94.4 m-85 -68.57 146.53 52.99 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.77 -0.372 . . . . 0.75 110.052 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.35 149.89 20.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.059 0.457 . . . . 0.72999999999999998 110.904 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -114.41 110.4 19.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.779 -0.823 . . . . 1.8100000000000001 108.779 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.431 HG23 HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -91.88 107.1 18.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.906 -0.775 . . . . 0.81000000000000005 108.906 177.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 64.5 mtp180 -122.77 143.05 39.25 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.346 -0.388 . . . . 3.79 110.93 -168.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 32.3 Cg_exo -59.29 139.33 89.47 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.026 2.484 . . . . 0.58999999999999997 111.721 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.0 ttt -70.28 79.18 0.53 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.433 -0.349 . . . . 1.71 111.274 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.8 t70 55.05 45.98 25.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.553 -0.748 . . . . 1.9199999999999999 112.134 172.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -113.95 -89.45 0.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.048 -0.407 . . . . 1.8899999999999999 111.59 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -114.66 166.36 11.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.763 0.316 . . . . 1.7 110.617 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.9 113.09 21.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.951 -0.568 . . . . 0.93999999999999995 110.583 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.572 ' CE2' ' HB3' ' A' ' 86' ' ' LYS . 11.2 m0 -104.56 137.43 42.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.652 -0.704 . . . . 0.5 110.465 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.3 m -65.26 125.06 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.47 -0.567 . . . . 0.51000000000000001 109.47 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -107.42 105.01 14.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.057 0.932 . . . . 0.58999999999999997 112.797 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -122.3 145.0 48.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.16 -1.422 . . . . 1.7 107.16 163.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.525 ' HB2' ' CD ' ' A' ' 53' ' ' LYS . 7.9 m120 -71.83 5.07 2.78 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 120.388 -0.525 . . . . 1.3899999999999999 112.15 -176.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.03 -13.41 2.19 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.81 -0.709 . . . . 0.65000000000000002 111.578 170.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.451 HG22 ' HZ1' ' A' ' 43' ' ' LYS . 57.5 t -131.83 114.74 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.981 -0.377 . . . . 1.1599999999999999 109.981 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.688 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.2 t80 -130.75 97.55 4.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.551 -0.907 . . . . 0.35999999999999999 108.551 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.59 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 12.2 p90 -137.35 150.1 47.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.975 0.417 . . . . 0.58999999999999997 111.124 -173.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 12.6 pttp -84.42 145.28 28.26 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.728 -0.669 . . . . 1.3899999999999999 110.951 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.16 -32.69 73.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.17 0.51 . . . . 2.1200000000000001 109.751 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.645 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -68.94 140.14 55.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.627 -0.715 . . . . 2.1000000000000001 110.412 174.106 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.428 HG12 ' HG3' ' A' ' 39' ' ' GLN . 31.2 m -101.38 131.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.214 0.531 . . . . 1.05 110.612 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 138.77 -164.5 25.74 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.459 -0.656 . . . . 0.46000000000000002 111.459 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.7 p -85.14 137.74 32.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.652 -0.499 . . . . 1.1699999999999999 109.652 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.618 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 89.7 t90 -102.47 -60.63 1.51 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.418 -0.956 . . . . 0.51000000000000001 108.418 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 48.43 112.75 0.01 OUTLIER Glycine 0 N--CA 1.468 0.811 0 O-C-N 124.556 1.16 . . . . 1.25 115.663 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.52 -130.5 1.62 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.352 -0.699 . . . . 0.71999999999999997 111.352 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 p -124.31 130.75 53.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.008 0.432 . . . . 0.59999999999999998 111.213 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.6 mm -111.5 126.21 68.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.31 -0.626 . . . . 1.6299999999999999 109.31 176.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.11 141.24 15.45 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.495 -0.86 . . . . 0.45000000000000001 111.869 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 mp -90.59 112.04 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.383 -0.599 . . . . 0.82999999999999996 109.383 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 70' ' ' ARG . 28.6 m-85 -109.59 142.07 41.22 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.33 -0.989 . . . . 1.28 108.33 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 103' ' ' GLN . 7.2 p -77.72 140.36 17.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.275 -0.57 . . . . 1.1399999999999999 109.63 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.16 88.97 3.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.277 -0.638 . . . . 1.02 109.277 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.78 107.23 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.823 -0.704 . . . . 1.53 111.45 -173.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.588 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 0.7 OUTLIER -46.74 127.82 10.1 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 121.226 0.536 . . . . 2.1099999999999999 112.031 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.5 ' HG2' HD21 ' A' ' 65' ' ' LEU . 57.3 tp60 -89.74 1.99 55.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.687 -0.688 . . . . 2.6200000000000001 110.095 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 m 60.91 22.91 13.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.717 -0.674 . . . . 2.4300000000000002 111.231 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 59.52 94.07 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.624 -0.716 . . . . 1.5600000000000001 111.207 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.468 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 11.3 t -102.98 146.11 31.82 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 107.435 -1.32 . . . . 1.6799999999999999 107.435 174.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 78.3 Cg_exo -24.19 90.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 1 C-N-CA 125.303 4.002 . . . . 1.26 114.313 -173.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.505 ' HG2' HG11 ' A' ' 142' ' ' VAL . 94.8 Cg_endo -104.37 -166.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 123.586 2.857 . . . . 0.76000000000000001 114.736 -171.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -175.35 -120.83 0.62 Allowed Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.202 -1.363 . . . . 0.76000000000000001 109.976 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -92.9 122.38 35.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.748 0.308 . . . . 2.04 110.315 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 56' ' ' LEU . 91.6 m-85 -116.02 123.69 48.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.271 0.558 . . . . 0.75 110.075 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.596 ' O ' HG22 ' A' ' 57' ' ' ILE . 16.2 m -100.58 140.34 34.99 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.434 -0.803 . . . . 0.82999999999999996 110.641 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.749 HD22 HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -143.36 92.43 2.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.447 0.642 . . . . 0.51000000000000001 109.634 173.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 32.3 m -86.72 116.84 25.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.562 -0.745 . . . . 0.58999999999999997 110.841 -176.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 93.8 mt -99.87 140.39 34.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.069 -0.514 . . . . 1.27 110.547 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.3 m -107.28 109.57 21.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.041 -0.527 . . . . 0.69999999999999996 109.82 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.1 129.11 29.03 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.785 -0.721 . . . . 0.80000000000000004 111.71 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.528 ' HA2' ' H ' ' A' ' 132' ' ' SER . . . -170.52 167.66 40.78 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.734 -0.746 . . . . 0.53000000000000003 111.824 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -102.64 161.43 13.74 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.009 0.433 . . . . 0.89000000000000001 110.007 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.605 ' HZ2' ' H ' ' A' ' 125' ' ' ASN . 4.3 t-105 -119.03 152.31 36.65 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.483 -0.781 . . . . 0.56000000000000005 109.705 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -134.45 137.06 43.67 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.803 -0.635 . . . . 1.4199999999999999 110.201 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.583 ' HG3' ' HE2' ' A' ' 126' ' ' LYS . 74.4 mmtt 82.21 -146.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.197 0.999 . . . . 3.4700000000000002 111.016 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 126' ' ' LYS . 8.2 p-10 -147.91 117.41 7.0 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.179 0.807 . . . . 2.0800000000000001 113.179 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.605 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 28.0 t-20 64.32 -19.85 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.892 1.277 . . . . 2.4700000000000002 114.126 171.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.583 ' HE2' ' HG3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -69.05 -2.99 11.4 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.493 0.317 . . . . 1.96 111.491 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 72.04 69.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.21 -0.905 . . . . 2.02 110.623 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -112.22 99.32 1.05 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 109.997 -1.241 . . . . 0.77000000000000002 109.997 168.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 40.5 p90 -144.57 145.86 32.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.103 0.952 . . . . 1.21 110.369 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 29.2 m -132.25 116.39 15.39 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.25 -0.432 . . . . 1.47 109.988 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.507 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 29.3 Cg_exo -60.7 125.09 16.37 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.856 2.37 . . . . 0.92000000000000004 112.222 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.528 ' H ' ' HA2' ' A' ' 119' ' ' GLY . 5.8 t -152.05 96.3 2.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.985 -0.746 . . . . 1.52 108.985 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.09 -112.61 0.53 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.83 -0.908 . . . . 1.1699999999999999 110.83 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.93 171.61 14.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.095 0.448 . . . . 2.4700000000000002 111.029 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.3 96.06 7.8 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.274 -0.639 . . . . 1.8200000000000001 109.274 171.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -97.67 113.49 4.73 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.776 -0.726 . . . . 0.67000000000000004 112.18 -174.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 77.9 m -88.84 107.13 18.82 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.106 0.479 . . . . 0.57999999999999996 110.546 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.591 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 10.2 m -78.83 120.55 23.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.958 -1.127 . . . . 0.52000000000000002 107.958 172.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -111.8 109.44 19.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.359 0.6 . . . . 2.1800000000000002 110.773 -173.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.666 HD23 HD22 ' A' ' 56' ' ' LEU . 7.7 tp -98.96 100.82 12.05 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.969 -1.014 . . . . 0.63 109.742 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 31.8 m -107.38 118.37 36.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.742 -0.663 . . . . 0.57999999999999996 109.507 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 15' ' ' THR . 58.2 t -79.28 108.95 13.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.012 0.434 . . . . 1.74 111.327 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.701 -0.666 . . . . 2.5800000000000001 109.774 176.672 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 7.0 t . . . . . 0 N--CA 1.445 -0.711 0 CA-C-O 121.423 0.63 . . . . 1.4299999999999999 110.158 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.643 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 58.9 tt0 -86.82 110.43 19.94 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.989 -1.005 . . . . 2.29 109.606 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.449 HG13 HG13 ' A' ' 30' ' ' VAL . 97.6 t -103.43 112.62 37.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.846 -0.616 . . . . 1.51 110.234 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -93.1 111.06 22.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.942 -0.572 . . . . 3.5699999999999998 110.075 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 116' ' ' LEU . 59.9 t -88.46 114.84 27.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.052 -0.721 . . . . 1.26 109.052 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.34 112.28 4.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.137 -0.554 . . . . 0.95999999999999996 112.75 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.9 106.37 4.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.244 -0.651 . . . . 2.1800000000000002 109.244 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.508 HD21 HG22 ' A' ' 28' ' ' VAL . 3.4 pp -137.61 154.43 49.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.054 -0.521 . . . . 1.4099999999999999 111.02 -175.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.5 m -119.08 123.6 44.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.804 -0.634 . . . . 1.03 110.187 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.527 HG22 ' HG2' ' A' ' 14' ' ' LYS . 14.6 p -121.23 141.72 40.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.801 -0.444 . . . . 1.45 109.801 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.728 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -108.91 99.66 8.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.652 0.263 . . . . 0.58999999999999997 110.966 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HG2' HG22 ' A' ' 12' ' ' VAL . 75.3 mmtt -142.5 172.88 12.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.3 0.571 . . . . 3.4199999999999999 110.573 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.46 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 1.0 OUTLIER -104.0 154.13 20.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.161 -0.927 . . . . 0.63 109.592 172.295 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.674 ' NH1' ' HG3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -86.61 -1.43 57.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.105 0.478 . . . . 3.1400000000000001 110.671 -176.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.534 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -85.8 -26.83 33.67 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.017 -0.611 . . . . 0.75 112.16 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 15' ' ' THR . 10.0 pt20 -79.83 -2.08 41.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.963 0.411 . . . . 2.1699999999999999 110.719 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.717 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 71.8 mt -76.4 -26.94 56.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.642 . . . . 1.6100000000000001 111.256 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 7.5 t 32.59 57.16 0.41 Allowed 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.215 0.947 . . . . 1.6499999999999999 113.286 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 20' ' ' THR . 70.4 m-20 76.72 -46.69 0.52 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.461 0.704 . . . . 1.8300000000000001 111.924 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.78 88.66 1.84 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.252 0.464 . . . . 0.81999999999999995 112.252 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.717 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -139.82 108.19 7.04 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.007 -0.542 . . . . 0.79000000000000004 110.493 171.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.619 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 38.6 Cg_endo -67.5 99.9 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.176 2.584 . . . . 1.1200000000000001 112.114 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.586 HG12 HD21 ' A' ' 19' ' ' LEU . 2.6 pp -101.08 -23.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.876 -0.602 . . . . 2.5800000000000001 111.829 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.45 ' N ' HD12 ' A' ' 25' ' ' ILE . . . -128.64 50.99 0.87 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.101 -1.047 . . . . 0.73999999999999999 113.396 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 10.0 Cg_endo -53.9 109.97 0.44 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.554 2.169 . . . . 0.67000000000000004 112.534 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.508 HG22 HD21 ' A' ' 10' ' ' LEU . 61.5 t -91.97 138.42 19.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.465 -0.788 . . . . 1.1799999999999999 110.543 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 p -78.62 97.92 5.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.944 0.402 . . . . 1.6399999999999999 110.844 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.663 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 97.4 t -103.51 113.93 41.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.114 -0.494 . . . . 1.01 110.271 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.653 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -109.05 108.32 18.97 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.75 -0.833 . . . . 2.48 108.75 177.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.66 91.22 4.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.094 0.473 . . . . 0.69999999999999996 110.448 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.25 112.75 21.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.708 -0.678 . . . . 1.9399999999999999 110.098 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.91 -17.97 17.05 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.531 -0.842 . . . . 1.8100000000000001 112.694 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 1.7 m -74.0 104.77 4.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.876 0.369 . . . . 1.8799999999999999 110.543 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -106.22 -39.75 5.84 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.301 -0.629 . . . . 2.1400000000000001 109.301 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.44 64.19 1.35 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.241 -0.89 . . . . 0.93999999999999995 109.217 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.592 ' HD3' ' H ' ' A' ' 39' ' ' GLN . 8.7 tpp180 -146.76 149.89 34.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.677 -0.692 . . . . 4.6399999999999997 110.756 -174.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.592 ' H ' ' HD3' ' A' ' 38' ' ' ARG . 36.6 mt-30 -84.81 125.96 33.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.912 -0.585 . . . . 1.75 109.669 176.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 22.1 t -92.29 125.36 44.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.838 -0.43 . . . . 0.54000000000000004 109.838 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.511 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -121.36 142.37 50.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.046 0.45 . . . . 0.35999999999999999 111.053 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.634 HD13 HD13 ' A' ' 96' ' ' ILE . 14.5 mt -103.0 112.42 25.24 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.149 -0.686 . . . . 0.83999999999999997 109.149 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.543 ' HG2' ' CD2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -109.32 151.32 26.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.179 -0.464 . . . . 1.9299999999999999 110.244 -178.545 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.407 ' HB1' ' OD1' ' A' ' 48' ' ' ASN . . . -100.61 167.44 10.34 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.978 -0.556 . . . . 0.40999999999999998 110.362 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 23.4 t70 -94.65 157.72 15.84 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.149 -0.686 . . . . 0.70999999999999996 109.149 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -53.22 -18.69 2.49 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.382 0.426 . . . . 1.3999999999999999 111.848 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.6 -37.37 68.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.726 -0.67 . . . . 2.2200000000000002 111.683 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 6.4 p30 -135.58 16.94 3.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.926 0.393 . . . . 1.3500000000000001 110.66 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 60.3 t80 -118.85 102.53 8.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 0.56000000000000005 109.382 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 14.4 pt-20 -102.06 100.6 10.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.824 0.345 . . . . 2.4100000000000001 110.409 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 71.31 -53.29 0.68 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.615 -0.72 . . . . 3.4300000000000002 111.289 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.1 39.17 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.604 -0.999 . . . . 0.56000000000000005 110.604 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 22.0 mmmt -137.7 133.7 34.51 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.986 -0.746 . . . . 2.1200000000000001 108.986 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -115.1 151.35 34.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.18 0.514 . . . . 0.56000000000000005 110.995 173.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HB3' ' HA ' ' A' ' 66' ' ' TYR . 13.8 p90 -156.24 176.94 12.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.534 -0.757 . . . . 0.58999999999999997 110.805 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.575 ' HA ' HD22 ' A' ' 114' ' ' LEU . 29.7 mt -80.34 111.22 16.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.176 -1.046 . . . . 1.53 108.176 170.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.536 ' CG2' ' HB3' ' A' ' 48' ' ' ASN . 8.7 tp -107.6 127.94 63.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.287 0.565 . . . . 0.62 110.32 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.542 ' HB2' ' OD2' ' A' ' 63' ' ' ASP . 47.4 t -70.86 152.4 43.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.793 -0.64 . . . . 1.4399999999999999 109.34 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.27 -32.87 72.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.087 0.47 . . . . 2.3100000000000001 110.269 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' A' ' 60' ' ' ASN . 12.8 m120 -80.34 -0.43 36.77 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.002 -0.544 . . . . 3.0899999999999999 110.699 178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 p30 37.3 60.81 1.02 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.454 1.102 . . . . 2.6200000000000001 113.394 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -127.56 -11.71 5.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.941 -0.572 . . . . 4.6600000000000001 110.037 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.542 ' OD2' ' HB2' ' A' ' 58' ' ' SER . 1.9 p-10 -136.63 152.02 49.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.484 -0.78 . . . . 2.5099999999999998 110.481 -176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.633 ' O ' HD23 ' A' ' 65' ' ' LEU . 9.5 ptpp? -156.89 152.98 27.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.544 -0.298 . . . . 2.0699999999999998 111.013 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.817 ' HB3' ' HG3' ' A' ' 104' ' ' GLN . 1.6 mt -141.29 124.98 16.86 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.149 -1.426 . . . . 1.98 107.149 170.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 99.2 m-85 -69.26 133.88 48.46 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.121 0.486 . . . . 0.75 110.806 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.94 HG12 ' HA ' ' A' ' 100' ' ' VAL . 29.2 m -128.83 175.23 10.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.388 -0.824 . . . . 0.72999999999999998 109.796 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.853 ' HB2' ' HE2' ' A' ' 84' ' ' PHE . 2.2 p30 -152.34 128.27 10.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.235 0.54 . . . . 1.8100000000000001 109.918 172.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.588 HG21 HD12 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -79.85 87.67 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.81000000000000005 110.382 -174.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.404 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 79.3 mtt180 -86.4 137.6 34.45 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.637 -0.711 . . . . 3.79 110.206 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 74.1 Cg_exo -51.15 124.65 14.43 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.453 2.102 . . . . 0.58999999999999997 112.047 174.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.2 ttt -75.4 82.47 2.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.828 0.347 . . . . 1.71 110.678 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 61.87 21.15 12.05 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.536 -0.756 . . . . 1.9199999999999999 112.063 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.96 -51.55 5.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.618 -0.265 . . . . 1.8899999999999999 111.432 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.7 t -167.72 179.15 4.93 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.738 -0.467 . . . . 1.7 109.738 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.15 123.88 45.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.93999999999999995 110.576 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 12.0 m0 -116.32 160.99 19.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.89 -0.596 . . . . 0.5 110.057 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.1 m -81.86 113.46 19.81 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.356 -0.609 . . . . 0.51000000000000001 109.356 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 t -95.56 108.55 20.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.579 0.704 . . . . 0.58999999999999997 112.484 -171.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -117.44 162.26 18.24 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.228 -1.027 . . . . 1.7 108.228 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.467 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 10.6 m120 -85.28 -8.52 58.47 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.377 -0.529 . . . . 1.3899999999999999 110.984 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.421 ' O ' ' HE1' ' A' ' 49' ' ' PHE . . . -100.93 -35.98 4.09 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.305 -0.95 . . . . 0.65000000000000002 111.725 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.559 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 27.5 m -140.08 156.27 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.626 -0.509 . . . . 1.1599999999999999 109.626 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.853 ' HE2' ' HB2' ' A' ' 68' ' ' ASN . 1.0 OUTLIER -134.5 97.96 3.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.201 -1.037 . . . . 0.35999999999999999 108.201 178.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.652 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 2.4 p90 -132.56 144.99 50.78 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.488 -0.485 . . . . 0.58999999999999997 111.456 -172.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.928 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 40.9 pttt -78.56 148.92 33.16 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.656 -0.702 . . . . 1.3899999999999999 110.555 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.3 -23.36 61.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 2.1200000000000001 109.443 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.928 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 5.7 m-20 -72.38 162.3 29.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.247 -0.888 . . . . 2.1000000000000001 110.297 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.9 m -121.86 139.52 48.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.783 0.325 . . . . 1.05 110.578 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.0 -159.03 17.68 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.674 -0.774 . . . . 0.46000000000000002 111.926 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.7 m -69.21 166.79 17.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.971 0.415 . . . . 1.1699999999999999 110.473 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.43 ' HZ2' ' HB3' ' A' ' 71' ' ' PRO . 63.2 t90 -152.46 -52.05 0.11 Allowed 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.263 -0.643 . . . . 0.51000000000000001 109.263 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 27.21 89.8 0.01 OUTLIER Glycine 0 N--CA 1.466 0.654 0 O-C-N 125.12 1.513 . . . . 1.25 115.448 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.18 -150.17 5.73 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.96 -0.638 . . . . 0.71999999999999997 112.39 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 p -112.4 125.58 54.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.446 0.536 . . . . 0.59999999999999998 112.446 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.634 HD13 HD13 ' A' ' 42' ' ' LEU . 1.2 pt -115.75 129.42 72.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.77 -0.65 . . . . 1.6299999999999999 109.685 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -108.4 160.32 13.82 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.211 -0.995 . . . . 0.45000000000000001 112.743 -173.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -91.34 113.65 27.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.905 0.384 . . . . 0.82999999999999996 110.189 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.619 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -116.5 126.83 53.92 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.92 -1.141 . . . . 1.28 107.92 174.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.94 ' HA ' HG12 ' A' ' 67' ' ' VAL . 13.9 p -62.98 124.96 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.316 -0.994 . . . . 1.1399999999999999 108.316 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.07 88.04 2.4 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.225 -0.657 . . . . 1.02 109.225 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA2' ' OD1' ' A' ' 21' ' ' ASP . . . 90.51 112.32 1.56 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.567 -1.013 . . . . 1.53 110.567 -171.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -51.08 114.23 1.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.354 0.597 . . . . 2.1099999999999999 110.967 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.817 ' HG3' ' HB3' ' A' ' 65' ' ' LEU . 11.9 mm-40 -91.98 20.81 5.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.476 -0.784 . . . . 2.6200000000000001 111.094 -174.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.6 m 72.7 -21.72 0.24 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.589 -0.732 . . . . 2.4300000000000002 112.816 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.534 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 8.9 t30 70.57 84.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.704 0.764 . . . . 1.5600000000000001 110.238 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.541 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 12.2 t -103.93 149.22 36.97 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.974 -1.121 . . . . 1.6799999999999999 107.974 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.541 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 91.4 Cg_exo -18.11 89.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 1 C-N-CA 125.76 4.307 . . . . 1.26 115.001 -172.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.687 ' CB ' HG11 ' A' ' 142' ' ' VAL . 3.3 Cg_exo -81.01 -150.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.693 2.929 . . . . 0.76000000000000001 114.214 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.91 -163.69 37.11 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 109.071 -1.612 . . . . 0.76000000000000001 109.071 -173.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.456 HD22 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -80.2 101.69 8.99 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.299 -0.63 . . . . 2.04 109.299 178.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -84.9 126.59 33.61 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.003 0.43 . . . . 0.75 109.965 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.9 m -130.71 97.36 4.33 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.906 -0.588 . . . . 0.82999999999999996 109.594 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.575 HD22 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -104.27 105.6 15.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.483 0.659 . . . . 0.51000000000000001 110.51 -176.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 1.3 m -78.27 121.57 24.58 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.148 -0.933 . . . . 0.58999999999999997 110.527 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.566 ' HB2' HG11 ' A' ' 7' ' ' VAL . 96.0 mt -107.29 146.0 32.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.87 0.367 . . . . 1.27 110.635 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.0 m -119.19 109.16 15.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.373 -0.376 . . . . 0.69999999999999996 110.415 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.97 162.09 54.07 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.957 -0.64 . . . . 0.80000000000000004 112.952 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 151.16 166.35 13.7 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.032 -0.604 . . . . 0.53000000000000003 111.621 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.678 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 46.9 p90 -89.19 -173.53 4.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.16 0.505 . . . . 0.89000000000000001 111.043 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.628 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 2.3 t-105 -137.76 149.97 46.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.631 -0.713 . . . . 0.56000000000000005 110.276 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.79 147.66 50.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.308 -0.406 . . . . 1.4199999999999999 110.49 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.577 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 5.8 tmtt? 70.41 -142.36 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.66 0.6 . . . . 3.4700000000000002 110.432 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.528 ' HA ' ' HZ2' ' A' ' 121' ' ' TRP . 6.9 p-10 -160.08 132.66 6.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.622 0.248 . . . . 2.0800000000000001 111.405 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.546 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 8.9 t30 66.86 -30.06 0.15 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.939 1.089 . . . . 2.4700000000000002 113.939 174.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.648 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -68.81 -3.51 12.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 1.96 110.951 178.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.628 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 20.4 tt0 68.57 59.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.208 -0.905 . . . . 2.02 110.856 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.648 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -89.06 48.55 3.46 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.603 -0.808 . . . . 0.77000000000000002 111.358 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.595 ' HD1' ' HG2' ' A' ' 127' ' ' GLN . 16.4 p90 -78.81 140.85 38.13 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 110.026 -0.361 . . . . 1.21 110.026 -174.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.549 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 36.6 m -118.94 137.59 25.21 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.315 -0.254 . . . . 1.47 110.315 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.08 111.09 2.39 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.977 2.451 . . . . 0.92000000000000004 111.274 172.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.1 m -153.08 108.68 3.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.851 0.357 . . . . 1.52 110.489 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.643 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 137.4 -127.51 3.99 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.534 -0.841 . . . . 1.1699999999999999 111.907 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 m -124.96 145.7 49.74 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.282 -0.266 . . . . 2.4700000000000002 110.282 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.2 m -92.31 95.75 9.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.103 -0.702 . . . . 1.8200000000000001 109.103 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -92.17 128.7 9.5 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.918 -0.658 . . . . 0.67000000000000004 111.975 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.88 105.44 17.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.888 0.375 . . . . 0.57999999999999996 110.211 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.538 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 21.7 m -78.32 108.8 11.92 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.845 -0.798 . . . . 0.52000000000000002 108.845 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -103.45 109.06 20.56 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.551 0.691 . . . . 2.1800000000000002 110.535 -174.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.4 tp -100.82 97.12 7.77 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.617 -1.174 . . . . 0.63 109.092 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.728 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 24.8 m -97.64 122.28 40.54 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.613 -0.721 . . . . 0.57999999999999996 109.802 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.687 HG11 ' CB ' ' A' ' 109' ' ' PRO . 33.2 m -75.24 114.66 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-O 121.55 0.69 . . . . 1.74 111.29 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.715 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 38.4 m . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.301 -0.856 . . . . 2.5800000000000001 109.834 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 53.9 m . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.633 0.254 . . . . 1.4299999999999999 110.623 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -86.46 110.17 19.56 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.565 -0.454 . . . . 2.29 110.018 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.43 117.92 49.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.894 -0.594 . . . . 1.51 109.73 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -82.7 109.59 17.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.946 -0.57 . . . . 3.5699999999999998 111.618 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.35 117.13 52.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.509 -0.923 . . . . 1.26 108.509 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.38 144.39 17.05 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.443 -0.884 . . . . 0.95999999999999996 113.23 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -62.05 146.84 49.13 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.492 0.317 . . . . 2.1800000000000002 110.227 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 2.2 pt? -156.14 126.66 6.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.937 0.399 . . . . 1.4099999999999999 110.901 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.474 ' HA ' ' HB3' ' A' ' 139' ' ' LYS . 28.0 m -108.75 114.58 28.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.111 -0.495 . . . . 1.03 109.827 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.519 ' HB ' ' NZ ' ' A' ' 14' ' ' LYS . 61.9 t -144.17 146.04 21.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.595 -0.73 . . . . 1.45 109.328 -176.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.724 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -92.99 124.85 37.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.524 0.565 . . . . 0.58999999999999997 112.524 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.519 ' NZ ' ' HB ' ' A' ' 12' ' ' VAL . 1.1 mptt -147.6 168.44 22.0 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.889 0.376 . . . . 3.4199999999999999 110.043 172.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.536 ' O ' HD23 ' A' ' 19' ' ' LEU . 73.4 p -112.66 161.89 16.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.313 -0.995 . . . . 0.63 108.313 169.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.1 0.29 19.35 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.555 -0.858 . . . . 3.1400000000000001 110.236 175.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.99 -26.91 25.14 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 110.251 -1.139 . . . . 0.75 110.251 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -62.57 -29.61 70.72 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.442 -0.947 . . . . 2.1699999999999999 108.442 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.866 HD21 HD13 ' A' ' 25' ' ' ILE . 2.3 mm? -75.33 129.16 36.93 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.394 -1.275 . . . . 1.6100000000000001 109.593 171.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.658 HG22 ' HB2' ' A' ' 23' ' ' ALA . 13.7 t -127.94 42.18 3.37 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.391 1.091 . . . . 1.6499999999999999 108.262 -176.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.497 ' HB2' ' NE2' ' A' ' 103' ' ' GLN . 29.4 t70 75.3 -69.72 0.17 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.54 -1.663 . . . . 1.8300000000000001 109.607 -171.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -99.15 85.02 3.14 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.799 -0.445 . . . . 0.81999999999999995 109.799 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.658 ' HB2' HG22 ' A' ' 20' ' ' THR . . . -142.51 94.63 6.7 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.219 -0.446 . . . . 0.79000000000000004 110.923 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.521 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 32.9 Cg_endo -68.43 85.9 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 123.189 2.593 . . . . 1.1200000000000001 111.72 177.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.866 HD13 HD21 ' A' ' 19' ' ' LEU . 12.3 pt -83.31 -16.62 11.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.734 -1.121 . . . . 2.5800000000000001 111.392 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.35 69.74 0.4 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.542 -0.837 . . . . 0.73999999999999999 112.802 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 9.3 Cg_exo -71.16 108.16 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.631 2.221 . . . . 0.67000000000000004 111.697 173.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.6 t -84.47 141.69 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.016 -0.538 . . . . 1.1799999999999999 110.299 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.5 p -71.05 97.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.391 . . . . 1.6399999999999999 110.371 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.746 HG23 ' HA ' ' A' ' 95' ' ' THR . 6.6 t -83.59 142.27 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.933 0.873 . . . . 1.01 111.397 -174.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.17 114.18 5.44 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.18 -1.373 . . . . 2.48 107.658 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.82 104.63 11.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.785 0.326 . . . . 0.69999999999999996 110.911 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 46.3 tp -81.7 120.16 24.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.868 -0.605 . . . . 1.9399999999999999 109.963 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.9 -144.44 17.26 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.604 -0.808 . . . . 1.8100000000000001 111.923 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 4.2 m 59.75 32.33 21.33 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 122.192 0.197 . . . . 1.8799999999999999 111.503 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -55.46 -30.36 60.42 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.102 0.477 . . . . 2.1400000000000001 110.77 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.56 54.6 1.93 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.901 -0.59 . . . . 0.93999999999999995 110.083 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.9 tpp180 -140.28 150.49 44.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.263 -0.426 . . . . 4.6399999999999997 111.287 -176.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -93.22 92.53 7.78 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.312 -0.625 . . . . 1.75 109.312 178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 58.1 t -56.61 134.08 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.678 -0.692 . . . . 0.54000000000000004 110.639 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 1.02 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -143.82 149.88 37.67 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.962 0.41 . . . . 0.35999999999999999 111.045 -176.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.48 HD12 ' HB ' ' A' ' 69' ' ' ILE . 11.7 mt -102.96 155.17 18.54 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.011 -0.54 . . . . 0.83999999999999997 109.549 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HZ1' ' HB3' ' A' ' 41' ' ' ALA . 1.7 mptp? -140.05 150.92 44.96 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.862 -0.792 . . . . 1.9299999999999999 108.862 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -86.25 155.45 20.68 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.307 -0.627 . . . . 0.40999999999999998 109.307 171.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 27.6 t70 -71.78 161.45 30.95 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.667 -0.494 . . . . 0.70999999999999996 109.667 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -55.96 -23.1 30.14 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.929 0.715 . . . . 1.3999999999999999 112.929 -173.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.0 -16.61 54.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 2.2200000000000002 111.424 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 20.3 m120 -123.04 8.19 9.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.215 -0.448 . . . . 1.3500000000000001 110.292 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 83.2 t80 -131.71 109.47 10.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.776 -0.647 . . . . 0.56000000000000005 110.24 -174.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.538 ' HG2' ' HE1' ' A' ' 55' ' ' PHE . 14.2 pt-20 -134.0 124.11 25.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.357 -0.383 . . . . 2.4100000000000001 110.193 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 54.68 39.04 31.04 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.98 -0.554 . . . . 3.4300000000000002 111.586 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.93 36.72 65.06 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.758 -0.655 . . . . 0.56000000000000005 112.854 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.523 ' HB3' ' HE2' ' A' ' 66' ' ' TYR . 47.2 mmtm -132.8 134.91 45.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.304 -0.628 . . . . 2.1200000000000001 109.304 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -116.98 141.18 48.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.418 0.628 . . . . 0.56000000000000005 111.639 176.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.538 ' HE1' ' HG2' ' A' ' 50' ' ' GLU . 41.8 p90 -155.04 160.87 41.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.453 -0.794 . . . . 0.58999999999999997 109.912 -175.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.761 ' HB3' HD22 ' A' ' 114' ' ' LEU . 1.7 pp -81.21 143.08 32.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.64 -0.504 . . . . 1.53 109.64 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 113' ' ' THR . 11.1 tp -121.05 146.9 25.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.697 -0.401 . . . . 0.62 110.36 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.438 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 2.8 p -100.3 174.4 6.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.963 -0.562 . . . . 1.4399999999999999 111.666 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -53.86 -41.37 67.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.54 -0.755 . . . . 2.3100000000000001 110.54 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.68 -14.04 46.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.156 -0.929 . . . . 3.0899999999999999 111.138 -174.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.403 ' HA ' HD11 ' A' ' 57' ' ' ILE . 43.3 m-80 62.29 18.97 10.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.167 0.508 . . . . 2.6200000000000001 110.285 -171.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -90.62 -50.01 6.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.857 -0.61 . . . . 4.6600000000000001 110.883 -175.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -100.75 134.22 44.04 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.712 -0.477 . . . . 2.5099999999999998 109.712 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HD2' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -144.39 154.67 43.22 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.846 -0.616 . . . . 2.0699999999999998 109.854 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.802 HD21 HG23 ' A' ' 100' ' ' VAL . 23.3 tp -150.95 134.74 16.52 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.11 -0.495 . . . . 1.98 109.88 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.523 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 65.3 m-85 -78.71 131.37 36.58 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.679 -0.691 . . . . 0.75 110.033 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.592 HG21 HD13 ' A' ' 114' ' ' LEU . 11.0 m -125.34 130.9 72.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.975 -0.557 . . . . 0.72999999999999998 110.702 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -99.77 121.78 41.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.102 -0.499 . . . . 1.8100000000000001 110.027 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.52 HD13 HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -83.17 87.64 2.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.165 -0.47 . . . . 0.81000000000000005 109.969 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.465 ' HE ' ' HB2' ' A' ' 99' ' ' TYR . 33.1 mtt180 -99.71 144.44 28.33 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.185 -0.461 . . . . 3.79 109.929 -173.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.683 ' HA ' HG22 ' A' ' 96' ' ' ILE . 77.7 Cg_exo -50.89 140.38 38.85 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.711 2.274 . . . . 0.58999999999999997 112.439 174.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tpt -77.5 74.63 4.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.25 -0.648 . . . . 1.71 109.25 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 43.02 84.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.01 -0.996 . . . . 1.9199999999999999 111.386 -174.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.757 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 2.2 t-20 -145.98 -67.08 0.29 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.241 -0.436 . . . . 1.8899999999999999 110.591 -173.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 m -142.88 164.52 29.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.71 -0.478 . . . . 1.7 109.71 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.06 107.33 17.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.212 0.53 . . . . 0.93999999999999995 110.604 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.4 m0 -101.89 137.45 40.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.663 -0.699 . . . . 0.5 110.067 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.7 m -69.75 114.51 8.02 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.568 -0.53 . . . . 0.51000000000000001 109.568 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -93.14 105.2 17.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.906 0.86 . . . . 0.58999999999999997 112.176 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -105.79 161.2 14.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.078 -1.082 . . . . 1.7 108.078 167.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -85.62 3.64 39.9 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.628 -0.429 . . . . 1.3899999999999999 111.1 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.65 -40.06 0.87 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.333 -0.937 . . . . 0.65000000000000002 111.826 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.582 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 30.9 m -133.03 156.88 42.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.988 -0.375 . . . . 1.1599999999999999 109.988 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.713 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -133.72 97.64 3.97 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.961 -1.126 . . . . 0.35999999999999999 107.961 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 1.02 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -125.71 142.21 51.63 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 120.754 0.312 . . . . 0.58999999999999997 110.717 -175.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.771 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 18.5 pttm -72.45 144.12 48.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.353 -0.61 . . . . 1.3899999999999999 109.353 173.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.65 43.8 0.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.009 0.909 . . . . 2.1200000000000001 108.88 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.771 ' HB3' ' HD2' ' A' ' 86' ' ' LYS . 17.4 t70 -149.16 154.41 39.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.591 -1.186 . . . . 2.1000000000000001 109.411 -171.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -115.71 124.38 72.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.094 0.473 . . . . 1.05 110.564 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.66 174.97 22.94 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.502 -0.856 . . . . 0.46000000000000002 112.432 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 p -74.66 124.15 26.19 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.99 -0.374 . . . . 1.1699999999999999 109.99 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.757 ' HZ2' ' HB3' ' A' ' 74' ' ' ASN . 13.4 t90 -100.64 -43.84 6.03 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.844 -0.342 . . . . 0.51000000000000001 111.677 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.579 ' O ' ' HB ' ' A' ' 30' ' ' VAL . . . 51.34 -122.1 14.07 Favored Glycine 0 C--O 1.213 -1.175 0 N-CA-C 110.968 -0.853 . . . . 1.25 110.968 -173.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 73.17 -144.68 35.04 Favored Glycine 0 C--N 1.321 -0.271 0 C-N-CA 120.908 -0.663 . . . . 0.71999999999999997 113.9 166.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.746 ' HA ' HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -152.09 134.06 14.94 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 122.647 0.379 . . . . 0.59999999999999998 110.746 -179.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.683 HG22 ' HA ' ' A' ' 71' ' ' PRO . 2.2 pp -124.92 151.58 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.601 -0.518 . . . . 1.6299999999999999 109.601 174.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.35 167.77 23.33 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.364 -0.922 . . . . 0.45000000000000001 112.56 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.587 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.9 mp -91.11 113.26 26.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 110.252 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.521 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 1.6 m-85 -113.89 124.14 51.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.864 -0.791 . . . . 1.28 108.864 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.802 HG23 HD21 ' A' ' 65' ' ' LEU . 11.4 p -55.58 139.07 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.632 0.253 . . . . 1.1399999999999999 110.709 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -86.61 82.75 7.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.813 -0.81 . . . . 1.02 108.813 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.8 100.7 0.41 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.266 -0.734 . . . . 1.53 111.266 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.497 ' NE2' ' HB2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -43.01 120.25 1.74 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.543 0.687 . . . . 2.1099999999999999 111.87 -179.132 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.501 ' HG3' ' OG1' ' A' ' 107' ' ' THR . 21.1 tp60 -75.94 -3.13 33.8 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.813 -0.63 . . . . 2.6200000000000001 110.719 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.9 m 66.73 24.81 9.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.345 0.593 . . . . 2.4300000000000002 111.446 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 60.71 71.34 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.77 0.795 . . . . 1.5600000000000001 111.529 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.501 ' OG1' ' HG3' ' A' ' 104' ' ' GLN . 3.1 m -82.64 139.62 44.01 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.971 -1.013 . . . . 1.6799999999999999 108.501 168.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 107' ' ' THR . 66.6 Cg_exo -24.9 94.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.096 1 C-N-CA 125.481 4.12 . . . . 1.26 114.558 -176.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.421 ' HB3' ' HE2' ' A' ' 112' ' ' TYR . 57.1 Cg_endo -87.67 -174.89 1.33 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.14 2.56 . . . . 0.76000000000000001 113.532 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.45 -121.18 0.57 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.215 -1.154 . . . . 0.76000000000000001 110.215 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -99.45 109.81 22.34 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.129 -0.693 . . . . 2.04 109.129 171.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.518 ' CD1' HD13 ' A' ' 56' ' ' LEU . 53.4 m-85 -107.11 104.77 14.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.803 0.811 . . . . 0.75 110.667 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 57' ' ' ILE . 86.6 m -98.04 118.21 34.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.889 -1.051 . . . . 0.82999999999999996 109.897 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.761 HD22 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -133.78 96.76 3.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.22 0.533 . . . . 0.51000000000000001 110.214 175.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 7.6 m -75.12 127.61 33.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.089 -0.505 . . . . 0.58999999999999997 110.157 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.52 HD13 HD13 ' A' ' 69' ' ' ILE . 90.2 mt -116.59 126.13 52.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.009 -0.367 . . . . 1.27 110.009 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.501 HG21 ' HB3' ' A' ' 131' ' ' PRO . 17.3 m -106.75 126.51 52.39 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.849 0.357 . . . . 0.69999999999999996 110.63 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.69 157.54 45.81 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.809 -0.71 . . . . 0.80000000000000004 111.619 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 171.79 -169.56 42.62 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.629 -0.796 . . . . 0.53000000000000003 111.923 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -111.97 179.92 3.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.181 0.515 . . . . 0.89000000000000001 110.325 177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.777 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 1.7 t-105 -145.48 148.31 33.12 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.495 -0.775 . . . . 0.56000000000000005 109.272 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.47 144.26 50.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.831 0.348 . . . . 1.4199999999999999 111.155 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.719 ' HD3' ' H ' ' A' ' 124' ' ' ASP . 4.7 tmtm? 67.83 -136.69 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.918 0.887 . . . . 3.4700000000000002 110.212 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.719 ' H ' ' HD3' ' A' ' 123' ' ' LYS . 4.1 p30 -161.56 138.59 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.067 0.394 . . . . 2.0800000000000001 110.934 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.513 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 55.9 m-80 64.85 -40.8 0.28 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.702 1.201 . . . . 2.4700000000000002 113.891 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.487 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -62.9 -3.63 1.72 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.21 0.604 . . . . 1.96 112.339 -174.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.777 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 44.1 mt-30 68.01 67.1 0.35 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.491 0.662 . . . . 2.02 111.576 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.487 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -95.13 39.61 2.84 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.948 -0.861 . . . . 0.77000000000000002 110.948 173.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.576 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 41.8 p90 -81.81 151.39 27.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.692 0.282 . . . . 1.21 110.611 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 74.6 m -147.37 125.79 6.13 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.598 -0.273 . . . . 1.47 110.707 174.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.501 ' HB3' HG21 ' A' ' 117' ' ' THR . 9.2 Cg_exo -72.17 114.18 3.91 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.933 2.422 . . . . 0.92000000000000004 111.51 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 p -151.04 126.98 10.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.045 0.45 . . . . 1.52 110.931 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.85 -113.55 2.69 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.633 -0.794 . . . . 1.1699999999999999 112.17 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.3 m -130.44 135.37 47.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.63 0.252 . . . . 2.4700000000000002 110.582 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.2 t -99.78 140.53 33.86 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.49 -0.559 . . . . 1.8200000000000001 109.49 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -130.41 119.84 2.87 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.45 -0.881 . . . . 0.67000000000000004 112.355 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 6.0 m -77.77 104.72 8.48 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.781 -0.452 . . . . 0.57999999999999996 109.781 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.427 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 50.7 m -78.59 108.26 11.86 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.062 -0.718 . . . . 0.52000000000000002 109.062 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.474 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 12.4 tppt? -98.68 112.97 24.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.762 0.791 . . . . 2.1800000000000002 110.405 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.624 HD23 HD22 ' A' ' 56' ' ' LEU . 9.4 tp -102.06 94.42 5.76 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 114.676 -1.147 . . . . 0.63 109.409 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 17.1 m -105.69 144.82 31.9 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.265 -0.642 . . . . 0.57999999999999996 109.265 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.4 p -95.41 135.97 27.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.157 0.503 . . . . 1.74 110.21 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.4 m . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.714 -0.66 . . . . 2.5800000000000001 109.728 178.888 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 51.9 t . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.502 0.668 . . . . 1.4299999999999999 109.538 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -94.62 120.46 34.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.385 -0.825 . . . . 2.29 110.392 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.6 115.78 42.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.184 -0.462 . . . . 1.51 110.669 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' A' ' 31' ' ' GLN . 37.5 ttm180 -80.12 108.16 13.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.688 -0.687 . . . . 3.5699999999999998 109.802 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -114.83 122.55 69.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.808 -0.633 . . . . 1.26 109.829 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.51 169.38 27.4 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.815 -0.707 . . . . 0.95999999999999996 112.389 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.57 123.39 40.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.049 -0.352 . . . . 2.1800000000000002 110.049 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.48 ' HB2' HG23 ' A' ' 138' ' ' THR . 55.8 mt -107.45 121.49 44.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.927 0.394 . . . . 1.4099999999999999 111.582 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.1 m -112.82 113.32 25.36 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.029 -0.73 . . . . 1.03 109.029 170.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.76 147.78 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.913 -0.403 . . . . 1.45 109.913 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -112.28 135.43 52.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.625 -0.261 . . . . 0.58999999999999997 110.99 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HE2' ' HB ' ' A' ' 25' ' ' ILE . 10.9 ptpp? 178.5 163.82 0.75 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.982 -0.554 . . . . 3.4199999999999999 109.957 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.861 ' HA ' HG13 ' A' ' 142' ' ' VAL . 76.1 p -85.44 161.71 19.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.132 -0.485 . . . . 0.63 109.865 175.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.705 ' NH1' ' HG3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -80.32 -0.4 36.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.3 -0.63 . . . . 3.1400000000000001 109.3 174.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -96.53 -18.41 30.62 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.197 -0.91 . . . . 0.75 110.962 176.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -71.12 -23.82 62.16 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.538 -0.912 . . . . 2.1699999999999999 108.538 172.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.402 HD23 HD12 ' A' ' 25' ' ' ILE . 46.9 mt -86.49 116.99 24.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.641 -1.163 . . . . 1.6100000000000001 108.989 173.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 p -111.42 77.13 1.02 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.77 0.319 . . . . 1.6499999999999999 110.682 -175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 29.5 t70 61.39 -83.56 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.155 -0.93 . . . . 1.8300000000000001 110.835 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.657 ' HA ' ' CD2' ' A' ' 99' ' ' TYR . . . -107.07 84.6 2.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.304 0.574 . . . . 0.81999999999999995 110.309 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.481 ' O ' HG13 ' A' ' 25' ' ' ILE . . . -146.68 87.72 6.28 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.191 -0.913 . . . . 0.79000000000000004 109.304 175.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.53 ' CB ' ' HA3' ' A' ' 97' ' ' GLY . 59.8 Cg_endo -69.57 94.86 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.657 2.238 . . . . 1.1200000000000001 112.683 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 23' ' ' ALA . 4.9 mt -111.82 23.46 4.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 122.005 0.907 . . . . 2.5800000000000001 110.056 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.518 ' N ' ' HD3' ' A' ' 27' ' ' PRO . . . -140.66 53.17 0.67 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.89 -1.05 . . . . 0.73999999999999999 111.578 168.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.789 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 48.4 Cg_exo -55.81 115.06 2.19 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.299 1.999 . . . . 0.67000000000000004 113.433 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.2 t -88.58 129.89 38.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.361 -0.836 . . . . 1.1799999999999999 109.282 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 p -76.95 88.13 3.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.244 0.545 . . . . 1.6399999999999999 110.868 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.1 115.44 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.673 -0.694 . . . . 1.01 110.755 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.598 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . 52.1 tt0 -114.35 113.01 23.98 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.251 -0.431 . . . . 2.48 109.988 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.609 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -95.98 101.27 12.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.843 -0.617 . . . . 0.69999999999999996 110.306 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 tt -95.83 126.35 41.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.765 -0.652 . . . . 1.9399999999999999 110.592 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.2 69.9 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.087 -0.577 . . . . 1.8100000000000001 114.4 169.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.609 ' SG ' ' HB1' ' A' ' 32' ' ' ALA . 31.3 m -80.54 -66.96 0.82 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.343 0.572 . . . . 1.8799999999999999 110.112 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 3.2 m-20 67.81 -45.98 0.5 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.136 1.162 . . . . 2.1400000000000001 114.136 172.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.52 29.08 2.69 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.062 -0.399 . . . . 0.93999999999999995 111.905 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -133.26 161.06 35.5 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.23 -0.285 . . . . 4.6399999999999997 110.23 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -91.73 141.14 29.01 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.904 -0.406 . . . . 1.75 109.904 172.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 53.1 t -94.03 136.28 26.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.849 -0.796 . . . . 0.54000000000000004 108.849 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -127.53 135.39 50.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.851 0.358 . . . . 0.35999999999999999 110.803 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 mt -103.54 105.57 15.84 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.164 -0.68 . . . . 0.83999999999999997 109.164 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.833 ' HG3' HG12 ' A' ' 83' ' ' VAL . 1.4 mppt? -108.4 125.41 51.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.52 -0.919 . . . . 1.9299999999999999 108.52 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.633 ' HB1' HD21 ' A' ' 48' ' ' ASN . . . -72.94 156.95 38.33 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.686 -0.406 . . . . 0.40999999999999998 110.248 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.709 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 21.5 t70 -71.77 147.4 47.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.205 -0.452 . . . . 0.70999999999999996 109.839 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -61.66 -6.27 2.43 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.91 0.707 . . . . 1.3999999999999999 112.91 -171.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.83 -29.24 44.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.992 0.425 . . . . 2.2200000000000002 110.378 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.633 HD21 ' HB1' ' A' ' 44' ' ' ALA . 5.5 p-10 -124.28 19.79 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 1.3500000000000001 109.553 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 84.7 t80 -137.45 107.4 6.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.281 -0.872 . . . . 0.56000000000000005 109.916 -175.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -103.07 96.91 7.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.411 -0.358 . . . . 2.4100000000000001 110.653 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 68.2 -52.32 0.54 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.983 0.802 . . . . 3.4300000000000002 112.047 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' CE1' ' A' ' 49' ' ' PHE . . . -174.33 37.08 0.12 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 111.671 -0.572 . . . . 0.56000000000000005 111.671 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.781 ' HD2' ' HB3' ' A' ' 81' ' ' ASN . 8.7 mmmm -138.95 133.52 31.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.64 -1.244 . . . . 2.1200000000000001 107.64 172.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.15 147.03 43.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.667 0.746 . . . . 0.56000000000000005 112.055 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 9.2 p90 -150.19 -179.63 7.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.568 -1.196 . . . . 0.58999999999999997 109.603 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.959 HD12 HD22 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -89.37 121.55 31.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.979 -1.119 . . . . 1.53 107.979 169.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.591 HG22 ' HB3' ' A' ' 48' ' ' ASN . 8.8 tp -106.79 116.86 51.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.571 0.701 . . . . 0.62 109.439 177.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 22.6 t -72.51 147.65 45.79 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.06 -0.518 . . . . 1.4399999999999999 110.214 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.84 -8.07 33.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.456 0.646 . . . . 2.3100000000000001 109.703 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -95.26 -3.12 48.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.385 -0.825 . . . . 3.0899999999999999 110.023 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.07 28.01 0.35 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.884 1.273 . . . . 2.6200000000000001 113.553 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -86.46 -53.83 4.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.087 -0.383 . . . . 4.6600000000000001 111.118 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.523 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 7.2 m-20 -125.66 159.64 31.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.414 -0.357 . . . . 2.5099999999999998 110.705 -175.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.503 ' HB2' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -145.63 133.11 20.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.78 -0.646 . . . . 2.0699999999999998 109.718 176.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.625 ' O ' HD22 ' A' ' 56' ' ' LEU . 2.0 mm? -128.37 133.35 48.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.336 -0.616 . . . . 1.98 109.336 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -75.25 138.34 41.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.147 0.498 . . . . 0.75 110.376 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.488 HG11 HD11 ' A' ' 56' ' ' LEU . 2.4 m -117.48 167.19 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-N 115.734 -0.667 . . . . 0.72999999999999998 110.476 177.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -121.78 110.34 15.79 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.775 -0.648 . . . . 1.8100000000000001 109.339 173.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.42 HG23 HG12 ' A' ' 98' ' ' ILE . 1.1 pt -88.77 84.93 2.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.021 -0.733 . . . . 0.81000000000000005 109.021 172.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.582 ' HB3' ' OH ' ' A' ' 99' ' ' TYR . 44.9 ttt180 -116.69 136.2 23.13 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 115.445 -0.798 . . . . 3.79 109.132 -173.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 91.9 Cg_exo -42.92 121.0 2.08 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.0 2.467 . . . . 0.58999999999999997 112.284 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.9 ttt -68.18 87.83 0.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 1.71 110.424 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t0 49.35 66.76 1.02 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.143 -0.935 . . . . 1.9199999999999999 111.019 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -140.17 -53.19 0.51 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 1.8899999999999999 111.559 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.0 m -149.57 161.42 42.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.576 0.227 . . . . 1.7 110.624 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.6 86.45 3.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.94 0.4 . . . . 0.93999999999999995 110.081 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.404 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 17.2 m0 -77.25 158.27 30.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.706 -0.679 . . . . 0.5 110.3 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.9 m -69.63 116.33 9.91 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.063 -0.717 . . . . 0.51000000000000001 109.063 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 t -98.01 97.31 8.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.819 0.819 . . . . 0.58999999999999997 112.094 -170.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.33 159.85 14.67 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.295 -1.002 . . . . 1.7 108.295 168.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.781 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -79.73 -7.31 58.54 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.335 -0.546 . . . . 1.3899999999999999 110.017 -178.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.452 ' CA ' ' HE1' ' A' ' 49' ' ' PHE . . . -118.64 -36.74 0.88 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.13 -1.033 . . . . 0.65000000000000002 112.887 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.833 HG12 ' HG3' ' A' ' 43' ' ' LYS . 33.4 m -124.52 151.76 30.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.275 -0.639 . . . . 1.1599999999999999 109.275 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -135.03 102.48 5.23 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.297 -1.001 . . . . 0.35999999999999999 108.297 -178.422 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.683 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 15.6 p90 -135.9 140.87 44.4 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.137 0.494 . . . . 0.58999999999999997 110.903 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 17.1 pttp -82.44 140.98 33.1 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.562 -0.745 . . . . 1.3899999999999999 110.986 -178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -67.47 -34.4 77.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.291 -1.003 . . . . 2.1200000000000001 108.291 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 2.2 m-20 -58.44 124.48 19.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.636 -1.166 . . . . 2.1000000000000001 110.31 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.8 131.46 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.512 -0.475 . . . . 1.05 109.818 174.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.589 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 146.07 -165.19 28.18 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.584 -0.817 . . . . 0.46000000000000002 111.832 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.8 p -81.82 -172.78 4.08 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.619 -0.511 . . . . 1.1699999999999999 109.619 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.586 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 22.5 t90 -154.0 -59.99 0.13 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.953 -0.388 . . . . 0.51000000000000001 109.953 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 39.69 88.44 0.01 OUTLIER Glycine 0 N--CA 1.467 0.724 0 O-C-N 124.275 0.985 . . . . 1.25 114.901 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.69 -139.6 2.68 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.022 -0.609 . . . . 0.71999999999999997 111.669 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 p -131.77 124.62 30.07 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.43 0.634 . . . . 0.59999999999999998 112.167 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.789 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 37.5 pt -100.0 161.54 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.375 -0.972 . . . . 1.6299999999999999 108.375 172.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 24' ' ' PRO . . . -128.02 147.9 17.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.53 -1.319 . . . . 0.45000000000000001 113.126 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 69' ' ' ILE . 79.8 mt -101.75 120.73 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 120.731 0.3 . . . . 0.82999999999999996 110.886 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.657 ' CD2' ' HA ' ' A' ' 22' ' ' ALA . 1.4 p90 -138.6 155.2 48.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.85 -0.614 . . . . 1.28 110.392 173.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 103' ' ' GLN . 12.8 p -85.58 136.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.822 -0.626 . . . . 1.1399999999999999 110.761 -170.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.13 101.87 0.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.825 -0.625 . . . . 1.02 111.391 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.75 34.83 66.4 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-O 119.451 -0.638 . . . . 1.53 113.848 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.496 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.4 pt20 38.92 96.88 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.984 0.897 . . . . 2.1099999999999999 113.187 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.528 ' HG3' ' HB3' ' A' ' 65' ' ' LEU . 14.7 mm100 -80.39 17.45 1.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.49 -0.777 . . . . 2.6200000000000001 111.927 -172.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.438 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 8.8 m 76.32 -29.15 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.392 0.677 . . . . 2.4300000000000002 112.671 168.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.514 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 15.0 t30 77.8 84.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.851 0.834 . . . . 1.5600000000000001 111.08 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.472 ' N ' HH12 ' A' ' 16' ' ' ARG . 25.9 m -93.79 137.43 23.17 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.542 -1.208 . . . . 1.6799999999999999 109.535 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' CG2' ' A' ' 107' ' ' THR . 72.2 Cg_exo -19.58 92.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 1 C-N-CA 126.198 4.598 . . . . 1.26 115.461 -174.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.832 ' HG2' HG11 ' A' ' 142' ' ' VAL . 10.2 Cg_endo -96.96 -155.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.355 3.37 . . . . 0.76000000000000001 114.31 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -172.94 -105.25 0.18 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 114.118 -1.401 . . . . 0.76000000000000001 109.603 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -102.74 130.11 49.59 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.57 -0.53 . . . . 2.04 109.57 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.778 ' HE2' ' HB3' ' A' ' 109' ' ' PRO . 6.7 m-85 -118.58 120.66 38.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.036 0.446 . . . . 0.75 110.587 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.2 m -97.48 135.36 39.45 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 0.82999999999999996 110.768 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.959 HD22 HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -153.84 94.06 1.72 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.463 0.649 . . . . 0.51000000000000001 109.783 175.08 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.709 ' HB ' ' CB ' ' A' ' 45' ' ' ASP . 14.8 m -84.45 140.65 31.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.741 -0.663 . . . . 0.58999999999999997 109.95 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.5 mt -118.42 119.93 36.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.409 -0.359 . . . . 1.27 110.496 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 43.5 m -98.47 121.34 40.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.014 0.435 . . . . 0.69999999999999996 110.236 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.12 -159.4 19.05 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.842 -0.694 . . . . 0.80000000000000004 112.673 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.702 ' HA2' ' HB2' ' A' ' 132' ' ' SER . . . 109.64 165.88 20.0 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.518 -0.633 . . . . 0.53000000000000003 111.518 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -89.34 177.26 6.64 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.142 -0.623 . . . . 0.89000000000000001 111.017 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.659 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 4.6 t-105 -129.25 151.95 49.35 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.804 -1.089 . . . . 0.56000000000000005 109.902 -174.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.45 149.85 52.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.105 -0.498 . . . . 1.4199999999999999 110.175 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt 64.25 -146.52 0.28 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.21 0.604 . . . . 3.4700000000000002 111.053 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 126' ' ' LYS . 4.2 p30 -151.02 136.14 17.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.516 0.198 . . . . 2.0800000000000001 110.945 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.594 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.7 OUTLIER 51.97 -7.9 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.306 1.842 . . . . 2.4700000000000002 115.883 176.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -80.5 -2.52 46.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.362 0.601 . . . . 1.96 109.999 176.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.659 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 7.7 tt0 68.47 54.43 0.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.432 -1.258 . . . . 2.02 110.839 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.416 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -89.47 110.68 3.75 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 109.823 -1.311 . . . . 0.77000000000000002 109.823 170.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 26.7 p90 -151.0 171.26 17.58 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.297 -0.631 . . . . 1.21 109.297 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.583 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 5.9 t -150.19 146.03 19.54 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 110.009 -0.367 . . . . 1.47 110.009 173.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.12 106.76 1.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.7 2.267 . . . . 0.92000000000000004 111.47 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.702 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 10.6 m -131.95 122.07 24.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.913 -0.585 . . . . 1.52 109.78 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.75 -110.57 3.78 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.714 -0.755 . . . . 1.1699999999999999 111.483 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.6 p -144.01 176.2 9.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.052 0.453 . . . . 2.4700000000000002 110.957 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.1 t -126.86 129.71 48.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.31 -0.626 . . . . 1.8200000000000001 109.31 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.49 138.18 14.65 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.647 -0.787 . . . . 0.67000000000000004 112.155 -175.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 19.2 m -99.06 103.73 15.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.992 -0.373 . . . . 0.57999999999999996 109.992 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 10' ' ' LEU . 21.6 m -81.81 113.18 19.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.355 -0.609 . . . . 0.52000000000000002 109.355 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -100.22 109.08 21.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.471 0.653 . . . . 2.1800000000000002 109.506 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.496 HD23 ' HG ' ' A' ' 56' ' ' LEU . 13.7 tp -92.58 95.85 9.85 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.711 -1.132 . . . . 0.63 109.415 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 24.7 m -93.64 126.8 39.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.76 -0.654 . . . . 0.57999999999999996 109.576 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' ' 15' ' ' THR . 30.7 t -107.23 106.18 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.675 -0.41 . . . . 1.74 111.242 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.289 -0.863 . . . . 2.5800000000000001 109.498 173.737 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.959 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 4.8 t . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 108.656 -0.868 . . . . 1.4299999999999999 108.656 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -97.67 141.42 30.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.25 -0.432 . . . . 2.29 110.928 -175.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.548 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 74.9 t -117.37 117.2 54.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.749 -0.659 . . . . 1.51 110.397 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -88.86 106.22 18.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.112 -0.495 . . . . 3.5699999999999998 110.79 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 5' ' ' VAL . 66.9 t -113.76 115.02 48.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.115 -0.493 . . . . 1.26 109.937 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.77 -178.53 25.72 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.63 -0.795 . . . . 0.95999999999999996 112.029 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.27 146.47 24.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.959 -0.385 . . . . 2.1800000000000002 109.959 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -140.92 142.11 34.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.12 -0.491 . . . . 1.4099999999999999 109.718 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -116.65 117.59 30.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.405 -0.362 . . . . 1.03 110.697 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.35 140.37 47.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.938 0.399 . . . . 1.45 110.534 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.45 ' HB1' ' OG1' ' A' ' 143' ' ' THR . . . -116.67 112.5 21.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 0.58999999999999997 110.222 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.561 ' HG3' ' H ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -163.81 179.7 6.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.049 0.452 . . . . 3.4199999999999999 110.417 -178.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.561 ' H ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -103.42 158.73 16.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.63 110.328 178.199 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.634 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -80.46 -9.2 59.76 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.961 -0.462 . . . . 3.1400000000000001 111.023 -175.81 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.57 -15.36 79.25 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.081 -0.807 . . . . 0.75 111.081 172.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.516 ' HA ' HE21 ' A' ' 18' ' ' GLN . 0.0 OUTLIER -66.07 -31.79 72.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.124 -0.538 . . . . 2.1699999999999999 110.856 176.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.87 ' HB2' HG12 ' A' ' 100' ' ' VAL . 12.2 mt -91.25 19.8 5.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.889 -0.596 . . . . 1.6100000000000001 112.183 -168.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -36.25 93.59 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 N-CA-C 114.007 1.114 . . . . 1.6499999999999999 114.007 -172.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 69.9 -53.34 0.62 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.858 -1.064 . . . . 1.8300000000000001 111.923 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.826 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -158.13 78.41 0.82 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.189 0.518 . . . . 0.81999999999999995 111.26 176.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 19' ' ' LEU . . . -138.93 117.87 9.25 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.488 -0.778 . . . . 0.79000000000000004 109.096 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.401 ' HD3' ' HE1' ' A' ' 99' ' ' TYR . 96.0 Cg_endo -79.74 132.48 9.79 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.88 2.387 . . . . 1.1200000000000001 114.417 -170.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.733 HG23 HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -77.49 -56.61 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.425 -0.807 . . . . 2.5800000000000001 110.162 169.104 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.444 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -138.91 98.24 0.25 Allowed Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.388 -0.824 . . . . 0.73999999999999999 111.67 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.577 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 31.3 Cg_endo -67.66 126.58 14.95 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.271 1.98 . . . . 0.67000000000000004 111.378 176.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.75 124.44 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 1.1799999999999999 109.653 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 t -77.7 74.98 4.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.472 0.654 . . . . 1.6399999999999999 110.508 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.486 HG13 ' CG1' ' A' ' 5' ' ' VAL . 70.0 t -72.42 113.2 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.728 -0.669 . . . . 1.01 109.949 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.409 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 14.0 pt20 -116.12 125.82 52.87 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.778 -0.646 . . . . 2.48 109.833 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.524 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -111.61 130.61 55.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.408 -0.815 . . . . 0.69999999999999996 110.351 -177.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 35.2 tp -111.44 116.45 30.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.137 -0.483 . . . . 1.9399999999999999 111.324 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.09 71.63 0.84 Allowed Glycine 0 C--N 1.331 0.304 0 O-C-N 123.573 0.545 . . . . 1.8100000000000001 113.423 173.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.959 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 9.9 m -106.71 -68.83 0.86 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.883 -0.327 . . . . 1.8799999999999999 111.465 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 68.41 -48.22 0.55 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.466 0.706 . . . . 2.1400000000000001 112.32 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.81 69.89 1.26 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.206 0.527 . . . . 0.93999999999999995 110.348 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.645 HH11 ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -149.95 131.8 15.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.994 -0.548 . . . . 4.6399999999999997 110.586 -177.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.707 ' HG3' HG12 ' A' ' 89' ' ' VAL . 98.6 mt-30 -85.48 124.19 31.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.109 0.48 . . . . 1.75 110.078 178.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.645 ' HA ' HH11 ' A' ' 38' ' ' ARG . 71.0 t -95.14 110.55 24.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.088 -0.506 . . . . 0.54000000000000004 109.946 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -117.72 144.44 45.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 123.624 0.578 . . . . 0.35999999999999999 111.039 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.852 HD11 HD12 ' A' ' 96' ' ' ILE . 64.5 mt -103.7 129.07 51.0 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.488 -0.56 . . . . 0.83999999999999997 109.488 172.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.718 ' HG3' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -120.28 152.12 38.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.858 -0.793 . . . . 1.9299999999999999 108.858 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.496 ' HB1' ' OD1' ' A' ' 48' ' ' ASN . . . -92.67 159.2 15.56 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.719 -0.392 . . . . 0.40999999999999998 110.036 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.588 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 14.8 t70 -87.61 170.01 11.66 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.563 -0.903 . . . . 0.70999999999999996 108.563 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -65.54 -1.98 3.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.975 0.361 . . . . 1.3999999999999999 111.975 -173.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -88.94 -26.34 21.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.72 -0.218 . . . . 2.2200000000000002 111.262 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.496 ' OD1' ' HB1' ' A' ' 44' ' ' ALA . 28.9 p-10 -131.73 12.16 4.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.732 0.301 . . . . 1.3500000000000001 111.699 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 55.2 t80 -114.44 101.37 9.07 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.537 -0.542 . . . . 0.56000000000000005 109.537 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.779 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 8.3 pt-20 -95.35 93.71 7.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.877 0.37 . . . . 2.4100000000000001 110.387 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 68.39 -50.95 0.56 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.428 -0.805 . . . . 3.4300000000000002 112.036 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -172.04 36.58 0.15 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.183 -0.767 . . . . 0.56000000000000005 111.183 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.629 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 10.3 mmmm -137.84 134.87 35.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.946 -0.761 . . . . 2.1200000000000001 108.946 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -117.9 148.69 41.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.493 0.663 . . . . 0.56000000000000005 112.307 177.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.779 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 7.6 p90 -156.58 176.94 12.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.019 -0.991 . . . . 0.58999999999999997 111.1 -174.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 20.1 mt -89.24 111.05 21.76 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.351 -0.981 . . . . 1.53 108.351 168.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.534 ' HB ' ' HE1' ' A' ' 55' ' ' PHE . 8.3 tp -107.33 138.69 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.703 -0.48 . . . . 0.62 109.703 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 3.1 t -102.41 152.73 20.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.529 -0.305 . . . . 1.4399999999999999 110.372 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -49.11 -42.48 39.27 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.053 0.846 . . . . 2.3100000000000001 113.023 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.31 -21.8 66.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.711 0.263 . . . . 3.0899999999999999 111.711 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 63.34 84.43 0.15 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.365 0.602 . . . . 2.6200000000000001 109.95 -176.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -154.79 -40.7 0.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.615 . . . . 4.6600000000000001 111.034 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.87 153.52 50.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.915 -0.584 . . . . 2.5099999999999998 110.322 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.6 pptp? -152.25 128.04 10.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.804 -0.635 . . . . 2.0699999999999998 109.739 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.472 HD22 ' HG2' ' A' ' 104' ' ' GLN . 4.5 mt -114.27 119.12 35.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.261 -0.427 . . . . 1.98 110.026 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.453 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 93.4 m-85 -67.85 128.73 37.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 0.75 110.156 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 100' ' ' VAL . 11.2 m -121.27 123.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.878 -0.601 . . . . 0.72999999999999998 111.428 -175.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -97.21 111.67 23.81 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.961 -0.563 . . . . 1.8100000000000001 109.53 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.537 HG22 ' HB ' ' A' ' 96' ' ' ILE . 2.6 mt -76.32 86.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.562 -0.745 . . . . 0.81000000000000005 110.454 -176.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -93.62 142.84 25.68 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.995 -0.548 . . . . 3.79 109.866 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.541 ' HA ' HG23 ' A' ' 96' ' ' ILE . 77.1 Cg_exo -51.12 134.08 42.64 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.693 2.262 . . . . 0.58999999999999997 112.52 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tpt -75.14 72.75 2.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.984 -0.553 . . . . 1.71 109.948 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.4 t70 52.58 75.59 0.23 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.363 -0.835 . . . . 1.9199999999999999 110.785 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -146.56 -59.94 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.866 -0.606 . . . . 1.8899999999999999 111.248 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 m -151.02 178.83 8.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 1.7 111.055 -175.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.26 121.75 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.751 -0.658 . . . . 0.93999999999999995 109.891 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.521 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 17.8 m0 -113.07 168.21 9.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.256 -0.429 . . . . 0.5 111.001 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -87.97 131.37 34.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.018 -0.734 . . . . 0.51000000000000001 109.018 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 t -107.93 113.59 26.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.605 0.717 . . . . 0.58999999999999997 112.353 -171.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -127.24 161.33 28.82 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.782 -1.192 . . . . 1.7 107.782 170.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.515 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 15.8 m120 -85.91 -5.52 59.22 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.295 -0.562 . . . . 1.3899999999999999 110.812 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.82 -38.37 3.66 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.19 -1.005 . . . . 0.65000000000000002 111.81 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.718 HG12 ' HG3' ' A' ' 43' ' ' LYS . 27.0 m -140.49 156.72 23.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.971 0.415 . . . . 1.1599999999999999 110.403 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.684 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -132.15 108.87 9.56 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.659 -0.867 . . . . 0.35999999999999999 108.659 177.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.627 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 12.7 p90 -145.75 149.24 34.03 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.22 0.325 . . . . 0.58999999999999997 110.675 -174.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.524 ' HZ1' ' HB2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -80.55 141.36 35.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.948 -0.701 . . . . 1.3899999999999999 109.205 174.306 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -57.97 -33.81 69.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.843 -0.617 . . . . 2.1200000000000001 110.412 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -61.99 122.14 14.74 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.741 -0.663 . . . . 2.1000000000000001 111.587 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 39' ' ' GLN . 13.1 m -80.94 105.59 11.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.141 0.496 . . . . 1.05 109.95 173.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.42 ' N ' ' H ' ' A' ' 38' ' ' ARG . . . 170.75 -162.77 35.83 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.134 -1.032 . . . . 0.46000000000000002 112.603 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -84.0 163.81 19.71 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.013 0.435 . . . . 1.1699999999999999 110.447 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.524 ' HB2' ' HZ1' ' A' ' 86' ' ' LYS . 41.3 t90 -148.86 -62.41 0.24 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.344 -0.613 . . . . 0.51000000000000001 109.344 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 38.54 91.72 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 O-C-N 124.341 1.026 . . . . 1.25 115.161 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.16 -127.45 0.91 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.701 -0.761 . . . . 0.71999999999999997 112.377 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 p -135.85 133.02 37.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.054 0.454 . . . . 0.59999999999999998 111.805 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.852 HD12 HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -130.87 134.26 62.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 1.6299999999999999 109.692 176.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -106.61 156.26 16.22 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.34 -0.933 . . . . 0.45000000000000001 113.005 -170.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 mp -97.56 117.75 42.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.9 0.381 . . . . 0.82999999999999996 110.089 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.826 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 1.1 m-85 -126.19 133.56 51.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.631 -0.713 . . . . 1.28 109.509 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.87 HG12 ' HB2' ' A' ' 19' ' ' LEU . 12.3 p -66.21 119.77 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.855 -0.794 . . . . 1.1399999999999999 108.855 173.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.92 83.54 1.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.579 0.704 . . . . 1.02 109.477 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.99 93.83 2.3 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 114.799 -1.091 . . . . 1.53 110.961 -171.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 16.5 pt20 -31.48 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.276 0.843 . . . . 2.1099999999999999 113.276 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.472 ' HG2' HD22 ' A' ' 65' ' ' LEU . 55.9 tp60 -82.59 -15.37 52.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 2.6200000000000001 110.692 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 m 62.6 26.31 15.61 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.361 0.6 . . . . 2.4300000000000002 111.134 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.634 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 7.2 t30 64.08 89.41 0.09 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.589 -0.732 . . . . 1.5600000000000001 112.204 172.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.3 m -89.6 133.87 33.55 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.819 -0.808 . . . . 1.6799999999999999 108.819 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -19.46 90.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.794 4.329 . . . . 1.26 115.1 -171.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.616 ' CB ' ' HE1' ' A' ' 112' ' ' TYR . 90.0 Cg_endo -99.99 -161.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.968 3.112 . . . . 0.76000000000000001 113.889 -174.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.55 -101.98 0.15 Allowed Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.926 -1.034 . . . . 0.76000000000000001 110.633 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -112.38 111.41 22.25 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.339 -0.615 . . . . 2.04 109.339 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.616 ' HE1' ' CB ' ' A' ' 109' ' ' PRO . 27.6 m-85 -95.35 128.09 41.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.233 0.54 . . . . 0.75 110.303 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.7 m -116.06 98.46 6.64 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.071 -0.968 . . . . 0.82999999999999996 110.395 -175.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.474 ' HG ' ' HB ' ' A' ' 138' ' ' THR . 0.2 OUTLIER -119.34 100.55 7.38 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.042 -0.527 . . . . 0.51000000000000001 110.367 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.711 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 23.8 m -88.37 132.52 34.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.148 -0.478 . . . . 0.58999999999999997 110.527 -178.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -114.63 124.84 52.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.083 0.468 . . . . 1.27 110.556 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.473 ' HA ' HG23 ' A' ' 135' ' ' THR . 27.5 m -91.06 113.04 25.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.752 -0.658 . . . . 0.69999999999999996 110.478 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.1 122.65 6.25 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.737 -0.744 . . . . 0.80000000000000004 111.754 177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.57 -176.33 39.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.241 -0.98 . . . . 0.53000000000000003 112.426 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 38' ' ' ARG . 39.3 p90 -102.96 177.84 4.73 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.278 0.561 . . . . 0.89000000000000001 110.294 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.805 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.9 OUTLIER -147.29 149.32 32.62 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.323 -0.992 . . . . 0.56000000000000005 108.323 -177.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.61 144.14 51.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.421 0.153 . . . . 1.4199999999999999 110.79 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.438 ' HG3' ' HE2' ' A' ' 126' ' ' LYS . 32.9 mmtp 74.97 -144.34 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.62 0.768 . . . . 3.4700000000000002 111.368 175.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -150.68 123.21 8.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.322 0.582 . . . . 2.0800000000000001 112.275 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.544 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 27.6 t-20 68.44 -28.58 0.15 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.445 1.098 . . . . 2.4700000000000002 113.947 174.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.438 ' HE2' ' HG3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -65.34 -3.19 3.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.219 0.533 . . . . 1.96 111.164 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.805 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 46.1 tt0 66.79 66.45 0.44 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.12 -0.946 . . . . 2.02 110.862 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 121' ' ' TRP . . . -90.89 46.96 2.93 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.329 -0.938 . . . . 0.77000000000000002 111.37 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.619 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 3.9 p90 -86.69 144.66 27.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.773 0.321 . . . . 1.21 110.856 -170.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 46.3 m -150.3 132.26 7.83 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 110.37 -0.233 . . . . 1.47 110.37 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.71 132.74 47.14 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.708 2.272 . . . . 0.92000000000000004 112.345 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -156.28 95.17 1.57 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.234 -0.439 . . . . 1.52 110.4 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 5' ' ' VAL . . . 130.25 -102.71 0.54 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.776 -0.726 . . . . 1.1699999999999999 112.162 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.4 m -152.3 147.45 26.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.711 0.256 . . . . 2.4700000000000002 110.741 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.473 HG23 ' HA ' ' A' ' 117' ' ' THR . 28.9 m -101.2 127.49 47.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.649 -0.5 . . . . 1.8200000000000001 109.649 174.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.96 141.11 12.41 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.467 -0.873 . . . . 0.67000000000000004 112.524 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.711 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 72.8 m -94.3 123.15 37.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.025 0.44 . . . . 0.57999999999999996 110.913 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.474 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 24.9 m -85.88 115.26 23.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.514 -0.921 . . . . 0.52000000000000002 108.514 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -100.88 111.91 24.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.21 0.528 . . . . 2.1800000000000002 110.208 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 tp -108.64 100.45 9.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.048 -0.978 . . . . 0.63 110.385 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 m -93.15 143.67 26.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.852 -0.613 . . . . 0.57999999999999996 109.809 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.631 ' HA ' HH12 ' A' ' 16' ' ' ARG . 7.3 p -71.02 132.79 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.467 0.651 . . . . 1.74 112.349 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.45 ' OG1' ' HB1' ' A' ' 13' ' ' ALA . 85.5 m . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.133 -0.94 . . . . 2.5800000000000001 109.129 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.852 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 48.2 t . . . . . 0 N--CA 1.44 -0.938 0 N-CA-C 108.3 -1.0 . . . . 1.4299999999999999 108.3 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -85.68 123.71 31.38 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.285 -0.566 . . . . 2.29 110.393 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.536 HG12 HG23 ' A' ' 7' ' ' VAL . 61.3 t -95.56 112.06 27.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.718 -0.673 . . . . 1.51 110.045 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.721 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 14.5 mmm180 -81.64 93.74 6.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.706 -0.679 . . . . 3.5699999999999998 110.834 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.58 HG12 ' HA3' ' A' ' 136' ' ' GLY . 37.2 t -107.62 115.62 49.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.394 -0.965 . . . . 1.26 108.394 171.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.76 -175.77 21.65 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.498 -0.858 . . . . 0.95999999999999996 112.261 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -100.59 146.15 27.49 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.926 -0.398 . . . . 2.1800000000000002 109.926 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -152.6 139.26 18.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.552 -0.536 . . . . 1.4099999999999999 109.552 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.9 m -107.77 115.89 30.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.183 -0.462 . . . . 1.03 110.305 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 140' ' ' LEU . 4.1 p -110.61 126.01 67.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.14 -0.482 . . . . 1.45 109.9 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -105.31 104.21 13.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.898 -0.592 . . . . 0.58999999999999997 110.452 -176.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -172.9 -178.68 1.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 3.4199999999999999 110.478 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.5 p -107.43 162.77 13.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.127 -0.488 . . . . 0.63 111.065 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.654 ' HB2' HH11 ' A' ' 16' ' ' ARG . 0.0 OUTLIER -80.27 -0.44 36.48 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.644 -0.502 . . . . 3.1400000000000001 109.644 176.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.603 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -79.39 -17.58 75.76 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.367 -0.693 . . . . 0.75 111.367 177.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -74.17 -22.62 59.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.847 -0.797 . . . . 2.1699999999999999 108.847 173.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.924 HD21 HG12 ' A' ' 25' ' ' ILE . 67.2 mt -87.16 95.9 10.12 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.699 -1.137 . . . . 1.6100000000000001 110.985 -175.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.0 m -101.3 68.05 1.2 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.045 -0.724 . . . . 1.6499999999999999 109.045 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.4 t70 69.56 -62.68 0.41 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.753 -1.112 . . . . 1.8300000000000001 111.036 -175.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -114.31 98.09 6.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.797 0.332 . . . . 0.81999999999999995 110.887 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -154.54 92.08 2.98 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.439 . . . . 0.79000000000000004 111.071 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 28.7 Cg_endo -64.19 80.82 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.349 2.699 . . . . 1.1200000000000001 112.372 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.924 HG12 HD21 ' A' ' 19' ' ' LEU . 1.1 pp -70.7 -53.71 21.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.405 -0.816 . . . . 2.5800000000000001 112.336 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.24 63.88 0.57 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.203 -0.998 . . . . 0.73999999999999999 113.249 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.634 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 5.5 Cg_endo -47.07 111.59 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.601 2.867 . . . . 0.67000000000000004 113.004 172.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 p -84.63 134.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.896 -0.593 . . . . 1.1799999999999999 109.813 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -88.64 102.87 15.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.672 0.748 . . . . 1.6399999999999999 110.804 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.663 ' CG2' HD11 ' A' ' 96' ' ' ILE . 41.5 t -94.79 116.26 35.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.556 -0.747 . . . . 1.01 110.204 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.721 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 34.7 tt0 -102.01 125.14 48.62 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.641 -0.709 . . . . 2.48 110.182 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.667 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -112.89 113.98 26.29 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.956 -0.387 . . . . 0.69999999999999996 109.956 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.1 mt -104.99 111.52 24.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.969 0.414 . . . . 1.9399999999999999 111.986 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.95 55.32 8.18 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.508 -0.769 . . . . 1.8100000000000001 113.283 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.852 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 84.1 m -87.14 -49.31 7.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.857 0.329 . . . . 1.8799999999999999 110.585 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.8 t30 71.14 -63.78 0.41 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.708 0.803 . . . . 2.1400000000000001 112.69 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.91 71.0 1.25 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.676 0.75 . . . . 0.93999999999999995 109.19 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.619 ' NE ' ' HB3' ' A' ' 120' ' ' TYR . 41.0 ttt-85 -146.54 133.19 19.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.178 -0.919 . . . . 4.6399999999999997 111.012 -169.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -83.17 96.86 8.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.615 -0.513 . . . . 1.75 109.615 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 46.7 t -73.6 117.22 17.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 0.54000000000000004 110.315 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -119.48 148.31 43.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.129 -0.487 . . . . 0.35999999999999999 110.977 -176.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 mt -102.77 113.79 27.5 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.115 -0.698 . . . . 0.83999999999999997 109.115 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.541 ' HG3' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -104.75 125.8 51.19 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.632 -0.507 . . . . 1.9299999999999999 109.632 -178.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.587 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -76.81 143.26 39.9 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.517 -0.549 . . . . 0.40999999999999998 109.517 174.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.63 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 27.2 t70 -76.02 148.34 38.11 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.918 -0.771 . . . . 0.70999999999999996 108.918 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.723 ' HA ' ' HB3' ' A' ' 49' ' ' PHE . 10.1 t -56.56 -16.51 6.18 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.866 0.691 . . . . 1.3999999999999999 112.866 -172.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.28 -31.45 72.04 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.239 0.543 . . . . 2.2200000000000002 110.289 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.587 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 5.1 p-10 -129.43 24.31 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.773 -0.648 . . . . 1.3500000000000001 109.479 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.723 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 10.1 t80 -134.03 108.5 8.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.257 -0.883 . . . . 0.56000000000000005 109.16 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.787 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 10.9 pt-20 -116.65 116.61 27.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.649 0.261 . . . . 2.4100000000000001 110.448 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 71.34 -51.45 0.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.793 0.837 . . . . 3.4300000000000002 111.805 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.468 ' O ' ' HD2' ' A' ' 53' ' ' LYS . . . 170.02 31.17 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.719 -0.952 . . . . 0.56000000000000005 110.719 -177.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.702 ' HA ' ' HB3' ' A' ' 81' ' ' ASN . 14.5 mptt -129.88 140.23 51.02 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.178 -0.675 . . . . 2.1200000000000001 109.178 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -120.69 147.68 44.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.585 0.707 . . . . 0.56000000000000005 111.636 176.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.787 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 16.9 p90 -157.46 174.93 14.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.886 -1.052 . . . . 0.58999999999999997 110.752 -170.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.557 HD13 HD23 ' A' ' 140' ' ' LEU . 8.6 mt -84.16 111.84 19.71 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.146 -1.057 . . . . 1.53 108.146 170.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.591 ' HB ' ' HE1' ' A' ' 55' ' ' PHE . 8.4 tp -105.3 125.83 60.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.805 0.812 . . . . 0.62 110.021 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.575 ' HB2' ' CE1' ' A' ' 112' ' ' TYR . 33.5 t -76.84 135.74 38.89 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.073 -0.967 . . . . 1.4399999999999999 110.714 -177.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.52 -34.17 72.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.868 -0.79 . . . . 2.3100000000000001 108.868 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -69.28 -24.67 63.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.566 -1.197 . . . . 3.0899999999999999 110.611 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 t30 63.83 97.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.701 -0.681 . . . . 2.6200000000000001 111.27 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -166.27 -44.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.716 -0.674 . . . . 4.6600000000000001 110.584 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.39 139.78 53.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.902 -0.59 . . . . 2.5099999999999998 109.955 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.59 ' HB2' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -135.35 106.51 6.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.989 0.899 . . . . 2.0699999999999998 109.429 170.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.789 HD21 HG23 ' A' ' 100' ' ' VAL . 7.9 tp -108.19 126.32 52.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.24 -0.891 . . . . 1.98 110.927 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 5.2 m-85 -72.95 141.4 47.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.956 -1.02 . . . . 0.75 110.306 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.572 HG12 ' HA ' ' A' ' 100' ' ' VAL . 16.4 m -136.65 142.61 37.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.549 -0.296 . . . . 0.72999999999999998 110.468 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -102.89 120.54 40.8 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.788 -0.449 . . . . 1.8100000000000001 109.788 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.485 HG22 ' HB ' ' A' ' 96' ' ' ILE . 0.9 OUTLIER -82.61 87.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.816 -0.629 . . . . 0.81000000000000005 109.876 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.498 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 60.0 ttt180 -93.99 128.63 40.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.414 -0.357 . . . . 3.79 110.812 -174.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.71 ' HA ' HG22 ' A' ' 96' ' ' ILE . 4.2 Cg_endo -50.36 139.77 36.01 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.319 2.679 . . . . 0.58999999999999997 112.216 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.6 ttt -72.66 64.11 0.63 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.661 -0.7 . . . . 1.71 111.304 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 t70 62.89 14.96 7.89 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.715 0.806 . . . . 1.9199999999999999 112.302 175.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.403 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 58.7 m-80 -78.13 -35.0 49.61 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.829 -0.544 . . . . 1.8899999999999999 111.559 -175.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.2 p -170.78 172.74 5.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.378 -0.23 . . . . 1.7 110.378 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.72 129.06 35.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.981 0.42 . . . . 0.93999999999999995 110.101 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.715 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 13.8 m0 -117.28 155.84 28.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.07 -0.513 . . . . 0.5 110.535 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.8 m -89.6 113.22 24.62 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.265 -0.643 . . . . 0.51000000000000001 109.265 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 t -88.58 124.25 33.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.796 0.807 . . . . 0.58999999999999997 111.91 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -130.56 160.98 32.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.44 -1.318 . . . . 1.7 107.44 168.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.702 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 16.1 m120 -85.94 -3.55 58.95 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.368 -0.533 . . . . 1.3899999999999999 111.262 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.92 -36.92 2.65 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.303 -0.951 . . . . 0.65000000000000002 111.664 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.541 HG12 ' HG3' ' A' ' 43' ' ' LYS . 29.3 m -137.01 156.67 34.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.997 0.427 . . . . 1.1599999999999999 110.306 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.615 ' HD1' ' HE3' ' A' ' 77' ' ' TRP . 0.7 OUTLIER -136.64 106.74 6.33 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.95 -1.13 . . . . 0.35999999999999999 107.95 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 8.7 p90 -138.19 146.5 42.76 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.913 -0.315 . . . . 0.58999999999999997 111.377 -174.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.733 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 49.3 pttt -78.22 157.57 29.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 1.3899999999999999 110.826 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -85.21 7.47 21.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.795 . . . . 2.1200000000000001 110.041 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.733 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 35.8 m-20 -106.48 128.04 53.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.538 -0.755 . . . . 2.1000000000000001 109.331 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -90.04 106.36 17.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.555 0.693 . . . . 1.05 111.002 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.28 -162.71 36.5 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.051 -0.819 . . . . 0.46000000000000002 111.051 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.4 m -84.14 147.25 27.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.976 0.417 . . . . 1.1699999999999999 109.941 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.487 ' CD2' ' HZ2' ' A' ' 77' ' ' TRP . 55.3 t90 -120.07 -59.05 1.83 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.65 -0.5 . . . . 0.51000000000000001 109.65 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 34.53 90.42 0.01 OUTLIER Glycine 0 N--CA 1.464 0.548 0 O-C-N 124.637 1.21 . . . . 1.25 115.477 176.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.16 -125.09 0.75 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.004 -0.617 . . . . 0.71999999999999997 111.955 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.457 ' O ' ' HH2' ' A' ' 92' ' ' TRP . 1.2 p -137.18 132.42 33.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 0.59999999999999998 111.571 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.71 HG22 ' HA ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -118.46 134.8 60.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.169 -0.678 . . . . 1.6299999999999999 109.169 174.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.634 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -99.58 158.52 19.81 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.331 -0.937 . . . . 0.45000000000000001 112.555 -175.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.513 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.8 mp -95.03 112.81 28.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.649 -0.5 . . . . 0.82999999999999996 109.649 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 70' ' ' ARG . 1.6 m-85 -110.95 120.91 43.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.817 -0.808 . . . . 1.28 108.817 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.789 HG23 HD21 ' A' ' 65' ' ' LEU . 14.5 p -58.68 137.34 21.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.816 0.341 . . . . 1.1399999999999999 110.993 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.65 81.94 8.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.715 -0.846 . . . . 1.02 108.715 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.65 110.34 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.525 -0.762 . . . . 1.53 111.815 -172.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.413 ' H ' ' HG3' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -40.09 125.11 1.95 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.493 0.663 . . . . 2.1099999999999999 112.582 177.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.587 HE21 HD13 ' A' ' 65' ' ' LEU . 7.7 tp-100 -92.69 21.27 5.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.559 . . . . 2.6200000000000001 110.461 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 6.1 m 69.25 -11.58 0.47 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.696 -0.684 . . . . 2.4300000000000002 112.714 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.603 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 1.9 t-20 68.18 88.21 0.11 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.73 0.776 . . . . 1.5600000000000001 110.629 -175.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.63 146.8 34.93 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 114.689 -1.141 . . . . 1.6799999999999999 109.007 173.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -38.26 93.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.999 3.132 . . . . 1.26 112.509 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.605 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 3.0 Cg_exo -76.84 -179.56 5.51 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.198 2.598 . . . . 0.76000000000000001 113.333 -169.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.06 -124.42 0.89 Allowed Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.151 -1.18 . . . . 0.76000000000000001 110.151 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 58' ' ' SER . 51.6 t-20 -97.5 107.4 19.9 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.129 -0.693 . . . . 2.04 109.129 172.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 58' ' ' SER . 68.4 m-85 -102.16 107.34 18.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.468 0.651 . . . . 0.75 109.524 174.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -97.85 126.79 43.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.017 -0.992 . . . . 0.82999999999999996 110.534 -175.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 138' ' ' THR . 0.1 OUTLIER -135.01 107.14 7.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.548 0.689 . . . . 0.51000000000000001 109.927 176.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 11.9 m -94.02 139.76 30.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.456 -0.793 . . . . 0.58999999999999997 110.299 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 44' ' ' ALA . 95.4 mt -124.96 126.14 45.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.909 0.385 . . . . 1.27 110.569 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 m -101.18 117.0 34.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.216 -0.447 . . . . 0.69999999999999996 110.219 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.27 147.71 47.79 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.748 -0.739 . . . . 0.80000000000000004 112.576 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.04 179.73 39.71 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.783 -0.722 . . . . 0.53000000000000003 112.214 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.619 ' HB3' ' NE ' ' A' ' 38' ' ' ARG . 48.6 p90 -102.63 174.16 6.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.051 0.453 . . . . 0.89000000000000001 110.325 177.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.724 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.8 OUTLIER -132.69 146.53 51.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.413 -0.812 . . . . 0.56000000000000005 109.101 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -118.85 141.28 48.78 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.069 0.461 . . . . 1.4199999999999999 111.208 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.537 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 7.0 tptm 71.97 -145.07 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.676 -1.147 . . . . 3.4700000000000002 111.265 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 126' ' ' LYS . 4.9 t70 -146.98 124.42 11.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.615 -0.266 . . . . 2.0800000000000001 111.496 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.589 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.5 OUTLIER 53.64 -5.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.132 1.773 . . . . 2.4700000000000002 115.542 176.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.608 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -79.03 -3.38 44.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 1.96 110.216 177.466 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.724 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 33.6 tt0 69.08 71.61 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.792 -1.095 . . . . 2.02 110.644 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.608 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -106.97 43.01 1.78 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.698 -0.763 . . . . 0.77000000000000002 112.134 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -78.19 130.08 35.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.15 0.5 . . . . 1.21 110.857 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 17.6 m -121.56 118.91 29.49 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.215 -0.448 . . . . 1.47 110.559 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 130' ' ' THR . 25.0 Cg_exo -63.93 123.37 11.83 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.964 2.443 . . . . 0.92000000000000004 112.27 177.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.01 94.15 1.5 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.967 -0.56 . . . . 1.52 110.193 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 145.58 -145.95 15.64 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.284 -0.726 . . . . 1.1699999999999999 111.284 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.532 HG21 ' NH1' ' A' ' 6' ' ' ARG . 38.3 p -110.12 158.08 18.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.989 0.423 . . . . 2.4700000000000002 111.398 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.0 m -99.93 100.32 11.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.824 -0.626 . . . . 1.8200000000000001 109.786 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.58 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -93.79 160.76 24.44 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.847 -0.692 . . . . 0.67000000000000004 111.775 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.1 m -126.82 109.51 12.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.026 0.413 . . . . 0.57999999999999996 111.311 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.602 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 3.7 m -82.23 116.43 21.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.634 -0.876 . . . . 0.52000000000000002 108.634 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -112.1 108.83 18.24 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.27 0.557 . . . . 2.1800000000000002 110.544 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.557 HD23 HD13 ' A' ' 56' ' ' LEU . 15.2 tp -96.56 109.16 21.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.031 -0.986 . . . . 0.63 109.072 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.0 m -121.52 144.47 48.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.529 -0.759 . . . . 0.57999999999999996 110.947 -173.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.605 ' HB ' ' HB2' ' A' ' 109' ' ' PRO . 13.0 p -83.16 141.73 14.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.433 -0.581 . . . . 1.74 109.433 172.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.243 0.749 0 CA-C-O 118.426 -0.797 . . . . 2.5800000000000001 109.723 178.923 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 120' ' ' TYR . 43.5 t . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.656 -0.498 . . . . 1.4299999999999999 109.656 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.414 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 9.9 tt0 -103.61 111.84 24.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.192 -0.458 . . . . 2.29 110.766 -177.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.703 HG21 HG13 ' A' ' 40' ' ' VAL . 38.5 t -107.49 125.32 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.118 -0.492 . . . . 1.51 110.701 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.594 ' HG2' ' HB3' ' A' ' 31' ' ' GLN . 11.1 ptp180 -92.18 142.54 27.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.036 0.446 . . . . 3.5699999999999998 110.684 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.7 t -120.53 115.43 47.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.781 -0.822 . . . . 1.26 108.781 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.38 126.6 11.5 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.554 -0.831 . . . . 0.95999999999999996 112.38 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -68.34 104.04 1.77 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.574 -0.528 . . . . 2.1800000000000002 109.574 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' A' ' 28' ' ' VAL . 72.8 mt -105.37 152.43 22.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.95 -0.568 . . . . 1.4099999999999999 110.739 -176.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 m -133.09 114.42 13.89 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.035 -0.728 . . . . 1.03 109.035 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.422 HG11 HG22 ' A' ' 25' ' ' ILE . 41.3 t -118.16 140.32 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.386 -0.37 . . . . 1.45 110.313 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.99 103.21 11.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.284 -0.416 . . . . 0.58999999999999997 110.028 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -165.02 176.04 8.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.433 -0.58 . . . . 3.4199999999999999 109.433 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.515 HG22 HG23 ' A' ' 142' ' ' VAL . 31.9 p -96.43 163.34 13.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.613 -0.267 . . . . 0.63 110.911 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.519 ' HD2' ' H ' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -86.98 -3.42 59.09 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.91 -0.774 . . . . 3.1400000000000001 108.91 176.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -79.77 -28.22 51.59 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.79 -0.924 . . . . 0.75 110.79 173.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.89 -39.08 87.92 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.624 -0.88 . . . . 2.1699999999999999 108.624 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 100' ' ' VAL . 62.8 mt -63.95 113.33 3.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.912 -1.04 . . . . 1.6100000000000001 109.746 171.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 m -130.4 85.28 2.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.562 0.22 . . . . 1.6499999999999999 110.536 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 7.9 m-20 63.48 -74.66 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.664 -0.698 . . . . 1.8300000000000001 111.854 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.13 81.71 1.87 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.191 0.52 . . . . 0.81999999999999995 110.671 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.18 100.27 4.2 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.544 -0.753 . . . . 0.79000000000000004 109.89 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.53 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 59.5 Cg_endo -72.1 105.51 1.85 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.816 2.344 . . . . 1.1200000000000001 112.847 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.422 HG22 HG11 ' A' ' 12' ' ' VAL . 49.4 mm -96.3 -26.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.181 -0.463 . . . . 2.5800000000000001 110.734 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.75 54.65 0.62 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.897 -1.144 . . . . 0.73999999999999999 113.689 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 12.1 Cg_endo -57.03 114.1 1.77 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.281 1.987 . . . . 0.67000000000000004 112.064 170.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.468 ' HA ' HD11 ' A' ' 10' ' ' LEU . 45.9 t -87.75 135.82 24.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.881 -0.6 . . . . 1.1799999999999999 110.433 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.95 102.24 4.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.603 0.716 . . . . 1.6399999999999999 110.133 174.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.899 HG21 HG12 ' A' ' 96' ' ' ILE . 6.7 t -94.08 141.96 14.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.862 -1.063 . . . . 1.01 111.879 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.594 ' HB3' ' HG2' ' A' ' 6' ' ' ARG . 31.4 tt0 -146.87 117.41 7.5 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.651 -1.159 . . . . 2.48 109.079 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.437 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -110.46 105.73 14.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.287 -0.415 . . . . 0.69999999999999996 110.144 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.4 tp -77.61 112.76 14.76 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.508 -0.553 . . . . 1.9399999999999999 109.508 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.64 -121.97 6.2 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.704 -0.76 . . . . 1.8100000000000001 111.773 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.437 ' SG ' ' HB1' ' A' ' 32' ' ' ALA . 66.7 m 65.13 11.6 7.3 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 122.598 0.359 . . . . 1.8799999999999999 111.707 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.661 ' HA ' ' HA2' ' A' ' 90' ' ' GLY . 19.3 m120 -63.36 -11.44 22.51 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.631 0.604 . . . . 2.1400000000000001 112.631 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.787 ' HA ' ' CG1' ' A' ' 89' ' ' VAL . . . -144.62 60.95 1.33 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.5 -0.556 . . . . 0.93999999999999995 109.5 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 38' ' ' ARG . 0.8 OUTLIER -170.07 159.96 7.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.361 -0.836 . . . . 4.6399999999999997 109.68 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -94.22 143.38 26.43 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.116 -0.698 . . . . 1.75 109.116 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.703 HG13 HG21 ' A' ' 5' ' ' VAL . 71.8 t -97.99 122.05 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.424 -0.584 . . . . 0.54000000000000004 109.424 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -122.48 141.33 51.75 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 123.368 0.418 . . . . 0.35999999999999999 111.099 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.445 ' CD1' HG21 ' A' ' 96' ' ' ILE . 31.3 mt -102.72 126.21 49.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.194 -0.669 . . . . 0.83999999999999997 109.194 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.8 ' HE2' ' HB2' ' A' ' 129' ' ' PHE . 6.3 mptt -119.2 152.12 37.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.571 -0.529 . . . . 1.9299999999999999 109.571 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -96.22 153.62 17.7 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.803 -0.443 . . . . 0.40999999999999998 109.803 173.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.712 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 31.2 t70 -82.44 164.79 20.74 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.719 -0.845 . . . . 0.70999999999999996 108.719 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -56.17 -18.48 10.24 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.336 0.588 . . . . 1.3999999999999999 110.677 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.77 -38.8 72.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.271 -0.877 . . . . 2.2200000000000002 111.526 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 27.0 p-10 -139.57 22.31 2.52 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.723 0.268 . . . . 1.3500000000000001 111.723 -176.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.67 ' HE1' ' HA2' ' A' ' 82' ' ' GLY . 60.0 t80 -123.48 102.39 7.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.435 -0.58 . . . . 0.56000000000000005 109.435 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -103.3 105.8 16.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 2.4100000000000001 110.385 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 67.19 -56.43 0.44 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.107 0.879 . . . . 3.4300000000000002 112.04 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -175.58 35.08 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.006 -0.838 . . . . 0.56000000000000005 111.006 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 81' ' ' ASN . 34.7 mmtp -135.07 135.57 41.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.001 -0.74 . . . . 2.1200000000000001 109.001 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -110.72 142.33 42.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.611 0.719 . . . . 0.56000000000000005 111.965 175.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 64' ' ' LYS . 44.1 p90 -151.32 -177.0 5.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.974 -1.012 . . . . 0.58999999999999997 110.014 -176.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.887 HD22 HD22 ' A' ' 114' ' ' LEU . 13.8 mt -99.53 123.81 44.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.579 -0.897 . . . . 1.53 108.579 172.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 113' ' ' THR . 9.0 tp -106.81 124.6 62.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.472 0.653 . . . . 0.62 111.035 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.5 t -68.88 125.08 25.49 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.275 -1.009 . . . . 1.4399999999999999 108.275 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -57.8 -26.2 61.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.119 0.415 . . . . 2.3100000000000001 112.119 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -84.26 -1.64 55.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.61 -0.268 . . . . 3.0899999999999999 111.368 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 57.99 89.21 0.05 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.167 0.587 . . . . 2.6200000000000001 111.244 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -155.79 -38.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 4.6600000000000001 111.055 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.74 144.71 37.6 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.415 -0.357 . . . . 2.5099999999999998 110.35 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.636 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 2.4 pptp? -146.7 145.77 30.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.971 -0.559 . . . . 2.0699999999999998 110.134 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.63 HD12 HG23 ' A' ' 100' ' ' VAL . 1.3 pt? -138.03 132.13 31.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.139 -0.482 . . . . 1.98 110.415 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -75.64 128.61 35.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.75 110.129 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.555 ' HB ' HG23 ' A' ' 98' ' ' ILE . 15.9 m -118.33 136.89 54.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.862 -0.608 . . . . 0.72999999999999998 110.544 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.51 ' HB3' ' HE ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -96.5 110.65 22.99 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.707 -0.679 . . . . 1.8100000000000001 109.356 178.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.429 HG23 HG12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -79.99 102.09 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.928 -0.767 . . . . 0.81000000000000005 108.928 174.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.558 ' HG2' ' CZ ' ' A' ' 84' ' ' PHE . 89.3 mtt180 -122.99 140.47 33.5 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.244 -0.434 . . . . 3.79 110.181 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.798 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 1.7 Cg_endo -48.3 132.93 24.58 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.942 2.428 . . . . 0.58999999999999997 111.927 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.4 ttt -63.22 -49.96 72.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.408 -0.36 . . . . 1.71 110.275 -177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -177.79 105.95 0.05 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.121 -0.49 . . . . 1.9199999999999999 110.566 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 1.1 m-80 -161.81 -62.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 1.8899999999999999 111.198 -177.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.8 t -154.69 163.68 39.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.915 -0.402 . . . . 1.7 109.915 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.9 127.58 32.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.069 0.461 . . . . 0.93999999999999995 111.252 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.664 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.1 m0 -112.28 150.75 30.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.651 -0.704 . . . . 0.5 110.27 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.6 m -83.21 125.1 31.2 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.142 -0.688 . . . . 0.51000000000000001 109.142 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -100.47 122.36 43.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.798 0.808 . . . . 0.58999999999999997 112.54 -171.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -135.42 159.71 40.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.725 -1.213 . . . . 1.7 107.725 167.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 11.4 m120 -82.93 -4.38 58.12 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.276 -0.57 . . . . 1.3899999999999999 110.833 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.67 ' HA2' ' HE1' ' A' ' 49' ' ' PHE . . . -100.48 -41.33 2.77 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.203 -0.998 . . . . 0.65000000000000002 111.885 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.68 155.4 30.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.963 -0.384 . . . . 1.1599999999999999 109.963 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -137.99 109.85 7.17 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.291 -1.003 . . . . 0.35999999999999999 108.291 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 13.5 p90 -140.09 143.89 36.52 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.15 0.281 . . . . 0.58999999999999997 111.498 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -77.91 137.5 38.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 120.328 -0.549 . . . . 1.3899999999999999 109.542 177.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -63.68 -24.47 67.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.734 -0.667 . . . . 2.1200000000000001 110.204 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 4.6 m-20 -73.92 147.14 43.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.519 -0.764 . . . . 2.1000000000000001 110.671 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.787 ' CG1' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -94.84 143.0 12.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.666 -0.864 . . . . 1.05 108.666 168.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.661 ' HA2' ' HA ' ' A' ' 36' ' ' ASN . . . 131.77 -175.59 19.64 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.411 -0.9 . . . . 0.46000000000000002 111.636 -177.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m -72.39 -178.73 2.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.976 -0.379 . . . . 1.1699999999999999 109.976 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.798 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 21.1 t90 -157.38 -42.54 0.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.733 -0.212 . . . . 0.51000000000000001 110.575 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.709 ' O ' ' HB ' ' A' ' 30' ' ' VAL . . . 50.84 -120.35 8.92 Favored Glycine 0 C--O 1.21 -1.366 0 N-CA-C 111.292 -0.723 . . . . 1.25 111.292 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.45 -151.68 43.68 Favored Glycine 0 C--N 1.318 -0.434 0 C-N-CA 121.142 -0.552 . . . . 0.71999999999999997 114.225 163.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.534 ' HA ' HG23 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -147.84 133.51 18.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.085 -0.557 . . . . 0.59999999999999998 110.427 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.899 HG12 HG21 ' A' ' 30' ' ' VAL . 6.8 mm -107.52 129.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.357 -0.609 . . . . 1.6299999999999999 109.357 177.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -100.82 149.2 18.45 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.712 -0.756 . . . . 0.45000000000000001 111.704 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.555 HG23 ' HB ' ' A' ' 67' ' ' VAL . 71.3 mt -99.58 114.45 37.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 120.897 0.38 . . . . 0.82999999999999996 110.567 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 8.6 m-85 -115.22 131.97 56.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 1.28 108.818 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.63 HG23 HD12 ' A' ' 65' ' ' LEU . 13.8 p -71.34 134.48 29.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.799 0.333 . . . . 1.1399999999999999 110.558 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -74.89 91.47 2.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.059 0.457 . . . . 1.02 110.902 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.13 13.34 62.15 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.132 -0.556 . . . . 1.53 113.918 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.585 ' HA ' HG11 ' A' ' 100' ' ' VAL . 64.9 tt0 62.22 113.71 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.709 0.766 . . . . 2.1099999999999999 112.367 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.496 ' H ' HG21 ' A' ' 100' ' ' VAL . 7.5 tp60 -76.8 -27.29 55.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.479 -0.782 . . . . 2.6200000000000001 109.645 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.1 m 65.42 20.52 11.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.126 -0.943 . . . . 2.4300000000000002 110.195 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.541 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 7.6 t30 60.79 87.94 0.09 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.905 -1.043 . . . . 1.5600000000000001 112.358 173.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.664 HG22 ' HD2' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -92.09 143.55 27.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.295 -1.002 . . . . 1.6799999999999999 108.295 174.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.664 ' HD2' HG22 ' A' ' 107' ' ' THR . 94.2 Cg_exo -20.3 88.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.348 1 C-N-CA 125.617 4.212 . . . . 1.26 114.818 -175.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.477 ' HG2' HG21 ' A' ' 142' ' ' VAL . 9.9 Cg_endo -92.2 -154.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.687 2.925 . . . . 0.76000000000000001 114.354 -171.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.42 -131.08 1.85 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.364 -1.895 . . . . 0.76000000000000001 108.364 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -97.22 123.43 41.0 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.101 -0.703 . . . . 2.04 109.101 170.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -105.84 128.45 53.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.002 0.43 . . . . 0.75 109.916 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 57' ' ' ILE . 91.4 m -106.38 134.22 49.86 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.334 -0.848 . . . . 0.82999999999999996 109.405 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.887 HD22 HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -138.91 89.55 2.37 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.487 0.66 . . . . 0.51000000000000001 109.358 175.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 7.4 m -78.39 116.05 18.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.124 -0.944 . . . . 0.58999999999999997 110.607 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 97.8 mt -105.11 136.41 44.66 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.04 0.448 . . . . 1.27 110.939 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.5 m -110.17 115.02 28.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.147 -0.478 . . . . 0.69999999999999996 110.441 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.16 167.88 47.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.702 -0.761 . . . . 0.80000000000000004 112.103 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 132' ' ' SER . . . 145.35 -175.15 25.07 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.557 -0.83 . . . . 0.53000000000000003 112.096 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 52.8 p90 -97.7 -176.52 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.358 0.599 . . . . 0.89000000000000001 111.403 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.616 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.5 OUTLIER -150.33 149.72 30.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.989 -1.005 . . . . 0.56000000000000005 108.687 178.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.42 144.48 49.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.893 0.378 . . . . 1.4199999999999999 111.578 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.639 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 22.9 mtpp 65.3 -143.71 0.22 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.067 0.947 . . . . 3.4700000000000002 111.807 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 126' ' ' LYS . 6.0 p-10 -149.46 124.39 9.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.075 0.464 . . . . 2.0800000000000001 112.239 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.597 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 7.7 t30 63.52 -18.0 0.06 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.698 1.199 . . . . 2.4700000000000002 113.676 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.639 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -71.36 -4.07 24.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.796 0.331 . . . . 1.96 110.82 178.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.616 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 8.9 tt0 70.08 77.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.39 -0.823 . . . . 2.02 110.923 -177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.431 ' CA ' ' HE3' ' A' ' 126' ' ' LYS . . . -107.88 32.22 7.27 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.442 -0.885 . . . . 0.77000000000000002 111.431 173.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.8 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 3.9 p90 -74.08 144.1 45.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.014 0.435 . . . . 1.21 110.661 -175.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 28.9 m -143.61 134.62 12.48 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.303 -0.408 . . . . 1.47 110.169 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.92 126.29 11.16 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.785 2.323 . . . . 0.92000000000000004 111.782 175.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.432 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 17.2 m -152.84 113.46 4.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.319 -0.4 . . . . 1.52 110.122 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.414 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 125.1 -105.21 0.82 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.088 -0.577 . . . . 1.1699999999999999 111.74 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.9 t -150.34 153.45 36.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.836 0.351 . . . . 2.4700000000000002 110.314 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.9 m -93.55 97.06 10.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.026 -0.534 . . . . 1.8200000000000001 109.775 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -83.99 132.29 10.98 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.954 -0.641 . . . . 0.67000000000000004 112.285 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 m -102.72 108.77 20.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.683 0.278 . . . . 0.57999999999999996 110.316 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.674 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 24.0 m -86.25 117.53 25.12 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.754 -0.832 . . . . 0.52000000000000002 108.754 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -104.08 127.31 51.65 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.879 -0.6 . . . . 2.1800000000000002 109.984 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.655 HD23 HD13 ' A' ' 56' ' ' LEU . 18.6 tp -125.58 102.25 7.28 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.542 -0.754 . . . . 0.63 110.829 -176.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.5 m -99.06 142.75 30.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.792 -0.64 . . . . 0.57999999999999996 109.966 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 15' ' ' THR . 7.3 p -93.27 104.82 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.689 0.757 . . . . 1.74 111.323 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.06 -0.971 . . . . 2.5800000000000001 109.352 176.219 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 110.262 -0.273 . . . . 5.7300000000000004 110.262 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -101.05 104.69 15.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.448 -0.575 . . . . 3.0800000000000001 109.448 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 56.6 m -84.11 103.93 13.74 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.617 -0.719 . . . . 1.4299999999999999 111.206 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 31.8 mm-40 -85.49 110.97 19.57 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.914 -0.773 . . . . 2.29 108.914 174.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.664 HG23 HG13 ' A' ' 30' ' ' VAL . 7.6 p -109.92 127.72 66.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.495 0.664 . . . . 1.51 111.167 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -87.61 107.27 18.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.183 -0.917 . . . . 3.5699999999999998 109.977 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.47 HG12 ' HA3' ' A' ' 136' ' ' GLY . 44.6 t -110.97 121.27 63.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.642 -0.503 . . . . 1.26 109.642 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.17 134.25 12.32 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.713 -0.756 . . . . 0.95999999999999996 112.725 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.33 117.85 14.5 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.31 -0.626 . . . . 2.1800000000000002 109.31 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.6 mt -117.25 98.54 6.49 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.873 -0.331 . . . . 1.4099999999999999 111.708 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.0 t -102.04 113.25 26.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.122 -0.696 . . . . 1.03 109.122 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.646 ' HB ' ' NZ ' ' A' ' 14' ' ' LYS . 76.8 t -152.41 148.67 14.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.093 -0.706 . . . . 1.45 109.093 -174.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -89.96 121.35 31.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.412 0.523 . . . . 0.58999999999999997 112.412 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.646 ' NZ ' ' HB ' ' A' ' 12' ' ' VAL . 2.7 mptt -143.38 175.99 9.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.119 0.485 . . . . 3.4199999999999999 110.335 172.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.502 ' HA ' ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -111.08 150.0 30.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.503 -0.771 . . . . 0.63 109.994 171.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.511 HH12 ' HB ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -86.5 -4.47 59.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.328 -0.619 . . . . 3.1400000000000001 109.328 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.478 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -88.24 -27.97 24.04 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.505 -1.038 . . . . 0.75 110.505 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -66.16 -34.08 77.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.734 -0.839 . . . . 2.1699999999999999 108.734 171.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.464 ' HB3' HG12 ' A' ' 100' ' ' VAL . 94.4 mt -65.99 96.34 0.31 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.876 -1.056 . . . . 1.6100000000000001 108.867 169.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 t -102.95 66.22 0.91 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.022 0.915 . . . . 1.6499999999999999 109.728 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.664 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 28.4 t70 65.48 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.515 -1.22 . . . . 1.8300000000000001 110.695 -174.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.443 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -95.11 76.05 3.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.17 0.51 . . . . 0.81999999999999995 110.686 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -142.69 99.32 5.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.992 -0.549 . . . . 0.79000000000000004 110.276 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.455 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 71.4 Cg_endo -75.98 100.27 1.36 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.748 2.299 . . . . 1.1200000000000001 112.484 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.573 ' CG2' ' HG2' ' A' ' 14' ' ' LYS . 5.4 mt -114.96 12.48 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.98 0.895 . . . . 2.5800000000000001 110.125 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.07 60.36 0.65 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.18 -0.918 . . . . 0.73999999999999999 111.829 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.67 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 34.3 Cg_endo -65.0 104.19 0.56 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.423 2.082 . . . . 0.67000000000000004 112.779 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.51 123.65 41.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.65 -0.705 . . . . 1.1799999999999999 109.874 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -78.98 89.41 4.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.271 0.558 . . . . 1.6399999999999999 110.663 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.664 HG13 HG23 ' A' ' 5' ' ' VAL . 23.7 t -91.4 118.36 36.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.701 . . . . 1.01 111.345 -176.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.445 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 8.4 tt0 -112.82 123.85 51.26 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.464 -0.789 . . . . 2.48 109.155 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.51 116.75 28.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.404 -0.362 . . . . 0.69999999999999996 111.013 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 8.9 mp -80.33 120.05 23.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 1.9399999999999999 110.504 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.79 -124.99 7.09 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.797 -0.716 . . . . 1.8100000000000001 112.303 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.4 m 63.85 24.06 13.6 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.693 0.397 . . . . 1.8799999999999999 111.217 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -49.76 -42.36 46.25 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.434 0.459 . . . . 2.1400000000000001 111.84 -171.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.1 25.03 10.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.258 -0.428 . . . . 0.93999999999999995 110.687 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.517 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 1.4 tpm_? -121.63 145.35 48.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.042 0.449 . . . . 4.6399999999999997 111.688 -172.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -82.71 149.58 27.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.103 -0.702 . . . . 1.75 109.103 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 93.1 t -109.37 129.86 63.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.851 -0.796 . . . . 0.54000000000000004 108.851 177.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 1.02 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -135.96 140.5 44.03 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 123.302 0.376 . . . . 0.35999999999999999 110.735 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 mt -103.19 150.55 23.57 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.127 -0.488 . . . . 0.83999999999999997 109.761 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.877 ' HE3' ' HB2' ' A' ' 129' ' ' PHE . 1.5 mptp? -134.84 151.66 51.1 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.297 -1.001 . . . . 1.9299999999999999 108.297 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -88.32 156.93 18.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.489 -0.559 . . . . 0.40999999999999998 109.489 174.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.642 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 5.8 t70 -89.5 172.57 8.89 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.899 -0.778 . . . . 0.70999999999999996 108.899 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.8 p -49.84 -25.26 2.98 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.816 1.043 . . . . 1.3999999999999999 113.816 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -65.57 -38.68 90.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.786 0.327 . . . . 2.2200000000000002 111.217 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.645 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 26.5 p-10 -131.3 18.95 4.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 1.3500000000000001 111.282 -174.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 52.3 t80 -122.55 101.5 7.52 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.417 -0.586 . . . . 0.56000000000000005 109.417 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.669 ' HG2' ' HE1' ' A' ' 55' ' ' PHE . 5.5 pt-20 -106.83 98.75 8.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.295 -0.411 . . . . 2.4100000000000001 110.5 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 73.13 -49.33 0.69 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.197 -0.911 . . . . 3.4300000000000002 111.337 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 177.7 38.52 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.696 -0.562 . . . . 0.56000000000000005 111.696 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.507 ' HD3' ' HB3' ' A' ' 81' ' ' ASN . 32.1 mmtp -136.48 135.17 38.37 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.491 -0.929 . . . . 2.1200000000000001 108.491 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.645 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -115.55 149.47 38.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.442 0.639 . . . . 0.56000000000000005 111.67 175.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.669 ' HE1' ' HG2' ' A' ' 50' ' ' GLU . 16.7 p90 -157.83 -179.96 8.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.039 -0.982 . . . . 0.58999999999999997 110.341 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.51 HD22 HD22 ' A' ' 114' ' ' LEU . 30.7 mt -94.08 112.12 23.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.662 -0.866 . . . . 1.53 108.662 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.617 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 9.8 tp -107.75 140.4 26.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.544 -0.539 . . . . 0.62 109.544 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 37.1 t -78.96 156.02 28.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.247 -0.433 . . . . 1.4399999999999999 110.52 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -54.79 -27.59 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 2.3100000000000001 111.425 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -109.7 13.49 23.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.476 -0.329 . . . . 3.0899999999999999 111.184 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 52.1 33.54 12.36 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.556 0.576 . . . . 2.6200000000000001 112.556 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -79.34 -27.35 42.04 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.963 0.357 . . . . 4.6600000000000001 111.963 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -149.77 140.55 22.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.592 -0.522 . . . . 2.5099999999999998 109.592 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -128.89 132.5 47.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.763 -0.458 . . . . 2.0699999999999998 109.763 177.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.087 ' HB2' ' HG3' ' A' ' 104' ' ' GLN . 1.3 pt? -140.18 125.17 18.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.853 0.358 . . . . 1.98 110.927 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -69.71 143.08 53.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.869 -0.605 . . . . 0.75 111.682 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.897 HG12 ' HA ' ' A' ' 100' ' ' VAL . 14.2 m -133.14 171.43 18.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.428 -0.805 . . . . 0.72999999999999998 110.015 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.483 ' HB2' ' HE2' ' A' ' 84' ' ' PHE . 5.4 p30 -130.89 129.13 41.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.289 -0.414 . . . . 1.8100000000000001 110.038 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.53 85.41 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.809 -0.811 . . . . 0.81000000000000005 108.809 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.572 ' O ' ' HE1' ' A' ' 99' ' ' TYR . 6.7 ttp180 -108.78 139.99 21.41 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.48 -0.782 . . . . 3.79 110.024 -170.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HA ' HG22 ' A' ' 96' ' ' ILE . 50.3 Cg_exo -52.55 135.75 55.93 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.356 2.037 . . . . 0.58999999999999997 112.155 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.402 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 15.5 tmm? -59.16 -58.9 6.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 1.71 109.761 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -172.97 103.45 0.13 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.541 -0.754 . . . . 1.9199999999999999 109.457 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -177.65 -32.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 1.8899999999999999 111.811 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 p -164.4 179.02 7.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.797 0.332 . . . . 1.7 111.128 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.28 130.54 56.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.818 -0.628 . . . . 0.93999999999999995 110.222 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.584 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 12.6 m0 -118.44 150.83 38.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.114 -0.494 . . . . 0.5 110.216 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.4 m -79.7 114.09 18.35 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.929 -0.397 . . . . 0.51000000000000001 109.929 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 t -87.48 114.43 24.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.998 0.904 . . . . 0.58999999999999997 112.409 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -114.63 162.49 16.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 106.949 -1.501 . . . . 1.7 106.949 167.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.507 ' HB3' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -82.39 -16.47 48.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.724 -0.79 . . . . 1.3899999999999999 110.277 -177.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.59 -37.51 3.71 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.601 -0.809 . . . . 0.65000000000000002 112.341 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.536 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 27.8 m -132.27 156.9 42.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.864 0.364 . . . . 1.1599999999999999 110.519 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.721 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -135.84 105.3 6.06 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.202 -1.036 . . . . 0.35999999999999999 108.202 179.621 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 1.02 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 4.0 p90 -134.92 144.19 47.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.196 0.522 . . . . 0.58999999999999997 111.48 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.876 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 15.5 pttm -75.11 149.97 38.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.469 -0.787 . . . . 1.3899999999999999 110.392 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -76.11 -15.56 60.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.779 0.8 . . . . 2.1200000000000001 108.878 173.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.876 ' HB3' ' HD2' ' A' ' 86' ' ' LYS . 28.6 t70 -78.87 155.65 29.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.677 -1.147 . . . . 2.1000000000000001 110.431 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.0 m -121.84 131.02 74.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.005 0.431 . . . . 1.05 109.861 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.79 172.83 16.49 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.845 -0.693 . . . . 0.46000000000000002 111.714 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.1 p -65.64 124.35 22.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.591 -0.522 . . . . 1.1699999999999999 109.591 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.814 ' HB2' ' HZ2' ' A' ' 86' ' ' LYS . 32.0 t90 -91.29 -51.13 5.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.189 -0.46 . . . . 0.51000000000000001 110.436 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 30.53 82.64 0.01 OUTLIER Glycine 0 N--CA 1.468 0.803 0 O-C-N 124.75 1.281 . . . . 1.25 115.26 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.35 -150.2 5.75 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.861 -0.685 . . . . 0.71999999999999997 112.005 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.5 p -123.13 124.64 43.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.42 0.629 . . . . 0.59999999999999998 112.449 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.67 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -110.85 168.73 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.175 -1.046 . . . . 1.6299999999999999 108.175 169.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.61 161.0 27.43 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.11 -1.043 . . . . 0.45000000000000001 112.243 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.42 113.44 24.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.107 0.48 . . . . 0.82999999999999996 110.139 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.664 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 5.9 m-85 -110.49 126.66 54.6 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.924 -1.139 . . . . 1.28 107.924 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.897 ' HA ' HG12 ' A' ' 67' ' ' VAL . 9.2 p -71.47 136.97 24.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.06 -0.719 . . . . 1.1399999999999999 109.06 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.23 98.91 1.08 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.864 0.364 . . . . 1.02 111.149 -175.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.87 20.73 79.74 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-O 119.17 -0.795 . . . . 1.53 114.207 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.432 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 18.4 tt0 51.98 99.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.49 0.645 . . . . 2.1099999999999999 110.742 -174.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 1.087 ' HG3' ' HB2' ' A' ' 65' ' ' LEU . 79.9 mm-40 -69.55 -63.99 0.97 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.18 -0.464 . . . . 2.6200000000000001 111.279 -172.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 62.5 m -178.86 -56.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.893 -0.594 . . . . 2.4300000000000002 110.858 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.492 ' OD1' ' HD2' ' A' ' 16' ' ' ARG . 8.2 t30 72.21 79.24 0.15 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.156 -0.929 . . . . 1.5600000000000001 109.471 -167.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.13 125.96 66.62 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.508 -0.769 . . . . 1.6799999999999999 109.145 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -21.95 88.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 1 C-N-CA 125.425 4.084 . . . . 1.26 114.275 -172.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.742 ' HB3' ' HE1' ' A' ' 112' ' ' TYR . 1.1 Cg_endo -85.16 -157.76 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.092 3.195 . . . . 0.76000000000000001 114.087 -171.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.89 -81.04 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.742 -1.343 . . . . 0.76000000000000001 109.742 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -126.83 137.56 53.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.643 -0.502 . . . . 2.04 109.643 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.742 ' HE1' ' HB3' ' A' ' 109' ' ' PRO . 13.7 m-85 -125.55 141.76 51.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.395 -0.366 . . . . 0.75 110.298 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.1 m -125.56 112.84 16.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.148 -0.478 . . . . 0.82999999999999996 110.778 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.51 HD22 HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -126.69 87.29 2.63 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.44 0.638 . . . . 0.51000000000000001 110.181 176.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.642 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 2.8 m -72.0 122.5 20.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.413 -0.812 . . . . 0.58999999999999997 110.099 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -111.17 120.2 41.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.083 0.468 . . . . 1.27 110.57 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.472 ' HA ' HG23 ' A' ' 135' ' ' THR . 19.3 m -92.18 121.22 33.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.69999999999999996 110.224 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -76.97 164.57 53.05 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.567 -0.825 . . . . 0.80000000000000004 111.866 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.18 179.62 36.92 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.87 -0.681 . . . . 0.53000000000000003 111.766 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.603 ' HB3' ' HB2' ' A' ' 3' ' ' CYS . 55.5 p90 -110.75 178.97 4.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.265 0.555 . . . . 0.89000000000000001 110.298 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.668 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 8.5 t-105 -140.9 143.22 34.52 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.378 -0.828 . . . . 0.56000000000000005 109.087 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.609 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -140.96 60.73 1.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.139 0.792 . . . . 1.4199999999999999 113.139 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 1.052 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER 169.88 -123.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.627 0.579 . . . . 3.4700000000000002 109.887 171.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -166.31 117.26 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 2.0800000000000001 111.455 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.668 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 23.3 t-20 61.43 -30.86 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.261 1.578 . . . . 2.4700000000000002 115.261 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -1.97 2.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 118.011 0.369 . . . . 1.96 111.434 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.542 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 40.1 mt-30 72.79 45.85 0.29 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.657 -0.701 . . . . 2.02 110.971 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.72 59.46 4.69 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.74 -0.944 . . . . 0.77000000000000002 110.74 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.877 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 50.3 p90 -105.19 146.56 29.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 110.071 -0.344 . . . . 1.21 110.071 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.4 m -131.12 113.47 15.99 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 110.148 -0.316 . . . . 1.47 110.148 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -62.11 118.51 5.4 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.822 2.348 . . . . 0.92000000000000004 111.595 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.9 m -145.82 154.71 42.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.924 -0.58 . . . . 1.52 110.259 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.33 -123.36 6.19 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.671 -0.776 . . . . 1.1699999999999999 112.647 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.7 m -125.04 143.02 51.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.71 0.291 . . . . 2.4700000000000002 111.291 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 117' ' ' THR . 12.4 m -93.21 113.2 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.407 -0.59 . . . . 1.8200000000000001 109.407 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.47 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -96.99 126.14 8.73 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.771 -0.728 . . . . 0.67000000000000004 112.035 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 25.1 m -94.48 99.63 11.77 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.029 0.442 . . . . 0.57999999999999996 110.31 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.443 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 24.9 m -79.78 119.08 22.19 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.178 -0.675 . . . . 0.52000000000000002 109.178 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -113.72 119.48 37.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.589 0.709 . . . . 2.1800000000000002 109.591 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 112' ' ' TYR . 4.7 tp -108.36 94.65 5.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.048 -0.978 . . . . 0.63 110.847 -173.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.2 m -91.07 147.5 23.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.909 -1.041 . . . . 0.57999999999999996 109.18 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.511 ' HB ' HH12 ' A' ' 16' ' ' ARG . 9.1 p -102.28 124.11 55.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.914 -0.714 . . . . 1.74 110.715 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.338 -0.839 . . . . 2.5800000000000001 109.497 178.759 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 121.131 0.491 . . . . 5.7300000000000004 110.373 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -151.86 97.38 2.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.891 -0.781 . . . . 3.0800000000000001 108.891 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.859 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 19.2 t -85.5 99.72 11.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.208 0.528 . . . . 1.4299999999999999 110.595 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -86.18 140.18 30.4 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.61 -0.723 . . . . 2.29 110.359 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 30' ' ' VAL . 3.2 p -111.69 124.22 68.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.696 -0.684 . . . . 1.51 109.674 175.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.546 ' HA ' ' OG1' ' A' ' 134' ' ' THR . 99.3 mtt180 -96.29 104.01 15.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.333 0.587 . . . . 3.5699999999999998 110.797 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.422 HG13 HG11 ' A' ' 28' ' ' VAL . 57.4 t -103.43 116.72 47.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.202 -0.908 . . . . 1.26 109.456 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.78 150.35 34.29 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.63 -0.795 . . . . 0.95999999999999996 112.378 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -74.43 111.88 10.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.771 -0.455 . . . . 2.1800000000000002 109.771 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.616 HD11 HG22 ' A' ' 28' ' ' VAL . 92.8 mt -93.49 94.01 8.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.22 -0.446 . . . . 1.4099999999999999 111.202 -177.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.1 m -94.9 112.69 24.39 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.052 -0.721 . . . . 1.03 109.052 171.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.14 144.23 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.425 -0.352 . . . . 1.45 110.387 -174.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.521 ' HB1' ' OG1' ' A' ' 143' ' ' THR . . . -101.42 96.83 7.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.149 -0.478 . . . . 0.58999999999999997 109.963 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.711 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 9.0 mmpt? -145.72 173.25 12.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 3.4199999999999999 110.453 -176.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.527 HG22 HG13 ' A' ' 142' ' ' VAL . 35.2 p -106.71 168.95 8.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.122 -0.49 . . . . 0.63 109.721 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.683 HH21 ' HD1' ' A' ' 112' ' ' TYR . 0.3 OUTLIER -87.01 -15.61 38.18 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.753 -0.832 . . . . 3.1400000000000001 108.753 178.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.8 -23.52 70.88 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.297 -0.865 . . . . 0.75 111.558 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -58.49 -31.15 67.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.4 0.619 . . . . 2.1699999999999999 109.707 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.612 HD21 HG23 ' A' ' 25' ' ' ILE . 9.9 mt -96.48 105.5 17.6 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.233 -0.894 . . . . 1.6100000000000001 109.711 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.593 ' H ' ' HB3' ' A' ' 23' ' ' ALA . 4.2 t -107.42 70.35 0.78 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.126 -0.694 . . . . 1.6499999999999999 109.126 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 17.8 t70 67.61 -80.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.7 -1.137 . . . . 1.8300000000000001 110.488 -174.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.34 63.69 0.99 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.613 0.72 . . . . 0.81999999999999995 110.646 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.593 ' HB3' ' H ' ' A' ' 20' ' ' THR . . . -143.35 117.87 6.22 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 114.897 -1.047 . . . . 0.79000000000000004 108.901 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -90.83 163.66 4.04 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.59 2.86 . . . . 1.1200000000000001 113.603 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.612 HG23 HD21 ' A' ' 19' ' ' LEU . 1.5 pt -118.7 -57.15 3.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.466 -0.788 . . . . 2.5800000000000001 110.899 174.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.515 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -116.15 99.17 0.86 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.85 -0.69 . . . . 0.73999999999999999 112.553 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 60.4 Cg_endo -80.41 105.17 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.714 2.276 . . . . 0.67000000000000004 112.051 173.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.616 HG22 HD11 ' A' ' 10' ' ' LEU . 18.1 t -74.96 125.96 35.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.701 -0.481 . . . . 1.1799999999999999 109.701 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 6.7 t -82.72 83.62 7.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.02 0.914 . . . . 1.6399999999999999 110.24 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.788 HG13 HG23 ' A' ' 5' ' ' VAL . 84.9 t -69.18 115.73 8.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.053 -0.976 . . . . 1.01 110.833 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.494 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 4.4 pt20 -110.38 132.89 53.78 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.159 -0.682 . . . . 2.48 109.159 173.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.518 ' HB1' ' SG ' ' A' ' 3' ' ' CYS . . . -101.67 127.95 48.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.095 -0.502 . . . . 0.69999999999999996 110.999 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.734 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 85.2 mt -107.59 111.78 24.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.511 -0.313 . . . . 1.9399999999999999 110.656 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.98 59.11 8.4 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.266 -0.492 . . . . 1.8100000000000001 113.211 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.859 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -87.08 -70.38 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.679 0.252 . . . . 1.8799999999999999 111.679 -177.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 69.25 -61.83 0.42 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.644 0.778 . . . . 2.1400000000000001 111.632 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.416 ' HA ' ' HB ' ' A' ' 89' ' ' VAL . . . -141.8 71.41 1.35 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.338 0.59 . . . . 0.93999999999999995 109.889 -176.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.713 ' HD2' ' SG ' ' A' ' 35' ' ' CYS . 1.4 tmt_? -143.42 131.81 22.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.544 -0.753 . . . . 4.6399999999999997 110.886 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.508 ' HG2' HG12 ' A' ' 89' ' ' VAL . 6.2 mt-30 -87.36 107.17 18.4 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.675 -0.861 . . . . 1.75 108.675 174.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 41.7 t -62.66 109.21 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 0.54000000000000004 109.954 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 1.018 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -127.11 137.63 53.03 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 123.531 0.519 . . . . 0.35999999999999999 109.895 -176.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.756 HD12 HG21 ' A' ' 69' ' ' ILE . 65.6 mt -104.21 128.65 51.95 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.946 -0.39 . . . . 0.83999999999999997 109.946 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.553 ' HG3' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -110.33 151.77 27.02 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.618 -0.882 . . . . 1.9299999999999999 108.618 175.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.62 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -100.32 155.17 17.94 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.379 -0.529 . . . . 0.40999999999999998 110.024 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -73.67 149.0 42.25 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.978 -0.749 . . . . 0.70999999999999996 108.978 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -58.6 -18.08 27.26 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.286 0.476 . . . . 1.3999999999999999 112.286 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.24 -27.18 68.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.151 0.5 . . . . 2.2200000000000002 110.33 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.62 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 4.1 p-10 -134.75 27.11 3.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.656 -0.702 . . . . 1.3500000000000001 109.916 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.609 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 75.1 t80 -140.75 102.41 4.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.436 -0.802 . . . . 0.56000000000000005 109.653 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.24 117.04 33.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.296 -0.411 . . . . 2.4100000000000001 110.583 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 68.46 -57.62 0.49 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.279 0.987 . . . . 3.4300000000000002 111.884 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.609 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -179.29 32.26 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.971 -0.633 . . . . 0.56000000000000005 111.93 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 81' ' ' ASN . 1.6 mptm? -129.9 134.28 47.39 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.396 -0.594 . . . . 2.1200000000000001 109.396 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.475 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -98.91 139.05 35.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.42 0.628 . . . . 0.56000000000000005 110.818 174.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.615 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 51.5 p90 -155.43 172.76 17.69 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.177 -0.919 . . . . 0.58999999999999997 110.338 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.991 ' HG ' HD22 ' A' ' 114' ' ' LEU . 5.9 mp -83.35 130.72 35.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.095 -0.705 . . . . 1.53 109.095 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 113' ' ' THR . 10.4 tp -104.93 134.7 45.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.13 -0.628 . . . . 0.62 109.322 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.5 t -68.06 179.96 1.38 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.294 -0.866 . . . . 1.4399999999999999 111.298 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -56.0 -43.2 77.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.883 -0.599 . . . . 2.3100000000000001 111.456 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -115.07 -62.26 1.63 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.549 -0.296 . . . . 3.0899999999999999 110.594 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.1 p30 177.28 25.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.829 -0.623 . . . . 2.6200000000000001 109.595 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -73.03 -46.31 52.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.428 -0.805 . . . . 4.6600000000000001 111.406 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.99 156.16 47.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.837 -0.62 . . . . 2.5099999999999998 110.491 -172.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -142.59 139.73 31.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.883 -0.599 . . . . 2.0699999999999998 109.776 174.252 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.741 ' HG ' HD13 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -141.14 122.04 14.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.37 -0.377 . . . . 1.98 110.237 178.016 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.443 ' HA ' ' CB ' ' A' ' 55' ' ' PHE . 62.8 m-85 -72.18 153.15 41.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.347 -0.388 . . . . 0.75 111.515 -173.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.486 ' HB ' HG23 ' A' ' 98' ' ' ILE . 29.2 m -117.24 161.78 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.72999999999999998 111.404 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -126.65 121.67 32.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 1.8100000000000001 108.952 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.756 HG21 HD12 ' A' ' 42' ' ' LEU . 3.6 mm -95.37 86.23 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.745 -0.382 . . . . 0.81000000000000005 110.04 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.514 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 8.1 mmm180 -93.55 128.27 42.85 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 120.491 -0.484 . . . . 3.79 110.974 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.74 ' HA ' HG22 ' A' ' 96' ' ' ILE . 49.2 Cg_exo -51.53 133.41 43.53 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.526 2.151 . . . . 0.58999999999999997 112.229 172.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.6 ttt -78.8 81.45 5.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.572 -0.529 . . . . 1.71 109.572 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 66.35 20.16 10.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.823 -0.626 . . . . 1.9199999999999999 112.227 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -119.7 107.59 13.4 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.464 0.542 . . . . 1.8899999999999999 112.464 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.6 p 61.18 179.71 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.648 1.179 . . . . 1.7 113.503 170.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.07 119.52 39.42 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.276 -0.874 . . . . 0.93999999999999995 110.485 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.685 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.6 m0 -110.18 149.08 30.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.93 -0.577 . . . . 0.5 110.388 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.0 m -83.23 112.92 20.3 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.003 -0.74 . . . . 0.51000000000000001 109.003 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 t -87.48 90.19 8.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.936 0.874 . . . . 0.58999999999999997 112.433 -171.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.25 148.44 23.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.91 -1.145 . . . . 1.7 107.91 166.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -87.17 11.06 14.93 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.226 -0.59 . . . . 1.3899999999999999 110.526 -174.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.88 -27.46 1.25 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.597 -0.601 . . . . 0.65000000000000002 111.597 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.553 HG12 ' HG3' ' A' ' 43' ' ' LYS . 36.0 m -140.54 137.77 36.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.005 -0.739 . . . . 1.1599999999999999 109.005 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.85 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -121.68 109.11 14.35 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.67 -0.812 . . . . 0.35999999999999999 108.946 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 1.018 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 2.0 p90 -137.35 139.26 40.7 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.512 0.508 . . . . 0.58999999999999997 111.394 -173.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.772 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 53.4 pttt -73.96 143.49 45.64 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.057 -0.72 . . . . 1.3899999999999999 109.057 171.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -64.72 -26.53 68.41 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.97 -0.559 . . . . 2.1200000000000001 110.103 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.772 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 12.6 m-20 -72.12 151.07 43.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.526 -0.761 . . . . 2.1000000000000001 110.573 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.508 HG12 ' HG2' ' A' ' 39' ' ' GLN . 30.9 m -114.04 123.26 69.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.026 0.441 . . . . 1.05 110.276 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.8 -173.32 24.7 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.387 -0.911 . . . . 0.46000000000000002 112.011 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.5 p -55.37 145.45 22.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.084 0.469 . . . . 1.1699999999999999 111.428 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.458 ' CH2' HG23 ' A' ' 96' ' ' ILE . 41.2 t90 -126.74 -53.86 1.43 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.912 -0.586 . . . . 0.51000000000000001 109.82 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 35.23 87.54 0.01 OUTLIER Glycine 0 N--CA 1.465 0.577 0 O-C-N 124.835 1.334 . . . . 1.25 114.978 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 29' ' ' THR . . . -159.01 -131.77 1.29 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.9 -0.667 . . . . 0.71999999999999997 112.126 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.64 132.92 23.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.951 0.405 . . . . 0.59999999999999998 111.459 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.74 HG22 ' HA ' ' A' ' 71' ' ' PRO . 1.7 pp -124.29 144.1 35.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.365 -0.605 . . . . 1.6299999999999999 109.365 172.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -117.97 151.8 17.81 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.118 -1.039 . . . . 0.45000000000000001 112.233 -174.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.486 HG23 ' HB ' ' A' ' 67' ' ' VAL . 77.1 mt -96.18 112.62 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.417 0.627 . . . . 0.82999999999999996 110.639 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 70' ' ' ARG . 1.2 m-85 -103.88 156.86 17.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.807 -1.088 . . . . 1.28 108.099 176.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.479 ' CG1' ' HA ' ' A' ' 103' ' ' GLN . 5.5 p -87.24 133.12 30.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.035 -0.666 . . . . 1.1399999999999999 109.393 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.92 101.83 0.3 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.381 -0.372 . . . . 1.02 111.756 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.11 23.4 77.21 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.804 -0.635 . . . . 1.53 114.026 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.479 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 62.9 tt0 57.93 97.98 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.237 0.541 . . . . 2.1099999999999999 110.905 -175.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.656 ' HG3' ' HB2' ' A' ' 65' ' ' LEU . 78.3 mm-40 -84.32 14.21 4.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 2.6200000000000001 111.312 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.1 m 74.01 -3.79 2.43 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.584 -0.735 . . . . 2.4300000000000002 112.239 170.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.54 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 7.3 t30 63.41 86.18 0.12 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.593 0.711 . . . . 1.5600000000000001 110.214 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.8 m -74.54 139.91 74.97 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.006 -0.997 . . . . 1.6799999999999999 109.355 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -30.5 89.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 125.162 3.908 . . . . 1.26 113.456 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.58 ' HB2' ' CG2' ' A' ' 142' ' ' VAL . 81.2 Cg_endo -93.23 -168.54 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.191 2.594 . . . . 0.76000000000000001 114.949 -167.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.13 -73.92 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.752 -1.339 . . . . 0.76000000000000001 109.752 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -135.13 126.93 29.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.546 -0.539 . . . . 2.04 109.546 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.683 ' HD1' HH21 ' A' ' 16' ' ' ARG . 69.6 m-85 -129.25 139.33 51.86 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.065 0.46 . . . . 0.75 110.922 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.597 ' O ' HG22 ' A' ' 57' ' ' ILE . 70.8 m -111.68 129.15 56.2 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.318 -0.856 . . . . 0.82999999999999996 110.021 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.991 HD22 ' HG ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -142.84 86.91 1.95 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.733 0.777 . . . . 0.51000000000000001 109.602 174.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.7 m -88.06 135.83 33.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.003 -0.999 . . . . 0.58999999999999997 110.476 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 8.6 mp -119.01 116.49 26.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 1.27 110.682 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 38.5 m -89.08 114.02 25.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.81 -0.632 . . . . 0.69999999999999996 110.125 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.403 ' HA3' HG13 ' A' ' 5' ' ' VAL . . . -67.84 145.11 44.6 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.724 -0.751 . . . . 0.80000000000000004 112.365 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.434 ' HA2' ' N ' ' A' ' 132' ' ' SER . . . -175.59 177.34 47.43 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.892 -0.67 . . . . 0.53000000000000003 111.484 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.408 ' CE2' ' HB ' ' A' ' 130' ' ' THR . 28.9 p90 -101.26 -178.33 3.71 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.918 -0.713 . . . . 0.89000000000000001 110.184 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.856 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 3.4 t-105 -151.69 144.45 24.35 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.253 -0.885 . . . . 0.56000000000000005 108.818 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.39 145.65 49.95 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.256 0.347 . . . . 1.4199999999999999 110.466 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.93 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER 72.17 -136.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.745 0.818 . . . . 3.4700000000000002 110.741 178.121 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.597 ' HA ' ' HZ2' ' A' ' 121' ' ' TRP . 5.6 p-10 -162.96 133.87 4.77 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.132 0.173 . . . . 2.0800000000000001 110.631 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.475 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 52.4 t30 67.76 -38.76 0.37 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.901 1.075 . . . . 2.4700000000000002 113.901 174.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.416 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -64.89 -5.04 5.18 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.341 0.591 . . . . 1.96 111.19 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.856 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 6.1 tt0 65.21 72.56 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.723 -1.126 . . . . 2.02 111.246 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.416 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -96.01 41.75 2.38 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.62 -0.8 . . . . 0.77000000000000002 111.213 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.514 ' CD1' ' HG2' ' A' ' 127' ' ' GLN . 3.7 p90 -82.74 154.44 24.79 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.783 0.325 . . . . 1.21 110.894 -172.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.408 ' HB ' ' CE2' ' A' ' 120' ' ' TYR . 50.2 m -154.93 123.99 3.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.436 -0.347 . . . . 1.47 110.082 173.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.2 128.81 31.18 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.975 2.45 . . . . 0.92000000000000004 112.254 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.434 ' N ' ' HA2' ' A' ' 119' ' ' GLY . 27.1 m -155.27 108.3 2.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.31 -0.404 . . . . 1.52 110.349 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.9 -127.85 7.52 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.45 -0.881 . . . . 1.1699999999999999 112.46 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 6' ' ' ARG . 5.2 p -118.71 154.53 32.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.951 0.405 . . . . 2.4700000000000002 111.417 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 t -108.98 114.64 28.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.412 -0.588 . . . . 1.8200000000000001 109.412 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.96 126.87 9.0 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.716 -0.754 . . . . 0.67000000000000004 112.122 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.3 m -91.82 101.3 13.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.745 0.307 . . . . 0.57999999999999996 110.725 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.523 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 28.3 m -80.63 108.65 14.45 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.14 -0.689 . . . . 0.52000000000000002 109.14 173.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -109.38 109.55 20.45 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.989 -0.745 . . . . 2.1800000000000002 108.989 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.604 ' HG ' ' NH2' ' A' ' 16' ' ' ARG . 16.1 tp -106.78 105.96 16.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.902 -1.045 . . . . 0.63 110.913 -174.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 30.3 m -99.45 143.99 29.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.159 -0.928 . . . . 0.57999999999999996 109.36 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.58 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 92.9 t -74.32 129.56 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 112.793 0.664 . . . . 1.74 112.793 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.521 ' OG1' ' HB1' ' A' ' 13' ' ' ALA . 95.0 m . . . . . 0 C--O 1.248 1.009 0 CA-C-N 115.06 -0.973 . . . . 2.5800000000000001 109.188 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.046 0.45 . . . . 5.7300000000000004 110.905 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -92.73 121.43 34.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.629 -0.714 . . . . 3.0800000000000001 109.831 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.3 m -119.45 100.51 7.33 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.34 -0.391 . . . . 1.4299999999999999 110.922 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -86.39 109.73 19.22 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.41 -0.589 . . . . 2.29 109.41 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.6 t -95.96 111.89 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.588 -0.523 . . . . 1.51 109.588 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.82 ' HB2' ' HB2' ' A' ' 31' ' ' GLN . 31.2 mmt180 -84.39 99.55 10.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.628 -0.715 . . . . 3.5699999999999998 110.451 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.95 115.59 48.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.382 -0.826 . . . . 1.26 109.238 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.24 -169.88 27.04 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.465 -0.874 . . . . 0.95999999999999996 112.082 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -99.83 142.39 31.37 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.676 -0.491 . . . . 2.1800000000000002 109.676 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.72 126.84 12.91 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.02 -0.537 . . . . 1.4099999999999999 109.911 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.9 m -108.93 115.69 30.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.987 -0.551 . . . . 1.03 110.479 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.458 HG12 ' HG2' ' A' ' 14' ' ' LYS . 44.3 t -122.69 117.9 53.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.152 -0.476 . . . . 1.45 110.17 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -91.4 97.03 10.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.97 0.414 . . . . 0.58999999999999997 110.893 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HG2' HG12 ' A' ' 12' ' ' VAL . 73.9 mmtt -143.64 -174.44 4.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.561 -0.745 . . . . 3.4199999999999999 109.454 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.627 ' HB ' ' OD1' ' A' ' 106' ' ' ASN . 20.4 p -100.68 159.78 14.89 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.135 -0.32 . . . . 0.63 110.135 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.902 ' HB2' ' HB3' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -86.35 -26.22 24.96 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.629 -0.428 . . . . 3.1400000000000001 109.992 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.79 -28.63 73.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.919 -0.658 . . . . 0.75 111.613 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -51.14 -34.81 32.72 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.594 0.757 . . . . 2.1699999999999999 111.442 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.841 ' HB2' HG23 ' A' ' 100' ' ' VAL . 49.8 mt -70.51 -17.61 62.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.591 -0.731 . . . . 1.6100000000000001 112.816 -170.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.3 m 34.25 55.42 0.63 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.256 0.972 . . . . 1.6499999999999999 112.778 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.757 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 31.0 t70 70.27 -62.84 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.631 -0.713 . . . . 1.8300000000000001 111.809 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.49 ' HA ' ' CG ' ' A' ' 99' ' ' TYR . . . -139.46 69.59 1.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.311 0.577 . . . . 0.81999999999999995 112.068 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.65 98.42 16.41 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.38 -0.827 . . . . 0.79000000000000004 109.056 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.487 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 54.4 Cg_endo -70.02 119.81 6.67 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.817 2.345 . . . . 1.1200000000000001 113.411 -172.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.731 HG12 HD21 ' A' ' 19' ' ' LEU . 2.9 pt -80.67 -65.11 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 2.5800000000000001 111.524 173.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.654 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -117.83 101.55 0.92 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.879 -0.676 . . . . 0.73999999999999999 111.935 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.612 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 37.7 Cg_endo -70.51 121.16 7.7 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.437 2.091 . . . . 0.67000000000000004 112.083 177.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.34 122.16 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.86 -0.609 . . . . 1.1799999999999999 109.431 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.5 m -74.59 101.96 4.39 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.218 -0.446 . . . . 1.6399999999999999 110.298 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.45 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 48.9 t -95.81 114.49 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.157 -0.474 . . . . 1.01 110.398 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.82 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 14.9 mm100 -103.07 133.91 47.38 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.343 -0.614 . . . . 2.48 109.343 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.4 108.29 13.94 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.172 -0.307 . . . . 0.69999999999999996 110.172 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.16 134.24 55.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.129 -0.487 . . . . 1.9399999999999999 110.724 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.55 -7.83 68.59 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.819 -0.628 . . . . 1.8100000000000001 112.264 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.0 m -84.32 93.56 8.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.001 0.429 . . . . 1.8799999999999999 110.73 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -96.32 -18.92 19.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.962 0.411 . . . . 2.1400000000000001 110.218 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -167.76 83.66 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.776 -0.647 . . . . 0.93999999999999995 110.048 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -165.11 150.09 9.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.898 -0.592 . . . . 4.6399999999999997 110.096 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -80.91 125.41 30.09 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.245 -0.65 . . . . 1.75 109.245 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 61.0 t -92.99 124.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.46 -0.57 . . . . 0.54000000000000004 109.46 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -119.66 146.52 45.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.087 0.47 . . . . 0.35999999999999999 110.963 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.493 HD13 HD13 ' A' ' 96' ' ' ILE . 14.6 mt -103.87 117.72 35.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.663 -0.698 . . . . 0.83999999999999997 109.329 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.62 ' NZ ' ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -118.73 152.02 36.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.552 -0.536 . . . . 1.9299999999999999 109.552 -177.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.523 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -104.23 157.19 17.3 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.369 -0.378 . . . . 0.40999999999999998 110.081 175.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 21.9 t70 -75.8 151.72 37.46 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.428 -0.582 . . . . 0.70999999999999996 109.428 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -56.75 -16.5 6.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.563 0.579 . . . . 1.3999999999999999 112.563 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.58 -32.37 73.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.981 0.42 . . . . 2.2200000000000002 110.628 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.523 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 6.0 p-10 -133.85 24.2 3.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 1.3500000000000001 110.247 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 82.0 t80 -132.33 101.33 5.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.492 -0.777 . . . . 0.56000000000000005 109.334 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 51' ' ' GLN . 56.5 mt-10 -95.07 100.26 12.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.422 -0.353 . . . . 2.4100000000000001 110.403 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 23.8 tt0 70.79 -58.56 0.56 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.875 0.734 . . . . 3.4300000000000002 111.184 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -172.32 38.12 0.16 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.6 -0.727 . . . . 0.56000000000000005 111.435 -177.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 2.1 mptm? -136.37 133.87 37.24 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.944 -0.762 . . . . 2.1200000000000001 108.944 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -106.08 141.67 37.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.245 0.545 . . . . 0.56000000000000005 110.96 174.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.511 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 16.9 p90 -147.27 167.04 25.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.674 -0.694 . . . . 0.58999999999999997 111.255 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.667 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 13.0 mt -85.33 113.66 21.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.457 -0.942 . . . . 1.53 108.457 171.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.7 tp -106.26 125.08 61.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.595 0.712 . . . . 0.62 110.85 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 112' ' ' TYR . 40.3 t -84.39 153.34 23.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.982 -1.008 . . . . 1.4399999999999999 111.21 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.16 -35.39 73.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.471 -0.786 . . . . 2.3100000000000001 110.368 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -78.3 -13.23 59.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.662 -0.699 . . . . 3.0899999999999999 110.775 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 53.77 30.44 11.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.661 -0.699 . . . . 2.6200000000000001 111.122 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.661 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 8.3 mmp_? -83.79 -39.95 19.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.244 0.545 . . . . 4.6600000000000001 109.871 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.672 ' HB3' HD21 ' A' ' 65' ' ' LEU . 1.1 m-20 -123.09 124.77 43.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.377 -0.828 . . . . 2.5099999999999998 111.111 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.667 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -127.18 98.89 5.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.208 1.004 . . . . 2.0699999999999998 108.737 168.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.676 HD13 ' HB2' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -99.4 118.72 36.65 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.987 -1.006 . . . . 1.98 109.853 -168.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.448 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 73.0 m-85 -67.51 122.15 17.37 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.285 -0.635 . . . . 0.75 109.285 -177.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.475 HG13 ' HG ' ' A' ' 56' ' ' LEU . 12.9 m -99.63 168.57 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.605 -0.725 . . . . 0.72999999999999998 111.62 -174.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -126.12 110.2 13.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.839 -1.073 . . . . 1.8100000000000001 108.841 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.469 HG23 HG12 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -91.46 84.25 2.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.506 0.669 . . . . 0.81000000000000005 109.196 173.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.804 ' HB3' ' OH ' ' A' ' 99' ' ' TYR . 32.6 ttm180 -101.82 131.78 22.42 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.979 -1.01 . . . . 3.79 108.317 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.621 ' HA ' HG22 ' A' ' 96' ' ' ILE . 45.0 Cg_endo -63.25 148.02 93.35 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.431 2.087 . . . . 0.58999999999999997 112.208 -173.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.0 tpt -74.03 84.6 1.78 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.668 -0.696 . . . . 1.71 110.412 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 74.21 -46.84 0.63 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.134 0.974 . . . . 1.9199999999999999 113.211 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.422 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 56.8 m-80 -60.22 114.28 2.81 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.433 0.901 . . . . 1.8899999999999999 113.433 -171.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.7 t 74.4 159.48 0.22 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.722 -1.126 . . . . 1.7 112.323 170.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.42 118.86 33.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.421 -0.809 . . . . 0.93999999999999995 110.113 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.857 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.4 m95 -112.39 142.49 44.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.16 -0.473 . . . . 0.5 109.945 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.2 m -82.65 110.63 17.88 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.249 -0.648 . . . . 0.51000000000000001 109.249 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -82.09 117.71 22.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.319 1.057 . . . . 0.58999999999999997 112.521 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 22.3 t70 -121.59 154.87 36.16 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.898 -1.519 . . . . 1.7 106.898 167.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -83.94 2.6 37.92 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.009 -0.676 . . . . 1.3899999999999999 110.924 -174.059 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -122.67 -31.47 1.04 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.156 -0.545 . . . . 0.65000000000000002 112.134 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 80' ' ' ASP . 26.6 m -131.51 148.64 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.847 -0.427 . . . . 1.1599999999999999 109.847 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -134.15 104.22 6.11 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.244 -1.021 . . . . 0.35999999999999999 108.244 -177.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.613 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 12.1 p90 -131.51 135.0 46.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.468 0.651 . . . . 0.58999999999999997 111.659 -174.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.857 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 18.9 pttp -74.42 139.68 44.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.829 -1.078 . . . . 1.3899999999999999 109.713 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -72.7 -17.86 61.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.176 -0.675 . . . . 2.1200000000000001 109.176 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 4.0 t70 -69.4 135.13 49.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.101 -0.954 . . . . 2.1000000000000001 109.684 172.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.0 m -99.57 122.79 51.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.232 0.539 . . . . 1.05 110.651 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.3 -155.2 24.48 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.616 -0.802 . . . . 0.46000000000000002 111.747 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.0 p -82.75 -173.56 4.73 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 122.501 0.321 . . . . 1.1699999999999999 110.276 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' A' ' 74' ' ' ASN . 33.3 t90 -157.68 -57.13 0.08 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.799 -0.445 . . . . 0.51000000000000001 109.799 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 42.15 92.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.42 1.075 . . . . 1.25 114.731 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.86 -141.83 3.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.663 -0.78 . . . . 0.71999999999999997 112.286 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 27' ' ' PRO . 11.1 p -133.12 140.43 47.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.139 0.495 . . . . 0.59999999999999998 112.218 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 71' ' ' PRO . 18.7 pt -118.38 142.87 31.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.807 -0.633 . . . . 1.6299999999999999 109.501 174.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 24' ' ' PRO . . . -105.1 141.09 15.26 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.23 -0.986 . . . . 0.45000000000000001 112.386 -174.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.469 HG12 HG23 ' A' ' 69' ' ' ILE . 59.7 mt -96.57 120.31 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.985 0.421 . . . . 0.82999999999999996 111.088 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.804 ' OH ' ' HB3' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -139.26 164.96 28.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.335 -0.848 . . . . 1.28 110.153 173.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.841 HG23 ' HB2' ' A' ' 19' ' ' LEU . 3.6 t -90.13 125.94 43.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.98 -0.554 . . . . 1.1399999999999999 110.791 -174.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.5 97.04 0.4 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.934 -0.395 . . . . 1.02 109.934 177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.62 -15.82 44.98 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.892 -0.67 . . . . 1.53 113.759 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.418 ' HB2' ' N ' ' A' ' 21' ' ' ASP . 65.2 tt0 67.27 118.35 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.067 0.547 . . . . 2.1099999999999999 110.769 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.676 ' HB2' HD13 ' A' ' 65' ' ' LEU . 12.7 mm100 -104.47 -6.83 20.3 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.316 0.487 . . . . 2.6200000000000001 112.316 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 m 71.16 14.63 6.63 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.984 0.421 . . . . 2.4300000000000002 111.317 168.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.902 ' HB3' ' HB2' ' A' ' 16' ' ' ARG . 0.3 OUTLIER 41.86 91.51 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.68 1.363 . . . . 1.5600000000000001 114.68 177.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.775 HG22 ' HD2' ' A' ' 108' ' ' PRO . 1.2 m -82.07 143.74 49.81 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 107.914 -1.143 . . . . 1.6799999999999999 107.914 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.775 ' HD2' HG22 ' A' ' 107' ' ' THR . 75.0 Cg_exo -12.04 83.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.669 1 C-N-CA 125.737 4.292 . . . . 1.26 114.705 -168.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -74.13 -157.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.849 3.033 . . . . 0.76000000000000001 113.993 -172.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.58 -140.74 6.62 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 109.878 -1.289 . . . . 0.76000000000000001 109.878 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -82.22 120.7 25.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.953 0.406 . . . . 2.04 110.097 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 58' ' ' SER . 14.1 m-85 -108.74 119.83 40.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.167 0.508 . . . . 0.75 109.972 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 77.0 m -106.74 98.54 8.19 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.414 -0.812 . . . . 0.82999999999999996 111.051 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.521 HD13 HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -120.57 107.97 13.49 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.268 0.556 . . . . 0.51000000000000001 110.526 178.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 20.2 m -96.18 140.21 31.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.58999999999999997 110.181 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 96.5 mt -117.5 125.79 51.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.893 0.378 . . . . 1.27 110.252 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.5 m -103.36 119.61 39.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.982 0.42 . . . . 0.69999999999999996 110.302 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -74.56 163.43 54.38 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.79 -0.719 . . . . 0.80000000000000004 112.632 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.49 166.57 14.38 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.494 -0.642 . . . . 0.53000000000000003 111.494 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -91.02 176.11 6.71 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.707 -0.397 . . . . 0.89000000000000001 110.663 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 129' ' ' PHE . 1.9 t-105 -133.09 152.8 51.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.265 -0.879 . . . . 0.56000000000000005 108.69 176.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.09 140.91 46.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.966 0.413 . . . . 1.4199999999999999 111.615 175.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 74.55 -143.31 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.381 1.073 . . . . 3.4700000000000002 111.358 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 126' ' ' LYS . 6.1 p-10 -147.62 124.38 11.2 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.336 -0.546 . . . . 2.0800000000000001 112.135 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.444 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 8.6 t30 65.53 -22.81 0.09 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.862 1.06 . . . . 2.4700000000000002 113.862 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.448 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -71.43 -3.36 20.52 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.873 0.469 . . . . 1.96 110.951 -178.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.859 ' HG3' ' CE2' ' A' ' 129' ' ' PHE . 51.4 tt0 70.37 79.24 0.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.433 -0.803 . . . . 2.02 110.384 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -109.61 27.69 11.88 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 119.793 -1.194 . . . . 0.77000000000000002 112.655 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.859 ' CE2' ' HG3' ' A' ' 127' ' ' GLN . 38.9 p90 -87.72 126.39 34.96 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.041 -0.664 . . . . 1.21 111.239 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 85.8 m -114.25 132.02 22.97 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.936 -0.575 . . . . 1.47 109.767 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.92 122.61 11.21 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.771 2.314 . . . . 0.92000000000000004 112.097 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.9 m -155.61 122.55 5.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.218 -0.446 . . . . 1.52 110.185 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 120.0 -117.62 3.63 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.267 -0.733 . . . . 1.1699999999999999 111.267 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 p -131.81 178.44 6.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.004 0.402 . . . . 2.4700000000000002 110.621 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 135' ' ' THR . 9.0 t -126.59 104.22 8.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.796 0.807 . . . . 1.8200000000000001 108.943 171.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.78 143.45 16.03 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.637 -0.711 . . . . 0.67000000000000004 112.414 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 73.8 m -101.0 117.41 34.98 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.958 0.409 . . . . 0.57999999999999996 110.903 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.449 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 18.7 m -86.61 111.44 20.63 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.664 -0.865 . . . . 0.52000000000000002 108.664 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -99.34 109.29 21.92 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.809 0.814 . . . . 2.1800000000000002 110.065 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.503 HD21 ' HG3' ' A' ' 16' ' ' ARG . 22.6 tp -103.21 95.98 6.47 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.444 -1.253 . . . . 0.63 109.765 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 12.0 m -100.07 144.02 29.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.546 -0.752 . . . . 0.57999999999999996 109.441 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.5 p -82.45 142.96 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.551 -0.537 . . . . 1.74 109.551 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.758 -0.639 . . . . 2.5800000000000001 111.472 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.885 -0.413 . . . . 5.7300000000000004 109.885 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -172.4 156.51 3.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.679 -0.86 . . . . 3.0800000000000001 108.679 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.1 t -90.49 110.29 21.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.16 0.505 . . . . 1.4299999999999999 110.363 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.436 ' HG3' ' HA3' ' A' ' 133' ' ' GLY . 7.6 tt0 -98.64 128.03 44.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.722 -0.672 . . . . 2.29 109.274 176.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.551 HG13 HG13 ' A' ' 30' ' ' VAL . 51.2 t -104.99 135.4 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.506 -0.553 . . . . 1.51 109.506 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.479 ' HA ' ' HE ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -92.57 101.21 13.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.084 0.468 . . . . 3.5699999999999998 110.99 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.497 HG12 ' HA3' ' A' ' 136' ' ' GLY . 73.4 t -129.73 115.32 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.873 -0.788 . . . . 1.26 108.873 173.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.83 -147.67 6.81 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.859 -0.686 . . . . 0.95999999999999996 112.412 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.29 142.16 27.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.209 0.528 . . . . 2.1800000000000002 111.413 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.75 124.38 7.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.276 -0.875 . . . . 1.4099999999999999 109.658 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 139' ' ' LYS . 31.1 m -116.03 116.57 28.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.212 -0.449 . . . . 1.03 110.709 -178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.465 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 27.8 t -121.49 116.75 50.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.931 0.396 . . . . 1.45 110.182 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -83.64 109.06 17.13 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.924 -0.58 . . . . 0.58999999999999997 111.436 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.5 ' HE3' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -168.63 175.9 5.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.703 -0.681 . . . . 3.4199999999999999 110.136 178.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.546 HG22 HG23 ' A' ' 142' ' ' VAL . 51.6 p -100.81 174.93 5.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.305 -0.407 . . . . 0.63 110.723 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.508 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -84.47 -6.56 59.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.774 -0.824 . . . . 3.1400000000000001 108.774 173.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.588 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -89.84 -22.0 37.69 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.128 -0.942 . . . . 0.75 111.569 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.47 -25.97 65.25 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.712 -0.848 . . . . 2.1699999999999999 108.712 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.663 HD13 ' HB ' ' A' ' 100' ' ' VAL . 18.5 mt -74.85 159.79 31.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.092 -0.958 . . . . 1.6100000000000001 109.087 172.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -153.8 60.29 0.73 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.467 -0.938 . . . . 1.6499999999999999 108.467 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 22.6 t70 61.28 -84.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.033 -1.439 . . . . 1.8300000000000001 110.255 -171.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.483 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -88.72 74.94 8.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.137 0.494 . . . . 0.81999999999999995 110.641 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.76 99.99 3.51 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.838 -0.619 . . . . 0.79000000000000004 110.134 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 91.5 Cg_endo -82.52 109.5 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.762 2.308 . . . . 1.1200000000000001 112.616 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -116.24 28.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.94 0.876 . . . . 2.5800000000000001 109.868 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.88 60.1 0.42 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.105 -0.952 . . . . 0.73999999999999999 112.265 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.63 97.89 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.328 2.019 . . . . 0.67000000000000004 112.948 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.1 t -80.31 126.22 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.856 -0.611 . . . . 1.1799999999999999 109.758 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -84.37 94.16 8.42 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 121.03 0.443 . . . . 1.6399999999999999 110.657 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.707 ' CG2' HD11 ' A' ' 96' ' ' ILE . 14.5 t -94.49 115.21 32.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.308 0.575 . . . . 1.01 111.065 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -102.71 124.92 49.13 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.29 -0.868 . . . . 2.48 109.687 174.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.74 93.97 6.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.019 -0.537 . . . . 0.69999999999999996 110.695 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 tp -87.28 112.76 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.811 -0.632 . . . . 1.9399999999999999 110.83 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.22 56.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.553 -0.832 . . . . 1.8100000000000001 112.306 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -83.72 95.7 8.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.962 0.411 . . . . 1.8799999999999999 110.444 177.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -103.09 -35.03 8.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.884 -0.598 . . . . 2.1400000000000001 110.155 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.42 ' C ' ' HB ' ' A' ' 89' ' ' VAL . . . -144.81 35.81 1.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.822 -0.626 . . . . 0.93999999999999995 110.417 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.549 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.7 tpp180 -120.34 148.01 44.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.044 0.45 . . . . 4.6399999999999997 111.649 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.532 ' HG3' HG12 ' A' ' 89' ' ' VAL . 18.2 mt-30 -92.48 128.23 38.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.173 -0.677 . . . . 1.75 109.173 173.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 72.1 t -92.9 128.97 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.141 -0.689 . . . . 0.54000000000000004 109.141 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.893 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -129.9 144.29 51.24 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.335 0.588 . . . . 0.35999999999999999 110.887 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 31.1 mt -102.08 143.95 31.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.495 -0.775 . . . . 0.83999999999999997 109.821 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.761 ' HE3' ' CB ' ' A' ' 129' ' ' PHE . 1.2 mptp? -143.73 152.99 41.97 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.284 -0.636 . . . . 1.9299999999999999 109.284 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -102.88 160.54 14.51 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.008 -0.542 . . . . 0.40999999999999998 109.606 171.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -83.36 159.65 21.8 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.129 -1.063 . . . . 0.70999999999999996 108.129 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -58.76 -9.64 1.89 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.982 0.42 . . . . 1.3999999999999999 111.744 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.44 -38.11 71.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.682 -0.69 . . . . 2.2200000000000002 111.449 171.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -141.66 23.18 2.12 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.971 0.415 . . . . 1.3500000000000001 110.406 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 62.8 t80 -126.14 108.15 11.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.56000000000000005 110.189 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -112.82 107.85 16.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.214 -0.291 . . . . 2.4100000000000001 110.214 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 71.11 -58.86 0.56 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.982 0.801 . . . . 3.4300000000000002 110.957 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.512 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -178.52 40.92 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.443 -0.799 . . . . 0.56000000000000005 111.148 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 3.4 mptp? -131.76 133.9 45.26 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.64 -0.874 . . . . 2.1200000000000001 108.64 173.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -109.91 135.96 49.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.148 0.499 . . . . 0.56000000000000005 110.507 172.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 21.7 p90 -142.52 167.5 21.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.553 0.692 . . . . 0.58999999999999997 111.85 -175.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 65' ' ' LEU . 16.0 mt -80.02 104.64 10.73 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.939 -1.028 . . . . 1.53 109.591 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.3 tp -108.2 138.51 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.751 -0.463 . . . . 0.62 109.751 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 p -83.55 166.16 18.47 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.935 -0.395 . . . . 1.4399999999999999 109.935 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.28 -28.14 68.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.939 -0.763 . . . . 2.3100000000000001 108.939 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -80.96 -20.38 42.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.031 -0.986 . . . . 3.0899999999999999 110.479 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.0 m120 67.25 27.78 8.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.647 -0.706 . . . . 2.6200000000000001 111.268 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 63' ' ' ASP . 19.7 ptt180 -88.09 -46.4 9.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.485 -0.325 . . . . 4.6600000000000001 111.287 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.471 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 7.5 m-20 -107.52 143.52 35.8 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.91 -0.404 . . . . 2.5099999999999998 109.91 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.75 153.87 47.28 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.297 0.373 . . . . 2.0699999999999998 110.277 174.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.682 ' HG ' ' HG3' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -154.09 118.61 4.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.442 -0.947 . . . . 1.98 108.442 177.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 1.5 m-85 -69.91 138.97 52.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.933 0.397 . . . . 0.75 109.945 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.472 HG11 HD21 ' A' ' 56' ' ' LEU . 15.1 m -117.38 176.53 2.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.139 -0.482 . . . . 0.72999999999999998 110.846 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.49 111.65 10.89 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.822 -0.626 . . . . 1.8100000000000001 109.673 175.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.402 HD12 HD13 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -86.85 85.46 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.719 0.771 . . . . 0.81000000000000005 109.196 171.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.684 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 37.7 ttt-85 -102.23 136.46 19.43 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 114.756 -1.111 . . . . 3.79 110.396 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.633 ' HA ' HG22 ' A' ' 96' ' ' ILE . 6.1 Cg_exo -46.05 110.63 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.178 2.585 . . . . 0.58999999999999997 112.267 176.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.08 97.34 8.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.72 -0.673 . . . . 1.71 110.033 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 71.61 17.7 5.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.094 -0.957 . . . . 1.9199999999999999 110.881 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -128.59 79.11 1.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.084 0.402 . . . . 1.8899999999999999 112.084 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.4 t 68.56 -172.2 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.837 -0.62 . . . . 1.7 111.804 172.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.57 141.48 48.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.792 -0.64 . . . . 0.93999999999999995 110.433 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.448 ' CG ' ' HG3' ' A' ' 71' ' ' PRO . 19.9 m0 -123.45 162.92 21.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.3 -0.409 . . . . 0.5 110.602 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 m -76.41 104.85 7.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.74 -0.837 . . . . 0.51000000000000001 108.74 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 t -93.43 110.5 22.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.813 0.816 . . . . 0.58999999999999997 112.515 -170.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -110.86 159.35 17.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.017 -1.105 . . . . 1.7 108.017 166.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -76.59 -5.1 46.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.469 -0.197 . . . . 1.3899999999999999 110.469 -176.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.435 ' CA ' ' HE1' ' A' ' 49' ' ' PHE . . . -126.74 -32.62 0.69 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.026 -0.607 . . . . 0.65000000000000002 112.822 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 15.8 m -121.51 148.22 25.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 122.325 -0.515 . . . . 1.1599999999999999 110.594 175.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.782 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -140.27 100.35 3.88 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.56 -0.533 . . . . 0.35999999999999999 109.56 -177.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.893 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 3.6 p90 -131.06 146.05 52.23 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.318 -0.252 . . . . 0.58999999999999997 110.318 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -81.86 150.58 27.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.01 -0.676 . . . . 1.3899999999999999 109.804 176.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -76.45 -13.52 60.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.59 0.709 . . . . 2.1200000000000001 110.069 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 19.4 m-20 -86.01 145.72 26.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.511 -0.768 . . . . 2.1000000000000001 110.136 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.532 HG12 ' HG3' ' A' ' 39' ' ' GLN . 19.5 m -103.85 123.39 57.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.282 0.563 . . . . 1.05 110.586 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.47 -147.17 18.85 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.701 -0.762 . . . . 0.46000000000000002 112.347 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.3 p -75.0 178.68 5.45 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.421 0.629 . . . . 1.1699999999999999 111.618 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.436 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 83.6 t90 -170.92 -55.63 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.087 -0.96 . . . . 0.51000000000000001 108.729 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 29.19 97.72 0.01 OUTLIER Glycine 0 N--CA 1.469 0.898 0 O-C-N 125.057 1.473 . . . . 1.25 115.894 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.55 -153.37 10.25 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.58 -0.819 . . . . 0.71999999999999997 112.964 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 p -101.38 129.66 47.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.871 0.693 . . . . 0.59999999999999998 112.871 -173.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.707 HD11 ' CG2' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -119.34 130.66 73.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.496 -0.928 . . . . 1.6299999999999999 108.496 170.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.17 153.23 17.06 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.137 -1.03 . . . . 0.45000000000000001 112.59 -171.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 mp -87.58 112.01 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.014 0.435 . . . . 0.82999999999999996 110.334 175.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.684 ' CE1' ' HB3' ' A' ' 70' ' ' ARG . 7.4 m-85 -101.66 153.48 19.73 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.935 -1.135 . . . . 1.28 107.935 171.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.663 ' HB ' HD13 ' A' ' 19' ' ' LEU . 3.6 p -87.48 124.7 40.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.323 -0.621 . . . . 1.1399999999999999 109.323 172.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -83.37 95.35 8.19 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.958 -0.697 . . . . 1.02 109.559 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.58 78.49 0.71 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.55 -0.833 . . . . 1.53 111.535 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.47 ' HA ' HG21 ' A' ' 100' ' ' VAL . 5.7 pt20 -37.97 120.66 0.87 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.724 0.773 . . . . 2.1099999999999999 112.527 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.682 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 9.7 mm-40 -92.41 19.79 6.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.326 -0.852 . . . . 2.6200000000000001 110.683 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 m 65.45 5.34 3.15 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.512 -0.767 . . . . 2.4300000000000002 112.302 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.588 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 12.5 t30 63.78 86.04 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.507 0.67 . . . . 1.5600000000000001 111.211 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.0 t -80.94 140.53 50.22 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 107.84 -1.17 . . . . 1.6799999999999999 107.84 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -26.76 92.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.835 3.69 . . . . 1.26 113.943 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -90.74 -161.05 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.192 2.594 . . . . 0.76000000000000001 112.682 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.73 -76.51 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.342 -1.103 . . . . 0.76000000000000001 110.342 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -140.58 122.27 15.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.678 -0.49 . . . . 2.04 109.678 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -117.62 124.46 48.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.438 0.637 . . . . 0.75 110.18 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.4 HG23 ' HE2' ' A' ' 139' ' ' LYS . 51.5 m -116.14 97.62 6.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.907 -1.042 . . . . 0.82999999999999996 109.509 -173.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -104.05 100.83 10.6 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.413 0.625 . . . . 0.51000000000000001 110.108 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.9 m -73.14 117.94 15.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.033 -0.985 . . . . 0.58999999999999997 110.002 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -111.44 136.23 50.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.133 0.492 . . . . 1.27 110.857 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 45.8 m -129.32 106.18 8.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.223 -0.658 . . . . 0.69999999999999996 109.223 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.603 ' H ' ' HB ' ' A' ' 134' ' ' THR . . . -89.01 -156.76 32.01 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.736 -0.745 . . . . 0.80000000000000004 111.767 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.64 -162.85 28.28 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.469 -0.872 . . . . 0.53000000000000003 111.932 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.559 ' CZ ' ' HB ' ' A' ' 130' ' ' THR . 52.6 p90 -101.65 144.82 29.9 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.987 0.422 . . . . 0.89000000000000001 110.269 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.648 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 15.1 t-105 -101.23 131.82 47.03 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.749 -0.834 . . . . 0.56000000000000005 108.749 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.18 54.87 1.55 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.233 0.54 . . . . 1.4199999999999999 112.22 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.705 ' CG ' ' HA3' ' A' ' 128' ' ' GLY . 29.0 mmtp -158.98 -142.28 0.09 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.566 -1.272 . . . . 3.4700000000000002 107.566 174.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -151.57 107.08 3.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.238 0.542 . . . . 2.0800000000000001 111.926 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.648 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 84.4 m-20 63.91 -36.74 0.17 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.474 -1.239 . . . . 2.4700000000000002 114.272 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -55.04 -51.48 66.18 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.478 0.547 . . . . 1.96 112.478 -170.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.687 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 36.4 tt0 152.82 22.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.082 0.864 . . . . 2.02 110.801 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.705 ' HA3' ' CG ' ' A' ' 123' ' ' LYS . . . -80.79 88.39 1.34 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 119.957 -1.116 . . . . 0.77000000000000002 112.222 -175.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.761 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 28.4 p90 -140.82 155.17 46.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.592 0.234 . . . . 1.21 110.395 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.559 ' HB ' ' CZ ' ' A' ' 120' ' ' TYR . 99.5 m -139.74 125.27 11.73 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.594 -0.275 . . . . 1.47 110.695 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 47.8 Cg_exo -56.59 134.06 61.95 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.076 2.517 . . . . 0.92000000000000004 112.018 177.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.7 t -151.84 103.51 2.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.44 -0.345 . . . . 1.52 110.78 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.436 ' HA3' ' HG3' ' A' ' 4' ' ' GLN . . . 82.08 -4.89 73.94 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.938 -0.648 . . . . 1.1699999999999999 112.901 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.603 ' HB ' ' H ' ' A' ' 118' ' ' GLY . 25.2 p -109.93 113.93 27.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.98 0.733 . . . . 2.4700000000000002 112.98 -170.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.6 m -140.11 95.18 2.85 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.954 -1.128 . . . . 1.8200000000000001 107.954 162.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.497 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -118.1 160.94 13.62 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.063 -1.065 . . . . 0.67000000000000004 113.02 -171.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -143.02 103.98 4.24 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.77 -0.456 . . . . 0.57999999999999996 109.77 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.509 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 39.5 m -79.97 108.45 13.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.937 -0.764 . . . . 0.52000000000000002 108.937 174.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.413 ' HB3' HG23 ' A' ' 11' ' ' THR . 2.7 tppp? -94.7 109.39 21.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.222 0.534 . . . . 2.1800000000000002 110.052 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.5 HD13 ' HE3' ' A' ' 14' ' ' LYS . 2.3 tp -98.99 104.27 16.29 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.176 -0.92 . . . . 0.63 109.317 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 9.2 m -119.23 140.02 50.92 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.848 -0.614 . . . . 0.57999999999999996 109.771 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.546 HG23 HG22 ' A' ' 15' ' ' THR . 12.3 p -82.07 149.12 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.459 . . . . 1.74 110.711 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.512 -0.756 . . . . 2.5800000000000001 109.449 175.639 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.752 0.311 . . . . 5.7300000000000004 111.611 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -131.59 140.31 49.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.673 0.273 . . . . 3.0800000000000001 110.929 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 41.8 t -80.9 98.09 7.71 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.61 -0.515 . . . . 1.4299999999999999 109.61 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -113.47 128.51 56.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.013 -0.539 . . . . 2.29 109.55 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.522 ' HB ' HG23 ' A' ' 134' ' ' THR . 35.1 t -106.56 111.79 36.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.407 -0.59 . . . . 1.51 109.407 -175.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 49.5 mtp180 -84.99 92.51 8.35 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.014 0.435 . . . . 3.5699999999999998 110.961 -176.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.637 HG23 HG22 ' A' ' 134' ' ' THR . 81.1 t -102.66 115.45 44.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.643 -0.873 . . . . 1.26 108.643 171.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.2 169.22 23.74 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.601 -0.809 . . . . 0.95999999999999996 112.984 -174.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -88.12 152.93 21.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.933 0.397 . . . . 2.1800000000000002 110.393 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.951 HD11 ' HB ' ' A' ' 28' ' ' VAL . 89.2 mt -134.74 144.67 47.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.844 -0.616 . . . . 1.4099999999999999 110.214 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 m -134.41 115.77 14.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.793 -0.447 . . . . 1.03 109.793 171.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.714 HG11 HG22 ' A' ' 25' ' ' ILE . 21.0 t -130.95 130.58 64.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.471 -0.332 . . . . 1.45 110.947 -176.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -99.89 99.67 10.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.377 -0.374 . . . . 0.58999999999999997 110.517 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -165.86 167.69 16.58 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.426 -0.352 . . . . 3.4199999999999999 110.256 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.506 ' HA ' HG22 ' A' ' 142' ' ' VAL . 70.4 p -87.25 167.24 14.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 0.63 111.095 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -88.18 -12.16 44.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.83 -0.804 . . . . 3.1400000000000001 108.83 173.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.72 -29.88 74.18 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.541 -0.754 . . . . 0.75 111.423 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -62.91 -35.02 78.68 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.601 -0.518 . . . . 2.1699999999999999 109.601 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.552 HD13 ' HB ' ' A' ' 100' ' ' VAL . 48.9 mt -64.8 95.14 0.14 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.421 -0.809 . . . . 1.6100000000000001 110.118 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -98.16 72.57 2.16 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.973 -0.751 . . . . 1.6499999999999999 108.973 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 34.0 t70 56.18 -95.7 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.828 -1.078 . . . . 1.8300000000000001 109.814 -169.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -84.6 77.15 10.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.164 0.507 . . . . 0.81999999999999995 111.016 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -132.41 96.75 18.66 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.718 -0.674 . . . . 0.79000000000000004 109.734 175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.45 ' HD3' ' HE1' ' A' ' 99' ' ' TYR . 55.2 Cg_endo -71.9 96.89 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.54 2.16 . . . . 1.1200000000000001 112.457 -177.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.714 HG22 HG11 ' A' ' 12' ' ' VAL . 16.2 mt -86.64 -30.09 5.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.366 0.603 . . . . 2.5800000000000001 110.513 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.18 63.51 0.63 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.374 -0.917 . . . . 0.73999999999999999 112.712 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 14.1 Cg_endo -58.67 106.32 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.342 2.028 . . . . 0.67000000000000004 111.494 172.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.951 ' HB ' HD11 ' A' ' 10' ' ' LEU . 7.6 p -91.78 130.66 40.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.163 -0.471 . . . . 1.1799999999999999 110.24 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.9 m -85.7 98.04 10.47 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.9 -0.591 . . . . 1.6399999999999999 110.626 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.654 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 52.1 t -89.96 115.11 28.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.915 -0.584 . . . . 1.01 110.213 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.484 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 0.2 OUTLIER -104.38 110.13 22.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.948 -0.569 . . . . 2.48 109.551 -176.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.31 105.51 17.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.245 -0.434 . . . . 0.69999999999999996 110.793 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.61 121.03 23.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.6 -0.727 . . . . 1.9399999999999999 110.002 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.74 -120.3 8.8 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.741 -0.742 . . . . 1.8100000000000001 112.141 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 56.4 m 70.36 -58.03 0.56 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.25 0.62 . . . . 1.8799999999999999 110.722 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.469 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 93.4 m-20 70.1 -48.13 0.63 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.921 0.888 . . . . 2.1400000000000001 113.272 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.1 77.91 1.22 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.239 -0.652 . . . . 0.93999999999999995 109.239 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.541 ' HG3' ' HB2' ' A' ' 120' ' ' TYR . 2.9 tpp85 -156.05 146.87 22.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.61 -0.723 . . . . 4.6399999999999997 110.493 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.729 ' HG3' HG12 ' A' ' 89' ' ' VAL . 55.3 mt-30 -83.2 116.43 22.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.365 -0.38 . . . . 1.75 110.518 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 59.3 t -84.15 124.67 39.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.69 -0.485 . . . . 0.54000000000000004 109.69 176.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.696 ' HB1' ' HE3' ' A' ' 43' ' ' LYS . . . -125.23 139.51 53.67 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.765 0.317 . . . . 0.35999999999999999 110.402 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 mt -102.85 129.28 49.48 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.79 -0.448 . . . . 0.83999999999999997 109.79 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.696 ' HE3' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -120.57 151.3 39.6 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.243 -0.651 . . . . 1.9299999999999999 109.243 176.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.601 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -100.54 152.91 19.84 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.081 0.467 . . . . 0.40999999999999998 110.632 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 17.7 t70 -75.18 148.46 39.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.359 -0.837 . . . . 0.70999999999999996 109.678 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.5 t -57.91 -17.07 14.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.026 0.75 . . . . 1.3999999999999999 113.026 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.62 -32.17 70.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.975 0.417 . . . . 2.2200000000000002 110.202 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 4.8 p-10 -123.73 20.1 9.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.05 -0.523 . . . . 1.3500000000000001 110.237 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.588 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 61.6 t80 -139.97 106.22 5.26 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.619 -0.719 . . . . 0.56000000000000005 109.932 -177.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -107.36 108.21 19.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.641 -0.254 . . . . 2.4100000000000001 110.36 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 71.23 -53.87 0.67 Allowed 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.974 0.796 . . . . 3.4300000000000002 111.778 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.588 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -179.96 31.88 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.904 -0.665 . . . . 0.56000000000000005 112.578 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 75.1 mmtt -134.63 134.91 41.72 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.757 -0.831 . . . . 2.1200000000000001 108.757 173.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -112.51 148.62 34.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.447 0.642 . . . . 0.56000000000000005 112.181 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.609 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 9.5 p90 -156.12 171.51 20.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.975 -1.012 . . . . 0.58999999999999997 110.304 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.629 HD22 HD22 ' A' ' 114' ' ' LEU . 10.2 mt -84.57 115.42 22.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.531 -0.914 . . . . 1.53 108.531 172.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.464 HG22 ' HB3' ' A' ' 48' ' ' ASN . 7.7 tp -107.54 116.43 51.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.687 0.756 . . . . 0.62 110.96 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 23.8 p -62.43 151.36 37.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.33 -0.85 . . . . 1.4399999999999999 111.561 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.65 -24.11 64.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.168 0.509 . . . . 2.3100000000000001 110.355 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -93.5 17.56 11.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.815 -0.629 . . . . 3.0899999999999999 110.581 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 25.82 67.3 0.05 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.438 1.095 . . . . 2.6200000000000001 112.771 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.522 HH21 HG22 ' A' ' 107' ' ' THR . 7.1 ptm85 -120.41 -44.59 2.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.552 -0.749 . . . . 4.6600000000000001 111.895 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' HB3' ' OH ' ' A' ' 112' ' ' TYR . 26.4 t0 -138.5 139.66 38.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.754 -0.462 . . . . 2.5099999999999998 109.754 -175.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 2.2 pptp? -128.68 138.92 52.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.08 0.467 . . . . 2.0699999999999998 110.703 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.647 HD23 ' HB2' ' A' ' 104' ' ' GLN . 6.1 mp -129.16 120.53 26.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.189 -0.46 . . . . 1.98 110.666 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -70.7 131.79 44.42 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.0 -0.37 . . . . 0.75 110.0 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 100' ' ' VAL . 15.7 m -128.6 124.47 61.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.248 -0.433 . . . . 0.72999999999999998 110.759 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.53 120.12 32.68 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.266 0.555 . . . . 1.8100000000000001 110.16 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.453 HG22 ' HB ' ' A' ' 96' ' ' ILE . 2.9 mt -82.6 85.3 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 0.81000000000000005 110.237 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.514 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 65.7 mtp180 -90.26 133.58 32.99 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.0 -0.741 . . . . 3.79 109.0 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.701 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 40.3 Cg_endo -66.87 134.99 36.48 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.569 1.513 . . . . 0.58999999999999997 111.157 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.5 ttt -79.32 92.1 5.12 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.855 -0.612 . . . . 1.71 110.666 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 68.24 36.04 3.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.465 -0.789 . . . . 1.9199999999999999 112.064 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -139.11 115.23 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.055 0.761 . . . . 1.8899999999999999 113.055 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.8 m 63.21 -167.15 0.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.076 -0.965 . . . . 1.7 113.0 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.41 114.31 19.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.655 -0.702 . . . . 0.93999999999999995 110.137 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.642 ' CD1' ' HG3' ' A' ' 71' ' ' PRO . 11.8 m95 -109.49 141.43 41.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.826 -0.625 . . . . 0.5 110.705 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.1 m -80.44 111.35 16.76 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.53 -0.544 . . . . 0.51000000000000001 109.53 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.6 t -86.04 113.47 22.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.798 0.809 . . . . 0.58999999999999997 112.079 -173.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -129.29 156.07 44.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.154 -0.93 . . . . 1.7 108.509 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -82.87 -0.53 48.63 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.716 -0.394 . . . . 1.3899999999999999 111.61 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.57 -34.23 2.3 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.467 -0.873 . . . . 0.65000000000000002 111.868 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.593 HG11 ' HZ3' ' A' ' 121' ' ' TRP . 10.7 m -138.73 154.64 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.634 -0.506 . . . . 1.1599999999999999 109.634 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -140.48 106.86 5.27 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.105 -1.072 . . . . 0.35999999999999999 108.105 178.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 2.0 p90 -139.49 141.98 37.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.757 0.789 . . . . 0.58999999999999997 112.895 -170.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.602 ' HB2' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -70.64 128.22 35.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.987 -1.46 . . . . 1.3899999999999999 111.04 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.56 -35.34 79.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.59 . . . . 2.1200000000000001 109.69 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.602 ' OD1' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -68.5 125.75 27.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.364 -0.834 . . . . 2.1000000000000001 109.673 175.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.729 HG12 ' HG3' ' A' ' 39' ' ' GLN . 16.4 m -91.91 118.4 37.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.159 0.504 . . . . 1.05 110.958 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.469 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 159.6 -169.14 35.6 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.393 -0.908 . . . . 0.46000000000000002 112.348 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.3 p -70.4 151.27 45.37 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.127 -0.694 . . . . 1.1699999999999999 109.127 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 37.0 t90 -135.71 -64.89 0.61 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.755 -0.378 . . . . 0.51000000000000001 110.121 -175.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.654 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 35.86 85.28 0.01 OUTLIER Glycine 0 N--CA 1.468 0.776 0 O-C-N 124.307 1.004 . . . . 1.25 114.618 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.17 -153.91 6.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.922 -0.656 . . . . 0.71999999999999997 112.236 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -106.11 132.9 51.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.198 0.523 . . . . 0.59999999999999998 112.363 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.701 ' HA ' ' HA ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -125.22 141.04 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.857 -0.794 . . . . 1.6299999999999999 108.857 171.306 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -114.56 151.1 18.55 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.16 -1.019 . . . . 0.45000000000000001 112.647 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -92.7 114.34 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.514 -0.55 . . . . 0.82999999999999996 109.514 174.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.54 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 10.1 m-85 -120.97 129.87 53.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.437 -0.802 . . . . 1.28 108.892 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.732 ' HA ' HG12 ' A' ' 67' ' ' VAL . 8.6 p -71.03 142.66 15.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.035 -0.357 . . . . 1.1399999999999999 110.035 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.57 95.45 0.33 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.385 -0.37 . . . . 1.02 110.867 176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 50.38 48.81 40.4 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.973 -0.558 . . . . 1.53 113.67 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.502 ' H ' HG13 ' A' ' 100' ' ' VAL . 3.9 pt20 38.41 88.47 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.005 0.907 . . . . 2.1099999999999999 112.34 -174.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.647 ' HB2' HD23 ' A' ' 65' ' ' LEU . 38.5 mm-40 -56.98 -76.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.816 -1.083 . . . . 2.6200000000000001 113.129 -175.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -146.37 -64.66 0.3 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.388 -0.369 . . . . 2.4300000000000002 111.979 -169.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 15.7 t30 60.85 47.2 7.98 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 122.259 1.028 . . . . 1.5600000000000001 108.393 -170.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.522 HG22 HH21 ' A' ' 62' ' ' ARG . 16.2 m -72.45 123.31 89.35 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 114.84 -1.073 . . . . 1.6799999999999999 109.246 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -11.82 84.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.342 1 C-N-CA 125.966 4.444 . . . . 1.26 114.44 -164.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 2.8 Cg_endo -87.0 -169.09 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.634 2.889 . . . . 0.76000000000000001 114.035 -168.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.35 -111.82 0.25 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.224 -1.55 . . . . 0.76000000000000001 109.224 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -89.39 131.23 35.56 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.848 0.356 . . . . 2.04 110.311 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 6.3 m-85 -125.35 125.31 43.27 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.778 -0.452 . . . . 0.75 109.778 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.9 m -96.63 129.36 44.04 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.698 -0.683 . . . . 0.82999999999999996 110.23 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.629 HD22 HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -144.68 104.57 4.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.522 -0.918 . . . . 0.51000000000000001 108.522 171.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 32.5 m -108.19 123.97 49.57 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.527 -0.916 . . . . 0.58999999999999997 108.527 -174.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 116' ' ' LEU . 2.8 mm? -113.35 110.92 21.14 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.397 0.618 . . . . 1.27 110.755 -173.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 9.8 m -98.27 103.71 15.68 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.256 -0.884 . . . . 0.69999999999999996 108.733 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.775 ' H ' ' HB ' ' A' ' 134' ' ' THR . . . -92.29 -157.13 33.36 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 120.378 -0.915 . . . . 0.80000000000000004 112.023 -173.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 147.87 -167.9 28.77 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.707 -0.957 . . . . 0.53000000000000003 110.707 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.541 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 50.5 p90 -98.86 138.24 36.27 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.83 -0.748 . . . . 0.89000000000000001 109.945 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.612 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 11.2 t-105 -91.72 141.7 28.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.473 -1.24 . . . . 0.56000000000000005 109.142 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.17 57.33 1.2 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.162 0.43 . . . . 1.4199999999999999 112.162 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.54 ' C ' ' HE1' ' A' ' 121' ' ' TRP . 55.5 mmtt -158.96 -139.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.364 -0.976 . . . . 3.4700000000000002 108.364 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -154.84 100.47 2.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.32 0.581 . . . . 2.0800000000000001 112.087 173.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.612 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 27.1 t-20 60.65 -41.58 0.11 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.454 1.502 . . . . 2.4700000000000002 114.309 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.514 ' HG3' ' N ' ' A' ' 127' ' ' GLN . 19.4 ptpt -52.56 -51.18 60.95 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.753 0.649 . . . . 1.96 112.753 -172.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.514 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 8.1 tt0 152.37 88.96 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.236 1.014 . . . . 2.02 109.239 -176.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 123' ' ' LYS . . . -142.31 90.65 0.17 Allowed Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.33 -0.938 . . . . 0.77000000000000002 111.129 172.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.442 ' CB ' ' HZ2' ' A' ' 43' ' ' LYS . 44.7 p90 -144.78 168.51 20.04 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.869 -0.419 . . . . 1.21 109.869 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 4.1 t -156.68 129.25 4.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.897 0.379 . . . . 1.47 110.615 173.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 24.0 Cg_exo -64.2 110.71 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.939 2.426 . . . . 0.92000000000000004 111.776 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.1 t -131.57 91.93 3.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.395 -0.366 . . . . 1.52 110.314 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.25 -3.18 85.54 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.98 -0.629 . . . . 1.1699999999999999 112.702 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.775 ' HB ' ' H ' ' A' ' 118' ' ' GLY . 16.5 p -100.5 113.6 26.52 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 113.376 0.88 . . . . 2.4700000000000002 113.376 -168.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 54.4 m -141.3 94.88 2.75 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.624 -0.51 . . . . 1.8200000000000001 109.624 165.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.505 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -110.01 85.03 0.39 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.205 -0.998 . . . . 0.67000000000000004 112.729 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.8 m -81.15 95.01 6.75 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.618 -0.512 . . . . 0.57999999999999996 109.618 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.609 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 27.5 m -89.15 108.5 19.64 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.106 -0.701 . . . . 0.52000000000000002 109.106 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.435 ' HB2' ' HE3' ' A' ' 139' ' ' LYS . 29.1 ttmt -103.89 108.79 20.28 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.848 0.832 . . . . 2.1800000000000002 109.583 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.505 HD23 HD13 ' A' ' 56' ' ' LEU . 21.6 tp -105.35 104.05 13.7 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.281 -1.327 . . . . 0.63 109.343 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.72 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.8 m -117.74 138.11 52.25 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.937 -0.574 . . . . 0.57999999999999996 110.883 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 15' ' ' THR . 40.3 t -91.58 111.35 23.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.518 -0.919 . . . . 1.74 108.518 170.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.407 -0.806 . . . . 2.5800000000000001 110.743 -176.555 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 109.111 -0.7 . . . . 5.7300000000000004 109.111 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.12 115.64 28.17 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.437 -0.579 . . . . 3.0800000000000001 109.437 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.1 m -91.68 109.54 20.85 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.0 -0.546 . . . . 1.4299999999999999 111.786 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -86.64 111.26 20.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.216 -0.661 . . . . 2.29 109.216 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.97 HG21 ' HA3' ' A' ' 118' ' ' GLY . 33.1 m -80.93 137.68 20.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.176 0.513 . . . . 1.51 110.417 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.564 ' HA ' ' NE ' ' A' ' 6' ' ' ARG . 5.2 mmp_? -96.46 95.07 7.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.146 -0.479 . . . . 3.5699999999999998 110.078 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.412 HG22 ' HA3' ' A' ' 136' ' ' GLY . 11.9 p -116.77 140.15 40.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.503 -0.771 . . . . 1.26 109.163 177.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.62 136.08 9.54 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.388 -0.911 . . . . 0.95999999999999996 111.895 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.81 106.52 2.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.803 -0.443 . . . . 2.1800000000000002 109.803 177.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.56 HD21 HG22 ' A' ' 28' ' ' VAL . 4.1 pp -116.73 151.29 36.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.308 -0.405 . . . . 1.4099999999999999 110.779 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -120.61 123.64 43.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.038 -0.528 . . . . 1.03 110.194 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.459 HG12 ' HG2' ' A' ' 14' ' ' LYS . 39.2 t -130.12 135.46 60.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.268 -0.424 . . . . 1.45 110.493 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.687 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -103.67 96.15 6.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.879 0.371 . . . . 0.58999999999999997 110.658 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.459 ' HG2' HG12 ' A' ' 12' ' ' VAL . 33.8 mmtp -144.32 163.44 33.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 3.4199999999999999 110.288 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.798 ' HA ' HG13 ' A' ' 142' ' ' VAL . 31.3 p -91.8 149.89 21.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.339 -0.392 . . . . 0.63 110.433 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.769 ' NH1' ' HG3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -81.97 -0.03 42.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.198 0.523 . . . . 3.1400000000000001 110.062 177.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.694 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -84.33 -22.75 53.54 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.816 -0.914 . . . . 0.75 110.816 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -56.61 -31.08 63.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.774 0.797 . . . . 2.1699999999999999 109.361 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.846 HD21 HG23 ' A' ' 25' ' ' ILE . 7.1 mt -89.61 111.27 22.17 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.832 -1.076 . . . . 1.6100000000000001 109.765 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -107.97 75.35 0.99 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.491 -0.929 . . . . 1.6499999999999999 108.491 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.639 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 36.4 t70 62.6 -93.18 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.401 -1.272 . . . . 1.8300000000000001 110.336 -170.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.23 73.84 10.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.321 0.581 . . . . 0.81999999999999995 111.065 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -152.79 121.6 3.23 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.259 -0.882 . . . . 0.79000000000000004 108.88 174.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 48.2 Cg_endo -89.85 151.06 4.97 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.074 2.516 . . . . 1.1200000000000001 113.654 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.846 HG23 HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.68 -64.46 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.627 -0.715 . . . . 2.5800000000000001 110.781 175.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.95 77.52 0.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.679 -0.772 . . . . 0.73999999999999999 112.898 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.524 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 5.2 Cg_endo -48.24 111.1 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.32 2.68 . . . . 0.67000000000000004 112.327 168.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.56 HG22 HD21 ' A' ' 10' ' ' LEU . 26.0 t -87.13 134.37 27.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.533 -0.758 . . . . 1.1799999999999999 110.305 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 32.4 p -78.09 79.26 4.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 1.6399999999999999 110.392 175.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.5 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 40.3 t -82.94 114.62 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.271 0.557 . . . . 1.01 110.46 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.669 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 8.9 tt0 -110.94 135.07 52.01 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.13 -0.941 . . . . 2.48 109.96 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.486 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -104.76 123.8 48.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.084 -0.507 . . . . 0.69999999999999996 110.572 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.39 123.05 49.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.258 -0.428 . . . . 1.9399999999999999 110.882 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.71 28.7 8.19 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.861 -0.685 . . . . 1.8100000000000001 111.939 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.486 ' SG ' ' HB1' ' A' ' 32' ' ' ALA . 19.6 m -120.74 94.65 4.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.893 0.378 . . . . 1.8799999999999999 111.019 -176.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.404 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 16.3 m120 -98.48 -19.37 17.7 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.372 -0.603 . . . . 2.1400000000000001 109.372 174.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.43 ' HA ' ' H ' ' A' ' 90' ' ' GLY . . . -167.78 72.35 0.11 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.78 -0.645 . . . . 0.93999999999999995 111.138 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 5.8 tpt180 -152.36 146.9 25.71 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 110.319 -0.252 . . . . 4.6399999999999997 110.319 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.89 131.52 36.44 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.408 -0.59 . . . . 1.75 109.408 174.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 95.1 t -103.1 120.34 52.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.193 -0.669 . . . . 0.54000000000000004 109.193 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.7 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -114.12 143.2 45.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.105 0.479 . . . . 0.35999999999999999 111.453 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.3 mt -102.78 114.75 29.27 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.719 -0.673 . . . . 0.83999999999999997 109.767 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 152.55 27.72 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.441 -0.8 . . . . 1.9299999999999999 109.093 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 116' ' ' LEU . . . -92.38 154.42 18.55 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.305 -0.628 . . . . 0.40999999999999998 109.305 170.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.72 159.13 31.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.203 -1.036 . . . . 0.70999999999999996 108.203 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.66 -20.58 34.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.707 1.003 . . . . 1.3999999999999999 113.707 -168.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.25 -32.89 73.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.016 0.436 . . . . 2.2200000000000002 110.903 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -115.36 13.23 16.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.634 0.73 . . . . 1.3500000000000001 109.924 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -130.52 101.75 5.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.848 -0.614 . . . . 0.56000000000000005 109.506 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.45 103.31 14.2 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.988 -0.375 . . . . 2.4100000000000001 109.988 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 71.48 -56.64 0.63 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 124.084 0.865 . . . . 3.4300000000000002 111.322 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.28 39.08 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.036 -0.826 . . . . 0.56000000000000005 111.036 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 81' ' ' ASN . 43.6 mmtm -138.36 135.03 34.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.172 -1.048 . . . . 2.1200000000000001 108.172 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.4 148.5 37.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.607 0.717 . . . . 0.56000000000000005 111.211 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.736 ' CE2' ' HB ' ' A' ' 57' ' ' ILE . 0.8 OUTLIER -145.93 -169.11 3.16 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.994 -1.003 . . . . 0.58999999999999997 110.755 -170.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.78 ' HG ' HD22 ' A' ' 114' ' ' LEU . 1.1 mp -111.2 104.24 12.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.567 -1.271 . . . . 1.53 107.567 167.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.736 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 9.4 tp -107.81 136.5 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.273 0.559 . . . . 0.62 111.669 -172.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.2 t -70.72 140.55 51.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.003 -0.74 . . . . 1.4399999999999999 109.003 171.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.21 -16.97 64.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.981 0.42 . . . . 2.3100000000000001 111.118 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -87.32 -14.43 40.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 3.0899999999999999 110.657 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.5 t30 59.89 94.46 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.798 -0.637 . . . . 2.6200000000000001 110.966 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -153.74 -46.5 0.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 4.6600000000000001 110.126 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -117.31 138.63 51.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.508 -0.769 . . . . 2.5099999999999998 109.555 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.94 153.27 46.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.227 1.013 . . . . 2.0699999999999998 111.499 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.776 ' HG ' HE21 ' A' ' 104' ' ' GLN . 6.4 mp -120.65 175.58 5.94 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 113.377 -1.738 . . . . 1.98 106.82 169.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -126.56 145.13 50.65 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.58 -0.896 . . . . 0.75 108.58 151.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.544 HG11 HD13 ' A' ' 56' ' ' LEU . 29.4 m -134.22 160.07 41.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.861 0.362 . . . . 0.72999999999999998 110.867 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 99' ' ' TYR . 14.4 p-10 -126.11 111.99 15.31 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.853 -0.612 . . . . 1.8100000000000001 109.865 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.425 HG23 HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -72.88 101.44 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.033 -0.729 . . . . 0.81000000000000005 109.033 173.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -122.14 139.86 31.28 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.825 -0.625 . . . . 3.79 110.215 -170.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.51 122.61 5.93 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.67 2.246 . . . . 0.58999999999999997 111.793 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 53.7 ttp -53.09 -54.01 41.89 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.702 0.626 . . . . 1.71 111.706 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -155.96 15.03 0.34 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.954 0.407 . . . . 1.9199999999999999 110.504 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -80.81 -81.83 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.032 -0.531 . . . . 1.8899999999999999 111.658 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.492 ' HB2' ' HE1' ' A' ' 92' ' ' TRP . 3.7 m -136.56 172.35 13.15 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.472 -0.196 . . . . 1.7 110.472 -175.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.98 122.46 32.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.989 0.423 . . . . 0.93999999999999995 110.859 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.497 ' HE3' ' HD1' ' A' ' 84' ' ' PHE . 12.5 m0 -107.79 156.94 18.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.892 -0.595 . . . . 0.5 110.319 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 m -72.44 121.03 18.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.958 -0.756 . . . . 0.51000000000000001 108.958 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 t -103.42 101.24 11.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.928 0.87 . . . . 0.58999999999999997 112.979 -168.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 83' ' ' VAL . 3.7 m-20 -110.33 161.29 15.78 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.721 -1.214 . . . . 1.7 107.721 168.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 53' ' ' LYS . 2.1 t-20 -86.82 -7.26 58.4 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.696 -0.801 . . . . 1.3899999999999999 110.154 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.53 -30.29 3.6 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.525 -0.845 . . . . 0.65000000000000002 112.556 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 32.1 m -135.68 149.39 28.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 110.047 -0.353 . . . . 1.1599999999999999 110.047 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -139.44 110.8 7.01 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.224 -0.658 . . . . 0.35999999999999999 109.224 -179.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 8.2 p90 -142.87 149.3 38.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.13 -0.322 . . . . 0.58999999999999997 110.13 -174.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -74.47 145.07 43.9 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.037 -0.665 . . . . 1.3899999999999999 110.524 -178.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.03 -27.45 65.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.215 -0.902 . . . . 2.1200000000000001 110.969 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -95.09 -166.19 1.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.623 -0.717 . . . . 2.1000000000000001 110.551 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.6 -169.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.838 -0.619 . . . . 1.05 109.413 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.43 ' H ' ' HA ' ' A' ' 37' ' ' ALA . . . 85.65 -154.0 27.84 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.623 -0.798 . . . . 0.46000000000000002 111.9 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.7 m -87.35 -171.69 3.59 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.156 -0.683 . . . . 1.1699999999999999 109.156 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.492 ' HE1' ' HB2' ' A' ' 75' ' ' SER . 77.9 t90 -168.33 -50.0 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.573 -0.529 . . . . 0.51000000000000001 109.573 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 18.44 92.71 0.01 OUTLIER Glycine 0 N--CA 1.474 1.186 0 O-C-N 125.208 1.567 . . . . 1.25 115.862 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 29' ' ' THR . . . -150.33 -125.37 1.29 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.797 -0.716 . . . . 0.71999999999999997 112.311 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.47 126.58 35.39 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.195 0.443 . . . . 0.59999999999999998 112.195 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -119.8 129.26 75.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.053 -0.721 . . . . 1.6299999999999999 109.053 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -112.79 152.34 17.95 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.257 -0.973 . . . . 0.45000000000000001 112.071 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.6 mp -90.12 112.48 24.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.898 -0.408 . . . . 0.82999999999999996 109.898 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.479 ' HD2' ' N ' ' A' ' 23' ' ' ALA . 2.9 m-85 -107.03 140.68 39.45 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.223 -1.029 . . . . 1.28 108.223 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 8.5 p -84.19 136.36 22.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.47 . . . . 1.1399999999999999 109.919 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.57 112.33 16.73 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.193 -0.317 . . . . 1.02 110.658 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.9 37.01 60.96 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 1.53 113.238 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 17.9 pt20 39.82 103.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.481 1.289 . . . . 2.1099999999999999 114.481 177.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.776 HE21 ' HG ' ' A' ' 65' ' ' LEU . 6.0 tp-100 -62.8 -27.09 69.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.873 -0.603 . . . . 2.6200000000000001 109.897 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.9 m 65.11 14.84 9.65 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.846 0.832 . . . . 2.4300000000000002 110.069 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.694 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 20.6 t30 59.83 92.04 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.416 -1.265 . . . . 1.5600000000000001 112.488 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.41 ' N ' HH12 ' A' ' 16' ' ' ARG . 21.1 m -94.93 124.51 54.14 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.621 -0.881 . . . . 1.6799999999999999 108.621 173.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -26.28 93.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.414 4.076 . . . . 1.26 114.934 -171.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.769 ' HG3' ' NH1' ' A' ' 16' ' ' ARG . 55.6 Cg_endo -100.18 -153.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 124.633 3.556 . . . . 0.76000000000000001 113.682 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.89 -104.73 0.18 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.504 -1.038 . . . . 0.76000000000000001 110.504 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.41 113.2 26.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.868 0.366 . . . . 2.04 110.323 175.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -107.52 135.64 48.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.208 0.527 . . . . 0.75 109.937 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 42.5 m -116.97 98.97 6.76 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.176 -0.92 . . . . 0.82999999999999996 110.447 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.78 HD22 ' HG ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -110.61 91.63 3.73 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.494 0.664 . . . . 0.51000000000000001 110.173 178.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 1.2 m -82.84 125.65 31.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.314 -0.857 . . . . 0.58999999999999997 110.195 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 91.0 mt -115.72 110.65 19.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.882 0.372 . . . . 1.27 111.158 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 135' ' ' THR . 28.7 m -90.19 108.52 19.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.112 -0.495 . . . . 0.69999999999999996 110.25 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.97 ' HA3' HG21 ' A' ' 5' ' ' VAL . . . -74.4 178.26 44.99 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.952 -0.642 . . . . 0.80000000000000004 113.289 -176.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 153.56 -170.24 32.33 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 121.073 -0.584 . . . . 0.53000000000000003 111.663 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -103.52 -176.23 3.02 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.452 -0.499 . . . . 0.89000000000000001 110.273 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.669 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 6.3 t-105 -144.8 151.63 39.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.655 -0.702 . . . . 0.56000000000000005 109.634 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -129.51 141.58 50.96 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.722 0.296 . . . . 1.4199999999999999 111.471 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 20.5 mmtp 71.66 -152.21 0.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.101 0.961 . . . . 3.4700000000000002 112.078 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.456 ' H ' ' HB3' ' A' ' 123' ' ' LYS . 19.9 m-20 -132.9 110.86 10.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.68 0.622 . . . . 2.0800000000000001 112.68 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.669 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 12.3 m120 59.43 -7.72 0.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.781 1.232 . . . . 2.4700000000000002 114.3 174.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -3.68 36.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.841 0.353 . . . . 1.96 110.767 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.93 HE21 ' HE2' ' A' ' 129' ' ' PHE . 59.7 tt0 74.61 85.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.978 -1.01 . . . . 2.02 110.83 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -120.48 33.0 4.65 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.484 -0.865 . . . . 0.77000000000000002 111.466 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.93 ' HE2' HE21 ' A' ' 127' ' ' GLN . 11.4 p90 -78.89 152.3 31.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.11 0.481 . . . . 1.21 110.535 -172.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 34.5 m -134.99 133.28 20.82 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.792 -0.64 . . . . 1.47 109.561 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.11 112.24 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.286 1.991 . . . . 0.92000000000000004 111.818 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.404 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 13.5 m -139.22 105.99 5.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.739 -0.664 . . . . 1.52 109.69 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 126.91 -128.12 6.15 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.561 -0.828 . . . . 1.1699999999999999 111.492 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.2 m -133.12 159.16 40.93 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.627 -0.508 . . . . 2.4700000000000002 109.627 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 12.6 t -97.18 110.37 22.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.616 0.722 . . . . 1.8200000000000001 109.342 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.412 ' HA3' HG22 ' A' ' 7' ' ' VAL . . . -90.16 118.39 5.28 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.754 -0.736 . . . . 0.67000000000000004 112.144 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 7.4 m -84.77 101.29 12.12 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.715 -0.476 . . . . 0.57999999999999996 109.715 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.547 HG23 HD11 ' A' ' 10' ' ' LEU . 19.6 m -77.91 108.9 11.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.244 -1.021 . . . . 0.52000000000000002 108.244 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.448 ' HB2' ' HE3' ' A' ' 139' ' ' LYS . 32.5 ttmt -97.05 108.99 21.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.688 0.756 . . . . 2.1800000000000002 110.439 -172.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 tp -107.11 108.15 19.48 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.461 -1.245 . . . . 0.63 110.253 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.687 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 10.6 m -108.43 117.32 33.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.37 -0.832 . . . . 0.57999999999999996 109.077 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.798 HG13 ' HA ' ' A' ' 15' ' ' THR . 39.5 t -93.11 116.26 33.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.206 0.527 . . . . 1.74 112.058 -172.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.5 m . . . . . 0 C--O 1.249 1.067 0 CA-C-N 115.262 -0.881 . . . . 2.5800000000000001 109.249 172.945 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.469 0.652 . . . . 5.7300000000000004 111.377 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -120.76 169.21 10.63 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.91 -0.774 . . . . 3.0800000000000001 108.91 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 91.5 m -62.36 88.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.527 0.517 . . . . 1.4299999999999999 112.146 -176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -87.86 108.65 19.27 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.873 -1.158 . . . . 2.29 107.873 171.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -93.21 111.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.597 -0.52 . . . . 1.51 109.597 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.563 HH21 ' NE2' ' A' ' 31' ' ' GLN . 71.4 mtm180 -94.45 97.42 10.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.951 -0.568 . . . . 3.5699999999999998 110.77 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.0 t -103.5 115.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.114 -0.948 . . . . 1.26 108.651 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.1 155.44 23.62 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.399 -0.905 . . . . 0.95999999999999996 112.249 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -73.34 142.95 47.06 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.973 -0.38 . . . . 2.1800000000000002 109.973 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -157.16 148.49 22.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.085 -0.507 . . . . 1.4099999999999999 109.95 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.5 t -109.55 133.58 52.93 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.093 0.473 . . . . 1.03 109.887 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.9 t -117.34 126.2 74.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.761 -0.654 . . . . 1.45 109.378 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -106.16 104.12 13.75 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.409 -0.219 . . . . 0.58999999999999997 110.409 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 mtmm -172.59 -178.67 1.99 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.155 -0.475 . . . . 3.4199999999999999 110.835 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 142' ' ' VAL . 46.3 p -102.93 167.09 10.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.89 -0.595 . . . . 0.63 110.933 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.773 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -87.8 -10.34 51.2 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.863 -0.791 . . . . 3.1400000000000001 108.863 175.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.614 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -71.29 -20.32 78.08 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.293 -0.867 . . . . 0.75 111.578 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -58.57 -41.33 85.46 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.596 0.712 . . . . 2.1699999999999999 109.365 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.627 HD21 HG12 ' A' ' 25' ' ' ILE . 4.5 mt -80.19 100.07 8.11 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.615 -1.175 . . . . 1.6100000000000001 110.449 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.686 HG22 HE21 ' A' ' 103' ' ' GLN . 0.8 OUTLIER -103.66 70.76 1.04 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.784 -0.821 . . . . 1.6499999999999999 108.784 174.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 1.0 OUTLIER 67.16 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.647 -1.16 . . . . 1.8300000000000001 110.295 -171.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.63 66.01 5.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.308 0.575 . . . . 0.81999999999999995 111.194 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -141.94 115.36 6.61 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.39 -0.823 . . . . 0.79000000000000004 109.858 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.5 Cg_endo -91.52 151.12 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.51 2.806 . . . . 1.1200000000000001 113.341 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.627 HG12 HD21 ' A' ' 19' ' ' LEU . 3.3 pt -116.97 -56.58 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 2.5800000000000001 112.174 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.487 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -114.04 88.97 0.5 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.475 -0.869 . . . . 0.73999999999999999 112.914 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 38.2 Cg_exo -60.46 126.93 21.24 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.601 2.201 . . . . 0.67000000000000004 112.067 172.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.5 t -98.66 127.7 50.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.984 -0.553 . . . . 1.1799999999999999 110.273 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 m -74.45 101.24 4.07 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 116.156 -0.475 . . . . 1.6399999999999999 110.489 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 99.3 t -104.04 115.6 46.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.101 -0.5 . . . . 1.01 110.525 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.64 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 8.2 tt0 -113.61 107.02 15.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.999 0.428 . . . . 2.48 110.713 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.75 109.06 20.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.644 -0.707 . . . . 0.69999999999999996 109.835 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.28 130.29 48.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.025 -0.534 . . . . 1.9399999999999999 110.287 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.68 29.51 10.73 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.798 -0.715 . . . . 1.8100000000000001 113.203 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.5 m -94.07 -74.07 0.55 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.926 0.343 . . . . 1.8799999999999999 111.926 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.549 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 9.1 t30 71.2 -44.69 0.6 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.85 0.46 . . . . 2.1400000000000001 112.062 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.14 76.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.205 0.526 . . . . 0.93999999999999995 110.282 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.564 ' H ' ' N ' ' A' ' 90' ' ' GLY . 1.7 tpm_? -157.82 148.52 20.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.436 -0.802 . . . . 4.6399999999999997 110.455 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.504 HE21 ' HD1' ' A' ' 121' ' ' TRP . 19.8 mt-30 -86.2 134.67 33.76 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.098 -0.705 . . . . 1.75 109.098 172.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 93.3 t -110.53 125.3 67.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.943 -0.391 . . . . 0.54000000000000004 109.943 -176.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.604 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -117.54 152.62 34.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 123.485 0.491 . . . . 0.35999999999999999 111.293 -173.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.447 HD12 ' HB3' ' A' ' 84' ' ' PHE . 28.2 mt -103.76 104.41 14.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.734 -0.666 . . . . 0.83999999999999997 109.868 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.604 ' HE2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -98.38 122.75 41.95 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.311 -0.626 . . . . 1.9299999999999999 109.311 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . . . -83.48 158.21 22.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.332 -0.395 . . . . 0.40999999999999998 110.774 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.714 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 13.6 t70 -87.19 152.2 22.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.188 -0.46 . . . . 0.70999999999999996 109.782 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -54.74 -20.37 8.26 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.803 0.668 . . . . 1.3999999999999999 112.803 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.9 -37.54 74.21 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.936 0.398 . . . . 2.2200000000000002 111.269 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.624 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 5.6 p-10 -129.27 16.14 6.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.895 -0.593 . . . . 1.3500000000000001 109.956 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 82.2 t80 -132.85 101.73 5.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.308 -0.86 . . . . 0.56000000000000005 109.148 -176.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -93.58 93.83 8.29 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.198 -0.456 . . . . 2.4100000000000001 110.571 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 69.46 -50.3 0.61 Allowed 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.154 0.909 . . . . 3.4300000000000002 112.103 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.51 35.73 0.16 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.772 -0.531 . . . . 0.56000000000000005 111.772 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 43.4 mmtm -137.49 133.28 34.42 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.404 -0.961 . . . . 2.1200000000000001 108.404 172.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -117.43 136.57 53.09 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.004 0.907 . . . . 0.56000000000000005 112.077 178.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.624 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 30.8 p90 -141.06 -176.7 4.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.049 -1.432 . . . . 0.58999999999999997 108.51 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.937 HD22 HD22 ' A' ' 114' ' ' LEU . 10.9 mt -102.7 127.58 49.77 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.549 -0.908 . . . . 1.53 108.549 172.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.45 133.88 49.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.406 0.622 . . . . 0.62 110.636 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 112' ' ' TYR . 29.5 t -83.87 150.06 25.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.323 -0.853 . . . . 1.4399999999999999 110.654 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.18 -26.41 68.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.962 -0.563 . . . . 2.3100000000000001 110.239 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -75.32 -13.62 60.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.658 . . . . 3.0899999999999999 110.537 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.6 m120 61.09 20.04 10.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.568 -0.742 . . . . 2.6200000000000001 111.999 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.888 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -95.49 -70.42 0.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.875 0.369 . . . . 4.6600000000000001 110.989 -177.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.67 158.48 16.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.788 -0.642 . . . . 2.5099999999999998 111.845 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -143.66 175.08 10.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.24 -0.891 . . . . 2.0699999999999998 110.319 -178.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.488 HD12 HG23 ' A' ' 100' ' ' VAL . 1.5 pt? -157.17 125.57 5.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.28 -0.418 . . . . 1.98 110.29 173.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 94.2 m-85 -72.83 144.74 47.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.052 -0.722 . . . . 0.75 109.052 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.442 HG11 HD21 ' A' ' 56' ' ' LEU . 15.7 m -123.66 157.18 30.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.308 0.575 . . . . 0.72999999999999998 111.784 -175.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.464 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -118.94 111.54 18.48 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.438 -0.949 . . . . 1.8100000000000001 108.438 171.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.407 HG22 HD12 ' A' ' 96' ' ' ILE . 0.9 OUTLIER -92.52 86.17 2.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.33 -0.619 . . . . 0.81000000000000005 109.33 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HG3' ' HD2' ' A' ' 71' ' ' PRO . 57.7 ttp180 -112.41 142.15 26.47 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.41 -0.589 . . . . 3.79 109.41 -174.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 84.9 Cg_exo -44.26 140.23 5.83 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.052 2.501 . . . . 0.58999999999999997 112.927 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 52.8 ttp -60.56 -52.96 62.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.693 -0.855 . . . . 1.71 108.693 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -153.34 107.63 3.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.138 -0.937 . . . . 1.9199999999999999 109.315 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -168.73 -163.15 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.737 0.303 . . . . 1.8899999999999999 111.191 -175.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 p -60.32 168.06 2.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.882 -0.599 . . . . 1.7 112.02 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 120.16 23.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.73 -0.668 . . . . 0.93999999999999995 111.153 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.802 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.8 m95 -107.34 134.11 50.89 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.543 -0.753 . . . . 0.5 109.967 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.9 m -76.35 116.73 17.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.524 -0.547 . . . . 0.51000000000000001 109.524 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 t -88.57 115.51 26.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.492 0.663 . . . . 0.58999999999999997 112.329 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -129.06 159.79 34.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.69 -1.226 . . . . 1.7 107.69 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -84.26 -6.71 59.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.42 -0.512 . . . . 1.3899999999999999 111.57 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.57 -35.39 3.83 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.126 -1.035 . . . . 0.65000000000000002 111.761 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.563 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 30.4 m -140.32 154.24 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.885 0.374 . . . . 1.1599999999999999 110.134 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.1 t80 -138.18 106.82 5.88 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.019 -1.104 . . . . 0.35999999999999999 108.019 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 6.0 p90 -140.65 144.08 35.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.817 0.341 . . . . 0.58999999999999997 111.662 -171.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.802 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 25.7 pttm -72.58 142.24 48.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 1.3899999999999999 109.625 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.452 HD22 ' N ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -77.63 -5.54 50.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.293 0.568 . . . . 2.1200000000000001 110.35 178.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.452 ' N ' HD22 ' A' ' 87' ' ' ASN . 6.6 m-20 -86.08 142.93 28.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.392 -0.822 . . . . 2.1000000000000001 110.182 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 m -99.5 108.62 22.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.483 0.658 . . . . 1.05 110.633 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.564 ' N ' ' H ' ' A' ' 38' ' ' ARG . . . 167.11 -164.12 37.63 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.648 -0.705 . . . . 0.46000000000000002 111.707 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.3 m -79.97 -178.19 6.36 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.2 -0.667 . . . . 1.1699999999999999 109.2 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.466 ' CH2' HG23 ' A' ' 96' ' ' ILE . 29.0 t90 -154.9 -61.84 0.12 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.571 -0.451 . . . . 0.51000000000000001 110.367 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 34.15 85.63 0.01 OUTLIER Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.436 1.085 . . . . 1.25 115.242 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.58 -151.35 6.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.771 -0.728 . . . . 0.71999999999999997 112.5 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -118.34 124.17 47.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.461 0.648 . . . . 0.59999999999999998 112.514 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 71' ' ' PRO . 13.7 pt -108.5 148.75 12.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.319 -0.855 . . . . 1.6299999999999999 109.159 174.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.35 151.25 17.55 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.303 -0.951 . . . . 0.45000000000000001 111.365 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 70.1 mt -95.11 112.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 120.295 -0.562 . . . . 0.82999999999999996 110.339 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.464 ' HD1' ' O ' ' A' ' 68' ' ' ASN . 10.5 m-85 -104.7 151.95 23.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.972 -1.013 . . . . 1.28 108.514 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 104' ' ' GLN . 8.1 p -83.07 140.03 16.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.441 -0.504 . . . . 1.1399999999999999 109.693 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.81 82.27 2.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.937 -0.764 . . . . 1.02 108.937 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.55 114.69 0.58 Allowed Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.636 -0.711 . . . . 1.53 111.459 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.686 HE21 HG22 ' A' ' 20' ' ' THR . 7.2 tt0 -32.53 107.11 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.973 0.909 . . . . 2.1099999999999999 112.64 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.506 ' HB2' HG21 ' A' ' 100' ' ' VAL . 48.8 tp60 -78.01 -13.26 59.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.571 . . . . 2.6200000000000001 110.461 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.2 m 64.71 15.85 10.02 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.791 -0.64 . . . . 2.4300000000000002 111.036 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.773 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 10.4 t30 58.29 77.67 0.28 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.351 0.596 . . . . 1.5600000000000001 110.918 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.423 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 11.2 t -77.81 144.1 68.06 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.386 -0.968 . . . . 1.6799999999999999 108.386 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 45.1 Cg_exo -27.51 92.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.984 3.789 . . . . 1.26 114.388 -173.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -100.1 -157.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 123.398 2.732 . . . . 0.76000000000000001 113.791 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.17 -91.06 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.683 -1.367 . . . . 0.76000000000000001 109.683 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -125.75 119.35 27.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.305 -0.628 . . . . 2.04 109.305 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 58' ' ' SER . 24.6 m-85 -108.81 128.42 54.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.352 0.596 . . . . 0.75 110.293 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.1 m -105.87 122.29 45.81 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.927 -1.033 . . . . 0.82999999999999996 110.369 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.937 HD22 HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -136.86 121.59 18.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.928 -0.578 . . . . 0.51000000000000001 109.688 176.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.714 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 6.5 m -112.08 128.42 56.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.797 -0.638 . . . . 0.58999999999999997 109.296 -174.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -121.57 119.7 32.67 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.02 0.438 . . . . 1.27 110.527 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.2 m -94.65 117.7 30.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.074 -0.512 . . . . 0.69999999999999996 110.605 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.15 146.72 49.4 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.838 -0.696 . . . . 0.80000000000000004 112.318 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.48 156.98 9.91 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 111.544 -0.623 . . . . 0.53000000000000003 111.544 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -89.48 -176.66 5.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.223 0.535 . . . . 0.89000000000000001 110.762 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.702 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 1.3 t-105 -142.08 151.92 42.81 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.182 -0.917 . . . . 0.56000000000000005 110.02 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.56 144.33 51.08 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.0 -0.546 . . . . 1.4199999999999999 111.23 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.676 ' HG2' ' H ' ' A' ' 124' ' ' ASP . 34.3 tttp 67.61 -147.79 0.15 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.455 1.102 . . . . 3.4700000000000002 111.906 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.676 ' H ' ' HG2' ' A' ' 123' ' ' LYS . 6.7 m-20 -139.67 118.65 12.57 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.573 0.583 . . . . 2.0800000000000001 112.573 -173.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.651 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.7 OUTLIER 45.49 14.02 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.427 1.639 . . . . 2.4700000000000002 115.427 175.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.572 ' HE2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -92.32 -2.18 56.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.56 0.695 . . . . 1.96 109.832 175.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.702 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 20.5 mt-30 72.71 54.19 0.15 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 114.37 -1.286 . . . . 2.02 111.923 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.532 ' N ' ' HD2' ' A' ' 126' ' ' LYS . . . -89.86 93.44 1.88 Allowed Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 108.826 -1.71 . . . . 0.77000000000000002 108.826 165.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.482 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 50.8 p90 -134.84 134.91 41.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 117.91 0.855 . . . . 1.21 110.863 -173.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.8 m -115.78 134.88 22.64 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 116.091 -0.504 . . . . 1.47 110.217 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.34 106.03 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.882 2.388 . . . . 0.92000000000000004 111.084 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.8 m -146.6 99.3 3.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.042 0.449 . . . . 1.52 110.342 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 141.61 -141.52 11.12 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.383 -0.913 . . . . 1.1699999999999999 112.603 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 6' ' ' ARG . 2.7 m -100.13 143.27 30.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.627 0.251 . . . . 2.4700000000000002 110.86 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 24.1 m -94.73 95.86 9.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.147 -0.686 . . . . 1.8200000000000001 109.147 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.45 155.65 21.83 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.777 -0.725 . . . . 0.67000000000000004 112.049 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -124.78 114.56 19.41 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.655 0.265 . . . . 0.57999999999999996 110.647 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.77 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 3.5 m -89.69 119.88 30.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.221 -1.029 . . . . 0.52000000000000002 108.221 172.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -117.48 109.36 16.64 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.687 0.756 . . . . 2.1800000000000002 110.392 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.413 ' HG ' ' NH2' ' A' ' 16' ' ' ARG . 23.9 tp -101.93 106.1 16.99 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.425 -1.262 . . . . 0.63 111.112 -172.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 6.2 m -105.02 143.77 32.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.49 -0.777 . . . . 0.57999999999999996 109.32 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 15' ' ' THR . 7.3 p -89.22 128.77 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.162 0.506 . . . . 1.74 111.065 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.624 -0.716 . . . . 2.5800000000000001 110.082 177.947 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 1' ' ' GLU . 5.5 mm-40 . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 120.628 0.251 . . . . 5.7300000000000004 110.46 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.432 ' OE2' ' HB2' ' A' ' 4' ' ' GLN . 41.1 tt0 -127.06 143.17 51.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.823 0.344 . . . . 3.0800000000000001 110.996 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.416 ' SG ' ' HG2' ' A' ' 38' ' ' ARG . 42.3 t -101.97 91.25 4.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.374 -0.973 . . . . 1.4299999999999999 108.374 172.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 1.127 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 5.4 tt0 -108.6 119.52 39.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.729 -0.669 . . . . 2.29 111.593 -172.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG22 HG13 ' A' ' 40' ' ' VAL . 22.5 t -91.61 111.54 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.046 -0.724 . . . . 1.51 109.046 173.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 88.2 mtt180 -87.83 109.49 19.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.254 -0.43 . . . . 3.5699999999999998 111.654 -177.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.535 HG11 ' HB2' ' A' ' 116' ' ' LEU . 48.9 t -125.21 115.37 43.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.293 -0.867 . . . . 1.26 109.152 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.37 -179.37 35.33 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.598 -0.81 . . . . 0.95999999999999996 111.965 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -99.02 147.25 25.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.922 0.391 . . . . 2.1800000000000002 109.978 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.48 147.36 20.48 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.364 -0.606 . . . . 1.4099999999999999 109.364 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.7 m -116.94 117.68 30.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.907 0.384 . . . . 1.03 111.09 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.15 109.48 28.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.884 -0.598 . . . . 1.45 109.431 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -83.61 96.65 8.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.229 -0.441 . . . . 0.58999999999999997 111.188 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -149.9 179.41 8.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.16 0.505 . . . . 3.4199999999999999 110.94 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.41 ' HA ' HH11 ' A' ' 16' ' ' ARG . 52.9 p -101.77 167.43 10.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.738 -0.664 . . . . 0.63 109.875 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.577 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.3 OUTLIER -86.3 -11.62 51.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.792 -0.818 . . . . 3.1400000000000001 108.792 177.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' A' ' 106' ' ' ASN . . . -81.21 -24.98 56.25 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.959 -1.019 . . . . 0.75 111.038 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -61.7 -26.62 68.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.41 0.624 . . . . 2.1699999999999999 110.119 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.661 ' HG ' HG23 ' A' ' 100' ' ' VAL . 0.6 OUTLIER -67.27 -54.46 20.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.053 -0.976 . . . . 1.6100000000000001 109.917 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.8 m 56.81 49.02 14.97 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.825 -1.079 . . . . 1.6499999999999999 109.221 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.496 ' N ' ' HB3' ' A' ' 103' ' ' GLN . 20.9 t70 77.38 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.279 -1.328 . . . . 1.8300000000000001 110.428 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -109.69 87.35 2.48 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.272 0.471 . . . . 0.81999999999999995 112.272 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.87 113.65 3.15 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.79000000000000004 109.916 169.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.604 ' HD3' ' HE2' ' A' ' 99' ' ' TYR . 50.8 Cg_endo -68.46 94.05 0.43 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.689 2.259 . . . . 1.1200000000000001 111.814 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.64 HG13 HD22 ' A' ' 19' ' ' LEU . 51.3 mm -89.34 -42.94 14.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.988 -0.551 . . . . 2.5800000000000001 111.639 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.77 51.98 0.75 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 119.636 -1.269 . . . . 0.73999999999999999 113.9 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.486 ' HD2' ' C ' ' A' ' 25' ' ' ILE . 8.9 Cg_endo -50.21 123.46 11.09 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.312 2.675 . . . . 0.67000000000000004 112.481 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.69 139.7 24.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.21 -0.45 . . . . 1.1799999999999999 110.047 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 t -82.75 102.88 11.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.92 0.867 . . . . 1.6399999999999999 110.751 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 67.0 t -94.17 114.52 30.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.963 -1.017 . . . . 1.01 110.292 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 57.5 tt0 -99.21 126.47 45.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.784 -0.45 . . . . 2.48 109.784 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.7 94.95 8.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.294 -0.412 . . . . 0.69999999999999996 109.996 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . 6.4 tt -80.01 114.1 18.67 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.006 -0.739 . . . . 1.9399999999999999 109.006 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.98 -129.91 10.57 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.603 -0.808 . . . . 1.8100000000000001 111.252 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.0 m 64.05 23.14 13.15 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.603 0.237 . . . . 1.8799999999999999 111.593 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.509 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 3.6 t-20 -59.81 -29.67 68.4 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.157 0.429 . . . . 2.1400000000000001 112.157 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.6 25.31 10.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.214 0.53 . . . . 0.93999999999999995 110.269 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.416 ' HG2' ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -123.92 154.71 39.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.133 -0.485 . . . . 4.6399999999999997 111.253 -172.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.728 ' HG3' HG12 ' A' ' 89' ' ' VAL . 16.1 mt-30 -93.14 128.75 39.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.945 -0.57 . . . . 1.75 109.533 173.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 87.2 t -101.7 117.13 46.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.492 -0.322 . . . . 0.54000000000000004 110.669 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.742 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -114.44 167.09 11.03 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 123.402 0.439 . . . . 0.35999999999999999 110.381 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.3 mt -120.11 109.66 15.72 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.061 -0.518 . . . . 0.83999999999999997 109.632 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.937 ' HE2' HG22 ' A' ' 83' ' ' VAL . 20.4 mmtp -105.86 119.77 40.02 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.552 0.691 . . . . 1.9299999999999999 110.131 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.65 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -71.48 155.3 40.75 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.553 -1.203 . . . . 0.40999999999999998 110.363 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 13.5 t70 -72.19 153.73 41.44 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.937 -0.764 . . . . 0.70999999999999996 108.937 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -58.56 -18.81 32.7 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.183 0.438 . . . . 1.3999999999999999 112.183 -172.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -62.89 -37.57 87.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.821 0.343 . . . . 2.2200000000000002 110.985 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.65 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 8.0 p-10 -125.18 20.28 8.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.178 0.514 . . . . 1.3500000000000001 110.335 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 27.3 t80 -127.92 107.42 9.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.296 -0.866 . . . . 0.56000000000000005 108.708 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 7.2 pt-20 -106.96 107.01 17.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.501 -0.318 . . . . 2.4100000000000001 110.454 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 70.79 -56.26 0.62 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.03 0.532 . . . . 3.4300000000000002 111.294 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.7 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -176.03 34.05 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.78 -0.928 . . . . 0.56000000000000005 110.78 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 18.5 mmtp -132.34 135.0 45.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.639 -0.874 . . . . 2.1200000000000001 108.639 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.494 ' CD2' ' HA2' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -107.49 140.11 40.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.47 0.652 . . . . 0.56000000000000005 110.934 171.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.794 ' CD2' ' HB2' ' A' ' 64' ' ' LYS . 40.6 p90 -147.49 174.36 11.78 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.208 -0.905 . . . . 0.58999999999999997 110.353 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.495 HD22 HD22 ' A' ' 114' ' ' LEU . 16.9 mt -88.31 116.95 26.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.392 -0.966 . . . . 1.53 108.392 171.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.587 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 8.0 tp -106.42 128.54 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.546 0.689 . . . . 0.62 110.927 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.6 p -66.56 129.23 39.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.254 -0.885 . . . . 1.4399999999999999 110.161 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.15 -30.33 70.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.325 0.583 . . . . 2.3100000000000001 109.67 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.91 -14.29 62.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.046 -0.979 . . . . 3.0899999999999999 110.487 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 59.66 81.91 0.16 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.244 -0.889 . . . . 2.6200000000000001 110.559 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.438 ' NH1' ' HB2' ' A' ' 108' ' ' PRO . 9.3 ptp180 -144.07 -41.44 0.27 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.68 -0.691 . . . . 4.6600000000000001 111.218 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -147.36 174.59 11.52 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.497 -0.481 . . . . 2.5099999999999998 111.483 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.794 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -160.29 142.77 13.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.706 -0.679 . . . . 2.0699999999999998 110.526 -177.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' HB3' ' NE2' ' A' ' 104' ' ' GLN . 1.8 pt? -140.6 132.44 27.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.551 0.215 . . . . 1.98 110.96 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 64' ' ' LYS . 17.0 m-85 -72.22 141.67 48.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.381 . . . . 0.75 110.749 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.704 HG12 ' HA ' ' A' ' 100' ' ' VAL . 13.3 m -135.31 128.85 49.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.056 -0.52 . . . . 0.72999999999999998 110.547 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -94.51 113.36 25.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.555 0.693 . . . . 1.8100000000000001 110.336 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -76.93 85.5 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.424 -0.807 . . . . 0.81000000000000005 109.907 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.688 ' HG2' ' HD2' ' A' ' 71' ' ' PRO . 13.8 ttp180 -98.32 140.59 21.95 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.36 -0.836 . . . . 3.79 109.216 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.688 ' HD2' ' HG2' ' A' ' 70' ' ' ARG . 97.4 Cg_exo -43.42 136.56 5.97 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.816 2.344 . . . . 0.58999999999999997 112.807 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.2 tpt -63.41 -58.91 5.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.876 -0.602 . . . . 1.71 110.3 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -159.66 105.04 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.991 -0.55 . . . . 1.9199999999999999 111.142 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.446 HD21 ' HZ2' ' A' ' 92' ' ' TRP . 2.8 p30 -174.47 -88.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.416 0.448 . . . . 1.8899999999999999 111.594 172.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.4 m -127.13 -175.44 3.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.638 0.256 . . . . 1.7 110.522 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.29 139.37 36.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.348 -0.387 . . . . 0.93999999999999995 111.264 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.496 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 11.2 m0 -114.0 151.18 32.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.669 -0.696 . . . . 0.5 109.779 176.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.2 m -70.69 116.29 10.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.31 -0.626 . . . . 0.51000000000000001 109.31 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t -96.49 117.45 30.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.469 0.652 . . . . 0.58999999999999997 112.584 -171.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.403 ' CB ' ' HB ' ' A' ' 83' ' ' VAL . 0.4 OUTLIER -126.18 161.99 26.42 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.287 -1.005 . . . . 1.7 108.287 170.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -21.02 63.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.818 0.303 . . . . 1.3899999999999999 111.818 -171.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA2' ' CD2' ' A' ' 54' ' ' PHE . . . -139.44 16.23 3.15 Favored Glycine 0 CA--C 1.509 -0.285 0 N-CA-C 111.519 -0.632 . . . . 0.65000000000000002 111.519 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.937 HG22 ' HE2' ' A' ' 43' ' ' LYS . 95.8 t -139.2 124.63 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.867 -0.79 . . . . 1.1599999999999999 108.867 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.742 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -139.22 105.47 5.26 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.087 -0.708 . . . . 0.35999999999999999 109.087 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 1.3 p90 -145.86 141.75 28.15 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.56 0.538 . . . . 0.58999999999999997 110.529 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.496 ' HB3' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -75.93 138.93 41.33 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.56 -0.456 . . . . 1.3899999999999999 109.81 177.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.84 -29.14 68.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.369 -0.832 . . . . 2.1200000000000001 110.259 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 16.6 m-20 -75.13 137.6 41.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.225 -0.898 . . . . 2.1000000000000001 110.75 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.728 HG12 ' HG3' ' A' ' 39' ' ' GLN . 27.7 m -90.46 132.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.729 -0.471 . . . . 1.05 109.729 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 36' ' ' ASN . . . 146.55 -170.4 27.59 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.645 -0.788 . . . . 0.46000000000000002 111.179 -174.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.5 m -77.65 -175.1 3.72 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 109.573 -0.528 . . . . 1.1699999999999999 109.573 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.446 ' HZ2' HD21 ' A' ' 74' ' ' ASN . 76.2 t90 -163.3 -56.47 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.752 -0.462 . . . . 0.51000000000000001 109.752 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 32.15 95.15 0.01 OUTLIER Glycine 0 N--CA 1.47 0.917 0 O-C-N 124.843 1.34 . . . . 1.25 115.674 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.64 -165.62 27.31 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.515 -0.634 . . . . 0.71999999999999997 111.515 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 p -101.35 128.74 47.38 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.063 0.459 . . . . 0.59999999999999998 111.908 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.572 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -112.71 158.54 13.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.442 -0.948 . . . . 1.6299999999999999 108.442 167.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -116.97 153.69 17.21 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.244 -0.979 . . . . 0.45000000000000001 112.449 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.8 mp -91.07 114.34 28.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.766 -0.457 . . . . 0.82999999999999996 109.766 175.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.604 ' HE2' ' HD3' ' A' ' 24' ' ' PRO . 2.3 m-85 -116.63 139.43 50.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.443 -0.947 . . . . 1.28 108.443 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.704 ' HA ' HG12 ' A' ' 67' ' ' VAL . 86.7 t -74.74 123.52 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.952 -0.388 . . . . 1.1399999999999999 109.952 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -78.58 86.42 4.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.693 -0.854 . . . . 1.02 108.693 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.72 83.44 1.4 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.684 -0.77 . . . . 1.53 111.742 -174.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.496 ' HB3' ' N ' ' A' ' 21' ' ' ASP . 2.6 pt20 -40.11 117.82 0.82 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.663 0.616 . . . . 2.1099999999999999 112.663 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.427 ' NE2' ' HB3' ' A' ' 65' ' ' LEU . 6.9 tt0 -90.56 5.14 49.04 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.53 -0.759 . . . . 2.6200000000000001 110.058 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.448 ' O ' HG22 ' A' ' 105' ' ' THR . 11.1 m 62.23 23.54 13.93 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.697 -0.683 . . . . 2.4300000000000002 111.287 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.614 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 8.2 t30 66.92 92.97 0.08 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.632 -0.713 . . . . 1.5600000000000001 111.86 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.599 HG22 ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -74.73 147.64 84.47 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-O 118.51 -0.757 . . . . 1.6799999999999999 109.427 172.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.599 ' HD2' HG22 ' A' ' 107' ' ' THR . 1.6 Cg_endo -43.11 93.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 124.106 3.204 . . . . 1.26 112.539 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -97.74 -165.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.265 2.643 . . . . 0.76000000000000001 114.615 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.88 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 108.789 -1.724 . . . . 0.76000000000000001 108.789 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -115.29 122.92 47.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.799 -0.815 . . . . 2.04 108.799 169.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.466 ' HB2' HH21 ' A' ' 16' ' ' ARG . 6.5 m-85 -109.24 113.91 27.15 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.63 0.728 . . . . 0.75 109.913 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 57' ' ' ILE . 47.3 m -94.82 135.49 36.25 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.553 -1.203 . . . . 0.82999999999999996 110.791 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.495 HD22 HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -147.84 91.01 1.89 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.497 0.665 . . . . 0.51000000000000001 109.687 173.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 44.7 m -82.5 135.63 35.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.651 -0.704 . . . . 0.58999999999999997 110.055 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.535 ' HB2' HG11 ' A' ' 7' ' ' VAL . 95.2 mt -118.34 120.04 36.43 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.118 -0.492 . . . . 1.27 109.705 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.3 m -92.69 110.83 22.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.306 -0.406 . . . . 0.69999999999999996 109.926 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.84 118.46 12.03 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.665 -0.779 . . . . 0.80000000000000004 111.555 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.568 ' HA2' ' H ' ' A' ' 132' ' ' SER . . . -165.8 145.0 9.67 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.851 -0.69 . . . . 0.53000000000000003 111.521 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 130' ' ' THR . 47.3 p90 -88.41 172.97 8.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.303 0.573 . . . . 0.89000000000000001 110.621 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.625 ' HZ2' ' N ' ' A' ' 125' ' ' ASN . 2.3 t-105 -123.2 148.47 45.77 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.471 -0.786 . . . . 0.56000000000000005 110.017 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.33 145.95 49.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.672 -0.694 . . . . 1.4199999999999999 110.431 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.948 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER 70.27 -140.97 0.07 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.762 0.825 . . . . 3.4700000000000002 110.519 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -159.74 125.38 4.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.067 0.46 . . . . 2.0800000000000001 111.604 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.625 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 17.6 m120 63.13 -24.7 0.06 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.002 1.482 . . . . 2.4700000000000002 115.002 177.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.473 ' HG2' ' HG2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -70.55 -3.25 17.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.925 0.393 . . . . 1.96 111.435 -178.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.557 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 22.7 tt0 74.45 61.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.365 -0.834 . . . . 2.02 111.22 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -102.53 113.17 4.5 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.619 -0.992 . . . . 0.77000000000000002 110.619 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 50.0 p90 -135.75 163.91 29.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.571 0.685 . . . . 1.21 110.296 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 120' ' ' TYR . 37.9 m -152.38 110.45 2.8 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.82 -0.437 . . . . 1.47 109.82 173.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 16.5 Cg_exo -65.37 116.36 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.617 2.211 . . . . 0.92000000000000004 112.228 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.568 ' H ' ' HA2' ' A' ' 119' ' ' GLY . 12.1 t -155.05 108.19 2.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.455 -0.793 . . . . 1.52 108.87 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 1.127 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 151.37 -138.07 6.36 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.519 -0.848 . . . . 1.1699999999999999 111.808 -176.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.4 m -111.72 138.61 48.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.648 0.261 . . . . 2.4700000000000002 110.394 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.6 m -94.44 98.46 10.89 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.72 -0.474 . . . . 1.8200000000000001 109.72 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.33 130.29 9.51 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.449 -0.881 . . . . 0.67000000000000004 112.504 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 86.1 m -96.25 114.82 26.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.629 0.252 . . . . 0.57999999999999996 110.426 178.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.493 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 13.9 m -78.32 116.86 19.04 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.222 -1.029 . . . . 0.52000000000000002 108.222 173.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -102.74 108.58 19.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.502 0.668 . . . . 2.1800000000000002 110.281 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.429 ' CD2' HD13 ' A' ' 56' ' ' LEU . 10.6 tp -106.28 94.67 5.28 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.938 -1.028 . . . . 0.63 109.844 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 12.1 m -102.28 144.4 30.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.707 -0.679 . . . . 0.57999999999999996 109.431 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.0 p -83.63 133.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.397 -0.521 . . . . 1.74 110.585 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.541 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 43.9 m . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.607 -0.711 . . . . 2.5800000000000001 109.516 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.043 0.449 . . . . 5.7300000000000004 110.224 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.87 131.1 47.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.174 -0.676 . . . . 3.0800000000000001 109.174 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 t -167.17 67.36 0.09 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.809 -1.182 . . . . 1.4299999999999999 107.809 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 10.1 mm100 -86.8 112.2 21.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.101 -0.954 . . . . 2.29 110.647 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 7' ' ' VAL . 61.5 t -82.16 110.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.877 -0.786 . . . . 1.51 108.877 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -80.77 91.25 5.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.65 0.738 . . . . 3.5699999999999998 110.616 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 5' ' ' VAL . 3.5 m -104.85 140.34 23.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.646 -1.161 . . . . 1.26 109.734 175.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.6 167.29 24.84 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.157 -1.021 . . . . 0.95999999999999996 112.706 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.47 131.42 35.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.079 -0.341 . . . . 2.1800000000000002 110.079 175.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.18 137.75 24.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.125 -0.489 . . . . 1.4099999999999999 109.929 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.6 m -103.29 122.42 44.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.043 -0.526 . . . . 1.03 110.442 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.749 HG11 ' HB ' ' A' ' 25' ' ' ILE . 45.2 t -118.76 111.3 33.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.918 -0.583 . . . . 1.45 109.877 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -92.54 101.41 13.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.41 -0.359 . . . . 0.58999999999999997 110.444 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 5.7 tppt? -163.39 165.47 23.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.981 0.419 . . . . 3.4199999999999999 110.566 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.622 ' HA ' HG13 ' A' ' 142' ' ' VAL . 82.4 p -89.79 159.01 17.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.017 -0.538 . . . . 0.63 110.558 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -0.03 27.31 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.393 -0.595 . . . . 3.1400000000000001 109.393 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.55 -20.81 76.22 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.586 -1.006 . . . . 0.75 110.586 171.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -66.39 -48.48 69.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.812 -0.81 . . . . 2.1699999999999999 108.812 168.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 25' ' ' ILE . 11.0 mt -73.04 92.72 1.7 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.9 -1.046 . . . . 1.6100000000000001 110.276 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.684 ' H ' ' HB3' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -96.35 69.24 2.64 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.318 -0.623 . . . . 1.6499999999999999 109.318 177.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.5 t70 63.89 -90.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 114.639 -1.164 . . . . 1.8300000000000001 109.89 -172.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.68 63.66 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.345 0.593 . . . . 0.81999999999999995 110.726 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.684 ' HB3' ' H ' ' A' ' 20' ' ' THR . . . -140.39 116.74 7.85 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.442 -0.799 . . . . 0.79000000000000004 109.805 175.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 93.0 Cg_endo -87.24 150.82 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.464 2.776 . . . . 1.1200000000000001 113.469 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.749 ' HB ' HG11 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -102.75 -62.76 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.3 -0.864 . . . . 2.5800000000000001 111.125 175.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.422 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -127.73 90.93 0.34 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.5 -0.857 . . . . 0.73999999999999999 112.646 -177.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.78 117.28 3.82 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.82 2.347 . . . . 0.67000000000000004 111.857 172.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -83.75 133.23 29.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 1.1799999999999999 109.825 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.9 p -75.91 83.77 2.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.3 0.571 . . . . 1.6399999999999999 110.36 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.6 t -94.07 115.18 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.709 -0.678 . . . . 1.01 110.315 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.659 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 63.7 tt0 -112.71 135.54 53.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.881 -0.6 . . . . 2.48 109.993 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.44 103.03 13.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.512 -0.551 . . . . 0.69999999999999996 109.512 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 4' ' ' GLN . 51.6 tp -82.25 112.29 19.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.367 -0.379 . . . . 1.9399999999999999 110.359 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 -117.73 5.1 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.779 -0.724 . . . . 1.8100000000000001 112.094 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 57.0 m 69.43 -71.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.66 0.784 . . . . 1.8799999999999999 111.112 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.416 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 51.1 m-80 66.22 -56.57 0.37 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.999 0.92 . . . . 2.1400000000000001 112.75 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.32 40.65 3.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.152 0.501 . . . . 0.93999999999999995 110.354 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 13.2 tpp180 -126.16 148.27 49.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.159 -0.473 . . . . 4.6399999999999997 111.509 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.428 ' HG3' HG12 ' A' ' 89' ' ' VAL . 41.5 mt-30 -87.6 124.15 33.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 1.75 109.879 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 57.8 t -91.08 121.05 41.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.733 -0.469 . . . . 0.54000000000000004 109.733 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.778 ' HB1' ' HE3' ' A' ' 43' ' ' LYS . . . -121.81 147.94 45.32 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 120.758 0.313 . . . . 0.35999999999999999 110.472 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -102.02 105.39 16.14 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.254 0.549 . . . . 0.83999999999999997 109.95 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.778 ' HE3' ' HB1' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -96.2 151.47 19.46 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.84 -0.8 . . . . 1.9299999999999999 108.84 176.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HB3' ' HD1' ' A' ' 49' ' ' PHE . . . -111.62 156.67 21.45 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 110.014 -0.365 . . . . 0.40999999999999998 110.014 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -79.9 152.93 29.34 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.506 -0.924 . . . . 0.70999999999999996 108.506 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -57.08 -13.67 3.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.946 0.339 . . . . 1.3999999999999999 111.851 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -56.54 -37.38 70.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 2.2200000000000002 111.077 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 26.0 p-10 -134.05 19.87 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.578 -0.283 . . . . 1.3500000000000001 110.509 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.734 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 63.1 t80 -124.62 102.55 7.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.78 -0.452 . . . . 0.56000000000000005 109.78 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.746 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 15.3 pt-20 -101.26 105.44 16.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.395 -0.366 . . . . 2.4100000000000001 110.585 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 71.61 -55.96 0.65 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.804 0.842 . . . . 3.4300000000000002 111.154 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.734 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -174.11 37.52 0.12 Allowed Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.932 -0.652 . . . . 0.56000000000000005 111.973 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 29.4 mmtm -146.15 139.07 25.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.009 -0.367 . . . . 2.1200000000000001 110.009 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.602 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -113.5 150.16 33.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.268 0.556 . . . . 0.56000000000000005 111.948 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.746 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 22.5 p90 -157.61 177.84 10.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.265 -0.88 . . . . 0.58999999999999997 111.159 -172.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.749 HD23 HD22 ' A' ' 114' ' ' LEU . 14.9 mt -81.12 115.51 20.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.328 -0.99 . . . . 1.53 108.328 170.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 113' ' ' THR . 9.2 tp -105.13 120.12 55.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.806 -0.757 . . . . 0.62 109.828 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.569 ' HB2' ' CE1' ' A' ' 112' ' ' TYR . 42.6 t -75.12 147.56 40.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.341 -0.845 . . . . 1.4399999999999999 111.465 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.59 -29.53 70.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.526 -0.761 . . . . 2.3100000000000001 109.753 170.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -81.29 -24.05 37.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.297 -0.865 . . . . 3.0899999999999999 110.124 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.4 t30 65.67 21.09 11.62 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.418 -0.81 . . . . 2.6200000000000001 111.948 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 62' ' ' ARG . 63.6 mtt180 -98.21 -6.66 30.81 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.077 -0.389 . . . . 4.6600000000000001 110.815 176.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.5 143.72 30.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.108 -0.497 . . . . 2.5099999999999998 111.249 -175.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -150.22 130.5 13.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.729 -0.669 . . . . 2.0699999999999998 110.232 172.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.632 ' HB2' HD12 ' A' ' 56' ' ' LEU . 2.9 mm? -120.21 130.11 54.4 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.315 -0.402 . . . . 1.98 110.329 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.445 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 94.4 m-85 -68.57 146.53 52.99 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.77 -0.372 . . . . 0.75 110.052 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.35 149.89 20.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.059 0.457 . . . . 0.72999999999999998 110.904 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -114.41 110.4 19.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.779 -0.823 . . . . 1.8100000000000001 108.779 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.431 HG23 HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -91.88 107.1 18.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.906 -0.775 . . . . 0.81000000000000005 108.906 177.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 64.5 mtp180 -122.77 143.05 39.25 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.346 -0.388 . . . . 3.79 110.93 -168.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 32.3 Cg_exo -59.29 139.33 89.47 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.026 2.484 . . . . 0.58999999999999997 111.721 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.0 ttt -70.28 79.18 0.53 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.433 -0.349 . . . . 1.71 111.274 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.8 t70 55.05 45.98 25.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.553 -0.748 . . . . 1.9199999999999999 112.134 172.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -113.95 -89.45 0.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.048 -0.407 . . . . 1.8899999999999999 111.59 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -114.66 166.36 11.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.763 0.316 . . . . 1.7 110.617 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.9 113.09 21.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.951 -0.568 . . . . 0.93999999999999995 110.583 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.572 ' CE2' ' HB3' ' A' ' 86' ' ' LYS . 11.2 m0 -104.56 137.43 42.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.652 -0.704 . . . . 0.5 110.465 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.3 m -65.26 125.06 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.47 -0.567 . . . . 0.51000000000000001 109.47 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -107.42 105.01 14.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.057 0.932 . . . . 0.58999999999999997 112.797 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -122.3 145.0 48.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.16 -1.422 . . . . 1.7 107.16 163.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.525 ' HB2' ' CD ' ' A' ' 53' ' ' LYS . 7.9 m120 -71.83 5.07 2.78 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 120.388 -0.525 . . . . 1.3899999999999999 112.15 -176.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.03 -13.41 2.19 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.81 -0.709 . . . . 0.65000000000000002 111.578 170.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.451 HG22 ' HZ1' ' A' ' 43' ' ' LYS . 57.5 t -131.83 114.74 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.981 -0.377 . . . . 1.1599999999999999 109.981 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.688 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.2 t80 -130.75 97.55 4.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.551 -0.907 . . . . 0.35999999999999999 108.551 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.59 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 12.2 p90 -137.35 150.1 47.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.975 0.417 . . . . 0.58999999999999997 111.124 -173.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 12.6 pttp -84.42 145.28 28.26 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.728 -0.669 . . . . 1.3899999999999999 110.951 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.16 -32.69 73.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.17 0.51 . . . . 2.1200000000000001 109.751 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.645 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -68.94 140.14 55.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.627 -0.715 . . . . 2.1000000000000001 110.412 174.106 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.428 HG12 ' HG3' ' A' ' 39' ' ' GLN . 31.2 m -101.38 131.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.214 0.531 . . . . 1.05 110.612 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 138.77 -164.5 25.74 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.459 -0.656 . . . . 0.46000000000000002 111.459 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.7 p -85.14 137.74 32.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.652 -0.499 . . . . 1.1699999999999999 109.652 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.618 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 89.7 t90 -102.47 -60.63 1.51 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.418 -0.956 . . . . 0.51000000000000001 108.418 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 48.43 112.75 0.01 OUTLIER Glycine 0 N--CA 1.468 0.811 0 O-C-N 124.556 1.16 . . . . 1.25 115.663 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.52 -130.5 1.62 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.352 -0.699 . . . . 0.71999999999999997 111.352 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 p -124.31 130.75 53.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.008 0.432 . . . . 0.59999999999999998 111.213 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.6 mm -111.5 126.21 68.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.31 -0.626 . . . . 1.6299999999999999 109.31 176.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.11 141.24 15.45 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.495 -0.86 . . . . 0.45000000000000001 111.869 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 mp -90.59 112.04 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.383 -0.599 . . . . 0.82999999999999996 109.383 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 70' ' ' ARG . 28.6 m-85 -109.59 142.07 41.22 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.33 -0.989 . . . . 1.28 108.33 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 103' ' ' GLN . 7.2 p -77.72 140.36 17.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.275 -0.57 . . . . 1.1399999999999999 109.63 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.16 88.97 3.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.277 -0.638 . . . . 1.02 109.277 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.78 107.23 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.823 -0.704 . . . . 1.53 111.45 -173.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.588 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 0.7 OUTLIER -46.74 127.82 10.1 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 121.226 0.536 . . . . 2.1099999999999999 112.031 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.5 ' HG2' HD21 ' A' ' 65' ' ' LEU . 57.3 tp60 -89.74 1.99 55.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.687 -0.688 . . . . 2.6200000000000001 110.095 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 m 60.91 22.91 13.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.717 -0.674 . . . . 2.4300000000000002 111.231 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 59.52 94.07 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.624 -0.716 . . . . 1.5600000000000001 111.207 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.468 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 11.3 t -102.98 146.11 31.82 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 107.435 -1.32 . . . . 1.6799999999999999 107.435 174.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 78.3 Cg_exo -24.19 90.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 1 C-N-CA 125.303 4.002 . . . . 1.26 114.313 -173.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.505 ' HG2' HG11 ' A' ' 142' ' ' VAL . 94.8 Cg_endo -104.37 -166.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 123.586 2.857 . . . . 0.76000000000000001 114.736 -171.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -175.35 -120.83 0.62 Allowed Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.202 -1.363 . . . . 0.76000000000000001 109.976 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -92.9 122.38 35.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.748 0.308 . . . . 2.04 110.315 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 56' ' ' LEU . 91.6 m-85 -116.02 123.69 48.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.271 0.558 . . . . 0.75 110.075 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.596 ' O ' HG22 ' A' ' 57' ' ' ILE . 16.2 m -100.58 140.34 34.99 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.434 -0.803 . . . . 0.82999999999999996 110.641 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.749 HD22 HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -143.36 92.43 2.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.447 0.642 . . . . 0.51000000000000001 109.634 173.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 32.3 m -86.72 116.84 25.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.562 -0.745 . . . . 0.58999999999999997 110.841 -176.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 93.8 mt -99.87 140.39 34.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.069 -0.514 . . . . 1.27 110.547 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.3 m -107.28 109.57 21.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.041 -0.527 . . . . 0.69999999999999996 109.82 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.1 129.11 29.03 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.785 -0.721 . . . . 0.80000000000000004 111.71 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.528 ' HA2' ' H ' ' A' ' 132' ' ' SER . . . -170.52 167.66 40.78 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.734 -0.746 . . . . 0.53000000000000003 111.824 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -102.64 161.43 13.74 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.009 0.433 . . . . 0.89000000000000001 110.007 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.605 ' HZ2' ' H ' ' A' ' 125' ' ' ASN . 4.3 t-105 -119.03 152.31 36.65 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.483 -0.781 . . . . 0.56000000000000005 109.705 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -134.45 137.06 43.67 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.803 -0.635 . . . . 1.4199999999999999 110.201 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.583 ' HG3' ' HE2' ' A' ' 126' ' ' LYS . 74.4 mmtt 82.21 -146.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.197 0.999 . . . . 3.4700000000000002 111.016 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 126' ' ' LYS . 8.2 p-10 -147.91 117.41 7.0 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.179 0.807 . . . . 2.0800000000000001 113.179 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.605 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 28.0 t-20 64.32 -19.85 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.892 1.277 . . . . 2.4700000000000002 114.126 171.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.583 ' HE2' ' HG3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -69.05 -2.99 11.4 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.493 0.317 . . . . 1.96 111.491 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 72.04 69.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.21 -0.905 . . . . 2.02 110.623 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -112.22 99.32 1.05 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 109.997 -1.241 . . . . 0.77000000000000002 109.997 168.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 40.5 p90 -144.57 145.86 32.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.103 0.952 . . . . 1.21 110.369 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 29.2 m -132.25 116.39 15.39 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.25 -0.432 . . . . 1.47 109.988 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.507 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 29.3 Cg_exo -60.7 125.09 16.37 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.856 2.37 . . . . 0.92000000000000004 112.222 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.528 ' H ' ' HA2' ' A' ' 119' ' ' GLY . 5.8 t -152.05 96.3 2.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.985 -0.746 . . . . 1.52 108.985 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.09 -112.61 0.53 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.83 -0.908 . . . . 1.1699999999999999 110.83 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.93 171.61 14.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.095 0.448 . . . . 2.4700000000000002 111.029 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.3 96.06 7.8 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.274 -0.639 . . . . 1.8200000000000001 109.274 171.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -97.67 113.49 4.73 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.776 -0.726 . . . . 0.67000000000000004 112.18 -174.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 77.9 m -88.84 107.13 18.82 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.106 0.479 . . . . 0.57999999999999996 110.546 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.591 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 10.2 m -78.83 120.55 23.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.958 -1.127 . . . . 0.52000000000000002 107.958 172.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -111.8 109.44 19.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.359 0.6 . . . . 2.1800000000000002 110.773 -173.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.666 HD23 HD22 ' A' ' 56' ' ' LEU . 7.7 tp -98.96 100.82 12.05 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.969 -1.014 . . . . 0.63 109.742 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 31.8 m -107.38 118.37 36.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.742 -0.663 . . . . 0.57999999999999996 109.507 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 15' ' ' THR . 58.2 t -79.28 108.95 13.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.012 0.434 . . . . 1.74 111.327 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.701 -0.666 . . . . 2.5800000000000001 109.774 176.672 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.546 0.212 . . . . 5.7300000000000004 110.778 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.703 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 31.0 tt0 -93.62 97.09 10.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.622 -0.881 . . . . 3.0800000000000001 108.622 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 7.0 t -106.36 99.01 8.61 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.423 0.63 . . . . 1.4299999999999999 110.158 -174.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.643 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 58.9 tt0 -86.82 110.43 19.94 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.989 -1.005 . . . . 2.29 109.606 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.449 HG13 HG13 ' A' ' 30' ' ' VAL . 97.6 t -103.43 112.62 37.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.846 -0.616 . . . . 1.51 110.234 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -93.1 111.06 22.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.942 -0.572 . . . . 3.5699999999999998 110.075 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 116' ' ' LEU . 59.9 t -88.46 114.84 27.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.052 -0.721 . . . . 1.26 109.052 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.34 112.28 4.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.137 -0.554 . . . . 0.95999999999999996 112.75 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.9 106.37 4.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.244 -0.651 . . . . 2.1800000000000002 109.244 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.508 HD21 HG22 ' A' ' 28' ' ' VAL . 3.4 pp -137.61 154.43 49.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.054 -0.521 . . . . 1.4099999999999999 111.02 -175.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.5 m -119.08 123.6 44.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.804 -0.634 . . . . 1.03 110.187 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.527 HG22 ' HG2' ' A' ' 14' ' ' LYS . 14.6 p -121.23 141.72 40.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.801 -0.444 . . . . 1.45 109.801 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.728 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -108.91 99.66 8.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.652 0.263 . . . . 0.58999999999999997 110.966 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HG2' HG22 ' A' ' 12' ' ' VAL . 75.3 mmtt -142.5 172.88 12.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.3 0.571 . . . . 3.4199999999999999 110.573 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.46 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 1.0 OUTLIER -104.0 154.13 20.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.161 -0.927 . . . . 0.63 109.592 172.295 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.674 ' NH1' ' HG3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -86.61 -1.43 57.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.105 0.478 . . . . 3.1400000000000001 110.671 -176.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.534 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -85.8 -26.83 33.67 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.017 -0.611 . . . . 0.75 112.16 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 15' ' ' THR . 10.0 pt20 -79.83 -2.08 41.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.963 0.411 . . . . 2.1699999999999999 110.719 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.717 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 71.8 mt -76.4 -26.94 56.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.642 . . . . 1.6100000000000001 111.256 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 7.5 t 32.59 57.16 0.41 Allowed 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.215 0.947 . . . . 1.6499999999999999 113.286 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 20' ' ' THR . 70.4 m-20 76.72 -46.69 0.52 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.461 0.704 . . . . 1.8300000000000001 111.924 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.78 88.66 1.84 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.252 0.464 . . . . 0.81999999999999995 112.252 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.717 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -139.82 108.19 7.04 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.007 -0.542 . . . . 0.79000000000000004 110.493 171.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.619 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 38.6 Cg_endo -67.5 99.9 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.176 2.584 . . . . 1.1200000000000001 112.114 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.586 HG12 HD21 ' A' ' 19' ' ' LEU . 2.6 pp -101.08 -23.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.876 -0.602 . . . . 2.5800000000000001 111.829 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' N ' HD12 ' A' ' 25' ' ' ILE . . . -128.64 50.99 0.87 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.101 -1.047 . . . . 0.73999999999999999 113.396 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 10.0 Cg_endo -53.9 109.97 0.44 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.554 2.169 . . . . 0.67000000000000004 112.534 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.508 HG22 HD21 ' A' ' 10' ' ' LEU . 61.5 t -91.97 138.42 19.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.465 -0.788 . . . . 1.1799999999999999 110.543 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 p -78.62 97.92 5.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.944 0.402 . . . . 1.6399999999999999 110.844 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.663 ' O ' ' HA2' ' A' ' 93' ' ' GLY . 97.4 t -103.51 113.93 41.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.114 -0.494 . . . . 1.01 110.271 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.653 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -109.05 108.32 18.97 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.75 -0.833 . . . . 2.48 108.75 177.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.66 91.22 4.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.094 0.473 . . . . 0.69999999999999996 110.448 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.25 112.75 21.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.708 -0.678 . . . . 1.9399999999999999 110.098 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.703 ' HA3' ' O ' ' A' ' 2' ' ' GLU . . . 114.91 -17.97 17.05 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.531 -0.842 . . . . 1.8100000000000001 112.694 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 1.7 m -74.0 104.77 4.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.876 0.369 . . . . 1.8799999999999999 110.543 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -106.22 -39.75 5.84 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.301 -0.629 . . . . 2.1400000000000001 109.301 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.44 64.19 1.35 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.241 -0.89 . . . . 0.93999999999999995 109.217 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.592 ' HD3' ' H ' ' A' ' 39' ' ' GLN . 8.7 tpp180 -146.76 149.89 34.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.677 -0.692 . . . . 4.6399999999999997 110.756 -174.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.592 ' H ' ' HD3' ' A' ' 38' ' ' ARG . 36.6 mt-30 -84.81 125.96 33.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.912 -0.585 . . . . 1.75 109.669 176.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 22.1 t -92.29 125.36 44.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.838 -0.43 . . . . 0.54000000000000004 109.838 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.511 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -121.36 142.37 50.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.046 0.45 . . . . 0.35999999999999999 111.053 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.634 HD13 HD13 ' A' ' 96' ' ' ILE . 14.5 mt -103.0 112.42 25.24 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.149 -0.686 . . . . 0.83999999999999997 109.149 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.543 ' HG2' ' CD2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -109.32 151.32 26.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.179 -0.464 . . . . 1.9299999999999999 110.244 -178.545 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.407 ' HB1' ' OD1' ' A' ' 48' ' ' ASN . . . -100.61 167.44 10.34 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.978 -0.556 . . . . 0.40999999999999998 110.362 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 23.4 t70 -94.65 157.72 15.84 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.149 -0.686 . . . . 0.70999999999999996 109.149 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -53.22 -18.69 2.49 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.382 0.426 . . . . 1.3999999999999999 111.848 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.6 -37.37 68.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.726 -0.67 . . . . 2.2200000000000002 111.683 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 6.4 p30 -135.58 16.94 3.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.926 0.393 . . . . 1.3500000000000001 110.66 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 60.3 t80 -118.85 102.53 8.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 0.56000000000000005 109.382 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 14.4 pt-20 -102.06 100.6 10.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.824 0.345 . . . . 2.4100000000000001 110.409 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 71.31 -53.29 0.68 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.615 -0.72 . . . . 3.4300000000000002 111.289 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.1 39.17 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.604 -0.999 . . . . 0.56000000000000005 110.604 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 22.0 mmmt -137.7 133.7 34.51 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.986 -0.746 . . . . 2.1200000000000001 108.986 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -115.1 151.35 34.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.18 0.514 . . . . 0.56000000000000005 110.995 173.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HB3' ' HA ' ' A' ' 66' ' ' TYR . 13.8 p90 -156.24 176.94 12.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.534 -0.757 . . . . 0.58999999999999997 110.805 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.575 ' HA ' HD22 ' A' ' 114' ' ' LEU . 29.7 mt -80.34 111.22 16.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.176 -1.046 . . . . 1.53 108.176 170.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.536 ' CG2' ' HB3' ' A' ' 48' ' ' ASN . 8.7 tp -107.6 127.94 63.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.287 0.565 . . . . 0.62 110.32 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.542 ' HB2' ' OD2' ' A' ' 63' ' ' ASP . 47.4 t -70.86 152.4 43.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.793 -0.64 . . . . 1.4399999999999999 109.34 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.27 -32.87 72.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.087 0.47 . . . . 2.3100000000000001 110.269 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' A' ' 60' ' ' ASN . 12.8 m120 -80.34 -0.43 36.77 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.002 -0.544 . . . . 3.0899999999999999 110.699 178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 p30 37.3 60.81 1.02 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.454 1.102 . . . . 2.6200000000000001 113.394 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -127.56 -11.71 5.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.941 -0.572 . . . . 4.6600000000000001 110.037 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.542 ' OD2' ' HB2' ' A' ' 58' ' ' SER . 1.9 p-10 -136.63 152.02 49.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.484 -0.78 . . . . 2.5099999999999998 110.481 -176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.633 ' O ' HD23 ' A' ' 65' ' ' LEU . 9.5 ptpp? -156.89 152.98 27.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.544 -0.298 . . . . 2.0699999999999998 111.013 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.817 ' HB3' ' HG3' ' A' ' 104' ' ' GLN . 1.6 mt -141.29 124.98 16.86 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.149 -1.426 . . . . 1.98 107.149 170.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 55' ' ' PHE . 99.2 m-85 -69.26 133.88 48.46 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.121 0.486 . . . . 0.75 110.806 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.94 HG12 ' HA ' ' A' ' 100' ' ' VAL . 29.2 m -128.83 175.23 10.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.388 -0.824 . . . . 0.72999999999999998 109.796 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.853 ' HB2' ' HE2' ' A' ' 84' ' ' PHE . 2.2 p30 -152.34 128.27 10.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.235 0.54 . . . . 1.8100000000000001 109.918 172.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.588 HG21 HD12 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -79.85 87.67 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.81000000000000005 110.382 -174.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.404 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 79.3 mtt180 -86.4 137.6 34.45 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.637 -0.711 . . . . 3.79 110.206 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 74.1 Cg_exo -51.15 124.65 14.43 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.453 2.102 . . . . 0.58999999999999997 112.047 174.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.2 ttt -75.4 82.47 2.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.828 0.347 . . . . 1.71 110.678 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 61.87 21.15 12.05 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.536 -0.756 . . . . 1.9199999999999999 112.063 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.96 -51.55 5.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.618 -0.265 . . . . 1.8899999999999999 111.432 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.7 t -167.72 179.15 4.93 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.738 -0.467 . . . . 1.7 109.738 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.15 123.88 45.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.93999999999999995 110.576 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 12.0 m0 -116.32 160.99 19.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.89 -0.596 . . . . 0.5 110.057 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.1 m -81.86 113.46 19.81 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.356 -0.609 . . . . 0.51000000000000001 109.356 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 t -95.56 108.55 20.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.579 0.704 . . . . 0.58999999999999997 112.484 -171.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -117.44 162.26 18.24 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.228 -1.027 . . . . 1.7 108.228 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.467 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 10.6 m120 -85.28 -8.52 58.47 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.377 -0.529 . . . . 1.3899999999999999 110.984 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.421 ' O ' ' HE1' ' A' ' 49' ' ' PHE . . . -100.93 -35.98 4.09 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.305 -0.95 . . . . 0.65000000000000002 111.725 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.559 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 27.5 m -140.08 156.27 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.626 -0.509 . . . . 1.1599999999999999 109.626 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.853 ' HE2' ' HB2' ' A' ' 68' ' ' ASN . 1.0 OUTLIER -134.5 97.96 3.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.201 -1.037 . . . . 0.35999999999999999 108.201 178.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.652 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 2.4 p90 -132.56 144.99 50.78 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.488 -0.485 . . . . 0.58999999999999997 111.456 -172.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.928 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 40.9 pttt -78.56 148.92 33.16 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.656 -0.702 . . . . 1.3899999999999999 110.555 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.3 -23.36 61.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 2.1200000000000001 109.443 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.928 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 5.7 m-20 -72.38 162.3 29.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.247 -0.888 . . . . 2.1000000000000001 110.297 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.9 m -121.86 139.52 48.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.783 0.325 . . . . 1.05 110.578 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.0 -159.03 17.68 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.674 -0.774 . . . . 0.46000000000000002 111.926 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.7 m -69.21 166.79 17.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.971 0.415 . . . . 1.1699999999999999 110.473 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.43 ' HZ2' ' HB3' ' A' ' 71' ' ' PRO . 63.2 t90 -152.46 -52.05 0.11 Allowed 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.263 -0.643 . . . . 0.51000000000000001 109.263 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 27.21 89.8 0.01 OUTLIER Glycine 0 N--CA 1.466 0.654 0 O-C-N 125.12 1.513 . . . . 1.25 115.448 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.18 -150.17 5.73 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.96 -0.638 . . . . 0.71999999999999997 112.39 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 p -112.4 125.58 54.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.446 0.536 . . . . 0.59999999999999998 112.446 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.634 HD13 HD13 ' A' ' 42' ' ' LEU . 1.2 pt -115.75 129.42 72.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.77 -0.65 . . . . 1.6299999999999999 109.685 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -108.4 160.32 13.82 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.211 -0.995 . . . . 0.45000000000000001 112.743 -173.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -91.34 113.65 27.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.905 0.384 . . . . 0.82999999999999996 110.189 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.619 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -116.5 126.83 53.92 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.92 -1.141 . . . . 1.28 107.92 174.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.94 ' HA ' HG12 ' A' ' 67' ' ' VAL . 13.9 p -62.98 124.96 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.316 -0.994 . . . . 1.1399999999999999 108.316 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.07 88.04 2.4 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.225 -0.657 . . . . 1.02 109.225 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA2' ' OD1' ' A' ' 21' ' ' ASP . . . 90.51 112.32 1.56 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.567 -1.013 . . . . 1.53 110.567 -171.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -51.08 114.23 1.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.354 0.597 . . . . 2.1099999999999999 110.967 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.817 ' HG3' ' HB3' ' A' ' 65' ' ' LEU . 11.9 mm-40 -91.98 20.81 5.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.476 -0.784 . . . . 2.6200000000000001 111.094 -174.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.6 m 72.7 -21.72 0.24 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.589 -0.732 . . . . 2.4300000000000002 112.816 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.534 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 8.9 t30 70.57 84.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.704 0.764 . . . . 1.5600000000000001 110.238 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.541 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 12.2 t -103.93 149.22 36.97 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.974 -1.121 . . . . 1.6799999999999999 107.974 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.541 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 91.4 Cg_exo -18.11 89.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 1 C-N-CA 125.76 4.307 . . . . 1.26 115.001 -172.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.687 ' CB ' HG11 ' A' ' 142' ' ' VAL . 3.3 Cg_exo -81.01 -150.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.693 2.929 . . . . 0.76000000000000001 114.214 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.91 -163.69 37.11 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 109.071 -1.612 . . . . 0.76000000000000001 109.071 -173.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.456 HD22 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -80.2 101.69 8.99 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.299 -0.63 . . . . 2.04 109.299 178.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -84.9 126.59 33.61 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.003 0.43 . . . . 0.75 109.965 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.9 m -130.71 97.36 4.33 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.906 -0.588 . . . . 0.82999999999999996 109.594 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.575 HD22 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -104.27 105.6 15.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.483 0.659 . . . . 0.51000000000000001 110.51 -176.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 1.3 m -78.27 121.57 24.58 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.148 -0.933 . . . . 0.58999999999999997 110.527 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.566 ' HB2' HG11 ' A' ' 7' ' ' VAL . 96.0 mt -107.29 146.0 32.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.87 0.367 . . . . 1.27 110.635 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.0 m -119.19 109.16 15.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.373 -0.376 . . . . 0.69999999999999996 110.415 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.97 162.09 54.07 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.957 -0.64 . . . . 0.80000000000000004 112.952 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 151.16 166.35 13.7 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.032 -0.604 . . . . 0.53000000000000003 111.621 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.678 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 46.9 p90 -89.19 -173.53 4.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.16 0.505 . . . . 0.89000000000000001 111.043 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.628 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 2.3 t-105 -137.76 149.97 46.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.631 -0.713 . . . . 0.56000000000000005 110.276 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.79 147.66 50.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.308 -0.406 . . . . 1.4199999999999999 110.49 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.577 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 5.8 tmtt? 70.41 -142.36 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.66 0.6 . . . . 3.4700000000000002 110.432 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.528 ' HA ' ' HZ2' ' A' ' 121' ' ' TRP . 6.9 p-10 -160.08 132.66 6.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.622 0.248 . . . . 2.0800000000000001 111.405 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.546 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 8.9 t30 66.86 -30.06 0.15 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.939 1.089 . . . . 2.4700000000000002 113.939 174.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.648 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -68.81 -3.51 12.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 1.96 110.951 178.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.628 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 20.4 tt0 68.57 59.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.208 -0.905 . . . . 2.02 110.856 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.648 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -89.06 48.55 3.46 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.603 -0.808 . . . . 0.77000000000000002 111.358 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.595 ' HD1' ' HG2' ' A' ' 127' ' ' GLN . 16.4 p90 -78.81 140.85 38.13 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 110.026 -0.361 . . . . 1.21 110.026 -174.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.549 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 36.6 m -118.94 137.59 25.21 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.315 -0.254 . . . . 1.47 110.315 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.08 111.09 2.39 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.977 2.451 . . . . 0.92000000000000004 111.274 172.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.1 m -153.08 108.68 3.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.851 0.357 . . . . 1.52 110.489 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.643 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 137.4 -127.51 3.99 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.534 -0.841 . . . . 1.1699999999999999 111.907 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 m -124.96 145.7 49.74 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.282 -0.266 . . . . 2.4700000000000002 110.282 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.2 m -92.31 95.75 9.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.103 -0.702 . . . . 1.8200000000000001 109.103 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -92.17 128.7 9.5 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.918 -0.658 . . . . 0.67000000000000004 111.975 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.88 105.44 17.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.888 0.375 . . . . 0.57999999999999996 110.211 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.538 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 21.7 m -78.32 108.8 11.92 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.845 -0.798 . . . . 0.52000000000000002 108.845 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -103.45 109.06 20.56 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.551 0.691 . . . . 2.1800000000000002 110.535 -174.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.4 tp -100.82 97.12 7.77 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.617 -1.174 . . . . 0.63 109.092 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.728 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 24.8 m -97.64 122.28 40.54 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.613 -0.721 . . . . 0.57999999999999996 109.802 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.687 HG11 ' CB ' ' A' ' 109' ' ' PRO . 33.2 m -75.24 114.66 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-O 121.55 0.69 . . . . 1.74 111.29 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.715 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 38.4 m . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.301 -0.856 . . . . 2.5800000000000001 109.834 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.844 0.354 . . . . 5.7300000000000004 110.141 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 4' ' ' GLN . 12.8 pt-20 -170.73 161.33 7.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.853 -0.612 . . . . 3.0800000000000001 110.004 -174.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 53.9 m -78.83 89.01 4.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.414 -0.357 . . . . 1.4299999999999999 110.623 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.421 ' HG3' ' HG3' ' A' ' 2' ' ' GLU . 93.8 mt-30 -86.46 110.17 19.56 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.565 -0.454 . . . . 2.29 110.018 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.43 117.92 49.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.894 -0.594 . . . . 1.51 109.73 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -82.7 109.59 17.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.946 -0.57 . . . . 3.5699999999999998 111.618 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.35 117.13 52.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.509 -0.923 . . . . 1.26 108.509 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.38 144.39 17.05 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.443 -0.884 . . . . 0.95999999999999996 113.23 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -62.05 146.84 49.13 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.492 0.317 . . . . 2.1800000000000002 110.227 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 2.2 pt? -156.14 126.66 6.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.937 0.399 . . . . 1.4099999999999999 110.901 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.474 ' HA ' ' HB3' ' A' ' 139' ' ' LYS . 28.0 m -108.75 114.58 28.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.111 -0.495 . . . . 1.03 109.827 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.519 ' HB ' ' NZ ' ' A' ' 14' ' ' LYS . 61.9 t -144.17 146.04 21.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.595 -0.73 . . . . 1.45 109.328 -176.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.724 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -92.99 124.85 37.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.524 0.565 . . . . 0.58999999999999997 112.524 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.519 ' NZ ' ' HB ' ' A' ' 12' ' ' VAL . 1.1 mptt -147.6 168.44 22.0 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.889 0.376 . . . . 3.4199999999999999 110.043 172.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.536 ' O ' HD23 ' A' ' 19' ' ' LEU . 73.4 p -112.66 161.89 16.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.313 -0.995 . . . . 0.63 108.313 169.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.1 0.29 19.35 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.555 -0.858 . . . . 3.1400000000000001 110.236 175.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.99 -26.91 25.14 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 110.251 -1.139 . . . . 0.75 110.251 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -62.57 -29.61 70.72 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.442 -0.947 . . . . 2.1699999999999999 108.442 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.866 HD21 HD13 ' A' ' 25' ' ' ILE . 2.3 mm? -75.33 129.16 36.93 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.394 -1.275 . . . . 1.6100000000000001 109.593 171.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.658 HG22 ' HB2' ' A' ' 23' ' ' ALA . 13.7 t -127.94 42.18 3.37 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.391 1.091 . . . . 1.6499999999999999 108.262 -176.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.497 ' HB2' ' NE2' ' A' ' 103' ' ' GLN . 29.4 t70 75.3 -69.72 0.17 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.54 -1.663 . . . . 1.8300000000000001 109.607 -171.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -99.15 85.02 3.14 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.799 -0.445 . . . . 0.81999999999999995 109.799 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.658 ' HB2' HG22 ' A' ' 20' ' ' THR . . . -142.51 94.63 6.7 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.219 -0.446 . . . . 0.79000000000000004 110.923 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.521 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 32.9 Cg_endo -68.43 85.9 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 123.189 2.593 . . . . 1.1200000000000001 111.72 177.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.866 HD13 HD21 ' A' ' 19' ' ' LEU . 12.3 pt -83.31 -16.62 11.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.734 -1.121 . . . . 2.5800000000000001 111.392 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.35 69.74 0.4 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.542 -0.837 . . . . 0.73999999999999999 112.802 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 9.3 Cg_exo -71.16 108.16 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.631 2.221 . . . . 0.67000000000000004 111.697 173.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.6 t -84.47 141.69 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.016 -0.538 . . . . 1.1799999999999999 110.299 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.5 p -71.05 97.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.391 . . . . 1.6399999999999999 110.371 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.746 HG23 ' HA ' ' A' ' 95' ' ' THR . 6.6 t -83.59 142.27 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.933 0.873 . . . . 1.01 111.397 -174.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.17 114.18 5.44 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.18 -1.373 . . . . 2.48 107.658 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.82 104.63 11.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.785 0.326 . . . . 0.69999999999999996 110.911 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 46.3 tp -81.7 120.16 24.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.868 -0.605 . . . . 1.9399999999999999 109.963 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.9 -144.44 17.26 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.604 -0.808 . . . . 1.8100000000000001 111.923 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 4.2 m 59.75 32.33 21.33 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 122.192 0.197 . . . . 1.8799999999999999 111.503 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -55.46 -30.36 60.42 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.102 0.477 . . . . 2.1400000000000001 110.77 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.56 54.6 1.93 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.901 -0.59 . . . . 0.93999999999999995 110.083 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.9 tpp180 -140.28 150.49 44.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.263 -0.426 . . . . 4.6399999999999997 111.287 -176.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -93.22 92.53 7.78 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.312 -0.625 . . . . 1.75 109.312 178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 58.1 t -56.61 134.08 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.678 -0.692 . . . . 0.54000000000000004 110.639 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 1.02 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -143.82 149.88 37.67 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.962 0.41 . . . . 0.35999999999999999 111.045 -176.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.48 HD12 ' HB ' ' A' ' 69' ' ' ILE . 11.7 mt -102.96 155.17 18.54 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.011 -0.54 . . . . 0.83999999999999997 109.549 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HZ1' ' HB3' ' A' ' 41' ' ' ALA . 1.7 mptp? -140.05 150.92 44.96 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.862 -0.792 . . . . 1.9299999999999999 108.862 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -86.25 155.45 20.68 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.307 -0.627 . . . . 0.40999999999999998 109.307 171.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 27.6 t70 -71.78 161.45 30.95 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.667 -0.494 . . . . 0.70999999999999996 109.667 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -55.96 -23.1 30.14 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.929 0.715 . . . . 1.3999999999999999 112.929 -173.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.0 -16.61 54.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 2.2200000000000002 111.424 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 20.3 m120 -123.04 8.19 9.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.215 -0.448 . . . . 1.3500000000000001 110.292 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 83.2 t80 -131.71 109.47 10.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.776 -0.647 . . . . 0.56000000000000005 110.24 -174.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.538 ' HG2' ' HE1' ' A' ' 55' ' ' PHE . 14.2 pt-20 -134.0 124.11 25.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.357 -0.383 . . . . 2.4100000000000001 110.193 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 54.68 39.04 31.04 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.98 -0.554 . . . . 3.4300000000000002 111.586 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.93 36.72 65.06 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.758 -0.655 . . . . 0.56000000000000005 112.854 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.523 ' HB3' ' HE2' ' A' ' 66' ' ' TYR . 47.2 mmtm -132.8 134.91 45.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.304 -0.628 . . . . 2.1200000000000001 109.304 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -116.98 141.18 48.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.418 0.628 . . . . 0.56000000000000005 111.639 176.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.538 ' HE1' ' HG2' ' A' ' 50' ' ' GLU . 41.8 p90 -155.04 160.87 41.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.453 -0.794 . . . . 0.58999999999999997 109.912 -175.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.761 ' HB3' HD22 ' A' ' 114' ' ' LEU . 1.7 pp -81.21 143.08 32.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.64 -0.504 . . . . 1.53 109.64 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 113' ' ' THR . 11.1 tp -121.05 146.9 25.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.697 -0.401 . . . . 0.62 110.36 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.438 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 2.8 p -100.3 174.4 6.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.963 -0.562 . . . . 1.4399999999999999 111.666 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -53.86 -41.37 67.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.54 -0.755 . . . . 2.3100000000000001 110.54 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.68 -14.04 46.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.156 -0.929 . . . . 3.0899999999999999 111.138 -174.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.403 ' HA ' HD11 ' A' ' 57' ' ' ILE . 43.3 m-80 62.29 18.97 10.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.167 0.508 . . . . 2.6200000000000001 110.285 -171.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -90.62 -50.01 6.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.857 -0.61 . . . . 4.6600000000000001 110.883 -175.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -100.75 134.22 44.04 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.712 -0.477 . . . . 2.5099999999999998 109.712 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HD2' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -144.39 154.67 43.22 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.846 -0.616 . . . . 2.0699999999999998 109.854 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.802 HD21 HG23 ' A' ' 100' ' ' VAL . 23.3 tp -150.95 134.74 16.52 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.11 -0.495 . . . . 1.98 109.88 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.523 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 65.3 m-85 -78.71 131.37 36.58 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.679 -0.691 . . . . 0.75 110.033 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.592 HG21 HD13 ' A' ' 114' ' ' LEU . 11.0 m -125.34 130.9 72.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.975 -0.557 . . . . 0.72999999999999998 110.702 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -99.77 121.78 41.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.102 -0.499 . . . . 1.8100000000000001 110.027 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.52 HD13 HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -83.17 87.64 2.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.165 -0.47 . . . . 0.81000000000000005 109.969 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.465 ' HE ' ' HB2' ' A' ' 99' ' ' TYR . 33.1 mtt180 -99.71 144.44 28.33 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.185 -0.461 . . . . 3.79 109.929 -173.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.683 ' HA ' HG22 ' A' ' 96' ' ' ILE . 77.7 Cg_exo -50.89 140.38 38.85 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.711 2.274 . . . . 0.58999999999999997 112.439 174.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tpt -77.5 74.63 4.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.25 -0.648 . . . . 1.71 109.25 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 43.02 84.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.01 -0.996 . . . . 1.9199999999999999 111.386 -174.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.757 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 2.2 t-20 -145.98 -67.08 0.29 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.241 -0.436 . . . . 1.8899999999999999 110.591 -173.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 m -142.88 164.52 29.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.71 -0.478 . . . . 1.7 109.71 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.06 107.33 17.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.212 0.53 . . . . 0.93999999999999995 110.604 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.4 m0 -101.89 137.45 40.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.663 -0.699 . . . . 0.5 110.067 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.7 m -69.75 114.51 8.02 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.568 -0.53 . . . . 0.51000000000000001 109.568 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -93.14 105.2 17.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.906 0.86 . . . . 0.58999999999999997 112.176 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -105.79 161.2 14.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.078 -1.082 . . . . 1.7 108.078 167.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -85.62 3.64 39.9 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.628 -0.429 . . . . 1.3899999999999999 111.1 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.65 -40.06 0.87 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.333 -0.937 . . . . 0.65000000000000002 111.826 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.582 HG21 ' CZ3' ' A' ' 121' ' ' TRP . 30.9 m -133.03 156.88 42.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.988 -0.375 . . . . 1.1599999999999999 109.988 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.713 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -133.72 97.64 3.97 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.961 -1.126 . . . . 0.35999999999999999 107.961 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 1.02 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -125.71 142.21 51.63 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 120.754 0.312 . . . . 0.58999999999999997 110.717 -175.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.771 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 18.5 pttm -72.45 144.12 48.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.353 -0.61 . . . . 1.3899999999999999 109.353 173.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.65 43.8 0.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.009 0.909 . . . . 2.1200000000000001 108.88 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.771 ' HB3' ' HD2' ' A' ' 86' ' ' LYS . 17.4 t70 -149.16 154.41 39.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.591 -1.186 . . . . 2.1000000000000001 109.411 -171.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -115.71 124.38 72.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.094 0.473 . . . . 1.05 110.564 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.66 174.97 22.94 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.502 -0.856 . . . . 0.46000000000000002 112.432 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 p -74.66 124.15 26.19 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.99 -0.374 . . . . 1.1699999999999999 109.99 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.757 ' HZ2' ' HB3' ' A' ' 74' ' ' ASN . 13.4 t90 -100.64 -43.84 6.03 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.844 -0.342 . . . . 0.51000000000000001 111.677 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.579 ' O ' ' HB ' ' A' ' 30' ' ' VAL . . . 51.34 -122.1 14.07 Favored Glycine 0 C--O 1.213 -1.175 0 N-CA-C 110.968 -0.853 . . . . 1.25 110.968 -173.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 73.17 -144.68 35.04 Favored Glycine 0 C--N 1.321 -0.271 0 C-N-CA 120.908 -0.663 . . . . 0.71999999999999997 113.9 166.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.746 ' HA ' HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -152.09 134.06 14.94 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 122.647 0.379 . . . . 0.59999999999999998 110.746 -179.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.683 HG22 ' HA ' ' A' ' 71' ' ' PRO . 2.2 pp -124.92 151.58 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.601 -0.518 . . . . 1.6299999999999999 109.601 174.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.35 167.77 23.33 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.364 -0.922 . . . . 0.45000000000000001 112.56 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.587 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.9 mp -91.11 113.26 26.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 110.252 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.521 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 1.6 m-85 -113.89 124.14 51.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.864 -0.791 . . . . 1.28 108.864 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.802 HG23 HD21 ' A' ' 65' ' ' LEU . 11.4 p -55.58 139.07 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.632 0.253 . . . . 1.1399999999999999 110.709 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -86.61 82.75 7.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.813 -0.81 . . . . 1.02 108.813 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.8 100.7 0.41 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.266 -0.734 . . . . 1.53 111.266 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.497 ' NE2' ' HB2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -43.01 120.25 1.74 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.543 0.687 . . . . 2.1099999999999999 111.87 -179.132 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.501 ' HG3' ' OG1' ' A' ' 107' ' ' THR . 21.1 tp60 -75.94 -3.13 33.8 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.813 -0.63 . . . . 2.6200000000000001 110.719 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.9 m 66.73 24.81 9.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.345 0.593 . . . . 2.4300000000000002 111.446 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 60.71 71.34 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.77 0.795 . . . . 1.5600000000000001 111.529 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.501 ' OG1' ' HG3' ' A' ' 104' ' ' GLN . 3.1 m -82.64 139.62 44.01 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.971 -1.013 . . . . 1.6799999999999999 108.501 168.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 107' ' ' THR . 66.6 Cg_exo -24.9 94.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.096 1 C-N-CA 125.481 4.12 . . . . 1.26 114.558 -176.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.421 ' HB3' ' HE2' ' A' ' 112' ' ' TYR . 57.1 Cg_endo -87.67 -174.89 1.33 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.14 2.56 . . . . 0.76000000000000001 113.532 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.45 -121.18 0.57 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.215 -1.154 . . . . 0.76000000000000001 110.215 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -99.45 109.81 22.34 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.129 -0.693 . . . . 2.04 109.129 171.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.518 ' CD1' HD13 ' A' ' 56' ' ' LEU . 53.4 m-85 -107.11 104.77 14.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.803 0.811 . . . . 0.75 110.667 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 57' ' ' ILE . 86.6 m -98.04 118.21 34.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.889 -1.051 . . . . 0.82999999999999996 109.897 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.761 HD22 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -133.78 96.76 3.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.22 0.533 . . . . 0.51000000000000001 110.214 175.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 7.6 m -75.12 127.61 33.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.089 -0.505 . . . . 0.58999999999999997 110.157 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.52 HD13 HD13 ' A' ' 69' ' ' ILE . 90.2 mt -116.59 126.13 52.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.009 -0.367 . . . . 1.27 110.009 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.501 HG21 ' HB3' ' A' ' 131' ' ' PRO . 17.3 m -106.75 126.51 52.39 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.849 0.357 . . . . 0.69999999999999996 110.63 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.69 157.54 45.81 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.809 -0.71 . . . . 0.80000000000000004 111.619 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 130' ' ' THR . . . 171.79 -169.56 42.62 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.629 -0.796 . . . . 0.53000000000000003 111.923 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -111.97 179.92 3.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.181 0.515 . . . . 0.89000000000000001 110.325 177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.777 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 1.7 t-105 -145.48 148.31 33.12 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.495 -0.775 . . . . 0.56000000000000005 109.272 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.47 144.26 50.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.831 0.348 . . . . 1.4199999999999999 111.155 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.719 ' HD3' ' H ' ' A' ' 124' ' ' ASP . 4.7 tmtm? 67.83 -136.69 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.918 0.887 . . . . 3.4700000000000002 110.212 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.719 ' H ' ' HD3' ' A' ' 123' ' ' LYS . 4.1 p30 -161.56 138.59 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.067 0.394 . . . . 2.0800000000000001 110.934 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.513 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 55.9 m-80 64.85 -40.8 0.28 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.702 1.201 . . . . 2.4700000000000002 113.891 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.487 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -62.9 -3.63 1.72 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.21 0.604 . . . . 1.96 112.339 -174.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.777 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 44.1 mt-30 68.01 67.1 0.35 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.491 0.662 . . . . 2.02 111.576 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.487 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -95.13 39.61 2.84 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.948 -0.861 . . . . 0.77000000000000002 110.948 173.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.576 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 41.8 p90 -81.81 151.39 27.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.692 0.282 . . . . 1.21 110.611 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 74.6 m -147.37 125.79 6.13 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.598 -0.273 . . . . 1.47 110.707 174.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.501 ' HB3' HG21 ' A' ' 117' ' ' THR . 9.2 Cg_exo -72.17 114.18 3.91 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.933 2.422 . . . . 0.92000000000000004 111.51 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 p -151.04 126.98 10.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.045 0.45 . . . . 1.52 110.931 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.85 -113.55 2.69 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.633 -0.794 . . . . 1.1699999999999999 112.17 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.3 m -130.44 135.37 47.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.63 0.252 . . . . 2.4700000000000002 110.582 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.2 t -99.78 140.53 33.86 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.49 -0.559 . . . . 1.8200000000000001 109.49 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -130.41 119.84 2.87 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.45 -0.881 . . . . 0.67000000000000004 112.355 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 6.0 m -77.77 104.72 8.48 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.781 -0.452 . . . . 0.57999999999999996 109.781 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.427 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 50.7 m -78.59 108.26 11.86 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.062 -0.718 . . . . 0.52000000000000002 109.062 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.474 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 12.4 tppt? -98.68 112.97 24.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.762 0.791 . . . . 2.1800000000000002 110.405 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.624 HD23 HD22 ' A' ' 56' ' ' LEU . 9.4 tp -102.06 94.42 5.76 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 114.676 -1.147 . . . . 0.63 109.409 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 17.1 m -105.69 144.82 31.9 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.265 -0.642 . . . . 0.57999999999999996 109.265 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.4 p -95.41 135.97 27.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.157 0.503 . . . . 1.74 110.21 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.4 m . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.714 -0.66 . . . . 2.5800000000000001 109.728 178.888 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 121.029 0.442 . . . . 5.7300000000000004 111.005 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -115.25 -166.5 1.13 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.622 -0.717 . . . . 3.0800000000000001 109.424 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 51.9 t -67.95 86.96 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.502 0.668 . . . . 1.4299999999999999 109.538 172.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -94.62 120.46 34.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.385 -0.825 . . . . 2.29 110.392 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.6 115.78 42.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.184 -0.462 . . . . 1.51 110.669 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' A' ' 31' ' ' GLN . 37.5 ttm180 -80.12 108.16 13.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.688 -0.687 . . . . 3.5699999999999998 109.802 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -114.83 122.55 69.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.808 -0.633 . . . . 1.26 109.829 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.51 169.38 27.4 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.815 -0.707 . . . . 0.95999999999999996 112.389 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.57 123.39 40.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.049 -0.352 . . . . 2.1800000000000002 110.049 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.48 ' HB2' HG23 ' A' ' 138' ' ' THR . 55.8 mt -107.45 121.49 44.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.927 0.394 . . . . 1.4099999999999999 111.582 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.1 m -112.82 113.32 25.36 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.029 -0.73 . . . . 1.03 109.029 170.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.76 147.78 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.913 -0.403 . . . . 1.45 109.913 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -112.28 135.43 52.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.625 -0.261 . . . . 0.58999999999999997 110.99 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HE2' ' HB ' ' A' ' 25' ' ' ILE . 10.9 ptpp? 178.5 163.82 0.75 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.982 -0.554 . . . . 3.4199999999999999 109.957 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.861 ' HA ' HG13 ' A' ' 142' ' ' VAL . 76.1 p -85.44 161.71 19.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.132 -0.485 . . . . 0.63 109.865 175.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.705 ' NH1' ' HG3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -80.32 -0.4 36.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.3 -0.63 . . . . 3.1400000000000001 109.3 174.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -96.53 -18.41 30.62 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.197 -0.91 . . . . 0.75 110.962 176.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -71.12 -23.82 62.16 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.538 -0.912 . . . . 2.1699999999999999 108.538 172.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.402 HD23 HD12 ' A' ' 25' ' ' ILE . 46.9 mt -86.49 116.99 24.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.641 -1.163 . . . . 1.6100000000000001 108.989 173.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 p -111.42 77.13 1.02 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.77 0.319 . . . . 1.6499999999999999 110.682 -175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 29.5 t70 61.39 -83.56 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.155 -0.93 . . . . 1.8300000000000001 110.835 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.657 ' HA ' ' CD2' ' A' ' 99' ' ' TYR . . . -107.07 84.6 2.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.304 0.574 . . . . 0.81999999999999995 110.309 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.481 ' O ' HG13 ' A' ' 25' ' ' ILE . . . -146.68 87.72 6.28 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.191 -0.913 . . . . 0.79000000000000004 109.304 175.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.53 ' CB ' ' HA3' ' A' ' 97' ' ' GLY . 59.8 Cg_endo -69.57 94.86 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.657 2.238 . . . . 1.1200000000000001 112.683 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 23' ' ' ALA . 4.9 mt -111.82 23.46 4.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 122.005 0.907 . . . . 2.5800000000000001 110.056 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.518 ' N ' ' HD3' ' A' ' 27' ' ' PRO . . . -140.66 53.17 0.67 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.89 -1.05 . . . . 0.73999999999999999 111.578 168.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.789 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 48.4 Cg_exo -55.81 115.06 2.19 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.299 1.999 . . . . 0.67000000000000004 113.433 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.2 t -88.58 129.89 38.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.361 -0.836 . . . . 1.1799999999999999 109.282 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 p -76.95 88.13 3.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.244 0.545 . . . . 1.6399999999999999 110.868 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.1 115.44 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.673 -0.694 . . . . 1.01 110.755 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.598 ' HB3' ' HB3' ' A' ' 6' ' ' ARG . 52.1 tt0 -114.35 113.01 23.98 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.251 -0.431 . . . . 2.48 109.988 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.609 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -95.98 101.27 12.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.843 -0.617 . . . . 0.69999999999999996 110.306 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 tt -95.83 126.35 41.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.765 -0.652 . . . . 1.9399999999999999 110.592 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.2 69.9 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.087 -0.577 . . . . 1.8100000000000001 114.4 169.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.609 ' SG ' ' HB1' ' A' ' 32' ' ' ALA . 31.3 m -80.54 -66.96 0.82 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.343 0.572 . . . . 1.8799999999999999 110.112 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' C ' ' HA2' ' A' ' 90' ' ' GLY . 3.2 m-20 67.81 -45.98 0.5 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.136 1.162 . . . . 2.1400000000000001 114.136 172.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.52 29.08 2.69 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.062 -0.399 . . . . 0.93999999999999995 111.905 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -133.26 161.06 35.5 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.23 -0.285 . . . . 4.6399999999999997 110.23 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -91.73 141.14 29.01 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.904 -0.406 . . . . 1.75 109.904 172.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 53.1 t -94.03 136.28 26.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.849 -0.796 . . . . 0.54000000000000004 108.849 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -127.53 135.39 50.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.851 0.358 . . . . 0.35999999999999999 110.803 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 mt -103.54 105.57 15.84 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.164 -0.68 . . . . 0.83999999999999997 109.164 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.833 ' HG3' HG12 ' A' ' 83' ' ' VAL . 1.4 mppt? -108.4 125.41 51.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.52 -0.919 . . . . 1.9299999999999999 108.52 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.633 ' HB1' HD21 ' A' ' 48' ' ' ASN . . . -72.94 156.95 38.33 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.686 -0.406 . . . . 0.40999999999999998 110.248 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.709 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 21.5 t70 -71.77 147.4 47.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.205 -0.452 . . . . 0.70999999999999996 109.839 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -61.66 -6.27 2.43 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.91 0.707 . . . . 1.3999999999999999 112.91 -171.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.83 -29.24 44.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.992 0.425 . . . . 2.2200000000000002 110.378 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.633 HD21 ' HB1' ' A' ' 44' ' ' ALA . 5.5 p-10 -124.28 19.79 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 1.3500000000000001 109.553 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 84.7 t80 -137.45 107.4 6.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.281 -0.872 . . . . 0.56000000000000005 109.916 -175.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -103.07 96.91 7.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.411 -0.358 . . . . 2.4100000000000001 110.653 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 68.2 -52.32 0.54 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.983 0.802 . . . . 3.4300000000000002 112.047 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' CE1' ' A' ' 49' ' ' PHE . . . -174.33 37.08 0.12 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 111.671 -0.572 . . . . 0.56000000000000005 111.671 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.781 ' HD2' ' HB3' ' A' ' 81' ' ' ASN . 8.7 mmmm -138.95 133.52 31.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.64 -1.244 . . . . 2.1200000000000001 107.64 172.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.15 147.03 43.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.667 0.746 . . . . 0.56000000000000005 112.055 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 9.2 p90 -150.19 -179.63 7.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.568 -1.196 . . . . 0.58999999999999997 109.603 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.959 HD12 HD22 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -89.37 121.55 31.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.979 -1.119 . . . . 1.53 107.979 169.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.591 HG22 ' HB3' ' A' ' 48' ' ' ASN . 8.8 tp -106.79 116.86 51.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.571 0.701 . . . . 0.62 109.439 177.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 22.6 t -72.51 147.65 45.79 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.06 -0.518 . . . . 1.4399999999999999 110.214 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.84 -8.07 33.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.456 0.646 . . . . 2.3100000000000001 109.703 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -95.26 -3.12 48.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.385 -0.825 . . . . 3.0899999999999999 110.023 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.07 28.01 0.35 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.884 1.273 . . . . 2.6200000000000001 113.553 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -86.46 -53.83 4.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.087 -0.383 . . . . 4.6600000000000001 111.118 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.523 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 7.2 m-20 -125.66 159.64 31.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.414 -0.357 . . . . 2.5099999999999998 110.705 -175.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.503 ' HB2' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -145.63 133.11 20.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.78 -0.646 . . . . 2.0699999999999998 109.718 176.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.625 ' O ' HD22 ' A' ' 56' ' ' LEU . 2.0 mm? -128.37 133.35 48.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.336 -0.616 . . . . 1.98 109.336 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -75.25 138.34 41.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.147 0.498 . . . . 0.75 110.376 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.488 HG11 HD11 ' A' ' 56' ' ' LEU . 2.4 m -117.48 167.19 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-N 115.734 -0.667 . . . . 0.72999999999999998 110.476 177.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -121.78 110.34 15.79 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.775 -0.648 . . . . 1.8100000000000001 109.339 173.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.42 HG23 HG12 ' A' ' 98' ' ' ILE . 1.1 pt -88.77 84.93 2.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.021 -0.733 . . . . 0.81000000000000005 109.021 172.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.582 ' HB3' ' OH ' ' A' ' 99' ' ' TYR . 44.9 ttt180 -116.69 136.2 23.13 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 115.445 -0.798 . . . . 3.79 109.132 -173.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 91.9 Cg_exo -42.92 121.0 2.08 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.0 2.467 . . . . 0.58999999999999997 112.284 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.9 ttt -68.18 87.83 0.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 1.71 110.424 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t0 49.35 66.76 1.02 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.143 -0.935 . . . . 1.9199999999999999 111.019 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -140.17 -53.19 0.51 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 1.8899999999999999 111.559 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.0 m -149.57 161.42 42.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.576 0.227 . . . . 1.7 110.624 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.6 86.45 3.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.94 0.4 . . . . 0.93999999999999995 110.081 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.404 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 17.2 m0 -77.25 158.27 30.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.706 -0.679 . . . . 0.5 110.3 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.9 m -69.63 116.33 9.91 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.063 -0.717 . . . . 0.51000000000000001 109.063 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 t -98.01 97.31 8.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.819 0.819 . . . . 0.58999999999999997 112.094 -170.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.33 159.85 14.67 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.295 -1.002 . . . . 1.7 108.295 168.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.781 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -79.73 -7.31 58.54 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.335 -0.546 . . . . 1.3899999999999999 110.017 -178.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.452 ' CA ' ' HE1' ' A' ' 49' ' ' PHE . . . -118.64 -36.74 0.88 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.13 -1.033 . . . . 0.65000000000000002 112.887 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.833 HG12 ' HG3' ' A' ' 43' ' ' LYS . 33.4 m -124.52 151.76 30.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.275 -0.639 . . . . 1.1599999999999999 109.275 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -135.03 102.48 5.23 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.297 -1.001 . . . . 0.35999999999999999 108.297 -178.422 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.683 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 15.6 p90 -135.9 140.87 44.4 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.137 0.494 . . . . 0.58999999999999997 110.903 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 17.1 pttp -82.44 140.98 33.1 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.562 -0.745 . . . . 1.3899999999999999 110.986 -178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -67.47 -34.4 77.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.291 -1.003 . . . . 2.1200000000000001 108.291 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 2.2 m-20 -58.44 124.48 19.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.636 -1.166 . . . . 2.1000000000000001 110.31 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.8 131.46 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.512 -0.475 . . . . 1.05 109.818 174.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.589 ' HA2' ' C ' ' A' ' 36' ' ' ASN . . . 146.07 -165.19 28.18 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.584 -0.817 . . . . 0.46000000000000002 111.832 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.8 p -81.82 -172.78 4.08 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.619 -0.511 . . . . 1.1699999999999999 109.619 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.586 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 22.5 t90 -154.0 -59.99 0.13 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.953 -0.388 . . . . 0.51000000000000001 109.953 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 31' ' ' GLN . . . 39.69 88.44 0.01 OUTLIER Glycine 0 N--CA 1.467 0.724 0 O-C-N 124.275 0.985 . . . . 1.25 114.901 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.69 -139.6 2.68 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.022 -0.609 . . . . 0.71999999999999997 111.669 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 p -131.77 124.62 30.07 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.43 0.634 . . . . 0.59999999999999998 112.167 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.789 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 37.5 pt -100.0 161.54 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.375 -0.972 . . . . 1.6299999999999999 108.375 172.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 24' ' ' PRO . . . -128.02 147.9 17.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.53 -1.319 . . . . 0.45000000000000001 113.126 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 69' ' ' ILE . 79.8 mt -101.75 120.73 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 120.731 0.3 . . . . 0.82999999999999996 110.886 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.657 ' CD2' ' HA ' ' A' ' 22' ' ' ALA . 1.4 p90 -138.6 155.2 48.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.85 -0.614 . . . . 1.28 110.392 173.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 103' ' ' GLN . 12.8 p -85.58 136.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.822 -0.626 . . . . 1.1399999999999999 110.761 -170.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.13 101.87 0.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.825 -0.625 . . . . 1.02 111.391 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.75 34.83 66.4 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-O 119.451 -0.638 . . . . 1.53 113.848 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.496 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.4 pt20 38.92 96.88 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.984 0.897 . . . . 2.1099999999999999 113.187 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.528 ' HG3' ' HB3' ' A' ' 65' ' ' LEU . 14.7 mm100 -80.39 17.45 1.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.49 -0.777 . . . . 2.6200000000000001 111.927 -172.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.438 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 8.8 m 76.32 -29.15 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.392 0.677 . . . . 2.4300000000000002 112.671 168.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.514 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 15.0 t30 77.8 84.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.851 0.834 . . . . 1.5600000000000001 111.08 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.472 ' N ' HH12 ' A' ' 16' ' ' ARG . 25.9 m -93.79 137.43 23.17 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.542 -1.208 . . . . 1.6799999999999999 109.535 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' CG2' ' A' ' 107' ' ' THR . 72.2 Cg_exo -19.58 92.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 1 C-N-CA 126.198 4.598 . . . . 1.26 115.461 -174.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.832 ' HG2' HG11 ' A' ' 142' ' ' VAL . 10.2 Cg_endo -96.96 -155.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.355 3.37 . . . . 0.76000000000000001 114.31 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -172.94 -105.25 0.18 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 114.118 -1.401 . . . . 0.76000000000000001 109.603 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -102.74 130.11 49.59 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.57 -0.53 . . . . 2.04 109.57 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.778 ' HE2' ' HB3' ' A' ' 109' ' ' PRO . 6.7 m-85 -118.58 120.66 38.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.036 0.446 . . . . 0.75 110.587 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.2 m -97.48 135.36 39.45 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 0.82999999999999996 110.768 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.959 HD22 HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -153.84 94.06 1.72 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.463 0.649 . . . . 0.51000000000000001 109.783 175.08 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.709 ' HB ' ' CB ' ' A' ' 45' ' ' ASP . 14.8 m -84.45 140.65 31.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.741 -0.663 . . . . 0.58999999999999997 109.95 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.5 mt -118.42 119.93 36.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.409 -0.359 . . . . 1.27 110.496 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 43.5 m -98.47 121.34 40.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.014 0.435 . . . . 0.69999999999999996 110.236 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.12 -159.4 19.05 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.842 -0.694 . . . . 0.80000000000000004 112.673 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.702 ' HA2' ' HB2' ' A' ' 132' ' ' SER . . . 109.64 165.88 20.0 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.518 -0.633 . . . . 0.53000000000000003 111.518 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -89.34 177.26 6.64 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.142 -0.623 . . . . 0.89000000000000001 111.017 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.659 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 4.6 t-105 -129.25 151.95 49.35 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.804 -1.089 . . . . 0.56000000000000005 109.902 -174.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.45 149.85 52.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.105 -0.498 . . . . 1.4199999999999999 110.175 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt 64.25 -146.52 0.28 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.21 0.604 . . . . 3.4700000000000002 111.053 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 126' ' ' LYS . 4.2 p30 -151.02 136.14 17.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.516 0.198 . . . . 2.0800000000000001 110.945 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.594 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.7 OUTLIER 51.97 -7.9 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.306 1.842 . . . . 2.4700000000000002 115.883 176.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -80.5 -2.52 46.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.362 0.601 . . . . 1.96 109.999 176.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.659 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 7.7 tt0 68.47 54.43 0.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.432 -1.258 . . . . 2.02 110.839 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.416 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -89.47 110.68 3.75 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 109.823 -1.311 . . . . 0.77000000000000002 109.823 170.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 121' ' ' TRP . 26.7 p90 -151.0 171.26 17.58 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.297 -0.631 . . . . 1.21 109.297 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.583 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 5.9 t -150.19 146.03 19.54 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 110.009 -0.367 . . . . 1.47 110.009 173.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.12 106.76 1.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.7 2.267 . . . . 0.92000000000000004 111.47 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.702 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 10.6 m -131.95 122.07 24.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.913 -0.585 . . . . 1.52 109.78 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.75 -110.57 3.78 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.714 -0.755 . . . . 1.1699999999999999 111.483 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.6 p -144.01 176.2 9.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.052 0.453 . . . . 2.4700000000000002 110.957 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.1 t -126.86 129.71 48.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.31 -0.626 . . . . 1.8200000000000001 109.31 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.49 138.18 14.65 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.647 -0.787 . . . . 0.67000000000000004 112.155 -175.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 19.2 m -99.06 103.73 15.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.992 -0.373 . . . . 0.57999999999999996 109.992 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 10' ' ' LEU . 21.6 m -81.81 113.18 19.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.355 -0.609 . . . . 0.52000000000000002 109.355 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -100.22 109.08 21.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.471 0.653 . . . . 2.1800000000000002 109.506 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.496 HD23 ' HG ' ' A' ' 56' ' ' LEU . 13.7 tp -92.58 95.85 9.85 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.711 -1.132 . . . . 0.63 109.415 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 24.7 m -93.64 126.8 39.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.76 -0.654 . . . . 0.57999999999999996 109.576 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' ' 15' ' ' THR . 30.7 t -107.23 106.18 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.675 -0.41 . . . . 1.74 111.242 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.289 -0.863 . . . . 2.5800000000000001 109.498 173.737 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.407 0.146 . . . . 5.7300000000000004 110.966 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -162.0 121.61 2.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.987 0.423 . . . . 3.0800000000000001 111.337 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.959 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 4.8 t -92.52 103.39 15.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.656 -0.868 . . . . 1.4299999999999999 108.656 168.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -97.67 141.42 30.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.25 -0.432 . . . . 2.29 110.928 -175.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.548 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 74.9 t -117.37 117.2 54.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.749 -0.659 . . . . 1.51 110.397 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -88.86 106.22 18.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.112 -0.495 . . . . 3.5699999999999998 110.79 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 5' ' ' VAL . 66.9 t -113.76 115.02 48.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.115 -0.493 . . . . 1.26 109.937 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.77 -178.53 25.72 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.63 -0.795 . . . . 0.95999999999999996 112.029 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.27 146.47 24.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.959 -0.385 . . . . 2.1800000000000002 109.959 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -140.92 142.11 34.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.12 -0.491 . . . . 1.4099999999999999 109.718 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -116.65 117.59 30.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.405 -0.362 . . . . 1.03 110.697 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.35 140.37 47.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.938 0.399 . . . . 1.45 110.534 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.45 ' HB1' ' OG1' ' A' ' 143' ' ' THR . . . -116.67 112.5 21.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 0.58999999999999997 110.222 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.561 ' HG3' ' H ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -163.81 179.7 6.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.049 0.452 . . . . 3.4199999999999999 110.417 -178.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.561 ' H ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -103.42 158.73 16.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.63 110.328 178.199 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.634 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -80.46 -9.2 59.76 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.961 -0.462 . . . . 3.1400000000000001 111.023 -175.81 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.57 -15.36 79.25 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.081 -0.807 . . . . 0.75 111.081 172.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.516 ' HA ' HE21 ' A' ' 18' ' ' GLN . 0.0 OUTLIER -66.07 -31.79 72.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.124 -0.538 . . . . 2.1699999999999999 110.856 176.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.87 ' HB2' HG12 ' A' ' 100' ' ' VAL . 12.2 mt -91.25 19.8 5.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.889 -0.596 . . . . 1.6100000000000001 112.183 -168.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -36.25 93.59 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 N-CA-C 114.007 1.114 . . . . 1.6499999999999999 114.007 -172.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 69.9 -53.34 0.62 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.858 -1.064 . . . . 1.8300000000000001 111.923 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.826 ' HA ' ' HB3' ' A' ' 99' ' ' TYR . . . -158.13 78.41 0.82 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.189 0.518 . . . . 0.81999999999999995 111.26 176.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 19' ' ' LEU . . . -138.93 117.87 9.25 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.488 -0.778 . . . . 0.79000000000000004 109.096 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.401 ' HD3' ' HE1' ' A' ' 99' ' ' TYR . 96.0 Cg_endo -79.74 132.48 9.79 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.88 2.387 . . . . 1.1200000000000001 114.417 -170.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.733 HG23 HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -77.49 -56.61 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.425 -0.807 . . . . 2.5800000000000001 110.162 169.104 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.444 ' H ' HG13 ' A' ' 25' ' ' ILE . . . -138.91 98.24 0.25 Allowed Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.388 -0.824 . . . . 0.73999999999999999 111.67 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.577 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 31.3 Cg_endo -67.66 126.58 14.95 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.271 1.98 . . . . 0.67000000000000004 111.378 176.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.75 124.44 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 1.1799999999999999 109.653 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 t -77.7 74.98 4.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.472 0.654 . . . . 1.6399999999999999 110.508 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.486 HG13 ' CG1' ' A' ' 5' ' ' VAL . 70.0 t -72.42 113.2 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.728 -0.669 . . . . 1.01 109.949 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.409 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 14.0 pt20 -116.12 125.82 52.87 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.778 -0.646 . . . . 2.48 109.833 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.524 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -111.61 130.61 55.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.408 -0.815 . . . . 0.69999999999999996 110.351 -177.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 3' ' ' CYS . 35.2 tp -111.44 116.45 30.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.137 -0.483 . . . . 1.9399999999999999 111.324 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.09 71.63 0.84 Allowed Glycine 0 C--N 1.331 0.304 0 O-C-N 123.573 0.545 . . . . 1.8100000000000001 113.423 173.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.959 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 9.9 m -106.71 -68.83 0.86 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.883 -0.327 . . . . 1.8799999999999999 111.465 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 68.41 -48.22 0.55 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.466 0.706 . . . . 2.1400000000000001 112.32 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.81 69.89 1.26 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.206 0.527 . . . . 0.93999999999999995 110.348 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.645 HH11 ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -149.95 131.8 15.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.994 -0.548 . . . . 4.6399999999999997 110.586 -177.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.707 ' HG3' HG12 ' A' ' 89' ' ' VAL . 98.6 mt-30 -85.48 124.19 31.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.109 0.48 . . . . 1.75 110.078 178.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.645 ' HA ' HH11 ' A' ' 38' ' ' ARG . 71.0 t -95.14 110.55 24.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.088 -0.506 . . . . 0.54000000000000004 109.946 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -117.72 144.44 45.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 123.624 0.578 . . . . 0.35999999999999999 111.039 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.852 HD11 HD12 ' A' ' 96' ' ' ILE . 64.5 mt -103.7 129.07 51.0 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.488 -0.56 . . . . 0.83999999999999997 109.488 172.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.718 ' HG3' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -120.28 152.12 38.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.858 -0.793 . . . . 1.9299999999999999 108.858 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.496 ' HB1' ' OD1' ' A' ' 48' ' ' ASN . . . -92.67 159.2 15.56 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.719 -0.392 . . . . 0.40999999999999998 110.036 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.588 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 14.8 t70 -87.61 170.01 11.66 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.563 -0.903 . . . . 0.70999999999999996 108.563 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -65.54 -1.98 3.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.975 0.361 . . . . 1.3999999999999999 111.975 -173.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -88.94 -26.34 21.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.72 -0.218 . . . . 2.2200000000000002 111.262 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.496 ' OD1' ' HB1' ' A' ' 44' ' ' ALA . 28.9 p-10 -131.73 12.16 4.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.732 0.301 . . . . 1.3500000000000001 111.699 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 55.2 t80 -114.44 101.37 9.07 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.537 -0.542 . . . . 0.56000000000000005 109.537 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.779 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 8.3 pt-20 -95.35 93.71 7.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.877 0.37 . . . . 2.4100000000000001 110.387 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 68.39 -50.95 0.56 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.428 -0.805 . . . . 3.4300000000000002 112.036 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -172.04 36.58 0.15 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.183 -0.767 . . . . 0.56000000000000005 111.183 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.629 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 10.3 mmmm -137.84 134.87 35.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.946 -0.761 . . . . 2.1200000000000001 108.946 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -117.9 148.69 41.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.493 0.663 . . . . 0.56000000000000005 112.307 177.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.779 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 7.6 p90 -156.58 176.94 12.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.019 -0.991 . . . . 0.58999999999999997 111.1 -174.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 20.1 mt -89.24 111.05 21.76 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.351 -0.981 . . . . 1.53 108.351 168.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.534 ' HB ' ' HE1' ' A' ' 55' ' ' PHE . 8.3 tp -107.33 138.69 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.703 -0.48 . . . . 0.62 109.703 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . 3.1 t -102.41 152.73 20.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.529 -0.305 . . . . 1.4399999999999999 110.372 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -49.11 -42.48 39.27 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.053 0.846 . . . . 2.3100000000000001 113.023 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.31 -21.8 66.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.711 0.263 . . . . 3.0899999999999999 111.711 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 63.34 84.43 0.15 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.365 0.602 . . . . 2.6200000000000001 109.95 -176.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -154.79 -40.7 0.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.615 . . . . 4.6600000000000001 111.034 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.87 153.52 50.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.915 -0.584 . . . . 2.5099999999999998 110.322 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.6 pptp? -152.25 128.04 10.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.804 -0.635 . . . . 2.0699999999999998 109.739 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.472 HD22 ' HG2' ' A' ' 104' ' ' GLN . 4.5 mt -114.27 119.12 35.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.261 -0.427 . . . . 1.98 110.026 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.453 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 93.4 m-85 -67.85 128.73 37.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 0.75 110.156 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 100' ' ' VAL . 11.2 m -121.27 123.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.878 -0.601 . . . . 0.72999999999999998 111.428 -175.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -97.21 111.67 23.81 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.961 -0.563 . . . . 1.8100000000000001 109.53 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.537 HG22 ' HB ' ' A' ' 96' ' ' ILE . 2.6 mt -76.32 86.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.562 -0.745 . . . . 0.81000000000000005 110.454 -176.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -93.62 142.84 25.68 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.995 -0.548 . . . . 3.79 109.866 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.541 ' HA ' HG23 ' A' ' 96' ' ' ILE . 77.1 Cg_exo -51.12 134.08 42.64 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.693 2.262 . . . . 0.58999999999999997 112.52 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tpt -75.14 72.75 2.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.984 -0.553 . . . . 1.71 109.948 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.4 t70 52.58 75.59 0.23 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.363 -0.835 . . . . 1.9199999999999999 110.785 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -146.56 -59.94 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.866 -0.606 . . . . 1.8899999999999999 111.248 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 m -151.02 178.83 8.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 1.7 111.055 -175.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.26 121.75 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.751 -0.658 . . . . 0.93999999999999995 109.891 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.521 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 17.8 m0 -113.07 168.21 9.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.256 -0.429 . . . . 0.5 111.001 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -87.97 131.37 34.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.018 -0.734 . . . . 0.51000000000000001 109.018 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 t -107.93 113.59 26.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.605 0.717 . . . . 0.58999999999999997 112.353 -171.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -127.24 161.33 28.82 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.782 -1.192 . . . . 1.7 107.782 170.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.515 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 15.8 m120 -85.91 -5.52 59.22 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.295 -0.562 . . . . 1.3899999999999999 110.812 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.82 -38.37 3.66 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.19 -1.005 . . . . 0.65000000000000002 111.81 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.718 HG12 ' HG3' ' A' ' 43' ' ' LYS . 27.0 m -140.49 156.72 23.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.971 0.415 . . . . 1.1599999999999999 110.403 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.684 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -132.15 108.87 9.56 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.659 -0.867 . . . . 0.35999999999999999 108.659 177.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.627 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 12.7 p90 -145.75 149.24 34.03 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.22 0.325 . . . . 0.58999999999999997 110.675 -174.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.524 ' HZ1' ' HB2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -80.55 141.36 35.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.948 -0.701 . . . . 1.3899999999999999 109.205 174.306 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -57.97 -33.81 69.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.843 -0.617 . . . . 2.1200000000000001 110.412 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -61.99 122.14 14.74 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.741 -0.663 . . . . 2.1000000000000001 111.587 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 39' ' ' GLN . 13.1 m -80.94 105.59 11.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.141 0.496 . . . . 1.05 109.95 173.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.42 ' N ' ' H ' ' A' ' 38' ' ' ARG . . . 170.75 -162.77 35.83 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.134 -1.032 . . . . 0.46000000000000002 112.603 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -84.0 163.81 19.71 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.013 0.435 . . . . 1.1699999999999999 110.447 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.524 ' HB2' ' HZ1' ' A' ' 86' ' ' LYS . 41.3 t90 -148.86 -62.41 0.24 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.344 -0.613 . . . . 0.51000000000000001 109.344 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 38.54 91.72 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 O-C-N 124.341 1.026 . . . . 1.25 115.161 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.16 -127.45 0.91 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.701 -0.761 . . . . 0.71999999999999997 112.377 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 p -135.85 133.02 37.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.054 0.454 . . . . 0.59999999999999998 111.805 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.852 HD12 HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -130.87 134.26 62.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 1.6299999999999999 109.692 176.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -106.61 156.26 16.22 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.34 -0.933 . . . . 0.45000000000000001 113.005 -170.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 mp -97.56 117.75 42.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.9 0.381 . . . . 0.82999999999999996 110.089 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.826 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 1.1 m-85 -126.19 133.56 51.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.631 -0.713 . . . . 1.28 109.509 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.87 HG12 ' HB2' ' A' ' 19' ' ' LEU . 12.3 p -66.21 119.77 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.855 -0.794 . . . . 1.1399999999999999 108.855 173.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.92 83.54 1.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.579 0.704 . . . . 1.02 109.477 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.99 93.83 2.3 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 114.799 -1.091 . . . . 1.53 110.961 -171.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 16.5 pt20 -31.48 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.276 0.843 . . . . 2.1099999999999999 113.276 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.472 ' HG2' HD22 ' A' ' 65' ' ' LEU . 55.9 tp60 -82.59 -15.37 52.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 2.6200000000000001 110.692 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 m 62.6 26.31 15.61 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.361 0.6 . . . . 2.4300000000000002 111.134 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.634 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 7.2 t30 64.08 89.41 0.09 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.589 -0.732 . . . . 1.5600000000000001 112.204 172.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.3 m -89.6 133.87 33.55 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.819 -0.808 . . . . 1.6799999999999999 108.819 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -19.46 90.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.794 4.329 . . . . 1.26 115.1 -171.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.616 ' CB ' ' HE1' ' A' ' 112' ' ' TYR . 90.0 Cg_endo -99.99 -161.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.968 3.112 . . . . 0.76000000000000001 113.889 -174.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.55 -101.98 0.15 Allowed Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.926 -1.034 . . . . 0.76000000000000001 110.633 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -112.38 111.41 22.25 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.339 -0.615 . . . . 2.04 109.339 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.616 ' HE1' ' CB ' ' A' ' 109' ' ' PRO . 27.6 m-85 -95.35 128.09 41.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.233 0.54 . . . . 0.75 110.303 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.7 m -116.06 98.46 6.64 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.071 -0.968 . . . . 0.82999999999999996 110.395 -175.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.474 ' HG ' ' HB ' ' A' ' 138' ' ' THR . 0.2 OUTLIER -119.34 100.55 7.38 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.042 -0.527 . . . . 0.51000000000000001 110.367 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.711 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 23.8 m -88.37 132.52 34.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.148 -0.478 . . . . 0.58999999999999997 110.527 -178.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -114.63 124.84 52.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.083 0.468 . . . . 1.27 110.556 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.473 ' HA ' HG23 ' A' ' 135' ' ' THR . 27.5 m -91.06 113.04 25.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.752 -0.658 . . . . 0.69999999999999996 110.478 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.1 122.65 6.25 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.737 -0.744 . . . . 0.80000000000000004 111.754 177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.57 -176.33 39.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.241 -0.98 . . . . 0.53000000000000003 112.426 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 38' ' ' ARG . 39.3 p90 -102.96 177.84 4.73 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.278 0.561 . . . . 0.89000000000000001 110.294 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.805 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.9 OUTLIER -147.29 149.32 32.62 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.323 -0.992 . . . . 0.56000000000000005 108.323 -177.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.61 144.14 51.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.421 0.153 . . . . 1.4199999999999999 110.79 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.438 ' HG3' ' HE2' ' A' ' 126' ' ' LYS . 32.9 mmtp 74.97 -144.34 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.62 0.768 . . . . 3.4700000000000002 111.368 175.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -150.68 123.21 8.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.322 0.582 . . . . 2.0800000000000001 112.275 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.544 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 27.6 t-20 68.44 -28.58 0.15 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.445 1.098 . . . . 2.4700000000000002 113.947 174.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.438 ' HE2' ' HG3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -65.34 -3.19 3.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.219 0.533 . . . . 1.96 111.164 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.805 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 46.1 tt0 66.79 66.45 0.44 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.12 -0.946 . . . . 2.02 110.862 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 121' ' ' TRP . . . -90.89 46.96 2.93 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.329 -0.938 . . . . 0.77000000000000002 111.37 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.619 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 3.9 p90 -86.69 144.66 27.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.773 0.321 . . . . 1.21 110.856 -170.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 46.3 m -150.3 132.26 7.83 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 110.37 -0.233 . . . . 1.47 110.37 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.71 132.74 47.14 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.708 2.272 . . . . 0.92000000000000004 112.345 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -156.28 95.17 1.57 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.234 -0.439 . . . . 1.52 110.4 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 5' ' ' VAL . . . 130.25 -102.71 0.54 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.776 -0.726 . . . . 1.1699999999999999 112.162 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.4 m -152.3 147.45 26.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.711 0.256 . . . . 2.4700000000000002 110.741 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.473 HG23 ' HA ' ' A' ' 117' ' ' THR . 28.9 m -101.2 127.49 47.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.649 -0.5 . . . . 1.8200000000000001 109.649 174.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.96 141.11 12.41 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.467 -0.873 . . . . 0.67000000000000004 112.524 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.711 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 72.8 m -94.3 123.15 37.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.025 0.44 . . . . 0.57999999999999996 110.913 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.474 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 24.9 m -85.88 115.26 23.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.514 -0.921 . . . . 0.52000000000000002 108.514 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -100.88 111.91 24.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.21 0.528 . . . . 2.1800000000000002 110.208 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 tp -108.64 100.45 9.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.048 -0.978 . . . . 0.63 110.385 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 m -93.15 143.67 26.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.852 -0.613 . . . . 0.57999999999999996 109.809 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.631 ' HA ' HH12 ' A' ' 16' ' ' ARG . 7.3 p -71.02 132.79 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.467 0.651 . . . . 1.74 112.349 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.45 ' OG1' ' HB1' ' A' ' 13' ' ' ALA . 85.5 m . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.133 -0.94 . . . . 2.5800000000000001 109.129 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.864 0.364 . . . . 5.7300000000000004 110.465 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -98.48 137.94 36.43 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.343 0.592 . . . . 3.0800000000000001 110.067 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.852 ' HB2' ' HA ' ' A' ' 35' ' ' CYS . 48.2 t -147.84 131.51 16.89 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.989 -1.005 . . . . 1.4299999999999999 108.3 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -85.68 123.71 31.38 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.285 -0.566 . . . . 2.29 110.393 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.536 HG12 HG23 ' A' ' 7' ' ' VAL . 61.3 t -95.56 112.06 27.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.718 -0.673 . . . . 1.51 110.045 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.721 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 14.5 mmm180 -81.64 93.74 6.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.706 -0.679 . . . . 3.5699999999999998 110.834 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.58 HG12 ' HA3' ' A' ' 136' ' ' GLY . 37.2 t -107.62 115.62 49.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.394 -0.965 . . . . 1.26 108.394 171.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.76 -175.77 21.65 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.498 -0.858 . . . . 0.95999999999999996 112.261 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -100.59 146.15 27.49 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.926 -0.398 . . . . 2.1800000000000002 109.926 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -152.6 139.26 18.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.552 -0.536 . . . . 1.4099999999999999 109.552 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.9 m -107.77 115.89 30.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.183 -0.462 . . . . 1.03 110.305 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 140' ' ' LEU . 4.1 p -110.61 126.01 67.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.14 -0.482 . . . . 1.45 109.9 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -105.31 104.21 13.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.898 -0.592 . . . . 0.58999999999999997 110.452 -176.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -172.9 -178.68 1.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 3.4199999999999999 110.478 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.5 p -107.43 162.77 13.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.127 -0.488 . . . . 0.63 111.065 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.654 ' HB2' HH11 ' A' ' 16' ' ' ARG . 0.0 OUTLIER -80.27 -0.44 36.48 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.644 -0.502 . . . . 3.1400000000000001 109.644 176.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.603 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -79.39 -17.58 75.76 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.367 -0.693 . . . . 0.75 111.367 177.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -74.17 -22.62 59.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.847 -0.797 . . . . 2.1699999999999999 108.847 173.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.924 HD21 HG12 ' A' ' 25' ' ' ILE . 67.2 mt -87.16 95.9 10.12 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.699 -1.137 . . . . 1.6100000000000001 110.985 -175.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.0 m -101.3 68.05 1.2 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.045 -0.724 . . . . 1.6499999999999999 109.045 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.4 t70 69.56 -62.68 0.41 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.753 -1.112 . . . . 1.8300000000000001 111.036 -175.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 99' ' ' TYR . . . -114.31 98.09 6.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.797 0.332 . . . . 0.81999999999999995 110.887 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . . . -154.54 92.08 2.98 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.439 . . . . 0.79000000000000004 111.071 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 28.7 Cg_endo -64.19 80.82 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.349 2.699 . . . . 1.1200000000000001 112.372 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.924 HG12 HD21 ' A' ' 19' ' ' LEU . 1.1 pp -70.7 -53.71 21.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.405 -0.816 . . . . 2.5800000000000001 112.336 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.24 63.88 0.57 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.203 -0.998 . . . . 0.73999999999999999 113.249 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.634 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 5.5 Cg_endo -47.07 111.59 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.601 2.867 . . . . 0.67000000000000004 113.004 172.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 p -84.63 134.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.896 -0.593 . . . . 1.1799999999999999 109.813 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -88.64 102.87 15.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.672 0.748 . . . . 1.6399999999999999 110.804 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.663 ' CG2' HD11 ' A' ' 96' ' ' ILE . 41.5 t -94.79 116.26 35.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.556 -0.747 . . . . 1.01 110.204 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.721 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 34.7 tt0 -102.01 125.14 48.62 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.641 -0.709 . . . . 2.48 110.182 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.667 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -112.89 113.98 26.29 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.956 -0.387 . . . . 0.69999999999999996 109.956 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.1 mt -104.99 111.52 24.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.969 0.414 . . . . 1.9399999999999999 111.986 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.95 55.32 8.18 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.508 -0.769 . . . . 1.8100000000000001 113.283 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.852 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 84.1 m -87.14 -49.31 7.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.857 0.329 . . . . 1.8799999999999999 110.585 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.8 t30 71.14 -63.78 0.41 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.708 0.803 . . . . 2.1400000000000001 112.69 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.91 71.0 1.25 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.676 0.75 . . . . 0.93999999999999995 109.19 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.619 ' NE ' ' HB3' ' A' ' 120' ' ' TYR . 41.0 ttt-85 -146.54 133.19 19.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.178 -0.919 . . . . 4.6399999999999997 111.012 -169.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -83.17 96.86 8.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.615 -0.513 . . . . 1.75 109.615 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 46.7 t -73.6 117.22 17.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 0.54000000000000004 110.315 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -119.48 148.31 43.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.129 -0.487 . . . . 0.35999999999999999 110.977 -176.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 mt -102.77 113.79 27.5 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.115 -0.698 . . . . 0.83999999999999997 109.115 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.541 ' HG3' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -104.75 125.8 51.19 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.632 -0.507 . . . . 1.9299999999999999 109.632 -178.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.587 ' HB1' ' ND2' ' A' ' 48' ' ' ASN . . . -76.81 143.26 39.9 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.517 -0.549 . . . . 0.40999999999999998 109.517 174.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.63 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 27.2 t70 -76.02 148.34 38.11 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.918 -0.771 . . . . 0.70999999999999996 108.918 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.723 ' HA ' ' HB3' ' A' ' 49' ' ' PHE . 10.1 t -56.56 -16.51 6.18 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.866 0.691 . . . . 1.3999999999999999 112.866 -172.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.28 -31.45 72.04 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.239 0.543 . . . . 2.2200000000000002 110.289 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.587 ' ND2' ' HB1' ' A' ' 44' ' ' ALA . 5.1 p-10 -129.43 24.31 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.773 -0.648 . . . . 1.3500000000000001 109.479 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.723 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 10.1 t80 -134.03 108.5 8.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.257 -0.883 . . . . 0.56000000000000005 109.16 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.787 ' HG2' ' HE2' ' A' ' 55' ' ' PHE . 10.9 pt-20 -116.65 116.61 27.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.649 0.261 . . . . 2.4100000000000001 110.448 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 71.34 -51.45 0.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.793 0.837 . . . . 3.4300000000000002 111.805 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.468 ' O ' ' HD2' ' A' ' 53' ' ' LYS . . . 170.02 31.17 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.719 -0.952 . . . . 0.56000000000000005 110.719 -177.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.702 ' HA ' ' HB3' ' A' ' 81' ' ' ASN . 14.5 mptt -129.88 140.23 51.02 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.178 -0.675 . . . . 2.1200000000000001 109.178 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' HB3' ' CB ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -120.69 147.68 44.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.585 0.707 . . . . 0.56000000000000005 111.636 176.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.787 ' HE2' ' HG2' ' A' ' 50' ' ' GLU . 16.9 p90 -157.46 174.93 14.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.886 -1.052 . . . . 0.58999999999999997 110.752 -170.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.557 HD13 HD23 ' A' ' 140' ' ' LEU . 8.6 mt -84.16 111.84 19.71 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.146 -1.057 . . . . 1.53 108.146 170.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.591 ' HB ' ' HE1' ' A' ' 55' ' ' PHE . 8.4 tp -105.3 125.83 60.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.805 0.812 . . . . 0.62 110.021 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.575 ' HB2' ' CE1' ' A' ' 112' ' ' TYR . 33.5 t -76.84 135.74 38.89 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.073 -0.967 . . . . 1.4399999999999999 110.714 -177.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.52 -34.17 72.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.868 -0.79 . . . . 2.3100000000000001 108.868 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -69.28 -24.67 63.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.566 -1.197 . . . . 3.0899999999999999 110.611 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 t30 63.83 97.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.701 -0.681 . . . . 2.6200000000000001 111.27 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -166.27 -44.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.716 -0.674 . . . . 4.6600000000000001 110.584 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.39 139.78 53.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.902 -0.59 . . . . 2.5099999999999998 109.955 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.59 ' HB2' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -135.35 106.51 6.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.989 0.899 . . . . 2.0699999999999998 109.429 170.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.789 HD21 HG23 ' A' ' 100' ' ' VAL . 7.9 tp -108.19 126.32 52.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.24 -0.891 . . . . 1.98 110.927 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 5.2 m-85 -72.95 141.4 47.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.956 -1.02 . . . . 0.75 110.306 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.572 HG12 ' HA ' ' A' ' 100' ' ' VAL . 16.4 m -136.65 142.61 37.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.549 -0.296 . . . . 0.72999999999999998 110.468 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -102.89 120.54 40.8 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.788 -0.449 . . . . 1.8100000000000001 109.788 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.485 HG22 ' HB ' ' A' ' 96' ' ' ILE . 0.9 OUTLIER -82.61 87.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.816 -0.629 . . . . 0.81000000000000005 109.876 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.498 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 60.0 ttt180 -93.99 128.63 40.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.414 -0.357 . . . . 3.79 110.812 -174.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.71 ' HA ' HG22 ' A' ' 96' ' ' ILE . 4.2 Cg_endo -50.36 139.77 36.01 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.319 2.679 . . . . 0.58999999999999997 112.216 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.6 ttt -72.66 64.11 0.63 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.661 -0.7 . . . . 1.71 111.304 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 t70 62.89 14.96 7.89 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.715 0.806 . . . . 1.9199999999999999 112.302 175.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.403 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 58.7 m-80 -78.13 -35.0 49.61 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.829 -0.544 . . . . 1.8899999999999999 111.559 -175.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.2 p -170.78 172.74 5.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.378 -0.23 . . . . 1.7 110.378 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.72 129.06 35.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.981 0.42 . . . . 0.93999999999999995 110.101 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.715 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 13.8 m0 -117.28 155.84 28.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.07 -0.513 . . . . 0.5 110.535 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.8 m -89.6 113.22 24.62 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.265 -0.643 . . . . 0.51000000000000001 109.265 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 t -88.58 124.25 33.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.796 0.807 . . . . 0.58999999999999997 111.91 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -130.56 160.98 32.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.44 -1.318 . . . . 1.7 107.44 168.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.702 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 16.1 m120 -85.94 -3.55 58.95 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.368 -0.533 . . . . 1.3899999999999999 111.262 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.92 -36.92 2.65 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.303 -0.951 . . . . 0.65000000000000002 111.664 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.541 HG12 ' HG3' ' A' ' 43' ' ' LYS . 29.3 m -137.01 156.67 34.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.997 0.427 . . . . 1.1599999999999999 110.306 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.615 ' HD1' ' HE3' ' A' ' 77' ' ' TRP . 0.7 OUTLIER -136.64 106.74 6.33 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.95 -1.13 . . . . 0.35999999999999999 107.95 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 8.7 p90 -138.19 146.5 42.76 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.913 -0.315 . . . . 0.58999999999999997 111.377 -174.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.733 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 49.3 pttt -78.22 157.57 29.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 1.3899999999999999 110.826 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -85.21 7.47 21.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.795 . . . . 2.1200000000000001 110.041 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.733 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 35.8 m-20 -106.48 128.04 53.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.538 -0.755 . . . . 2.1000000000000001 109.331 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -90.04 106.36 17.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.555 0.693 . . . . 1.05 111.002 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.28 -162.71 36.5 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.051 -0.819 . . . . 0.46000000000000002 111.051 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.4 m -84.14 147.25 27.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.976 0.417 . . . . 1.1699999999999999 109.941 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.487 ' CD2' ' HZ2' ' A' ' 77' ' ' TRP . 55.3 t90 -120.07 -59.05 1.83 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.65 -0.5 . . . . 0.51000000000000001 109.65 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 34.53 90.42 0.01 OUTLIER Glycine 0 N--CA 1.464 0.548 0 O-C-N 124.637 1.21 . . . . 1.25 115.477 176.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.16 -125.09 0.75 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.004 -0.617 . . . . 0.71999999999999997 111.955 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.457 ' O ' ' HH2' ' A' ' 92' ' ' TRP . 1.2 p -137.18 132.42 33.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 0.59999999999999998 111.571 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.71 HG22 ' HA ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -118.46 134.8 60.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.169 -0.678 . . . . 1.6299999999999999 109.169 174.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.634 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -99.58 158.52 19.81 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.331 -0.937 . . . . 0.45000000000000001 112.555 -175.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.513 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.8 mp -95.03 112.81 28.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.649 -0.5 . . . . 0.82999999999999996 109.649 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 70' ' ' ARG . 1.6 m-85 -110.95 120.91 43.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.817 -0.808 . . . . 1.28 108.817 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.789 HG23 HD21 ' A' ' 65' ' ' LEU . 14.5 p -58.68 137.34 21.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.816 0.341 . . . . 1.1399999999999999 110.993 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.65 81.94 8.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.715 -0.846 . . . . 1.02 108.715 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.65 110.34 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.525 -0.762 . . . . 1.53 111.815 -172.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.413 ' H ' ' HG3' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -40.09 125.11 1.95 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.493 0.663 . . . . 2.1099999999999999 112.582 177.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.587 HE21 HD13 ' A' ' 65' ' ' LEU . 7.7 tp-100 -92.69 21.27 5.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.559 . . . . 2.6200000000000001 110.461 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 6.1 m 69.25 -11.58 0.47 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.696 -0.684 . . . . 2.4300000000000002 112.714 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.603 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 1.9 t-20 68.18 88.21 0.11 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.73 0.776 . . . . 1.5600000000000001 110.629 -175.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.63 146.8 34.93 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 114.689 -1.141 . . . . 1.6799999999999999 109.007 173.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -38.26 93.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.999 3.132 . . . . 1.26 112.509 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.605 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 3.0 Cg_exo -76.84 -179.56 5.51 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.198 2.598 . . . . 0.76000000000000001 113.333 -169.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.06 -124.42 0.89 Allowed Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.151 -1.18 . . . . 0.76000000000000001 110.151 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 58' ' ' SER . 51.6 t-20 -97.5 107.4 19.9 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.129 -0.693 . . . . 2.04 109.129 172.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 58' ' ' SER . 68.4 m-85 -102.16 107.34 18.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.468 0.651 . . . . 0.75 109.524 174.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -97.85 126.79 43.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.017 -0.992 . . . . 0.82999999999999996 110.534 -175.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 138' ' ' THR . 0.1 OUTLIER -135.01 107.14 7.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.548 0.689 . . . . 0.51000000000000001 109.927 176.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 11.9 m -94.02 139.76 30.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.456 -0.793 . . . . 0.58999999999999997 110.299 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 44' ' ' ALA . 95.4 mt -124.96 126.14 45.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.909 0.385 . . . . 1.27 110.569 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 m -101.18 117.0 34.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.216 -0.447 . . . . 0.69999999999999996 110.219 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.27 147.71 47.79 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.748 -0.739 . . . . 0.80000000000000004 112.576 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.04 179.73 39.71 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.783 -0.722 . . . . 0.53000000000000003 112.214 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.619 ' HB3' ' NE ' ' A' ' 38' ' ' ARG . 48.6 p90 -102.63 174.16 6.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.051 0.453 . . . . 0.89000000000000001 110.325 177.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.724 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.8 OUTLIER -132.69 146.53 51.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.413 -0.812 . . . . 0.56000000000000005 109.101 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -118.85 141.28 48.78 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.069 0.461 . . . . 1.4199999999999999 111.208 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.537 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 7.0 tptm 71.97 -145.07 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.676 -1.147 . . . . 3.4700000000000002 111.265 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 126' ' ' LYS . 4.9 t70 -146.98 124.42 11.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.615 -0.266 . . . . 2.0800000000000001 111.496 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.589 ' N ' ' HZ2' ' A' ' 121' ' ' TRP . 0.5 OUTLIER 53.64 -5.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.132 1.773 . . . . 2.4700000000000002 115.542 176.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.608 ' HE3' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -79.03 -3.38 44.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 1.96 110.216 177.466 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.724 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 33.6 tt0 69.08 71.61 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.792 -1.095 . . . . 2.02 110.644 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.608 ' HA3' ' HE3' ' A' ' 126' ' ' LYS . . . -106.97 43.01 1.78 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.698 -0.763 . . . . 0.77000000000000002 112.134 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -78.19 130.08 35.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.15 0.5 . . . . 1.21 110.857 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 17.6 m -121.56 118.91 29.49 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.215 -0.448 . . . . 1.47 110.559 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 130' ' ' THR . 25.0 Cg_exo -63.93 123.37 11.83 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.964 2.443 . . . . 0.92000000000000004 112.27 177.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.01 94.15 1.5 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.967 -0.56 . . . . 1.52 110.193 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 145.58 -145.95 15.64 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.284 -0.726 . . . . 1.1699999999999999 111.284 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.532 HG21 ' NH1' ' A' ' 6' ' ' ARG . 38.3 p -110.12 158.08 18.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.989 0.423 . . . . 2.4700000000000002 111.398 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.0 m -99.93 100.32 11.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.824 -0.626 . . . . 1.8200000000000001 109.786 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.58 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -93.79 160.76 24.44 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.847 -0.692 . . . . 0.67000000000000004 111.775 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.1 m -126.82 109.51 12.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.026 0.413 . . . . 0.57999999999999996 111.311 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.602 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 3.7 m -82.23 116.43 21.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.634 -0.876 . . . . 0.52000000000000002 108.634 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -112.1 108.83 18.24 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.27 0.557 . . . . 2.1800000000000002 110.544 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.557 HD23 HD13 ' A' ' 56' ' ' LEU . 15.2 tp -96.56 109.16 21.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.031 -0.986 . . . . 0.63 109.072 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 7.0 m -121.52 144.47 48.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.529 -0.759 . . . . 0.57999999999999996 110.947 -173.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.605 ' HB ' ' HB2' ' A' ' 109' ' ' PRO . 13.0 p -83.16 141.73 14.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.433 -0.581 . . . . 1.74 109.433 172.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.243 0.749 0 CA-C-O 118.426 -0.797 . . . . 2.5800000000000001 109.723 178.923 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 110.246 -0.279 . . . . 5.7300000000000004 110.246 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.405 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 14.9 pt-20 44.88 -151.34 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.487 1.117 . . . . 3.0800000000000001 112.466 175.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 120' ' ' TYR . 43.5 t -111.37 87.22 2.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.656 -0.498 . . . . 1.4299999999999999 109.656 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.414 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 9.9 tt0 -103.61 111.84 24.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.192 -0.458 . . . . 2.29 110.766 -177.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.703 HG21 HG13 ' A' ' 40' ' ' VAL . 38.5 t -107.49 125.32 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.118 -0.492 . . . . 1.51 110.701 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.594 ' HG2' ' HB3' ' A' ' 31' ' ' GLN . 11.1 ptp180 -92.18 142.54 27.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.036 0.446 . . . . 3.5699999999999998 110.684 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.7 t -120.53 115.43 47.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.781 -0.822 . . . . 1.26 108.781 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.38 126.6 11.5 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.554 -0.831 . . . . 0.95999999999999996 112.38 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -68.34 104.04 1.77 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.574 -0.528 . . . . 2.1800000000000002 109.574 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' A' ' 28' ' ' VAL . 72.8 mt -105.37 152.43 22.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.95 -0.568 . . . . 1.4099999999999999 110.739 -176.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 m -133.09 114.42 13.89 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.035 -0.728 . . . . 1.03 109.035 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.422 HG11 HG22 ' A' ' 25' ' ' ILE . 41.3 t -118.16 140.32 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.386 -0.37 . . . . 1.45 110.313 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.99 103.21 11.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.284 -0.416 . . . . 0.58999999999999997 110.028 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -165.02 176.04 8.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.433 -0.58 . . . . 3.4199999999999999 109.433 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.515 HG22 HG23 ' A' ' 142' ' ' VAL . 31.9 p -96.43 163.34 13.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.613 -0.267 . . . . 0.63 110.911 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.519 ' HD2' ' H ' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -86.98 -3.42 59.09 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.91 -0.774 . . . . 3.1400000000000001 108.91 176.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' N ' ' HB2' ' A' ' 106' ' ' ASN . . . -79.77 -28.22 51.59 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.79 -0.924 . . . . 0.75 110.79 173.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.89 -39.08 87.92 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.624 -0.88 . . . . 2.1699999999999999 108.624 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 100' ' ' VAL . 62.8 mt -63.95 113.33 3.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.912 -1.04 . . . . 1.6100000000000001 109.746 171.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 m -130.4 85.28 2.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.562 0.22 . . . . 1.6499999999999999 110.536 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 7.9 m-20 63.48 -74.66 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.664 -0.698 . . . . 1.8300000000000001 111.854 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.13 81.71 1.87 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.191 0.52 . . . . 0.81999999999999995 110.671 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.18 100.27 4.2 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.544 -0.753 . . . . 0.79000000000000004 109.89 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.53 ' HD3' ' CE2' ' A' ' 99' ' ' TYR . 59.5 Cg_endo -72.1 105.51 1.85 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.816 2.344 . . . . 1.1200000000000001 112.847 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.422 HG22 HG11 ' A' ' 12' ' ' VAL . 49.4 mm -96.3 -26.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.181 -0.463 . . . . 2.5800000000000001 110.734 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.75 54.65 0.62 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.897 -1.144 . . . . 0.73999999999999999 113.689 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 12.1 Cg_endo -57.03 114.1 1.77 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.281 1.987 . . . . 0.67000000000000004 112.064 170.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.468 ' HA ' HD11 ' A' ' 10' ' ' LEU . 45.9 t -87.75 135.82 24.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.881 -0.6 . . . . 1.1799999999999999 110.433 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.95 102.24 4.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.603 0.716 . . . . 1.6399999999999999 110.133 174.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.899 HG21 HG12 ' A' ' 96' ' ' ILE . 6.7 t -94.08 141.96 14.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.862 -1.063 . . . . 1.01 111.879 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.594 ' HB3' ' HG2' ' A' ' 6' ' ' ARG . 31.4 tt0 -146.87 117.41 7.5 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.651 -1.159 . . . . 2.48 109.079 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.437 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -110.46 105.73 14.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.287 -0.415 . . . . 0.69999999999999996 110.144 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.4 tp -77.61 112.76 14.76 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.508 -0.553 . . . . 1.9399999999999999 109.508 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 2' ' ' GLU . . . 88.64 -121.97 6.2 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.704 -0.76 . . . . 1.8100000000000001 111.773 -177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.437 ' SG ' ' HB1' ' A' ' 32' ' ' ALA . 66.7 m 65.13 11.6 7.3 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 122.598 0.359 . . . . 1.8799999999999999 111.707 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.661 ' HA ' ' HA2' ' A' ' 90' ' ' GLY . 19.3 m120 -63.36 -11.44 22.51 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.631 0.604 . . . . 2.1400000000000001 112.631 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.787 ' HA ' ' CG1' ' A' ' 89' ' ' VAL . . . -144.62 60.95 1.33 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.5 -0.556 . . . . 0.93999999999999995 109.5 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 38' ' ' ARG . 0.8 OUTLIER -170.07 159.96 7.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.361 -0.836 . . . . 4.6399999999999997 109.68 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -94.22 143.38 26.43 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.116 -0.698 . . . . 1.75 109.116 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.703 HG13 HG21 ' A' ' 5' ' ' VAL . 71.8 t -97.99 122.05 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.424 -0.584 . . . . 0.54000000000000004 109.424 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 84' ' ' PHE . . . -122.48 141.33 51.75 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 123.368 0.418 . . . . 0.35999999999999999 111.099 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.445 ' CD1' HG21 ' A' ' 96' ' ' ILE . 31.3 mt -102.72 126.21 49.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.194 -0.669 . . . . 0.83999999999999997 109.194 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.8 ' HE2' ' HB2' ' A' ' 129' ' ' PHE . 6.3 mptt -119.2 152.12 37.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.571 -0.529 . . . . 1.9299999999999999 109.571 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -96.22 153.62 17.7 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.803 -0.443 . . . . 0.40999999999999998 109.803 173.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.712 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 31.2 t70 -82.44 164.79 20.74 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.719 -0.845 . . . . 0.70999999999999996 108.719 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -56.17 -18.48 10.24 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.336 0.588 . . . . 1.3999999999999999 110.677 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.77 -38.8 72.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.271 -0.877 . . . . 2.2200000000000002 111.526 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 27.0 p-10 -139.57 22.31 2.52 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.723 0.268 . . . . 1.3500000000000001 111.723 -176.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.67 ' HE1' ' HA2' ' A' ' 82' ' ' GLY . 60.0 t80 -123.48 102.39 7.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.435 -0.58 . . . . 0.56000000000000005 109.435 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -103.3 105.8 16.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 2.4100000000000001 110.385 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 67.19 -56.43 0.44 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.107 0.879 . . . . 3.4300000000000002 112.04 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -175.58 35.08 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.006 -0.838 . . . . 0.56000000000000005 111.006 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 81' ' ' ASN . 34.7 mmtp -135.07 135.57 41.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.001 -0.74 . . . . 2.1200000000000001 109.001 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -110.72 142.33 42.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.611 0.719 . . . . 0.56000000000000005 111.965 175.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 64' ' ' LYS . 44.1 p90 -151.32 -177.0 5.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.974 -1.012 . . . . 0.58999999999999997 110.014 -176.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.887 HD22 HD22 ' A' ' 114' ' ' LEU . 13.8 mt -99.53 123.81 44.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.579 -0.897 . . . . 1.53 108.579 172.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 113' ' ' THR . 9.0 tp -106.81 124.6 62.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.472 0.653 . . . . 0.62 111.035 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.5 t -68.88 125.08 25.49 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.275 -1.009 . . . . 1.4399999999999999 108.275 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -57.8 -26.2 61.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.119 0.415 . . . . 2.3100000000000001 112.119 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -84.26 -1.64 55.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.61 -0.268 . . . . 3.0899999999999999 111.368 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 57.99 89.21 0.05 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.167 0.587 . . . . 2.6200000000000001 111.244 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -155.79 -38.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 4.6600000000000001 111.055 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.74 144.71 37.6 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.415 -0.357 . . . . 2.5099999999999998 110.35 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.636 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . 2.4 pptp? -146.7 145.77 30.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.971 -0.559 . . . . 2.0699999999999998 110.134 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.63 HD12 HG23 ' A' ' 100' ' ' VAL . 1.3 pt? -138.03 132.13 31.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.139 -0.482 . . . . 1.98 110.415 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -75.64 128.61 35.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.75 110.129 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.555 ' HB ' HG23 ' A' ' 98' ' ' ILE . 15.9 m -118.33 136.89 54.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.862 -0.608 . . . . 0.72999999999999998 110.544 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.51 ' HB3' ' HE ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -96.5 110.65 22.99 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.707 -0.679 . . . . 1.8100000000000001 109.356 178.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.429 HG23 HG12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -79.99 102.09 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.928 -0.767 . . . . 0.81000000000000005 108.928 174.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.558 ' HG2' ' CZ ' ' A' ' 84' ' ' PHE . 89.3 mtt180 -122.99 140.47 33.5 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.244 -0.434 . . . . 3.79 110.181 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.798 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 1.7 Cg_endo -48.3 132.93 24.58 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.942 2.428 . . . . 0.58999999999999997 111.927 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.4 ttt -63.22 -49.96 72.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.408 -0.36 . . . . 1.71 110.275 -177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -177.79 105.95 0.05 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.121 -0.49 . . . . 1.9199999999999999 110.566 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 1.1 m-80 -161.81 -62.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 1.8899999999999999 111.198 -177.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.8 t -154.69 163.68 39.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.915 -0.402 . . . . 1.7 109.915 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.9 127.58 32.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.069 0.461 . . . . 0.93999999999999995 111.252 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.664 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 11.1 m0 -112.28 150.75 30.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.651 -0.704 . . . . 0.5 110.27 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.6 m -83.21 125.1 31.2 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.142 -0.688 . . . . 0.51000000000000001 109.142 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -100.47 122.36 43.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.798 0.808 . . . . 0.58999999999999997 112.54 -171.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -135.42 159.71 40.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.725 -1.213 . . . . 1.7 107.725 167.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 11.4 m120 -82.93 -4.38 58.12 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.276 -0.57 . . . . 1.3899999999999999 110.833 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.67 ' HA2' ' HE1' ' A' ' 49' ' ' PHE . . . -100.48 -41.33 2.77 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.203 -0.998 . . . . 0.65000000000000002 111.885 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.68 155.4 30.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.963 -0.384 . . . . 1.1599999999999999 109.963 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -137.99 109.85 7.17 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.291 -1.003 . . . . 0.35999999999999999 108.291 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 13.5 p90 -140.09 143.89 36.52 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.15 0.281 . . . . 0.58999999999999997 111.498 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -77.91 137.5 38.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 120.328 -0.549 . . . . 1.3899999999999999 109.542 177.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -63.68 -24.47 67.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.734 -0.667 . . . . 2.1200000000000001 110.204 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 4.6 m-20 -73.92 147.14 43.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.519 -0.764 . . . . 2.1000000000000001 110.671 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.787 ' CG1' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -94.84 143.0 12.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.666 -0.864 . . . . 1.05 108.666 168.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.661 ' HA2' ' HA ' ' A' ' 36' ' ' ASN . . . 131.77 -175.59 19.64 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.411 -0.9 . . . . 0.46000000000000002 111.636 -177.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m -72.39 -178.73 2.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.976 -0.379 . . . . 1.1699999999999999 109.976 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.798 ' CZ2' ' HB3' ' A' ' 71' ' ' PRO . 21.1 t90 -157.38 -42.54 0.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.733 -0.212 . . . . 0.51000000000000001 110.575 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.709 ' O ' ' HB ' ' A' ' 30' ' ' VAL . . . 50.84 -120.35 8.92 Favored Glycine 0 C--O 1.21 -1.366 0 N-CA-C 111.292 -0.723 . . . . 1.25 111.292 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.45 -151.68 43.68 Favored Glycine 0 C--N 1.318 -0.434 0 C-N-CA 121.142 -0.552 . . . . 0.71999999999999997 114.225 163.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.534 ' HA ' HG23 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -147.84 133.51 18.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.085 -0.557 . . . . 0.59999999999999998 110.427 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.899 HG12 HG21 ' A' ' 30' ' ' VAL . 6.8 mm -107.52 129.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.357 -0.609 . . . . 1.6299999999999999 109.357 177.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 27' ' ' PRO . . . -100.82 149.2 18.45 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.712 -0.756 . . . . 0.45000000000000001 111.704 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.555 HG23 ' HB ' ' A' ' 67' ' ' VAL . 71.3 mt -99.58 114.45 37.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 120.897 0.38 . . . . 0.82999999999999996 110.567 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CE2' ' HD3' ' A' ' 24' ' ' PRO . 8.6 m-85 -115.22 131.97 56.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 1.28 108.818 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.63 HG23 HD12 ' A' ' 65' ' ' LEU . 13.8 p -71.34 134.48 29.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.799 0.333 . . . . 1.1399999999999999 110.558 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -74.89 91.47 2.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.059 0.457 . . . . 1.02 110.902 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.13 13.34 62.15 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.132 -0.556 . . . . 1.53 113.918 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.585 ' HA ' HG11 ' A' ' 100' ' ' VAL . 64.9 tt0 62.22 113.71 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.709 0.766 . . . . 2.1099999999999999 112.367 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.496 ' H ' HG21 ' A' ' 100' ' ' VAL . 7.5 tp60 -76.8 -27.29 55.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.479 -0.782 . . . . 2.6200000000000001 109.645 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.1 m 65.42 20.52 11.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.126 -0.943 . . . . 2.4300000000000002 110.195 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.541 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 7.6 t30 60.79 87.94 0.09 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.905 -1.043 . . . . 1.5600000000000001 112.358 173.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.664 HG22 ' HD2' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -92.09 143.55 27.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.295 -1.002 . . . . 1.6799999999999999 108.295 174.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.664 ' HD2' HG22 ' A' ' 107' ' ' THR . 94.2 Cg_exo -20.3 88.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.348 1 C-N-CA 125.617 4.212 . . . . 1.26 114.818 -175.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.477 ' HG2' HG21 ' A' ' 142' ' ' VAL . 9.9 Cg_endo -92.2 -154.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.687 2.925 . . . . 0.76000000000000001 114.354 -171.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.42 -131.08 1.85 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.364 -1.895 . . . . 0.76000000000000001 108.364 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -97.22 123.43 41.0 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.101 -0.703 . . . . 2.04 109.101 170.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -105.84 128.45 53.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.002 0.43 . . . . 0.75 109.916 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 57' ' ' ILE . 91.4 m -106.38 134.22 49.86 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.334 -0.848 . . . . 0.82999999999999996 109.405 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.887 HD22 HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -138.91 89.55 2.37 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.487 0.66 . . . . 0.51000000000000001 109.358 175.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' ' 45' ' ' ASP . 7.4 m -78.39 116.05 18.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.124 -0.944 . . . . 0.58999999999999997 110.607 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 97.8 mt -105.11 136.41 44.66 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.04 0.448 . . . . 1.27 110.939 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.5 m -110.17 115.02 28.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.147 -0.478 . . . . 0.69999999999999996 110.441 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.16 167.88 47.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.702 -0.761 . . . . 0.80000000000000004 112.103 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 132' ' ' SER . . . 145.35 -175.15 25.07 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.557 -0.83 . . . . 0.53000000000000003 112.096 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 52.8 p90 -97.7 -176.52 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.358 0.599 . . . . 0.89000000000000001 111.403 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.616 ' CZ3' ' HA ' ' A' ' 127' ' ' GLN . 0.5 OUTLIER -150.33 149.72 30.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.989 -1.005 . . . . 0.56000000000000005 108.687 178.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.42 144.48 49.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.893 0.378 . . . . 1.4199999999999999 111.578 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.639 ' HB2' ' HE2' ' A' ' 126' ' ' LYS . 22.9 mtpp 65.3 -143.71 0.22 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.067 0.947 . . . . 3.4700000000000002 111.807 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 126' ' ' LYS . 6.0 p-10 -149.46 124.39 9.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.075 0.464 . . . . 2.0800000000000001 112.239 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.597 ' H ' ' HZ2' ' A' ' 121' ' ' TRP . 7.7 t30 63.52 -18.0 0.06 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.698 1.199 . . . . 2.4700000000000002 113.676 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.639 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -71.36 -4.07 24.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.796 0.331 . . . . 1.96 110.82 178.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.616 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 8.9 tt0 70.08 77.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.39 -0.823 . . . . 2.02 110.923 -177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.431 ' CA ' ' HE3' ' A' ' 126' ' ' LYS . . . -107.88 32.22 7.27 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.442 -0.885 . . . . 0.77000000000000002 111.431 173.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.8 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 3.9 p90 -74.08 144.1 45.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.014 0.435 . . . . 1.21 110.661 -175.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 28.9 m -143.61 134.62 12.48 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.303 -0.408 . . . . 1.47 110.169 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.92 126.29 11.16 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.785 2.323 . . . . 0.92000000000000004 111.782 175.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.432 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 17.2 m -152.84 113.46 4.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.319 -0.4 . . . . 1.52 110.122 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.414 ' HA2' ' HG3' ' A' ' 4' ' ' GLN . . . 125.1 -105.21 0.82 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.088 -0.577 . . . . 1.1699999999999999 111.74 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.9 t -150.34 153.45 36.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.836 0.351 . . . . 2.4700000000000002 110.314 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.9 m -93.55 97.06 10.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.026 -0.534 . . . . 1.8200000000000001 109.775 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -83.99 132.29 10.98 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.954 -0.641 . . . . 0.67000000000000004 112.285 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 m -102.72 108.77 20.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.683 0.278 . . . . 0.57999999999999996 110.316 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.674 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 24.0 m -86.25 117.53 25.12 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.754 -0.832 . . . . 0.52000000000000002 108.754 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -104.08 127.31 51.65 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.879 -0.6 . . . . 2.1800000000000002 109.984 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.655 HD23 HD13 ' A' ' 56' ' ' LEU . 18.6 tp -125.58 102.25 7.28 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.542 -0.754 . . . . 0.63 110.829 -176.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.5 m -99.06 142.75 30.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.792 -0.64 . . . . 0.57999999999999996 109.966 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 15' ' ' THR . 7.3 p -93.27 104.82 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.689 0.757 . . . . 1.74 111.323 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.06 -0.971 . . . . 2.5800000000000001 109.352 176.219 . . . . . . . . 0 0 . 1 stop_ save_